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What Is a TIP?
Treatment Improvement Protocols (TIPs), developed by the Center for
Substance Abuse Treatment (CSAT), part of the Substance Abuse and
Mental Health Services Administration (SAMHSA) within the U.S.
Department of Health and Human Services (DHHS), are best-practice
guidelines for the treatment of substance use disorders. CSAT draws on
the experience and knowledge of clinical, research, and administrative
experts to produce the TIPs, which are distributed to a growing number
of facilities and individuals across the country. The audience for the
TIPs is expanding beyond public and private treatment facilities as alco-
hol and other drug disorders are increasingly recognized as a major
problem.
CSAT’s Knowledge Application Program (KAP) Expert Panel, a distin-
guished group of experts on substance use disorders and professionals in
such related fields as primary care, mental health, and social services,
works with the State Alcohol and Drug Abuse Directors to generate top-
ics for the TIPs. Topics are based on the field’s current needs for infor-
mation and guidance.
After selecting a topic, CSAT invites staff from pertinent Federal agen-
cies and national organizations to a Resource Panel that recommends
specific areas of focus as well as resources that should be considered in
developing the content for the TIP. Then recommendations are commu-
nicated to a Consensus Panel composed of experts on the topic who have
been nominated by their peers. This Panel participates in a series of dis-
cussions; the information and recommendations on which they reach
consensus form the foundation of the TIP. The members of each
Consensus Panel represent substance abuse treatment programs, hospi-
tals, community health centers, counseling programs, criminal justice
and child welfare agencies, and private practitioners. A Panel Chair (or
Co-Chairs) ensures that the guidelines mirror the results of the group’s
collaboration.
A large and diverse group of experts closely reviews the draft document.
Once the changes recommended by these field reviewers have been
incorporated, the TIP is prepared for publication, in print and online.
ix
xThe TIPs can be accessed via the Internet at
the URL: www.kap.samhsa.gov. The move to
electronic media also means that the TIPs can
be updated more easily so that they continue to
provide the field with state-of-the-art informa-
tion.
While each TIP strives to include an evidence
base for the practices it recommends, CSAT
recognizes that the field of substance abuse
treatment is evolving, and research frequently
lags behind the innovations pioneered in the
field. A major goal of each TIP is to convey
“front-line” information quickly but responsi-
bly. For this reason, recommendations prof-
fered in the TIP are attributed to either
Panelists’ clinical experience or the literature.
If research supports a particular approach,
citations are provided.
This TIP, Substance Abuse Treatment for
Persons With Co-Occurring Disorders, revises
TIP 9, Assessment and Treatment of Patients
With Coexisting Mental Illness and Alcohol and
Other Drug Abuse. The revised TIP provides
information about new developments in the
rapidly growing field of co-occurring substance
use and mental disorders and captures the
state-of-the-art in the treatment of people with
co-occurring disorders. The TIP focuses on
what the substance abuse treatment clinician
needs to know and provides that information in
an accessible manner. The TIP synthesizes
knowledge and grounds it in the practical reali-
ties of clinical cases and real situations so the
reader will come away with increased knowl-
edge, encouragement, and resourcefulness in
working with clients with co-occurring disor-
ders. 
What Is a TIP?
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Foreword
The Treatment Improvement Protocol (TIP) series fulfills SAMHSA’s
mission of building resilience and facilitating recovery for people with or
at risk for mental or substance use disorders by providing best-practices
guidance to clinicians, program administrators, and payors to improve
the quality and effectiveness of service delivery, and, thereby promote
recovery. TIPs are the result of careful consideration of all relevant clin-
ical and health services research findings, demonstration experience,
and implementation requirements. A panel of non-Federal clinical
researchers, clinicians, program administrators, and client advocates
debates and discusses its particular areas of expertise until it reaches a
consensus on best practices. This panel’s work is then reviewed and cri-
tiqued by field reviewers.
The talent, dedication, and hard work that TIPs panelists and reviewers
bring to this highly participatory process have helped to bridge the gap
between the promise of research and the needs of practicing clinicians
and administrators to serve people who abuse substances in the most sci-
entifically sound and effective ways. We are grateful to all who have
joined with us to contribute to advances in the substance abuse treat-
ment field.
Charles G. Curie, M.A., A.C.S.W.
Administrator
Substance Abuse and Mental Health Services Administration
H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM
Director
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
xv

Executive Summary
For purposes of this TIP, co-occurring disorders refers to co-occurring
substance use (abuse or dependence) and mental disorders. Clients said
to have co-occurring disorders have one or more disorders relating to
the use of alcohol and/or other drugs of abuse as well as one or more
mental disorders. A diagnosis of co-occurring disorders (COD) occurs
when at least one disorder of each type can be established independent
of the other and is not simply a cluster of symptoms resulting from the
one disorder. Many may think of the typical person with COD as having
a severe mental disorder combined with a severe substance use disorder,
such as schizophrenia combined with alcohol dependence. However,
counselors working in addiction agencies are more likely to see persons
with severe addiction combined with mild- to moderate-severity mental
disorders; an example would be a person with alcohol dependence com-
bined with a depressive disorder or an anxiety disorder. Efforts to pro-
vide treatment that will meet the unique needs of people with COD have
gained momentum over the past 2 decades in both substance abuse treat-
ment and mental health services settings.
Throughout this TIP, the term “substance abuse” refers to both sub-
stance abuse and substance dependence (as defined by the Diagnostic
and Statistical Manual of Mental Disorders, 4th edition, Text Revision
[DSM-IV-TR] [American Psychiatric Association 2000]) and encompass-
es the use of both alcohol and other psychoactive substances. Though
unfortunately ambiguous, this term was chosen partly because the lay
public, politicians, and many substance abuse treatment professionals
commonly use “substance abuse” to describe any excessive use of any
addictive substance. Readers should attend to the context in which the
term occurs to determine the range of possible meanings; in most cases,
however, the term refers to all substance use disorders described by the
DSM-IV. It should be noted, however, that although nicotine dependency
is recognized as a disorder in DSM-IV, an important difference between
tobacco addiction and other addictions is that tobacco’s chief effects are
medical rather than behavioral, and, as such, it is not treated as sub-
stance abuse in this TIP. Nonetheless, because of the high numbers of
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the COD population addicted to nicotine as
well as the devastating health consequences of
tobacco use, nicotine dependency is included as
an important cross-cutting issue for people with
substance use disorders and mental illness. 
Terms for mental disorders may have some-
what different lay and professional definitions.
For example, while most people might become
depressed or anxious briefly around a life
stress, this does not mean that they have a
“mental disorder” as is used in this text.
Because the DSM-IV is the national standard
for definitions of mental disorders, it is used in
this TIP. In certain States, however, only cer-
tain trained professionals “officially” can diag-
nose either a mental or substance use disorder.
In the late 1970s, practitioners began to recog-
nize that the presence of substance abuse in
combination with mental disorders had pro-
found and troubling implications for treatment
outcomes. This growing awareness has culmi-
nated in today’s emphasis on the need to recog-
nize and address the interrelationship of these
disorders through new approaches and appro-
priate adaptations of traditional treatment. In
the decades from the 1970s to the present, sub-
stance abuse treatment programs typically
reported that 50 to 75 percent of their clients
had COD, while corresponding mental-health
settings cited proportions of 20 to 50 percent.
During the same period of time, a body of
knowledge has evolved that clarifies the treat-
ment challenges presented by the combination
of substance use and mental disorders and illu-
minates the likelihood of poorer outcomes for
such clients in the absence of targeted treat-
ment efforts. 
The treatment and research communities have
not been passive in the face of this challenge.
Innovative strategies have emerged and been
tested, and the treatment population has been
defined more precisely. Findings have shown
that many substance abuse treatment clients
with less serious mental disorders do well with
traditional substance abuse treatment methods,
while those with more serious mental disorders
need intervention modifications and additions
to enhance treatment effectiveness and, in most
instances, to result in successful treatment out-
comes.
The Quadrants of Care, developed by the
National Association of State Alcohol and Drug
Abuse Directors (NASADAD) and the National
Association of State Mental Health Program
Directors (NASMHPD), is a useful classifica-
tion of service coordination by severity in the
context of substance abuse and mental health
settings. The NASADAD–NASMHPD four-
quadrant framework provides a structure for
fostering consultation, collaboration, and inte-
gration among drug abuse and mental health
treatment systems and providers to deliver
appropriate care to every client with COD.
Although the material in this TIP relates to all
four quadrants, the TIP is designed primarily
to provide guidance for addiction counselors
working in quadrant II and III settings. The
four categories of COD are
• Quadrant I: Less severe mental disorder/less
severe substance disorder
• Quadrant II: More severe mental
disorder/less severe substance disorder
• Quadrant III: Less severe mental
disorder/more severe substance disorder
• Quadrant IV: More severe mental disor-
der/more severe substance disorder
The American Society of Addiction Medicine
(ASAM) also has developed a client placement
system to facilitate effective treatment. The
ASAM Patient Placement Criteria (ASAM
PPC-2R) describe three types of substance
abuse programs for people with COD: addic-
tion only services, dual diagnosis capable, and
dual diagnosis enhanced. This TIP employs a
related system that classifies both substance
abuse and mental health programs as basic,
intermediate, and advanced in terms of their
progress toward providing more integrated
care. Further, counselors or other readers who
use this TIP will have beginning, intermediate,
or advanced backgrounds and experience in
COD, and, therefore, different needs. The TIP
is structured to meet the needs of addiction
counselors with basic backgrounds as well as
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the differing needs of those with intermediate
and advanced backgrounds. 
The integration of substance abuse treatment
and mental health services for persons with
COD has become a major treatment initiative.
Integrated treatment coordinates substance
abuse and mental health interventions to treat
the whole person more effectively; the term
refers broadly to any mechanism by which
treatment interventions for COD are combined
within a primary treatment relationship or ser-
vice setting. As such, integrated treatment
reflects the longstanding concern within sub-
stance abuse treatment programs for treating
the whole person, and recognizes the impor-
tance of ensuring that entry into any one sys-
tem can provide access to all needed systems. 
As developed in the substance abuse treatment
field, the recovery perspective acknowledges
that recovery is a long-term process of internal
change in which progress occurs in stages, an
understanding critical to treatment planning.
In preparing a treatment plan, the clinician
should recognize that treatment takes place in
different settings (e.g., residential and outpa-
tient) over time, and that much of the recovery
process typically occurs outside of, or follow-
ing, treatment (e.g., through participation in
mutual self-help groups). Practitioners often
divide treatment into phases, usually including
engagement, stabilization, primary treatment,
and continuing care (also known as aftercare).
Use of these phases enables the clinician
(whether within the substance abuse or mental
health treatment system) to apply coherent,
stepwise approaches in developing and using
treatment protocols. 
This TIP identifies key elements of program-
ming for COD in substance abuse treatment
agencies; the paragraphs that follow provide an
outline of these essential elements. While the
needs and functioning of substance abuse treat-
ment are accentuated, the elements described
have relevance for mental health agencies and
other service systems that seek to coordinate
mental health and substance abuse services for
their clients who need both. 
Treatment planning begins with screening and
assessment. The screening process is designed
to identify those clients seeking substance abuse
treatment who show signs of mental health
problems that warrant further attention. Easy-
to-use screening instruments will accomplish
this purpose and can be administered by coun-
seling staff with minimal preparation.
A basic assessment consists of gathering infor-
mation that will provide evidence of COD and
mental and substance use disorder diagnoses;
assess problem areas, disabilities, and
strengths; assess readiness for change; and
gather data to guide decisions regarding the
necessary level of care. Intake information con-
sists of the following categories and items:
• Background is described by obtaining data
on family; relevant cultural, linguistic, gen-
der, and sexual orientation issues; trauma
history; marital status; legal involvement
and financial situation; health; education;
housing status; strengths and resources; and
employment. 
• Substance use is established by age of first
use, primary drugs used, patterns of drug
use (including information related to diag-
nostic criteria for abuse or dependence),
and past or current treatment. It is impor-
tant to identify periods of abstinence of 30
days or longer to isolate the mental health
symptoms, treatment, and disability
expressed during these abstinent periods.
• Psychiatric problems are elaborated by
determining both family and client histories
of psychiatric problems (including diagnosis,
hospitalization, and other treatments), cur-
rent diagnoses and symptoms, and medica-
tions and medication adherence. It is impor-
tant to identify past periods of mental health
stability, determine past successful treat-
ment for mental disorders, and discover the
nature of substance use disorder issues aris-
ing during these stable periods. Identifica-
tion of any current treatment providers
enables vitally important information shar-
ing and cooperation.
• Integrated assessment identifies the interac-
tions among the symptoms of mental disor-
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ders and substance use, as well as the inter-
actions of the symptoms of substance use
disorders and mental health symptoms.
Integrated assessment also considers how all
the interactions relate to treatment experi-
ences, especially stages of change, periods of
stability, and periods of crisis.
Diagnosis is an important part of the assess-
ment process. The TIP provides a discussion of
mental disorders selected from the DSM-IV-TR
and the diagnostic criteria for each disorder.
Key information about substance abuse and
particular mental disorders is distilled, and
appropriate counselor actions and approaches
are recommended for the substance abuse
treatment client who manifests symptoms of
one or more of these mental disorders. The
consensus panel recognizes that addiction
counselors are not expected to diagnose mental
disorders. The limited aims of providing this
material are to increase substance abuse treat-
ment counselors’ familiarity with mental disor-
der terminology and criteria and to provide
advice on how to proceed with clients who
demonstrate the symptoms of these disorders.
The use of proper medication is an essential
program element, helping clients to stabilize
and control their symptoms, thereby increasing
their receptivity to other treatment. Pharmaco-
logical advances over the past few decades have
produced more effective psychiatric medica-
tions with fewer side effects. With the support
of better medication regimens, many people
with serious mental disorders who once would
have been institutionalized, or who would have
been too unstable for substance abuse treat-
ment, have been able to participate in treat-
ment, make progress, and lead more
productive lives. To meet the needs of this pop-
ulation, the substance abuse treatment coun-
selor needs better understanding of the signs
and symptoms of mental disorders and access
to medical support. The counselor’s role is first
to provide the prescribing physician with an
accurate description of the client’s behavior
and symptoms, which ensures that proper med-
ication is chosen, and then to assist the client in
adhering to the medication regimen. The sub-
stance abuse counselor and program can, and
often do, employ peers or the peer community
to help and support individual efforts to follow
prescription instructions.
Several other features complete the list of
essential components of treatment for COD,
including enhanced staffing that incorporates
professional mental health specialists, psychi-
atric consultation, or an onsite psychiatrist 
(for assessment, diagnosis, and medication);
psychoeducational classes (e.g., mental disor-
ders and substance abuse, relapse prevention)
that provide increased awareness about the 
disorders and their symptoms; onsite double
trouble groups to discuss the interrelated prob-
lems of mental and substance use disorders,
which will help to identify triggers for relapse;
and participation in community-based dual
recovery mutual self-help groups, which afford
an understanding, supportive environment and
a safe forum for discussing medication, mental
health, and substance abuse issues.
Treatment providers are advised to view clients
with COD and their treatment in the context of
their culture, ethnicity, geographic area,
socioeconomic status, gender, age, sexual orien-
tation, religion, spirituality, and any physical
or cognitive disabilities. The provider especial-
ly needs to appreciate the distinctive ways in
which a client’s culture may view disease or dis-
order, including COD. Using a model of disease
familiar and culturally relevant to the client
can help communication and facilitate treat-
ment.
In addition to the essential elements described
above, several well-developed and successful
strategies from the substance abuse field are
being adapted for COD. The TIP presents
those strategies (briefly noted in the following
paragraphs) found to have promise for effec-
tive treatment of clients with COD. 
Motivational Interviewing (MI) is a client-cen-
tered, directive method for enhancing intrinsic
motivation to change (by exploring and resolv-
ing ambivalence) that has proven effective in
helping clients clarify goals and commit to
change. MI has been modified to meet the spe-
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cial circumstances of clients with COD, with
promising results from initial studies to
improve client engagement in treatment.
Contingency Management (CM) maintains that
the form or frequency of behavior can be
altered through the introduction of a planned
and organized system of positive and negative
consequences. It should be noted that many
counselors and programs employ CM principles
informally by rewarding or praising particular
behaviors and accomplishments. Similarly, CM
principles are applied formally (but not neces-
sarily identified as such) whenever the attain-
ment of a level or privilege is contingent on
meeting certain behavioral criteria.
Demonstration of the efficacy of CM principles
for clients with COD is still needed. 
Cognitive–Behavioral Therapy (CBT) is a gen-
eral therapeutic approach that seeks to modify
negative or self-defeating thoughts and behav-
iors, and is aimed at achieving change in both.
CBT uses the client’s cognitive distortions as
the basis for prescribing activities to promote
change. Distortions in thinking are likely to be
more severe with people with COD who are, by
definition, in need of increased coping skills.
CBT has proven useful in developing these cop-
ing skills in a variety of clients with COD. 
Relapse Prevention (RP) has proven to be a
particularly useful substance abuse treatment
strategy and it appears adaptable to clients
with COD. The goal of RP is to develop the
client’s ability to recognize cues and to inter-
vene in the relapse process, so lapses occur less
frequently and with less severity. RP endeavors
to anticipate likely problems, and then helps
clients to apply various tactics for avoiding
lapses to substance use. Indeed, one form of
RP treatment, Relapse Prevention Therapy,
has been specifically adapted to provide inte-
grated treatment of COD, with promising
results from some initial studies. 
Because outpatient treatment programs are
widely available and serve the greatest number
of clients, it is imperative that these programs
use the best available treatment models to
reach the greatest possible number of persons
with COD. In addition to the essential elements
and the strategies described above, two outpa-
tient models from the mental health field have
been valuable for outpatient clients with both
substance use and serious mental disorders:
Assertive Community Treatment (ACT) and
Intensive Case Management (ICM).
ACT programs, historically designed for clients
with serious mental illness, employ extensive
outreach activities, active and continuing
engagement with clients, and a high intensity of
services. ACT emphasizes multidisciplinary
teams and shared decisionmaking. When work-
ing with clients who have COD, the goals of the
ACT model are to engage them in helping rela-
tionships, assist them in meeting basic needs
(e.g., housing), stabilize them in the communi-
ty, and ensure that they receive direct and inte-
grated substance abuse treatment and mental
health services. Randomized trials with clients
having serious mental and substance use disor-
ders have demonstrated better outcomes on
many variables for ACT compared to standard
case management programs. 
The goals of ICM are to engage individuals in a
trusting relationship, assist in meeting their
basic needs (e.g., housing), and help them
access and use brokered services in the commu-
nity. The fundamental element of ICM is a low
caseload per case manager, which translates
into more intensive and consistent services for
each client. ICM has proven useful for clients
with serious mental illness and co-occurring
substance use disorders. (The consensus panel
notes that direct translation of ACT and ICM
models from the mental health settings in which
they were developed to substance abuse settings
is not self-evident. These initiatives likely must
be modified and evaluated for application in
such settings.)
Residential treatment for substance abuse
occurs in a variety of settings, including long-
(12 months or more) and short-term residential
treatment facilities, criminal justice institu-
tions, and halfway houses. In many substance
abuse treatment settings, psychological distur-
bances have been observed in an increasing
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proportion of clients over time; as a result,
important initiatives have been developed to
meet their needs. 
The Modified Therapeutic Community (MTC)
is a promising residential model from the sub-
stance abuse field for those with substance use
and serious mental disorders. The MTC adapts
the principles and methods of the therapeutic
community to the circumstances of the client,
making three key alterations: increased flexibil-
ity, more individualized treatment, and
reduced intensity. The latter point refers espe-
cially to the conversion of the traditional
encounter group to a conflict resolution group,
which is highly structured, guided, of very low
emotional intensity, and geared toward achiev-
ing self-understanding and behavior change.
The MTC retains the central feature of TC
treatment; a culture is established in which
clients learn through mutual self-help and affil-
iation with the peer community to foster change
in themselves and others. A series of studies
has established better outcomes and benefit
cost of the MTC model compared to standard
services. A need for more verification of the
MTC approach remains. 
Because acute and primary care settings
encounter chronic physical diseases in combi-
nation with substance use and mental disor-
ders, treatment models appropriate to medical
settings are emerging, two of which are
described in the TIP. In these and other set-
tings, it is particularly important that adminis-
trators assess organizational readiness for
change prior to implementing a plan of inte-
grated care. The considerable differences
between the medical and social service cultures
should not be minimized or ignored; rather,
opportunities should be provided for relation-
ship and team building. 
Within the general population of persons with
COD, the needs of a number of specific sub-
groups can best be met through specially
adapted or designed programs. These include
persons with specific disorders (such as bipolar
disorder) and groups with unique requirements
(such as women, the homeless, and clients in
the criminal justice system). The two categories
often overlap; for example, a number of recov-
ery models are emerging for women with sub-
stance use disorders who are survivors of trau-
ma, many of whom have posttraumatic stress
disorder. The TIP highlights a number of
promising approaches to treatment for particu-
lar client groups, while recognizing that further
development is needed, both of disorder-specif-
ic interventions and of interventions targeted to
the needs of specific populations. 
Returning to life in the community after resi-
dential placement is a major undertaking for
clients with COD, and relapse is an ever-pre-
sent danger. Discharge planning is important to
maintain gains achieved through residential or
outpatient treatment. Depending on program
and community resources, a number of contin-
uing care (aftercare) options may be available
for clients with COD who are leaving treat-
ment. These options include mutual self-help
groups, relapse prevention groups, continued
individual counseling, psychiatric services
(especially important for clients who will con-
tinue to require medication), and ICM to con-
tinue monitoring and support. A carefully
developed discharge plan, produced in collabo-
ration with the client, will identify and relate
client needs to community resources, ensuring
the supports needed to sustain the progress
achieved in treatment.
During the past decade, dual recovery mutual
self-help approaches have been developed for
individuals affected by COD and are becoming
an important vehicle for providing continued
support in the community. These approaches
apply a broad spectrum of personal responsi-
bility and peer support principles, often
employing 12-Step methods that provide a
planned regimen of change. The clinician can
help clients locate a suitable group, find a
sponsor (ideally one who also has COD and is
at a late stage of recovery), and become com-
fortable in the role of group member. 
Continuity of care refers to coordination of
care as clients move across different service
systems and is characterized by three features:
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and ancillary services, seamless transitions
across levels of care (e.g., from residential to
outpatient treatment), and coordination of pre-
sent with past treatment episodes. Because
both substance use and mental disorders typi-
cally are long-term chronic disorders, continu-
ity of care is critical; the challenge in any sys-
tem of care is to institute mechanisms to ensure
that all individuals with COD experience the
benefits of continuity of care. 
The consensus panel recognizes that the role of
the client (the consumer) with COD in the
design of, and advocacy for, improved services
should continue to expand. The consensus
panel recommends that program design and
development activities of agencies serving
clients with COD continue to incorporate con-
sumer and advocacy groups. These groups help
to further the refinement and responsiveness of
the treatment program, thus enhancing clients’
self-esteem and investment in their own treat-
ment.
All good treatment depends on a trained staff.
The consensus panel underscores the impor-
tance of creating a supportive environment for
staff and encouraging continued professional
development, including skills acquisition, val-
ues clarification, and competency attainment.
An organizational commitment to staff develop-
ment is necessary to implement programs suc-
cessfully and to maintain a motivated and
effective staff. It is essential to provide consis-
tently high-quality and supportive supervision,
favorable tuition reimbursement and release
time policies, appropriate pay and health/
retirement benefits, helpful personnel policies
that bolster staff well-being, and incentives or
rewards for work-related achievements.
Together, these elements help create the infras-
tructure needed for quality service. 
The consensus panel supports and encourages
the development of a unified substance abuse
and mental health approach to co-occurring
disorders. Recognizing that system integration
is difficult to achieve and that the need for
improved COD services in substance abuse
treatment agencies is urgent, the panel recom-
mends that, at this stage, the emphasis be
placed on assisting the substance abuse treat-
ment system in the development of increased
internal capability to treat individuals with
COD effectively. A parallel effort should be
undertaken in the mental health system, with
the two systems continuing to work coopera-
tively on services to individual clients.
Much has been accomplished in the field of
COD in the last 10 years, and the knowledge
acquired is ready for broader dissemination
and application. The importance of the trans-
fer and application of knowledge and technolo-
gy has likewise become better understood. The
consensus panel emphasizes the need for new
government initiatives that improve services by
promoting innovative technology transfer
strategies using material from this TIP and
from other resources (e.g., the Substance
Abuse and Mental Health Services
Administration’s [SAMHSA’s] Report to
Congress on the Treatment and Prevention of
Co-Occurring Substance Abuse and Mental
Disorders and SAMHSA’s Center for Mental
Health Service’s Co-Occurring Disorders:
Integrated Dual Disorders Treatment
Implementation Resource Kit) are adapted and
shaped to the particular program context and
circumstances.
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11 Introduction
In This
Chapter…
The Evolving Field of 
Co-Occurring Disorders
Important Developments
That Led to This TIP
Organization of This TIP
Overview
Over the past few decades, practitioners and researchers increasingly
have recognized the link between substance abuse and mental disor-
ders. Treatment Improvement Protocol (TIP) 9, Assessment and
Treatment of Patients With Coexisting Mental Illness and Alcohol and
Other Drug Abuse (Center for Substance Abuse Treatment [CSAT]
1994a), answered the treatment field’s need for an overview of diag-
nostic criteria, assessment, psychopharmacology, specific mental dis-
orders, and the need for linkage between the mental health services
system and substance abuse treatment system. 
Subsequent to TIP 9, research has provided a more in-depth under-
standing of co-occurring substance use and mental disorders—how
common they are, the multiple problems they create, and the impact
they have on treatment and treatment outcome. As knowledge of co-
occurring disorders (COD) continues to evolve, new challenges arise:
How do we treat specific populations such as the homeless and those in
our criminal justice system? What is the role of housing? What about
those with specific mental disorders such as posttraumatic stress disor-
der? Where is the best locus for treatment? Can we build an integrated
system of care? The main purpose of this TIP is to provide addiction
counselors and other practitioners with this state-of-the-art informa-
tion on the rapidly advancing field of co-occurring substance use and
mental disorders.
Following a discussion of the evolving field of co-occurring disorders,
this chapter addresses the developments that led to this TIP. It then
describes the scope of this TIP (both what is included and what is
excluded by design), its intended audience, and the basic approach
that has guided the selection of strategies, techniques, and models
highlighted in the text. The organization of the TIP is laid out for the
reader, with the components of each chapter and appendix described
in an effort to help users of the TIP quickly locate subjects of immedi-
ate interest.
The Evolving Field of
Co-Occurring Disorders
Today’s emphasis on the relationship between
substance use and mental disorders dates to
the late 1970s, when practitioners increasing-
ly became aware of the implications of these
disorders, when occurring together, for treat-
ment outcomes. The association between
depression and substance abuse was particu-
larly striking and became the subject of sev-
eral early studies (e.g., Woody and Blaine
1979). In the 1980s and 1990s, however, both
the substance abuse and mental health com-
munities found that a wide range of mental
disorders were associated with substance
abuse, not just depression (e.g., De Leon
1989; Pepper et al. 1981; Rounsaville et al.
1982b; Sciacca 1991). During this period,
studies conducted in substance abuse pro-
grams typically reported that 50 to 75 percent
of clients had some type of co-occurring men-
tal disorder (although not usually a severe
mental disorder) while studies in mental
health settings reported that between 20 and
50 percent of their clients had a co-occurring
substance use disorder. (See Sacks et al.
1997b for a summary of studies and Compton
et al. 2000 for a more recent study.)
The multiple studies reflect the extent to
which COD constitutes a clinical concern. At
the same time, however, these studies varied
in that they (1) were conducted in an array of
settings and on a range of sample sizes from
68 to 20,291, (2) used different measures and
criteria for determining a disorder, and (3)
reported on different time periods (i.e., either
lifetime or current, or both). This diversity in
reporting can produce differing estimates and
suggests a need to address the broad range of
survey and analytic strategies used to gener-
ate estimates. Further work to clarify the
type, severity, and clinical significance of co-
occurring disorders can contribute to an
improved understanding of the phenomenon
and treatment. Nevertheless, it is important
that, in spite of those differences, there is a
consistency in reporting significant rates of
disorder across all studies.
Researchers not only found a link between
substance abuse and mental illness, they also
found the dramatic impact the complicating
presence of substance abuse may have on the
course of treatment for mental illness. One
study of 121 clients with psychoses found that
those with substance abuse problems (36 per-
cent) spent twice as many days in the hospital
over the 2 years prior to treatment as clients
without substance abuse problems (Crome
1999; Menezes et al. 1996). These clients
often have poorer outcomes, such as higher
rates of HIV infection, relapse, rehospitaliza-
tion, depression, and suicide risk (Drake et
al. 1998b; Office of the Surgeon General
1999).
Researchers also have clearly demonstrated
that substance abuse treatment for clients
with co-occurring mental illness and sub-
stance use disorders can be beneficial—even
for clients with serious mental symptoms. For
example, the National Treatment Improve-
ment Evaluation Study (NTIES) found
marked reductions in suicidality the year fol-
lowing substance abuse treatment compared
to the year prior to treatment for both male
and female clients and nonabused women.
Suicide attempts declined about four fifths
for both the 3,037 male clients and the 1,374
female clients studied (Karageorge 2001).
Many clients in traditional substance abuse
treatment settings who had mild to moderate
mental disorders were found to do well with
traditional substance abuse treatment meth-
ods (Hser et al. 2001; Hubbard et al. 1989;
Joe et al. 1995; Simpson et al. 2002; Woody et
al. 1991). However, modifications designed to
address mental disorders may further
enhance treatment effectiveness and can be
essential for people with severe mental disor-
ders. This TIP will discuss the modifications
and approaches practitioners have found to
be helpful. For examples, see the sections on
suicide assessment and intervention in chap-
ter 8 and appendix D.
2 Introduction
Just as the field of treatment for substance
use and mental disorders has evolved to
become more precise, so too has the terminol-
ogy used to describe people with both sub-
stance use and mental disorders. The term
co-occurring disorders replaces the terms
dual disorder or dual diagnosis. These latter
terms, though used commonly to refer to the
combination of substance use and mental dis-
orders, are confusing in that they also refer
to other combinations of disorders (such as
mental disorders and mental retardation).
Furthermore, the terms suggest that there are
only two disorders occurring at the same
time, when in fact there may be more. For
purposes of this TIP, co-occurring disorders
refers to co-occurring substance use (abuse or
dependence) and mental disorders. Clients
said to have co-occurring disorders have one
or more disorders relating to the use of alco-
hol and/or other drugs of abuse as well as one
or more mental disorders. A diagnosis of co-
occurring disorders occurs when at least one
disorder of each type can be established inde-
pendent of the other and is not simply a clus-
ter of symptoms resulting from the one disor-
der. (See chapter 2 for more discussion of ter-
minology used in this TIP.)
New models and strategies are receiving
attention and encouraging treatment innova-
tion (Anderson 1997; De Leon 1996; Miller
1994a; Minkoff 1989; National Advisory
Council [NAC] 1997; Onken et al. 1997;
Osher and Drake 1996). Reflecting the
increased interest in issues surrounding effec-
tive treatment for this population, the
American Society of Addiction Medicine
(ASAM) added substantial new sections on
clients with COD to an update of its patient
placement criteria. These sections refine cri-
teria both for placing clients with COD in
treatment and for establishing and operating
programs to provide services for such clients
(ASAM 2001). 
In another important development, the
National Association of State Alcohol and
Drug Abuse Directors (NASADAD) began
surveying its members about effective treat-
ment of clients with COD in their States
(Gustafson et al. 1999). In addition,
NASADAD has joined with the National
Association of State Mental Health Program
Directors (NASMHPD) (NASMHPD-
NASADAD 1999, 2000) and other collabora-
tors in a series of national efforts designed to
•Foster improvement in treatment by empha-
sizing the impor-
tance of knowledge
of both mental
health and sub-
stance abuse treat-
ment when working
with clients for
whom both issues
are relevant.
•Provide a classifica-
tion of treatment
settings to facilitate
systematic planning,
consultations, col-
laborations, and
integration.
•Reduce the stigma
associated with both
disorders and
increase the accep-
tance of substance
abuse and mental
health concerns as a
standard part of
healthcare informa-
tion gathering. 
These efforts are slow-
ly changing the way that the public, policymak-
ers, and substance abuse counselors view men-
tal illness. Still, stigma attached to mental ill-
ness remains. One topic worth mentioning is
the public perception that people with mental
illness are dangerous and pose a risk of vio-
lence. However, studies have shown that the
public’s fear is greater than the actual risk,
and that often, people with mental disorders
are not particularly violent; it is when sub-
stance abuse is added that violence can ensue.
For example, Steadman et al. (1998) found that
substance abuse symptoms significantly raised
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the rate of violence in both individuals with
mental illness and those without mental illness.
This research adds support to the importance
of treating both mental illness and substance
abuse.
In recent years, dissemination of knowledge
has been widespread. Numerous books and
hundreds of articles have been published,
from counseling manuals and instruction
(Evans and Sullivan 2001; Pepper and
Massaro 1995) to database analysis of linkage
among treatment systems and payors (Coffey
et al. 2001). Several annual “dual diagnosis”
conferences emerged. One of the most long-
standing is the annual conference on The
Person With Mental Illness and Substance
Abuse, hosted by MCP Hahnemann
University (now Drexel University), which
began in 1988. 
In spite of these developments, individuals
with substance use and mental disorders com-
monly appear at facilities that are not pre-
pared to treat them. They may be treated for
one disorder without consideration of the
other disorder, often “bouncing” from one
type of treatment to another as symptoms of
one disorder or another become predomi-
nant. Sometimes they simply “fall through the
cracks” and do not receive needed treatment.
This TIP captures the current state-of-the-art
treatment strategies to assist counselors and
treatment agencies in providing appropriate
services to clients with COD. 
Important
Developments That
Led to This TIP
Important developments in a number of areas
pointed to the need for a revised TIP on co-
occurring disorders. Among the factors that
contributed to the need for this document are
the availability of significant data on the
prevalence of COD, the emergence of new
treatment populations with COD (such as
people who are homeless, people with
HIV/AIDS, and persons in the criminal jus-
tice system), and changes in treatment deliv-
ery (including an increasing number of pro-
grams serving persons with COD). The follow-
ing section provides a summary of data rele-
vant to each of these key areas. 
The Availability of Prevalence
and Other Data
Prevalence and other data on COD have
established the scope and impact of the prob-
lem, and the need for appropriate treatment
and services. Four key findings are borne out
by prevalence and other available data, each
of which is important in understanding the
challenges of providing effective treatment to
this population.
(1) COD are common in the general adult
population, though many individuals
with COD go untreated.
National surveys suggest COD are common in
the adult population. For example, the
National Survey on Drug Use and Health
(NSDUH) reports that in 2002, 4 million
adults met the criteria for both serious mental
illness (SMI) and substance dependence and
abuse. NSDUH information is based on a
sample of 67,500 American civilians aged 12
or older in noninstitutionalized settings
(Office of Applied Studies [OAS] 2003b). The
NSDUH defined SMI as having at some time
during the past year a diagnosable mental,
behavioral, or emotional disorder that met
the criteria specified in the Diagnostic and
Statistical Manual of Mental Disorders, 4th
edition (DSM-IV) (American Psychiatric
Association 1994) and resulted in functional
impairment that substantially interfered with
or limited one or more major life activities.
The NSDUH classification scheme was not
diagnosis specific, but function specific.
Results from the survey are highlighted
below.
•SMI is highly correlated with substance
dependence or abuse. Among adults with
SMI in 2002, 23.2 percent were dependent on
or abused alcohol or illicit drugs, while the
rate among adults without SMI was only 8.2
percent. Among adults with substance depen-
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dence or abuse, 20.4 percent had SMI; the
rate of SMI was 7 percent among adults who
were not dependent on or abusing a sub-
stance.
•Among adults who used an illicit drug in the
past year, 17.1 percent had SMI in that
year, while the rate was 6.9 percent among
adults who did not use an illicit drug.
Conversely, among adults with SMI, 28.9
percent used an illicit drug in the past year
while the rate was 12.7 percent among those
without SMI (OAS 2003b).
•SMI was correlated with binge alcohol use
(defined as drinking five or more drinks on
the same occasion on at least one day in the
past 30 days). Among adults with SMI, 28.8
percent were binge drinkers, while 23.9
percent of adults with no SMI were binge
drinkers.
Earlier, the National Comorbidity Study (NCS)
reported 1991 information on mental disorders
and substance abuse or dependence in a sample
of 8,098 American civilians aged 15 to 54 in
noninstitutionalized settings. Figure 1-1 shows
estimates from the NCS of the comparative
number of any alcohol, drug abuse, or mental
disorder (52 million), any mental disorder (40
million), any substance abuse/dependence dis-
order (20 million), and both mental disorder
and substance abuse/dependence (8 million) in
the past year. 
In a series of articles derived from the NCS,
Kessler and colleagues give a range of esti-
mates related to both the lifetime and 12-
month prevalence of COD (Kessler et al.
1994, 1996a, b, 1997). They estimate that 10
million Americans of all ages and in both
institutional and noninstitutional settings
have COD in any given year. Kessler et al.
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Figure 1-1
Persons With Alcohol, Drug Abuse, or Mental Disorder in the Past Year
(See Endnote1)
U.S. Population, Age 15 to 54, 1991
Source: Kessler et al. 1994. Table 2 and unpublished data from the survey.
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also estimate the lifetime prevalence of COD
(not shown in Figure 1-1, which relates only
the prevalence in the past 12 months) (1996a,
p. 25) as follows: “…51 percent of those with
a lifetime addictive disorder also had a life-
time mental disorder, compared to 38 percent
in the ECA.” (The ECA—Epidemiologic
Catchment Area study—predated the NCS
study; this National Institute of Mental
Health study of 20,291 people was represen-
tative of the total U.S. community and insti-
tutional populations [Regier et al. 1990]). 
Comparative figures for individuals with COD
whose addictive disorders involve alcohol ver-
sus drugs are also available. Fifty-three per-
cent of the respon-
dents with lifetime
alcohol abuse or
dependence also
had one or more
lifetime mental dis-
orders. For respon-
dents with lifetime
illicit drug
abuse/dependence,
59 percent also had
a lifetime mental
disorder, and 71
percent of those
with lifetime illicit
drug abuse/ depen-
dence had alcohol
abuse or depen-
dence over their
lifetime (Office of
the Inspector
General 1995).
A recent first report from the National
Comorbidity Survey Replication, conducted
between February 2001 and December 2002
(Kessler and Walters 2002), provides more
precise information on rates of specific disor-
ders. For example, rates of major depressive
disorder were reported at 6.6 percent in the
general population in the last year, or an esti-
mated number between 13.1 and 14.2 million
people (Kessler et al. 2003b). Additional data
from a new and expanded NCS survey are
now available (e.g., Breslau et al. 2004a, b;
Kessler 2003; Kessler et al. 2003a; see also
the Web site www.hcp.med.harvard.edu/ncs).
Research suggests that the likelihood of seek-
ing treatment is strongly increased in the
presence of at least one co-occurring condi-
tion. The National Longitudinal Alcohol
Epidemiologic Study (NLAES)—a nationwide
household survey of 42,862 respondents aged
18 or older conducted by the National
Institute on Alcohol Abuse and Alcoholism—
reveals that a large increase in treatment for
an alcohol disorder and a drug disorder
occurs when there is a co-occurring “major
depressive disorder” (Grant 1997). NCS data
suggest that people with more than two disor-
ders are more likely to receive treatment than
those with “only” two. People with three or
more diagnosable conditions were the most
likely to be severely impaired and to require
hospitalization (NAC 1997). 
While people with co-occurring disorders are
more likely to seek treatment, research con-
sistently shows a gap between the number of
people who are identified in a survey as hav-
ing a disorder and the number of people
receiving any type of treatment. Even of those
with three or more disorders, a troubling 60
percent never received any treatment (Kessler
et al. 1994; NAC 1997). Based on NLAES
data, Grant (1997, p. 13) notes that one of
the most interesting results of the survey is
the “sheer number of respondents with alco-
hol and drug use disorders missing from the
treated population. Only 9.9 percent and 8.8
percent of the respondents classified with
past-year alcohol and drug use disorders,
respectively, sought treatment.” 
(2) Some evidence supports an 
increased prevalence of people 
with COD and of more programs for
people with COD.
NASADAD conducts voluntary surveys of
State Alcohol and Drug Abuse Agencies and
produces the State Alcohol and Drug Abuse
Profile (SADAP) reports. In 1996, NASADAD
asked the States to describe any special pro-
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grams in their States for clients with COD
and to provide any available fiscal year (FY)
1995 statistics on the number of “dually diag-
nosed” clients treated (Gustafson et al. 1997).
Forty-one States plus Palau, Puerto Rico,
and the U.S. Virgin Islands responded. About
3 years later, 31 States responded to a
request for detailed statistics on the number
of persons admitted in FYs 1996 and 1997 to
programs for treatment of COD (Gustafson et
al. 1999). In general, examination of SADAP
State profiles for information related to COD
suggests about a 10 percent increase since the
NASADAD survey in both the number of peo-
ple with COD entering treatment and in the
number of programs in many States over that
3-year period (Gustafson et al. 1999).
The 2002 National Survey of Substance
Abuse Treatment Services (N-SSATS) indicat-
ed that about 49 percent of 13,720 facilities
nationwide reporting substance abuse services
offered programs or groups for those with
COD (OAS 2003a). However, only 38 percent
of the 8,292 responding facilities that focused
primarily on substance abuse offered such
COD programming. Sixty-three percent of the
1,126 responding mental health services that
offered substance abuse services offered COD
programs or groups. About 70 percent of the
3,440 facilities that have a mix of mental
health and substance abuse treatment ser-
vices offer COD programs or groups.
Still it must be kept in mind that of all the
approximately 1.36 million clients in treat-
ment for substance use disorders in 2002,
about 68 percent were treated in facilities
whose primary focus was substance abuse ser-
vices and 23 percent were treated in facilities
whose focus was a mix of both mental health
and substance abuse services. Only 4 percent
of these individuals were in facilities whose
primary focus was the provision of mental
health services.
(3) Rates of mental disorders increase as
the number of substance use disor-
ders increases, further complicating
treatment.
In their analysis of data from a series of 
studies supported by the National Institute on
Drug Abuse, the Drug Abuse Treatment
Outcome Study (DATOS), Flynn et al. (1996)
demonstrate that the likelihood of mental dis-
orders rises with the increasing number of
substance dependencies. Participating clients
were assessed according to DSM-III-R criteria
(Diagnostic and Statistical Manual for Mental
Disorders, 3d edition revised) for lifetime
antisocial personality, major depression, gen-
eralized anxiety disorder, and/or any combi-
nation of these disorders.
DATOS was a national study of clients enter-
ing more than 90 substance abuse treatment
programs in 11 metropolitan areas, mainly
during 1992 (Flynn et al. 1997). Of the initial
intake sample of 10,010 clients, 7,402 com-
pleted an intake and a clinical assessment
interview and met DSM-III-R criteria for
dependence on alcohol, cocaine, and/or hero-
in. Figure 1-2 (p. 8) shows a general trend of
increase in the rates of DSM-III-R lifetime
antisocial personality disorder, major depres-
sion, and generalized anxiety disorder as the
number of substance dependencies involving
alcohol, heroin, and cocaine increases (except
for the relationship between alcohol depen-
dence only and major depression and general-
ized anxiety). Since the use of multiple drugs
is common in those with substance use disor-
ders, treatment is further complicated for
these people by the greater incidence of men-
tal disorders that accompanies multiple drug
use. 
(4) Compared to people with mental 
or substance use disorders alone,
people with COD are more likely 
to be hospitalized. Some evi-
dence suggests that the rate of 
hospitalization for people with 
COD is increasing.
According to Coffey and colleagues, the rate of
hospitalization for clients with both a mental
and a substance use disorder was more than 20
times the rate for substance-abuse–only clients
and five times the rate for mental-
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disorder–only clients (Coffey et al. 2001). This
estimate is based on an analysis of the
CSAT/Center for Mental Health Services
(CMHS) Integrated Data Base Project, in
which a team studied information from the
mental health, substance abuse, and Medicaid
agencies in Delaware, Oklahoma, and
Washington. Using a broad coding for health
policy research to study discharges between
1990–1995 from community hospitals nation-
wide, Duffy (2004, p. 45) estimated that clients
classified as having both a substance-related
disorder and a mental disorder significantly
“...increased from 9.4 to 17.22 per 10,000 pop-
ulation ...” with the 35–45 year age group
increasing the most among the 7 age groups
studied from childhood to 65 or older.
Treatment Innovation for
Other Populations With COD 
Further treatment innovation has been
required to meet the needs and associated
problems of other treatment populations with
high rates of COD such as people who are
homeless, those in the criminal justice system,
persons living with HIV/AIDS and other infec-
tious diseases (e.g., hepatitis), and those with
trauma and posttraumatic stress disorder
(PTSD).
Homeless populations
Data on the increasing rates of co-occurring
mental and substance use disorders in home-
less populations are now available (North et
al. 2004). North and colleagues estimate that
rates of co-occurring Axis I and substance use
disorders among females who are homeless
increased from 14.3 percent in 1990 to 36.7
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Figure 1-2
Rates of Antisocial Personality, Depression, and Anxiety Disorder by
Drug Dependency (%). Taken From the Drug Abuse Treatment Outcome
Study (DATOS)
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Source: Flynn et al. 1996; data are from the NIDA-supported DATOS study.
percent in 2000 and that rates among men
who are homeless increased from 23.2 percent
in 1990 to 32.2 percent in 2000.
North and colleagues also compared data col-
lected in their 2000 study with estimates from
ECA data collected in the early 1980s. They
found that alcohol and drug use for both
males and females rose considerably over the
2 decades. In 2000, 84 percent of the men
who were homeless and 58 percent of the
women who were homeless had a substance
use disorder (North et al. 2004). The article
reports an increase in bipolar disorder from
1990 to 2000 and an increase in major
depression from 1980 to 2000. (Major depres-
sion accounted for the majority of all Axis I
non-substance disorders.) The authors also
noted that non-Axis I antisocial personality
disorder (APD) appeared to change little
from 1980 to 2000, with 10 to 20 percent of
women who were homeless and 20 to 25 per-
cent of men who were homeless receiving APD
diagnoses in both time periods (North et al.
2004).
The increased prevalence of COD among peo-
ple who are homeless and the need to provide
services to this growing population has led to
treatment innovations and research on service
delivery. One of the main challenges is how to
engage this group in treatment. CMHS’s Access
to Community Care and Effective Services and
Supports initiative, which supported programs
in nine States over a 5-year period, indicated
the effectiveness of integrated systems, includ-
ing the value of street outreach (Lam and
Rosenheck 1999; Rosenheck et al. 1998). Both
systems integration and comprehensive ser-
vices, such as Assertive Community Treatment
(ACT) and Intensive Case Management (ICM),
were seen as essential and effective (Integrating
Systems of Care 1999; Winarski and Dubus
1994). (See chapter 6 for a discussion of these
approaches.)
Offenders
The Bureau of Justice Statistics estimates that
“at midyear 1998, an estimated 283,800 men-
tally ill offenders were incarcerated in the
Nation’s prisons and jails” (Ditton 1999, p.
1). Surveys by the Bureau found that “16
percent of State prison inmates, 7 percent of
Federal inmates, and 16 percent of those in
local jails reported either a mental condition
or an overnight stay in a mental hospital”
(Ditton 1999). In addition, an estimated
547,800 probationers—16 percent—said they
had had a mental condition or stayed
overnight in a mental hospital at some point
in their lifetime (Ditton 1999).
The Office of National Drug Control Policy
(ONDCP) emphasized that “the fastest and
most cost-effective way to reduce the demand
for illicit drugs is to treat chronic, hard core
drug users” (ONDCP 1995, p. 53). These
“hard core users” are in need of COD services.
The NTIES study reported that, when given
the choice to rate their desire for certain ser-
vices as “not important,” “somewhat impor-
tant,” or “very important,” 37 percent of a
population that was predominantly criminal-
justice–involved rated mental health services as
“very important” (Karageorge 2000).
The substance abuse treatment and mental
health services communities have been called
on to provide, or assist in providing, treatment
to these individuals. This requires the integra-
tion of substance abuse treatment and mental
health services and the combination of these
approaches with those that address criminal
thinking and behavior, while attending to both
public health and public safety concerns. 
HIV/AIDS and infectious 
diseases
The association between psychological dys-
function and a tendency to engage in high-
risk behaviors (Joe et al. 1991; Simpson et al.
1993) suggests that it is important to integrate
HIV/AIDS prevention and treatment with
9Introduction
substance abuse treatment and mental health
services for the COD population. Advances in
the treatment of HIV/AIDS (such as anti-
retroviral combination therapy, including
protease inhibitors) and the improved out-
comes resulting from such therapies potential-
ly will extend the survival of those with
HIV/AIDS and co-occurring disorders. This
will extend their requirement for continued
mental health and substance abuse services.
For persons with COD who also have
HIV/AIDS or other infectious diseases (e.g.,
hepatitis C), primary medical care should be
integrated with COD treatment. To be suc-
cessful, this treatment should include an
emphasis on treatment adherence (see chap-
ter 7 for one such model).
Trauma and PTSD
Many persons with substance use disorders
have experienced trauma, often as a result of
abuse. A significant number of them have the
recognized mental disorder known as PTSD.
Recent studies have demonstrated strong con-
nections between trauma and addictions,
including the possibility that childhood abuse
plays a part in the development of substance
use disorders (Anderson et al. 2002; Brady et
al. 2000; Chilcoat and Breslau 1998b;
Jacobsen et al. 2001). Although substance
abuse treatment clinicians have counseled
these clients for years, new treatment strate-
gies for PTSD and trauma have expanded
treatment options (see chapter 8 and appen-
dix D). The forthcoming TIP Substance
Abuse Treatment and Trauma will explore
these issues in depth (CSAT in development d).
Changes in Treatment
Delivery 
The substance abuse treatment field has rec-
ognized the importance of COD program-
ming. In 1995, only 37 percent of the sub-
stance use disorder treatment programs
reporting data to the Substance Abuse and
Mental Health Services Administration
(SAMHSA) offered COD programming. By
1997, this percentage had increased to almost
half (data not shown). 
According to 2002 N-SSATS data, the number
of programs for COD peaked in 1999, fol-
lowed by a slight decline in 2000 that
remained constant in 2002. This tracked the
number of substance use disorder treatment
providers, which also peaked in 1999. In
1999, there were 15,239 substance abuse
treatment programs reporting to SAMHSA; in
2000, there were 13,428; in 2002, there were
13,720 (OAS 2003a). Figure 1-3 shows that
the number of programs for people with COD
decreased slightly from 1999 to 2000, from
6,818 to 6,696, but remained constant in 2002
at 6,696 (OAS 2003a). However, the ratio
between the total number of substance abuse
treatment programs and those offering COD
programming has been relatively stable since
1997, increasing slightly from 44.7 percent in
1999 to 49.9 percent in 2000, and then
remaining roughly constant at 48.8 percent in
2002.
An important consideration for the public
mental health and substance abuse delivery
systems is the recognition that not all people
with emotional problems are candidates for
care within the public mental health system.
Because many States prioritize the funding of
mental health slots by providing access to
those who meet the criteria for the most
severe and persistent mental illnesses, it is
important for treatment providers to recog-
nize the criteria that their State jurisdiction
uses to provide care. For example, a treat-
ment program may be aware that a person
has psychological symptoms signifying stress,
a diagnosable mental disorder, a serious men-
tal disorder, a severe and persistent mental
disorder, or, finally, a severe and persistent
mental disorder with disability. From the
point of view of the behavioral healthcare
delivery system, these distinctions are impor-
tant. In a State that restricts the use of its
Federal community mental health services
dollars to those with severe and persistent
mental illness, a person not meeting the crite-
ria for that condition may not be eligible for
mental health services.
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If a client/consumer has a primary substance
abuse problem and a “non-eligible” mental
disorder—that is, a disorder that cannot by
regulation or law be treated in a public men-
tal health program—then all providers should
be aware of this. The difference between ideal
care and available care is critical to the utility
of this TIP. Furthermore, during periods of
financial difficulty, the prospect of additional
resources being created to address complex
problems is not likely. Thus, an integrated
care framework is preferred in this TIP. An
integrated framework recognizes that quality
evidence-based individualized care can be
provided within a behavioral health delivery
system using existing resources and partner-
ships.
Advances in Treatment
Advances in the treatment of COD, such as
improved assessments, psychological interven-
tions, psychiatric medications, and new models
and methods, have greatly increased available
options for the counselor and the client.
“No wrong door” policy
The publication of Changing the Conver-
sation (CSAT 2000a) signaled several funda-
mental advances in the field. Of particular
importance is the principle of “no wrong
door.” This principle has served to alert
treatment providers that the healthcare deliv-
ery system, and each provider within it, has a
responsibility to address the range of client
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Figure 1-3
Substance Abuse Treatment Facilities Offering Special Programs for
Clients With COD: 1999–20021
1
Survey reference dates were October 1 for 1999 and 2000 and March 29, 2002. See appendix C of source for changes in
the survey base, methods, and instruments that affect analysis of trends over time.
Source: Office of Applied Studies, Substance Abuse and Mental Health Services Administration, UFDS Survey,
1996–1999; National Survey of Substance Abuse Treatment Services (N-SSATS), 2000 and 2002.
wwwdasis.samhsa.gov/02nssats/nssats2002report.pdf
needs wherever and whenever a client pre-
sents for care. When clients appear at a facil-
ity that is not qualified to provide some type
of needed service, those clients should care-
fully be guided to appropriate, cooperating
facilities, with followup by staff to ensure that
clients receive proper care. The evolution of
the Changing the Conversation paradigm sig-
nals a recognition that recovery is applicable
to all people in need of substance abuse ser-
vices: to the client
with psychiatric
problems in the
substance abuse
treatment delivery
system, the client
with substance
abuse problems in
the traditional men-
tal health services
delivery system, or
the client with co-
occurring behavior
problems in a tradi-
tional physical
health delivery sys-
tem. Every “door”
in the healthcare
delivery system
should be the
“right” door.
Mutual self-help for people
with COD
Based on the Alcoholics Anonymous model, the
mutual self-help movement has grown to
encompass a wide variety of addictions.
Narcotics Anonymous and Cocaine Anonymous
are two of the largest mutual self-help organiza-
tions for chemical addiction; Recoveries
Anonymous and Schizophrenics Anonymous
are the best known for mental illness. Though
these typically are referred to as “self-help”
groups, this TIP adopts the term “mutual self-
help” because it is more descriptive of the way
most participants see these groups—as a means
of both helping themselves and supporting each
other in achieving specific personal goals. 
Mutual self-help programs, which include but
are not limited to 12-Step groups, apply a
broad spectrum of personal responsibility and
peer support principles, usually including 12-
Step methods that prescribe a planned regimen
of change. In recent years, mutual self-help
groups that have been adapted to clients with
COD have become increasingly available. A
more extensive discussion of these dual recov-
ery mutual self-help programs can be found in
chapter 7.
Integrated care as a priority
for people with severe and
persistent mental illness
For those with severe and persistent mental ill-
ness, integrated treatment, as originally articu-
lated by Minkoff (1989), emphasized the corre-
spondence between the treatment models for
mental illness and addiction in a residential set-
ting. The model stressed a parallel view of
recovery, concomitant treatment of mental ill-
ness and substance abuse, application of treat-
ment stages, and the use of strategies from both
the mental health and substance abuse treat-
ment fields. During the last decade, integrated
treatment has continued to evolve, and several
models have been described (Drake and
Mueser 1996b; Lehman and Dixon 1995;
Minkoff and Drake 1991; Solomon et al. 1993). 
For the purposes of this TIP, integrated treat-
ment refers more broadly to any mechanism
by which treatment interventions for COD
are combined within the context of a primary
treatment relationship or service setting.
Integrated treatment is a means of coordinat-
ing substance abuse and mental health inter-
ventions to treat the whole person more effec-
tively. In a review of mental health center-
based research for clients with serious and
persistent mental illness, Drake and col-
leagues (1998b) concluded that comprehen-
sive, integrated treatment, “especially when
delivered for 18 months or longer, resulted in
significant reductions of substance abuse and,
in some cases, in substantial rates of remis-
sion, as well as reductions in hospital use
and/or improvements in other outcomes” (p.
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601). Several studies based in substance
abuse treatment centers addressing a range of
COD have demonstrated better treatment
retention and outcome when mental health
services were integrated onsite (Charney et al.
2001; McLellan et al. 1993; Saxon and Calsyn
1995; Weisner et al. 2001). 
An integrated care framework supports the
provision of some assessment and treatment
wherever the client enters the treatment sys-
tem, ensures that arrangements to facilitate
consultations are in place to respond to client
issues for which a provider does not have in-
house expertise, and encourages all coun-
selors and programs to develop increased
competency in treating individuals with COD.
Several States have received Community
Action Grants from SAMHSA to develop com-
prehensive continuous integrated systems of
care. It is especially important that appropri-
ate substance abuse and mental health ser-
vices for clients with COD be designed specifi-
cally for the substance abuse treatment sys-
tem—a system that addresses a wide range of
COD, not mainly those with severe and per-
sistent mental illness. This subject is explored
in chapter 3, and some approaches to inte-
grated treatment in substance abuse treat-
ment settings are examined in chapter 3 and
chapter 6. 
Development of effective
approaches, models, and
strategies
Treatment approaches are emerging with
demonstrated effectiveness in achieving posi-
tive outcomes for clients with COD. These
include a variety of promising treatment
approaches that provide comprehensive inte-
grated treatment. Successful strategies with
important implications for clients with COD
also include interventions based on addiction
work in contingency management, cognitive–
behavioral therapy, relapse prevention, and
motivational interviewing. These strategies
are discussed in chapter 5. In fact, it is now
possible to identify “guiding principles” and
“fundamental elements” for COD treatment
in COD settings that are common to a variety
of approaches. These are discussed at length
in chapter 3 and chapter 6, respectively.
Specific program models that have proven
effective for the COD population with serious
mental illness include ACT and the Modified
Therapeutic Community. ICM also has
proven useful in treating clients with COD.
See chapter 6 for a discussion of these 
models.
Pharmacological advances
Pharmacological advances over the past
decade have produced antipsychotic, antide-
pressant, anticonvulsant, and other medica-
tions with greater effectiveness and fewer side
effects (see appendix F for a listing of medica-
tions). With the support available from better
medication regimens, many people who once
would have been too unstable for substance
abuse treatment, or institutionalized with a
poor prognosis, have been able to lead more
functional lives. To meet the needs of this
population, the substance abuse treatment
counselor needs both greater understanding
of the signs and symptoms of mental illness
and greater capacity for consultation with
trained mental healthcare providers. As sub-
stance abuse treatment counselors learn more
about mental illness, they are better able to
partner with mental health counselors to
design effective treatment for both types of
disorders. Such partnerships benefit mental
health agencies as well, helping them enhance
their ability to treat clients with substance
abuse issues. 
Increasingly, substance abuse treatment
counselors and programs have come to appre-
ciate the importance of providing medication
to control symptoms as an essential part of
treatment. The counselor has an important
role in describing client behavior and symp-
toms to ensure that proper medication is pre-
scribed when needed. The peer community
also is a powerful tool that can be employed
to support and monitor medication adher-
ence. Support from mutual self-help groups
can include learning about the effects of med-
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ication and learning to accept medication as
part of recovery. Monitoring involves clients
learning from and reflecting on their own and
others’ reactions, thoughts, and feelings
about the ways medications affect them, both
positively as symptoms are alleviated, and
negatively as unwanted side effects may
occur. 
Some Recent Developments
Since the consensus panel for this TIP was
convened, there have been several important
developments in the field of co-occurring dis-
orders. Following is a description of the most
recent developments in the field.
National Registry of Effective
Programs and Practices
To help its practice and policymaking con-
stituents learn more about evidence-based
programs, SAMHSA’s Center for Substance
Abuse Prevention created the National
Registry of Effective Programs and Practices
(NREPP), a resource to review and identify
effective programs derived primarily from
existing scientific literature, effective pro-
grams assessed by other rating processes,
SAMHSA, and solicitations to the field. When
co-occurring disorder treatment programs are
submitted for NREPP consideration, teams of
scientists review the programs based on four
criteria: (1) co-occurring disorders programs,
(2) psychopharmacological programs, (3)
workplace programs, and (4) general sub-
stance abuse prevention and treatment pro-
grams. Evaluation is based on methodological
quality (a program’s overall rigor and sub-
stantive contribution) and appropriateness
(dissemination capability, cultural sensitivity,
and consumer involvement to inform a total
rating that describes a program’s readiness
for adoption and replication). Programs that
demonstrate a commitment to complete
assessment and comprehensive services
receive priority. For programs that target
persons with serious mental disorders, priori-
ty is given to approaches that integrate sub-
stance abuse treatment and mental health ser-
vices. Targeted techniques and strategies are
also eligible for NREPP review. For more
detailed information about NREPP, see
www.modelprograms.samhsa.gov.
Co-Occurring Disorders State
Incentive Grants
The Co-Occurring Disorders State Incentive
Grants (COSIG) (funded through SAMHSA’s
CSAT and CMHS) provide funding to the
States to develop or enhance their infrastruc-
ture to increase their capacity to provide
accessible, effective, comprehensive, coordi-
nated/integrated, and evidence-based treat-
ment services to persons with COD. COSIG
uses the definition of co-occurring disorders
from this TIP (see the beginning of this chap-
ter). It supports infrastructure development
and services across the continuum of COD,
from least severe to most severe, but the
emphasis is on people with less severe mental
disorders and more severe substance use dis-
orders, and on people with more severe men-
tal disorders and less severe substance use
disorders (i.e., quadrants II and III—see
chapter 2 for a description of the four quad-
rants). COSIG is appropriate for States at
any level of infrastructure development.
COSIG also provides an opportunity to evalu-
ate the feasibility, validity, and reliability of
the proposed co-occurring performance mea-
sures for the future Performance Partnership
Grants. Some States and communities
throughout the country already have initiated
system-level changes and developed innova-
tive programs that overcome barriers to pro-
viding services for individuals of all ages who
have COD. The COSIG program reflects the
experience of States to date. For more infor-
mation, see www.samhsa.gov.
Co-Occurring Center for
Excellence
As a result of the pressing need to disseminate
and support the adoption of evidence- and
consensus-based practices in the field of
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COD, SAMHSA established the Co-Occurring
Center for Excellence (COCE) in 2003. COCE
provides SAMHSA and the field with key
resources needed to disseminate knowledge
and increase adoption of evidence-based
practices in the systems and programs that
serve people with COD. The COCE mission 
is to
•Transmit advances in substance abuse and
mental health treatment that address all
levels of mental disorder severity and that
can be adapted to the unique needs of each
client.
•Guide enhancements in the infrastructure
and clinical capacities of the substance
abuse and mental health service systems.
•Foster the infusion and adoption of evi-
dence-based treatment and program inno-
vation into clinical practice.
To guide its work, COCE has developed a
framework that locates the key topics in COD
along three dimensions: services and service
systems, infrastructure, and special popula-
tions. Services and service systems include
providers and the services they offer; the
nature and structure of the organizations and
systems in which services are delivered; and
the interrelationships among various providers,
organizations, and systems. Infrastructure
includes the wide variety of national, State,
and local policies, programs, and resources
that support, facilitate, catalyze, and otherwise
contribute to the work of service providers and
service systems. Special populations identifies
groups who may require special services, set-
tings, or accommodations to reap the full bene-
fit of COD-related services. At this time, the
core products and services of the COCE are
envisioned as technical assistance and training,
a Web site (www.coce.samhsa.gov), meetings
and conferences, and future COCE products
and services.
Report to Congress on the
Prevention and Treatment of
Co-Occurring Substance Use
Disorders and Mental
Disorders
In response to a Congressional mandate, in
December 2002 the Department of Health and
Human Services provided Congress with a
comprehensive report
on treatment and pre-
vention of co-occur-
ring substance abuse
and mental disorders.
The report empha-
sizes that people with
co-occurring disorders
can and do recover
with appropriate
treatment and support
services. It also finds
there are many long-
standing systemic bar-
riers to appropriate
treatment and support
services for people
with co-occurring dis-
orders, including sep-
arate administrative
structures, eligibility
criteria, and funding
streams, as well as
limited resources for
both mental health
services and substance
abuse treatment. The
report identifies the need for various Federal
and State agencies, providers, researchers,
recovering persons, families, and others to
work together to create a system in which both
disorders are addressed as primary and treated
as such. It also outlines a 5-year blueprint for
action to improve the opportunity for recovery
by increasing the availability of quality preven-
tion, diagnosis, and treatment services for peo-
ple with co-occurring disorders. To access the
full report, see www.samhsa.gov/reports/
congress2002/index.html. 
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As substance abuse
treatment counselors
learn more about
mental illness, they
can better  partner
with mental health
counselors to design
effective treatment
for both disorders.
Co-Occurring Disorders:
Integrated Dual Disorders
Treatment Implementation
Resource Kit
Known simply as the “tool kit,” and developed
by the Psychiatric Research Center at New
Hampshire-Dartmouth under the leadership of
Robert E. Drake, M.D., Ph.D., this resource
package specifically targets clients with COD
who have SMI and who are seeking care
through mental health services available in
their community.
The six evidence-
based practices
described in the tool
kit are collaborative
psychopharmacolo-
gy, ACT, family psy-
choeducation, sup-
ported employment,
illness management
and recovery, and
integrated dual dis-
orders treatment
(substance use and
mental illness).
Using materials ger-
mane to a variety of
audiences (i.e., con-
sumers, family
members/caregivers,
mental health pro-
gram leaders, public
mental health
authorities, and
practitioners/clinical
supervisors), the
tool kit articulates a
flexible basic plan
that allows materials to be used to implement
best practices to their maximum effect. The
tool kit is being produced under a contract
with SAMHSA’s CMHS and through a grant
from The Robert Wood Johnson Foundation
(CMHS in development). 
Organization of 
This TIP 
Scope
The TIP attempts to summarize for the clini-
cian the state-of-the-art in the treatment of
COD in the substance abuse and mental health
fields. It contains chapters on terminology,
assessment, and treatment strategies and mod-
els, as well as recommendations for treatment,
research, and policy planning.
The primary concern of this TIP is co-occur-
ring substance use (abuse and dependence)
and mental disorders, even though it is recog-
nized that this same vulnerable population
also is subject to many other physical and
social ills. The TIP includes important work
on nicotine dependence, a somewhat large
and separate body of work that admittedly
does need further integration into the general
field of COD. Nicotine dependency is treated
here as an important cross-cutting issue.
Finally, although the TIP does address sever-
al specific populations (i.e., homeless, crimi-
nal justice, and women), it does this briefly
and does not describe programs specifically
for adolescents or for such specialized popu-
lations as new Asian and Hispanic/Latino
immigrants. At the same time, the authors
fully recognize, and the TIP states, that all
COD treatment must be culturally relevant. 
Audience
The primary audience for this TIP is substance
abuse treatment clinicians and counselors,
many, but not all, of whom possess certification
in substance abuse counseling or related pro-
fessional licensing. Some may have credentials
in the treatment of mental disorders or in crim-
inal justice services. The TIP is structured to
meet the needs of the addiction counselor with
a basic background as well as the differing
needs of those with intermediate and advanced
backgrounds. Another equally important audi-
ence for the TIP is mental health staff.
Secondary audiences include educators,
researchers, primary care providers, criminal
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The TIP is struc-
tured to meet the
needs of the
addiction coun-
selor with a basic
background as
well as the differ-
ing needs of those
with intermediate
and advanced
backgrounds.
justice staff, and other healthcare and social
service personnel who work with people with
COD.
Approach
The TIP uses three criteria for inclusion of a
particular strategy, technique, or model: (1)
definitive research (i.e., evidence-based treat-
ments), (2) well-articulated approaches with
empirical support, and (3) consensus panel
agreement about established clinical practice.
The information in this TIP derives from a
variety of sources, including the research liter-
ature, conceptual writings, descriptions of
established program models, accumulated clini-
cal experience and expertise, government
reports, and other available empirical evi-
dence. It is a document that reflects the current
state of clinical wisdom in the treatment of
clients with COD.
The TIP keeps two questions in the forefront: 
1. What does the clinician need to know? 
2. How can the information be conveyed in a
manner that makes it readily accessible?
Guidance for the Reader
This TIP is both a resource document and a
guide on COD that contains both up-to-date
knowledge and instructive material. It includes
selected literature reviews, synopses of many
COD treatment approaches, and some empiri-
cal information. The scope of the work in this
field generated a complex and extensive docu-
ment that is probably best read by chapter or
section. It contains text boxes, case histories,
illustrations, and summaries to synthesize
knowledge that is grounded in the practical
realities of clinical cases and real situations. A
special feature throughout the TIP—”Advice
to the Counselor”—provides the TIP’s most
direct and accessible guidance for the coun-
selor. Readers with basic backgrounds, such as
addiction counselors or other practitioners,
can study the Advice to the Counselor boxes
first for the most immediate practical guidance.
In particular, the Advice to the Counselor
boxes provide a distillation of what the coun-
selor needs to know and what steps to take,
which can be followed by a more detailed read-
ing of the relevant material in the section or
chapter.
The chair and co-chair of the TIP consensus
panel plan to continue working with
providers and treatment agencies, and
encouraging others to do likewise, to translate
the concepts and methods of the TIP into
other useable tools specifically shaped to the
needs and resources of each agency and situa-
tion. It is the hope of the consensus panel that
the reader will come away with increased
knowledge, encouragement, and resources for
the important work of treating persons with
COD.
Organization
The TIP is organized into 9 chapters and 14
appendices. Subject areas addressed in each of
the remaining chapters and appendices are as
follows:
Chapter 2. Definitions, terms,
and classification systems for
co-occurring disorders 
This chapter reviews terminology and classifi-
cations related to substance use, clients, treat-
ment, programs, and systems for clients with
COD. Key terms used in the TIP and in the
field are defined to help the reader understand
the framework and language used in this TIP
and how this language relates to other termi-
nology and classifications that are familiar to
the reader. The main classification systems cur-
rently in use in the field are presented.
Chapter 3. Keys to successful
programming 
The chapter begins with a review of some guid-
ing principles in treatment of clients with COD,
and key challenges to establishing services in
substance abuse treatment settings are high-
lighted. This section also presents a system for
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classifying substance abuse treatment programs
to determine an appropriate level of services
and care. The chapter describes some service
delivery issues including access, assessment,
integrated treatment, comprehensive services,
and continuity of care. Finally, critical issues in
workforce development are discussed, includ-
ing values, competencies, education, and train-
ing. 
Chapter 4. Assessment 
This chapter reviews the key principles of
assessment, selected assessment instruments,
and the assessment process. The chapter also
addresses the specific relationship of assess-
ment to treatment planning.
Chapter 5. Strategies for
working with clients with 
co-occurring disorders
This chapter presents guidelines for developing
a successful therapeutic relationship with indi-
viduals who have COD. It describes specific
techniques for counselors that appear to be the
most successful in treating clients with COD
and introduces guidelines that are important
for the successful use of all these strategies.
Chapter 6. Traditional 
settings and models
The chapter begins by addressing essential pro-
gramming for clients with COD that can readily
be offered in most substance abuse treatment
settings. Overarching considerations in effec-
tive treatment for this population, regardless of
setting, are reviewed. Practices are highlighted
that have proven effective for the treatment of
persons with COD in outpatient and residential
settings. The chapter also highlights several dis-
tinctive models. 
Chapter 7. Special settings
and specific populations
This chapter addresses issues related to provid-
ing treatment to clients with COD in acute care
and other medical settings, as well as the need
to sustain these programs. Because of the criti-
cal role mutual self-help groups play in recov-
ery, several dual recovery mutual self-help
groups that address the specific concerns of
clients with COD are described. Resources
available through advocacy groups are high-
lighted. Finally, the chapter discusses the need
to address the particular needs of people with
COD within three key populations: homeless
persons, criminal justice populations, and
women.
Chapter 8. A brief overview
of specific mental disorders
and cross-cutting issues
With the permission of American Psychiatric
Publishing, Inc. (APPI), the consensus panel
has taken the opportunity to present to the
substance abuse treatment audience basic
information contained in the Diagnostic and
Statistical Manual for Mental Disorders, 4th
edition, Text Revised (DSM-IV-TR). The
chapter updates material that was presented
on the major disorders covered in TIP 9 (i.e.,
personality disorders, mood disorders, anxi-
ety disorders, and psychotic disorders) and
adds other mental disorders with particular
relevance to COD that were not covered in
TIP 9 (i.e., attention deficit/hyperactivity dis-
order, PTSD, eating disorders, and patholog-
ical gambling). Suicidality and nicotine
dependency are presented as cross-cutting
issues. The consensus panel is pleased that
APPI has allowed this liberal use of its mate-
rials to help foster the co-occurring disorders
field and positive interchange between the
substance abuse treatment and mental health
services fields.
The chapter contains key information about
substance abuse and the particular mental
disorder, highlighting advice to the counselor
to help in working with clients with those dis-
orders. A relevant case history accompanies
each disorder in this chapter. This chapter is
meant to function as a “quick reference” to
help the substance abuse treatment counselor
understand the mental disorder diagnosis and
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its implications for treatment planning.
Appendix D contains a more extensive discus-
sion of the same disorders.
Chapter 9. Substance-induced
disorders
This chapter provides information on mental
disorder symptoms caused by the use of sub-
stances. It outlines the toxic effect of sub-
stances and provides an overview of substance-
induced symptoms that can mimic mental dis-
orders. 
Appendices
Appendix A. Bibliography
Appendix A contains the references cited in
this TIP and other resources used for back-
ground purposes but not specifically cited.
Appendix B. Acronyms
Appendix B contains a key to all the acronyms
used in this TIP.
Appendix C. Glossary of terms
This appendix contains the definitions of terms
used in this TIP, with the exception of termi-
nology related to specific mental disorders dis-
cussed in chapter 8 and appendix D. For these
specialized terms, the reader is advised to con-
sult a medical dictionary.
Appendix D. Specific mental disor-
ders: Additional guidance for the
counselor
Clients with COD entering treatment often have
several disorders, each of which is associated
with a growing body of knowledge and range of
treatment options. This appendix is meant to
serve substance abuse treatment counselors
and programs as a resource and training docu-
ment that provides more extensive information
on individual mental disorders than could be
included in chapter 8. Although most readers
will not read the entire appendix at one time,
this mental disorder-oriented section is includ-
ed so that a counselor who is working with a
new client with one or more of these disorders
can have detailed information readily avail-
able. 
Appendix E. Emerging models
In this appendix, the reader can find descrip-
tions of several recent models of care for per-
sons with COD that were (or are being) evalu-
ated under initiatives funded by SAMHSA’s
CSAT. Though selective and based primarily
on available information from recent SAMHSA
initiatives, it is hoped that these models will
suggest ways in which readers working with a
variety of client types and symptom severities
in different settings can improve their capaci-
ties to assess and treat these clients. 
Appendix F. Common medications
for disorders
Because medication is such an important
adjunct to treatment, this appendix offers a
brief review of key issues in pharmacologic
management. A table of common medications
for various disorders follows this discussion,
with comments on the effects of these medica-
tions and their implications for addiction
counselors and treatment. This material is
taken from the Pharmacological Management
section of TIP 9 (CSAT 1994a, pp. 91–94),
followed by the complete text of Psycho-
therapeutic Medications 2004: What Every
Counselor Should Know (Mid-America
Addiction Technology Transfer Center 2004).
Appendix G. Screening and assess-
ment instruments
A list of selected screening and assessment tools
referenced in chapter 4, along with key infor-
mation on the use of each instrument, appears
in this appendix. As a full review of these
instruments was beyond the scope of this TIP,
readers are urged to review the literature to
determine their reliability, validity, and utility,
and to gain an understanding of their applica-
bility to specific situations. 
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Appendix H. Sample screening
instruments 
This appendix offers two screening instruments
available for unrestricted use:
•The Mental Health Screening Form-III
•The Simple Screening Instrument for
Substance Abuse 
Appendix I. Selected resources of
training
Here the reader finds some of the most readily
available and well-used sources of training in
substance abuse treatment, mental health ser-
vices, and co-occurring disorders.
Appendix J. Dual recovery mutual
self-help programs and other
resources for consumers and
providers
This appendix provides a brief description and
contact information for several mutual self-
help groups discussed in the TIP.
Appendix K. Confidentiality 
This appendix provides a brief description of
the Federal Alcohol and Drug Confidentiality
Law and Regulations (42 C.F.R. Part 2) and
the Health Insurance Portability and
Accountability Act of 1996.
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1
“These estimates are from the National Comorbidity Survey. The survey was based on interviews administered to a
probability sample of the noninstitutionalized U.S. civilian population. The NCS sample consisted of 8,098 respondents,
age 15 to 54 years. This survey was conducted from September 1990 to February 1992. DSM-III-R criteria were used as
the basis for assessing disorders in the general population. A random sample of initial nonrespondents was contacted
further and received a financial incentive to participate. A nonresponse weight was used to adjust for the higher rates of
[alcohol, drugs, or mental (ADM) disorders] found in the sample of initial nonresponders. The Composite International
Diagnostic Interview was modified to eliminate rare diagnoses in the age group studied and to add probes to improve
understanding and motivation. The ‘substance abuse/dependence’ category includes drugs and alcohol. ‘Any ADM dis-
order’ includes the following: affective, anxiety, substance abuse/dependence, nonaffective psychosis, and antisocial per-
sonality disorders. ‘Affective disorders’ include major depressive episode, manic episode, and dysthymia. Anxiety disor-
ders include panic disorder, agoraphobia, social phobia, simple phobia, and generalized anxiety disorder. Antisocial
personality was assessed only on a lifetime basis. Nonaffective psychoses include schizophrenias, delusional disorder,
and atypical psychoses. Substance abuse/dependence includes both abuse of and dependence on alcohol and other
drugs” (SAMHSA 1998, p. 7).
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2 Definitions, Terms,
and Classification
Systems for Co-
Occurring Disorders
Overview
This chapter reviews and defines many of the terms that are applied
commonly to co-occurring substance use and mental disorders (COD).
Discussion points include how different terms have emerged, the con-
texts in which various classification systems are likely to be used, and
why many of the specific terms and classification systems used through-
out this TIP were chosen.
After a review of basic terminology related to substance use (including
the distinction between abuse and dependence) and a brief description of
mental disorders, the chapter discusses terms related to clients. A key
point is the importance of using person-centered terminology as a way of
acknowledging each client’s individuality. The chapter notes the many
terms that may be used to describe co-occurring disorders, reviews the
terms related to treatment and programs, and concludes with an
overview of terms that describe the systems of care within which treat-
ment occurs and programs operate.
The addiction counselor should be aware that the terminology and
classifications introduced in this chapter, though important and use-
ful, were developed by different groups for different purposes.
Therefore, these terms do not necessarily form a seamless picture or
work smoothly together. Nevertheless, they are useful and appropri-
ate when used in the intended context. The reader who becomes con-
versant with these terms and classifications will find it easier to navi-
gate the discussion of treatment issues (chapter 3) and to follow the
TIP’s narrative.
Finally, this chapter contains brief Advice to the Counselor boxes,
which readers with basic backgrounds, such as addiction counselors
or other practitioners, can refer to for the most immediate practical
guidance. (For a full listing of these boxes see the table of contents.)
In This
Chapter…
Terms Related to
Substance Use
Disorders 
Terms Related to
Mental Disorders
Terms Related 
to Clients
Terms Related 
to Treatment
Terms Related 
to Programs
Terms Related 
to Systems
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Terms Related to
Substance Use
Disorders
Substance abuse and substance dependence
are two types of substance use disorders and
have distinct meanings. The standard use of
these terms derives from the Diagnostic and
Statistical Manual of Mental Disorders, 4th
edition (DSM-IV) (American Psychiatric
Association [APA] 1994). Produced by the
APA and updated periodically, DSM-IV is
used by the medical and mental health fields
for diagnosing mental and substance use dis-
orders. This reference provides clinicians
with a common language for communicating
about these disorders. The reference also
establishes criteria for diagnosing specific dis-
orders. 
Substance abuse, as defined in DSM-IV-TR
(4th edition, Text Revision; APA 2000), is a
“maladaptive pattern of substance use mani-
fested by recurrent and significant adverse
consequences related to the repeated use of
substances” (APA 2000, p. 198). Individuals
who abuse substances may experience such
harmful consequences of substance use as
repeated failure to fulfill roles for which they
are responsible, legal difficulties, or social
and interpersonal problems. It is important
to note that the chronic use of an illicit drug
still constitutes a significant issue for treat-
ment even when it does not meet the criteria
for substance abuse specified in the text box
below.
For individuals with more severe or disabling
mental disorders, as well as for those with
developmental disabilities and traumatic
brain injuries, even the threshold of sub-
stance use that might be harmful (and there-
fore defined as abuse) may be significantly
lower than for individuals without such disor-
ders. Further-more, the more severe the dis-
ability, the lower the amount of substance use
that might be harmful.
Substance dependence is more serious than
abuse. This maladaptive pattern of substance
use includes such features as increased toler-
ance for the substance, resulting in the need
for ever-greater amounts of the substance to
achieve the intended effect; an obsession with
securing the substance and with its use; or
persistence in using the substance in the face
of serious physical or mental health prob-
lems. See the text box on page 23 for more
information.
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Criteria for a Diagnosis of Substance Abuse
A. A maladaptive pattern of substance use leading to clinically significant impairment or distress, as mani-
fested by one (or more) of the following, occurring within a 12-month period:
1. Recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home
(e.g., repeated absences or poor work performance related to substance use; substance-related
absences, suspensions, or expulsions from school; neglect of children or household)
2. Recurrent substance use in situations in which it is physically hazardous (e.g., driving an automobile or
operating a machine when impaired by substance use)
3. Recurrent substance-related legal problems (e.g., arrests for substance-related disorderly conduct)
4. Continued substance use despite having persistent or recurrent social or interpersonal problems caused
by or exacerbated by the effects of the substance (e.g., arguments with spouse about consequences of
intoxication, physical fights)
B. The symptoms have never met the criteria for Substance Dependence for this class of substance.
Source: APA 2000, p. 199.
The term substance abuse has come to be
used informally to refer to both abuse and
dependence. Substance abuse treatment pro-
fessionals commonly use the term “substance
abuse” to describe any excessive use of addic-
tive substances, whether the substance is
alcohol or another drug. By and large the
terms “substance dependence” and “addic-
tion” have come to mean the same thing,
though there is debate about the interchange-
able use of these terms. When only those who
are diagnosed as dependent are referenced,
the specific term will be used. 
Terms Related to
Mental Disorders
The standard use of terms for non-substance
use mental disorders, like the terms for sub-
stance use disorders, derive from the DSM-IV-
TR (APA 2000). These terms are used through-
out the medical and mental health fields for
diagnosing mental disorders. As with substance
use disorders, this reference provides clinicians
with a common language for communicating
about these disorders. The reference also
establishes criteria for diagnosing specific dis-
orders. (See chapter 1, Figure 1-2 for an
overview of the association between specific
mental disorders and substance use disorders.)
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Criteria for a Diagnosis of Substance Dependence
A maladaptive pattern of substance use, leading to clinically significant impairment or distress, as manifested by
three (or more) of the following, occurring at any time in the same 12-month period:
1. Tolerance, as defined by either of the following:
a. A need for markedly increased amounts of the substance to achieve intoxication or desired effect.
b. Markedly diminished effect with continued use of the same amount of the substance.
2. Withdrawal, as manifested by either of the following:
a. The characteristic withdrawal syndrome for the substance (refer to the DSM-IV-TR, Criteria A and B of
the criteria sets for withdrawal from the specific substances).
b. The same (or a closely related) substance is taken to relieve or avoid withdrawal symptoms.
3. The substance is often taken in larger amounts or over a longer period than was intended.
4. There is a persistent desire or unsuccessful efforts to cut down or control substance use.
5. A great deal of time is spent in activities necessary to obtain the substance (e.g., visiting multiple doctors
or driving long distances), use the substance (e.g., chain-smoking), or recover from its effects.
6. Important social, occupational, or recreational activities are given up or reduced because of substance
use.
7. The substance use is continued despite knowledge of having a persistent or recurrent physical or mental
health problem that is likely to have been caused or exacerbated by the substance (e.g., current cocaine
use despite recognition of cocaine-induced depression, or continued drinking despite recognition that an
ulcer was made worse by alcohol consumption).
Source: APA 2000, p. 197.
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The following section provides a brief introduc-
tion to some (not, by any means, all) of these
disorders and offers advice to the addiction
counselor and other practitioners for working
with clients with these disorders. The consen-
sus panel recognizes that addiction counselors
are not expected to diagnose mental disorders.
Clinicians in the substance abuse treatment
field, however, should familiarize themselves
with the mental disorders that co-occur with
substance use disorders and/or that mimic
symptoms of substance use disorders, particu-
larly withdrawal or intoxication. The aim of
providing this material is only to increase sub-
stance abuse treatment counselors’ familiarity
with the mental disorders terminology and cri-
teria necessary to provide advice on how to
proceed with clients who demonstrate these dis-
orders. (See chapter 8 and appendix D for
more complete material on mental disorders co-
occurring with substance use disorders.) 
Personality Disorders
These are the disorders most commonly seen by
the addiction counselor and in quadrant III
substance abuse treatment settings (see Figure
2-1 for a depiction of the four quadrants).
Individuals with personality disorders have
symptoms and personality traits that are
enduring and play a major role in most, if not
all, aspects of the person’s life. These individu-
als have personality traits that are persistent
and cause impairment in social or occupational
functioning or cause personal distress.
Symptoms are evident in their thoughts (ways
of looking at the world, thinking about self or
others), emotions (appropriateness, intensity,
and range), interpersonal functioning (relation-
ships and interpersonal skills), and impulse
control.
Personality disorders are listed in the DSM-
IV under three distinct areas, referred to as
“clusters.” The clusters are listed below with
the types of symptoms or traits seen in that
category. The specific personality disorders
included in each cluster also are listed. For
personality disorders that do not fit any of
the specific disorders, the diagnosis of “per-
sonality disorder not otherwise specified” is
used.
Cluster A: Hallmark traits of this cluster
involve odd or eccentric behavior. It includes
paranoid, schizoid, and schizotypal personal-
ity disorders.
Cluster B: Hallmark traits of this cluster
involve dramatic, emotional, or erratic
behavior. It includes antisocial, borderline,
histrionic, and narcissistic personality disor-
ders.
Cluster C: Hallmark traits of this cluster
involve anxious, fearful behavior. It includes
avoidant, dependent, and obsessive-compul-
sive personality disorders.
The prevalence of co-occurring substance
abuse and antisocial personality disorder is
high (Flynn et al. 1997). In fact, much of sub-
stance abuse treatment is targeted to those
with antisocial personality disorders and sub-
stance abuse treatment alone has been espe-
cially effective for these disorders. Below is
an Advice to the Counselor box on working
with clients who have antisocial personality
disorder; similar and more
detailed advice boxes can
be found throughout the
TIP.
Psychotic
Disorders
The common characteristics
of these disorders are symp-
toms that center on prob-
Advice to the Counselor: 
Antisocial Personality Disorders
• Confront dishonesty and antisocial behavior directly and 
firmly.
• Hold clients responsible for the behavior and its conse-
quences.
• Use peer communities to confront behavior and foster
change.
Definitions, Terms, and Classification Systems for Co-Occurring Disorders
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lems of thinking. The most promi-
nent (and problematic) symptoms
are delusions or hallucinations.
Delusions are false beliefs that sig-
nificantly hinder a person’s abili-
ty to function. For example, a
client may believe that people are
trying to hurt him, or he may
believe he is someone else (a CIA
agent, God, etc.). Hallucinations
are false perceptions in which a
person sees, hears, feels, or smells
things that aren’t real (i.e., visu-
al, auditory, tactile, or olfactory).
Psychotic disorders are seen most frequently
in mental health settings and, when combined
with substance use disorders, the substance
disorder tends to be severe. Clients with psy-
chotic disorders constitute what commonly is
referred to as the serious and persistent men-
tally ill population. Increasingly, individuals
with serious mental illness are present in sub-
stance abuse treatment programs (Gustafson
et al. 1999).
Drugs (e.g., cocaine, methamphetamine, or
phencyclidine) can produce delusions and/or
hallucinations secondary to drug intoxication.
Furthermore, psychotic-like symptoms may
persist beyond the acute intoxication period.
Schizophrenia
This is one of the most common of the psy-
chotic disorders and one of the most destruc-
tive in terms of the effect it has on a person’s
life. Symptoms may include the following: hal-
lucinations, delusions, disorganized speech,
grossly disorganized or catatonic behavior,
social withdrawal, lack of interest, and poor
hygiene. The disorder has several specific types
depending on what other symptoms the person
experiences. In the paranoid type there is a
preoccupation with one or more delusions or
frequent auditory hallucinations. These often
are experienced as threatening to the person.
In the disorganized type there is a prominence
of all of the following: disorganized speech, dis-
organized behavior, and flat or inappropriate
affect (i.e., emotional expression).
Mood Disorders
The disorders in this category include those
where the primary symptom is a disturbance in
mood, where there may be inappropriate, exag-
gerated, or a limited range of feelings or emo-
tions. Everyone feels “down” sometimes, and
everybody experiences feelings of excitement or
emotional pleasure. However, when a
client has a mood disorder, these feelings
or emotions are experienced to the
extreme. Many people with substance use
disorders also have a co-occurring mood
disorder and tend to use a variety of
drugs in association with their mood dis-
order. There are several types of mood
disorders, including depression, mania,
and bipolar disorder.
Depression. Instead of just feeling
“down,” the client might not be able to
work or function at home, might feel
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Advice to the Counselor:
Psychotic Disorders
• Screen for psychotic disorders and refer identified clients
for further diagnostic evaluation.
• Obtain a working knowledge of the signs and symptoms
of the disorder. 
• Educate the client and family about the condition.
• Help the client detect early signs of its re-occurrence by
recognizing the symptoms associated with the disorder.
Advice to the Counselor: 
Mood and Anxiety Disorders
• Differentiate between mood disorders, common-
place expressions of depression, and depression asso-
ciated with more serious mental illness.
• Conduct careful and continuous assessment since
mood symptoms may be the result of substance
abuse and not an underlying mental disorder.
• Combine addiction counseling with medication and
mental health treatment.
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suicidal, lose his or her appetite, and feel
very tired or fatigued. Other symptoms can
include loss of interest, weight changes,
changes in sleep and appetite, feelings of
worthlessness, loss of concentration, and
recurrent thoughts of death.
Mania. This includes feelings that are toward
the opposite extreme of depression. There
might be an excess of energy where sleep is
not needed for days at a time. The client may
be feeling “on top of the world,” and during
this time, the client’s decisionmaking process
might be significantly impaired and expansive
and he may experience irritability and have
aggressive outbursts, although he might think
such outbursts are perfectly rational.
Bipolar. A person with bipolar disorder
cycles between episodes of mania and depres-
sion. These episodes are characterized by a
distinct period of abnormally elevated,
expansive, or irritable mood. Symptoms may
include inflated self-esteem or grandiosity,
decreased need for sleep, being more
talkative than usual, flight of ideas or a feel-
ing that one’s thoughts are racing, dis-
tractibility, increase in goal-directed activity,
excessive involvement in pleasurable activities
that have a high potential for painful conse-
quences (sexual indiscretions, buying sprees,
etc.). Excessive use of alcohol is common dur-
ing periods of mania.
Anxiety disorders. As with mood disorders,
anxiety is something that everyone feels now
and then, but anxiety disorders exist when
anxiety symptoms reach the point of frequen-
cy and intensity that they cause significant
impairment. In addiction treatment popula-
tions, the most common anxiety syndrome
seen is that associated with early recovery,
which can be a mix of substance withdrawal
and learning to live without the use of drugs
or alcohol. This improves with time and
addiction treatment. However, other anxiety
disorders that may occur, but need particular
assessment and treatment, are social phobia
(fear of appearing or speaking in front of
groups), panic disorder (recurrent panic
attacks that usually last a few hours, cause
great fear, and make it hard to breathe), and
posttraumatic stress disorders (which cause
recurrent nightmares, anxiety, depression,
and the experience of reliving the traumatic
issues).
Terms Related to
Clients
Person-Centered Terminology
In recent years, consumer advocacy groups
have expressed concerns related to how clients
are classified. Many take exception to terminol-
ogy that seems to put them in a “box” with a
label that follows them through life, that does
not capture the fullness of their identities. A
person with COD also may be a mother, a
plumber, a pianist, a student, or a person with
diabetes, to cite just a few examples. Referring
to an individual as a person who has a specific
disorder—a person with depression rather
than “a depressive,” a person with schizophre-
nia rather than “a schizophrenic,” or a person
who uses heroin rather than “an addict”—is
more acceptable to many clients because it
implies that they have many characteristics
besides a stigmatized illness, and therefore that
they are not defined by this illness.
Terms for Co-Occurring
Disorders
Many terms have been used in the field to
describe the group of individuals who have
COD (most of these terms do not reflect the
“people-first” approach used in this TIP).
Some of these terms represent an attempt to
identify which problem or disorder is seen as
primary or more severe. Others have devel-
oped in the literature in order to argue for set-
ting aside funding for special services or to
identify a group of clients who may benefit
from certain interventions. These terms include
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•MICA—mentally ill chemical abuser. This
acronym is sometimes seen with two As
(MICAA) to signify mentally ill chemically
addicted or affected. There are regional dif-
ferences in the meaning of this acronym.
Many States use it to refer specifically to per-
sons with serious mental disorders.
•MISA—mentally ill substance abuser.
•MISU—mentally ill substance using.
•CAMI—chemically abusing mentally ill, or
chemically addicted and mentally ill.
•SAMI—substance abusing mentally ill.
•MICD—mentally ill chemically dependent.
•Dually diagnosed.
•Dually disordered.
•Comorbid disorders.
•ICOPSD—individuals with co-occurring psy-
chiatric and substance disorders.
While all of these terms have their uses, many
have developed connotations that are not help-
ful or that have become too broad or varied in
interpretation to be useful. For example, “dual
diagnosis” also can mean having both mental
and developmental disorders. Readers who
hear these terms should not assume they all
have the same meaning as COD and should
seek to clarify the client characteristics associ-
ated with a particular term. Readers also
should realize that the term “co-occurring dis-
order” is not inherently precise and distinctive;
it also may become distorted by popular use,
with other conditions becoming included within
the term. The issue here is that clients/con-
sumers may have a number of health condi-
tions that “co-occur,” including physical health
problems. Nevertheless, for the purpose of this
TIP, co-occurring disorders refers to substance
use disorders and mental disorders.
Some clients’ mental health problems may not
fully meet the strict definition of co-occurring
substance use and mental disorders criteria
for diagnoses in DSM-IV categories. However,
many of the relevant principles that apply to
the treatment of COD also will apply to these
individuals. Careful assessment and treat-
ment planning to take each disorder into
account will still be important. Suicidal
ideation is an excellent example of a mental
health symptom that creates a severity prob-
lem, but alone doesn’t necessarily meet crite-
ria for a formal DSM-IV condition since suici-
dality is a symptom and not a diagnosis.
Substance-induced suicidal ideation can pro-
duce catastrophic consequences. Some indi-
viduals may exhibit symptoms that could indi-
cate the existence of COD but could also be
transitory; for example, substance-induced
mood swings, which can mimic bipolar disor-
der, or amphetamine-induced hallucinations
or paranoia, which could mimic schizophre-
nia. Depending on the severity of their symp-
toms, these individuals also may require the
full range of services needed by those who
meet the strict criterion of having both condi-
tions independently, but generally for acute
periods until the substance-induced symp-
toms resolve.
Terms Related to
Treatment
Levels of Service
The American Society of Addiction Medicine’s
Patient Placement Criteria (ASAM PPC-2R)
(ASAM 2001) envisions treatment as a continu-
um within which there are five levels of care.
These levels of care are as follows:
• Level 0.5: Early Intervention
• Level I: Outpatient Treatment
• Level II: Intensive Outpatient/Partial
Hospitalization Treatment
• Level III: Residential/Inpatient Treatment
• Level IV: Medically Managed Intensive
Inpatient Treatment
Each level of care includes several levels of
intensity indicated by a decimal point. For
example, Level III.1 refers to “Clinically
Managed Low-Intensity Residential
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Treatment.” A client who has COD might be
appropriately placed in any of these levels of
service. 
Substance abuse counselors also should be
aware that some mental health professionals
may use another system, the Level of Care
Utilization System for Psychiatric and
Addiction Services. This system also identifies
levels of care, including
• Level 1: Recovery Maintenance Health
Management
• Level 2: Low Intensity Community Based
Services
• Level 3: High Intensity Community Based
Services
• Level 4: Medically Monitored Non-
Residential Services
• Level 5: Medically Monitored Residential
Services
• Level 6: Medically Managed Residential
Services
These levels, like the ASAM levels, use a vari-
ety of specific dimensions to describe a client in
order to determine the most appropriate place-
ment (see the section in chapter 4, “Assessment
Step 5,” for more information about these
dimensions).
Quadrants of Care 
The quadrants of care are a conceptual frame-
work that classifies clients in four basic groups
based on relative symptom severity, not 
diagnosis. 
• Category I: Less severe mental disorder/
less severe substance disorder
• Category II: More severe mental disorder/
less severe substance disorder
• Category III: Less severe mental disorder/
more severe substance 
disorder
• Category IV: More severe mental disorder/
more severe substance disor-
der (National Association of
State Mental Health Program
Directors [NASMHPD] and
National Association of State
Alcohol and Drug Abuse
Directors [NASADAD] 1999) 
For a more detailed description of each quad-
rant, see Figure 2-1 and text box on p. 30.
The quadrants of care were derived from a
conference, the National Dialogue on Co-
Occurring Mental Health and Substance
Abuse Disorders, which was supported by the
Substance Abuse and Mental Health Services
Administration (SAMHSA) and two of its cen-
ters—the Center for Substance Abuse
Treatment (CSAT) and the Center for Mental
Health Services—and co-sponsored by
NASMHPD and NASADAD. The quadrants
of care is a model originally developed by
Ries (1993) and used by the State of New
York (NASMHPD and NASADAD 1999; see
also Rosenthal 1992).
The four-quadrant model has two distinct
uses:
•To help conceptualize an individual client’s
treatment and to guide improvements in sys-
tem integration (for example, if the client has
acute psychosis and is known to the treat-
ment staff to have a history of alcohol depen-
dence, the client will clearly fall into
Category IV—that is, severe mental disorder
and severe substance use disorder). However,
the severity of the client’s needs, diagnosis,
symptoms, and impairments all determine
level of care placement.
•To guide improvements in systems integra-
tion, including efficient allocation of
resources. The NASMHPD–NASADAD
National Dialogue recognized that currently
“there is no single locus of responsibility for
people with COD. The mental health and
substance abuse treatment systems operate
independently of one another, as separate
cultures, each with its own treatment philoso-
phies, administrative structures, and funding
mechanisms. This lack of coordination means
that neither consumers nor providers move
easily among service settings” (NASMHPD
and NASADAD 1999, p. ii).
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Although the chapters of this TIP are not orga-
nized around the four-quadrant framework,
most of the material in chapters 3 through 7 is
directed primarily to addiction counselors
working in quadrant III settings and other
practitioners working in quadrant II settings.
Interventions
Intervention refers to the specific treatment
strategies, therapies, or techniques that are
used to treat one or more disorders.
Interventions may include psychopharmacol-
ogy, individual or group counseling, cogni-
tive–behavioral therapy, motivational
enhancement, family interventions, 12-Step
recovery meetings, case management, skills
training, or other strategies. Both substance
use and mental disorder interventions are
targeted to the management or resolution of
acute symptoms, ongoing treatment, relapse
prevention, or rehabilitation of a disability
associated with one or more disorders,
whether that disorder is mental or associated
with substance use. 
Integrated Interventions
Integrated interventions are specific treat-
ment strategies or therapeutic techniques in
which interventions for both disorders are
combined in a single session or interaction, or
in a series of interactions or multiple sessions.
Integrated interventions can include a wide
range of techniques. Some examples include
•Integrated screening and assessment 
processes
•Dual recovery mutual self-help meetings
•Dual recovery groups (in which recovery
skills for both disorders are discussed)
•Motivational enhancement interventions
(individual or group) that address issues
related to both mental health and substance
abuse or dependence problems
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Category I
Mental disorders less severe
Substance abuse disorders
less severe Locus of care
Primary health care set-
tings
Category II
Mental disorders more severe
Substance abuse disorders less
severe Locus of care
Mental health system
Category III
Mental disorders less severe
Substance abuse disorders
more severe Locus of care
Substance Abuse System
Category IV
Mental disorders more severe
Substance abuse disorders
more severe Locus of care
State hospitals, jails/prisons,
emergency rooms, etc.
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•Group interventions for persons with the
triple diagnosis of mental disorder, substance
use disorder, and trauma, or which are
designed to meet the needs of persons with
COD and another shared problem such as
homelessness or criminality
•Combined psychopharmacological interven-
tions, in which an individual receives medica-
tion designed to reduce cravings for sub-
stances as well as medication for a mental
disorder
Integrated interventions can be part of a single
program or can be used in multiple program
settings.
Episodes of Treatment
An individual with COD may participate in
recurrent episodes of treatment involving acute
stabilization (e.g., crisis intervention, detoxifi-
cation, psychiatric hospitalization) and specific
ongoing treatment (e.g., mental-health–sup-
ported housing, mental-health day treatment,
or substance abuse residential treatment). It is
important to recognize the reality that clients
engage in a series of treatment episodes, since
many individuals with COD progress gradually
through repeated involvement in treatment.
Integrated Treatment
Integrated treatment refers broadly to any
mechanism by which treatment interventions
for COD are combined within the context of a
Level of Care Quadrants
Quadrant I: This quadrant includes individuals with low severity substance abuse and low severity
mental disorders. These low severity individuals can be accommodated in intermediate outpatient set-
tings of either mental health or chemical dependency programs, with consultation or collaboration
between settings if needed. Alternatively, some individuals will be identified and managed in primary
care settings with consultation from mental health and/or substance abuse treatment providers.
Quadrant II: This quadrant includes individuals with high severity mental disorders who are usually
identified as priority clients within the mental health system and who also have low severity substance
use disorders (e.g., substance dependence in remission or partial remission). These individuals ordi-
narily receive continuing care in the mental health system and are likely to be well served in a variety
of intermediate level mental health programs using integrated case management.
Quadrant III: This quadrant includes individuals who have severe substance use disorders and low or
moderate severity mental disorders. They are generally well accommodated in intermediate level sub-
stance abuse treatment programs. In some cases there is a need for coordination and collaboration
with affiliated mental health programs to provide ongoing treatment of the mental disorders.
Quadrant IV: Quadrant IV is divided into two subgroups. One subgroup includes individuals with seri-
ous and persistent mental illness (SPMI) who also have severe and unstable substance use disorders.
The other subgroup includes individuals with severe and unstable substance use disorders and severe
and unstable behavioral health problems (e.g., violence, suicidality) who do not (yet) meet criteria for
SPMI. These individuals require intensive, comprehensive, and integrated services for both their sub-
stance use and mental disorders. The locus of treatment can be specialized residential substance abuse
treatment programs such as modified therapeutic communities in State hospitals, jails, or even in set-
tings that provide acute care such as emergency rooms (see chapter 7 for an example in an emergency
room setting). 
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primary treatment relationship or service set-
ting. Integrated treatment is a means of
actively combining interventions intended to
address substance use and mental disorders
in order to treat both disorders, related prob-
lems, and the whole person more effectively.
Culturally Competent
Treatment
One definition of cultural competence refers
to “the capacity of a service provider or of an
organization to understand and work effec-
tively with the cultural beliefs and practices
of persons from a given ethnic/racial group”
(Castro et al. 1999, p. 504). Treatment
providers working with individuals with COD
should view these clients and their treatment
in the context of their language, culture, eth-
nicity, geographic area, socioeconomic status,
gender, age, sexual orientation, religion, spir-
ituality, and any physical or cognitive disabil-
ities. For a full discussion of cultural issues in
treatment for persons with substance use dis-
orders, see the forthcoming TIP Improving
Cultural Competence in Substance Abuse
Treatment (CSAT in development a).
Cultural factors that may have an impact on
treatment include heritage, history and expe-
rience, beliefs, traditions, values, customs,
behaviors, institutions, and ways of communi-
cating. The client’s culture may include dis-
tinctive ways of understanding disease or dis-
order, including mental and substance use
disorders, which the provider needs to under-
stand. Referencing a model of disease that is
familiar to the client can help communication
and enhance treatment. The counselor
acquires cultural knowledge by becoming
aware of the cultural factors that are impor-
tant to a particular ethnic group or client.
Cultural competence may be viewed as a con-
tinuum on which, through learning, the
provider increases his or her understanding
and effectiveness with different ethnic groups.
Various researchers have described the mark-
ers on this continuum (Castro et al. 1999;
Cross 1988; Kim et al. 1992). The continuum
moves from cultural destructiveness, in which
an individual regards other cultures as inferi-
or to the dominant culture, through cultural
incapacity and blindness to the more positive
attitudes and greater levels of skill described
below:
•Cultural sensitivity is being “open to work-
ing with issues of culture and diversity”
(Castro et al. 1999, p. 505). Viewed as a
point on the continuum, however, a cultur-
ally sensitive individual has limited cultural
knowledge and may still think in terms of
stereotypes.
•Cultural competence, when viewed as the
next stage on this continuum, includes an
ability to “examine and understand
nuances” and exercise “full cultural empa-
thy.” This enables the counselor to “under-
stand the client from the client’s own cul-
tural perspective” (Castro et al. 1999, p.
505).
•Cultural proficiency is the highest level of
cultural capacity. In addition to under-
standing nuances of culture in even greater
depth, the culturally proficient counselor
also is working to advance the field through
leadership, research, and outreach (Castro
et al. 1999, p. 505).
It is important to remember that clients, not
counselors, define what is culturally relevant
to them. It is possible to damage the relation-
ship with a client by making assumptions,
however well intentioned, about the client’s
cultural identity. For example, a client of
Hispanic origin may be a third-generation
United States citizen, fully acculturated, who
feels little or no connection with her Hispanic
heritage. A counselor who assumes this client
shares the beliefs and values of many
Hispanic cultures would be making an erro-
neous generalization. Similarly, it is helpful to
remember that all of us represent multiple
cultures. Clients are not simply African–
American, white, or Asian. A client who is a
20-year-old African-American man from the
rural south may identify, to some extent, with
youth, rural south, or African-American cul-
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tural elements—or may, instead, identify
more strongly with another cultural element,
such as his faith, that is not readily apparent.
Counselors are advised to open a respectful
dialog with clients around the cultural ele-
ments that have significance to them.
Integrated Counselor
Competencies
A counselor has integrated competencies if he
or she has the specific attitudes, values, knowl-
edge, and skills needed to provide appropriate
services to individuals with COD in the context
of his or her actual job and program setting. 
Just as other types of integration exist on a
continuum, so too does integrated competency.
Some interventions and/or programs require
clinicians only to have basic competency in wel-
coming, screening, assessing, and identifying
treatment needs of individuals with COD.
Other interventions, programs, or job func-
tions (e.g., those of supervisory staff) may
require more advanced integrated competency.
The more complex or unstable the client, the
more formal mechanisms are required to coor-
dinate the various staff members working with
that client in order to provide effective inte-
grated treatment.
A number of service delivery systems are
moving toward identification of a required
basic level of integrated competency for all
clinicians in the mental health and substance
abuse treatment systems. Many States also
are developing curricula for initial and ongo-
ing training and supervision to help clinicians
achieve these competencies. Other State sys-
tems (e.g., Illinois) have created career lad-
ders and certification pathways to encourage
clinicians to achieve higher levels of integrat-
ed competency and to reward them for this
achievement. (See chapter 3 for a full discus-
sion of counselor competencies.)
Terms Related to
Programs 
A program is a formally organized array of ser-
vices and interventions provided in a coherent
manner at a specific level or levels of care in
order to address the needs of particular target
populations. Each program has its own staff
competencies, policies, and procedures.
Programs may be operated directly by public
funders (e.g., States and counties) or by pri-
vately funded agencies. An individual agency
may operate many different programs. Some
agencies operate only mental health programs,
some operate only substance abuse treatment
programs, and some do both. An individual,
licensed healthcare practitioner (such as a psy-
chiatrist or psychologist) may offer her or his
own integrated treatment services as an inde-
pendent practitioner.
Key Programs
Mental health-based 
programs
A mental health program is an organized array
of services and interventions with a primary
focus on treating mental disorders, whether by
providing acute stabilization or ongoing treat-
ment. These programs may exist in a variety of
settings, such as traditional outpatient mental
health centers (including outpatient clinics and
psychosocial rehabilitation programs) or more
intensive inpatient treatment units.
Many mental health programs treat signifi-
cant numbers of individuals with COD.
Programs that are more advanced in treating
persons with COD may offer a variety of
interventions for substance use disorders
(e.g., motivational interviewing, substance
abuse counseling, skills training) within the
context of the ongoing mental health treat-
ment.
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Substance abuse treatment
programs
A substance abuse treatment program is an
organized array of services and interventions
with a primary focus on treating substance use
disorders, providing both acute stabilization
and ongoing treatment.
Substance abuse treatment programs that are
more advanced in treating persons with COD
may offer a variety of interventions for mental
disorders (e.g., psychopharmacology, symptom
management training) within the context of the
ongoing substance abuse treatment. 
Program Types
The ASAM PPC-2R (ASAM 2001) describes
three different types of programs for people
with COD:
•Addiction only services. This term refers to
programs that “either by choice or for lack
of resources, cannot accommodate patients
who have mental illnesses that require
ongoing treatment, however stable the ill-
ness and however well-functioning the
patient” (ASAM 2001, p. 10). 
•Dual diagnosis capable (DDC) programs are
those that “address co-occurring mental
and substance-related disorders in their
policies and procedures, assessment, treat-
ment planning, program content and dis-
charge planning” (ASAM 2001, p. 362).
Even where such programs are geared pri-
marily to treat substance use disorders,
program staff are “able to address the
interaction between mental and substance-
related disorders and their effect on the
patient’s readiness to change—as well as
relapse and recovery environment issues—
through individual and group program con-
tent” (ASAM 2001, p. 362).
•Dual diagnosis enhanced programs have a
higher level of integration of substance
abuse and mental health treatment services.
These programs are able to provide prima-
ry substance abuse treatment to clients who
are, as compared to those treatable in DDC
programs, “more
symptomatic
and/or functionally
impaired as a
result of their co-
occurring mental
disorder” (ASAM
2001, p. 10).
Enhanced-level ser-
vices “place their
primary focus on
the integration of
services for mental
and substance-
related disorders in
their staffing, ser-
vices and program
content” (ASAM
2001, p. 362).
See chapter 3 for a
discussion of pro-
gram terminology proposed by the consensus
panel that works well for both the substance
abuse and mental health fields (i.e., “basic,”
“intermediate,” and “advanced”) and for a
crosswalk of this terminology with the ASAM
program types. 
Terms Related to
Systems 
For the purposes of this TIP, a system is a
means of organizing a number of different
treatment programs and related services to
implement a specific mission and common
goals. A basic example of a system is 
SAMHSA. Single State Agencies are systems
that organize statewide services. There may
also be county, city, or local systems in vari-
ous areas.
A system executes specific functions by pro-
viding services and related activities. It is
often, but not always, a government agency.
Systems may be defined according to a num-
ber of different characteristics: a section of
government, a geographic entity, or a payor
(e.g., the Medicaid system of care). 
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common goals.
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Systems work with other systems in a variety
of ways and with different degrees of integra-
tion. The primary systems with which people
with COD interact are the substance abuse
treatment and mental health services systems.
Other systems that frequently come into play
are health care, criminal justice, and social
services. Systems are usually the entities that
determine funding, standards of care, licens-
ing, and regulation.
Substance Abuse Treatment
System
The substance abuse treatment system encom-
passes a broad array of services organized
into programs intended to treat substance use
disorders (including illegal substances, such
as marijuana and methamphetamine, and
legal substances, such as alcohol for adults
over 21 years of age). It also includes services
organized in accord with a particular treat-
ment approach or philosophy (e.g.,
methadone treatment for opioid dependence
or therapeutic communities). A system may
be defined by a combination of administrative
leadership (e.g., through a designated direc-
tor of substance abuse treatment services),
regulatory oversight (e.g., all programs that
have substance abuse treatment licenses), or
funding (e.g., all programs that receive cate-
gorical substance abuse funding, or, more
rarely, bill third-party payors for providing
substance abuse services).
In most substance abuse treatment systems,
the primary focus is on providing distinct
treatment episodes for the acute stabilization,
engagement, active treatment, ongoing reha-
bilitation of substance use disorders, and
relapse prevention. More intensive services
are almost invariably targeted to the treat-
ment of substance dependence. The primary
focus of intervention is abstinence from illicit
drugs for those who use illicit drugs and from
alcohol for those who use alcohol excessively.
Mental Health Service System
The mental health service system includes a
broad array of services and programs intended
to treat a wide range of mental disorders. Like
the substance abuse treatment system, the
coherence of the mental health system is
defined by a combination of administrative
leadership (e.g., through a designated director
of mental health services), regulatory oversight
(e.g., all programs which have mental health
licenses), and funding (e.g., all programs which
receive categorical mental health funding or
that primarily bill third party payors for pro-
viding mental health services). 
In most mental health systems, services are
provided for a wide range of mental disor-
ders; however, in many publicly financed
mental health programs, the priority is on
acute crisis intervention and stabilization and
on the provision of ongoing treatment and
rehabilitative services for individuals identi-
fied as having SPMI. Typically, the mental
health system identifies a cohort of priority
clients (identified by a State’s definition of
SPMI) for which it assumes continuing
responsibility, often by providing continuing
case management, psychiatric rehabilitation
services, and/or housing support services.
Interlinking Systems
Depending on the life area affected at a given
moment, individuals with COD may present
themselves at different venues. For example, a
person who experiences an array of problems
in addition to the COD—such as homelessness,
legal problems, and general medical prob-
lems—may first be seen at a housing agency or
medical clinic. Historically, the distinctive
boundaries maintained between systems have
impeded the ability of individuals with COD to
access needed services (Baker 1991; Schorske
and Bedard 1989).
Intersystem linkages are essential to a compre-
hensive service delivery system. Fundamental
to effective linkage is the collaboration between
substance abuse treatment and mental health
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systems, because they are the primary care sys-
tems for persons with COD. The coordination
of these systems enhances the quality of ser-
vices by removing barriers that impede access
to needed services. For example, access to care
and quality of care have been impeded histori-
cally by the failure to address issues of lan-
guage and culture. Intersystem coordination
can lead to cohesive and coordinated delivery
of program and services, where the burden is
not on the individual to negotiate services and
the system’s resources are used more effective-
ly. The criminal justice system now plays a cen-
tral role in the delivery of treatment for both
mental health and substance use disorders,
especially for those persons with COD, so it is
important to ensure coordination with this sys-
tem as well. Community health centers and
other primary health providers also play criti-
cal roles in substance use disorder treatment
and mental health treatment.
Comprehensive Continuous
Integrated System of Care
The Comprehensive Continuous Integrated
System of Care model (CCISC) is a model to
bring the mental health and substance abuse
treatment systems (and other systems, poten-
tially) into an integrated planning process to
develop a comprehensive, integrated system of
care. The CCISC is based on the awareness
that COD are the expectation throughout the
service system. The entire system is organized
in ways consistent with this assumption. This
includes system-level policies and financing, the
design of all programs, clinical practices
throughout the system, and basic clinical com-
petencies for all clinicians. This model derives
from the work of the SAMHSA Managed Care
Initiative Consensus Panel on developing stan-
dards of care for individuals with COD (Center
for Mental Health Services 1998; Minkoff
2001a). CCISCs are grounded in the following
assumptions: 
•The four-quadrant model is a valid model for
service planning. 
•Individuals with COD benefit from continu-
ous, integrated treatment relationships.
•Programs should provide integrated primary
treatment for substance use and mental dis-
orders in which interventions are matched to
diagnosis, phase of recovery, stage of change,
level of functioning, level of care, and the
presence of external supports and/or contin-
gencies. 
This model has been identified by SAMHSA as
an exemplary practice and is at various stages
of implementation in a number of States. States
in various stages of implementing the CCISC
model include Alabama, Alaska, Arizona,
Maine, Maryland, Massachusetts, Montana,
and New Mexico, as well as the District of
Columbia. Regional projects are underway in
Florida, Louisiana, Michigan, Oregon, Texas,
and Virginia.
Definitions, Terms, and Classification Systems for Co-Occurring Disorders
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In This
Chapter…
Guiding Principles
Delivery of
Services
Improving
Substance Abuse
Treatment Systems
and Programs
Workforce
Development and
Staff Support
Overview
Many treatment agencies may recognize the need to provide quality care
to persons with co-occurring disorders (COD), but see it as a daunting
challenge beyond their resources. Programs that already have incorpo-
rated some elements of integrated services and want to do more may lack
a clear framework for determining priorities. As programs look to
improve their effectiveness in treating this population, what should they
consider? How could the experience of other agencies inform their plan-
ning process? Are resources available that could help turn such a vision
into reality? This chapter is designed both to help agencies that want to
design programs for their clients with COD and to assist agencies that
are trying to improve existing ones.
The chapter begins with a review of guiding principles derived from
proven models, clinical experience, and the growing base of empirical
evidence. Building on these guiding principles, the chapter turns to the
core components for effective service delivery. It suggests that the
provider needs to address in concrete terms the challenges of providing
access, assessment, appropriate level of care, integrated treatment, com-
prehensive services, and continuity of care. This section provides guid-
ance relevant to designing processes that are appropriate for this popu-
lation within each of these key areas. 
The chapter then moves onto a discussion of strategies for agencies that
want to improve established systems, beginning with the too-familiar
issue of how to access funding—a major hurdle for most, if not all, sub-
stance abuse treatment agencies. This portion of the chapter also gives
an example of how one collaborative project crosses agency lines to
share resources among a variety of partners and ensure continuity of
care. The chapter then discusses difficulties of achieving equitable
resource allocations for a venture of this nature, and highlights efforts to
integrate research and practice.
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Finally, the critical issues in workforce devel-
opment are discussed, for without a well-pre-
pared staff, the needs of these often-challenging
clients cannot be met—regardless of what other
systemic changes are made. The chapter
describes the attitudes and values needed to
successfully treat these clients, required compe-
tencies, paths to professional development for
those who wish to increase their skills in treat-
ing clients with COD, and ways of avoiding
staff burnout and reducing turnover—an espe-
cially pressing concern for providers who work
closely with this demanding population.
Guiding Principles
The consensus panel developed a list of guiding
principles to serve as fundamental building
blocks for programs that offer services to
clients with COD (see Figure 3-1). These princi-
ples derive from a variety of sources: conceptu-
al writings, well-articulated program models, a
growing understanding of the essential features
of COD, elements common to separate treat-
ment models, clinical experience, and available
empirical evidence. These principles may be
applied at both a program level (e.g., providing
literature for people with cognitive impair-
ments) or at the individual level (e.g., address-
ing the client’s basic needs). 
In identifying these principles, the TIP consen-
sus panel recognizes that there are a number of
carefully elaborated protocols to guide treat-
ment for individuals with COD, including prin-
ciples identified by Drake and colleagues (1993)
and by the Center for Mental Health Services
Managed Care Initiative Panel (1998), as well
as the assumptions that underlie the model
Comprehensive Continuous Integrated Systems
of Care described in chapter 2. The principles
suggested in this chapter are consistent with
these protocols, but reflect the specific focus of
the consensus panel on how best to provide
COD treatment in substance abuse treatment
agencies. (However, the principles apply equal-
ly well to the treatment of COD in mental
health agencies.)
The following section discusses each of the six
principles in turn, highlighting the related field
experience that underlies each one.
Employ a Recovery
Perspective
There are two main features of the recovery
perspective: It acknowledges that recovery is a
long-term process of internal change, and it
recognizes that these internal changes proceed
through various stages. (See De Leon 1996 and
Prochaska et al. 1992 for a detailed descrip-
tion. Also see chapter 5 of this TIP for a dis-
cussion of the recovery perspective as a guide-
line for practice.)
The recovery perspective is applicable to
clients who have COD. It generates at least two
main principles for practice:
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Figure 3-1
Six Guiding Principles in Treating Clients With COD
1. Employ a recovery perspective.
2. Adopt a multi-problem viewpoint.
3. Develop a phased approach to treatment. 
4. Address specific real-life problems early in treatment.
5. Plan for the client’s cognitive and functional impairments.
6. Use support systems to maintain and extend treatment effectiveness.
Develop a treatment plan that provides for
continuity of care over time. In preparing this
plan, the clinician should recognize that treat-
ment may occur in different settings over time
(i.e., residential, outpatient) and that much of
the recovery process typically occurs outside of
or following treatment (e.g., through participa-
tion in mutual self-help groups and through
family and community support, including the
faith community). It is important to reinforce
long-term participation in these continuous
care settings.
Devise treatment interventions that are specific
to the tasks and challenges faced at each stage
of the co-occurring disorder recovery process.
Whether within the substance abuse treatment
or mental health services system, the clinician
is advised to use sensible stepwise approaches
in developing and using treatment protocols. In
addition, markers that are unique to individu-
als—such as those related to their cultural,
social, or spiritual context—should be consid-
ered. It is important to engage the client in
defining markers of progress meaningful to the
individual and to each stage of recovery.
Adopt a Multi-Problem
Viewpoint
People with COD generally have an array of
mental health, medical, substance abuse, fami-
ly, and social problems. Most are in need of
substantial rehabilitation and habilitation (i.e.,
initial learning and acquisition of skills).
Treatment should address immediate and long-
term needs for housing, work, health care, and
a supportive network. Therefore, services
should be comprehensive to meet the multi-
dimensional problems typically presented by
clients with COD. 
Develop a Phased Approach
to Treatment
Many clinicians view clients as progressing
though phases (Drake and Mueser 1996a;
McHugo et al. 1995; Osher and Kofoed 1989;
Sacks et al. 1998b). Generally, three to five
phases are identified, including engagement,
stabilization, treatment, and aftercare or con-
tinuing care. These phases are consistent
with, and parallel to, stages identified in the
recovery perspective. As noted above, use of
these phases enables the clinician (whether
within the substance abuse treatment or men-
tal health services system) to develop and use
effective, stage-appropriate treatment proto-
cols. (See chapter 5 for a discussion of how to
use motivational enhancement therapy appro-
priate to the client’s stage of recovery. Also
see TIP 35, Enhancing Motivation for Change
in Substance Abuse Treatment [Center for
Substance Abuse Treatment (CSAT) 1999b]).
Address Specific Real-Life
Problems Early in Treatment
The growing recognition that co-occurring dis-
orders arise in a context of personal and social
problems, with a corresponding disruption of
personal and social life, has given rise to
approaches that address specific life problems
early in treatment. These approaches may
incorporate case management and intensive
case management to help clients find housing or
handle legal and family matters. It may also be
helpful to use specialized interventions that tar-
get important areas of client need, such as
money management (e.g., Conrad et al. 1999)
and housing-related support services (e.g.,
Clark and Rich 1999). Psychosocial rehabilita-
tion, which helps the client develop the specific
skills and approaches she needs to perform her
chosen roles (e.g., student, employee, commu-
nity member) also is a useful strategy for
addressing these specific problems (Anthony
1996; Cnaan et al. 1990). 
Solving such problems often is an important
first step toward achieving client engagement in
continuing treatment. Engagement is a critical
part of substance abuse treatment generally
and of treatment for COD specifically, since
remaining in treatment for an adequate length
of time is essential to achieving behavioral
change. 
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Plan for the Client’s Cognitive
and Functional Impairments 
Services for clients with COD, especially those
with more serious mental disorders, must be
tailored to individual needs and functioning.
Clients with COD often display cognitive and
other functional impairments that affect their
ability to comprehend information or complete
tasks (CSAT 1998e; Sacks et al. 1997b). The
manner in which interventions are presented
must be compatible with client needs and func-
tioning. Such impairments frequently call for
relatively short, highly structured treatment
sessions that are focused on practical life prob-
lems. Gradual pacing, visual aids, and repeti-
tion often are helpful. Even impairments that
are comparatively subtle (e.g., certain learning
disabilities) may still have significant impact on
treatment success. Careful assessment of such
impairments and a treatment plan consistent
with the assessment are therefore essential.
Use Support Systems To
Maintain and Extend
Treatment Effectiveness
The mutual self-help movement, the family, the
faith community, and other resources that exist
within the client’s community can play an
invaluable role in recovery. This can be partic-
ularly true for the client with COD, as many
clients with COD have not enjoyed a consistent-
ly supportive environment for decades. In some
cultures, the stigma surrounding substance use
or mental disorders is so great that the client
and even the entire family may be ostracized
by the immediate community. Furthermore, the
behaviors associated with active substance use
may have alienated the client’s family and com-
munity. The clinician plays a role in ensuring
that the client is aware of available support sys-
tems and motivated to use them effectively.
Mutual self-help
Based on the Alcoholics Anonymous model, the
mutual self-help movement has grown to
encompass a wide variety of addictions.
Narcotics Anonymous and Cocaine Anonymous
are two of the largest mutual self-help organiza-
tions for substance use disorders; Recoveries
Anonymous and Schizophrenics Anonymous
are among the best known for mental illness.
Personal responsibility, self-management, and
helping one another are the basic tenets of
mutual self-help approaches. Such programs
apply a broad spectrum of personal responsi-
bility and peer support principles, usually
including 12-Step methods that prescribe a
planned regimen of change (see Peyrot 1985 for
the history, structure, and approach of
Narcotics Anonymous, representative of 12-
Step approaches in general). However, in the
past clients with COD felt that either their men-
tal health or their substance use issues could
not be addressed in a single-themed mutual
self-help group; that has changed.
Mutual self-help principles, highly valued in
the substance abuse treatment field, are now
widely recognized as important components in
the treatment of COD. Mutual self-help groups
may be used as an adjunct to primary treat-
ment, as a continuing feature of treatment in
the community, or both. These groups not only
provide a vital means of support during outpa-
tient treatment, but also are used commonly in
residential programs such as therapeutic com-
munities. As clients gain employment, travel,
or relocate, mutual self-help meetings may
become the most easily accessible means of pro-
viding continuity of care. For a more extensive
discussion of dual recovery mutual self-help
programs applicable to persons with COD, see
chapter 7.
Building community
The need to build an enduring community aris-
es from three interrelated factors—the persis-
tent nature of COD, the recognized effective-
ness of mutual self-help principles, and the
importance of client empowerment. The thera-
peutic community (TC), modified mutual self-
help programs for COD (e.g., Double Trouble
in Recovery), and the client consumer move-
ment all reflect an understanding of the critical
role clients play in their own recovery, as well
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as the recognition that support from other
clients with similar problems promotes and sus-
tains change. 
Reintegration with family
and community
The client with COD who successfully com-
pletes treatment must face the fragility of
recovery, the toxicity of the past environment,
and the negative impact of previous associates
who may encourage drug or alcohol use and
illicit or maladaptive behaviors. There is a
need for groups and activities that support
change. In this context it is important that
these clients receive support from family and
significant others where that support is avail-
able or can be developed. There is also the
need to help the client reintegrate into the com-
munity through such resources as religious,
recreation, and social organizations. (See chap-
ter 6 for a discussion of continuing care issues
in treatment.)
Delivery of Services
While the guiding principles described above
serve as the fundamental building blocks for
effective treatment, ensuring effective treat-
ment requires attention to other variables. This
section discusses six core components that form
the ideal delivery of services for clients with
COD. These include:
1. Providing access
2. Completing a full assessment
3. Providing an appropriate level of care
4. Achieving integrated treatment
5. Providing comprehensive services
6. Ensuring continuity of care
Providing Access
“Access” refers to the process by which a per-
son with COD makes initial contact with the
service system, receives an initial evaluation,
and is welcomed into services that are appro-
priate for his or her needs. 
Access occurs in four main ways:
1. Routine access for individuals seeking ser-
vices who are not in crisis
2. Crisis access for individuals requiring imme-
diate services due to an emergency
3. Outreach, in which agencies target individu-
als in great need (e.g., people who are
homeless) who are not seeking services or
cannot access ordinary routine or crisis ser-
vices
4. Access that is involuntary, coerced, or man-
dated by the criminal justice system,
employers, or the child welfare system
Treatment access may
be complicated by
clients’ criminal jus-
tice involvement,
homelessness, or
health status. CSAT’s
“no wrong door” poli-
cy should be applied
to the full range of
clients with COD, and
programs should
address obstacles that
bar entry to treatment
for either the mental
or substance use dis-
orders. (See chapter 7
for recommendations
on removing systemic
barriers to care and
the text box on p. 42
for more on CSAT’s
“no wrong door” 
policy.)
Completing a Full Assessment
While chapter 4 provides a complete descrip-
tion of the assessment process, this section
highlights several important features of assess-
ment that must be considered in the context of
effective service delivery. Assessment of indi-
viduals with COD involves a combination of the
following:
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It is important
that clients receive
support from fam-
ily and significant
others where that 
support is 
available or can
be developed.
•Screening to detect the possible presence of
COD in the setting where the client is first
seen for treatment
•Evaluation of background factors (family,
trauma history, marital status, health, educa-
tion and work history), mental disorders,
substance abuse, and related medical and
psychosocial problems (e.g., living circum-
stances, employment, family) that are critical
to address in treatment planning
•Diagnosis of the type and severity of sub-
stance use and mental disorders
•Initial matching of individual client to ser-
vices (often, this must be done before a full
assessment is completed and diagnoses clari-
fied; also, the client’s motivation to change
with regard to one or more of the co-occur-
ring disorders may not be well established)
•Appraisal of existing social and community
support systems
•Continuous evaluation (that is, re-evaluation
over time as needs and symptoms change and
as more information becomes available)
The challenge of assessment for individuals
with COD in any system involves maximizing
the likelihood of the identification of COD,
immediately facilitating accurate treatment
planning, and revising treatment over time as
the client’s needs change. 
Providing an Appropriate
Level of Care 
Clients enter the treatment system at various
levels of need and encounter agencies with
varying capacity to meet those needs. Ideally,
clients should be placed in the level of care
appropriate to the severity of both their sub-
stance use disorder and their mental illness. 
The American Society of Addiction Medicine’s
(ASAM) classification is one standard way of
identifying programs that offer the needed ser-
vices. As described in chapter 2, ASAM
describes programs’ ability to address COD as
“addiction only services,” “dual diagnosis
capable,” and “dual diagnosis enhanced.” 
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Making “No Wrong Door” a Reality
CSAT’s “no wrong door” policy states that effective systems must ensure that an individual needing treatment
will be identified and assessed and will receive treatment, either directly or through appropriate referral, no
matter where he or she enters the realm of services (CSAT 2000a). The consensus panel strongly endorses this
policy.
The focus of the “no wrong door” imperative is on constructing the healthcare delivery system so that treatment
access is available at any point of entry. A client with COD needing treatment might enter the service system by
means of primary healthcare facilities, homeless shelters, social service agencies, emergency rooms, or criminal
justice settings. Some clients require the creation of a “right door” for treatment entry—for example, mobile
outreach teams who can access clients with COD who are unlikely to knock on the door of any treatment facili-
ty. 
The “no wrong door” approach has five major implications for service planning:
1. Assessment, referral, and treatment planning for all settings must be consistent with a “no wrong door” poli-
cy.
2. Creative outreach strategies may be needed to encourage some people to engage in treatment. 
3. Programs and staff may need to change expectations and program requirements to engage reluctant and
“unmotivated” clients. 
4. Treatment plans should be based on clients’ needs and should respond to changes as they progress through
stages of treatment.
5. The overall system of care needs to be seamless, providing continuity of care across service systems. This can
only be achieved through an established pattern of interagency cooperation or a clear willingness to attain
that cooperation.
While recognizing ASAM’s contribution, the
consensus panel suggests an alternative classifi-
cation system: basic, intermediate, advanced,
or fully integrated. As conceived by the consen-
sus panel
•A basic program has the capacity to provide
treatment for one disorder, but also screens
for the other disorder and can access neces-
sary consultations.
•A program with an intermediate level of
capacity tends to focus primarily on one
disorder without substantial modification to
its usual treatment, but also explicitly
addresses some specific needs of the other
disorder. For example, a substance abuse
treatment program may recognize the
importance of continued use of psychiatric
medications in recovery, or a psychiatrist
could provide motivational interviewing
regarding substance use while prescribing
medication for mental disorders.
•A program with an advanced level of capac-
ity provides integrated substance abuse
treatment and mental health services for
clients with COD. Several program models
of this sort are described in chapter 6.
Essentially, these programs address COD
using an integrated perspective and provide
services for both disorders. This usually
means strengthening substance abuse treat-
ment in the mental health setting by adding
interventions such as mutual self-help and
relapse prevention groups. It also means
adding mental health services, such as psy-
choeducational classes on mental disorder
symptoms and groups for medication moni-
toring, in substance abuse treatment set-
tings. Collaboration with other agencies
may add to the comprehensiveness of ser-
vices.
•A program that is fully integrated actively
combines substance abuse and mental
health interventions to treat disorders,
related problems, and the whole person
more effectively. 
The suggested classification has several advan-
tages. For one, it avoids the use of the term
“dual diagnosis” (instead of COD) and allows a
more general, flexible approach to describing
capacity without specific criteria. In addition,
the recommended classification system concep-
tualizes a bidirectionality of movement where
either substance abuse or mental health agen-
cies can advance toward more integrated care
for clients with COD, as shown in Figure 3-2 
(p. 44). 
Figure 3-2 depicts a model of basic, intermedi-
ate (COD capable), and advanced (COD
enhanced) programming within mental health
services and substance abuse treatment sys-
tems. The idea of integrated COD treatment is
shown in the center. For the purpose of this
TIP, both mental health and substance abuse
treatment providers may be conceived of as
beginning, intermediate, or advanced in terms
of their progress toward the highest level of
capacity to treat persons with COD. 
It should also be recognized that not all ser-
vices want or need to be fully integrated, since
many clients do not need a full array of ser-
vices. (See Figure 2-1 in chapter 2.) In Figure
3-2, the middle box—fully integrated—refers
to a system that has achieved an integrated set-
ting in which staff, administration, regulations,
and funding streams are fully integrated. 
Achieving Integrated
Treatment
The concept of integrated treatment for per-
sons with severe mental disorders and sub-
stance use disorders, as articulated by Minkoff
(1989), emphasized the need for correlation
between the treatment models for mental health
services and substance abuse treatment in a
residential setting. Minkoff’s model stressed the
importance of well-coordinated, stage-specific
treatment (i.e., engagement, primary treat-
ment, continuing care) of substance use and
mental disorders, with emphasis on dual recov-
ery goals as well and the use effective treatment
strategies from both the mental health services
and the substance abuse treatment fields. 
During the last decade integrated treatment
continued to evolve. Several successful treat-
ment models have been described for addiction
settings (Charney et al. 2001; McLellan et al.
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1993; Saxon and Calsyn 1995; Weisner et al.
2001), including the addition of psychiatric and
mental health services to methadone treatment
(Kraft et al. 1997; Woody et al. 1983), and a
modified therapeutic community for providing
integrated care to persons with COD (De Leon
1993b; Guydish et al. 1994; Sacks 2000; Sacks
et al. 1997a, b, 1998a, 2002). Likewise, the lit-
erature also describes numerous models for
mental health settings (CSAT 1994a; Drake and
Mueser 1996b; Lehman and Dixon 1995;
Minkoff and Drake 1991; Zimberg 1993).
Figure 3-3 illustrates one vision of a compre-
hensive, fully integrated approach to treatment
for persons with severe mental disorders and
substance use disorders from the mental health
literature. However, as noted in the following
section, programs may be integrated in a vari-
ety of ways.
The literature from both the substance abuse
and mental health fields has evolved to
describe integrated treatment as a unified
treatment approach to meet the substance
abuse, mental health, and related needs of a
client. It is the preferred model of treatment. 
Integrated treatment can occur on different
levels and through different mechanisms. For
example:
•One clinician delivers a variety of needed 
services.
•Two or more clinicians work together to pro-
vide needed services.
•A clinician may consult with other specialties
and then integrate that consultation into the
care provided.
•A clinician may coordinate a variety of efforts
in an individualized treatment plan that inte-
grates the needed services. For example, if
someone with housing needs was not accepted
at certain facilities, the clinician might work
with a State-level community-housing pro-
gram to find the transitional or supported
housing the client needs.
•One program or program model (e.g., modi-
fied TC or Assertive Community Treatment)
can provide integrated care. 
•Multiple agencies can join together to create a
program that will serve a specific population.
For example, a substance abuse treatment
program, a mental health center, a local
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Figure 3-2
Levels of Program Capacity in Co-Occurring Disorders
housing authority, a foundation, a county
government funding agency, and a neighbor-
hood association could join together to estab-
lish a treatment center to serve women with
COD and their children. 
Integrated treatment also is based on positive
working relationships between service
providers. The National Association of State
Mental Health Program Directors 
(NASMHPD) and the National Association of
State Alcohol and Drug Abuse Directors’
(NASADAD) four-quadrant category frame-
work described in chapter 2 provides a useful
structure for fostering consultation, collabora-
tion, and integration among systems and
providers to deliver appropriate care to every
client with COD (see chapter 2, Figure 2-1).
According to the NASMHPD–NASADAD
(1999) framework
•Consultation refers to the traditional types
of informal relationships among
providers—from referrals to requests for
exchanging information and keeping each
other informed. The framework calls for
particular attention to the consultation
relationship during identification, engage-
ment, prevention, and early intervention
activities.
•Collaboration is essential when a person
who is receiving care in one treatment set-
ting also requires services from another
provider. Collaboration is distinguished
from consultation on the basis of the formal
quality of collaborative agreements, such as
memoranda of understanding or service
contracts, which document the roles and
responsibilities each party will assume in a
continuing relationship. For example, par-
ties must ensure that they can share infor-
mation without violating Federal Law 42
C.F.R. Part 2 on confidentiality (see
appendix K for more information). This will
require the client to give written authoriza-
tion for release of information to all
providers.
•Integration denotes “those relationships
among mental health and substance abuse
providers in which the contributions of pro-
fessionals in both fields are moved into a
single treatment setting and treatment regi-
men” (p. 15).
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Figure 3-3
A Vision of Fully Integrated Treatment for COD
•The client participates in one program that provides treatment for both disorders. 
•The client’s mental and substance use disorders are treated by the same clinicians.
•The clinicians are trained in psychopathology, assessment, and treatment strategies for both mental and sub-
stance use disorders.
•The clinicians offer substance abuse treatments tailored for clients who have severe mental disorders. 
•The focus is on preventing anxiety rather than breaking through denial.
•Emphasis is placed on trust, understanding, and learning.
•Treatment is characterized by a slow pace and a long-term perspective.
•Providers offer stagewise and motivational counseling. 
•Supportive clinicians are readily available. 
•12-Step groups are available to those who choose to participate and can benefit from participation. 
•Neuroleptics and other pharmacotherapies are indicated according to clients’ psychiatric and other medical
needs. 
Source: Adapted from Drake et al. 1998b, p. 591.
For the purposes of this TIP, integration is seen
as a continuum. Depending on the needs of the
client and the constraints and resources of par-
ticular systems, appropriate degrees and means
of integration will differ. 
Providing Comprehensive
Services
People with COD have a range of medical and
social problems—multidimensional problems
that require comprehensive services. In addi-
tion to treatment for their substance use and
mental disorders, these clients often require a
variety of other services to address other social
problems and stabilize their living conditions.
Treatment providers should be prepared to
help clients access a broad array of services,
including life skills development, English as a
second language, parenting, nutrition, and
employment assistance.
McLellan and colleagues have shown the need
for wraparound services to address difficult-to-
treat public-sector clients, not all of whom were
diagnosed with COD (Gould et al. 2000;
McLellan et al. 1997). Two areas of particular
value, highlighted below, are housing and
work.
Housing
The high proportion of homelessness among
clients with COD has focused attention on the
importance of providing housing for people
with COD and of integrating housing into treat-
ment. Approaches vary from those that provide
housing at the point of entry into the service
system combined with case management and
supportive services (Tsemberis and Asmussen
1999), to those that provide housing as a
reward contingent on successful completion of
treatment (Milby et al. 1996; Schumacher et al.
1995), or as part of a continuing care strategy
that combines housing and continuing care ser-
vices (Sacks et al. 1998a, 2003a).
Addressing housing needs requires an ongoing
relationship with housing authorities, land-
lords, and other housing providers. Groups
and seminars that discuss housing issues also
may be necessary to help clients with COD
transition from residential treatment to hous-
ing. Another effective strategy for easing the
transition has been organizing and coordinat-
ing housing tours with supportive housing pro-
grams. Finally, relapse prevention efforts are
essential, since substance abuse generally dis-
qualifies clients from public housing in the
community.
Work
Vocational rehabilitation has long been one of
the services offered to clients recovering from
mental disorders and, to some degree, to those
recovering from substance use disorders.
However, in the past clients often were expect-
ed first to maintain a period of abstinence. As a
result of this policy, people with serious mental
disorders often were underserved, if served at
all (CSAT 2000c). For people with COD,
Blankertz and colleagues contend that, “work
can serve as a rehabilitative tool and be an
integral part of the process of stabilizing the
mental illness and attaining sobriety”
(Blankertz et al. 1998, p. 114).
The fact is that many individuals with COD
are unemployed. However, it is unreasonable
to expect employers to tolerate employees who
are actively using alcohol on the job or who
violate their drug-free workplace policies.
Therefore, if work is to become an achievable
goal for individuals with COD, vocational
rehabilitation and substance abuse treatment
must be closely integrated into mental health
rehabilitation (Blankertz et al. 1998). For
more information about incorporating voca-
tional rehabilitation into treatment, see TIP
38, Integrating Substance Abuse Treatment
and Vocational Services (CSAT 2000c).
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Ensuring Continuity of Care
Continuity of care implies coordination of care
as clients move across different service systems
(e.g., Morrissey et al. 1997). Since both sub-
stance use and mental disorders frequently are
long-term conditions, treatment for persons
with COD should take into consideration reha-
bilitation and recovery over a significant period
of time. Therefore, to be effective, treatment
must address the three features that character-
ize continuity of care:
•Consistency between primary treatment and
ancillary services
•Seamlessness as clients move across levels of
care (e.g., from residential to outpatient
treatment)
•Coordination of present and past treatment
episodes
It is important to set up systems that prevent
gaps between service system levels and between
clinic-based services and those outside the clin-
ic. The ideal is to include outreach, employ-
ment, housing, health care and medication,
financial supports, recreational activities, and
social networks in a comprehensive and inte-
grated service delivery system.
Empirical evidence related to
continuity of care 
Evidence for the benefits of ensuring continuity
of care comes from multiple sources. In one
study of criminal justice populations not specif-
ically identified as having COD, Wexler and
colleagues (1999) found that at 3 years post-
treatment only 27 percent of those prison pro-
gram completers who also completed an after-
care program were returned to custody. In con-
trast, about three-fourths of the subjects in all
other study groups were returned. Similar
findings have been reported by Knight and col-
leagues (1999). Although selection bias exists in
these studies for entry into aftercare, the long-
term outcomes suggest the critical role of after-
care in maintaining positive treatment effects in
the criminal justice population. 
A study of homeless
clients with COD pro-
vided further evi-
dence (again with
selection bias into
aftercare) that after-
care is crucial to posi-
tive treatment out-
comes. In this study,
clients who lived in
supported housing
after residing in a
modified therapeutic
community demon-
strated reductions in
antisocial behavior
occurring during the
residential modified
therapeutic community program and stabilizing
during supported housing, while increases in
prosocial behavior were largely incremental
and continuous throughout both the residential
and supported housing programs (Sacks et al.
2003a).
Organizing continuity of care 
In organizing continuity of care—a high-priori-
ty aspect of any treatment plan for a client with
COD—the substance abuse treatment agency
must carefully consider and strive to overcome
systemic barriers. It is important to recognize
that the public mental health and substance
abuse treatment systems have evolved in differ-
ent ways, and these differing histories must be
recognized as collaborative ventures are
formed. 
Community mental health centers were creat-
ed to be relatively comprehensive in nature,
but have not been funded to deliver compre-
hensive services. Furthermore, there are wide
variations in the types of mental disorders
that publicly funded mental health centers
are permitted to treat; many restrict their
services to those in acute crisis or who have
serious and persistent mental illnesses, such
as schizophrenia, bipolar affective disorder,
or major depression. Many States explicitly
prevent public mental health programs from
47Keys to Successful Programming
Continuity of care
implies coordina-
tion of care as
clients move
across different
service systems.
treating those with primary substance use dis-
orders. 
Substance abuse treatment programs exist
within a variety of organizational structures.
Many of them are stand-alone substance abuse
treatment programs, several are part of com-
prehensive drug treatment agencies, some are
affiliated with hospitals, some are located with-
in hospitals, many have evolved as part of the
criminal justice system, some exist in communi-
ty mental health settings, and still others are
faith-based programs. Many substance abuse
treatment programs are the last refuge of the
most underserved populations (e.g., the home-
less).
The different organizational structures and set-
tings in which services occur influence the ease
or difficulty of providing a service delivery net-
work that is integrated, comprehensive, and
continuous. Many of the larger drug treatment
agencies are to be commended for developing
state-of-the-art programming for COD, and
some smaller programs also have extended
themselves to serve this population. Neverthe-
less, the strains imposed by organizational and
system constraints should be recognized. As
substance abuse treatment agencies continue to
develop their capabilities for treating clients
with COD, the consensus panel recommends
that groups of providers organize themselves
into coherent systems of care that enable them
to provide comprehensive services. 
An example of a collaborative that promotes
the development of a local infrastructure in
support of co-occurring treatment is the Co-
Occurring Collaborative of Southern Maine.
The Collaborative’s ways of working, accom-
plishments, and the critical elements for suc-
cess identified at the close of Figure 3-4 may
well inspire others to weave similar structures,
crossing agency boundaries to better serve
shared clients. 
Improving Substance
Abuse Treatment
Systems and Programs
Critical challenges face substance abuse treat-
ment systems and programs that are intent on
improving care for clients with COD. One of
the most critical of these is how to organize a
system that will provide continuity of care for
these clients, who, as noted previously, often
have multifaceted needs and require long-term
treatment plans. Another, of course, is how to
access funding for program improvement.
When treatment providers from different sys-
tems cooperate, equitable allocation of funds
also becomes an issue. Finally, at every level
there is the problem of how best to integrate
research and practice to give clients the benefit
of the proven treatment strategies. This section
addresses each of these major concerns in turn.
Assessing the Agency’s
Potential To Serve Clients
With COD 
Every agency that already is treating or plan-
ning to treat clients with COD should assess the
current profile of its clients, as well as the esti-
mated number and type of potential new clients
in the community. It also must consider its cur-
rent capabilities, its resources and limitations,
and the services it wants to provide in the
future. 
Programs should consider performing a needs
assessment to determine the prevalence of COD
in their client population, the demographics of
those clients, and the nature of the disorders
and accompanying problems they present.
These data help create a picture of client needs
that can be useful not only to the agency itself,
but also to other systems of care at various lev-
els. All levels of government demand some form
of needs assessment from provider agencies.
Block grant requirements from the Federal
government require a statewide needs assess-
ment. In turn, States look to regional and
county groups to perform a needs assessment
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Figure 3-4
The Co-Occurring Collaborative of Southern Maine
The Co-Occurring Collaborative of Southern Maine, a 501(c)(3) nonprofit corporation, is an alliance of member
agencies, consumers, and family members in Cumberland County in southern Maine. Formed in 1992 through
a State initiative on COD, the Collaborative provided the umbrella structure for a demonstration grant from
The Bingham Program and The Robert Wood Johnson Foundation. It received additional support from
Maine’s Office of Substance Abuse and Maine’s Medicaid Program for a project comparing the efficacy of inte-
grated and coordinated care. The Collaborative has continued its work beyond the 3-year demonstration grant
with funding from the Maine Office of Substance Abuse, becoming an integral part of the community’s efforts to
address COD. In 1998, the Collaborative formalized its structure by becoming a Maine nonprofit corporation.
The number of member agencies has expanded from an initial dozen to more than 30, including consumer
groups, family groups, and mental health, substance abuse, criminal justice, HIV, and public health service
providers. Each member agency has an identified liaison who serves as the bridge between the Collaborative
and the agency. Each member agency formally commits through a memorandum of understanding to do the fol-
lowing: 
1. Support the Collaborative’s mission.
2. Examine and make changes to the services and organizational structures to support improved service provi-
sion for persons with COD.
3. Exchange information, share resources, and alter activities to enhance the capacities of all agencies to
improve services for persons with COD.
4. Participate actively in, and share responsibility for, the Collaborative.
The Collaborative structure provides a mechanism for cross-agency and cross-disciplinary communication,
coordination, training and education, creative interagency problemsolving, resource development for co-occur-
ring recovery capacity, and advocacy. The Collaborative’s accomplishments to date include
•Promoting dual competence expectations in the workforce
•Obtaining grants and collaborating on grant submission 
•Expanding consumer, family, and provider partnerships 
•Developing the mutual self-help option of dual recovery 
•Supporting diversion planning from the criminal justice system
•Supporting the creation of an Assertive Community Treatment team for individuals with COD
•Creating a community service consultation team
•Supporting transfer of knowledge to develop new clinical models for treatment of persons with personality
and substance use disorders
To achieve success in forging a collaborative structure, the following were found to be critical elements: 
•Inviting all relevant agencies to participate and air their concerns
•Nurturing one-to-one relationships among service providers across service sectors
•Creating and maintaining a shared knowledge base and a common vision
•Collaboration, support, and empowerment
•Early and frequent successes
•Encouraging participation in planning and decisionmaking
•Clarifying roles and process
•Ensuring ongoing consumer and family participation
•Conducting periodic self-review
•Having visionary, consistent, and effective leadership
focused on the local level. Local needs assess-
ment information feeds back to the State level
and is used to develop a statewide picture that,
in turn, is provided to higher-level funding
authorities. The data generated through needs
assessments also can be used to demonstrate
need in support of grant proposals for increas-
ing service capacity prepared by the treatment
agency.
It is important to determine what changes need
to be made with respect to staff, training,
accreditation, and other factors to provide
effective services for clients with COD. The
agency also should know what resources and
services are already available within their local
and State systems of care before deciding what
services to provide. This assessment of commu-
nity capacity and the resulting decisionmaking
process should involve all stakeholders in the
program. Whatever changes the provider
decides to make will require an active commit-
ment from all levels of staff as well as from
members of the community, advocacy groups,
and other interested parties. 
The various classification systems described
previously can be used to identify missing levels
of care and gaps in specific services. Such tools
permit clinicians to relate program services to
clients’ needs for specific activities. They also
enable planners to identify gaps in the current
system of care and then to design programs
that address these gaps. Figure 3-5 provides a
list of domains and questions to guide agencies
in assessing their potential to serve clients with
COD. In doing so, it is assumed that each agen-
cy will use the best approach to each task that
is possible, given its level of resources. It may,
for example, need to use estimates rather than
precise data in some instances. 
Accessing Funding
System components and financing
principles
Both mental health services and substance
abuse treatment systems must face the chal-
lenge of obtaining funding that supports pro-
gramming for clients with COD. For substance
abuse treatment agencies, which are seeing
more clients with COD and clients with more
serious COD, it often is difficult to obtain funds
to provide needed screening, assessment, spe-
cialized mental health service enhancement,
and case management.
Developing a comprehensive system of care for
people with COD requires committed leader-
ship, joint planning, and the willingness and
ability to find creative solutions to difficult
problems. Financing a comprehensive system
of care requires no less a commitment of time,
creativity, and expertise. The process of contin-
uing dialog between NASMHPD and
NASADAD has identified key system develop-
ment components and financing principles
shown in Figure 3-6 (p. 52). Like the conceptu-
al framework, these components and principles
represent a set of flexible guidelines that can be
adapted for use in any State or community. 
Each of the six financing principles is a critical
element of success and is described below:
1. Plan To Purchase Together. It has been
found that “in most successful demonstra-
tion programs for people with co-occurring
disorders, the State mental health agency
and the State alcohol and drug abuse
agency jointly planned and purchased ser-
vices” (NASMHPD and NASADAD 2000,
pp. 19–20).
2. Define the Population. Individuals with
COD may fall into any of the four quad-
rants. Program services must target popu-
lations based on the severity of their men-
tal or substance use disorders, among
other considerations. However, it is impor-
tant to keep in mind that due to the illegal-
ity of drug use denying services to those
whose current condition is not severe may
increase the severity of problems associat-
ed with that drug use, increasing severity
by producing arrests, job loss, and con-
flicts with the child welfare system.
3. Secure Financing. The following section of
this chapter will provide some suggestions
on this challenging and often complex
task.
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4. Purchase Effective Services. It is impor-
tant to purchase services that research has
shown to be effective. Unfortunately, COD
research tends to focus on those with seri-
ous mental disorders. As a result, guid-
ance on which strategies are most cost-
effective in treating persons with less seri-
ous mental disorders and co-occurring
substance use disorders is not readily
available.
5. Purchase Performance. NASMHPD and
NASADAD strongly recommend perfor-
mance-based contracts that focus on out-
comes. “A program’s effectiveness should
be judged not only by how many people it
serves or units of service it delivers, but
rather by the level of real change it helps
bring about in the lives of consumers who
have co-occurring mental health and sub-
stance use disorders” (NASMHPD and
NASADAD 2000).
6. Evaluate and Improve. It is essential to
evaluate performance. Findings help
providers revise protocols to get better
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Figure 3-5
Assessing the Agency’s Potential To Serve Clients With COD
1. Describe the profile of current clients with COD and any potential changes anticipated.
• Estimate the prevalence of persons with COD among the agency’s clients. (One of the screening tools
recommended in chapter 4 may be appropriate for this purpose.) 
• What are the demographics of persons with COD?
• What functional problems do they have?
• Are there clients with COD who seek care at the agency who are referred elsewhere? What is the profile
of these clients?
2. Identify services needed by clients.
• What services are needed by existing and potential clients?
3. Identify and assess resources available to meet client needs. 
• What services are immediately available to the program?
• What services could be added within the program? 
• What services are available from the community that would enhance care?
• How well are outside agencies meeting clients’ needs?
4. Assess resource gaps.
• What resources are needed to enhance treatment for persons with COD?
• What can your agency, specifically, do to enhance its capacity to serve these clients?
5. Assess capacity.
• Realistically assess the capacity of your agency to address these resource gaps. 
6. Develop a plan to enhance capacity to treat clients with COD.
• How can the skills of existing staff be increased?
• Can additional expertise be accessed through consulting agreements or similar arrangements?
• What additional programs or services can be offered?
• What sources of funding might support efforts to enhance capacity?
results and give them a vital two-way
channel for communicating with key stake-
holders (NASMHPD and NASADAD
2000).
Federal funding 
opportunities
Federal funding opportunities include a variety
of grants from diverse agencies. In its efforts to
enhance services, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) is currently emphasizing the use of
strategies that have been demonstrated to be
effective in research (“science to service”). 
Other Federal agencies such as the National
Institutes of Health (NIH), including the
National Institute on Drug Abuse (NIDA) and
the National Institute on Alcohol Abuse and
Alcoholism (NIAAA), and the National Institute
of Mental Health (NIMH), emphasize funds for
research and likely will provide only modest
funds for treatment—typically in conjunction
with research projects. Overall, SAMHSA will
focus on working with States and helping com-
munities use the latest research findings to
implement effective treatment and prevention
programs, while NIH institutes will conduct
research on best practices in substance abuse
treatment, prevention, and mental health ser-
vices. The reader can determine what funding
opportunities are currently available by visiting
funder Web sites (e.g., SAMHSA’s Web site at
www.samhsa.gov, NIDA’s Web site at
www.nida.nih.gov, NIAAA’s Web site at
www.niaaa.nih.gov, and NIMH’s Web site at
www.nimh.nih.gov).
Although SAMHSA and NIH probably will
remain the main Federal funding sources for
initiatives related to people with COD, other
Federal agencies also may provide funding
opportunities. Examples of such Federal agen-
cies include the Health Resources and Services
Administration within the U.S. Department of
Health and Human Services, the U.S.
Department of Justice, the U.S. Department of
Labor, and so on. The reader can determine
what funding opportunities are currently avail-
able by visiting the Web sites of these agencies
or by searching the Catalog of Federal
Domestic Assistance Web site (www.cfda.gov),
which provides a database of all Federal pro-
grams available to State and local governments
(including the District of Columbia); federally
recognized Indian tribal governments;
Territories (and possessions) of the United
States; domestic public, quasi-public, and 
private profit and nonprofit organizations 
and institutions; specialized groups; and 
individuals.
State funding opportunities
Administrators or treatment professionals
should be familiar with the funding mecha-
nisms in their State. Information is also avail-
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Figure 3-6
Financing a Comprehensive System of Care for People With COD
Key System Development Components
• Provide Leadership/Build Consensus
• Identify Resources
• Develop New Models/Train Staff
• Decide on Outcomes
• Evaluate Program
Source: NASMHPD and NASADAD 2000, p. 19.
Financing Principles
• Plan To Purchase Together
• Define the Population
• Secure Financing
• Purchase Effective Services
• Purchase Performance
• Evaluate and Improve
able through the National Association of State
Alcohol/Drug Abuse Directors
(www.nasadad.org) and the National
Association of State Mental Health Program
Directors (www.nasmhpd.org).
Private funding 
opportunities
Foundation matching funds can be used to
leverage change within a system in specific
areas and increasingly should be explored in
the area of COD treatment. For example,
Robert Wood Johnson Foundation funding has
driven improved access to primary care within
addiction services.
A wide variety of funding initiatives exist in
health care, including in the area of substance
abuse treatment. Eligibility and procedures for
getting funding will vary depending on the spe-
cific foundation. The best procedure is to use
the Web site of the Foundation Center
(www.fdncenter.org) to identify a possible fun-
der, then call or write to ask for information on
its current funding interests and application
procedures. The Web site allows visitors to
search profiles of more than 65,000 private and
community foundations. The Foundation
Center also produces a CD-ROM version of its
database and print publications containing
information on grants. Among the many foun-
dations that have a broad interest in this field
are the Ittleson Foundation, Inc., the van
Ameringen Foundation, the Trull Foundation,
the Carlisle Foundation, the Mary Owen
Border Foundation, and the Chevron
Corporation. 
For the most part, private funding provides an
opportunity to enhance existing larger pro-
grams with a specific “add-on” service, such as
employment counseling or a substance abuse
prevention group for children of people who
abuse substances. Programs can be significant-
ly strengthened through the aggressive pursuit
of available grants and by combining several
funding opportunities. Treatment providers
seeking funding should not overlook the possi-
bility that major businesses operating in their
geographic area may have charitable founda-
tions that could be tapped for promising pro-
gram initiatives.
Attaining Equitable Allocation
of Resources
It is recognized that the acquisition of adequate
program resources is both a challenging and
essential task. Moreover, though a number of
advances have been made in recent years in the
treatment of people with COD, systems of care
across the country often have not improved
accordingly. For example, while programs are
now working to treat COD in an integrated
manner, mental health services and substance
abuse treatment still are funded separately.
This can cause programs to spend significantly
increased amounts of time in administrative
tasks needed to acquire funds for a client’s
treatment through multiple streams. Also, pay-
ors in many places continue to fund treatment
using an acute care model, even though treat-
ment providers recognize that clients can pre-
sent with long-term disorders. 
In addition to the amount of money spent on
COD, it is important to address issues of effi-
ciency. One study of the expenditures on COD
found that annual spending per client with
COD in 1997 was $5,000 to $11,000 (depending
on the State), which is nearly twice as high as
clients with mental disorders only and nearly
four times as high as clients with substance use
disorders only.
Clients with COD compared to clients with a
single diagnosis receive more treatment services
of the major types—hospital inpatient, residen-
tial, and outpatient services. While clients with
COD do not remain in the hospital as long as
clients with mental disorders only, they do stay
longer in residential treatment than clients with
single diagnoses. 
Clients with COD have higher outpatient
expenses. Those expenses are 40 to over 100
percent higher than those of clients with mental
disorders only, and 200 to over 300 percent
higher than those of clients with substance use
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disorders only. The average amount spent for
outpatient treatment is $2,700 to $4,600 per
client with COD.
In addressing COD, it is also important to look
at medication costs when addressing the issue
of equitable allocation of resources. In the
three States reviewed, the estimated costs for
those with mental disorders only and with COD
was about $400 to $600 per person per year.
However, clients with substance use disorders
only generally do not get prescription medica-
tion therapy; their
medication spending
range was $100 to
$200.
When looking at the
existing allocation of
resources for clients
with COD and the
demographics of
covered clients, the
three-State estimat-
ed study found that
they are more likely
to be adults over the
age of 18 and are
more likely to be
male, but less likely
to be minorities,
than are clients with
single diagnoses.
They are also more
likely to be the
exclusive responsi-
bility of mental
health or substance abuse agencies rather than
Medicaid’s total responsibility; across the three
States, 40 to 84 percent of clients with COD
receive services only from mental health or
substance abuse agencies.
The Expenditures on Treatment of Co-
Occurring Mental and Substance Use Disorders
reference study involved only three States:
Delaware, Oklahoma, and Washington.
However, the data presented raise the issue of
efficiency and effectiveness rather than cost.
For those with more serious mental illness,
strategies that are more efficient may make the
better use of the larger amounts spent on those
with COD, rather than creating disturbances in
the existing system by forcing the shifting of
resources from the treatment of those with
either substance use disorders or mental disor-
ders only.
Ultimately, we are challenged not only to advo-
cate on behalf of our own programs and
clients, but for systemic change. Effective advo-
cacy will help ensure that resources are allocat-
ed in a manner that takes appropriate cog-
nizance of the needs of our clients and the com-
plexity of the treatment field for clients with
COD. However, in any advocacy caution
against unintended consequences must be
taken; with the de-institutionalization of
patients hospitalized for severe and persistent
mental illnesses, the expected reallocation of
funds did not occur as expected.
Any savings that could come from integrated
treatment must not be diverted into general
revenues. Any efficiencies that result from
more effective treatment of those without COD,
but with mental disorders or substance use dis-
orders alone, should be invested into integrated
treatment. Any transformation of the existing
system of care that results in a decrease in
access to substance abuse treatment for those
without COD will only create stresses in the
criminal justice, workplace, and child welfare
systems.
Integrating Research and
Practice 
To be effective, resources must be used to
implement the evidence-based practices most
appropriate to the client population and the
program needs. The importance of the transfer
of knowledge and technology has come to be
well understood. Conferences to explore
“bridging the gap” between research and field
practice are now common.
Although not specific to COD, these efforts
have clear implications for our attempts to
share knowledge of what is working for clients
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To be effective,
resources must be
used to implement
the evidence-
based practices
most appropriate
to the client popu-
lation and the
program needs. 
with COD. As emphasized in the 1998 report
by Lamb and colleagues, Bridging the Gap
Between Research and Practice, there is a
need for, and value in, “enhancing collabora-
tive relationships between the drug abuse
research community and the world of commu-
nity-based treatment programs” (Lamb et al.
1998, p. v). Brown (1998) has underscored
the fundamental importance of making
research relevant to practice, emphasizing the
need for new government initiatives that focus
on interpersonal contacts to achieve organiza-
tional change and that promote technology
transfer as a significant area of investigation.
Several recent government initiatives high-
light this effort and are described in Changing
the Conversation (CSAT 2000a). They include
•Practice Improvement Collaboratives
(SAMHSA/CSAT)
•Clinical Trials Network Program
(NIH/NIDA)
•Improving the Delivery of Alcohol Treatment
and Prevention Services (NIH/NIAAA)
•Evidence-based Practice Centers (Agency for
Healthcare Research and Quality)
•The Addiction Technology Transfer Centers
(SAMHSA/CSAT)
•The Knowledge Application Program
(SAMHSA/CSAT)
•Researcher in Residence Program
(NIH/NIAAA)
CSAT’s Practice Improvement
Collaboratives
Knowledge exchange is one of the most criti-
cal elements in efforts to move best practices
in substance abuse treatment to community
programs working on the front lines of sub-
stance abuse interventions. Formerly known
as the Practice/Research Collaboratives, the
Practice Improvement Collaboratives pro-
gram—designed, in part, to achieve this
goal—supports the development of collabora-
tions among a broad spectrum of substance
abuse treatment organizations (including, but
not limited to, community-based treatment
organizations, units of government, colleges,
universities, and other public research enti-
ties). Key objectives of the program include
the following: 
•To develop and sustain community involve-
ment in, and commitment to, practice
improvement in the delivery of substance
abuse treatment services.
•To improve the quality of substance abuse
treatment through the adoption of evidence-
based practices in community-based treat-
ment organizations. 
•To identify successful methods and models for
implementing evidence-based practices in
community-based treatment organizations. 
Workforce
Development and
Staff Support
This section focuses on some key issues
providers face in developing a workforce able
to meet the needs of clients with COD. These
include
•The attitudes and values providers must have
to work successfully with these clients
•Essential competencies for clinicians (basic,
intermediate, and advanced)
•Opportunities for continuing professional
development
•Ways to avoid burnout and reduce
turnover—common problems for any sub-
stance abuse treatment provider, but particu-
larly so for those who work with clients who
have COD
The consensus panel underscores the impor-
tance of an investment in creating a supportive
environment for staff that encourages profes-
sional development to include skill acquisition,
values clarification, training, and competency
attainment equal to an investment in new COD
program development. An organizational com-
mitment to both is necessary for successful
implementation of programs. Examples of staff
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support may include standards of practice
related to consistent high-quality supervision,
favorable tuition reimbursement and release
time policies, helpful personnel policies related
to bolstering staff wellness practices, and incen-
tives or rewards for work-related achievement,
etc. Together these elements help in the cre-
ation of needed infrastructure for quality of
service. 
Attitudes and Values
Attitudes and values guide the way providers
meet client needs and affect the overall treat-
ment climate. They not only determine how the
client is viewed by the provider (thereby gener-
ating assumptions that could either facilitate or
deter achievement of the highest standard of
care), but also profoundly influence how the
client feels as he or she experiences a program.
Attitudes and values are particularly important
in working with clients with COD since the
counselor is confronted with two disorders that
require complex interventions.
The essential attitudes and values for working
with clients with COD shown in Figure 3-7 are
adapted from Technical Assistance Publica-
tion 21, Addiction Counseling Competencies:
The Knowledge, Skills, and Attitudes of
Professional Practice (Center for Substance
Abuse Treatment 1998a). The consensus
panel believes these attitudes and values also
are consistent with the attitudes and values of
the vast majority of those who commit them-
selves to the challenging fields of substance
abuse treatment and mental health services.
Clinicians’ Competencies 
Clinicians’ competencies are the specific and
measurable skills that counselors must possess.
Several States, university programs, and
expert committees have defined the key compe-
tencies for working with clients with COD.
Typically, these competencies are developed by
training mental health and substance abuse
treatment counselors together, often using a
case-based approach that allows trainees to
experience the insights each field affords the
other.
One challenge of training is to include cultural-
ly sensitive methods and materials that reflect
consideration for the varying levels of expertise
and background of participants. The consensus
panel recommends viewing competencies as
basic, intermediate, and advanced to foster
continuing professional development of all
counselors and clinicians in the field of COD.
This classification does not crosswalk with the
program classification system using the same
terminology illustrated in Figure 3-2 (p. 44)
and is derived from various sources. Clearly,
the sample competencies listed within each cat-
egory cannot be completely separated from
each other (e.g., competencies in the “basic”
category may require some competency in the
“intermediate” category). Some of the catego-
rizations may be debatable, but the grouping
within each category reflects, on the whole, dif-
ferent levels of clinician competency.
Providers in the field face unusual challenges
and often provide effective treatment while
working within their established frameworks.
In fact, research studies previously cited have
established the effectiveness of substance
abuse treatment approaches in working with
persons who have low- to moderate-severity
mental disorders. Still, the classification of
competencies supports continued professional
development and promotes training opportu-
nities. 
Basic competencies
Every substance abuse treatment and mental
health service program should require coun-
selors to have certain basic skills. In keeping
with the principle that there is “no wrong
door,” the consensus panel recommends that
clinicians working in substance abuse treat-
ment settings should be able to carry out the
mental-health–related activities shown in
Figure 3-8 (p. 58). 
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Intermediate competencies
Intermediate competencies encompass skills in
engaging substance abuse treatment clients with
COD, screening, obtaining and using mental
health assessment data, treatment planning,
discharge planning, mental health system link-
age, supporting medication, running basic men-
tal disorder education groups, and implement-
ing routine and emergent mental health refer-
ral procedures. In a mental health unit, mental
health providers would exhibit similar compe-
tencies related to substance use disorders. The
consensus panel recommends the intermediate
level competencies shown in Figure 3-9 (p. 59),
developed jointly by the New York State Office
of Mental Health and the New York State
Office of Alcohol and Substance Abuse
Services. 
Advanced competencies
At the advanced level, the practitioner goes
beyond an awareness of the addiction and men-
tal health fields as individual disciplines to a
more sophisticated appreciation for how co-
occurring disorders interact in an individual.
This enhanced awareness leads to an improved
ability to provide appropriate integrated treat-
ment. Figure 3-10 (p. 60) gives examples of
advanced skills.
Continuing Professional
Development
The consensus panel is aware that many
providers in the substance abuse treatment and
mental health services fields have performed
effectively the difficult task of providing ser-
vices for clients with COD, until recently with-
out much guidance from an existing body of
knowledge or available systematic approaches.
The landscape has changed and a solid knowl-
edge base is now available to the counselor,
although that knowledge typically is scattered
through many journals and reports. This TIP
makes an effort to integrate the available infor-
mation. Counselors reading this TIP can
review their own knowledge and determine
what they need to continue their professional
development. 
At the time of this writing, Arizona,
Connecticut, Illinois, New Mexico, New York,
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Figure 3-7
Essential Attitudes and Values for Clinicians Who Work With Clients Who
Have COD
•Desire and willingness to work with people who have COD
•Appreciation of the complexity of COD
•Openness to new information
•Awareness of personal reactions and feelings
•Recognition of the limitations of one’s own personal knowledge and expertise
•Recognition of the value of client input into treatment goals and receptivity to client feedback
•Patience, perseverance, and therapeutic optimism
•Ability to employ diverse theories, concepts, models, and methods
•Flexibility of approach
•Cultural competence
•Belief that all individuals have strengths and are capable of growth and development (added by consensus
panel)
•Recognition of the rights of clients with COD, including the right and need to understand assessment results
and the treatment plan
and Pennsylvania have developed consensus
guidelines that define the competencies sub-
stance abuse treatment counselors should have
to claim expertise in this area. Others are in
the process of identifying mechanisms for
licensing or certifying expertise in COD.
Counselors may check with their States’ certifi-
cation bodies to determine whether training
leading to formal credentials in counseling per-
sons with co-occurring disorders is available.
Appendix I identifies some resources coun-
selors can use to enhance their professional
knowledge and development.
Education and training
Discipline-specific education
Staff education and training are fundamental
to all substance abuse treatment programs.
Although there have been improvements in the
past decade, there are still very few university-
based programs that offer a formal curriculum
on COD. Numerous observers have commented
on the lack of adequate discipline-based train-
ing for professionals in the substance abuse
treatment field (Brown 1996; Galanter 1989;
Miller and Brown 1997).
Many professional organizations are promoting
the development of competencies and practice
standards for intervening with substance abuse
problems, including the Council on Addictions
of the American Psychiatric Association; the
American Academy of Addiction Psychiatry;
the American Osteopathic Academy of
Addiction Medicine; American Psychological
Association; the American Society of Addiction
Medicine; the Association for Medical
Education and Research on Substance Abuse;
the American Association of Obstetricians and
Gynecologists; the Alcohol, Tobacco and Other
Addictions Section of the National Association
of Social Workers; and the International
Nurses Society on Addictions. They are also
specifically encouraging faculty members to
enhance their knowledge in this area so they
can better prepare their students to meet the
needs of clients with COD. The consensus panel
encourages all such organizations to identify
standards and competencies for their member-
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Figure 3-8
Examples of Basic Competencies Needed for Treatment of Persons With COD 
•Perform a basic screening to determine whether COD might exist and be able to refer the client for a formal
diagnostic assessment by someone trained to do this. 
•Form a preliminary impression of the nature of the disorder a client may have, which can be verified by some-
one formally trained and licensed in mental health diagnosis.
•Conduct a preliminary screening of whether a client poses an immediate danger to self or others and coordi-
nate any subsequent assessment with appropriate staff and/or consultants.
•Be able to engage the client in such a way as to enhance and facilitate future interaction.
•De-escalate the emotional state of a client who is agitated, anxious, angry, or in another vulnerable emotional
state.
•Manage a crisis involving a client with COD, including a threat of suicide or harm to others. This may involve
seeking out assistance by others trained to handle certain aspects of such crises; for example, processing com-
mitment papers and related matters. 
•Refer a client to the appropriate mental health or substance abuse treatment facility and follow up to ensure
the client receives needed care. 
•Coordinate care with a mental health counselor serving the same client to ensure that the interaction of the
client’s disorders is well understood and that treatment plans are coordinated.
ship related to COD and to encourage the
development of training for specific disciplines.
Since the consequences of both addiction and
mental disorders can present with physical or
psychiatric manifestations, it is equally impor-
tant for medical students, internal medicine
and general practice residents, and general
psychiatry residents to be educated in the
problems of COD. Too few hours of medical
education are devoted to the problems of
addiction and mental disorders. Since pharma-
cologic therapies play a critical role in the
treatment of those with COD, it is important to
have adequately trained physicians who can
manage the medication therapies for those
clients.
Continuing education and training
Many substance abuse treatment counselors
learn through continuing education and facili-
ty-sponsored training. Continuing education
and training involves participation in a vari-
ety of courses and workshops from basic to
advanced level offered by a number of train-
ing entities (see appendix I). The strength of
continuing education and training courses
and workshops is that they provide the coun-
selor with the opportunity to review and pro-
cess written material with a qualified instruc-
tor and other practitioners.
Continuing education is useful because it can
respond rapidly to the needs of a workforce
that has diverse educational backgrounds and
experience. To have practical utility, competen-
cy training must address the day-to-day issues
that counselors face in working with clients
with COD. The educational context must be
rich with information, culturally sensitive,
designed for adult students, and must include
examples and role models. It is optimal if the
instructors have extensive experience as practi-
tioners in the field. Figure 3-11 (p. 61) provides
an example description for one of many possi-
ble continuing education courses in this dynam-
ic field.
Continuing education is essential for effective
provision of services to people with COD, but it
is not sufficient in and of itself. Counselors
must have ongoing support, supervision, and
opportunity to practice new skills if they are to
truly integrate COD content into their practice.
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Figure 3-9
Six Areas of Intermediate-Level Competencies Needed for the 
Treatment of Persons With COD
• Competency I: Integrated Diagnosis of Substance Abuse and Mental Disorders. Differential diagno-
sis, terminology (definitions), pharmacology, laboratory tests and physical examination, withdrawal
symptoms, cultural factors, effects of trauma on symptoms, staff self-awareness
• Competency II: Integrated Assessment of Treatment Needs. Severity assessment, lethality/risk, assess-
ment of motivation/readiness for treatment, appropriateness/treatment selection
• Competency III: Integrated Treatment Planning. Goal-setting/problemsolving, treatment planning, doc-
umentation, confidentiality,1 legal/reporting issues, documenting issues for managed care providers
• Competency IV: Engagement and Education. Staff self-awareness, engagement, motivating, educating
• Competency V: Early Integrated Treatment Methods. Emergency/crisis intervention, knowledge and
access to treatment services, when and how to refer or communicate
• Competency VI: Longer Term Integrated Treatment Methods. Group treatment, relapse prevention,
case management, pharmacotherapy, alternatives/risk education, ethics, confidentiality,1 mental health,
reporting requirements, family interventions
1Confidentiality is governed by the Federal “Confidentiality of Alcohol and Drug Abuse Patient Records” regulations (42 C.F.R. Part 2) and the Federal
“Standards for Privacy of Individually Identifiable Health Information” (45 C.F.R. Parts 160 and 164).
Cross-training
Cross-training is the simultaneous provision of
material and training to more than one disci-
pline at a time (e.g., substance abuse and social
work counselors; substance abuse counselors
and corrections officers). Counselors who have
primary expertise in either substance abuse or
mental health will be able to work far more
effectively with clients who have COD if they
have some degree of cross-training in the other
field. The consensus panel recommends that
counselors of either field receive at least basic
level cross-training in the other field to better
assess, refer, understand, and work effectively
with the large number of clients with COD.
Cross-trained individuals who know their pri-
mary field of training well, and also have an
appreciation for the other field, provide a rich-
ness of capacity that cannot be attained using
any combination of personnel familiar with one
system alone. 
When training is offered in this manner, inter-
action and communication between the coun-
selors from each discipline is facilitated. This
helps to remove barriers, increase understand-
ing, and promote integrated work. Cross-train-
ing is particularly valuable for staff members
who will work together in the same program.
Consensus panel members have found cross-
training very valuable in mental health, sub-
stance abuse, and criminal justice settings.
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Figure 3-10
Examples of Advanced Competencies in the Treatment of Clients With COD
•Use the current edition of criteria from the Diagnostic and Statistical Manual of Mental Disorders, 4th edi-
tion (American Psychiatric Association 2000) to assess substance-related disorders and Axis I and Axis II
mental disorders.
•Comprehend the effects of level of functioning and degree of disability related to both substance-related
and mental disorders, separately and combined.
•Recognize the classes of psychotropic medications, their actions, medical risks, side effects, and possible
interactions with other substances.
•Use integrated models of assessment, intervention, and recovery for persons having both substance-related
and mental disorders, as opposed to parallel treatment efforts that resist integration.
•Apply knowledge that relapse is not considered a client failure but an opportunity for additional learning
for all. Treat relapses seriously and explore ways of improving treatment to decrease relapse frequency
and duration.
•Display patience, persistence, and optimism.
•Collaboratively develop and implement an integrated treatment plan based on thorough assessment that
addresses both/all disorders and establishes sequenced goals based on urgent needs, considering the stage
of recovery and level of engagement.
•Involve the person, family members, and other supports and service providers (including peer supports
and those in the natural support system) in establishing, monitoring, and refining the current treatment
plan.
•Support quality improvement efforts, including, but not limited to consumer and family satisfaction sur-
veys, accurate reporting and use of outcome data, participation in the selection and use of quality moni-
toring instruments, and attention to the need for all staff to behave respectfully and collaboratively at all
times.
Source: Adapted from Minkoff 1999.
Program orientation and ongoing
supervision
Orientation. Staff education and training
have two additional components: (1) a state-
ment of program orientation that clearly pre-
sents the mission, values, and aims of service
delivery, and (2) strong, ongoing supervision.
The orientation can use evidence-based initia-
tives as well as promising practices. Success-
ful program orientation for working with
clients with COD will equip staff members
with skills and decisionmaking tools that will
enable them to provide optimal services in
real-world environments.
Supervision. Many agree that relational skills
are requisite for staff working in COD pro-
grams (Gerber and Basham 1999; Martino et
al. 2000; Miller 2000b), skills that are best
learned though direct supervision. Active lis-
tening, interviewing techniques, the ability to
summarize, and the capacity to provide feed-
back are all skills that can be best modeled by
a supervisor. Strong, active supervision of
ongoing cases is a key element in assisting
staff to develop, maintain, and enhance rela-
tional skills. 
National training resources
Training resources. Curricula and other
forms of educational materials are available
through Addiction Technology Transfer
Centers (ATTCs), universities, State entities,
and private consultants. These materials can
help enhance the ability of substance abuse
treatment counselors to work with clients who
have mental disorders, as well as to enable
mental health personnel to improve their
efforts with persons with substance use disor-
ders. ATTCs offer workshops, courses, and
online remote location courses. (See appendix
I for training sources.)
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Figure 3-11
Treatment Planning and Documentation Issues for Mental and Substance
Use Disorders
Description 
This course provides an opportunity for participants to review the principles of collaborative treatment plan-
ning, including working from a comprehensive assessment; identifying and mutually setting long- and short-
term goals; identifying steps for accomplishing goals, the persons responsible for collaborative treatment
planning, and a defined timeline; and reviewing and altering such plans when necessary. Progress tracking is
reviewed, including how to write clear and concise notes, and the principles for their review. This course
focuses on effective treatment principles and the practices of writing and reviewing plans.
Course Objectives
By the end of this course, participants will be able to
•Review the principles and processes that support thorough and accurate assessment and diagnosis, includ-
ing strengths-based interviewing skills and cultural diversity issues.
•Examine each step in treatment/service planning, its rationale, and the similarities and differences in ser-
vice and treatment planning.
•Describe the importance of the person with COD having active involvement and real choice in all post-acute
treatment planning processes (and some means for incorporating these features in acute care settings).
•Identify means of writing brief and useful progress notes that support movement toward positive outcomes.
•Discuss means of using progress notes with the person as a useful piece of the ongoing treatment/service 
process.
Source: Supplied by consensus panelist Donna McNelis, Ph.D.
Listservs and discussion lists. There are a
number of e-mail listservs and Internet dis-
cussion groups on the topic of COD (e.g., Co-
Occurring Dialogues, The Dual Diagnosis
Listserv, The Dual Diagnosis Bulletin Board,
The Dual Diagnosis Pages: Colleagues List,
and MIDAS: A Discussion Group). These
online communication networks offer mem-
bers the opportunity to post suggestions or
questions to a large number of people at the
same time. Listservs are generally geared
more toward professionals and are more
closely monitored. Discussion groups usually
are open to anyone, and may not be moni-
tored closely. (See appendix I for more
detailed descriptions of the listservs and dis-
cussion groups mentioned above.)
COD certification in health
disciplines
The disciplines of medicine and psychology
have recognized subspecialties in COD with a
defined process for achieving a certificate in
this area. Figure 3-12 summarizes current
information on certification by discipline. 
Avoiding Burnout and
Reducing Staff Turnover
Burnout
Often, substance abuse and mental health
clinicians are expected to manage growing
and more complex caseloads. “Compassion
fatigue” may occur when the pressures of
work erode a counselor’s spirit and outlook
and begin to interfere with the counselor’s
personal life (see TIP 36, Substance Abuse
Treatment for Persons With Child Abuse and
Neglect Issues [CSAT 2000d], p. 64.)
Assisting clients who have COD is difficult
and emotionally taxing; the danger of
burnout is considerable. It is especially
important that program administrators main-
tain awareness of the problem of burnout and
the benefits of reducing turnover. It is vital
that staff feel that program administrators
are interested in their well-being in order to
sustain morale and esprit de corps.
To lessen the possibility of burnout when
working with a demanding caseload that
includes clients with COD, the consensus pan-
elists for TIP 36, Substance Abuse Treatment
for Persons With Child Abuse and Neglect
Issues (CSAT 2000d, p. 64) suggest that pro-
gram directors and supervisors assist coun-
selors to
•Work within a team structure rather than in
isolation.
•Build in opportunities to discuss feelings and
issues with other staff who handle similar
cases. 
•Develop and use a healthy support network.
•Maintain the caseload at a manageable size.
•Incorporate time to rest and relax. 
•Separate personal and professional time.
Most important, supervision should be sup-
portive, providing guidance and technical
knowledge.
Farmer (1995) found that much of the per-
ceived stress among substance abuse treat-
ment counselors was attributable to workload
factors and factors relating to management—
for example, authoritarian and controlling
management styles that allow staff too little
autonomy and command over their own
work. Performance goals should be realistic
and clearly understood. Supervision should
be not only a means of ensuring standards of
practice, but also a way of encouraging and
enabling professional growth.
Grosch and Olsen (1994) suggest that when
professionals begin to exhibit signs of bore-
dom or malaise, varying the nature of the job
is a helpful strategy. This can be accom-
plished via a negotiated dialog with the super-
visor that is initiated by a staff member who
requests an opportunity to try new or differ-
ing activities.
Some programs have proactively addressed
the issue of burnout among staff to help staff
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morale, improve care, and reduce turnover in
their program. Pavillon International, an
addiction treatment residential program in
North Carolina, proactively addresses
burnout by placing high values on staff well-
being; routinely discussing well-being issues;
providing activities such as retreats, weekend
activities, yoga, and other healing activities at
the work site; and creating a network of on-
going support.
Turnover
The issue of staff turnover is especially impor-
tant for staff working with clients with COD
because of the limited workforce pool and the
high investment of time and effort involved in
developing a trained workforce. It matters,
too, because of the crucial importance of the
treatment relationship to successful outcomes.
Rapid turnover disrupts the context in which
recovery occurs. Clients in such agencies may
become discouraged about the possibility of
being helped by others. 
Turnover sometimes results from the unique
professional and emotional demands of work-
ing with clients with COD. On the other hand,
most providers in this area are unusually dedi-
cated and find the work to be rewarding.
Figure 3-13 (p. 64) provides some methods for
reducing staff turnover.
Conclusion: Workforce
Development
In concluding this section on workforce devel-
opment, the consensus panel strongly encour-
ages counselors to acquire the competencies
needed to work effectively with clients who
have COD. The difficulty of juggling a high and
demanding workload and the desire for contin-
ued professional development should be recog-
nized and accommodated. To the extent possi-
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Figure 3-12
Certification in Health Professions
Health Profession Certification in Co-Occurring Disorders
Physicians Physicians from any specialty, including primary care, psychiatry, and internal
medicine can become certified by ASAM. Psychiatrists can receive added qualifications
in Addiction Psychiatry through the formal American College of Graduate Medical
Education Board Certification process or through the American Academy of Addiction
Psychiatry. Osteopathic physicians from any specialty can receive addiction qualifica-
tions though the American Osteopathic Association. 
www.asam.org
www.aaap.org
www.DO-Online.org
Psychologists Psychologists may achieve a “Certificate of Proficiency in the Treatment of Alcohol and
Other Psychoactive Substance Use Disorders” through the American Psychological
Association’s College of Professional Psychology.
www.apa.org/college/
Social Workers The Alcohol, Tobacco and Other Addictions Section of the National Association of Social
Workers offers a curriculum leading to a certificate of specialty in addiction.
www.naswdc.org/
ble, education and training efforts should be
customized—in terms of content, schedule, and
location—to meet the needs of the counselors in
the field. That is, bring the training to the
counselor. Agency and program administra-
tors, including both line-level and clinical
supervisors, are urged to demonstrate support
and encouragement for the continuing educa-
tion and training of the workforce, as well as
develop COD competencies themselves.
Rewards can include both salary and advance-
ment tied to the counselor’s efforts to increase
his or her effectiveness in serving clients with
COD, as demonstrated by job performance.
Naturally, non-counselor clinicians working in
primary care settings, community mental
health centers, or private mental health offices
also should enhance their knowledge of alcohol
and drug use in clients with mental health
issues.
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Figure 3-13
Reducing Staff Turnover in Programs for Clients With COD
To decrease staff turnover, whenever possible, programs should
•Hire staff members who have familiarity with both substance abuse and mental disorders and have a posi-
tive regard for clients with either disorder. 
•Hire staff members who are critically minded and can think independently, but who are also willing to ask
questions and listen, remain open to new ideas, maintain flexibility, work cooperatively, and engage in cre-
ative problemsolving. 
•Provide staff with a framework of realistic expectations for the progress of clients with COD.
•Provide opportunities for consultation among staff members who share the same client (including medica-
tion providers). 
•Ensure that supervisory staff members are supportive and knowledgeable about issues specific to clients
with COD.
•Provide and support opportunities for further education and training.
•Provide structured opportunities for staff feedback in the areas of program design and implementation.
•Promote sophistication about, and advocacy for, COD issues among administrative staff, including both
those in decisionmaking positions (e.g., the director and clinical director) and others (e.g., financial offi-
cers, billing personnel, and State reporting monitors). 
•Provide a desirable work environment through adequate compensation, salary incentives for COD exper-
tise, opportunities for training and for career advancement, involvement in quality improvement or clinical
research activities, and efforts to adjust workloads. 
4 Assessment
In This
Chapter…
Screening and
Basic Assessment
for COD
The Assessment
Process
Overview
This chapter consists of three parts: (1) an overview of the basic screen-
ing and assessment approach that should be a part of any program for
clients with co-occurring disorders (COD); (2) an outline of the 12 steps
to an ideal assessment, including some instruments that can be used in
assessing COD; and (3) a discussion of key considerations in treatment
matching.
Ideally, information needs to be collected continuously, and assessments
revised and monitored as the client moves through recovery. A compre-
hensive assessment as described in the main section of this chapter leads
to improved treatment planning, and it is the intent of this chapter to
provide a model of optimal process of evaluation for clients with COD
and to encourage the field to move toward this ideal. Nonetheless, the
panel recognizes that not all agencies and providers have the resources
to conduct immediate and thorough screenings. Therefore, the chapter
provides a description of the initial screening and the basic or minimal
assessment of COD necessary for the initial treatment planning. 
A basic assessment covers the key information required for treatment
matching and treatment planning. Specifically, the basic assessment
offers a structure with which to obtain
•Basic demographic and historical information, and identification of
established or probable diagnoses and associated impairments
•General strengths and problem areas
•Stage of change or stage of treatment for both substance abuse and
mental health problems
•Preliminary determination of the severity of the COD as a guide to
final level of care determination
Note that medical issues (including physical disability and sexually trans-
mitted diseases), cultural issues, gender-specific and sexual orientation
issues, and legal issues always must be addressed, whether basic or more
comprehensive assessment is performed. The consensus panel assumes
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that appropriate procedures are in place to
address these and other important issues that
must be included in treatment planning.
However, the focus of this chapter, in keeping
with the purpose of this TIP, is on screening
and assessment related to COD. 
Screening and Basic
Assessment for COD 
This section provides an overview of the
screening and assessment process for COD. In
carrying out these processes, counselors should
understand the limitations of their licensure or
certification authority to diagnose or assess
mental disorders. Generally, however, collect-
ing assessment information is a legitimate and
legal activity even for unlicensed providers,
provided that they do not use diagnostic labels
as conclusions or opinions about the client.
Information gathered in this way is needed to
ensure the client is placed in the most appro-
priate treatment setting (as discussed later in
this chapter) and to assist in providing mental
disorder care that addresses each disorder. 
In addition, there are a number of circum-
stances that can affect validity and test
responses that may not be obvious to the
beginning counselor, such as the manner in
which instructions are given to the client, the
setting where the screening or assessment
takes place, privacy (or the lack thereof), and
trust and rapport between the client and
counselor. Throughout the process it is
important to be sensitive to cultural context
and to the different presentations of both
substance use and mental disorders that may
occur in various cultures. 
The following Advice to the Counselor section
gives an overview of the basic “do’s and
don’ts” for assessing for COD. Detailed dis-
cussions of these important screening/assess-
ment and cultural issues are beyond the scope
of this TIP. For more information on basic
screening and assessment information, see
chapters 4 and 5 in Evans and Sullivan
(2001), National Institute on Drug Abuse
(NIDA) (1994), and the National Institute on
Alcohol Abuse and Alcoholism (NIAAA)
(Allen and Wilson 2003). For information on
cultural issues, see the forthcoming TIP
Improving Cultural Competence in Substance
Abuse Treatment (Center for Substance
Abuse Treatment [CSAT] in development a). 
Screening
Screening is a formal process of testing to
determine whether a client does or does not
warrant further attention at the current time
in regard to a particular disorder and, in this
context, the possibility of a co-occurring sub-
stance use or mental disorder. The screening
process for COD seeks to answer a “yes” or
“no” question: Does the substance abuse (or
mental health) client being screened show
signs of a possible mental health (or substance
abuse) problem? Note that the screening pro-
cess does not necessarily identify what kind of
problem the person might have or how seri-
ous it might be, but determines whether or
not further assessment is warranted. A
screening process can be designed so that it
can be conducted by counselors using their
basic counseling skills. There are seldom any
legal or professional restraints on who can be
trained to conduct a screening.
Screening processes always should define a
protocol for determining which clients screen
positive and for ensuring that those clients
receive a thorough assessment. That is, a pro-
fessionally designed screening process estab-
lishes precisely how any screening tools or
questions are to be scored and indicates what
constitutes scoring positive for a particular
possible problem (often called “establishing
cut-off scores”). Additionally, the screening
protocol details exactly what takes place after
a client scores in the positive range and pro-
vides the necessary standard forms to be used
to document both the results of all later
assessments and that each staff member has
carried out his or her responsibilities in the
process.
Assessment
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So, what can a substance abuse treatment
counselor do in terms of screening? All coun-
selors can be trained to screen for COD. This
screening often entails having a client respond
to a specific set of questions, scoring those
questions according to how the counselor was
trained, and then taking the next “yes” or
“no” step in the process depending on the
results and the design of the screening pro-
cess. In substance abuse treatment or mental
health service settings, every counselor or
clinician who conducts intake or assessment
should be able to screen for the most common
COD and know how to implement the proto-
col for obtaining COD assessment information
and recommendations. For substance abuse
treatment agencies that are instituting a men-
tal health screening process, appendix H
reproduces the Mental Health Screening
Form-III (Carroll and McGinley 2001). This
Advice to the Counselor:
Do’s and Don’ts of Assessment for COD
1. Do keep in mind that assessment is about getting to know a person with complex and individu-
al needs. Do not rely on tools alone for a comprehensive assessment.
2. Do always make every effort to contact all involved parties, including family members, persons
who have treated the client previously, other mental health and substance abuse treatment
providers, friends, significant others, probation officers as quickly as possible in the assessment
process. (These other sources of information will henceforth be referred to as collaterals.)
3. Don’t allow preconceptions about addiction to interfere with learning about what the client
really needs (e.g., “All mental symptoms tend to be caused by addiction unless proven other-
wise”). Co-occurring disorders are as likely to be underrecognized as overrecognized. Assume
initially that an established diagnosis and treatment regime for mental illness is correct, and
advise clients to continue with those recommendations until careful reevaluation has taken
place.
4. Do become familiar with the diagnostic criteria for common mental disorders, including person-
ality disorders, and with the names and indications of common psychiatric medications. Also
become familiar with the criteria in your own State for determining who is a mental health pri-
ority client. Know the process for referring clients for mental health case management services
or for collaborating with mental health treatment providers.
5. Don’t assume that there is one correct treatment approach or program for any type of COD. The
purpose of assessment is to collect information about multiple variables that will permit individ-
ualized treatment matching. It is particularly important to assess stage of change for each prob-
lem and the client’s level of ability to follow treatment recommendations.
6. Do become familiar with the specific role that your program or setting plays in delivering ser-
vices related to COD in the wider context of the system of care. This allows you to have a clearer
idea of what clients your program will best serve and helps you to facilitate access to other set-
tings for clients who might be better served elsewhere.
7. Don’t be afraid to admit when you don’t know, either to the client or yourself. If you do not
understand what is going on with a client, acknowledge that to the client, indicate that you will
work with the client to find the answers, and then ask for help. Identify at least one supervisor
who is knowledgeable about COD as a resource for asking questions.
8. Most important, do remember that empathy and hope are the most valuable components of
your work with a client. When in doubt about how to manage a client with COD, stay connect-
ed, be empathic and hopeful, and work with the client and the treatment team to try to figure
out the best approach over time.
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instrument is intended for use as a rough
screening device for clients seeking admission
to substance abuse treatment programs. (Note
that while the consensus panel believes that
this instrument is useful, it has received limit-
ed validation [Carroll and McGinley 2001].)
Basic Assessment
While both screening and assessment are ways
of gathering information about the client in
order to better treat him, assessment differs
from screening in the following way: 
•Screening is a process for evaluating the pos-
sible presence of a particular problem. 
•Assessment is a process for defining the
nature of that problem and developing specif-
ic treatment recommendations for addressing
the problem.
A basic assessment consists of gathering key
information and engaging in a process with
the client that enables the counselor to under-
stand the client’s readiness for change, prob-
lem areas, COD diagnosis(es), disabilities,
and strengths. An assessment typically
involves a clinical examination of the func-
tioning and well-being of the client and
includes a number of tests and written and
oral exercises. The COD diagnosis is estab-
lished by referral to a psychiatrist, clinical
psychologist, or other qualified healthcare
professional. Assessment of the client with
COD is an ongoing process that should be
repeated over time to capture the changing
nature of the client’s status. Intake informa-
tion consists of 
1. Background—family, trauma history, histo-
ry of domestic violence (either as a batterer
or as a battered person), marital status,
legal involvement and financial situation,
health, education, housing status, strengths
and resources, and employment
2. Substance use—age of first use, primary
drugs used (including alcohol, patterns of
drug use, and treatment episodes), and fami-
ly history of substance use problems
3. Mental health problems—family history of
mental health problems, client history of
mental health problems including diagnosis,
hospitalization and other treatment, current
symptoms and mental status, medications,
and medication adherence 
In addition, the basic information can be aug-
mented by some objective measurement, such
as that provided in the University of Rhode
Island Change Assessment Scale (URICA)
(McConnaughy et al. 1983), Addiction Severity
Index (ASI) (McLellan et al. 1992), the Mental
Health Screening Form-III (Carroll and
McGinley 2001), and the Symptom Distress
Scale (SDS) (McCorkle and Young 1978) (see
appendices G and H for further information on
selected instruments). It is essential for treat-
ment planning that the counselor organize the
collected information in a way that helps identi-
fy established mental disorder diagnoses and
current treatment. The text box on page 71
highlights the role of instruments in the assess-
ment process.
Careful attention to the characteristics of past
episodes of substance abuse and abstinence
with regard to mental health symptoms,
impairments, diagnoses, and treatments can
illuminate the role of substance abuse in
maintaining, worsening, and/or interfering
with the treatment of any mental disorder.
Understanding a client’s mental health symp-
toms and impairments that persist during
periods of abstinence of 30 days or more can
be useful, particularly in understanding what
the client copes with even when the acute
effects of substance use are not present. For
any period of abstinence that lasts a month or
longer, the counselor can ask the client about
mental health treatment and/or substance
abuse treatment—what seemed to work, what
did the client like or dislike, and why? On the
other hand, if mental health symptoms (even
suicidality or hallucinations) resolve in less
than 30 days with abstinence from sub-
stances, then these symptoms are most likely
substance induced and the best treatment is
maintaining abstinence from substances.
The counselor also can ask what the mental
health “ups and downs” are like for the
client. That is, what is it like for the client
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when he or she gets worse (or “destabilizes”)?
What—in detail—has happened in the past?
And, what about getting better (“stabiliz-
ing”)—how does the client usually experience
that? Clinician and client together should try
to understand the specific effects that sub-
stances have had on that individual’s mental
health symptoms, including the possible trig-
gering of psychiatric symptoms by substance
use. Clinicians also should attempt to docu-
ment the diagnosis of a mental disorder, when
it has been established, and determine diag-
nosis through referral when it has not been
established. The consensus panel notes that
many, if not most, individuals with COD have
well-established diagnoses when they enter
substance abuse treatment and encourages
counselors to find out about any known diag-
noses.
Treatment Planning
A comprehensive assessment serves as the basis
for an individualized treatment plan.
Appropriate treatment plans and treatment
interventions can be quite complex, depending
on what might be discovered in each domain.
This leads to another fundamental principle:
•There is no single, correct intervention or
program for individuals with COD. Rather,
the appropriate treatment plan must be
matched to individual needs according to
these multiple considerations.
The following three cases illustrate how the
above factors help to generate an integrated
treatment plan that is appropriate to the needs
and situation of a particular client.
• Ideal Integrated Treatment Plan: The
plan for Maria M. might include medica-
tion-assisted treatment (e.g., methadone or
buprenorphine), continued antidepressant
medication, 12-Step program attendance,
and other recovery group support for
cocaine dependence. She also could be
The Role of Assessment Tools
A frequent question asked by clinicians is
•What is the best (most valuable) assessment tool for COD?
The answer is
•There is no single gold standard assessment tool for COD. Many traditional clinical tools have a narrow focus
on a specific problem, such as the Beck Depression Inventory (BDI) (Beck and Steer 1987), a list of 21 ques-
tions about mood and other symptoms of feeling depressed. Other tools have a broader focus and serve to
organize a range of information so that the collection of such information is done in a standard, regular way
by all counselors. The ASI, which is not a comprehensive assessment tool but a measure of addiction severity
in multiple problem domains, is an example of this type of tool (McLellan et al. 1992). Not only does a tool
such as the ASI help a counselor, through repetition, become adept at collecting the information, it also helps
the counselor refine his or her sense of similarities and differences among clients. A standard mental status
examination can serve a similar function for collecting information on current mental health symptoms.
Despite the fact that there are some very good tools, no one tool is the equivalent of a comprehensive clinical
assessment. 
Case 1: Maria M.
The client is a 38-year-old Hispanic/Latina
woman who is the mother of two teenagers.
Maria M. presents with an 11-year history
of cocaine dependence, a 2-year history of
opioid dependence, and a history of trauma
related to a longstanding abusive relation-
ship (now over for 6 years). She is not in an
intimate relationship at present and there is
no current indication that she is at risk for
either violence or self-harm. She also has
persistent major depression and panic treat-
ed with antidepressants. She is very moti-
vated to receive treatment.
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referred to a group for trauma survivors
that is designed specifically to help reduce
symptoms of trauma and resolve long-term
issues. 
Individual, group, and family interventions
could be coordinated by the primary coun-
selor from opioid maintenance treatment.
The focus of these interventions might be on
relapse prevention skills, taking medication
as prescribed, and identifying and managing
trauma-related symptoms without using. An
appropriate long-term goal would be to estab-
lish abstinence and engage Maria in longer-
term psychotherapeutic interventions to
reduce trauma symptoms and help resolve
trauma issues. On the other hand, if a local
mental health center had a psychiatrist
trained and licensed to provide Suboxone
(the combination of buprenorphine and
nalaxone), her case could be based in the
mental health center.
• Ideal Integrated Treatment Plan: The
ideal plan for this man might include par-
ticipation in outpatient addiction treatment,
plus continued provision of mood-stabiliz-
ing medication. In addition, he should be
encouraged to attend a recovery group such
as Cocaine Anonymous or Narcotics
Anonymous. The addiction counselor would
provide individual, group, and family inter-
ventions. The focus might be on gaining the
skills and strategies required to handle
cocaine cravings and to maintain abstinence
from cocaine, as well as the skills needed to
manage mood swings without using sub-
stances. Motivational counseling regarding
alcohol and assistance in maintaining medi-
cation (lithium) adherence also could be
part of the plan.
• Ideal Integrated Treatment Plan: The
plan for Jane B. might include an integrat-
ed case management team that is either
based in the shelter or in a mental health
service setting. The team would apply a
range of engagement, motivational, and
positive behavioral change strategies aimed
at slowly developing a trusting relationship
with this woman. Engagement would be
promoted by providing assistance to Jane
B. in obtaining food and disability benefits,
and using those connections to help her
engage gradually in treatment for either
mental disorders or addiction—possibly by
an initial offer of help in obtaining safe and
stable housing. Peer support from other
Case 2: George T.
The client is a 34-year-old married,
employed African-American man with
cocaine dependence, alcohol abuse, and
bipolar disorder (stabilized on lithium) who
is mandated to cocaine treatment by his
employer due to a failed drug test. George
T. and his family acknowledge that he needs
help not to use cocaine but do not agree that
alcohol is a significant problem (nor does his
employer). He complains that his mood
swings intensify when he is using cocaine.
Case 3: Jane B.
The client is a 28-year-old single Caucasian
female with a diagnosis of paranoid
schizophrenia, alcohol dependence, crack
cocaine dependence, and a history of multi-
ple episodes of sexual victimization. Jane B.
is homeless (living in a shelter), actively psy-
chotic, and refuses to admit to a drug or
alcohol problem. She has made frequent vis-
its to the local emergency room for both
mental health and medical complaints, but
refuses any followup treatment. Her main
requests are for money and food, not treat-
ment. Jane has been offered involvement in
a housing program that does not require
treatment engagement or sobriety but has
refused due to paranoia regarding working
with staff to help her in this setting. Jane B.
refuses all medication due to her paranoia,
but does not appear to be acutely dangerous
to herself or others.
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women also might be of value in promoting
her sense of safety and engagement.
All of these cases are appropriate examples of
integrated treatment. The purpose of the
assessment process is to develop a method for
gathering information in an organized manner
that allows the clinician to develop an appro-
priate treatment plan or recommendation. The
remainder of this chapter will discuss how this
assessment process might occur, and how the
information gathered leads to a rational pro-
cess of treatment planning. In Step 12 of the
assessment process, readers will find an
expanded treatment plan for the three clients
discussed above.
The Assessment
Process
This chapter is organized around 12 specific
steps in the assessment process. Through these
steps, the counselor seeks to accomplish the fol-
lowing aims:
•To obtain a more detailed chronological his-
tory of past mental symptoms, diagnosis,
treatment, and impairment, particularly
before the onset of substance abuse, and
during periods of extended abstinence.
•To obtain a more detailed description of
current strengths, supports, limitations,
skill deficits, and cultural barriers related
to following the recommended treatment
regimen for any disorder or problem.
•To determine stage of change for each prob-
lem, and identify external contingencies
that might help to promote treatment
adherence.
Note that although the steps appear sequential,
in fact some of them could occur simultaneous-
ly or in a different order, depending on the sit-
uation. It is particularly important to identify
and attend to any acute safety needs, which
often have to be addressed before a more com-
prehensive assessment process can occur.
Sometimes, however, components of the assess-
ment process are essential to address the
client’s specific safety needs. For example, if a
person is homeless, more information on that
person’s mental status, resources, and overall
situation is required to address that priority
appropriately. Finally, it must be recognized
that while the assessment seeks to identify indi-
vidual needs and vulnerabilities as quickly as
possible to initiate appropriate treatment,
assessment is an ongoing process: As treatment
proceeds and as other changes occur in the
client’s life and mental status, counselors must
actively seek current information rather than
proceed on assumptions that might be no
longer valid.
In the following discussion, validated assess-
ment tools that are available to assist in this
process are discussed with regard to their
utility for counselors. There are a number of
tools that are required by various States for
use in their addiction systems (e.g., ASI
[McLellan et al. 1992], American Society of
Addiction Medicine (ASAM) Patient
Placement Criteria [ASAM PPC-2R]).
Particular attention will be given to the role
of these tools in the COD assessment process,
suggesting strategies to reduce duplication of
effort where possible. It is beyond the scope
of this TIP to provide detailed instructions
for administering the tools mentioned in this
TIP (with the exceptions of the Mental Health
Screening Form-III [MHSF-III] and the
Simple Screening Instrument for Substance
Abuse [SSI-SA] in appendix H). Basic infor-
mation about each instrument is given in
appendix G, and readers can obtain more
detailed information regarding administration
and interpretation from the sources given for
obtaining these instruments.
As a final point, this discussion primarily is
directed toward substance abuse treatment
clinicians working in substance abuse treat-
ment settings, though many of the steps apply
equally well to mental health clinicians in
mental health settings. At certain key points
in the discussion, particular information rele-
vant to mental health clinicians is identified
and described.
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Assessment Step 1: Engage
the Client
The first step in the assessment process is to
engage the client in an empathic, welcoming
manner and build a rapport to facilitate open
disclosure of information regarding mental
health problems, substance use disorders,
and related issues. The aim is to create a safe
and nonjudgmental environment in which
sensitive personal issues may be discussed.
Counselors should recognize that cultural
issues, including the use of the client’s pre-
ferred language, play a role in creating a
sense of safety and promote accurate under-
standing of the client’s situation and options.
Such issues therefore must be addressed sen-
sitively at the outset and throughout the
assessment process. 
The consensus panel identified five key con-
cepts that underlie effective engagement dur-
ing the initial clinical contact: universal
access (“no wrong door”), empathic detach-
ment, person-centered assessment, cultural
sensitivity, and trauma sensitivity. All staff,
as well as substance abuse treatment and
mental health clinicians, in any service setting
need to develop competency in engaging and
welcoming individuals with COD. It is also
important to note that while engagement is
presented here as the first necessary step for
assessment to take place, in a larger sense
engagement represents an ongoing concern of
the counselor—to understand the client’s
experience and to keep him or her positive
and engaged relative to the prospect of better
health and recovery.
No wrong door
“No wrong door” refers to formal recognition
by a service system that individuals with COD
may enter a range of community service sites;
that they are a high priority for engagement
in treatment; and that proactive efforts are
necessary to welcome them into treatment and
prevent them from falling through the cracks.
Substance abuse and mental health coun-
selors are encouraged to identify individuals
with COD, welcome them into the service sys-
tem, and initiate proactive efforts to help
them access appropriate treatment in the sys-
tem, regardless of their initial site of presen-
tation. The recommended attitude is as fol-
lows: The purpose of this assessment is not
just to determine whether the client fits in my
program, but to help the client figure out
where he or she fits in the system of care, and
to help him or her get there.
Twelve Steps in the Assessment Process
Step 1: Engage the client
Step 2: Identify and contact collaterals (family, friends, other providers) to gather additional information
Step 3: Screen for and detect COD
Step 4: Determine quadrant and locus of responsibility
Step 5: Determine level of care
Step 6: Determine diagnosis
Step 7: Determine disability and functional impairment
Step 8: Identify strengths and supports
Step 9: Identify cultural and linguistic needs and supports
Step 10: Identify problem domains
Step 11: Determine stage of change
Step 12: Plan treatment
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Empathic detachment
Empathic detachment requires the assessing
clinician to
•Acknowledge that the clinician and client are
working together to make decisions to sup-
port the client’s best interest
•Recognize that the clinician cannot transform
the client into a different person, but can
only support change that he or she is already
making
•Maintain empathic connection even if the
client does not seem to fit into the clini-
cian’s expectations, treatment categories, or
preferred methods of working 
In the past, the attitude was that the client with
COD was the exception. Today, clinicians
should be prepared to demonstrate responsive-
ness to the requirements clients with COD pre-
sent. Counselors should be careful not to label
mental health symptoms immediately as caused
by addiction, but instead should be comfort-
able with the strong possibility that a mental-
health condition may be present independently
and encourage disclosure of information that
will help clarify the meaning of any COD for
that client.
Person-centered assessment
Person-centered assessment emphasizes that
the focus of initial contact is not on filling out a
form or answering several questions or on
establishing program fit, but rather on finding
out what the client wants, in terms of his or her
perception of the problem, what he or she
wants to change, and how he or she thinks that
change will occur. Mee-Lee (1998) has devel-
oped a useful guide that illustrates the types of
questions that might be asked in a person-cen-
tered assessment in an addiction setting (see
Figure 4-1, p. 74). (It should be noted, howev-
er, that this is not a validated tool.) While each
step in this decision tree leads to the next, the
final step can lead back to a previous step,
depending on the client’s progress in treatment.
Answers to some of these important questions
inevitably will change over time. As the
answers change, adjustments in treatment
strategies may be appropriate to help the client
continue to engage in the treatment process. 
Sensitivity to culture, gender,
and sexual orientation
An important component of a person-centered
assessment is the continual recognition that cul-
ture plays a significant role in determining the
client’s view of the problem and the treatment.
(For a comprehensive discussion of culturally
sensitive assessment strategies in addiction set-
tings, see the forthcoming TIP Improving
Cultural Competence in Substance Abuse
Treatment [CSAT in development a]). With
regard to COD, clinicians must remember that
ethnic cultures may differ significantly in their
approach to substance use disorders and men-
tal disorders, and that this may affect how the
client presents. In addition, clients may partici-
pate in treatment cultures (12-Step recovery,
Dual Recovery Self-Help, psychiatric rehabili-
tation) that also may affect how they view treat-
ment. Cultural sensitivity also requires recogni-
tion of one’s own cultural perspective and a
genuine spirit of inquiry into how cultural fac-
tors influence the client’s request for help. (See
also chapter 2 for a discussion of culturally
competent treatment.) 
During the assessment process, it is important
to ascertain the individual’s sexual orienta-
tion as part of the counselor’s appreciation
for the client’s personal identity, living situa-
tion, and relationships. Counselors also
should be aware that women often have fami-
ly-related and other concerns that must be
addressed to engage them in treatment, such
as the need for child care. See chapter 7 of
this TIP for a more extended consideration of
women with COD as a population with specif-
ic needs. More information about women’s
issues is provided in the forthcoming TIP
Substance Abuse Treatment: Addressing the
Specific Needs of Women (CSAT in develop-
ment b).
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Trauma sensitivity
The high prevalence of trauma in individuals
with COD requires that the clinician consider
the possibility of a trauma history even before
the assessment begins. Trauma may include
early childhood physical, sexual, or emotional
abuse; experiences of rape or interpersonal
violence as an adult; and traumatic experi-
ences associated with political oppression, as
might be the case in refugee or other immi-
grant populations. This pre-interview consid-
eration means that the approach to the client
must be sensitive to the possibility that the
client has suffered previous traumatic experi-
ences that may interfere with his or her abili-
ty to be trusting of the counselor. Clinicians
who observe guardedness on the part of the
client should consider the possibility of trau-
ma and try to promote safety in the interview
through providing support and gentleness,
rather than trying to “break through” eva-
siveness that erroneously might look like
resistance or denial. All questioning should
avoid “retraumatizing” the client—see section
on trauma screening later in this chapter and,
for additional details, see the forthcoming
TIP Substance Abuse Treatment and Trauma
(CSAT in development d).
Assessment Step 2: Identify
and Contact Collaterals
(Family, Friends, Other
Providers) To Gather
Additional Information
Clients presenting for substance abuse treat-
ment, particularly those who have current or
past mental health symptoms, may be unable
or unwilling to report past or present circum-
stances accurately. For this reason, it is recom-
mended that all assessments include routine
procedures for identifying and contacting any
family and other collaterals who may have use-
ful information to provide. Information from
collaterals is valuable as a supplement to the
client’s own report in all of the assessment steps
Figure 4-1
Assessment Considerations
Engagement:
•What does the client want?
•What is the treatment contract?
•What are the immediate needs?
•What are the multiaxial DSM-IV diagnoses?
Multidimensional severity/level of functioning profile:
•Identify which assessment dimensions are most severe to determine treatment priorities.
•Choose a specific priority for each medium/severe dimension.
What specific services are needed to address these priorities?
What “dose” or intensity of services is needed?
Where can these services be provided in the least intensive, but safe, level of care or site of care?
How will outcomes be measured?
What is the progress of the treatment plan and placement decision?
Source: Adapted from Mee-Lee 1998.
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listed in the remainder of this chapter. It is
valuable particularly in evaluating the nature
and severity of mental health symptoms when
the client may be so impaired that he or she is
unable to provide that information accurately.
Note, however, that the process of seeking such
information must be carried out strictly in
accordance with applicable guidelines and laws
regarding confidentiality
1
and with the client’s
permission. 
Assessment Step 3: Screen for
and Detect Co-Occurring
Disorders
Because of the high prevalence of co-occurring
mental disorders in substance abuse treatment
settings, and because treatment outcomes for
individuals with multiple problems improve if
each problem is addressed specifically, the con-
sensus panel recommends that
•All individuals presenting for substance abuse
treatment should be screened routinely for
co-occurring mental disorders.
•All individuals presenting for treatment for a
mental disorder should be screened routinely
for any substance use disorder.
The content of the screening will vary upon the
setting. Substance abuse screening in mental
health settings should
•Screen for acute safety risk related to serious
intoxication or withdrawal
•Screen for past and present substance use,
substance related problems, and substance-
related disorders
Mental health screening has four major compo-
nents in substance abuse treatment settings:
•Screen for acute safety risk: suicide, violence,
inability to care for oneself, HIV and hepati-
tis C virus risky behaviors, and danger of
physical or sexual victimization
•Screen for past and present mental health
symptoms and disorders
•Screen for cognitive and learning deficits
•Regardless of the setting, all clients should be
screened for past and present victimization
and trauma.
Safety screening
Safety screening requires that early in the
interview the clinician specifically ask the client
if he or she has any immediate impulse to
engage in violent or self-injurious behavior, or
if the client is in any immediate danger from
others. These questions should be asked direct-
ly of the client and of anyone else who is pro-
viding information. If the answer is yes, the
clinician should obtain more detailed informa-
tion about the nature and severity of the dan-
ger, the client’s ability to avoid the danger, the
immediacy of the danger, what the client needs
to do to be safe and feel safe, and any other
information relevant to safety. Additional
information can be gathered depending on the
counselor/staff training for crisis/emergency sit-
uations and the interventions appropriate to
the treatment provider’s particular setting and
circumstances. Once this information is gath-
ered, if it appears that the client is at some
immediate risk, the clinician should arrange
for a more in-depth risk assessment by a men-
tal-health–trained clinician, and the client
should not be left alone or unsupervised.
A variety of tools are available for use in safety
screening: 
•ASAM PPC-2R identifies considerations for
immediate risk assessment and recommends
follow up procedures (ASAM 2001).
•ASI (McLellan et al. 1992) and Global
Appraisal of Individual Needs (GAIN)
(Dennis 1998) also include some safety
screening questions.
•Some systems use LOCUS (American
Association of Community Psychiatrists
[AACP] 2000a) as the tool to determine level
of care for both mental disorders and addic-
tion. One dimension of LOCUS specifically
provides guides for scoring severity of risk of
1Confidentiality is governed by the Federal “Confidentiality of Alcohol and Drug Abuse Patient Records” regulations (42 C.F.R.
Part 2) and the Federal “Standards for Privacy of Individually Identifiable Health Information” (45 C.F.R. Parts 160 and 164).
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harm. See Potential Risk of Harm on 
page 77.
None of these tools is definitive for safety
screening. Clinicians and programs should use
one of these tools only as a starting point, and
then elaborate more detailed questions to get
all relevant information.
Clinicians should not underestimate risk
because the client is using substances actively.
For example, although people who are intoxi-
cated might only seem to be making threats of
self-harm (e.g., “I’m just going to go home
and blow my head off if nobody around here
can help me”), all statements about harming
oneself or others must be taken seriously.
Individuals who have suicidal or aggressive
impulses when intoxicated may act on those
impulses; remember, alcohol and drug abuse
are among the highest predictors of danger-
ousness to self or others—even without any
co-occurring mental disorder. Determining
which intoxicated suicidal client is “serious”
and which one is not requires a skilled mental
health assessment, plus information from col-
laterals who know the client best. (See chap-
ter 8 and appendix D of this TIP for a more
detailed discussion of suicidality.) In addi-
tion, it is important to remember that the vast
majority of people who are abusing or depen-
dent on substances will experience at least
transient symptoms of depression, anxiety,
and other mental symptoms. Moreover, it
may not be possible, even with a skilled clini-
cian, to determine whether an intoxicated sui-
cidal patient is making a serious threat of self
harm; however, safety is a critical and
paramount concern. A more detailed discus-
sion of each symptom subgroup is provided in
appendix D. Safety screening conducted in
mental health settings is highlighted in the
text box below.
Screening for past and pre-
sent mental disorders
Screening for past and present mental disor-
ders has three goals: 
1. To understand a client’s history and, if the
history is positive for a mental disorder, to
alert the counselor and treatment team to
the types of symptoms that might reappear
so that the counselor, client, and staff can
be vigilant about the emergence of any such
symptoms.
2. To identify clients who might have a current
mental disorder and need both an assess-
ment to determine the nature of the disor-
der and an evaluation to plan for its treat-
ment.
Safety Screening in Mental Health Settings
Evaluating safety considerations in mental health settings involves direct questioning of client and collaterals
regarding current substance use and/or recent discontinuation of heavy use, along with past and present expe-
riences of withdrawal. If clients obviously are intoxicated, they need to be treated with empathy and firmness,
and provision needs to be made for their physical safety. If clients report that they are experiencing withdraw-
al, or appear to be exhibiting signs of withdrawal, use of formal withdrawal scales can help even inexperienced
clinicians to gather information from which medically trained personnel can determine whether medical inter-
vention is required. Such tools include the Clinical Institute Withdrawal Assessment (CIWA-Ar) (Sullivan et al.
1989) for alcohol withdrawal and the Clinical Institute Narcotic Assessment (CINA) (Zilm and Sellers 1978) for
opioid withdrawal.
Mental health clinicians need to be aware that not all drugs have a physiological withdrawal associated with
them, and it should not be assumed that withdrawal from any drug of abuse will require medical intervention.
Only in the case of alcohol, opioids, sedative-hypnotics, or benzodiazepines is medical intervention likely to be
required due to the pharmacological properties of the substance.
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Potential Risk of Harm
• Risk of Harm: This dimension of the assessment considers a person’s potential to cause significant harm to self or
others. While this may most frequently be due to suicidal or homicidal thoughts or intentions, in many cases uninten-
tional harm may result from misinterpretations of reality, from inability to care adequately for oneself, or from
altered states of consciousness due to use of intoxicating substances. For the purpose of evaluation in this parameter,
deficits in ability to care for oneself are considered only in the context of their potential to cause harm. Likewise, only
behaviors associated with substance use are used to rate risk of harm, not the substance use itself. In addition to
direct evidence of potentially dangerous behavior from interview and observation, other factors may be considered in
determining the likelihood of such behavior such as past history of dangerous behaviors, ability to contract for safety,
and availability of means. When considering historical information, recent patterns of behavior should take prece-
dence over patterns reported from the remote past. Risk of harm may be rated according to the following criteria:
Minimal risk of harm: 
(a) No indication of suicidal or homicidal thoughts or impulses, no history of suicidal or homicidal ideation, and no
indication of significant distress.
(b) Clear ability to care for self now and in the past.
Low risk of harm:
(a) No current suicidal or homicidal ideation, plan, intentions or serious distress, but may have had transient or pas-
sive thoughts recently or in the past. 
(b) Substance use without significant episodes of potentially harmful behaviors.
(c) Periods in the past of self-neglect without current evidence of such behavior.
Moderate risk of harm:
(a) Significant current suicidal or homicidal ideation without intent or conscious plan and without past history.
(b) No active suicidal/homicidal ideation, but extreme distress and/or a history of suicidal/homicidal behavior exists.
(c) History of chronic impulsive suicidal/homicidal behavior or threats and current expressions do not represent sig-
nificant change from baseline.
(d) Binge or excessive use of substances resulting in potentially harmful behaviors without current involvement in
such behavior.
(e) Some evidence of self neglect and/or compromise in ability to care for oneself in current environment.
Serious risk of harm:
(a) Current suicidal or homicidal ideation with expressed intentions and/or past history of carrying out such behavior
but without means for carrying out the behavior, or with some expressed inability or aversion to doing so, or with
ability to contract for safety.
(b) History of chronic impulsive suicidal/homicidal behavior or threats with current expressions or behavior repre-
senting a significant elevation from baseline.
(c) Recent pattern of excessive substance use resulting in disinhibition and clearly harmful behaviors with no demon-
strated ability to abstain from use.
(d) Clear compromise of ability to care adequately for oneself or to be aware adequately of environment.
Extreme risk of harm:
(a) Current suicidal or homicidal behavior or such intentions with a plan and available means to carry out this
behavior without expressed ambivalence or significant barriers to doing so; or with a history of serious past
attempts which are not of a chronic, impulsive, or consistent nature; or in presence of command hallucinations or
delusions which threaten to override usual impulse control.
(b) Repeated episodes of violence toward self or others, or other behaviors resulting in harm while under the influ-
ence of intoxicating substances with pattern of nearly continuous and uncontrolled use.
(c) Extreme compromise of ability to care for oneself or to monitor adequately the environment with evidence of dete-
rioration in physical condition or injury related to these deficits.
Source: AACP 2000a.
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3. For clients with a current COD, to deter-
mine the nature of the symptoms that might
wax and wane to help the client monitor the
symptoms, especially how the symptoms
improve or worsen in response to medica-
tions, “slips” (i.e., substance use), and
treatment interventions. For example,
clients often need help seeing that the treat-
ment goal of avoiding isolation improves
their mood—that when they call their spon-
sor and go to a meeting they break the
vicious cycle of depressed mood, seclusion,
dwelling on oneself and one’s mood,
increased depression, greater isolation, and
so on.
A number of screening, assessment, and treat-
ment planning tools are available to assist the
substance abuse treatment team. For assess-
ment of specific disorders and/or for differen-
tial diagnosis and treatment planning, there are
literally hundreds of assessment and treatment
planning tools. NIAAA operates a web-based
service that provides quick information about
alcoholism treatment assessment instruments
and immediate online access to most of them,
and the service is updated continually with new
information and assessment instruments
(www.niaaa.nih.gov/publications/Assesing%20
Alcohol/index.pdf). NIDA has a publication
from a decade ago (Rounsaville et al. 1993)
that provides broad background information
on assessment issues pertinent to COD and spe-
cific information about numerous mental
health, treatment planning, and substance
abuse tools. Of course, NIDA continues to
explore issues related to screening and assess-
ment (e.g., see www.drugabuse.gov/DirReports/
DirRep203/DirectorReport6.html and
www.drugabuse.gov/Meetings/Childhood/
Agenda/agenda.html). The mental health field
contains a vast array of screening and assess-
ment devices, as well as subfields devoted pri-
marily to the study and development of evalua-
tive methods. Almost all Substance Abuse and
Mental Health Services Administration TIPs,
which are available online
(www.kap.samhsa.gov), have a section on
assessment, many have appendices with wholly
reproduced assessment tools or information
about locating such tools, and TIPs 31, 16, 13,
11, 10, 9, 7, and 6 are centered specifically on
assessment issues.
Advanced assessment techniques include
assessment instruments for general and spe-
cific purposes and advanced guides to differ-
ential diagnosis. Most high-power assessment
techniques center on a specific type of prob-
lem or set of symptoms, such as the BDI-II
(Beck et al. 1996), the Beck Anxiety
Inventory (BAI) (Beck et al. 1988), or the
Hamilton Anxiety Scale (Hamilton 1959) or
the Hamilton Rating Scale for Depression
(Hedlung and Vieweg 1979). There are high-
power broad assessment measures such as the
Minnesota Multiphasic Personality Inventory-
2 (MMPI-2) (Butcher et al. 2001). However,
such assessment devices typically are lengthy
(the MMPI is more than 500 items), often
require specific doctoral training to use, and
can be difficult to adapt properly for some
substance abuse treatment settings. 
For both clinical and research activities,
there are a number of well-known and widely
used guides to the differential diagnostic pro-
cess in the mental health field, such as the
Structured Clinical Interview for Diagnosis
(SCID). Again, the SCIDs involve consider-
able time and training, with a separate SCID
for Axis I, Axis II, and dissociative disorders.
Other broad high-power diagnostic tools are
the Diagnostic Interview Schedule (DIS) and
the Psychiatric Research Interview for
Substance and Mental Disorders (PRISM),
but these methods can require 1 to 3 hours
and extensive training. These tools generally
provide information beyond the requirements
of most substance abuse treatment programs.
When using any of the wide array of tools
that detect symptoms of mental disorders,
counselors should bear in mind that symp-
toms of mental disorder can be mimicked by
substances. For example, hallucinogens may
produce symptoms that resemble psychosis,
and depression commonly occurs during with-
drawal from many substances. Even with
well-tested tools, it can be difficult to distin-
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guish between a mental disorder and a sub-
stance-related disorder without additional
information such as the history and chronolo-
gy of symptoms. In addition to interpreting
the results of such instruments in the broader
context of what is known about the client’s
history, counselors also are reminded that
retesting often is important, particularly to
confirm diagnostic conclusions for clients who
have used substances.
The section below briefly highlights some
available instruments available for mental
health screening.
Mental Health Screening
Form-III 
The Mental Health Screening Form-III
(MHSF-III) has only 18 simple questions and
is designed to screen for present or past
symptoms of most of the main mental disor-
ders (Carroll and McGinley 2001). It is avail-
able to the public at no charge from the
Project Return Foundation, Inc. and it is
reproduced in its entirety in appendix H,
along with instructions for its use and contact
information (a Spanish form and instructions
can be downloaded). The MHSF-III was
developed within a substance abuse treatment
setting and it has face validity—that is, if a
knowledgeable diagnostician reads each item,
it seems clear that a “yes” answer to that item
would warrant further evaluation of the client
for the mental disorder for which the item
represents typical symptomatology. 
On the other hand, the MHSF-III is only a
screening device as it asks only one question
for each disorder for which it attempts to
screen. If a client answers “no” because of a
misunderstanding of the question or a
momentary lapse in memory or test-taking
attitude, the screen would produce a “false-
negative,” where the client might have the
mental disorder but the screen falsely indi-
cates that the person probably does not have
the disorder. In a journal article the MHSF-
III is referred to as a “rough screening
device” (Carroll and McGinley 2001, p. 35),
and the authors make suggestions about its
use, comments about its limitations, and
review favorable validity and reliability data.
Mini-International
Neuropsychiatric Interview
For a more complete screening instrument, the
Mini-International
Neuropsychiatric
Interview (M.I.N.I.)
is a simple 15- to 30-
minute device that
covers 20 mental dis-
orders, including
substance use disor-
ders. Considerable
validation research
has accumulated on
the M.I.N.I.
(Sheehan et al.
1998). 
For each disorder
the M.I.N.I. has an
ordered series of about 6 to 12 questions, and
it has a simple and immediate scoring proce-
dure. For example, in terms of suicidality the
M.I.N.I. contains questions about whether in
the past month the client has 
1. Thought about being better off dead or
wishing to be dead (1 point)
2. Wanted to harm himself/herself (2 points)
3. Thought about suicide (6 points)
4. Attempted suicide (10 points)
5. Developed a suicide plan (10 points)
M.I.N.I. contains a sixth question asking if the
client has ever attempted suicide (4 points).
Scoring rates low current suicide risk as 1 to 5
points, moderate as 6 to 9 points, and high as
10 or more points.
Counselors should
bear in mind that
symptoms of mental
disorder can be
mimicked by 
substances.
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The M.I.N.I. family consists of 
•The M.I.N.I. (a low-power, broad screening
device to see if the client requires further
assessment)
•A two-page M.I.N.I. screen for research pur-
poses or when time is limited
•The M.I.N.I. Plus (an expanded version of
the M.I.N.I. designed specifically to deter-
mine whether symptoms were associated with
alcohol and other drug use and/or periods of
abstinence)
•The M.I.N.I. Tracking (a 17-page document
that provides symptom descriptors that can
be used to monitor a client’s progress in
treatment, monitor how a client’s symptoms
are affected by treatment interventions or
medications or other factors, and help with
documenting where, when, and why changes
occur)
Brief Symptom Inventory-18
Another proprietary instrument that can be
used to track clients from session to session or
over longer periods of time is the Brief
Symptom Inventory-18 (BSI-18). The BSI-18
questionnaire contains 18 items and asks
clients to rate each question on a five-point
scale. In addition to a Global Severity Index
score, there are separate scores for anxiety,
depression, and somatization subscales. The
BSI-18 was derived from the 53-item Brief
Symptom Inventory, which was derived from
the Symptom Checklist-90-Revised (SCL-90-R)
(Derogatis 1975), and the 15-item SDS
(McCorkle and Young 1978) also was a deriva-
tive of the BSI that has been superceded by the
relatively new BSI-18. 
ASI
The ASI (McLellan et al. 1992) does not screen
for mental disorders and provides only a low-
power screen for generic mental health prob-
lems. Use of the ASI ranges widely, with some
substance abuse treatment programs using a
scaled-down approach to gather basic informa-
tion about a client’s alcohol use, drug use, legal
status, employment, family/social, medical, and
psychiatric status, to an in-depth assessment
and treatment planning instrument to be
administered by a trained interviewer who
makes complex judgments about the client’s
presentation and ASI-taking attitudes.
Counselors can be trained to make clinical
judgments about how the client comes across,
how genuine and legitimate the client’s way of
responding seems, whether there are any safety
or self-harm concerns requiring further investi-
gation, and where the client falls on a nine-
point scale for each dimension. With about 200
items, the ASI is a low-power instrument but
with a very broad range, covering the seven
areas mentioned above and requiring about 1
hour for the interview. Development of and
research into the ASI continues, including
training programs, computerization, and criti-
cal analyses. It is a public domain document
that has been used widely for 2 decades. It is
reproduced in TIP 38 as appendix D (CSAT
2000c, pp. 193–204), and information about
obtaining the manual for the ASI and up-to-
date information is in appendix G. Over the
past several years, NIDA’s Clinical Trials
Network (CTN) has been researching both the
use of and the training for the ASI 
(www.drugabuse.gov/CTN/asi_team.html).
Screening for past and pre-
sent substance use disorder
This section is intended primarily for coun-
selors working in mental health service settings.
It suggests ways to screen clients for substance
abuse problems. 
Screening begins with inquiry about past and
present substance use and substance-related
problems and disorders. If the client answers
yes to having problems and/or a disorder, fur-
ther assessment is warranted. It is important to
remember that if the client acknowledges a past
substance problem but states that it is now
resolved, assessment is still required. Careful
exploration of what current strategies the indi-
vidual is using to prevent relapse is warranted.
Such information can help ensure that those
strategies continue while the individual is focus-
ing on mental health treatment. 
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Screening for the presence of substance abuse
symptoms and problems involves four compo-
nents: 
• Substance abuse symptom checklists
•Substance abuse severity checklists
•Formal screening tools that work around
denial 
•Screening of urine, saliva, or hair samples
Symptom checklists: These include checklists
of common categories of substances, history
of associated problems with use, and a history
of meeting criteria for substance dependence
for that substance. It is not helpful to develop
checklists that are overly detailed, because
they begin to lose value as simple screening
tools. It is helpful to remember to include
abuse of over-the-counter medication (e.g.,
cold pills), abuse of prescribed medication,
and gambling behavior in the checklist. It
also is reasonable to screen for compulsive
sexual behavior, Internet addiction, and com-
pulsive spending.
Severity checklists: It is useful to monitor the
severity of substance use disorder (if present)
and to determine the possible presence of
dependence. This process can begin with sim-
ple questions about past or present diagnosis
of substance dependence, and the client’s
experience of associated difficulties. Some
programs may use formal substance use dis-
order diagnostic tools; others use the ASI
(McLellan et al. 1992) or similar instrument,
even in the mental health setting. The New
Hampshire Dartmouth Psychiatric Research
Center has developed clinician-rated alcohol-
and drug-use scales for monitoring substance
abuse severity in individuals with mental dis-
orders: the Alcohol Use Scale (AUS) and
Drug Use Scale (DUS) (Drake et al. 1996b)
and others (www.dartmouth.edu/~psychrc/
instru.html).
Screening tools: Most common substance
abuse screening tools have been used with
individuals with COD. These include the
CAGE (Mayfield et al. 1974), the Michigan
Alcoholism Screen Test (MAST) (Selzer 1971),
the Drug Abuse Screening Test (DAST)
(Skinner 1982), and the Alcohol Use
Disorders Identification Test (AUDIT) (Babor
et al. 1992). The Dartmouth Assessment of
Lifestyle Inventory (DALI) is used routinely
as a screening tool in some research settings
working with individuals with serious mental
disorders (Rosenberg et al. 1998). 
The SSI-SA was developed by the consensus
panel of TIP 11, Simple Screening
Instruments for Outreach for Alcohol and
Other Drug Abuse and Infectious Diseases
(CSAT 1994c). The SSI-SA is reproduced in
its entirety in
appendix H. It is a
16-item scale,
although only 14
items are scored so
that scores can
range from 0 to 14.
These 14 items were
selected by the TIP
11 consensus pan-
elists from existing
alcohol and drug
abuse screening
tools. A score of 4
or greater has
become the estab-
lished cut-off point
for warranting a
referral for a full
assessment. Since
its publication in
1994 the SSI-SA has been widely used and its
reliability and validity investigated. For
example, Peters and colleagues (2004) report-
ed on a national survey of correctional treat-
ment for COD. Reviewing 20 COD treatment
programs in correctional settings from 13
States, the SSI-SA was identified as among
the most common screening instruments used.
For more information, see appendix H.
Toxicology screening: Given the high preva-
lence of substance use disorders in patients
with mental health problems, the routine use
of urine or other screening is indicated for all
new mental health clients. It especially is sug-
Screening begins
with inquiry
about past and
present sub-
stance use and
substance-relat-
ed problems and
disorders.
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gested in settings in which the likelihood of
clients regularly presenting unreliable infor-
mation is particularly great; for example, in
adolescent and/or criminal justice settings.
Use of urine screening is highly recommended
whenever the clinical presentation does not
seem to fit the client’s story, or where there
appear to be unusual mental status symptoms
or changes not explained adequately. Saliva
testing may be less intrusive than hair or
urine testing in patients who are shy or who
are extremely paranoid.
Trauma screening
Research projects focusing on the needs of
people with COD who are victims of trauma
have led to the development of specific
screening tools to identify trauma in treat-
ment populations. To screen for posttraumat-
ic stress disorder (PTSD), assuming the client
has a trauma, the Modified PTSD Symptom
Scale: Self-Report Version would be a good
choice (this instrument can be found in TIP
36, Substance Abuse Treatment for Persons
With Child Abuse and Neglect Issues [CSAT
2000d, p. 170]). This scale also is useful for
monitoring and tracking PTSD symptoms
over time. The PTSD Checklist (Blanchard et
al. 1996) is a validated instrument that sub-
stance abuse treatment agencies also may find
useful in trauma screening.
It is important to emphasize that in screening
for a history of trauma or in obtaining a pre-
liminary diagnosis of PTSD, it can be damag-
ing to ask the client to describe traumatic
events in detail. To screen, it is important to
limit questioning to very brief and general
questions, such as “Have you ever experi-
enced childhood physical abuse? Sexual
abuse? A serious accident? Violence or the
threat of it? Have there been experiences in
your life that were so traumatic they left you
unable to cope with day-to-day life?” See the
discussion of screening and assessment for
PTSD in appendix D for more complete infor-
mation.
Assessment Step 4: Determine
Quadrant and Locus of
Responsibility
Determination of quadrant assignment is based
on the severity of the mental and substance use
disorders (see chapter 2 for a detailed discus-
sion of the four-quadrant model). Most of the
information needed for this determination will
have been acquired during step 2, but there
are a few added nuances. Quadrant determina-
tion may be specified formally by procedures in
certain States. For example, New York has
drafted (but not yet adopted) a set of objective
criteria for determining at screening who
should be considered as belonging in quadrant
IV. Where no such formal procedures are pre-
sent, the following sequence may be useful and
is certainly within the capability of substance
abuse treatment clinicians in any setting.
The Four Quadrants
III
•Less severe mental disorder/more severe substance
disorder
IV
•More severe mental disorder/more severe substance
disorder
I
•Less severe mental disorder/less severe substance
disorder
II
•More severe mental disorder/less severe substance
disorder
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Determination of serious
mental illness (SMI) status
Every State mental health system has devel-
oped a set of specific criteria for determining
who can be considered seriously mentally ill
(and therefore eligible to be considered a men-
tal health priority client). These criteria are
based on combinations of specific diagnoses,
severity of disability, and duration of disability
(usually 6 months to 1 year). Some require that
the condition be independent of a substance
use disorder. These criteria are different for
every State. It would be helpful for substance
abuse treatment providers to obtain copies of
the criteria for their own States, as well as
copies of the specific procedures by which eligi-
bility is established by their States’ mental
health systems. By determining that a client
might be eligible for consideration as a mental
health priority client, the substance abuse
treatment counselor can assist the client in
accessing a range of services and/or benefits
that the client may not know is open to her or
him.
Determining SMI status begins with finding out
if the client already is receiving mental health
priority services (e.g., Do you have a mental
health case manager? Are you a Department of
Mental Health client?).
• If the client already is a mental health
client, then he or she will be assigned to
quadrant II or IV. Contact needs to be
made with the mental health case manager
and a means of collaboration established to
promote case management.
• If the client is not already a mental health
client, but appears to be eligible and the
client and family are willing, referral for
eligibility determination should be
arranged.
• Clients who present in addiction treatment
settings who look as if they might be SMI,
but have not been so determined, should be
considered to belong to quadrant IV.
For assistance in determination of the severi-
ty of symptoms and disability, the substance
abuse treatment clinician can use the
Dimension 3 (Emotional/Behavioral) sub-
scales in the ASAM PPC-2R or LOCUS, espe-
cially the levels of severity of comorbidity and
impairment/functionality.
Determination of severity of
substance use disorders
Presence of active or unstable substance
dependence or serious substance abuse (e.g.,
recurrent substance-induced psychosis without
meeting other criteria for dependence) would
identify the individual as being in quadrant III
or IV. Less serious substance use disorder (mild
to moderate substance abuse; substance depen-
Assessment Step 4—Application to Case Examples
Cases 1 and 2. Both Maria M. and George T. are examples of clients with serious addiction who also have
serious mental disorders, but do not appear to be seriously disabled. They would therefore meet criteria for
quadrant III and should be placed in programs for people who have less serious mental disorders and more
serious substance use disorders. Note that though the diagnosis of bipolar disorder is typically considered a
serious mental illness, the quadrant system emphasizes the acute level of disability/severity of the mental
and substance use disorders of the individual, rather than relying solely on diagnostic classification.
Case 3. Jane B., the homeless woman with paranoid schizophrenia, generally would meet criteria for seri-
ous and persistent mental illness in almost every State, based on the severity of the diagnosis and disability,
combined with the persistence of the disorder. Jane B. also has serious addiction. In the quadrant model, if
she already has been identified as a mental health priority client (e.g., has a mental health case manager),
she would be considered quadrant IV, and referral for mental health case management services would be
important.
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dence in full or partial remission) identifies the
individual as being in quadrant I or II.
If the client is determined to have SMI with
serious substance use disorder, he falls in
quadrant IV; those with SMI and mild sub-
stance use disorder fall in quadrant II. A
client with serious substance use disorder who
has mental health symptoms that do not con-
stitute SMI falls into quadrant III. A client
with mild to moderate mental health symp-
toms and less serious substance use disorder
falls into quadrant I.
Clients in quadrant III who present in sub-
stance abuse treatment settings are often best
managed by receiving care in the addiction
treatment setting, with collaborative or con-
sultative support from mental health
providers. Individuals in quadrant IV usually
require intensive intervention to stabilize and
determination of eligibility for mental health
services and appropriate locus of continuing
care. If they do not meet criteria for SMI,
once their more serious mental symptoms
have stabilized and substance use is con-
trolled initially, they begin to look like indi-
viduals in quadrant III, and can respond to
similar services. 
Note, however, that this discussion of quad-
rant determination is not validated by clinical
research. It is merely a practical approach to
adapting an existing framework for clinical
use, in advance of more formal processes
being developed, tested, and disseminated.
In many systems, the process of assessment
stops largely after assessment step 4 with the
determination of placement. Some information
from subsequent steps (especially step 7) may
be included in this initial process, but usually
more in-depth or detailed consideration of
treatment needs may not occur until after
“placement” in an actual treatment setting.
Assessment Step 5: Determine
Level of Care
The use of the ASAM PPC-2R provides a
mechanism for an organized assessment of indi-
viduals presenting for substance use disorder
treatment to determine appropriate placement
in “level of care.” This process involves consid-
eration of six dimensions of assessment:
• Dimension 1: Acute Intoxication and/or
Withdrawal Potential
Assessment Step 5—Application to Case Examples
Case 3. The severity of Jane B.’s condition and her psychosis, homelessness, and lack of stability may lead
the clinician initially to consider psychiatric hospitalization or referral for residential substance abuse
treatment. In fact, application of assessment criteria in ASAM PPC-2R might have led easily to that conclu-
sion. In ASAM PPC-2R, more flexible matching is possible. The first consideration is whether the client
meets criteria for involuntary psychiatric commitment (usually, suicidal or homicidal impulses, or inability
to feed oneself or obtain shelter). In this instance, she is psychotic and homeless but has been able to find
food and shelter; she is unwilling to accept voluntary mental health services. Further, residential substance
abuse treatment is inappropriate, both because she is completely unmotivated to get help and because she is
likely to be too psychotic to participate in treatment effectively. ASAM PPC-2R would therefore recom-
mend Level I.5 intensive mental disorder case management as described above. 
If after extended participation in the engagement strategies described earlier, she began to take antipsy-
chotic medication, after a period of time her psychosis might clear up, and she might begin to express inter-
est in getting sober. In that case, if she had determined that she is unable to get sober on the street, residen-
tial substance abuse treatment would be indicated. Because of the longstanding severity of her mental ill-
ness, it is likely that she would continue to have some level of symptoms of her mental disorder and disabili-
ty even when medicated. In this case, Jane B. probably would require a residential program able to supply
an enhanced level of services.
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• Dimension 2: Biomedical Conditions and
Complications
• Dimension 3: Emotional, Behavioral, or
Cognitive Conditions and Complications
• Dimension 4: Readiness to Change 
• Dimension 5: Relapse, Continued Use, or
Continued Problem Potential
• Dimension 6: Recovery/Living Environment
The ASAM PPC-2R (ASAM 2001) evaluates
level of care requirements for individuals with
COD. Dimension 3 encompasses “Emotional,
Behavioral or Cognitive Conditions and
Complications.” Five areas of risk must be con-
sidered related to this dimension (ASAM 2001,
pp. 283–284):
•Suicide potential and level of lethality
•Interference with addiction recovery efforts
(“The degree to which a patient is distracted
from addiction recovery efforts by emotional,
behavioral and/or cognitive problems and
conversely, the degree to which a patient is
able to focus on addiction recovery”)
•Social functioning
•Ability for self-care
•Course of illness (a prediction of the patient’s
likely response to treatment)
Consideration of these dimensions permits the
client to be placed in a particular level on a
continuum of services ranging from intensive
case management for individuals with serious
mental disorders who are not motivated to
change (Level I.5) to psychiatric inpatient care
(Level IV). In addition, there is the capacity to
distinguish, at each level of care, individuals
with lower severity of mental symptoms or
impairments that require standard or Dual
Diagnosis Capable programming at that level of
care from individuals with moderately severe
symptoms or impairments that require Dual
Diagnosis Enhanced programming at that level
of care. (See below for assessment of the level
of impairment.) The ASAM PPC have under-
gone limited validity testing in previous ver-
sions, are used to guide addiction treatment
matching in more than half the States, and are
influential in almost all of the rest. 
Tools: The LOCI–2R (Hoffmann et al. 2001)
(see www.evinceassessment.com/
product_loci2r.html for more information) is
a proprietary tool designed specifically to
perform a structured assessment for level of
care placement based on ASAM PPC-2R lev-
els of care (ASAM 2001). The GAIN (Dennis
1998) is another broad set of tools and train-
ing developed within an addiction setting;
however, GAIN products are also propri-
etary.
In some systems, the LOCUS Adult Version
2000 (AACP 2000a) is being introduced as a
systemwide level of care assessment instru-
ment for either mental health settings only, or
for both mental health and substance abuse
treatment settings. Like the ASAM, LOCUS
uses multiple dimensions of assessment:
•Risk of Harm
•Functionality
•Comorbidity (Medical, Addictive,
Psychiatric)
•Recovery Support and Stress
•Treatment Attitude and Engagement
•Treatment History
LOCUS is simpler to use than ASAM PPC-2R.
It has a point system for each dimension that
permits aggregate scoring to suggest level of ser-
vice intensity. LOCUS also permits level of care
assessment for individuals with mental disor-
ders or substance use disorders only, as well as
for those with COD. Some pilot studies of
LOCUS have supported its validity and relia-
bility. However, compared to ASAM PC-2R,
LOCUS is much less sensitive to the needs of
individuals with substance use disorders and
has greater difficulty distinguishing the sepa-
rate contributions of mental and substance-
related symptoms to the clinical picture.
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Assessment Step 6: Determine
Diagnosis 
Determining the diagnosis can be a formidable
clinical challenge in the assessment of COD.
Clinicians in both mental health services and
substance abuse treatment settings recognize
that it can be impossible to establish a firm
diagnosis when confronted with the mixed pre-
sentation of mental symptoms and ongoing sub-
stance abuse. Of course, substance abuse con-
tributes to the emergence or severity of mental
symptoms and therefore confounds the diag-
nostic picture. Therefore, this step often
includes dealing with confusing diagnostic pre-
sentations. 
Addiction counselors who want to improve
their competencies to address COD are urged
to become conversant with the basic resource
used to diagnose mental disorders, the
Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition, Text Revision (DSM-
IV-TR) (American Psychiatric Association
2000).
The importance of client 
history
• Principle #1: Diagnosis is established more
by history than by current symptom pre-
sentation. This applies to both mental and
substance use disorders.
The first step in determining the diagnosis is to
determine whether the client has an established
diagnosis and/or is receiving ongoing treatment
for an established disorder. This information
can be obtained by the counselor as part of the
routine intake process. If there is evidence of a
disorder but the diagnosis and/or treatment
recommendations are unclear, the counselor
immediately should begin the process of obtain-
ing this information from collaterals. If there is
a valid history of a mental disorder diagnosis at
admission to substance abuse treatment, that
diagnosis should be considered presumptively
valid for initial treatment planning, and any
existing stabilizing treatment should be main-
tained. In addition to confirming an established
diagnosis, the client’s history can provide
insight into patterns that may emerge and add
depth to knowledge of the client.
For example, if a client comes into the clini-
cian’s office under the influence of alcohol, it
is reasonable to suspect alcohol dependence,
but the only diagnosis that can be made based
on that datum is “alcohol intoxication.” It is
important to note that this warrants further
investigation; on the one hand, false positives
can occur, while on the other, detoxification
may be needed. Conversely, if a client comes
into the clinician’s office and has not had a
drink in 10 years, attends Alcoholics
Anonymous (AA) meetings three times per
week, and had four previous detoxification
admissions, the clinician can make a diagnosis
of alcohol dependence (in remission at pre-
sent). Moreover, the clinician can predict that
20 years from now that client will still have
the diagnosis of alcohol dependence since the
history of alcohol dependence and treatment
sustains a lifetime diagnosis of alcohol depen-
dence.
Similarly, if a client comes into the clinician’s
office and says she hears voices (whether or
Assessment Step 6—Application to Case Examples
Case 2. George T. has cocaine dependence and bipolar disorder stabilized with lithium. He reports that
when he uses cocaine he has mood swings, but that these go away when he stops using for a while, as long as
he takes his medication. At the initial visit, George T. states he has not used for a week and has been taking
his medication regularly. He displays no significant symptoms of mania or depression and appears reason-
ably calm. The counselor should not conclude that because George T. has no current symptoms the diagno-
sis of bipolar disorder is incorrect, or that all the mood swings are due to cocaine dependence. At initial
contact, the presumption should be that the diagnosis of bipolar disorder is accurate, and lithium needs to
be maintained.
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not the client is sober currently), no diagnosis
should be made on that basis alone. There
are many reasons people hear voices. They
may be related to substance-related syn-
dromes (e.g., substance-induced psychosis or
hallucinosis, which is the experience of hear-
ing voices that the client knows are not real,
and that may say things that are distressing
or attacking—particularly when there is a
trauma history—but are not bizarre). With
COD, most causes will be independent of sub-
stance use (e.g., schizophrenia, schizoaffec-
tive disorder, affective disorder with psy-
chosis or dissociative hallucinosis related to
PTSD). Psychosis usually involves loss of
ability to tell that the voices are not real, and
increased likelihood that they are bizarre in
content. Methamphetamine psychosis is par-
ticularly confounding because it can mimic
schizophrenia. Many individuals with psy-
chotic disorders will still hear voices when on
medication, but the medication makes the
Assessment Step 6—Application to Case Example
Case 1. Maria M., the 38-year-old Hispanic/Latina female with cocaine and opioid dependence, initially was
receiving methadone maintenance treatment only. She also used antidepressants prescribed by her outside
primary care physician. She presented to methadone maintenance program staff with complaints of depres-
sion. Maria M. reported that since treatment with methadone (1 year) she had not used illicit opioids.
However, she stated that when she does not use cocaine, she often feels depressed “for no reason.”
Nevertheless, she has many stressors involving her children, who also have drug problems. She reports that
depression is associated with impulses to use cocaine, and consequently she has recurrent cocaine binges.
These last a few days and are followed by persistent depression.
What is the mental diagnosis? To answer this question it is important to obtain a mental disorder history
that relates mental symptoms to particular time periods and patterns of substance use and abuse.
The client’s history reveals that although she grew up with an abusive father with an alcohol problem, she
herself was not abused physically or sexually. Although hampered by poor reading ability, she stayed in
school with no substance abuse until she became pregnant at age 16 and dropped out of high school. Despite
becoming a single mother at such a young age, she worked three jobs and functioned well, while her mother
helped raise the baby. At age 23, she began a 9-year relationship with an abusive person with an alcohol and
illicit drug problem, during which time she was exposed to a period of severe trauma and abuse. She is able
to recall that during this relationship, she began to lose her self-esteem and experience persistent depression
and anxiety.
She began using cocaine at age 27, initially to relieve those symptoms. Later, she lost control and became
addicted. Four years ago, she was first diagnosed as having major depression, and was prescribed antide-
pressant medication, which she found helpful. Two years ago, she began using opioids, became addicted,
and then entered methadone treatment. She receives no specific treatment for cocaine dependence. She has
noticed that her depression persists during periods of cocaine and opioid abstinence lasting more than 30
days. On one occasion, during one of these periods, her medication ran out, and she noticed her depression
became much worse. Even at her baseline, she remains troubled by lack of self-confidence and fearfulness,
as well as depressed mood.
Her depression persists during periods of more than 30 days of abstinence and responds to some degree to
antidepressants. The fact that her depression persists even when she is abstinent and responds to antide-
pressants suggests strongly a co-occurring affective disorder. There are also indications of the persistent
effects of trauma, possibly posttraumatic stress disorder. Trauma issues have never been addressed. Her
opioid dependence has been stabilized with methadone. She has resisted recommendations to obtain more
specific treatment for cocaine dependence.
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voices less bizarre and helps the client know
they are not real.
If the client states he has heard voices,
though not as much as he used to, that he has
been clean and sober for 4 years, that he
remembers to take his medication most days
though every now and then he forgets, and
that he had multiple psychiatric hospitaliza-
tions for psychosis 10 years ago but none
since, then the client clearly has a diagnosis
of psychotic illness (probably schizophrenia
or schizoaffective disorder). Given the client’s
continuing symptoms while clean and sober
and on medication, it is quite possible that
the diagnosis will persist. 
Documenting prior diagnoses
• Principle #2: It is important to document
prior diagnoses and gather information
related to current diagnoses, even though
substance abuse treatment counselors may
not be licensed to make a mental disorder
diagnosis. 
Diagnoses established by history should not be
changed at the point of initial assessment. If the
clinician has a suspicion that a long-established
diagnosis may be invalid, it is important that he
or she takes time to gather additional informa-
tion, consult with collaterals, get more careful
and detailed history (see below), and develop a
better relationship with the client before rec-
ommending diagnostic re-evaluation. It is
important for the counselor to raise issues
related to diagnosis with the clinical supervisor
or at a team meeting.
In many instances, of course, no well-estab-
lished mental disorder diagnosis exists, or
multiple diagnoses give a confusing picture.
Even when there is an established diagnosis,
it is helpful to gather information to confirm
that diagnosis. During the initial assessment
process, substance abuse treatment coun-
selors can gather data that can assist in the
diagnostic process, either by supporting the
findings of the existing mental health assess-
ment, or providing useful background infor-
mation in the event a new mental health
assessment is conducted. The key to doing
this is not merely to gather lists of past and
present symptoms, but to connect those symp-
toms to key time periods in the client’s life
that are helpful in the diagnostic process—
namely, before the onset of a substance use
disorder and during periods of abstinence (or
during periods of very limited use) or those
that occur after the onset of the substance use
disorder and persist for more than 30 days.
The clinician also must seek to determine
whether mental symptoms occur only when
the client is using substances actively.
Therefore, it is important to determine the
nature and severity of the symptoms of the
mental disorder when the substance disorder
is stabilized. 
Linking mental symptoms to
specific periods
• Principle #3: For diagnostic purposes, it is
almost always necessary to tie mental symp-
toms to specific periods of time in the
client’s history, in particular those times
when active substance use disorder was not
present.
Unfortunately, most substance abuse assess-
ment tools are not structured to require con-
nection of mental symptoms to such periods
of use or abstinence. For this reason, mental
disorder symptom information obtained from
such tools can be confusing and often con-
tributes to counselors feeling the whole pro-
cess is not worth the effort. In fact, it is strik-
ing that when clinicians seek information
about mental symptoms during periods of
abstinence, such information is almost never
part of traditional assessment forms. The
mental history and substance use history have
in the past been collected separately and
independently. As a result, the opportunity to
evaluate interaction, which is the most impor-
tant diagnostic information beyond the histo-
ry, has been routinely lost. Newer and more
detailed assessment tools overcome these his-
torical, unnecessary divisions.
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One instrument that may be helpful in this
regard is the M.I.N.I. Plus (described above),
which has a structure to connect any identi-
fied symptoms to periods of abstinence.
Clinicians can use this information to distin-
guish substance-induced mental disorders
from independent mental disorders. Drake
and others in their work on mental disorder
treatment teams in New Hampshire have
adapted the Timeline Follow Back Method
(www.dartmouth.edu/~psychrc/instru.html),
developed by Sobell and Mueser (Mueser et
al. 1995b; Sobell et al. 1979), that can be
used with individuals who have serious men-
tal disorders and substance use disorders.
More detailed mental health research diag-
nostic tools (e.g., the SCID) encourage a simi-
lar process. 
Consequently, the substance abuse treatment
counselor can proceed in two ways:
1. Inquire whether any mental symptoms or
treatments identified in the screening pro-
cess were present during periods of 30 days
of abstinence or longer, or were present
before onset of substance use. (“Did this
symptom or episode occur during a period
when you were clean and sober for at least
30 days?”)
2. Define with the client specific time periods
where substance use disorder was in remis-
sion, and then get detailed information
about mental symptoms, diagnoses, impair-
ments, and treatments during those periods
of time. (“Can you recall a specific period
when you were not using? Did these symp-
toms [or whatever the client has reported]
occur during that period?”) This approach
may yield more reliable information.
During this latter process, the counselor can
use one of the medium-power symptom screen-
ing tools as a guide. Alternatively, the coun-
selor can use the handy outlines of the DSM-IV
criteria for common disorders and inquire
whether those criteria symptoms were met,
whether they were diagnosed and treated, and
if so, with what methods and how successfully.
This information can suggest or support the
accuracy of diagnoses. Documentation also can
facilitate later diagnostic assessment by a men-
tal-health–trained clinician.
Assessment Step 7: Determine
Disability and Functional
Impairment
Determination of both current and baseline
functional impairment contributes to identifica-
tion of the need for case management and/or
higher levels of support. This step also relates
to the determination of level of care require-
ments. Assessment of current cognitive capaci-
ty, social skills, and other functional abilities
also is necessary to determine if there are
deficits that may require modification in the
treatment protocols of relapse prevention
efforts or recovery programs. For example, the
counselor might inquire about past participa-
tion in special education or related testing.
Assessment Step 7—Application to Case Example
Case 1. Assessment of Maria M.’s functional capacity at baseline indicated that she could read only at a
second grade level. Consequently, educational materials presented in written form needed to be presented
in alternative formats. These included audiotapes and videos to teach her about addiction, depression,
trauma, and recovery from these conditions. In addition, Maria M.’s history of trauma (previously dis-
cussed) led her to experience anxiety in large group situations, particularly where men were present. This
led her counselor to recommend attending 12-Step meetings that were smaller and/or women only. The
counselor also suggested that she attend in the company of female peers. Further, the clinician referred her
to trauma-specific counseling.
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Assessing functional 
capability
Current level of impairment is determined by
assessing functional capabilities and deficits in
each of the areas listed below. Similarly, base-
line level of impairment is determined by iden-
tifying periods of extended abstinence and
mental health stability (greater than 30 days)
according to the methods described in the pre-
vious assessment step. The clinician deter-
mines:
•Is the client capable of living independently
(in terms of independent living skills, not in
terms of maintaining abstinence)? If not,
what types of support are needed?
•Is the client capable of supporting himself
financially? If so, through what means? If
not, is the client disabled, or dependent on
others for financial support?
•Can the client engage in reasonable social
relationships? Are there good social sup-
ports? If not, what interferes with this ability,
and what supports would the client need?
•What is the client’s level of intelligence? Is
there a developmental or learning disability?
Are there cognitive or memory impairments
that impede learning? Is the client limited in
ability to read, write, or understand? Are
there difficulties with focusing, concentrat-
ing, and completing tasks?
The ASI (McLellan et al. 1992) and the GAIN
(Dennis 1998) provide some information
about level of functioning for individuals with
substance use disorders. They are valuable
when supplemented by interview information
in the above areas. (Note that the ASI also
exists in an expanded version specifically for
women [ASI-F, CSAT 1997c].) The counselor
also should inquire about any current or past
difficulties the client has had in learning or
using relapse prevention skills, participating
in self-help recovery programs, or obtaining
medication or following medication regimens.
In the same vein, the clinician may inquire
about use of transportation, budgeting, self-
care, and other related skills, and their 
effect on life functioning and treatment 
participation.
For individuals with COD, the impairment
may be related to intellectual/cognitive ability
or the mental disability. These disorders may
exist in addition to the substance use disor-
Assessment Step 7—Application to Case Example
Case 3. Once Jane B. had begun to stabilize on medication and expressed interest in residential addiction treat-
ment, it became necessary to assess her ability to participate in standard dual diagnosis capable (DDC) treatment
versus her need for more dual diagnosis enhanced (DDE) treatment. Jane B. was still living in a shelter, but was
able to maintain her personal hygiene and dress appropriately now that she was on medication. She looked
somewhat suspicious and guarded, but could answer questions appropriately and denied having hallucinations.
To determine her ability to succeed in standard residential substance abuse treatment, her counselor asked her
to attend an AA meeting. The clinician also asked her to complete an assignment to read some substance abuse
literature and write down what she had learned. The client reported that she was nervous at the meeting but was
able to stay the whole time. She said that she related well to what one of the speakers was saying. She also com-
pleted the written assignment quite well; it turned out she was very bright and had completed 1 year of college.
Noting that she was complying with medication and her mental status was stable, the counselor felt comfortable
referring her to the DDC program. 
Had this client been unable to attend AA without individual support, or if she experienced obvious difficulty
with the assignment, it would have been clearer that a program with an enhanced capacity to treat persons with
COD would be indicated. If such a program were not available, she would have needed to continue to build skills
slowly to address her substance use with the assistance of her outpatient case management program.
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der. The clinician should try to establish both
level of intellectual/cognitive functioning in
childhood and whether any impairment per-
sists, and if so, at what level, during the peri-
ods when substance use is in full or partial
remission, just as in the above discussion of
diagnosis.
Determining the need for
“Capable” or “Enhanced”
level services
A specific tool to assess the need for
“Capable” or “Enhanced” level services for
persons with COD currently is not available.
The consensus panel recommends a process of
“practical assessment” that seeks to match
the client’s assessment (mental health, sub-
stance abuse, level of impairment) to the type
of services needed. The individual may even
be given trial tasks or assignments to deter-
mine in concert with the counselor if her per-
formance meets the requirements of the pro-
gram being considered.
Assessment Step 8: Identify
Strengths and Supports
All assessment must include some specific
attention to the individual’s current strengths,
skills, and supports, both in relation to general
life functioning, and in relation to his or her
ability to manage either mental or substance
use disorders. This often provides a more posi-
tive approach to treatment engagement than
does focusing exclusively on deficits that need
to be corrected. This is no less true for individ-
uals with serious mental disorders than it is for
people with substance use disorders only.
Questions might focus on
•Talents and interests
•Areas of educational interest and literacy;
vocational skill, interest, and ability, such as
vocational skills, social skills, or capacity for
creative self-expression
•Areas connected with high levels of motiva-
tion to change, for either disorder or both
•Existing supportive relationships, treatment,
peer, or family, particularly ongoing mental
disorder treatment relationships
•Previous mental health services and addic-
tion treatment successes, and exploration of
what worked
•Identification of current successes: What has
the client done right recently, for either dis-
order?
•Building treatment plans and interventions
based on utilizing and reinforcing strengths,
and extending or supporting what has
worked previously
Assessment Step 8—Application to Case Examples
Case 2. George T. had significant strengths in three areas: He had a strong desire to maintain his family,
significant pride in his job, and attachment to a mutual self-help group for individuals with bipolar disor-
der—Manic-Depressive and Depressive Association (MDDA). Therefore his treatment plan involved attend-
ing a recovery group managed by the Employee Assistance Program (EAP) at his company (which included
regularly monitored urine screens), family counseling sessions, and utilization of his weekly MDDA group
for peer support. Despite not feeling engaged fully, George T. continued to attend 12-Step meetings two
times per week, as there was no Dual Recovery Anonymous or Double Trouble meeting available in his area.
Case 3. Jane B. expressed significant interest in work, once her paranoia subsided. She was attempting to
address her substance use on an outpatient basis, as an appropriate residential treatment program was not
available. Her case management team found that she had some interest and experience in caring for ani-
mals, and, using individualized placement and support, helped her obtain a part-time job at a local pet shop
two afternoons per week. She felt very proud of being able to do this, and reported that this helped her to
maintain her motivation to stay away from substances and to keep taking medication.
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For individuals with mental disabilities and
COD, the Individualized Placement and
Support model of psychiatric rehabilitation has
been demonstrated to promote better vocation-
al outcomes and (consequently) better sub-
stance abuse outcomes compared both to other
models of vocational rehabilitation for this pop-
ulation and to outcomes when rehabilitative
interventions are not offered (Becker et al.
2001). In this model, clients with disabilities
who want to work may be placed in sheltered
work activities based on strengths and prefer-
ences, even when actively using substances and
inconsistently complying with medication regi-
mens. In nonsheltered work activities, it is crit-
ical to remember that many employers have
alcohol- and drug-free workplace policies.
Participating in ongoing jobs is valuable to self-
esteem in itself and can generate the motivation
to address mental disorders and substance
issues as they appear to interfere specifically
with work success. Taking advantage of educa-
tional and volunteer opportunities also may
enhance self-esteem and are often first steps in
securing employment. 
Social Security Disability secondary to a men-
tal disorder, such as schizophrenia, usually is
referred to as Supplemental Security Income
(if the person never worked regularly), or
Social Security Disability Insurance (if the
person worked regularly and contributed
social security payments while working). To
qualify as having a mental disability, a person
must have not only a confirmed major mental
disorder diagnosis, but also a pattern related
to the impact of that mental disorder diagno-
sis on his social and functional behavior that
prevents employment. Social security disabili-
ty benefits for an addiction disorder alone
were abandoned by the Federal government
in 1997. For persons with COD, disability
must be caused by the mental disorder alone
and not the combination of both mental and
addiction disorders. Social security disability
evaluation forms ask carefully about these
issues and also ask whether the person is
actively participating in treatments for their
COD and substance abuse problems.
Assessment Step 9: Identify
Cultural and Linguistic Needs
and Supports
As noted above, detailed cultural assessment of
individuals with substance use disorders is
beyond the scope of this chapter. Cultural
assessment of individuals with COD is not sub-
stantially different from cultural assessment for
individuals with substance abuse or mental dis-
orders only, but there are some specific issues
that are worth addressing. These include
• Not fitting into the treatment culture (do not
fit into either substance abuse or mental
health treatment culture) and conflict in
treatment
• Cultural and linguistic service barriers
• Problems with literacy
Not fitting into the 
treatment culture
To a certain degree, individuals with COD and
SMI tend not to fit into existing treatment cul-
tures. Most of these clients are aware of a vari-
ety of different attitudes and suggestions
toward their disorders that can affect relation-
ships with others. Traditional culture carriers
(parents, grandparents) may have different
Assessment Step 9—Application to Case Example
Case 1. Maria M. initially had difficulty identifying herself as being a victim of trauma both because she
had normalized her perception of her early family experience with her abusive father and because she had
received cultural reinforcement in the past that condoned the behavior of her abusive boyfriend as “nor-
mal machismo.” Referral to a group that included other Hispanic women who also had suffered abuse was
very helpful to her. With the help of the group, she began to recognize the reality of the impact that trauma
had had in her life.
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views of their problems and the most appropri-
ate treatment compared to peers. Individual
clients may have positive or negative allegiance
to a variety of peer or treatment cultures (e.g.,
mental health consumer movement, having
mild or moderate severity mental disorders
versus severe and persistent mental illness
[SPMI], 12-Step or dual recovery self-help,
etc.) based on past experience or on fears and
concerns related to the mental disorder.
Specific considerations to explore with the
client include
•How are your substance abuse and mental
health problems defined by your parents?
Peers? Other clients? 
•What do they think you should be doing to
remedy these problems? 
•How do you decide which suggestions to 
follow?
•In what kinds of treatment settings do you
feel most comfortable?
•What do you think I (the counselor) should
be doing to help you improve your situation?
Cultural and linguistic 
service barriers
Access to COD treatment is compounded by
cultural or linguistic barriers. The assessment
process must address specifically whether these
barriers prevent access to care (e.g., the client
reads or speaks only Spanish, or does not read
any language) and if so, determine some possi-
bilities for providing more individualized inter-
vention or for integrating intervention into nat-
uralistic culturally and linguistically appropri-
ate human service settings.
Assessment Step 10: Identify
Problem Domains
Individuals with COD may have difficulties in
multiple life domains (e.g., medical, legal,
vocational, family, social). As noted earlier,
research by McLellan and others has deter-
mined the value of providing assistance in
each problem area in promoting better out-
comes (McLellan et al. 1997). The ASI is a
tool that is used widely to identify and quanti-
fy addiction-related problems in multiple
Assessment Step 9—Application to Case Example
Case 2. George T. originally was referred to Cocaine Anonymous (CA) by his counselor because the coun-
selor knew of several local meetings with a large membership of African-American men. When George T.
went, however, he reported back to the counselor that he did not feel comfortable there. First, he felt that
as a family man with a responsible job he had pulled himself out of the “street culture” that was prevalent
at the meeting. Second, unlike many people with COD who feel more ashamed of mental disorders than
addiction, he felt more ashamed at the CA meeting than at his support group for persons with mental disor-
ders. Therefore, for George, it was more “culturally appropriate” to refer him to 12-Step meetings attended
by other middle class individuals (regardless of race) and to continue to encourage him to attend his MDDA
support group for his mental disorder.
Assessment Step 10—Application to Case Example
Case 2. Evaluation of George T. revealed several interrelated problem domains. First, it was established
that work represented a major problem area, and that he risked losing his job if he did not comply with
treatment. Further inquiry into the details of this expectation led the counselor to discover that the client
had been evaluated by the EAP and had a very specific requirement to maintain cocaine abstinence with
mandatory urine screens, meet treatment program attendance requirements, and adhere to a lithium treat-
ment regimen, with mandatory reports of lithium levels.
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domains, thereby determining which domains
require specific attention. The value of the
ASI is that it permits identification of prob-
lem domains. It is used most effectively as a
component of a comprehensive assessment.
A comprehensive evaluation for individuals
with COD requires clarifying how each disor-
der interacts with the problems in each
domain, as well as identifying contingencies
that might promote treatment adherence for
mental health and/or substance abuse treat-
ment. Information about others who might
assist in the implementation of such contin-
gencies (e.g., probation officers, family,
friends) needs to be gathered, including
appropriate releases of information.
Assessment Step 11:
Determine Stage of Change
A key evidence-based best practice for treat-
ment matching of individuals with COD in both
substance abuse treatment and mental health
services settings is the following:
•For each disorder or problem, interventions
have to be matched not only to specific diag-
nosis, but also to stage of change; the inter-
ventions also should be consistent with the
stage of treatment for each disorder.
In substance abuse treatment settings, stage of
change assessment usually involves determina-
tion of Prochaska and DiClemente Stages of
Change: precontemplation, contemplation,
preparation (or determination), action, mainte-
nance, and relapse (Prochaska and DiClemente
1992). This can involve using questionnaires
such as the URICA (McConnaughy et al. 1983)
or the Stages of Change Readiness and
Treatment Eagerness Scale (SOCRATES)
(Miller and Tonigan 1996). It also can be deter-
mined clinically by interviewing the client and
evaluating the client’s responses in terms of
stages of change. For example, a simple
approach to identification of stage of change
can be the following.
For each problem, select the statement that
most closely fits the client’s view of that 
problem:
•No problem and/or no interest in change
(Precontemplation)
•Might be a problem; might consider change
(Contemplation)
•Definitely a problem; getting ready to change
(Preparation)
•Actively working on changing, even if slowly
(Action)
•Has achieved stability, and is trying to main-
tain (Maintenance)
Stage of change assessment ideally will be
applied separately to each mental disorder and
to each substance use disorder. For example, a
client may be willing to take medication for a
depressive disorder, but unwilling to discuss
trauma issues (as in case 1, Maria M.); or moti-
vated to stop cocaine, but unwilling to consider
alcohol as a problem (as in case 2, George T.). 
Assessment Step 11—Application to Case Example
A 50-year-old Liberian woman with a diagnosis of paranoid schizophrenia, Lila B. illustrates the existence of
differential stages of change for mental and substance abuse problems. The client permitted the case manag-
er nurse to come to her home to give her intramuscular antipsychotic injections for her “nerves,” but would
not agree to engage in any other treatment activity or acknowledge having a serious mental disorder. She
also had significant alcohol dependence, with an alcohol level of 0.25 to 0.3 most of the time, with high toler-
ance. She denied adamantly that she had used alcohol in the last 18 months, stating that her liver was
impaired and therefore unable to get rid of the alcohol. She was able to agree that she had a “mysterious
alcohol level problem” that might warrant medical hospitalization for testing and perhaps treatment, as well
as evaluation of her recent onset rectal bleeding.
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Although literature supporting the importance
of stage-specific treatment has been available in
both mental health and addiction literature for
over a decade, very few programs routinely
evaluate stage of change for the purpose of
treatment matching. 
In mental health settings working with individ-
uals with SMI, the Substance Abuse Treatment
Scale (SATS) (McHugo et al. 1995) is recom-
mended strongly (www.dartmouth.edu/
~psychrc/instru.html). This is a case-manager
rated scale with eight items identified by the
degree of the client’s engagement in treatment.
The stages are
•Pre-Engagement
•Engagement
•Early Persuasion
•Late Persuasion
•Early Active Treatment
•Late Active Treatment
•Relapse Prevention
•Remission
For more in-depth discussion of the stages of
change and motivational enhancement, the
reader is referred to TIP 35, Enhancing
Motivation for Change in Substance Abuse
Treatment (CSAT 1999b). 
Assessment Step 12: 
Plan Treatment 
A major goal of the screening and assessment
process is to ensure the client is matched with
appropriate treatment. Acknowledging the
overriding importance of this goal, this discus-
sion of the process of clinical assessment for
individuals with COD begins with a fundamen-
tal statement of principle:
•Since clients with COD are not all the same,
program placements and treatment interven-
tions should be matched individually to the
needs of each client.
The ultimate purpose of the assessment process
is to develop an appropriately individualized
integrated treatment plan. In this model, fol-
lowing the work of McLellan on comprehensive
services for populations with substance use dis-
orders, Minkoff on COD, and others, the con-
sensus panel recommends the following
approach:
•Treatment planning for individuals with COD
and associated problems should be designed
according to the principle of mental disorder
dual (or multiple) primary treatment, where
each disorder or problem has a specific inter-
vention that is matched to problem or diag-
nosis, as well as to stage of change and exter-
nal contingencies. Figure 4-2 (p. 96) shows a
sample treatment plan consisting of the prob-
lem, intervention, and goal. 
•Integrated treatment planning involves help-
ing the client to make the best possible treat-
ment choices for each disorder and adhere to
that treatment consistently. At the same time,
the counselor needs to help the client adjust
the recommended treatment strategies for
each disorder as needed in order to take into
account issues related to the other disorder.
These principles are best illustrated by using a
case example to develop a sample treatment
plan. For this purpose, case 2 (George T.) is
used and incorporates the data gathered during
the assessment process discussion above (see
Figure 4-1). Note that the problem description
presents a variety of information bearing on
the problem, including stage of change and
client strengths. Also note that no specific per-
son is recommended to carry out the interven-
tion proposed in the second column, since a
range of professionals might carry out each
intervention appropriately. 
Considerations in Treatment
Matching
Previous chapters introduced a variety of con-
cepts for categorizing individuals with COD
and the clinicians, programs, and systems
responsible for serving those individuals. The
consensus panel has identified critical factors
that have been determined, either by research
evidence or by consensus clinical practice, to
be relevant to the process of matching individu-
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al clients to available treatment. These consid-
erations are shown in Figure 4-3.
Assessment Process Summary
The assessment process described above is a
systematic approach for substance abuse treat-
ment clinicians (and mental health clinicians) to
gather the information needed to develop
appropriately matched treatment plans for
individuals with COD. The most important
question about this process, from the clinician’s
standpoint, is the following:
But—can this really be done?
To answer the question, this process is
approached from the perspective of a real sys-
tem. Many public sector substance abuse treat-
ment systems already define assessment proce-
dures that require use of a level of care assess-
ment tool (often the ASAM, but sometimes a
State-derived version of the ASAM) and a com-
prehensive addiction severity and outcome
measure (such as the ASI [McLellan et al.
1992]). How can the assessment process
described here be built on these existing assess-
ment procedures in a reasonably efficient 
manner?
The first steps involve engaging the client,
gathering information from family and other
providers, and beginning to screen for the
presence of mental symptoms and disorders.
The ASAM PPC-2R (and other level of care
tools, such as LOCUS) will provide a reason-
Figure 4-2
Sample Treatment Plan for George T. (Case 2)
PROBLEM INTERVENTION GOAL
1. Cocaine Dependence
•Work problem primary rea-
son for referral
•Family and work support
•Resists 12-Step
•Mental symptoms trigger use
•Action phase
Outpatient treatment
•EAP monitoring
•Family meetings
•Work support group
•Teach skills to manage symptoms
without using
•12-Step meetings
Abstinence
•Clean urines
•Daily recovery plans
2. Rule Out Alcohol Abuse
• No clear problem
• May trigger cocaine use
• Precontemplation
• Outpatient motivational
enhancement; thorough evalua-
tion of role of alcohol in patient’s
life, including family education
•Move into contemplation phase
of readiness to change
• Willing to consider the risk of
use and/or possible abuse
3. Bipolar Disorder
• Long history
• On lithium
• Some mood symptoms
• Maintenance phase
• Medication management
• Help to take medication while in
recovery programs
• MDDA meetings
• Advocate/collaborate with pre-
scribing health professional
• Identify mood symptoms that are
triggers
• Maintain stable mood
• Able to manage fluctuating mood
symptoms that do occur without
using cocaine or other substances
to regulate his bipolar disorder
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Figure 4-3
Considerations in Treatment Matching
Variable Key Data
Acute Safety Needs
Determines need for immediate acute stabilization to
establish safety prior to routine assessment 
•Immediate risk of harm to self or others
•Immediate risk of physical harm or abuse from oth-
ers (ASAM 2001)
•Inability to provide for basic self-care
•Medically dangerous intoxication or withdrawal
•Potentially lethal medical condition
•Acute severe mental symptoms (e.g., mania, psy-
chosis) leading to inability to function or communi-
cate 
effectively
Quadrant Assignment
Guides the choice of the most appropriate setting for
treatment
•SPMI versus non-SPMI
•Severely acute and/or disabling mental symptoms
versus mild to moderate severity symptoms
•High severity substance use disorder (e.g., active
substance dependence) versus lower severity sub-
stance use disorder (e.g., substance abuse)
•Substance dependence in full versus partial remis-
sion (ASAM 2001; National Association of State
Mental Health Program Directors/National
Association of State Alcohol and Drug Abuse
Directors 1999)
Level of Care
Determines the client’s program assignment
•Dimensions of assessment for each disorder using
criteria from ASAM PPC-2R and/or the LOCUS
(see chapter 2)
Diagnosis
Determines the recommended treatment intervention
• Specific diagnosis of each mental and substance use
disorder, including distinction between substance
abuse and substance dependence and substance-
induced symptoms
• Information about past and present successful and
unsuccessful treatment efforts for each diagnosis
• Identification of trauma-related disorders and cul-
ture-bound syndromes, in addition to other mental
disorders and substance-related problems
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Figure 4-3 (continued)
Considerations in Treatment Matching
Disability
Determines case management needs and whether a
standard intervention is sufficient—one that is at the
“capable” or intermediate level—or whether a more
advanced “enhanced” level intervention is essential 
•Cognitive deficits, functional deficits, and skill
deficits that interfere with ability to function inde-
pendently and/or follow treatment recommenda-
tions and which may require varying types and
amounts of case management and/or support
•Specific functional deficits that may interfere with
ability to participate in substance abuse treatment
in a particular program setting and may therefore
require a DDE setting rather than DDC
•Specific deficits in learning or using basic recovery
skills that require modified or simplified learning
strategies
Strengths and Skills
Determines areas of prior success around which to
organize future treatment interventions
Determines areas of skills building needed for disease
management of either disorder
•Areas of particular capacity or motivation in rela-
tion to general life functioning (e.g., capacity to
socialize, work, or obtain housing) 
•Ability to manage treatment participation for any
disorder (e.g., familiarity and comfort with 12-Step
programs, commitment to medication adherence)
Availability and Continuity of Recovery Support
Determines whether continuing relationships need to
be established and availability of existing relation-
ships to provide contingencies to promote learning
•Presence or absence of continuing treatment rela-
tionships, particularly mental disorder treatment
relationships, beyond the single episode of care
•Presence or absence of an existing and ongoing sup-
portive family, peer support, or therapeutic com-
munity; quality and safety of recovery environment
(ASAM 2001)
Cultural Context
Determines most culturally appropriate treatment
interventions and settings
•Areas of cultural identification and support in rela-
tion to each of the following
•Ethnic or linguistic culture identification (e.g.,
attachment to traditional American-Indian cultural
healing practices)
•Cultures that have evolved around treatment of
mental and/or substance use disorders (e.g., identi-
fication with 12-Step recovery culture; commitment
to mental health empowerment movement)
•Gender
•Sexual orientation
•Rural versus urban
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able way of screening for acute safety issues
and presence of persistent mental disorders
and disability. The ASI also provides a low-
power screen for mental health difficulties
(McLellan et al. 1992). These tools alone can
provide a beginning picture of whether there
is a need for acute mental health services
intervention, ongoing case management,
and/or in-depth mental assessment. The con-
sensus panel recommends use of a low- or
medium-power symptom screening tools in
addition to low-power tools (e.g., M.I.N.I. or
Mental Health Screening Form [Carroll and
McGinley 2001]), but in many settings, ASAM
plus ASI will suffice.
Next, the information gathered from ASAM
and ASI can give a sufficient picture of men-
tal impairment and substance use disorder
severity to promote quadrant identification,
and the ASAM itself clearly is used to identify
level of care. The ASI further screens for
problem domains, including a beginning pic-
ture of mental health disability.
Finally, ASAM PPC-2R includes attention to
stage of change for both mental health and
Figure 4-3 (continued)
Considerations in Treatment Matching
Problem Domains
Determines problems to be solved specifically, and
opportities for contingencies to promote treatment
participation
Is there impairment, need, or (conversely) strength in
any of the following areas
•Financial
•Legal
•Employment
•Housing
•Social/family
•Medical, parenting/child protective, abuse/victimiza-
tion/victimizer
Note: Each area of need may be associated with the
presence of contingencies and/or supports that may
affect treatment motivation and participation
(McLellan et al. 1993, 1997)
Phase of Recovery/Stage of Change (for each prob-
lem)
Determines appropriate phase-specific or stage-specif-
ic treatment intervention and outcomes
•Requirement for acute stabilization of symptoms,
engagement, and/or motivational enhancement
•Active treatment to achieve prolonged stabilization
• Relapse prevention/maintenance
• Rehabilitation, recovery, and growth
• Within the motivational enhancement sequence,
precontemplation, contemplation, preparation,
action, maintenance, or relapse (Prochaska and
DiClemente 1992)
• Engagement, persuasion, active treatment, or
relapse prevention (McHugo et al. 1995; Osher and
Kofoed 1989)
substance-related issues in dimension 4.
Other level of care tools cover similar ground.
Through the assessment process, the coun-
selor seeks to accomplish the following aims:
•To obtain a more detailed chronological histo-
ry of past mental symptoms, diagnosis, treat-
ment, and impairment, particularly before
the onset of substance abuse, and during
periods of extended abstinence.
•To obtain a more detailed description of
current strengths, supports, limitations,
skill deficits, and cultural barriers related
to following the recommended treatment
regime for any disorder or problem.
•To determine the stage of change for each
problem, and identify external contingen-
cies that might help to promote treatment
adherence.
Most of these activities are already a natural
component of substance abuse-only assessment;
the key addition is to attend to treatment
requirements and stage of change for mental
disorders, and the possible interference of
mental health symptoms and disabilities
(including personality disorder symptoms) in
addiction treatment participation.
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5 Strategies for Working
With Clients With Co-
Occurring Disorders
In This
Chapter…
Guidelines for a
Successful
Therapeutic
Relationship With
a Client Who Has
COD 
Techniques for
Working With
Clients With COD
Overview
Maintaining a therapeutic alliance with clients who have co-occurring
disorders (COD) is important—and difficult. The first section of this
chapter reviews guidelines for addressing these challenges. It stresses the
importance of the counselor’s ability to manage feelings and biases that
could arise when working with clients with COD (sometimes called coun-
tertransference). Together, clinicians and clients should monitor the
client’s disorders by examining the status of each disorder and alerting
each other to signs of relapse. The consensus panel recommends that
counselors use primarily a supportive, empathic, and culturally appro-
priate approach when working with clients with COD. With some clients
who have COD, it is important to distinguish behaviors and beliefs that
are cultural in origin from those indicative of a mental disorder. Finally,
counselors should increase structure and support to help their clients
with COD make steady progress throughout recovery. 
The second part of this chapter describes techniques effective in counsel-
ing clients with COD. One is the use of motivational enhancement consis-
tent with the client’s specific stage of recovery. This strategy is helpful
even for clients whose mental disorder is severe. Other strategies include
contingency management, relapse prevention, and cognitive–behavioral
techniques. For clients with functional deficits in areas such as under-
standing instructions, repetition and skill-building strategies can aid
progress. Finally, 12-Step and other dual recovery mutual self-help
groups have value as a means of supporting individuals with COD in the
abstinent life. Clinicians often play an important role in facilitating the
participation of these clients in such groups. This chapter will provide a
basic overview of how counselors can apply each of these strategies to
their clients who have COD. The material in this chapter is consistent
with national or State consensus practice guidelines for COD treatment,
and consonant with many of their recommendations. 
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The purpose of this chapter is to describe for
the addiction counselor and other practitioners
how these guidelines and techniques, many of
which are useful in the treatment of substance
abuse or as general treatment principles, can
be modified specifically and applied to people
with COD. These guidelines and techniques are
particularly relevant in working with clients in
quadrants II and III. Additionally, this chapter
contains Advice to the Counselor boxes to high-
light the most immediate practical guidance
(for a full listing of these boxes see the table of
contents).
Guidelines for a
Successful Therapeutic
Relationship With a
Client Who Has COD
The following section reviews seven guidelines
that have been found to be particularly help-
ful in forming a therapeutic relationship with
clients who have COD (see text box below). 
Develop and Use a
Therapeutic Alliance To
Engage the Client in
Treatment
General. Research suggests that a therapeutic
alliance is “one of the most robust predictors
of treatment outcome” in psychotherapy
(Najavits et al. 2000, p. 2172). Some studies
in the substance abuse treatment field also
have found associations between the strength
of the therapeutic alliance and counseling
effectiveness. One research team found that
both clinician and client ratings of the
alliance were strong predictors of alcoholic
outpatients’ treatment participation in treat-
ment, drinking behavior during treatment,
and drinking behavior at a 12-month follow-
up, even after controlling for a variety of
other sources of variance (Connors et al.
1997). Similarly, Luborsky and colleagues
(1985) found that the development of a “help-
ing alliance” was correlated with positive out-
comes.
A number of researchers have verified that
clients are more responsive when the thera-
pist acts consistently as a nurturing and non-
judgmental ally (Frank and Gunderson 1990;
Luborsky et al. 1997; Siris and Docherty
1990; Ziedonis and D’Avanzo 1998). For
example, in a study of clients with opioid
dependence and psychopathology, Petry and
Bickel (1999) found that among clients with
moderate to severe psychiatric problems,
fewer than 25 percent of those with weak
therapeutic alliances completed treatment,
while more than 75 percent of those with
strong therapeutic alliances completed treat-
ment. In this study, they did not find the
strength of the therapeutic alliance to be
Guidelines for Developing Successful Therapeutic
Relationships With Clients With COD
1. Develop and use a therapeutic alliance to engage the client in treatment
2. Maintain a recovery perspective
3. Manage countertransference
4. Monitor psychiatric symptoms
5. Use supportive and empathic counseling
6. Employ culturally appropriate methods
7. Increase structure and support
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related to treatment completion
among clients with few psychi-
atric symptoms.
Challenges for the
clinician
General. The clinician’s ease in
working toward a therapeutic
alliance also is affected by his or
her comfort level in working with
the client. Substance abuse coun-
selors may find some clients with
significant mental illnesses or
severe substance use disorders to
be threatening or unsettling. It is
therefore important to recognize
certain patterns that invite these
feelings and not to let them inter-
fere with the client’s treatment.
This discomfort may be due to a
lack of experience, training, or mentoring.
Likewise, some mental health clinicians may
feel uncomfortable or intimidated by clients
with substance use disorders. Clinicians who
experience difficulty forming a therapeutic
alliance with clients with COD are advised to
consider whether this is related to the client’s
difficulties; to a limitation in the clinician’s
own experience and skills; to demographic
differences between the clinician and the
client in areas such as age, gender, education,
race, or ethnicity; or to issues involving coun-
tertransference (see the discussion of counter-
transference below). A consultation with a
supervisor or peer to discuss this issue is
important. Often these reactions can be over-
come with further experience, training,
supervision, and mentoring.
Individuals with COD often experience
demoralization and despair because of the
complexity of having two problems and the
difficulty of achieving treatment success.
Inspiring hope often is a necessary precursor
for the client to give up short-term relief in
exchange for long-term work with some
uncertainty as to timeframe and benefit.
Challenges in working with clients with seri-
ous mental and substance use disorders.
Achieving a therapeutic alliance with clients
with serious mental illness and substance use
disorders can be challenging. According to
Ziedonis and D’Avanzo (1998), many people
who abuse substances also may have some
antisocial traits. Such individuals are “less
amenable to psychological and pharmacologi-
cal interventions and avoid contact with the
mental health treatment staff.” Therefore, it
is reasonable to conclude that “the dually
diagnosed are less likely to develop a positive
therapeutic alliance than non–substance-
abusing patients with schizophrenia…” (p.
443).
Individuals with both schizophrenia and a
substance use disorder may be particularly
challenging to treat. These individuals “pre-
sent and maintain a less involved and more
distant stance in relation to the therapist than
do non–substance-abusing individuals with
schizophrenia” (Ziedonis and D’Avanzo 1998,
Advice to the Counselor:
Forming a Therapeutic Alliance
The consensus panel recommends the following
approaches for forming a therapeutic alliance with
clients with COD:
• Demonstrate an understanding and acceptance of the
client.
• Help the client clarify the nature of his difficulty.
• Indicate that you and the client will be working 
together.
• Communicate to the client that you will be helping her
to help herself.
• Express empathy and a willingness to listen to the client’s
formulation of the problem.
• Assist the client to solve some external problems directly
and immediately.Foster hope for positive change.
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p. 443). The presence or level of these deficits
may vary widely for people living with
schizophrenia, and also may vary significant-
ly for that individual within the course of his
illness and the course of his lifetime. While
“this configuration of interpersonal style sug-
gests that developing a therapeutic alliance
can be difficult,” Ziedonis and D’Avanzo
insist, “working with the dually diagnosed
requires a primary focus on the therapeutic
alliance” (Ziedonis and D’Avanzo 1998, p.
444). 
For all clients with co-occurring disorders, the
therapeutic relationship must build on the
capacity that does exist. These clients often
need the therapeutic alliance to foster not only
their engagement in treatment but as the cor-
nerstone of the entire recovery process. Once
established, the therapeutic alliance is reward-
ing for both client and clinician and facilitates
their participation in a full range of therapeutic
activities; documentation of these types of
interactions provides an advantage in risk
management.
Maintain a Recovery
Perspective
Varied meanings of 
“recovery”
The word “recovery” has different meanings in
different contexts. Substance abuse treatment
clinicians may think of a person who has
changed his or her substance abuse behavior as
being “in recovery” for the rest of his or her
life (although not necessarily in formal treat-
ment forever). Mental health clinicians, on the
other hand, may think of recovery as a process
in which the client moves toward specific
behavioral goals through a series of stages.
Recovery is assessed by whether or not these
goals are achieved. For persons involved with
12-Step programs, recovery implies not only
abstinence from drugs or alcohol but also a
commitment to “work the steps,” which
includes changing the way they interact with
others and taking responsibility for their
actions. Consumers with mental disorders may
see recovery as the process of reclaiming a
meaningful life beyond mental disorder, with
symptom control and positive life activity.
While “recovery” has many meanings, general-
ly, it is recognized that recovery does not refer
solely to a change in substance use, but also to
a change in an unhealthy way of living.
Markers such as improved health, better abili-
ty to care for oneself and others, a higher
degree of independence, and enhanced self-
worth are all indicators of progress in the
recovery process.
Implications of the recovery
perspective
The recovery perspective as developed in the
substance abuse field has two main features:
(1) It acknowledges that recovery is a long-term
process of internal change, and (2) it recognizes
that these internal changes proceed through
various stages (see De Leon 1996 and
Prochaska et al. 1992 for a detailed descrip-
tion). 
The recovery perspective generates at least two
main principles for practice:
• Develop a treatment plan that provides
for continuity of care over time. In
preparing this plan, the clinician should
recognize that treatment may occur in dif-
ferent settings over time (e.g., residential,
outpatient) and that much of the recovery
process is client-driven and occurs typically
outside of or following professional treat-
ment (e.g., through participation in mutual
self-help groups) and the counselor should
reinforce long-term participation in these
constantly available settings.
• Devise treatment interventions that are
specific to the tasks and challenges
faced at each stage of the COD recov-
ery process. The use of treatment inter-
ventions that are specific to the tasks and
challenges faced at each stage of the COD
recovery process enables the clinician
(whether within the substance abuse or
mental health treatment system) to use sen-
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sible stepwise approaches in developing and
using treatment protocols. In addition,
markers that are unique to individuals—
such as those related to their cultural,
social, or spiritual context—should be con-
sidered. It is therefore important to engage
the client in defining markers of progress
that are meaningful to him and to each
stage of recovery. 
Stages of change and stages
of treatment
Working within the recovery perspective
requires a thorough understanding of the
interrelationship between stages of change
(see De Leon 1996 and Prochaska et al. 1992)
and stages of treatment (see section on moti-
vational enhancement below for a description
of the stages of change; see also TIP 35,
Enhancing Motivation for Change in
Substance Abuse Treatment [Center for
Substance Abuse Treatment (CSAT) 1999b]).
De Leon has developed a measure of motiva-
tion for change and readiness for treatment—
The Circumstances, Motivation and
Readiness Scales—and provided scores for
samples of persons with COD (De Leon et al.
2000a). De Leon has demonstrated the rela-
tionship between these scales and retention in
treatment for general substance
abuse treatment populations and
programs (De Leon 1996). It is
important that the expectation for
the client’s progress through treat-
ment stages (e.g., outreach, stabi-
lization, early-middle-late primary
treatment, continuing care, and
long-term care/cycles into and out
of treatment) be consistent with
the client’s stage of change. 
Client empowerment
and responsibility
The recovery perspective also
emphasizes the empowerment and
responsibility of the client and the
client’s network of family and sig-
nificant others. As observed by the
American Association of
Community Psychiatrists (AACP), the strong
client empowerment movement within the men-
tal health field is a cornerstone for recovery:
Pessimistic attitudes about people with COD
represent major barriers to successful system
change and to effective treatment interven-
tions ... recovery is defined as a process by
which a person with persistent, possibly dis-
abling disorders, recovers self-esteem, self-
worth, pride, dignity, and meaning, through
increasing his or her ability to maintain stabi-
lization of the disorders and maximizing
functioning within the constraints of the dis-
orders. As a general principle, every person,
regardless of the severity and disability asso-
ciated with each disorder, is entitled to expe-
rience the promise and hope of dual recov-
ery, and is considered to have the potential to
achieve dual recovery (AACP 2000b). 
Continuous support
Another implication of the recovery perspective
is the need for continuing support for recovery.
This means the provider encourages clients to
build a support network that offers respect,
acceptance, and appreciation. For example, an
important element of long-term participation in
Advice to the Counselor:
Maintaining a Recovery Perspective
The consensus panel recommends the following ap-
proaches for maintaining a recovery perspective with
clients who have COD:
• Assess the client’s stage of change (see section on
Motivational Enhancement below).
• Ensure that the treatment stage (or treatment expecta-
tions) is (are) consistent with the client’s stage of change.
• Use client empowerment as part of the motivation for
change.
• Foster continuous support.
• Provide continuity of treatment. 
• Recognize that recovery is a long-term process and that
even small gains by the client should be supported and
applauded.
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Alcoholics Anonymous (AA) is the offering of a
place of belonging or a “home.” AA accom-
plishes this supportive environment without
producing overdependence because the client is
expected to contribute, as well as receive, 
support. 
Continuity of treatment
An emphasis on continuity of treatment also
flows from a recovery perspective. Continuity
of treatment implies that the services provided
by the program are constant, and a client
might remain a consumer of substance abuse or
mental health services indefinitely. Treatment
continuity for individuals with COD begins
with proper and thorough identification,
assessment, and diagnosis. It includes easy and
early access to the appropriate service
providers “...through multiple episodes of
acute and subacute treatment ... independent
of any particular setting or locus of care”
(AACP 2000b).
Manage Countertransference 
Though somewhat dated and infrequently used
in the COD literature, the concept of “counter-
transference” is useful for understanding how
the clinician’s past experience can influence
current attitudes toward a particular client.
“Transference” describes the process whereby
clients project attitudes, feelings, reactions,
and images from the past onto the clinician.
For example, the client may regard the clini-
cian as an “authoritative father,” “know-it-all
older brother,” or “interfering mother.” 
Once considered a technical error, counter-
transference now is understood to be part of
the treatment experience for the clinician.
Particularly when working with multiple and
complicated problems, clinicians are vulnera-
ble to the same feelings of pessimism, despair,
anger, and the desire to abandon treatment as
the client. Inexperienced clinicians often are
confused and ashamed when faced with feelings
of anger and resentment that can result from
situations where there is a relative absence of
gratification from working with clients with
these disorders (Cramer 2002). Less experi-
enced practitioners may have more difficulty
identifying countertransference, accessing feel-
ings evoked by interactions with a client, nam-
ing them, and working to keep these feelings
from interfering with the counseling relation-
ship. 
Both substance use disorders and mental disor-
ders are illnesses that are stigmatized by the
general public. These same attitudes can be
present among clinicians. Mental health clini-
cians who usually do not treat persons with
substance abuse issues may not
have worked out their own
response to the disorder, which
can influence their interactions
with the client. Similarly, sub-
stance abuse treatment clinicians
may not be aware of their own
reactions to persons with specific
mental disorders and may have
difficulty preventing these reac-
tions from influencing treatment.
The clinician’s negative attitudes
or beliefs may be communicated,
directly or subtly, to the client.
For example: “I was depressed
too, but I never took medications
for it—I just worked the steps
Advice to the Counselor:
Managing Countertransference
The consensus panel recommends the following
approach for managing countertransference with clients
who have COD:
• The clinician should be aware of strong personal reac-
tions and biases toward the client.
• The clinician should obtain further supervision where
countertransference is suspected and may be interfering
with counseling. 
• Clinicians should have formal and periodic clinical
supervision to discuss countertransference issues with
their supervisors and the opportunity to discuss these
issues at clinical team meetings.
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and got over it. So why should this guy need
medication?”
Such feelings often are related to burnout and
are exacerbated by the long time required to
see progress in many clients with COD. For
example, one study found that therapists’ atti-
tudes toward their substance abuse clients
tended to become more negative over time,
though the increasing negativity was found to
be less extreme for substance abuse counselors
without graduate degrees who used the 12 steps
to inform their counseling approach than for
psychotherapists with graduate training who
participated in the study (Najavits et al. 1995).
(For a full discussion of countertransference in
substance abuse treatment see Powell and
Brodsky 1993.)
Cultural issues also may arouse strong and
often unspoken feelings and, therefore, gener-
ate transference and countertransference.
Although counselors working with clients in
their area of expertise may be familiar with
countertransference issues, working with an
unfamiliar population will introduce different
kinds and combinations of feelings. 
The clinician is advised to understand and be
familiar with some of the issues related to coun-
tertransference and strategies to manage it.
Such countertransference issues are particular-
ly important when working with
persons with COD because many
people with substance abuse and
mental disorders may evoke
strong feelings in the clinician that
could become barriers to treat-
ment if the provider allows them
to interfere. The clinician may
feel angry, used, overwhelmed,
confused, anxious, uncertain how
to proceed with a case, or just
worn out. 
Monitor Psychiatric
Symptoms
In working with clients who have
COD, especially those requiring
medications or who also are
receiving therapy from a mental health services
provider, it is especially important for the sub-
stance abuse counselor to participate in the
development of the treatment plan and to mon-
itor psychiatric symptoms. At a minimum, the
clinician should be knowledgeable about the
overall treatment plan to permit reinforcement
of the mental health part of the plan as well as
the part specific to recovery from addiction. 
It is equally important that the client partici-
pate in the development of the treatment plan.
For example, for a client who has both bipolar
disorder and alcoholism, and who is receiving
treatment at both a substance abuse treatment
agency and a local mental health center, the
treatment plan might include individual sub-
stance abuse treatment counseling, medication
management, and group therapy. In another
example, the substance abuse treatment clini-
cian may assist in medication monitoring of a
person taking lithium. The clinician can ask
such questions as, “How are your meds doing?
Are you remembering to take them? Are you
having any problems with them? Do you need
to check in with the prescribing doctor?” It also
is prudent to ask the client to bring in all medi-
cations and ask the client how he is taking
them, when, how much, and if medication is
helping and how. Clinicians should help edu-
cate clients about the effects of medication,
teach clients to monitor themselves (if possible),
Advice to the Counselor: 
Monitoring Psychiatric Symptoms
The consensus panel recommends the following
approaches for monitoring psychiatric symptoms with
clients with COD:
• Obtain a mental status examination to evaluate the
client’s overall mental health and danger profile. Ask
questions about the client’s symptoms and use of medi-
cation and look for signs of the mental disorder 
regularly.
• Keep track of changes in symptoms.
• Ask the client directly and regularly about the extent of
his or her depression and any associated suicidal
thoughts.
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and consult with clients’ physicians whenever
appropriate. 
Status of symptoms 
Substance abuse counselors need to have a
method by which to monitor changes in severity
and number of symptoms over time. For exam-
ple, most clients present for substance abuse
treatment with some degree of anxiety or
depressive symptoms. As discussed in chapters
2 and 4, these symptoms are referred to as sub-
stance induced if caused by substances and
resolved within 30 days of abstinence.
Substance-induced symptoms tend to follow the
“teeter totter” principle of “what goes up, must
come down,” and vice versa—so that after a
run of amphetamine or cocaine the individual
will appear fatigued and depressed, while after
using depressants such as alcohol or opioids,
the individual more likely will appear agitated
and anxious. These “teeter totter” symptoms
are substance withdrawal effects and usually
are seen for days or weeks. They may be fol-
lowed by a substance-related depression (which
can be seen as a neurotransmitter depletion
state), which should begin to improve within a
few weeks. If depressive or other symptoms
persist, then a co-occurring (additional) mental
disorder is likely, and the differential diagnos-
tic process ensues. These symptoms may be
appropriate target symptoms for establishing a
diagnosis or determining treatment choices
(medication, therapy, etc.). Clients using
methamphetamines may present with psychotic
symptoms that require medications.
A number of different tools are available to
substance abuse treatment providers to help
monitor psychiatric symptoms. Some tools are
simply questions and require no formal instru-
ment. For example, to gauge the status of
depression quickly, ask the client: “On a scale
of 0 to 10, how depressed are you? (0 is your
best day, 10 is your worst).” This simple scale,
used from session to session, can provide much
useful information. Adherence to prescribed
medication also should be monitored by asking
the client regularly for information about its
use and effect. 
To identify changes, it is important to track
symptoms that the client mentions at the onset
of treatment from week to week. The clinician
should keep track of any suggestions made to
the client to alleviate symptoms to determine
whether the client followed through, and if so,
with what result. For example: “Last week you
mentioned low appetite, sleeplessness, and a
sense of hopelessness. Are these symptoms bet-
ter or worse now?” 
Potential for harm to 
self or others
Blumenthal (1988) has written an important
paper on suicide and the risk for suicide in
clients with COD. The following is derived
largely from her writing. 
Suicidality is a major concern for many clients
with COD. Persons with mental disorders are
at 10 times greater risk for suicide than the
general population, and the risk for suicidal
behavior and suicide is increased with almost
every major mental disorder. Of adults who
commit suicide, 90 percent have a mental dis-
order, most frequently a major affective illness
or posttraumatic stress disorder (PTSD).
Alcohol and substance abuse often are associat-
ed with suicides and also represent major risk
factors. Clients with COD—especially those
with affective disorders—have two of the high-
est risk factors for suicide.
For clients who mention or appear to be expe-
riencing depression or sadness, it is always
important to explore the extent to which suici-
dal thinking is present. Similarly, a client who
reports that he or she is thinking of doing harm
to someone else should be monitored closely.
The clinician always should ask explicitly about
suicide or the intention to do harm to someone
else when the client assessment indicates that
either is an issue.
In addition to asking the client about suicidal
thoughts and plans as a routine part of every
session with a suicidal or depressed person,
Blumenthal stresses that the clinician should
immediately follow up appointments missed
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by an acutely suicidal person. Management of
the suicidal client requires securing an appro-
priate mental health professional for the
client and having the client monitored closely
by that mental health professional. The coun-
selor also should have 24-hour coverage avail-
able, such as a hotline for the client to call for
help during off hours. However, there are
effective ways of managing individuals who
have suicidal thoughts but no immediate plan,
and are willing and able to contact the coun-
selor in the event these thoughts become too
strong, prior to action. See the more exten-
sive discussion of suicidality in chapter 8 and
in appendix D of this TIP. Screening for sui-
cide risk is discussed in chapter 4.
Use Supportive and Empathic
Counseling 
Definition and importance
A supportive and empathic counseling style is
one of the keys to establishing an effective ther-
apeutic alliance. According to Ormont, empa-
thy is the ability to “experience another per-
son’s feeling or attitude while still holding on to
our own attitude and outlook”; it is the founda-
tion adults use for relating to and interacting
with other adults (Ormont 1999, p. 145). The
clinician’s empathy enables clients to begin to
recognize and own their feelings, an essential
step toward managing them and learning to
empathize with the feelings of others. 
However, this type of counseling must be used
consistently over time to keep the alliance
intact. This caveat often is critical for clients
with COD, who usually have lower motivation
to address either their mental or substance
abuse problems, have greater difficulty
understanding and relating to other people,
and need even more understanding and sup-
port to make a major lifestyle change such as
adopting abstinence. Support and empathy
on the clinician’s part can help maintain the
therapeutic alliance, increase client motiva-
tion, assist with medication adherence, model
behavior that can help the client build more
productive relationships, and support the
client as he or she makes a major life transi-
tion.
Confrontation and empathy
The overall utility of confrontational tech-
niques is well accepted in the substance abuse
literature. It is used widely in substance abuse
treatment programs, including those surveyed
in the Drug Abuse Treatment Outcomes Study
in which the effectiveness of such programs was
demonstrated. Confrontation is a form of inter-
personal exchange in which individuals present
Using an Empathic Style
Empathy is a key skill for the counselor, without which little could be accomplished. The practice of empathy
“requires sharp attention to each new client statement, and a continual generation of hypotheses as to the
underlying meaning” (Miller and Rollnick 1991, p. 26). An empathic style
•Communicates respect for and acceptance of clients and their feelings
•Encourages a nonjudgmental, collaborative relationship
•Allows the clinician to be a supportive and knowledgeable consultant
•Compliments and reinforces the client whenever possible 
•Listens rather than tells
•Gently persuades, with the understanding that the decision to change is the client’s
•Provides support throughout the recovery process 
(See also TIP 35, Enhancing Motivation for Change in Substance Abuse Treatment [CSAT 1999b], p. 41.)
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to each other their observations of, and reac-
tions to, behaviors and attitudes that are mat-
ters of concern and should change (De Leon
2000b). 
In substance abuse treatment counseling,
some tension always is felt between being
empathic and supportive, and having to han-
dle minimization, evasion, dishonesty, and
denial. However, a counselor can be empathic
and firm at the same time. This is especially
true when working with clients with COD.
The heart of confrontation is not the aggres-
sive breaking down of the client and his or
her defenses, but feedback on behavior and
the compelling appeal to the client for person-
al honesty, truthfulness in interacting with
others, and responsible behavior. A straight-
forward and factual presentation of conflict-
ing material or of problematic behavior in an
inquisitive and caring manner can be both
“confrontative” and caring. The ability to do
this well and with balance often is critical in
maintaining the therapeutic alliance with a
client who has COD. Chapter 6 includes a
more complete discussion of confrontation
including a definition, description of its appli-
cation, and suggested modifications for using
this technique with clients who have COD. 
Employ Culturally Appropriate
Methods
Understanding the client’s
cultural background
It is well known that population shifts are
resulting in increasing numbers of minority
racial and ethnic groups in the United States.
Each geographic area has its own cultural mix,
and providers are advised to learn as much as
possible about the cultures represented in their
treatment populations. Of particular impor-
tance are the backgrounds of those served,
conventions of interpersonal communication,
understanding of healing, views of mental dis-
order, and perception of substance abuse.
To work effectively with persons of various
cultural groups, the provider should learn as
much as possible about characteristics of the
cultural group such as communication style,
interpersonal interactions, and expectations
of family. For example, some cultures may
tend to somaticize symptoms of mental disor-
ders, and clients from such groups may
expect the clinician to offer relief for physical
complaints. The same client may be offended
by too many probing, personal questions
early in treatment and never return.
Similarly, understanding the client’s role in
the family and its cultural significance always
is important (e.g., expectations of the oldest
son, a daughter’s responsibilities to her par-
ents, grandmother as matriarch).
At the same time, the clinician should not
make assumptions about any client based on
his or her perception of the client’s culture.
The level of acculturation and the specific
experiences of an individual may result in
that person identifying with the dominant cul-
ture, or even other cultures. For example, a
person from India adopted by American par-
ents at an early age may know little about the
cultural practices in his birth country. For
such clients, it is still important to recognize
the birth country and discover what this asso-
ciation means to the client; however, it may
exert little influence on his beliefs and prac-
tices. For more detailed information about
cultural issues in substance abuse treatment,
see the forthcoming TIP Improving Cultural
Competence in Substance Abuse Treatment
(CSAT in development a).
Clients’ perceptions of sub-
stance abuse, mental disor-
ders, and healing
Clients may have culturally driven concepts of
what it means to abuse substances or to have a
mental disorder, what causes these disorders,
and how they may be “cured.” Clinicians are
encouraged to explore these concepts with peo-
ple who are familiar with the cultures repre-
sented in their client population. Counselors
should be alert to differences in how their role
and the healing process are perceived by per-
sons who are of cultures other than their own. 
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Wherever appropriate, familiar healing prac-
tices meaningful to these clients should be
integrated into treatment. An example would
be the use of acupuncture to calm a Chinese
client or help control cravings, or the use of
traditional herbal tobacco with some
American Indians to establish rapport and
aid emotional balance.
Cultural perceptions and
diagnosis
It is important to be aware of cultural and eth-
nic bias in diagnosis. For example, in the past
some African Americans were stereotyped as
having paranoid personality disorders, while
women have been diagnosed frequently as
being histrionic. American Indians with spiritu-
al visions have been misdiagnosed as delusional
or as having borderline or schizotypal person-
ality disorders. Some clinicians would be likely
to over diagnose obsessive-compulsive disorder
among Germans or histrionic disorder in
Hispanic/Latino populations. The diagnostic
criteria should be tempered by sensitivity to
cultural differences in behavior and emotional
expression and by an awareness of
the clinician’s own biases and
stereotyping. 
Cultural differences
and treatment:
Empirical 
evidence on 
effectiveness
Studies related to cultural differ-
ences and treatment issues among
clients with COD are scarce.
However, one study that compared
nonwhite and white clients with
COD who were treated in mental
health settings suggests issues that
deserve providers’ attention.
Researchers found that African-
American, Asian-American, and
Hispanic/Latino clients tended to
self-report a lower level of function-
ing and to be “viewed by clinical staff as suffer-
ing from more severe and persistent symptoma-
tology and as having lower psychosocial func-
tioning.” Researchers noted “this was due in
part to the chronicity of their mental disorders
and persistent substance abuse, but also was
magnified by cross-cultural misperceptions; for
example, system bias, countertransference, or
inadequate support systems” (Jerrell and
Wilson 1997, p. 138). 
The study also found that nonwhite clients
tended to have fewer community resources
available to them than white clients, and that
clinicians had more difficulty connecting them
with needed services. For example, staff
members experienced “extraordinary difficul-
ties in identifying willing and suitable spon-
sors for the young ethnic clients” in 12-Step
programs (Jerrell and Wilson 1997, p. 138).
To address such issues, researchers stressed
the importance of developing cultural compe-
tence in staff, giving extra attention to the
needs of such clients, and engaging in “more
active advocacy for needed, culturally rele-
vant services” (Jerrell and Wilson 1997, 
p. 139). 
Advice to the Counselor:
Using Culturally Appropriate Methods
The consensus panel recommends the following
approach for using culturally appropriate treatment
methods with clients with COD:
• Take cultural context, background, and experiences into
account in the evaluation, diagnosis, and treatment of
clients from various groups, cultures, or countries. 
• Recognize the importance of culture and language,
acknowledging the cultural strengths of a people.
• Adapt services to meet the unique needs and value sys-
tems of persons in all groups.
• Expand and update [the provider’s/system’s] cultural
knowledge.
• Work on stigma reduction with a culturally sensitive
approach.
Source: Center for Mental Health Services 2001.
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Increase Structure and
Support 
To assist clients with COD, counselors should
provide an optimal amount of structure for the
individual. Free time is both a trigger for sub-
stance use cravings and a negative influence for
many individuals with mental disorders; there-
fore it is a particular issue for clients with
COD. Strategies for managing free time include
structuring one’s day to have meaningful activi-
ties and to avoid activities that will be risky.
Clinicians often help clients to plan their time
(especially weekends). Creating new pleasur-
able activities can both help depression and
help derive “highs” from sources other than
substance use. Other important activities to
include are working on vocational and relation-
ship issues.
In addition to structure, it is also important
that the daily activities contain opportunities
for receiving support and encouragement.
Counselors should work with clients to create
a healthy support system of friends, family,
and activities. Increasing support, time orga-
nization, and structured activities are strate-
gies in cognitive–behavioral therapies (see
section below) for both mental disorders and
substance abuse treatment.
Techniques for
Working With Clients
With COD
The following section reviews techniques, main-
ly from the substance abuse field, that have
been found to be particularly helpful in the
treatment of clients with substance abuse and
that are being adapted for work with clients
with COD (see text box below). 
Provide Motivational
Enhancement Consistent With
the Client’s Specific Stage of
Change 
Definition and description
Motivational Interviewing (MI) is a “client-cen-
tered, directive method for enhancing intrinsic
motivation to change by exploring and resolv-
ing ambivalence” (Miller and Rollnick 2002, p.
25). MI has proven effective in helping clients
clarify goals and make commitment to change
(CSAT 1999b; Miller 1996; Miller and Rollnick
2002; Rollnick and Miller 1995). This approach
shows so much promise that it is one of the first
two psychosocial treatments being sponsored in
multisite trials in the National Institute on
Drug Abuse (NIDA) Clinical Trials Network
program.
As Miller and Rollnick have pointed out, MI
is “a way of being with a client, not just a set
of techniques for doing counseling” (Miller
and Rollnick 1991, p. 62). This approach
involves accepting a client’s level of motiva-
tion, whatever it is, as the only possible start-
ing point for change. For example, if a client
says she has no interest in changing her
drinking amounts or frequency, but only is
interested in complying with the interview to
be eligible for something else (such as the
right to return to work or a housing voucher),
the clinician would avoid argumentation or
Key Techniques for Working With Clients Who Have COD
1. Provide motivational enhancement consistent with the client’s specific stage of change. 
2. Design contingency management techniques to address specific target behaviors.
3. Use cognitive–behavioral therapeutic techniques.
4. Use relapse prevention techniques.
5. Use repetition and skills-building to address deficits in functioning.
6. Facilitate client participation in mutual self-help groups.
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confrontation in favor of establishing a posi-
tive rapport with the client—even remarking
on the positive aspect of the client wishing to
return to work or taking care of herself by
obtaining housing. The clinician would seek
to probe the areas in which the client does
have motivation to change. The clinician is
interested in eventually having an impact on
the client’s drinking or drug use, but the
strategy is to get to that point by working with
available openings.
A variety of adaptations of MI have emerged.
Examples include brief negotiation, motiva-
tional consulting, and motivational enhance-
ment therapy (MET). MET combines the clin-
ical style associated with MI with systematic
feedback of assessment results in the hope of
producing rapid, internally motivated
change. For more information, see the
Project MATCH Motivational Enhancement
Therapy Manual (National Institute on
Alcohol Abuse and Alcoholism 1994).
Rollnick and other practitioners of MI find
that the many variants differ widely in their
reliance on the key principles and elements of
MI (Miller and Rollnick 2002).
Guiding principles of motiva-
tional interviewing
The four principles outlined below guide the
practice of MI (see text box p. 114). In this sec-
tion, each principle is summarized. For each
principle, some of the related strategies that
practitioners use when applying this principle
to client interactions are highlighted. 
1. Expressing empathy 
Miller and Rollnick state that “an empathic
counseling style is one fundamental and defin-
ing characteristic of motivational interviewing”
(Miller and Rollnick 2002, p. 37). The coun-
selor refrains from judging the client; instead,
through respectful, reflective listening, the
counselor projects an attitude of acceptance.
This acceptance of the person’s perspectives
does not imply agreement. It “does not prohibit
the counselor from differing with the client’s
views and expressing that divergence” (Miller
and Rollnick 2002, p. 37). It simply accepts the
individual’s ambivalence to change as normal
and expected behavior in the human family.
Practitioners find that projecting acceptance
rather than censure helps free the client to
change (Miller and Rollnick 2002). 
2. Developing discrepancies
While recognizing the client’s ambivalence to
change as normal, the counselor is not neutral
or ambivalent about the need for change. The
counselor advances the cause of change not by
insisting on it, but by helping the client per-
ceive the discrepancy between the current situ-
ation and the client’s personal goals (such as a
supportive family, successful employment, and
good health). The task of the counselor is to
call attention to this discrepancy between “the
present state of affairs and how one wants it to
be,” making it even more significant and larger
in the client’s eyes. The client is therefore more
likely to change, because he sees that the cur-
rent behavior is impeding progress to his
goals—not the counselor’s (Miller and Rollnick
2002, p. 39).
3. Rolling with resistance
Practitioners believe that “the least desirable
situation, from the standpoint of evoking
change, is for the counselor to advocate for
change while the client argues against it”
(Miller and Rollnick 2002, p. 39). The desired
situation is for clients themselves to make the
argument for change. Therefore, when resis-
tance is encountered, the counselor does not
oppose it outright. Instead, the counselor offers
new information and alternative perspectives,
giving the client respectful permission to “take
what you want and leave the rest” (Miller and
Rollnick 2002, p. 40).
The counselor’s response to resistance can
defuse or inflame it. Miller and Rollnick
describe a number of techniques the skillful
clinician can use when resistance is encoun-
tered. For example, the counselor may use var-
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ious forms of reflection, shift the focus of dis-
cussion, reframe the client’s observation, or
emphasize the client’s personal choice or con-
trol. While description of these and other spe-
cific techniques for “rolling with resistance” is
beyond the scope of this TIP, the reader is
referred to chapter 8 of Miller and Rollnick
2002, “Responding to Resistance” (pp.
98–110).
4. Supporting self-efficacy
The final principle of Motivational Interviewing
recognizes that an individual must believe he or
she actually can make a change before attempt-
ing to do so. Therefore, the counselor offers
support for the change and communicates to
the client a strong sense that change is possible.
Self-efficacy also can be enhanced through the
use of peer role models, as well as by pointing
out past and present evidence of the client’s
capacity for change.
One way practitioners put this principle into
action is by evoking “confidence talk” in
which the client is invited to share “ideas,
experiences, and perceptions that are consis-
tent with ability to change” (Miller and
Rollnick 2002, p. 113). This could involve
reviewing past successes, discussing specific
steps for making change happen, identifying
personal strengths, and acknowledging
sources of support.
“Change talk”
Clients’ positive remarks about change, or
“change talk,” are the opposite of resistance.
The counselor responds to any expression of
desire to change with interest and encourages
the client to elaborate on the statement. For
example in a person with combined alcohol
dependence and PTSD, the clinician might ask,
“What are some other reasons why you might
want to make a change?” (Miller and Rollnick
2002, p. 87). The counselor also can use reflec-
Guiding Principles of Motivational Interviewing
1. Express empathy • Acceptance facilitates change.
• Skillful reflective listening is fundamental.
• Ambivalence is normal.
2. Develop discrepancy • The client rather than the counselor should present the arguments for change.
• Change is motivated by a perceived discrepancy between present behavior and
important personal goals or values.
3. Roll with resistance • Avoid arguing for change.
• Resistance is not opposed directly.
• New perspectives are invited but not imposed.
• The client is a primary resource in finding answers and solutions.
• Resistance is a signal to respond differently.
4. Support self-efficacy • A person’s belief in the possibility of change is an important motivator.
• The client, not the counselor, is responsible for choosing and carrying out
change.
• The counselor’s own belief in the person’s ability to change becomes a self-ful-
filling prophecy.
Source: Miller and Rollnick 2002, pp. 36–41.
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tive listening to clarify the client’s meaning and
explore what is being said. It is important,
however, to do this in a way that does not
appear to be taking a side in the argument.
This sometimes results in resistance and the
client may begin to argue with the counselor
instead of continuing to think about change.
“Decisional balance”
Practitioners of MI have coined the term “deci-
sional balance” to describe a way of looking at
ambivalence. Picture a seesaw, with the costs of
the status quo and the benefits of change on
one side, and the costs of change and the bene-
fits of the status quo on the other (Miller and
Rollnick 2002). The counselor’s role is to
explore the costs and benefits of substance use
with the aim of tipping the balance toward
change. That change will be stronger and more
likely to endure if it is owned by the client’s
perception that the benefits of change are
greater than the costs.
Matching motivational
strategies to the client’s
stage of change
The motivational strategies selected should be
consistent with the client’s stage of change
(summarized in Figure 5-1, p. 116). Clients
could be at one stage of recovery or change
for the mental disorder and another for the
substance use disorder; to complicate things
further, a client may be at one stage of change
for one substance and another stage of change
for another substance. For example, a client
with combined alcohol and cocaine depen-
dence with co-occurring panic disorder may
be in the contemplation stage (i.e., aware that
a problem exists and considering overcoming
it, but not committed to taking action) in
regard to alcohol, precontemplation (i.e.,
unaware that a problem exists, with no inten-
tion of changing behavior) in regard to
cocaine, and action (i.e., actively modifying
behavior, experiences, or environment to
overcome the problem) for the panic 
disorder. 
In each case, the clinician examines the inter-
nal and external leverage available to move
the client toward healthy change. For exam-
ple, a client may want to talk about her mar-
riage, but not about the substance abuse
problem. The clinician can use this as an
opening; the marriage doubtless will be affect-
ed by the substance abuse, and the motiva-
tion to improve the marriage may lead to a
focus on substance abuse. Evaluating a
client’s motivational state necessarily is an
ongoing process. It should be recognized that
court mandates, rules for clients engaged in
group therapy, the treatment agency’s operat-
ing restrictions, or other factors may place
some barriers on how this strategy is imple-
mented in particular situations.
Figure 5-2 (pp. 117–118) illustrates approach-
es that a clinician might use at different stages
of readiness to change to apply MI techniques
when working with a substance abuse client
showing evidence of COD. For a thorough
discussion of MI and the stages of change, the
reader is referred to Miller and Rollnick 2002
(pp. 201–216).
Although MI is a well-accepted and commonly
used strategy in the substance abuse treat-
ment field, the issue of when it is appropriate
to avoid or postpone addressing the client’s
substance use is the subject of some debate.
MI does make a distinction between agreeing
with a client’s denial system (which is coun-
terproductive) and sidestepping it in order to
make some progress. As shown above, these
motivational strategies are employed to help
both clinician and client work together
toward the common goal of helping the client.
With practice and experience, the clinician
will come to recognize when to sidestep dis-
agreements and pursue MI and when to move
forward with traditional methods with clients
who are motivated sufficiently and ready for
change. The details of these strategies and
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techniques are presented in TIP 35 (CSAT
1999b) and in Miller and Rollnick 2002. 
Motivational interviewing
and co-occurring disorders
Approaches based on MI have been adapted
for people with COD with some initial evidence
of efficacy for improved treatment engagement.
In a sample of 100 inpatient clients with COD
from a large university hospital, Daley and
Zuckoff (1998, p. 472) found that with only one
“motivational therapy” session prior to hospi-
tal discharge, “...the show rate for the initial
outpatient appointment almost doubled,
increasing from 35 percent to 67 percent.” In
this study MI approaches were modified to
focus on contrasting the goals and methods of
hospital and outpatient treatment. Also, the
client was invited to consider the advantages
and challenges of continuing in outpatient
treatment. Daley and Zuckoff’s results are rele-
vant for people in most quadrants (see chapters
2 and 3), as the majority of their clientele are
described as “public sector clients who have
mood, anxiety, personality, or psychotic disor-
ders combined with alcohol, cocaine, heroin,
sedative hypnotic, cannabis, or polysubstance
use disorders.” 
Swanson and colleagues (1999) modified MI
techniques by increasing the amount of dis-
cussion of the client’s perception of the prob-
lem and his understanding of his clinical con-
dition. Of the 121 study participants who
were selected from psychiatric inpatients at
two inner-city hospitals, 93 had concomitant
substance use disorders. Participants were
assigned randomly to either standard treat-
ment or standard treatment with the addition
of a motivational interview. The MI focused
on exploring the clients’ commitment to treat-
ment, plans for continuing care, and under-
standing of their role in their own recovery.
Figure 5-1
Stages of Change
Stage Characteristics
Precontemplation No intention to change in the foreseeable future; may be unaware or under-aware of
problems.
Contemplation Aware that a problem exists and thinking seriously about overcoming it, but have no
commitment to take action yet made; weighing pros and cons of the problem and its
solution.
Preparation Combines intention and behavior—action is planned within the next month, and
action has been taken unsuccessfully in the past year; some reductions have been
made in problem behaviors, but a criterion for effective action has not been reached.
Action Behavior, experiences, or environment are modified to overcome the problem; suc-
cessful alteration of the addictive behavior for anywhere between 1 day to 6 months
(note that action does not equal change).
Maintenance Working to prevent relapse and consolidate gains attained during the Action stage;
remaining free from addictive behavior and engaging consistently in a new incompati-
ble behavior for more than 6 months.
Source: Adapted from Prochaska et al. 1992.
117Strategies for Working With Clients With Co-Occurring Disorders
Essentially, the therapists were attempting to
elicit a motivational statement that indicated
the clients’ commitment to treatment. The
authors found that, whether considering the
entire sample or only those with COD, study
participants who received the MI were signifi-
cantly more likely to attend an initial outpa-
tient treatment session. 
Motivational strategies have been shown to be
helpful with persons who have serious mental
disorders. Most programs designed for per-
sons with such disorders recognize “that the
majority of psychiatric clients have little
readiness for abstinence-oriented substance
use disorder (SUD) treatments;” therefore,
they “incorporate motivational interventions
designed to help clients who either do not rec-
Figure 5-2
Motivational Enhancement Approaches
Stage of Readiness Motivational Enhancement Approaches
Precontemplation •Express concern about the client’s substance use, or the client’s mood, anxiety, or
other symptoms of mental disorder.
•State nonjudgmentally that substance use (or mood, anxiety, self-destructiveness) is a
problem.
•Agree to disagree about the severity of either the substance use or the psychological
issues.
•Consider a trial of abstinence to clarify the issue, after which psychological evaluation
can be reconsidered.
•Suggest bringing a family member to an appointment.
•Explore the client’s perception of a substance use or psychiatric problem.
•Emphasize the importance of seeing the client again and that you will try to help.
Contemplation •Elicit positive and negative aspects of substance use or psychological symptoms.
•Ask about positive and negative aspects of past periods of abstinence and substance
use, as well as periods of depression, hypomania, etc.
•Summarize the client’s comments on substance use, abstinence, and psychological
issues.
•Make explicit discrepancies between values and actions.
•Consider a trial of abstinence and/or psychological evaluation.
Preparation •Acknowledge the significance of the decision to seek treatment for one or more disor-
ders.
•Support self-efficacy with regard to each of the COD.
•Affirm the client’s ability to seek treatment successfully for each of the COD.
•Help the client decide on appropriate, achievable action for each of the COD.
•Caution that the road ahead is tough but very important.
•Explain that relapse should not disrupt the client–clinician relationship.
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ognize their SUD or do not desire substance
abuse treatment to become ready for more
definitive interventions aimed at abstinence”
(Drake and Mueser 2000). 
A four-session intervention has been devel-
oped specifically to enhance readiness for
change and treatment engagement of persons
with schizophrenia who also abuse alcohol
and other substances (Carey et al. 2001). This
intervention is summarized in Figure 5-3 
(p. 119). In a pilot study of the intervention,
92 percent of the 22 participants completed
the series of sessions, all of whom reported
that intervention was both positive and help-
ful. A range of motivational variables showed
post-intervention improvements in recogni-
tion of substance use problems and greater
treatment engagement, confirmed by indepen-
dent clinician ratings. Those who began the
intervention with low problem recognition
made gains in that area; those who began with
greater problem recognition made gains in the
frequency of use and/or involvement in treat-
ment. Although these data are preliminary,
the technique is well articulated. It shows
promise and warrants further research,
including efforts to determine its efficacy
among clients with COD who have mental dis-
orders other than schizophrenia. 
It should be noted, however, that assessment
of readiness to change could differ markedly
between the client and the clinician.
Addington et al. (1999) found little agreement
between self-report of stage of readiness to
Figure 5-2 (continued)
Motivational Enhancement Approaches
Stage of Readiness Motivational Enhancement Approaches
Action •Be a source of encouragement and support; remember that the client may be in the
action stage with respect to one disorder but only in contemplation with respect to
another; adapt your interview approach accordingly.
•Acknowledge the uncomfortable aspects of withdrawal and/or psychological symptoms.
•Reinforce the importance of remaining in recovery from both problems.
Maintenance •Anticipate and address difficulties as a means of relapse prevention.
•Recognize the client’s struggle with either or both problems, working with separate
mental health and substance abuse treatment systems, and so on.
•Support the client’s resolve.
•Reiterate that relapse or psychological symptoms should not disrupt the counseling
relationship.
Relapse •Explore what can be learned from the relapse, whether substance-related or related to
the mental disorder.
•Express concern and even disappointment about the relapse.
•Emphasize the positive aspect of the effort to seek care.
•Support the client’s self-efficacy so that recovery seems achievable.
Source: Reproduced from Samet et al. 1996 (used with permission).
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change and the assessment of stage of readi-
ness determined by interviewers for their 39
outpatients with diagnoses of both schizo-
phrenia and a substance use disorder. In view
of these observations, clinicians should be
careful to establish a mutual agreement on
the issue of readiness to change with their
clients. 
Applying the motivational
interviewing approach to
clients with COD
To date, motivational interviewing strategies
have been applied successfully to the treatment
of clients with COD, especially in
•Assessing the client’s perception of the 
problem
•Exploring the client’s understanding of his or
her clinical condition
Figure 5-3
A Four-Session Motivation-Based Intervention
Session 1—Introduction, Assessment, and Information Feedback
Goals Therapeutic Activities Purpose
Establish therapeu-
tic alliance and col-
laborative
approach
Begin to develop
discrepancy (raise
awareness of the
extent of use and
negative conse-
quences)
Introduce intervention •To elicit reasons and motivations for attending 
•To establish understanding of the nature and purpose
of the intervention
Assess and discuss readi-
ness to change
•To establish mutual understanding of attitudes toward
substance use and prospects for change
•To convey respect for the client’s attitudes
•To evaluate using open-ended and structured techniques
Feedback of current use,
consequences, and risks
•To foster client’s awareness of extent of use, comparison
to norms, negative consequences, and risks of pattern of
use
Session 2—Decisional Balance
Goals Therapeutic Activities Purpose
Continue emphasis
on therapeutic
alliance and collab-
orative approach
Place more empha-
sis on developing
discrepancy 
Review Session 1 and
introduce Session 2
•To let the client know what to expect (alleviates anxiety)
•To help the client remember insights/reactions to rein-
force gains
Decisional balance •To help the client identify and verbalize salient cons of
using and pros of quitting
•To foster dissatisfaction with use, and interest in quit-
ting, clarifying barriers to change
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Figure 5-3 (continued)
A Four-Session Motivation-Based Intervention
Session 3—Strivings and Efficacy
Goals Therapeutic Activities Purpose
Continue emphasis
on developing dis-
crepancy
Place more empha-
sis on self-efficacy 
Review Session 2 and
introduce Session 3
•To reorient the client to the treatment process and
reinforce past gains
Assess and discuss
expectancies with regard
to behavior change
•To monitor changes in perceived importance and self-
efficacy to change substance use
•To shore up motivation for change or address reasons for
low motivation
Strivings list •To develop discrepancy between a future with and with-
out change in substance use by verbalizing personal aspi-
rations, likely negative effects of use to achieving goals,
and potential facilitative effects of abstinence 
Session 4—Goals and Action Plan
Goals Therapeutic Activities Purpose
Reinforce motiva-
tional gains (in per-
ceived importance
of change, self-effi-
cacy)
To leave the client
with a clear plan of
action 
Review treatment •To reinforce motivational changes
•To extend the principle of providing periodic summaries
of discussion throughout the course of each session
•To use repetition to compensate for deficits in attention
and memory
Elicit goals and develop
written plan of action
•To help identify and clarify specific, realistic goals
around substance use reduction
•To help develop a plan of action, including mobilizing
external supports and internal resources
•To help the client anticipate barriers and solve problems
around him
Source: Carey et al. 2001.
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•Examining the client’s desire for continued
treatment
•Ensuring client attendance at initial sessions
•Expanding the client’s assumption of respon-
sibility for change
Future directions include
•Further modification of MI protocols to make
them more suitable for clients with COD,
particularly those with serious mental disor-
ders
•Tailoring and combining MI techniques with
other treatments to solve the problems (e.g.,
engagement, retention, etc.) of all treatment
modalities
See the text box below for a case study apply-
ing MET.
Design Contingency
Management Techniques To
Address Specific Target
Behaviors
Description
Contingency Management (CM) maintains that
the form or frequency of behavior can be
altered through a planned and organized sys-
tem of positive and negative consequences. CM
Case Study: Using MET With a Client Who Has COD
Gloria M. is a 34-year-old African-American female with a 10-year history of alcohol dependence and 12-year
history of bipolar disorder. She has been hospitalized previously both for her mental disorder and for sub-
stance abuse treatment. She has been referred to the outpatient substance abuse treatment provider from
inpatient substance abuse treatment services after a severe alcohol relapse. 
Over the years, she sometimes has denied the seriousness of both her addiction and mental disorders.
Currently, she is psychiatrically stable and is prescribed valproic acid to control the bipolar disorder. She
has been sober for 1 month.
At her first meeting with Gloria M., the substance abuse treatment counselor senses that she is not sure
where to focus her recovery efforts—on her mental disorders or her addiction. Both have led to hospitaliza-
tion and to many life problems in the past. Using motivational strategies, the counselor first attempts to find
out Gloria M.’s own evaluation of the severity of each disorder and its consequences to determine her stage of
change in regard to each one. 
Gloria M. reveals that while in complete acceptance and an active stage of change around alcohol depen-
dence, she is starting to believe that if she just goes to enough recovery meetings she will not need her bipolar
medication. Noting her ambivalence, the counselor gently explores whether medications have been stopped in
the past and, if so, what the consequences have been. Gloria M. recalls that she stopped taking medications
on at least half a dozen occasions over the last 10 years; usually, this led her to jail, the emergency room, or a
period of psychiatric hospitalization. The counselor explores these times, asking: Were you feeling then as
you were now—that you could get along? How did that work out? Gloria M. remembers believing that if she
attended 12-Step meetings and prayed she would not be sick. In response to the counselor’s questions, she
observes, “I guess it hasn’t ever really worked in the past.”
The counselor then works with Gloria M. to identify the best strategies she has used for dual recovery in the
past. “Has there been a time you really got stable with both disorders?” Gloria M. recalls a 3-year period
between the ages of 25 and 28 when she was stable, even holding a job as a waitress for most of that period.
During that time, she recalls, she saw a psychiatrist at a local mental health center, took medications regular-
ly, and attended AA meetings frequently. She recalls her sponsor as being supportive and helpful. The coun-
selor then affirms the importance of this period of success and helps Gloria M. plan ways to use the strategies
that have already worked for her to maintain recovery in the present.
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assumes that neurobiological and environmen-
tal factors influence substance use behaviors
and that the consistent application of reinforc-
ing environmental consequences can change
these behaviors. CM principles for substance
abuse treatment have been structured around
four central principles (Higgins and Petry
1999): 
• The clinician arranges for regular drug test-
ing to ensure the client’s use of the targeted
substance is detected readily. 
• The clinician provides positive reinforcement
when abstinence is demonstrated. These posi-
tive reinforcers are agreed on mutually. 
• The clinician withholds the designated incen-
tives from the individual when the substance
is detected.
• The clinician helps the client establish alter-
nate and healthier activities. 
CM techniques are best applied to specific tar-
geted behaviors such as
•Drug abstinence
•Clinic attendance and group participation
•Medication adherence 
•Following treatment plan
•Attaining particular goals
The clinician may use a variety of CM tech-
niques or reinforcers. The most common are
•Cash
•Vouchers
•Prizes
•Retail items
•Privileges
Figure 5-4 contains a checklist for a clinician
designing CM programs. See also p. 124 for a
case study applying CM.
Empirical evidence on the
effectiveness of contingency
management
A substantial empirical base supports CM tech-
niques, which have been applied effectively to a
variety of behaviors. CM techniques have
demonstrated effectiveness in enhancing reten-
tion and confronting drug use (e.g., Higgins
1999; Petry et al. 2000). The techniques have
been shown to address use of a variety of spe-
cific substances, including opioids (e.g., Higgins
et al. 1986; Magura et al. 1998), marijuana
(Budney et al. 1991), alcohol (e.g., Petry et al.
2000), and a variety of other drugs including
cocaine (Budney and Higgins 1998). However,
CM techniques have not been implemented in
community-based settings until recently. The
use of vouchers and other reinforcers has con-
siderable empirical support (e.g., Higgins 1999;
Silverman et al. 2001), but little evidence is
apparent for the relative efficacy of different
reinforcers. The effectiveness of CM principles
when applied in community-based treatment
settings and specifically with clients who have
COD remains to be demonstrated. 
Some examples of the use of CM techniques
have direct implications for people with COD:
•Housing and employment contingent on
abstinence. CM, where housing and employ-
ment are contingent on abstinence, has
been used and studied among populations
of homeless persons, many with COD
(Milby et al. 1996; Schumacher et al. 1995).
Results show that participants in treatment
with contingencies were more likely than
those in conventional treatment to test clean
for drugs, to move into stable housing, and
to gain regular employment following treat-
ment.
•Managing benefits and establishing repre-
sentative payeeships. Procedures have been
established to manage benefits for persons
with serious mental illness and substance
use disorders (Ries and Comtois 1997) and
for establishing representative payeeships
for clients with COD that involve managing
money and other benefits (e.g., Conrad et
al. 1999). In these approaches, once absti-
nence is achieved, clients are allowed
greater latitude for management of their
own finances.
•A token economy for homeless clients with
COD. A token economy has been developed
with clients with COD in a shelter to pro-
vide immediate and systematic reinforce-
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ment for an array of behaviors during the
engagement phase. Points were awarded for
the successful accomplishment of a stan-
dard list of behaviors essential to the devel-
opment of commitment, such as medication
adherence, abstinence, attendance at pro-
gram activities, and followthrough on refer-
rals. Points were tallied weekly and tangible
rewards (phone cards, treats, toiletries,
etc.) were distributed commensurate with
the earned point totals (Sacks et al. 2002).
Awareness of the principles of CM can help the
clinician to focus on quantifiable behaviors that
occur with a good deal of frequency and to pro-
vide the reinforcers in an immediate and con-
sistent fashion. CM principles and methods can
be accommodated flexibly and applied to a
range of new situations that can increase clini-
cian effectiveness. It should be noted that many
counselors and programs employ CM principles
informally when they praise or reward particu-
lar behaviors and accomplishments and that
even formal use of CM principles are found in
Figure 5-4
Checklist for Designing CM Programs
Step Description
1. Choose a behavior •One that is objectively quantifiable, occurs frequently, and is considered to be
most important.
•Set reasonable expectations.
2. Choose a reinforcer • Determine available resources (in-house rewards or donations of cash or services
from local businesses such as movie theaters and restaurants).
•Identify intangible rewards, such as frequent positive reports to parole officers,
flexibility in methadone dosing, and increased freedom (smoke breaks, passes,
etc.).
3. Use behavioral 
principles
•Develop a monitoring and reinforcement schedule that is optimized through
application of behavioral principles.
•Keep the schedule simple so staff can apply principles consistently and clients can
understand what is expected.
4. Prepare a behavioral
contract
•Draw up a contract for the target behavior that considers the monitoring system
and reinforcement schedule.
•Be specific and consider alternate interpretations; have others review the con-
tract and comment.
•Include any time limitations.
5. Implement the 
contract
•Ensure consistent application of the contract; devise methods of seeing that staff
understands and follows procedures.
•Remind the client of behaviors and their consequences (their “account balance”
and what is required to obtain a bonus) to increase the probability that the esca-
lating reward system will have the desired effect.
Source: Petry 2000a.
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Case Study: Using CM With a Client With COD
Initial Assessment
Mary A. is a 45-year-old Caucasian woman diagnosed with heroin and cocaine dependence, depression, antiso-
cial personality disorder, and cocaine-induced psychotic episodes. She has a long history of prostitution and
sharing injection equipment. She contracted HIV 5 years ago. 
Mary A. had been on a regimen of methadone maintenance for about 2 years. Despite dose increases up to 120
mg/day, she continued using heroin at the rate of 1 to 15 bags per day as well as up to 3 to 4 dime bags per day
of cocaine. After cessation of a cocaine run, Mary A. experienced tactile and visual hallucinations character-
ized by “bugs crawling around in my skin.” She mutilated herself during severe episodes and brought in some
of the removed skin to show the “bugs” to her therapist.
Mary A. had been hospitalized four times for cocaine-induced psychotic episodes. Following an 11-day stay in
an inpatient dual diagnosis program subsequent to another cocaine-induced psychotic episode, Mary A. was
referred to an ongoing study of contingency management interventions for methadone-maintained, cocaine-
dependent outpatients.
Behaviors To Target
Mary A.’s primary problem was her drug use, which was associated with cocaine-induced psychosis and an
inability to adhere to a regimen of psychiatric medications and methadone. Because her opioid and cocaine use
were linked intricately, it was thought that a CM intervention that targeted abstinence from both drugs would
improve her functioning. As she was already maintained on a high methadone dose, methadone dose adjust-
ments were not made.
CM Plan
Following discharge from the psychiatric unit, Mary A. was offered participation in a NIDA-funded study eval-
uating lower-cost contingency management treatment (e.g., Petry et al. 2000, pp. 250–257) for cocaine-abusing
methadone clients. As part of participation in this study, Mary A. agreed to submit staff-observed urine sam-
ples on 2 to 3 randomly selected days each week for 12 weeks. She was told that she had a 50 percent chance of
receiving standard methadone treatment plus frequent urine sample testing of standard treatment along with a
contingency management intervention. She provided written informed consent, as approved by the
University’s Institutional Review Board.
Mary A. was assigned randomly to the CM condition. In this condition, she earned one draw from a bowl for
every urine specimen that she submitted that was clean from cocaine or opioids and four draws for every speci-
men that was clean from both substances. The bowl contained 250 slips of paper. Half of them said “Good job”
but did not result in a prize. Other slips stated “small prize” (N=109), “large prize” (N=15), or “jumbo prize”
(N=1). Slips were replaced after each drawing so that probabilities remained constant. A lockable prize cabinet
was kept onsite in which a variety of small prizes (e.g., socks, lipstick, nail polish, bus tokens, $1 gift certifi-
cates to local fast-food restaurants, and food items), large prizes (sweatshirts, portable CD players, watches,
and gift certificates to book and record stores), and jumbo prizes (VCRs, televisions, and boom boxes) were
kept. When a prize slip was drawn, Mary A. could choose from items available in that category. All prizes were
purchased through funds from the research grant.
In addition to the draws from the bowl for clean urine specimens, for each week of consecutive abstinence from
both cocaine and opioids Mary A. earned bonus draws. The first week of consecutive cocaine and opioid absti-
nence resulted in five bonus draws, the second week resulted in six bonus draws, the third week seven and so
on. In total, Mary A. could earn about 200 draws if she maintained abstinence throughout the 12-week study.
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programs where attainment of certain levels
and privileges are contingent on meeting cer-
tain behavioral criteria. 
Use Cognitive–Behavioral
Therapeutic Techniques 
Description 
Cognitive–behavioral therapy (CBT) is a ther-
apeutic approach that seeks to modify nega-
tive or self-defeating thoughts and behavior.
CBT is aimed at both thought and behavior
change (i.e., coping by thinking differently
and coping by acting differently). One cogni-
tive technique is known as “cognitive restruc-
turing.” For example, a client may think ini-
tially, “The only time I feel comfortable is
when I’m high,” and learn through the coun-
seling process to think instead, “It’s hard to
learn to be comfortable socially without doing
drugs, but people do so all the time” (TIP 34,
Brief Interventions and Brief Therapies for
Substance Abuse [CSAT 1999a], pp. 64–65).
CBT includes a focus on overt, observable
behaviors—such as the act of taking a drug—
and identifies steps to avoid situations that
lead to drug taking. CBT also explores the
interaction among beliefs, values, percep-
tions, expectations, and the client’s explana-
tions for why events occurred.
An underlying assumption of CBT is that the
client systematically and negatively distorts
her view of the self, the environment, and the
future (O’Connell 1998). Therefore, a major
tenet of CBT is that the person’s thinking is
the source of difficulty and that this distorted
thinking creates behavioral problems. CBT
approaches use cognitive and/or behavioral
strategies to identify and replace irrational
beliefs with rational beliefs. At the same time,
the approach prescribes new behaviors the
client practices. These approaches are educa-
tional in nature, active and problem-focused,
and time-limited. 
CBT for substance abuse
CBT for substance abuse combines ele-
ments of behavioral theory, cognitive
social learning theory, cognitive theory,
and therapy into a distinctive therapeutic
approach that helps clients recognize situ-
ations where they are likely to use sub-
stances, find ways of avoiding those situa-
tions, and learn better ways to cope with
feelings and situations that might have, in
the past, led to substance use (Carroll
1998). 
Clinical Course
Mary A. earned 175 draws during treatment, receiving prizes purchased for a total of $309. She never
missed a day of methadone treatment, attended group sessions regularly, and honored all her individual
counseling sessions at the clinic. At 6-month follow-up, she had experienced only one drug use lapse,
which she self-reported. Her depression cleared with her abstinence, and so did her antisocial behavior.
She was pleased with the prizes and stated, “Having good stuff in my apartment and new clothes makes
me feel better about myself. When I feel good about me, I don’t want to use cocaine.”
Source: Adapted from Petry et al. 2001b.
Advice to the Counselor: 
Using Contingency Management
Techniques
The consensus panel recommends that substance
abuse treatment clinicians and programs employ CM
techniques with clients with COD in such activities as
• Providing refreshments for attendance at groups or
social activities
• Monitoring urine specimens
• Checking medication adherence
• Rewarding clients for obtaining particular goals in
their treatment plan
• Reinforcing appropriate verbal and social behavior
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CBT for people with substance use disorders
also addresses “coping behaviors.” Coping
“refers to what an individual does or thinks
in a relapse crisis situation so as to handle the
risk for renewed substance use” (Moser and
Annis 1996, p. 1101). The approach assumes
that “substance abusers are deficient in their
ability to cope with interpersonal, social,
emotional, and personal problems. In the
absence of these skills, such problems are
viewed as threatening, stressful, and poten-
tially unsolvable. Based on the individual’s
observation of both family members’ and
peers’ responses to similar situations and on
their own initial experimental use of alcohol
or drugs, the individual uses substances as a
means of trying to address these problems
and the emotional reactions they create”
(CSAT 1999a, p. 71). The clinician seeks to
help the client increase his coping skills so he
will not use drugs in high-stress situations.
(See TIP 34 [CSAT 1999a] for a more
detailed explanation of the theoretical back-
ground of CBT and how it is applied in sub-
stance abuse treatment.)
CBT and COD
Distortions in thinking generally are more
severe with people with COD than with other
substance abuse treatment clients. For exam-
ple, a person with depression and an alcohol
use disorder who has had a bad reaction to a
particular antidepressant may claim that all
antidepressant medication is bad and must be
avoided at all costs. Likewise, individuals may
use magnification and minimization to exagger-
ate the qualities of others, consistently present-
ing themselves as “losers” who are incapable of
accomplishing anything. Clients with COD are,
by definition, in need of better coping skills.
The Substance Abuse Management Model in
the section on Relapse Prevention Therapy
later in this chapter provides a pertinent exam-
ple of how to increase behavioral coping skills. 
Grounding
Some clients with COD, such as those who have
experienced trauma or sexual abuse, can bene-
fit from a particular coping skill known as
“grounding” (Najavits 2002). Many such clients
frequently experience overwhelming feelings
linked to past trauma, which can be triggered
by a seemingly small comment or event.
Sometimes, this sets off a craving to use sub-
stances. Grounding refers to the use of strate-
gies that soothe and distract the client who is
experiencing tidal waves of pain or other strong
emotions, helping the individual anchor in the
present and in reality. These techniques work
by directing the mental focus outward to the
external world, rather than inward toward the
self. Grounding also can be referred to as “cen-
tering,” “looking outward,” “distraction,” or
“healthy detachment” (Najavits 2002). 
Grounding “can be done anytime, anywhere,
by oneself, without anyone else noticing it. It
can also be used by a supportive friend or
partner who can guide the patient in it when
the need arises” (Najavits 2002, p. 125). It is
used commonly for PTSD, but can be applied
to substance abuse cravings, or any other
intense negative feeling, such as anxiety, panic
attacks, and rage. Grounding is so basic and
simple that it gives even the most impaired
clients a useful strategy. However, it must be
practiced frequently to be maximally helpful.
For a lesson plan and other materials on
grounding, see Najavits 2002. See also the sec-
tion on PTSD in chapter 8 and appendix D of
this TIP.
Roles of the client and 
clinician
CBT is an active approach that works most
effectively with persons who are stabilized in
the acute phase of their substance use and
mental disorders. To be effective, the clinician
and the client must develop rapport and a
working alliance. The client’s problem is
assessed extensively and thorough historical
data are collected. Then, collaboratively, dys-
functional automatic thoughts, schemas, and
cognitive distortions are identified. Treatment
consists of the practice of adaptive skills within
the therapeutic environment and in homework
sessions. Booster sessions are used following
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termination of treatment to assist people who
have returned to old maladaptive patterns of
thinking. 
The client with COD is an active participant in
treatment, while the role of the clinician is pri-
marily that of educator. The clinician collabo-
rates with the client or group in identifying
goals and setting an agenda for each session.
The counselor also guides the client by explain-
ing how thinking affects mood and behavior.
Clients with COD may need very specific cop-
ing skills to overcome the combined challenges
of their substance abuse and their mental dis-
order. For example, Ziedonis and Wyatt (1998,
p. 1020) address the need to target “the
schizophrenic’s cognitive difficulties (attention
span, reading skills, and ability to abstract).”
Their approach for these clients includes role-
playing to help build communication and prob-
lemsolving skills.
Some specific CBT strategies for programs
working with clients with COD are described
below. See also the text box above for a case
example.
Use Relapse Prevention
Techniques
Description
Marlatt defines relapse as “a breakdown or set-
back in a person’s attempt to change or modify
any target behavior” (1985, p. 3). NIDA elabo-
rates this definition by describing relapse as
“any occasion of drug use by recovering
Case Study: Using CBT With a Client With COD
Jack W. is referred to the substance abuse treatment agency for evaluation after a positive urine test that
revealed the presence of cocaine. He is a 38-year-old African American. Initially, Jack W. engages in treatment
in intensive outpatient therapy three times weekly, has clean urine tests, and seems to be doing well. However,
after 2 months he starts to appear more depressed, has less to say in group therapy sessions, and appears with-
drawn. In a private session with the substance abuse treatment counselor, he says that, “All this effort just
isn’t worth it. I feel worse than I did when I started. I might as well quit treatment and forget the job. What’s
the point?” The counselor explores what has changed, and Jack W. reveals that his wife has been having a
hard time interacting with him as a sober person. Now that he is around the house more than he used to be (he
was away frequently, dealing drugs to support his habit), they have more arguments. He feels defeated. 
In the vocabulary of CBT, Jack W. demonstrates “all or nothing” thinking (I might as well lose everything
because I’m having arguments), overgeneralization, and discounting the positive (he is ignoring the fact that he
still has his job, has been clean for 2 months, looks healthier and, until recently, had an improved outlook).
His emotionally clouded reasoning is blackening the whole recovery effort, as he personalizes the blame for
what he sees as failure to improve his life.
Clearly, Jack W. has lost perspective and seems lost in an apparently overwhelming marital problem. The
counselor, using a pad and pencil, draws a circle representing the client and divides it into parts, showing Jack
that they represent physical health, his work life, his recovery, risk for legal problems, and family or mar-
riage. He invites Jack to review each one, comparing where he is now and where he was when he first arrived
at the clinic in order to evaluate the whole picture. Jack observes that everything is actually getting better with
the exception of his marriage. The counselor helps Jack gain the skills needed to stand back from his situation
and put a problem in perspective. He also negotiates to determine the kind of help that Jack would see as use-
ful in his marriage. This might be counseling for the couple or an opportunity to practice and rehearse ways of
engaging his wife without either of them becoming enraged. 
If Jack’s depression continues despite these interventions, the counselor may refer him to a mental health
provider for evaluation and treatment of depression.
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addicts that violates their own prior commit-
ment and that often they regret almost immedi-
ately” (NIDA 1993, p. 139), and adds Relapse
Prevention Therapy (RPT) to its list of effec-
tive substance abuse treatment approaches.
Relapse can be understood not only as the
event of resuming substance use, but also as a
process in which indicators of increasing
relapse risk can be observed prior to an
episode of substance use, or lapse (Daley 1987;
Daley and Marlatt 1992).
A variety of relapse prevention models are
described in the literature (e.g., Gorski 2000;
Marlatt et al. 1999; Monti et al. 1993; NIDA
1993; Rawson et al. 1993). However, a central
element of all clinical approaches to relapse
prevention is anticipating problems that are
likely to arise in maintaining change and
labeling them as high-risk situations for
resumed substance use, then helping clients to
develop effective strategies to cope with those
high-risk situations without having a lapse. A
key factor in preventing relapse is to under-
stand that relapses are preceded by triggers
or cues that signal that trouble is brewing and
that these triggers precede exposure to events
or internal processes (high-risk situations)
where or when resumed substance use is like-
ly to occur. A lapse will occur in response to
these high-risk situations unless effective cop-
ing strategies are available to the person and
are implemented quickly and performed ade-
quately. Clinicians using relapse prevention
techniques recognize that lapses (single
episodes or brief returns to drug use) are an
expected part of overcoming a drug problem,
rather than a signal of failure and an indica-
tion that all treatment progress has been lost.
Therapy sessions aimed at relapse prevention
can occur individually or in small groups,
and may include practice or role-play on how
to cope effectively with high-risk situations.
According to Daley and Marlatt (1992),
approaches to relapse prevention have many
common elements. Generally they focus on
the need for clients to
1. Have a broad repertoire of cognitive and
behavioral coping strategies to handle high-
risk situations and relapse warning signs.
2. Make lifestyle changes that decrease the
need for alcohol, drugs, or tobacco.
3. Increase healthy activities.
4. Prepare for interrupting lapses, so that they
do not end in full-blown relapse.
5. Resume or continue to practice relapse pre-
vention skills even when a full-blown relapse
does occur by renewing their commitment to
abstinence rather than giving up the goal of
living a drug-free life. 
RPT is an intervention designed to teach indi-
viduals who are trying to maintain health
behavior changes how to anticipate and cope
with the problem of relapse (Marlatt 1985).
RPT strategies can be placed in five cate-
gories: Assessment Procedures, Insight/
Awareness Raising Techniques, Coping Skills
Adapting CBT for Clients With COD
•Use visual aids, including illustrations and concept mapping (a visual presentation of concepts that makes
patterns evident).
•Practice role preparation and rehearse for unexpected circumstances.
•Provide specific in vivo feedback on applying principles and techniques.
•Use outlines for all sessions that list specific behaviorally anchored learning objectives.
•Test for knowledge acquisition.
•Make use of memory enhancement aids, including notes, tapes, and mnemonic devices.
Source: Adapted from Peters and Hills 1997.
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Training, Cognitive Strategies, and Lifestyle
Modification (Marlatt 1985). RPT Assessment
Procedures are designed to help clients
appreciate the nature of their problems in
objective terms, to measure motivation for
change, and to identify risk factors that
increase the probability of relapse.
Insight/Awareness Raising Techniques are
designed to provide clients with alternative
beliefs concerning the nature of the behavior
change process (e.g., to view it as a learning
process) and, through self-monitoring, to help
clients identify patterns of emotion, thought,
and behavior related to both substance use
and co-occurring mental disorders. Coping
Skills Training strategies include teaching
clients behavioral and cognitive strategies.
Cognitive Strategies are used to manage urges
and craving, to identify early warning signals,
and to reframe reactions to an initial lapse.
Finally, Lifestyle Modification Strategies
(e.g., meditation and exercise) are designed to
strengthen clients’ overall coping capacity.
In Marlatt’s model of RPT, lapses are seen as
a “fork in the road” or a “crisis.” Each lapse
contains the dual elements of “danger” (pro-
gression to full-blown relapse) and “opportu-
nity” (reduced relapse risk in the future due
to the lessons learned from debriefing the
lapse). The goal of effective RPT is to teach
clients to recognize increasing relapse risk
and to intervene at earlier points in the
relapse process in order to encourage clients
to progress toward maintaining abstinence
from drugs and living a life in which lapses
occur less often and are less severe. 
Specific aspects of RPT might include
•Exploring with the client both the positive
and negative consequences of continued drug
use (“decisional balance,” as discussed in the
motivational interviewing section of this
chapter)
•Helping clients to recognize high-risk situa-
tions for returning to drug use 
•Helping clients to develop the skills to avoid
those situations or cope effectively with them
when they do occur
•Developing a “relapse emergency plan” in
order to exercise “damage control” to limit
the duration and severity of lapses 
•Learning specific skills to identify and cope
effectively with drug urges and craving 
Clients also are encouraged to begin the pro-
cess of creating a more balanced lifestyle to
manage their COD more effectively and to ful-
fill their needs without using drugs to cope with
life’s demands and opportunities. In the treat-
ment of clients with COD, it often is critical to
consider adherence to a medical regimen
required to manage disruptive and disorganiz-
ing symptoms of mental disorder as a relapse
issue. In terms of medication adherence, a
“lapse” is defined as not taking the prescribed
drugs one needs rather than the resumption of
taking illicit drugs for self-medication or plea-
sure seeking.
Empirical evidence related to
relapse prevention therapy
Carroll (1996) reviewed 24 randomized con-
trolled trials of RPT among smokers and
abusers of alcohol, marijuana, cocaine, opi-
oids, and other drugs. While many of the stud-
ies were of smokers—in which Carroll noted
the strongest support for RPT in terms of
improved outcomes for relapse severity, dura-
bility of effects, and client-treatment matching,
as compared to no-treatment controls—compa-
rable results were found for alcohol and illicit
drugs as well. Of particular importance was the
observation that the positive effects of RPT
treatment were greater among those with high-
er severities of both psychiatric symptoms and
addiction impairment, which suggests the tech-
nique would be helpful in the treatment of
clients with COD. 
In a meta-analytic review of 26 published and
unpublished studies using Marlatt’s RPT
model, Irvin et al. (1999) found that RPT
generally was effective particularly for alco-
hol problems and was most effective when
applied to alcohol or polysubstance use disor-
ders, combined with medication. The efficacy
of RPT has been demonstrated sufficiently to
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be included by NIDA (1999a) as a recom-
mended approach “to supplement or
enhance—not replace—existing treatment
programs” (p. 35).
Adaptations for clients with
COD
Several groups have developed relapse preven-
tion interventions aimed at clients with differ-
ent mental disorders or substance use diag-
noses (see Evans and Sullivan 2001). Weiss and
colleagues (1998) developed a 20-session
relapse prevention group therapy for the treat-
ment of clients with co-occurring bipolar and
substance use disorders. This group stressed
concepts of importance to both disorders—for
example, it contrasts “may as well” thinking,
which allows for relapse and failure to take
medication, with “it matters what you do.” It
also teaches useful skills relevant to both disor-
ders, such as coping with high-risk situations
and modifying lifestyle to improve self-care (p.
49). Ziedonis and Stern (2001) have developed
a dual recovery therapy, which blends tradi-
tional mental health and addiction treatments
(including both motivational enhancement ther-
apy and relapse prevention) for clients with
serious mental illness. Also,
Nigam and colleagues (1992)
developed a relapse prevention
group for clients with COD.
Substance abuse 
management module
Roberts et al. (1999) developed
The Substance Abuse
Management Module (SAMM)
based on the previously
described RPT approach of
Marlatt and his colleagues.
SAMM originally was designed
to be a component of a compre-
hensive approach to the treat-
ment of co-occurring substance
use dependence and schizophre-
nia. This detailed treatment
manual illustrates many RPT
techniques and focuses on the most common
problems encountered by clients with severe
COD. SAMM offers a detailed cognitive–
behavioral strategy for each of several com-
mon problems that clients face. Each strategy
includes both didactics and detailed skills
training procedures including role-play prac-
tice. Emphasis is placed on rehearsing such
key coping behaviors as refusing drugs, nego-
tiating with treatment staff, acting appropri-
ately at meetings for mutual self-help, and
developing healthy habits. Both counselor
and client manuals are available. 
The text box beginning on p. 131 describes the
SAMM protocol (Roberts et al. 1999) shows
how a clinician might work with a substance
abuse treatment client with COD to help the
client avoid drugs.
Integrated treatment
RPT (Marlatt and Gordon 1985) and other
cognitive–behavioral approaches to psy-
chotherapy and substance abuse treatment
allow clinicians to treat COD in a integrated
way by
Advice to the Counselor:
Using Relapse Prevention Methods
The consensus panel recommends using the following
relapse prevention methods with clients with COD:
• Provide relapse prevention education on both mental
disorders and substance abuse and their interrelations.
• Teach skills to help the client handle pressure for discon-
tinuing psychotropic medication and to increase medica-
tion adherence.
• Encourage attendance at dual recovery groups and teach
social skills necessary for participation.
• Use daily inventory to monitor psychiatric symptoms and
symptoms changes.
• If relapse occurs, use it as a learning experience to
investigate triggers with the client. Reframe the
relapse as an opportunity for self-knowledge and a
step toward ultimate success.
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Overview of SAMM Concepts and Skills
How to Avoid Drugs (Made Simple)
The concepts and skills taught in this module are designed to help clients follow these four recommendations:
•If you slip, quit early.
•When someone offers drugs, say no.
•Don’t get into situations where you can’t say no.
•Do things that are fun and healthy.
Overview of Module Concepts and Skills
Clients learn how to follow these recommendations by learning key concepts and the skills. Here are four rec-
ommendations restated in terms of the module’s key concepts:
Plain English Module Concepts
If you slip, quit early. Practice damage control.
When someone offers drugs, say no. Escape high-risk situations.
Don’t get into situations where you can’t say no. Avoid high-risk situations.
Do things that are fun and healthy. Seek healthy pleasures.
Concepts and Skills Associated With Each Recommendation
Practice damage control
Main point: If you slip and use drugs or alcohol again, stop early and get right back into treatment. This will
reduce damage to your health, relationships, and finances.
Concepts: Maintain recovery, slip versus full-blown relapse, risk reduction, abstinence violation effect, bounc-
ing back into treatment.
Skills: Leaving a drug-using situation despite some use; reporting a slip to a support person
Escape high-risk situations
Main point: Some situations make it very hard to avoid using drugs. Be prepared to escape from these situa-
tions without using drugs. Realize that it would be much better to avoid these situations in the first place.
Concepts: High-risk situations.
Skills: Refusing drugs from a pushy dealer; refusing drugs offered by a friend.
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1. Doing a detailed functional analysis of the
relationships between substance use, Axis I
or II symptoms, and any reported criminal
conduct 
2. Evaluating the unique and common high-
risk factors for each problem and determin-
ing their interrelationships
3. Assessing both cognitive and behavioral cop-
ing skills deficits 
4. Implementing both cognitive and behavioral
coping skills training tailored to meet the
specific needs of an individual client with
respect to all three target behaviors (i.e.,
substance use, symptoms of mental disor-
der, and criminal conduct)
Overview of SAMM Concepts and Skills (continued)
Avoid high-risk situations
Main point: Avoid high-risk situations by learning to recognize the warning signs that you might be headed
toward drug use.
Concepts: Drug habit chain (trigger, craving, planning, getting, using), warning signs, U-turns, removing trig-
gers, riding the wave, money management, representative payee.
Skills: Getting an appointment with a busy person; reporting symptoms and side effects; getting a support 
person.
Seek healthy pleasures
Main point: You can avoid drugs by focusing on the things that are most important and enjoyable to you. Do
things that are fun and healthy.
Concepts: Healthy pleasures, healthy habits, activities schedule.
Skills: Getting someone to join you in a healthy pleasure; negotiating with a representative payee.
Additional Recommendations and Concepts
Understand how you learned to use drugs.
Main point: Drug abuse is learned and can be unlearned.
Concepts: Habits, reinforcement, craving, conditioning, extinction, riding the wave.
Know why you decided to quit.
Main point: Make sure you can always remember why you decided to quit using drugs.
Concepts: Advantages and disadvantages of using drugs and of not using drugs.
Carry an emergency card.
Main point: Make an emergency card that contains vital information and reminders about how and why to
avoid drugs. Carry it with you at all times.
Concepts: Support person, coping skills, why quit.
Source: Adapted from Roberts et al. 1999 (used with permission).
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Summary of RP strategies for
clients with COD
Daley and Lis (1995) summarize RP strategies
that can be adapted for clients with COD, some
of which are listed below:
•Regardless of the client’s motivational level or
recovery stage, relapse education should be
provided and related to the individual’s men-
tal disorder. The latter is important, particu-
larly because the pattern typically followed
by clients with COD begins with an increase
in substance use leading to lowered efficacy
or discontinuation of psychiatric medication,
or missed counseling sessions. As a conse-
quence, symptoms of mental disorders reap-
pear or worsen, the client’s tendency to self-
medicate through substance use is exacerbat-
ed, and the downward spiral is perpetuated.
•Clients with COD need effective strategies to
cope with pressures to discontinue their pre-
scribed psychiatric medication. One such
strategy simply is to prepare clients for exter-
nal pressure from other people to stop taking
their medications. Rehearsing circumstances
in which this type of pressure is applied,
along with anticipating the possibility,
enables clients with COD to react appropri-
ately. Reinforcing the difference between
substances of abuse—getting “high”—and
taking psychiatric medication to treat an ill-
ness is another simple but effective strategy.
•An integral component of recovery is the use
of mutual self-help and dual recovery groups
to provide the support and understanding of
shared experience. To maximize the effective-
ness of their participation, clients with COD
usually need help with social skills (listening,
self-disclosure, expressing feelings/desires,
and addressing conflict).
Clients can use daily self-ratings of persistent
psychiatric symptoms to monitor their status.
Use of the daily inventory and symptom review
should be encouraged to help clients with COD
to track changes and take action before deteri-
orating status becomes critical. See the text 
box on p. 134 for a case study applying RP
strategies.
Use Repetition and Skills-
Building To Address Deficits in
Functioning
In applying the approaches described above,
keep in mind that clients with COD often have
cognitive limitations, including difficulty con-
centrating. Sometimes these limitations are
transient and improve during the first several
weeks of treatment; at other times, symptoms
persist for long periods. In some cases, individ-
uals with specific disorders (schizophrenia,
attention deficit disorder) may manifest these
symptoms as part of their disorder. 
General treatment strategies to address cogni-
tive limitations in clients include being more
concrete and less abstract in communicating
ideas, using simpler concepts, having briefer
discussions, and repeating the core concepts
many times. In addition, individuals often
learn and remember better if information is
presented in multiple formats (verbally; visual-
ly; or affectively through stories, music, and
experiential activities). Role-playing real-life
situations also is a useful technique when work-
ing with clients with cognitive limitations. For
example, a client might be assigned to practice
“asking for help” phone calls using a prepared
script. This can be done individually with the
counselor coaching, or in a group, to obtain
feedback from the members.
When compared to individuals without addi-
tional disorders or disabilities, persons with
COD and additional deficits often will require
more substance abuse treatment in order to
attain and maintain abstinence. A primary
reason for this is that abstinence requires the
development and utilization of a set of recov-
ery skills, and persons with mental disorders
often have a harder time learning new skills.
They may require more support in smaller
steps with more practice, rehearsal, and repe-
tition. The challenge is not to provide more
intensive or more complicated treatment for
clients with COD, but rather to tailor the pro-
cess of acquiring new skills to the needs and
abilities of the client.
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Case Study: Preventing Relapse in a Client With COD
Stan Z. is a 32-year-old with diagnoses of recurrent major depression, antisocial personality disorder,
crack/cocaine dependence, and polysubstance abuse. He has a 15-year history of addiction, including a 2-year
history of crack addiction. Stan Z. has been in a variety of psychiatric and substance abuse treatment pro-
grams during the past 10 years. His longest clean time has been 14 months. He has been attending a dual-diag-
nosis outpatient clinic for the past 9 months and going to Narcotics Anonymous (NA) meetings off and on for
several years. Stan Z. has been clean from all substances for 7 months. Following is a list of high-risk relapse
factors and coping strategies identified by Stan Z. and his counselor:
High-Risk Factor 1
Stan Z. is tired and bored “with just working, staying at home and watching TV, or going to NA meetings.”
Recently, he has been thinking about how much he “misses the action of the good old days” of hanging with
old friends and does not think he has enough things to do that are interesting.
Possible coping strategies for Stan Z. include the following: (1) remind him of problems caused by hanging
out with people who use drugs and using drugs by writing out a specific list of problems associated with
addiction; (2) challenge the notion of the “good old days” by looking closely at the “bad” aspects of those
days; (3) remind him of how far he has come in his recent recovery, especially being able to get and keep a
job, maintain a relationship with one woman, and stay out of trouble with the law; (4) discuss current feel-
ings and struggles with an NA sponsor and NA friends to find out how they handled similar feelings and
thoughts; and (5) make a list of activities that will not threaten recovery and can provide a sense of fun and
excitement and plan to start active involvement in one of these activities.
High-Risk Factor 2
Stan Z. is getting bored with his relationship with his girlfriend. He feels she is too much of a “home body”
and wants more excitement in his relationship with her. He also is having increased thoughts of having sex
with other women.
Possible coping strategies for Stan Z. include the following: (1) explore in therapy sessions why he is really
feeling bored with his girlfriend, noting he has a long-standing pattern of dumping girlfriends after just a
few months; (2) challenge his belief that the problem is mainly his girlfriend so that he sees how his atti-
tudes and beliefs play a role in this problem; (3) talk directly with his girlfriend in a nonblaming fashion
about his desire to work together to find ways to instill more excitement in the relationship; (4) remind him
of potential dangers of casual sex with a woman he does not know very well and that he cannot reach his
goal of maintaining a meaningful, mutual relationship if he gets involved sexually with another woman. His
past history is concrete proof that such involvement always leads to sabotaging his primary relationship.
High-Risk Factor 3
Stan Z. wants to stop taking antidepressant medications. His mood has been good for several months and
he does not see the need to continue medications.
Possible coping strategies include the following: (1) discuss his concern about medications with his coun-
selor and psychiatrist before making a final decision; (2) review with his treatment team the reasons for
being on antidepressant medications; (3) remind him that because he had several episodes of depression,
even during times when he has been drug-free for a long period, medication can help “prevent” the likeli-
hood of a future episode of depression.
Source: Daley and Lis 1995, pp. 255–256.
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Facilitate Client Participation
in Mutual Self-Help Groups
Just as the strategies discussed in this chapter
have proven helpful both to clients who have
only substance use disorders as well as to those
with COD, so the use of mutual self-help
groups is a key tool for the clinician in assisting
both categories of clients. In addition to tradi-
tional 12-Step groups, dual recovery mutual
self-help approaches are becoming increasingly
common in most large communities. The clini-
cian plays an important role in helping clients
with COD access appropriate mutual self-help
resources and benefit from them. (See chapter
7 for an extended presentation of Dual
Recovery Mutual Self-Help approaches tai-
lored to meet the needs of persons with COD.)
Groups for those who do not speak English
may not be available, and the clinician is
advised to seek resources in other counties or,
if the number of clients warrants it, to initiate
organization of a group for those who speak the
same non-English language. 
The clinician can assist the client by:
•Helping the client locate an appropriate
group. The clinician should strive to be
aware not only of what local 12-Step and
other dual recovery mutual self-help 
groups meet in the community, but also
which 12-Step groups are known to be
friendly to clients with COD, have other
members with COD, or are designed specifi-
cally for people with COD. Clinicians do
this by visiting groups to see how they are
conducted, collaborating with colleagues to
discuss groups in the area, updating their
own lists of groups periodically, and gather-
ing information from clients. The clinician
should ensure that the group the client
attends is a good fit for the client in terms
of the age, gender, and cultural factors of
the other members. In some communities,
alternatives to 12-Step groups are available,
such as Secular Organizations for Sobriety.
•Helping the client find a sponsor, ideally
one who also has COD and is at a later
stage of recovery. Knowing that he or she
has a sponsor who truly understands the
impact of two or more disorders will be
encouraging for the client. Also, some
clients may “put people off” in a group and
have particular difficulty finding a sponsor
without the clinician’s support.
•Helping the client prepare to participate
appropriately in the group. Some clients,
particularly those with serious mental ill-
ness or anxiety about group participation,
may need to have the group process
explained ahead of time. Clients should be
told the structure of a meeting, expectations
of sharing, and how to participate in the
closing exercises, which may include hold-
ing hands and repeating sayings or prayers.
They may need to rehearse the kinds of
things that are and are not appropriate to
share at such meetings. Clients also should
be taught how to “pass” and when this
would be appropriate. The counselor
should be familiar enough with group func-
tion and dynamics to actually “walk the
Case Study: Using Repetition and Skills Building With a 
Client With COD
In individual counseling sessions with Susan H., a 34-year-old Caucasian woman with bipolar disorder and
alcohol dependence, the counselor observes that often she is forgetful about details of her recent past,
including what has been said and agreed to in therapy. Conclusions the counselor thought were clear in one
session seem to be fuzzy by the next. The counselor begins to start sessions with a brief review of the last ses-
sion. He also allows time at the end of each session to review what has just happened. As Susan H. is having
difficulty remembering appointment times and other responsibilities, he helps her devise a system of
reminders in big letters on her refrigerator.
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client” through the meeting before attend-
ing. 
•Helping overcome barriers to group partici-
pation. The clinician should be aware of the
genuine difficulties a client may have in
connecting with a group. While clients with
COD, like any others, may have some resis-
tance to change, they also may have legiti-
mate barriers they cannot remove alone.
For example, a client with cognitive difficul-
ties may need help working out how he or
she can physically get to the meeting. The
counselor may need to write down very
detailed instructions for this person that
another client would not need (e.g., “Catch
the number 9 bus on the other side of the
street from the treatment center, get off at
Main Street, and walk three blocks to the
left to the white church. Walk in at the
basement entrance and go to Room 5.”)
•Debriefing with the client after he or she
has attended a meeting to help process his
or her reactions and prepare for future
attendance. The clinician’s work does not
end with referral to a mutual self-help
group. The clinician must be prepared to
help the client overcome any obstacles after
attending the first group to ensure engage-
ment in the group. Often this involves a dis-
cussion of the client’s reaction to the group
and a clarification of how he or she can
participate in future groups.
Case Study: Helping a Client Find a Sponsor
Linda C. had attended her 12-Step group for about 3 months, and although she knew she should ask someone
to sponsor her, she was shy and afraid of rejection. She had identified a few women who might be good spon-
sors, but each week in therapy she stated that she was afraid to reach out, and no one had approached her,
although the group members seemed “friendly enough.” The therapist suggested that Linda C. “share” at a
meeting, simply stating that she’d like a sponsor but was feeling shy and didn’t want to be rejected. The ther-
apist and Linda C. role-played together in a session, and the therapist reminded Linda C. that it was okay to
feel afraid and if she couldn’t share at the next meeting, they would talk about what stopped her. 
After the next meeting, Linda C. related that she almost “shared” but got scared at the last minute, and
was feeling bad that she had missed an opportunity. They talked about getting it over with, and Linda C.
resolved to reach out, starting her sharing statement with, “It’s hard for me to talk in public, but I want
to work this program, so I’m going to tell you all that I know it’s time to get a sponsor.” This therapy
work helped Linda C. to put her need out to the group, and the response from group members was helpful
to Linda C., with several women offering to meet with her to talk about sponsorship. This experience also
helped Linda C. to become more attached to the group and to learn a new skill for seeking help. While
Linda C. was helped by counseling strategies alone, others with “social phobia” also may need antidepres-
sant medications in addition to counseling.
6 Traditional Settings
and Models
In This
Chapter…
Essential
Programming for
Clients With COD
Outpatient
Substance Abuse
Treatment
Programs for
Clients With COD
Residential
Substance Abuse
Treatment
Programs for
Clients With COD
Overview
What happens to clients with co-occurring disorders (COD) who enter
traditional substance abuse settings? How can programs provide the best
possible services to these people?
This chapter adopts a program perspective to examine both outpatient
and residential settings, highlighting promising treatment models that
have emerged both within the substance abuse field and elsewhere. It
also discusses the various treatment approaches and models available to
those working in substance abuse settings.
The chapter opens with a review of the seven essential programming ele-
ments in COD programming for substance abuse treatment agencies that
treat clients with COD: (1) screening, assessment, and referral; (2) men-
tal and physical health consultation; (3) the use of a prescribing onsite
psychiatrist; (4) medication and medication monitoring; (5) psychoedu-
cational classes; (6) onsite double trouble groups; and (7) offsite dual
recovery mutual self-help groups. These elements are applicable in both
residential and outpatient programs. This section of the chapter also dis-
cusses general considerations in treatment of clients with COD.
Essential background related to outpatient care for this population,
including available data on its effectiveness, follows the discussion of
essential programming. The chapter then turns to an overview of the
critical factors in the successful design, implementation, evaluation, and
maintenance of effective outpatient programs for clients with COD. Two
examples of successful outpatient programs are highlighted: the
Clackamas County Mental Health Center of Oregon City, Oregon, an
outpatient substance abuse and mental health treatment center; and the
Arapahoe House of Denver, Colorado, which is the State’s largest
provider of substance abuse treatment services. These are intended to
“prime the pump” for readers considering the addition of new program
elements to serve clients with COD. The section closes with an explo-
ration of two specialized outpatient models for clients with co-occurring
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substance use and serious mental disorders,
Assertive Community Treatment and Intensive
Case Management. 
A discussion of residential substance abuse
treatment programs for clients with COD com-
pletes the chapter. Like the discussion of outpa-
tient care, this section describes the back-
ground and effectiveness of residential care for
the COD population, the key issues that arise
in program design and implementation, and the
challenges of evaluating and sustaining residen-
tial programs. Modified therapeutic communi-
ties (MTCs)—forms of residential care particu-
larly well suited to clients with COD—are
described in detail. The chapter closes with a
presentation of two other residential models:
Gaudenzia, Inc., located in Norristown,
Pennsylvania, which uses an MTC to provide
care for its clients, the majority of whom have
serious mental illness, and the Na’nizhoozi
Center, Inc., located in the rural community of
Gallup, New Mexico, a program that uses a
range of culturally appropriate interventions to
meet the needs of its predominantly American-
Indian clients. 
Essential Programming
for Clients With COD
Individuals with COD are found in all addic-
tion treatment settings, at every level of care.
Although some of these individuals have serious
mental illness and/or are unstable or disabled,
many of them have relatively stable disorders
of mild to moderate severity. As substance
abuse treatment programs serve the increasing
number of clients with COD, the essential pro-
gram elements required to meet their needs
must be defined clearly and set in place.
Program components described in this section
should be developed by any substance abuse
treatment program seeking to provide integrat-
ed substance abuse and mental health services
to clients with COD (that is, to attain the level
of capacity associated with the “COD capable”
classification defined in chapter 2). These ele-
ments have been culled from a variety of
strategies, approaches, and models described
in the TIP and from consensus panel discussion
of current clinical programming. The panel
believes these elements constitute the best prac-
tices currently available for designing COD
programs in substance abuse treatment agen-
cies. A detailed discussion of these elements
appears in chapter 1. What follows are pro-
gram considerations for implementing these
essential components.
Screening, Assessment, and
Referral
All substance abuse treatment programs should
have in place appropriate procedures for
screening, assessing, and referring clients with
COD. It is the responsibility of each provider
to be able to identify clients with both mental
and substance use disorders and ensure that
they have access to the care needed for each
disorder. For a detailed discussion, see chapter
4. If the screening and assessment process
establishes a substance abuse or mental disor-
der beyond the capacity and resources of the
agency, referral should be made to a suitable
residential or mental health facility, or other
community resource. Mechanisms for ongoing
consultation and collaboration are needed to
ensure that the referral is suitable to the treat-
ment needs of persons with COD.
Physical and Mental Health
Consultation
Any substance abuse treatment program that
serves a significant number of clients with COD
would do well to expand standard staffing to
include mental health specialists and to incor-
porate consultation (for assessment, diagnosis,
and medication) into treatment services.
Adding a master’s level clinical specialist with
strong diagnostic skills and expertise in work-
ing with clients with COD can strengthen an
agency’s ability to provide services for these
clients. These staff members could function as
consultants to the rest of the team on matters
related to mental disorders, in addition to
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being the liaison for a mental health consultant
and provision of direct services.
A psychiatrist provides services crucial to sus-
taining recovery and stable functioning for peo-
ple with COD: assessment, diagnosis, periodic
reassessment, medication, and rapid response
to crises. (See the section below on the advan-
tages of having a psychiatrist on staff as part of
the treatment team.) If lack of funding pre-
vents the substance abuse treatment agency
from hiring a consultant psychiatrist, the agen-
cy could establish a collaborative relationship
with a mental health agency to provide those
services. A memorandum of agreement formal-
izes this arrangement and ensures the availabil-
ity of a comprehensive service package for
clients with COD. Such arrangements are used
widely in the field, and examples of “best prac-
tices” are available (Ridgely et al. 1998;
Treatment of Persons 2000).
Prescribing Onsite Psychiatrist
Adding an onsite psychiatrist in an addiction
treatment setting to evaluate and prescribe
medication for clients with COD has been
shown to improve treatment retention and
decrease substance use (Charney et al. 2001;
Saxon and Calsyn 1995). The onsite psychia-
trist brings diagnostic, medication, and psychi-
atric counseling services directly to the location
clients are based for the major part of their
treatment. This approach often is the most
effective way to overcome barriers presented
by offsite referral, including distance and trav-
el limitations, the inconvenience of enrolling in
another agency and of the separation of clinical
services (more “red tape”), fears of being seen
as “mentally ill” (if referred to a mental health
agency), cost, and the difficulty of becoming
comfortable with different staff.
The consensus panel is aware that the cost of
an onsite psychiatrist is a concern for many
programs. Many agencies that use the onsite
psychiatrist model find that they can afford to
hire a psychiatrist part-time, even 4 to 16
hours per week, and that a significant number
of clients can be seen that way. A certain
amount of that cost can be billed to Medicaid,
Medicare, insurance agencies, or other fun-
ders. For larger agencies, the psychiatrist may
be full time or share a full-time position with a
nurse practitioner. The psychiatrist also can be
employed concurrently by the local mental
health program, an arrangement that helps to
facilitate access to such other mental health
services as intensive outpatient treatment, psy-
chosocial programs, and even inpatient psychi-
atric care if needed. Studies describing this
model more fully and including outcome data
include Saxon and Calsyn (1995) and Charney
and colleagues
(2001). The
approach also has
been shown to be
cost effective in a
large health mainte-
nance organization
(Weisner et al.
2001).
Some substance
abuse programs may
be reluctant to hire
a psychiatrist or to
provide psychiatric
services. This issue
can be resolved
through agencywide
discussions of the
types of clients with
COD seen by the
agencies, how their
services are coordi-
nated, and the bar-
riers clients experi-
ence to receiving all
the elements of COD
treatment. In many cases, the largest and most
obviously missing elements of good, integrated,
onsite COD treatment are mental disorder
diagnosis and treatment. It also should be
noted that an onsite psychiatrist fosters the
development of substance abuse treatment
staff, enhancing their comfort and skill in
assisting clients with COD. The psychiatrist
may be able upgrade counselors’ skills through
seminars on medication management and other
An onsite psy-
chiatrist fosters
the development
of substance
abuse treatment
staff, enhancing
their comfort
and skill in
assisting clients
with COD.
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pertinent topics. Also, the psychiatrist usually
attends the weekly meeting of the clinical team,
helping to develop effective treatment plans for
active cases of clients with COD. For many psy-
chiatrists, this arrangement also affords a wel-
come opportunity for further exposure to sub-
stance abuse treatment. 
Ideally, agencies should hire a psychiatrist
with substance abuse treatment expertise to
work onsite at the substance abuse treatment
agency. Finding psychiatrists with this back-
ground may present a challenge. Psychiatrists
certified by the American Society of
Addiction Medicine (ASAM), the American
Academy of Addiction Psychiatry, or the
American Osteopathic Association (for osteo-
pathic physicians) are good choices. They can
provide leadership, advocacy, development,
and consultation for substance abuse staff.
Historically, however, substance abuse educa-
tion in medical schools and residencies has
received little attention, though promising
efforts on multiple levels are working to
ensure that all physicians receive at least a
basic knowledge of substance use disorders.
Thus, learning usually flows both ways, to the
benefit of the client. When recruiting a psy-
chiatrist, the substance abuse treatment pro-
gram should discuss key issues around this bi-
directional flow of clinical information and
knowledge. In addition, a discussion of pre-
scribing guidelines (such as those included in
appendix F) is in order.
The prescribing onsite psychiatrist model is a
useful and recommended step that substance
abuse treatment agencies can take to provide
integrated COD treatment services. A detailed
manual is needed to help agencies install this
model and to guide the participating psychia-
trists to provide the best services within the
model. Further research is needed to docu-
ment cost offsets for implementing the model
and gauge its clinical effectiveness in a variety
of substance abuse treatment settings.
Medication and Medication
Monitoring
Many clients with COD require medication to
control their psychiatric symptoms and to sta-
bilize their psychiatric status. The importance
of stabilizing the client with COD on psychi-
atric medication when indicated is now well
established in the substance abuse treatment
field. (See appendix F for a comprehensive
description of the role of medication and the
available medications.) One important role of
the psychiatrist working in a substance abuse
treatment setting is to provide psychiatric med-
ication based on the assessment and diagnosis
of the client, with subsequent regular contact
and review of medication. These activities
include careful monitoring and review of medi-
cation adherence.
Psychoeducational Classes
Substance abuse treatment programs can help
their clients with COD by offering psychoedu-
cational classes such as those described below.
Mental and substance use
disorders
Psychoeducational classes on mental and sub-
stance use disorders are important elements in
basic COD programs. These classes typically
focus on the signs and symptoms of mental dis-
orders, medication, and the effects of mental
disorders on substance abuse problems.
Psychoeducational classes of this kind increase
client awareness of their specific problems and
do so in a safe and positive context. Most
important, however, is that education about
mental disorders be open and generally avail-
able within substance abuse treatment pro-
grams. Information should be presented in a
factual manner, similar to the presentation of
information on sexually transmitted diseases
(STDs). Some mental health clinics have pre-
pared synopses of mental illnesses for clients in
terms that are factual but unlikely to cause dis-
tress. A range of literature written for the
layperson also is available through government
141Traditional Settings and Models
agencies and advocacy groups (see appendix I).
This material provides useful background
information for the substance abuse treatment
counselor as well as for the client.
Relapse prevention
Programs also can adopt strategies designed to
help clients become aware of cues or “triggers”
that make them more likely to abuse substances
and help them develop alternative coping
responses to those cues. Some providers suggest
the use of “mood logs” that clients can use to
increase their consciousness of the situational
factors that underlie the urge to use or drink.
These logs help answer the question, “When I
have an urge to drink or use, what is happen-
ing?” Similarly, basic treatment agencies can
offer clients training on recognizing cues for the
return of psychiatric symptoms and for affect
or emotion management, including how to 
identify, contain, and express feelings 
appropriately. 
Double Trouble Groups
(Onsite)
Onsite groups such as “Double Trouble” pro-
vide a forum for discussion of the interrelated
problems of mental disorders and substance
abuse, helping participants to identify triggers
for relapse. Clients describe their
psychiatric symptoms (e.g., hear-
ing voices) and their urges to use
drugs. They are encouraged to
discuss, rather than to act on,
these impulses. Double Trouble
groups also can be used to moni-
tor medication adherence, psychi-
atric symptoms, substance use,
and adherence to scheduled activ-
ities. Double Trouble provides a
constant framework for assess-
ment, analysis, and planning.
Through participation, the indi-
vidual with COD develops per-
spective on the interrelated
nature of mental disorders and
substance abuse and becomes bet-
ter able to view his or her behavior within this
framework.
Dual Recovery Mutual Self-
Help Groups (Offsite)
Fortunately, a variety of dual recovery mutual
self-help groups exist in many communities.
Substance abuse treatment programs can refer
clients to dual recovery mutual self-help
groups, which are tailored to the special needs
of a variety of people with COD. These groups
provide a safe forum for discussion about med-
ication, mental health, and substance abuse
issues in an understanding, supportive environ-
ment wherein coping skills can be shared.
Chapter 7 contains a comprehensive descrip-
tion of this approach and a listing of organiza-
tions that provide such services. See also
appendix J, which provides a list of such pro-
grams, their characteristics, and contacts.
General Considerations for
Treatment
In addition to these seven essential elements of
COD programming, all treatment providers
would do well to develop specific approaches to
working with COD clients in groups and find
meaningful ways of including them in program
design. Since families can have a powerful
Advice to Administrators:
Recommendations for Providing
Essential Services for People With COD
Develop a COD Program with the following components:
1. Screening, assessment, and referral for persons with
COD
2. Physical and mental health consultation
3. Prescribing onsite psychiatrist
4. Medication and medication monitoring
5. Psychoeducational classes
6. Double trouble groups (onsite)
7. Dual recovery self-help groups (offsite)
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influence on a client’s recovery, it is especially
important to reach out to the families of per-
sons with COD and help them understand more
about COD and how they can best support the
client and help the person recover. 
Working in groups
Group therapy in substance abuse treatment
settings is regarded generally as a key feature
of substance abuse treatment. However, group
therapy should be augmented by individual
counseling since
individual contact is
important in helping
the client with COD
make maximum use
of group interven-
tions. 
Group therapy
should be modified
for clients with
COD. Generally, it
is best to reduce the
emotional intensity
of interpersonal
interaction in COD
group sessions;
issues that are non-
provocative to
clients without COD
may lead to reac-
tions in clients with
COD. Moreover,
because many
clients with COD often have difficulty staying
focused, their treatment groups usually need
stronger direction from staff than those for
clients who do not have COD. Typically, some
persons with COD have trouble sitting still,
while others may have trouble getting moving
at all (for instance, some people with depres-
sion); therefore, the duration of a group (and
other activities) should be shortened to less
than an hour, with the typical group or activity
running for no more than 40 minutes. Because
of the need for stability, the groups should run
regularly and without cancellation. 
Because many clients with COD have difficul-
ty in social settings, group sizes may need to
be smaller than is typical. There is benefit
even to allowing a few individuals to be con-
sidered a group, so long as sessions are
group-oriented and used as a means to intro-
duce the client to a larger group setting. It is
not uncommon for groups tailored to individ-
uals with COD to consist of between two and
four individuals in the early stages. Co-lead-
ers are especially important in these groups,
as one leader may need to leave the group
with one member, while the group continues
with the co-leader. With appropriate staff
guidance, peers who have completed the pro-
gram or advanced to its latter stages can
sometimes be used as group cofacilitators.
Considerable tolerance is needed for varied
(and variable) levels of participation depend-
ing on the client’s level of functioning, stabili-
ty of symptoms, response to medication, and
mental status. Many clients with serious men-
tal illness (e.g., those with a diagnosis of
schizophrenia, schizoid and paranoid person-
ality) may not fit well in groups and must be
incorporated gradually at their own pace and
to the degree they are able to participate.
Even minimal or inappropriate participation
can be viewed as positive in a given case or
circumstance. Verbal communication from
group leaders should be brief, simple, con-
crete, and repetitive. This is especially impor-
tant to reach clients with cognitive and func-
tional impairments. Affirmation of accom-
plishments should be emphasized over disap-
proval or sanctions. Negative behavior should
be amended rapidly with a positive learning
experience designed to teach the client a cor-
rect response to a situation. In general, group
leaders will need to be sensitive and respon-
sive to needs of the client with COD and the
addition of special training can enhance his
or her competency. TIP 41, Substance Abuse
Treatment: Group Therapy (Center for
Substance Abuse Treatment [CSAT] 2005)
contains more information on the techniques
and types of groups used in substance abuse
treatment. 
It is not uncom-
mon for groups
tailored to indi-
viduals with
COD to consist
of between two
and four indi-
viduals in the
early stages.
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Involving clients in treatment
and program design
Because clients can provide important guidance
relative to their treatment and valuable feed-
back on program design and effectiveness, they
should be involved in program discussions.
Some guidelines for involving client/consumers
include:
•Form a Consumer Advisory Group.
•Include both current clients from the pro-
gram and past clients.
•Elect a client representative to discuss client
concerns with staff.
•Provide a staff liaison to help coordinate
client meetings and to provide a continuing
link to staff.
•Hold regular meetings and phone confer-
ences.
•Provide incentives to clients for participa-
tion.
•Solicit input on a variety of matters and in an
ongoing way.
•Involve clients in meaningful projects.
•When client input is solicited and received,
consider it respectfully, respond appropriate-
ly, and give the client feedback on your
response. 
Family education
It is important that family members and signifi-
cant others who are close to the client receive
information on mental disorders and substance
abuse, as well as on how the disorders interact
with one another. Particularly in cultures that
value interdependence and are community-
and/or family-oriented, a family and communi-
ty education and support group can be helpful.
In an effort to build or maintain support for
the client and his treatment, family members
and significant others need to understand the
implications of having COD and the treatment
options available to the client. Programs must
provide this instruction in an interactive style
that allows questions, not in a lecture mode.
The essentials of this information include:
• The name of the disorder
• Its symptoms 
• Its prevalence
• Its cause
• How it interacts with substance abuse—that
is, the implications of having both disorders
• Treatment options and considerations in
choosing the best treatment
• The likely course of the illness 
• What to expect
• Programs, resources, and individuals who
can be helpful
Outpatient Substance
Abuse Treatment
Programs for Clients
With COD
Background and Effectiveness
Treatment for substance abuse occurs most
frequently in outpatient settings—a term that
subsumes a wide variety of disparate pro-
grams (Simpson et al. 1997b). Some offer sev-
eral hours of treatment each week, which can
include mental health and other support ser-
vices as well as individual and group counsel-
ing for substance abuse; others provide mini-
mal services, such as only one or two brief
sessions to give clients information and refer
them elsewhere (Etheridge et al. 1997). Some
agencies offer outpatient programs that pro-
vide services several hours per day and sever-
al days per week, thus meeting ASAM’s crite-
ria for Intensive Outpatient Programs.
Typically, treatment includes individual and
group counseling, with referrals to appropri-
ate community services. Until recently, there
were few specialized approaches for people
with COD in outpatient substance abuse
treatment settings. One of many small excep-
tions was a methadone maintenance program
that also made psychiatrists and mental
health services available to its clients (Woody
et al. 1983).
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Deinstitutionalization and other factors are
increasing the prevalence of persons with
COD in outpatient programs. Many of these
individuals have multiple health and social
problems that complicate their treatment.
Evidence from prior studies indicates that a
mental disorder often makes effective treat-
ment for substance use more difficult (Mueser
et al. 2000; National Association of State
Mental Health Program Directors and
National Association of State Alcohol and
Drug Abuse Directors 1999). Because outpa-
tient treatment programs are available widely
and serve the greatest number of clients
(Committee on Opportunities in Drug Abuse
Research 1996; Lamb et al. 1998), using cur-
rent best practices from the substance abuse
treatment and mental health services fields is
vital. Doing so enables these programs to use
the best available treatment models to reach
the greatest possible number of persons with
COD.
Prevalence
COD is clearly a defining characteristic com-
monly found in clients who enter substance
abuse treatment. A Drug Abuse Treatment
Outcome Study (DATOS) of 99 treatment pro-
grams in 11 U.S. metropolitan areas between
1991 and 1993 found the following distribu-
tion of co-occurring mental disorders: 39.3
percent met DSM-III-R (Diagnostic and
Statistical Manual of Mental Disorders, 3rd
edition, revised [American Psychiatric
Association 1987]) diagnostic criteria for anti-
social personality disorder, 11.7 percent met
criteria for a major depressive episode, and
about 3.7 percent met criteria for a general
anxiety disorder (Flynn et al. 1996) (see also
Figure 1-2 in chapter 1). DATOS and other
data indicate that substance abuse programs
can expect a substantial proportion of the
clientele to have COD.
Empirical evidence of effec-
tiveness 
Evidence suggests that outpatient treatment
can lead to positive outcomes for certain
clients with COD, even when treatment is not
tailored specifically to their needs. Outpatient
substance abuse treatment programs can be
effective settings for treating substance abuse
in clients with less serious mental disorders.
This conclusion is supported by evidence
from the most current and comprehensive
database on substance abuse treatment, the
DATOS dataset (Flynn et al. 1997).
Clients who were in outpatient treatment,
including individual and group counseling
and mutual self-help groups, showed reduc-
tions in drug use after treatment. Clients with
3 months or more of outpatient treatment
reported even lower rates of drug use com-
pared to their rate of use prior to treatment
(Hubbard et al. 1997; Simpson et al. 1997a).
These data show that substance abuse treat-
ment outpatient programs can help clients,
many with COD, who remain in treatment at
least 3 months. However, modifications
designed to address issues faced even by those
with less serious mental disorders can
enhance treatment effectiveness and in some
instances are essential. 
Designing Outpatient
Programs for Clients With
COD
The population of persons with COD is het-
erogeneous in terms of motivation for treat-
ment, nature and severity of substance use
disorder (e.g., drug of choice, abuse versus
dependence, polysubstance abuse), and
nature and severity of mental disorder. For
the most part, however, clients with COD in
outpatient treatment have less serious and
more stabilized mental and substance abuse
problems compared to those in residential
treatment (Simpson et al. 1999).
145Traditional Settings and Models
Outpatient treatment can be the primary
treatment or can provide continuing care for
clients subsequent to residential treatment,
which implies a degree of flexibility in the
activities/interventions and the intensity of
the treatment approaches. However, reports
from clinical administrators indicate that an
increasing number of clients with serious
mental illness (SMI) and substance abuse
problems are entering the outpatient sub-
stance abuse treatment system. Treatment
failures occur with both people with SMI and
those with less serious mental illness for sev-
eral reasons, but among the most important
are that programs lack the resources to pro-
vide the time for mental health services and
medications that, in all likelihood, significant-
ly would improve recovery rates and recovery
time.
If lack of funding prevents the full integration
of mental health assessment and medication
services within a substance abuse treatment
agency that provides outpatient services,
establishing a collaborative relationship with
a mental health agency (through the mecha-
nism of a memorandum of agreement) would
ensure that the services for the clients with
COD are adequate and comprehensive. In
addition, modifications are needed both to
the design of treatment interventions and to
the training of staff to ensure implementation
of interventions appropriate to the needs of
the client with COD.
To meet the needs of specific populations
among persons with COD, the consensus
panel encourages outpatient treatment pro-
grams to develop special services for popula-
tions that are represented in significant num-
bers in their programs. Examples include
women, women with dependent children,
homeless individuals and families, racial and
ethnic minorities, and those with health prob-
lems such as HIV/AIDS. Several substance
abuse treatment agencies have already devel-
oped programs for specialized subpopula-
tions. Two such programs—the Clackamas
County Mental Health Center (women, crimi-
nal justice, young adults) and Arapahoe
House (women with children, homeless per-
sons)—are described later in this chapter.
Since the types of co-occurring disorder will
vary according to the subpopulation targeted,
each of these programs must deal with COD
in a somewhat different manner, often by
adding other treatment components for COD
to existing program models.
Screening and assessment 
As chapter 4 provides a full discussion of
assessment, this
section will address
only those screen-
ing and assessment
issues of concern in
outpatient settings
or that deserve
reiteration in this
specific context.
Screening and
assessment are used
to make two essen-
tial decisions:
1. Is the individual
stable enough to
remain in an
outpatient set-
ting, or is more
intense care indi-
cated, warrant-
ing rapid refer-
ral to an appro-
priate alterna-
tive treatment? 
2. What services
will the client need?
To answer either question, staff must first
determine the scope of the client’s problems,
including his physical and mental status, living
situation, and the support he has available to
face these problems. Whereas screening
requires basic counseling skills, the consensus
panel recommends that only specially trained
or highly capable staff should perform assess-
A centralized
intake team is a
useful approach
to screening and
assessment, pro-
viding a com-
mon point of
entry for many
clients entering
treatment.
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ments—not, as is too often the case, less experi-
enced personnel.
A thorough assessment should establish the
client’s mental and physical status. The pro-
cess should determine any preexisting medical
conditions or complications, substance use
history, level of cognitive functioning, pre-
scription drug needs, current mental status,
and mental health history.
Centralized intake
A centralized intake team is a useful
approach to screening and assessment, pro-
viding a common point of entry for many
clients entering treatment. When applied in
an agency with multiple programs, central-
ized intake reduces duplication of referral
materials as well as assessment services. At
Arapahoe House (a model described later in
this chapter), the information and access
team manages hundreds of telephone calls
weekly, conducts screenings, and sets
appointments for admission to any of the pro-
grams within the agency, with the exception of
three detoxification programs. Where central-
ized intake serves a multi-modality treatment
organization or a community with multiple
settings (the latter being especially difficult),
the intake process can be used to refer clients
to the treatment modality most appropriate to
their needs (e.g., residential or outpatient), so
long as careful attention is paid to the accu-
rate coordination of intake information.
Reassessment
Once admitted to treatment, clients need regu-
lar reassessment as reductions in acute symp-
toms of mental distress and substance abuse
may precipitate other changes. Periodic assess-
ment will provide measures of client change
and enable the provider to adjust service plans
as the client progresses through treatment.
Referral and placement
Careful assessment will help to identify those
clients who require more secure inpatient
treatment settings (e.g., clients who are
actively suicidal or homicidal), as well as
those who require 24-hour medical monitor-
ing, those who need detoxification, and those
with serious substance use disorders who may
require a period of abstinence or reduced use
before they can engage actively in all treat-
ment components. TIP 29, Substance Use
Disorder Treatment for People With Physical
and Cognitive Disabilities (CSAT 1998e), con-
tains information on assessing physical and
cognitive functioning that is relevant for all
populations.
It is important to view the client’s placement
in outpatient care in the context of continuity
of care and the network of available
providers and programs. Outpatient treat-
ment programs may serve a variety of func-
tions, including outreach/engagement, prima-
ry treatment, and continuing care. Ideally, a
full range of outpatient substance abuse treat-
ment programs would include interventions
for unmotivated, disaffiliated clients with
COD, as well as for those seeking abstinence-
based primary treatments and those requiring
continuity of supports to sustain recovery.
Likewise, ideal outpatient programs will facil-
itate access to services through rapid
response to all agency and self-referral con-
tacts, imposing few exclusionary criteria, and
using some client/treatment matching criteria
to ensure that all referrals can be engaged in
some level of treatment. In those instances
where funding for treatment is controlled by
managed care, additional levels of control
over admission may be imposed on the treat-
ment agency. The consensus panel has men-
tioned that treatment providers should be
careful not to place clients in a higher level of
care (i.e., more intense) than is necessary. A
client who might remain engaged in a less
intense treatment environment may drop out
in response to the demands of a more intense
treatment program.
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Engagement 
Clients with COD, especially those opposed to
traditional treatment approaches and those
who do not accept that they have COD, have
particular difficulty committing to and main-
taining treatment. By providing continuous
outreach, engagement, direct assistance with
immediate life problems (e.g., housing), advo-
cacy, and close monitoring of individual
needs, the Assertive Community Treatment
(ACT) and Intensive Case Management (ICM)
models (described below) provide techniques
that enable clients to access services and fos-
ter the development of treatment relation-
ships. In the absence of such supports, those
individuals with COD who are not yet ready
for abstinence-oriented treatment may not
adhere to the treatment plan and may be at
high risk for dropout (Drake and Mueser
2000). 
Because clients with COD often have poor
treatment engagement, it is particularly
important that every effort be made to
employ methods with the best prospects for
increasing engagement. Daley and Zuckoff
(1998) note a number of useful strategies for
improving engagement and adherence with
this population.
Discharge planning 
Discharge planning is important to maintain
gains achieved through outpatient care. Clients
with COD leaving an outpatient substance
abuse treatment program have a number of
continuing care options. These options include
mutual self-help groups, relapse prevention
groups, continued individual counseling, men-
tal health services (especially important for
clients who will continue to require medica-
tion), as well as intensive case management
monitoring and supports. A carefully devel-
oped discharge plan, produced in collaboration
with the client, will identify and match client
needs with community resources, providing the
supports needed to sustain the progress
achieved in outpatient treatment.
Clients with COD often need a range of ser-
vices besides substance abuse treatment and
mental health services. Generally, prominent
needs include housing and case management
services to establish access to community
health and social services. In fact, these two
services should not be considered “ancillary,”
but key ingredients for clients’ successful
recovery. Without a place to live and some
degree of economic stability, clients with COD
are likely to return to substance abuse or
experience a return of symptoms of mental
disorder. Every substance abuse treatment
Improving Adherence of Clients With COD in 
Outpatient Settings
•Use telephone or mail reminders.
•Provide reinforcement for attendance (e.g., snacks, lunch, or reimbursement for transportation).
•Increase the frequency and intensity of the outpatient services offered.
•Develop closer collaboration between referring staff and the outpatient program’s staff.
•Reduce waiting times for outpatient appointments.
•Have outpatient programs designed particularly for clients with COD.
•Provide clients with case managers who engage in outreach and provide home visits.
•Coordinate treatment and monitoring with other systems of care providing services to the same client.
Source: Adapted from Daley and Zuckoff 1998.
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provider should have, and many do have, the
strongest possible linkages with community
resources that can help address these and
other client needs. Clients with COD often
will require a wide variety of services that
cannot be provided by a single program.
It is imperative that discharge planning for
the client with COD ensures continuity of psy-
chiatric assessment
and medication
management, with-
out which client
stability and recov-
ery will be severely
compromised.
Relapse prevention
interventions after
outpatient treat-
ment need to be
modified so that
the client can rec-
ognize symptoms of
psychiatric or sub-
stance abuse
relapse on her own
and can call on a
learned repertoire
of symptom man-
agement techniques
(e.g., self-monitor-
ing, reporting to a
“buddy,” and
group monitoring).
This also includes
the ability to access
assessment services
rapidly, since the return of psychiatric symp-
toms can often trigger substance abuse
relapse.
Developing positive peer networks is another
important facet of discharge planning for con-
tinuing care. The provider seeks to develop a
support network for the client that involves
family, community, recovery groups, friends,
and significant others. Where a client’s family
of origin is not healthy and supportive, other
networks can be accessed or developed that
will support him. Programs also should
encourage client participation in mutual self-
help groups, particularly those that focus on
COD (e.g., dual recovery mutual self-help
programs). These groups can provide a con-
tinuing supportive network for the client, who
usually can continue to participate in such
programs even if he moves to a different com-
munity. Therefore, these groups are an
important method of providing continuity of
care.
The consensus panel also recommends that
programs working with clients with COD try
to involve advocacy groups in program activi-
ties. These groups can help clients become
advocates themselves, furthering the 
development and responsiveness of the treat-
ment program while enhancing clients’ sense
of self-esteem and providing a source of 
affiliation.
Continuing care
Continuing care and relapse prevention are
especially important with this population,
since people with COD are experiencing two
long-term conditions (i.e., mental disorder
often is a cyclical, recurring illness; substance
abuse is likewise a condition subject to
relapse). Clients with COD often require long-
term continuity of care that supports their
progress, monitors their condition, and can
respond to a return to substance use or a
return of symptoms of mental disorder.
Continuing care is both a process of post-
treatment monitoring and a form of treatment
itself. (In the present context, the term “con-
tinuing care” is used to describe the treat-
ment options available to a client after 
leaving one program for another, less intense,
program.)
The relative seriousness of a client’s mental
and substance use disorders may be very dif-
ferent at the time she leaves a primary treat-
ment provider; thus, different levels of inter-
vention will be appropriate. After leaving an
outpatient program, some clients with COD
The provider
seeks to develop
a support net-
work for the
client that
involves family,
community,
recovery
groups, friends,
and significant
others.
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may need to continue intensive mental health
care but can manage their substance abuse
treatment by participation in mutual self-help
groups. Others may need minimal mental
health care but require some form of contin-
ued formal substance abuse treatment. For
people with SMI, continued treatment often is
warranted; a treatment program can provide
these clients with structure and varied ser-
vices not usually available from mutual self-
help groups. 
Upon leaving a program, clients with COD
always should be encouraged to return if they
need assistance with either disorder. Because
the status of these individuals can be fragile,
they need to be able to receive help or a
referral quickly in times of crisis. Regular
informal check-ins with clients also can help
alleviate potential problems before they
become serious enough to threaten recovery.
A good continuing care plan will include steps
for when and how to reconnect with services.
The plan and provision of these services also
makes readmission easier for clients with
COD who need to come back. The client with
COD should maintain contact postdischarge
(even if only by telephone or informal gather-
ings). Increasingly, substance abuse programs
are undertaking follow-up contact and peri-
odic groups to monitor client progress and
assess the need for further service.
Implementing Outpatient
Programs
The challenge of implementing outpatient
programs for COD is to incorporate specific
interventions for a particular subgroup of
outpatient clients into the structure of generic
services available for a typically heteroge-
neous population. Often this is best accom-
plished by establishing a separate track for
COD consisting of the services described in
the section on essential programming above.
Accomplishing this implies organizational
change as substance abuse and mental health
service agencies modify their mission to
address the special needs of persons with
COD. Note that the section on residential
treatment contains some additional principles
of implementation that are equally applicable
to outpatient programs.
Staffing
To accommodate clients with COD, standard
outpatient drug treatment staffing should
include both mental health specialists and
psychiatric consultation and access to onsite
or offsite psychopharmacologic consultation.
All treatment staff should have sufficient
understanding of the substance use and men-
tal disorders to implement the essential ele-
ments described above. Ideally, this staffing
pattern would include mental health clini-
cians with master’s level education, strong
diagnostic skills, and substantial experience
with clients with COD. These clinicians could
provide a link to psychiatric services as well
as to consultation on other clinical activities
within the program. It is important that the
staff function as an integrated team. Staff
cooperation can often be fostered by cross-
training, clinical team meetings and, most
importantly, a treatment culture that stresses
teamwork and collaboration. 
Training
An integrated model of treatment for clients
with COD requires that each member of the
treatment team has substantial competency in
both fields. Both mental health and substance
abuse treatment staff require training, cross-
training, and on-the-job training to meet ade-
quately the needs of clients with COD. Within
substance abuse treatment settings, this means
training in these areas:
•Recognizing and understanding the symptoms
of the various mental disorders
•Understanding the relationships between dif-
ferent mental symptoms, drugs of choice, and
treatment history 
•Individualizing and modifying approaches to
meet the needs of specific clients and achieve
treatment goals
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•Accessing services from multiple systems and
negotiating integrated treatment plans 
The addition of mental health staff into a sub-
stance abuse treatment setting also raises the
need for training. Training should address
•Differing perspectives regarding the charac-
teristics of the person with COD
•The nature of addiction
•The nature of mental disability 
•The conduct of treatment and staff roles in
the treatment process
•The interactive effects of both conditions on
the person and his or her outcomes
•Staff burnout
Staff trained exclusively either in mental health
services or in substance abuse treatment mod-
els often have difficulty accepting the other’s
view of the person, the problem, and the
approach to treatment. Cross-training and
open discussion of differing viewpoints and
challenging issues can help staff to reach a com-
mon perspective and approach for the treat-
ment of clients with COD within each agency or
program setting. Chapter 3 provides a more
complete discussion of staff training, while
appendix I identifies a number of training
resources. 
Evaluating Outpatient
Programs
Five elements are needed to design an evalua-
tion process for an outpatient program that can
provide useful feedback to program staff and
administrators on the effectiveness or outcome
of treatment for persons with COD. These
important data can be used to improve pro-
grams.
1. Define the operational goals of the pro-
gram in terms of the client behaviors for
which change is sought. Programs may
define their goals for client change nar-
rowly in terms of reductions in alcohol and
drug use and crime only or more broadly,
to include reductions in psychological
symptoms, homelessness, unemployment,
and so on.
2. Decide who the study clients will be and
devise a plan for selecting or sampling
those clients. Depending on the rate of
client entry into a program and the num-
ber of clients sought for the outcome study
(typically at least 35), a program may
select every client presenting to treatment
over the course of a designated time period
or may sample systematically (e.g., taking
every third client) or randomly (e.g., using
a coin toss). It is important to use a system
that avoids bias (i.e., avoids the selection
of clients who, for one reason or another,
are believed to be more likely to respond
particularly well or particularly poorly to
the treatment program).
3. Locate and/or develop instruments that
can be used to assess client functioning in
the areas of concern for outcome. Include
areas about which the program staff feels
information is needed (e.g., demographic
characteristics and background variables
such as source of referral, drug use and
criminal justice histories, education or
employment histories, prior drug treat-
ment, social support, physical and mental
health histories, etc.). For studies general-
ly, and for in-treatment studies in particu-
lar, it is also important to gather informa-
tion about client retention. Indeed, a num-
ber of studies now suggest that length of
retention is a useful proxy measure for
understanding posttreatment outcomes,
and that retention to 3 months in outpa-
tient programs is critical for clients to
achieve meaningful behavior change.
4. Develop a plan for data collection.
Information on client functioning can be
gathered using selected instruments at the
time of entry into treatment (baseline) and
at intervals of 1 or more months from time
of entry while the individual is in treat-
ment. Data gathered may be restricted to
self-report or may include biological mark-
ers such as urinalysis and/or data gathered
from others knowledgeable about the
client’s functioning (e.g., family or school
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personnel). Outcome studies frequently
involve continuing assessment after the
client leaves treatment, and again at desig-
nated intervals; typically, assessments at
6- to 12-month intervals.
5. Develop a plan for data analysis and
reporting. Data analysis may be compara-
tively simple, describing client functioning
at baseline in the areas of concern (e.g.,
drug use) and client functioning in those
same areas at times of assessment or fol-
low-up; alternatively, it may be complex,
comparing client functioning in the areas
of concern at multiple points in time and
controlling for variables that might affect
that functioning (e.g., prior treatment his-
tory). The findings obtained through data
analysis are communicated through writ-
ten and oral reporting to interested par-
ties, particularly program staff who can
use this information on program effective-
ness to its greatest advantage (i.e., to
improve the program’s capacity to facili-
tate client change). Both the National
Institute on Drug Abuse (NIDA) and CSAT
have developed manuals for outcome stud-
ies designed to be conducted by treatment
program staff. NIDA’s document (1993) is
titled How Good Is Your Drug Abuse
Treatment Program? A Guide to
Evaluation. CSAT’s document (1997b) is
titled Demystifying Evaluation: A Manual
for Evaluating Your Substance Abuse
Treatment Program.
Sustaining Outpatient
Programs 
Funding resources for substance abuse treat-
ment remain significantly lower per client than
those available for mental health services.
Models demonstrating positive results originat-
ing in the mental health field often are too
expensive to be implemented fully in more fis-
cally limited substance abuse treatment set-
tings. The consensus panel recommends devel-
oping funding for the essential programming
described in this chapter and, where possible,
for adapting the successful models for the treat-
ment of mental disorders in outpatient settings
described below. 
Financing integrated 
treatment
As noted earlier, systemic difficulties related to
the organization and financing of integrated
treatment models, including funding for
enhanced mental health services, have delayed
implementation of
integrated treatment
models in many out-
patient substance
abuse treatment set-
tings. Resources for
funding extended
continuity of treat-
ment, which are
available generally
in mental health set-
tings, are not usually
provided in sub-
stance abuse treat-
ment systems. Since
the majority of sub-
stance abuse treat-
ment agencies treat
clients with COD, an
obvious solution to
funding shortfalls is
to access funding
streams that support
mental health ser-
vices. Such funding
may be based on
demonstrating the
nature, severity, and
extent of co-occur-
ring mental disor-
ders among their
clients, with docu-
mentation of the full
range of diagnosed disabilities of clients with
COD. This information also helps programs to
modify their programs to address current client
needs, and to educate and promote an appreci-
ation for the documented efficacy of integrated
treatment for those with COD (Drake et al.
Since the major-
ity of substance
abuse treatment
agencies treat
clients with
COD, an obvi-
ous solution to
funding short-
falls is to access
funding streams
that support
mental health
services.
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1998b). Chapter 3 presents additional informa-
tion on overcoming barriers and for accessing
funding for COD in substance abuse treatment
settings. 
Planning for organizational
change
Substance abuse treatment agencies should
plan for any organizational changes needed to
introduce new or altered approaches into
program settings (e.g., adding and integrating
mental health staff into the substance abuse
setting). Agencies should be aware, however,
that changing the processes and approaches
in an organization is challenging. Strategies
should be grounded in sound organizational
change principles and may be effective in
helping all parties understand, accept, and
adjust to the changes. A recommended
sourcebook administrators might find useful
is The Change Book: A Blueprint for
Technology Transfer (Addiction Technology
Transfer Center National Office 2000). 
Examples of Outpatient
Programs
A CSAT initiative, titled Grants for
Evaluation of Outpatient Treatment Models
for Persons With Co-Occurring Substance
Abuse and Mental Health Disorders
(Substance Abuse and Mental Health Services
Administration [SAMHSA] 2000) promotes
the development and evaluation of new mod-
els for the treatment of COD in outpatient
substance abuse treatment settings. A variety
of models for treatment of clients with COD
in outpatient substance abuse treatment set-
tings are now emerging, some of which are
outlined in appendix E.
Recognizing that providers must address
these issues within the constraints of particu-
lar systems that differ significantly from each
other, two providers have been chosen—the
Clackamas County Mental Health Center,
Oregon, and Arapahoe House, Colorado—to
illustrate different approaches to providing
outpatient care for clients with COD.
Assertive Community
Treatment and Intensive Case
Management: Specialized
Outpatient Treatment Models
for Clients With COD 
This section focuses on two existing outpatient
models, ACT and ICM (both from the mental
health field) and the challenges of employing
them in the substance abuse field. The ratio-
nale for selecting these specialized models is
that the framework, model, and methods of
each are articulated clearly, both have been
disseminated widely and applied, and each
has support from a body of empirical evi-
dence (though the empirical support for ICM
is relatively modest compared to ACT).
Because service systems are layered and diffi-
cult to negotiate, and because people with COD
need a wide range of services but often lack the
knowledge and ability to access them, the utili-
ty of case management is recognized widely for
this population. Although ACT and ICM can be
thought of as similar in several features (e.g.,
both emphasize case management, skills train-
ing, and individual counseling), they function
differently from each other with regard to
goals, operational characteristics, and the
nature and extent of the activities and interven-
tions they provide. Therefore, each is
described separately below.
Assertive Community 
Treatment
Developed in the 1970s by Stein and Test (Stein
and Test 1980; Test 1992) in Madison,
Wisconsin, for clients with SMI, the ACT
model was designed as an intensive, long-term
service for those who were reluctant to engage
in traditional treatment approaches and who
required significant outreach and engagement
activities. ACT has evolved and been modified
to address the needs of individuals with serious
mental disorders and co-occurring substance
use disorders (Drake et al. 1998a; Stein and
Santos 1998).
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Program model
ACT programs typically employ intensive out-
reach activities, active and continued engage-
ment with clients, and a high intensity of ser-
vices. ACT emphasizes shared decisionmaking
with the client as essential to the client’s
engagement process (Mueser et al. 1998).
Multidisciplinary teams including specialists in
key areas of treatment provide a range of ser-
vices to clients. Members typically include men-
tal health and substance abuse treatment coun-
selors, case managers, nursing staff, and psy-
chiatric consultants. The ACT team provides
the client with practical assistance in life man-
agement as well as direct treatment, often with-
in the client’s home environment, and remains
responsible and available 24 hours a day (Test
1992). The team has the capacity to intensify
services as needed and may make several visits
each week (or even per day) to a client.
Caseloads are kept smaller than other commu-
nity-based treatment models to accommodate
the intensity of service provision (a 1:12 staff-
to-client ratio is typical).
ACT treatment activities and
interventions
Examples of ACT interventions include
•Outreach/engagement. To involve and sus-
tain clients in treatment, counselors and
administrators must develop multiple means
of attracting, engaging, and re-engaging
clients. Often the expectations placed on
The Clackamas County Mental Health Center, Oregon
Overview
Clackamas County is a geographically large county in northwest Oregon that is about the size of the State of
Delaware and encompasses urban, suburban, and rural areas. Oregon City, the county seat, is home to
15,000 people. The County provides outpatient substance abuse and mental health treatment services at four
major clinics throughout the county. Its substance abuse treatment program has made a concerted and sus-
tained effort to develop working agreements with major sources of referral, reflecting client needs in the com-
munity (e.g., corrections, child protective services, adult and family services, and a local community college).
In addition, the program continues to consult with other service providers to build further linkages.
All staff members who provide initial assessment and treatment have at least master’s level training and sub-
stance abuse certification (or its equivalent), which has facilitated the awareness of potential co-occurring
interactions beginning at intake. It is recognized that this level of staffing is unusual within substance abuse
treatment programs.
Clients Served
The county provides treatment for clients with substance abuse and COD. The Clackamas County Mental
Health Center has a number of programs that target specific populations, including a women’s program; a
program for clients involved in the criminal justice system who are on electronic surveillance or who were
referred by juvenile and adult Drug Courts; clients with serious and persistent mental illness; and through
the Passport Program, young adult men and women ages 17 to 23 who have co-occurring substance use disor-
ders and significant mental disorders.
Services
Each clinic offers both Level 1 and 2 services (as defined by ASAM) (2001) and has working agreements with
residential treatment programs for those who need that level of care. Outpatient services include treatment
for individuals, families, and groups; case management; and consultation. More specialized treatment has
been developed for some subpopulations within the program (e.g., clients with serious and persistent mental
illness, clients on electronic surveillance, women). 
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clients are minimal to nonexistent, especial-
ly in those programs serving very resistant
or hard-to-reach clients.
•Practical assistance in life management.
This feature incorporates case management
activities that facilitate linkages with sup-
port services in the community. While the
role of a counselor in the ACT approach
includes standard counseling, in many
instances substantial time also is spent on
life management and behavioral manage-
ment matters.
Arapahoe House, Colorado
Overview
Arapahoe House, a nonprofit corporation located near Denver, Colorado, is the State’s largest provider of
substance abuse treatment services. In addition, Arapahoe House is a licensed mental health clinic and strives
to provide fully integrated services for clients with COD in all of its treatment programs. Because all Arapahoe
House programs are designed to provide integrated treatment for clients with COD, the agency employs several
psychiatrists on contract in both the residential and outpatient settings.
Clients Served
The Arapahoe House Adult Outpatient Programs admit clients with substance use disorders who do not
require 24-hour medical monitoring or detoxification and do not have symptoms of mental illness that place
them at high risk of harming themselves or others. Adult clients who do not meet these criteria are referred to
Arapahoe House’s detoxification services or its inpatient treatment program where they can receive compre-
hensive assessment and stabilization. Arapahoe House also has a number of programs for specific populations.
There is a residential treatment program for women with dependent children and specialized services for
homeless persons.
Services
Arapahoe House provides a full continuum of treatment services, including residential and outpatient treat-
ment for adults and adolescents of multiple levels of intensity; case management services for specific target
populations; nonmedical detoxification services; housing and vocational services; and, for adolescents, school-
based counseling. The organization offers outpatient services at six locations in the metropolitan Denver area.
These outpatient programs provide individual and group therapy, education, family counseling, sobriety moni-
toring, and mental health evaluation. 
Arapahoe House also provides a wide array of services devoted to the needs of homeless persons, including
intensive case management services and a housing program. Specific services for persons with COD include the
20-bed adult short-term intensive residential treatment program, the six adult outpatient clinics, and the New
Directions for Families program, which is a comprehensive residential treatment program for women and their
dependent children. New Directions has a capacity of sixteen families, with an expected length of stay of 4
months, followed by 4 months of outpatient continuing care. 
Finally, with respect to adult services, The Wright Center, which is a 22-bed transitional residential program
for men and women, has been modified to serve clients with COD. In addition to these programs for adults,
Arapahoe House offers an array of programs designed to meet the needs of adolescents, and all of these pro-
grams target young persons with COD. This continuum of adolescent services includes counselors who work
onsite in 16 high schools across the metropolitan Denver area; outpatient services at two sites, including day
treatment; and two intensive residential treatment centers: one comprising 20 beds for male and female adoles-
cents and the other a center for 15 adolescent females. These residential treatment centers offer comprehensive
substance abuse and mental health treatment using an integrated model, and both sites contain an accredited
school. 
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•Close monitoring. For some clients, espe-
cially those with SMI, close monitoring is
required.
This can include (Drake et al. 1993):
– Medication supervision and/or management
– Protective (representative) payeeships
– Urine drug screens
•Counseling. The nature of the counseling
activity is matched to the client’s motivation
and readiness for treatment.
• Crisis intervention. This is provided during
extended service hours (24 hours a day, ide-
ally through a system of on-call rotation).
Key modifications for 
integrating COD
When working with a client who has COD, the
goals of the ACT model are to engage the client
in a helping relationship, to assist in meeting
basic needs (e.g., housing), to stabilize the
client in the community, and to provide direct
and integrated substance abuse treatment and
mental health services. The standard ACT
model as developed by Test (1992) has been
modified to include treatment for persons who
have substance use disorders as well as mental
disorders (Stein and Santos 1998). The key ele-
ments in this evolution have been
•The use of direct substance abuse treatment
interventions for clients with COD (often
through the inclusion of a substance abuse
treatment counselor on the multidisciplinary
team)
•A team focus on clients with COD (Drake et
al. 1998a)
•COD treatment groups (Drake et al. 1998a)
•Modifications of traditional mental health
interventions, including a strong focus on
the relationships between mental health and
substance use issues (e.g., providing skills
training that focuses on social situations
involving substance use [Drake and Mueser
2000])
Substance abuse treatment strategies are relat-
ed to the client’s motivation and readiness for
treatment and include
• Enhancing motivation (for example, through
use of motivational interviewing)
•Cognitive–behavioral skills for relapse pre-
vention
•12-Step programming, including use of the
peer recovery community to strengthen sup-
ports for recovery
•Psychoeducational instruction about addic-
tive disorders
For clients who are not motivated to achieve
abstinence, motivational approaches are struc-
tured to help them recognize the impact of sub-
stance use on their lives and on the lives of
those around them. Therapeutic interventions
are modified to meet the client’s current stage
of change and receptivity.
Populations served
When modified as described above to serve
clients with COD, the ACT model is capable of
including clients with greater mental and func-
tional disabilities who do not fit well into many
traditional treatment approaches. The charac-
teristics of those served by ACT programs for
Making ACT Work
Team cohesion and smooth functioning are critical to success. The ACT multidisciplinary team has shared
responsibility for the entire defined caseload of clients and meets frequently (ideally, teams meet daily) to
ensure that all members are fully up-to-date on clinical issues. While team members may play different roles,
all are familiar with every client on the caseload. Additionally, the ACT model includes the clients’ family and
friends within treatment services.
Source: Wingerson and Ries 1999.
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COD include those with a substance use disor-
der and
•Significant mental disorders
•Serious and persistent mental illness
•Serious functional impairments
•Who avoided or did not respond well to tra-
ditional outpatient mental health services and
substance abuse treatment
•Co-occurring homelessness
•Co-occurring criminal justice involvement
(National Alliance for the Mentally Ill
[NAMI] 1999)
In addition to, and perhaps as a consequence
of, the characteristics cited above, clients tar-
geted for ACT often are high utilizers of expen-
sive service delivery systems (emergency rooms
and hospitals) as immediate resources for men-
tal health and substance abuse services.
Empirical evidence for ACT
The ACT model has been researched widely
as a program for providing services to people
who are chronically mentally ill. The general
consensus of research to date is that the ACT
model for mental disorders is effective in
reducing hospital recidivism and, less consis-
tently, in improving other client outcomes
(Drake et al. 1998a; Wingerson and Ries
1999). 
Randomized trials comparing clients with
COD assigned to ACT programs with similar
clients assigned to standard case management
programs have demonstrated better outcomes
for ACT. ACT resulted in reductions in hospi-
tal use, improvement on clinician ratings of
alcohol and substance abuse, lower 3-year
posttreatment relapse rates for substance use,
and improvements on measures of quality of
life (Drake et al. 1998a; Morse et al. 1997;
Wingerson and Ries 1999). It is important to
note that ACT has not been effective in
reducing substance use when the substance
use services were brokered to other providers
and not provided directly by the ACT team
(Morse et al. 1997). Researchers also consid-
ered the cost-effectiveness of these interven-
tions, concluding that ACT has better client
outcomes at no greater cost and is, therefore,
more cost-effective than brokered case man-
agement (Wolff et al. 1997).
Other studies of ACT were less consistent in
demonstrating improvement of ACT over
other interventions (e.g., Lehman et al.
1998). In addition, the 1998 study cited previ-
ously (Drake et al. 1998b) did not show dif-
ferential improvement on several measures
important for establishing the effectiveness of
Nine Essential Features of ACT
1. Services provided in the community, most frequently in the client’s living environment
2. Assertive engagement with active outreach
3. High intensity of services
4. Small caseloads
5. Continuous 24-hour responsibility
6. Team approach (the full team takes responsibility for all clients on the caseload)
7. Multidisciplinary team, reflecting integration of services
8. Close work with support systems
9. Continuity of staffing
Source: Drake et al. 1998a.
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ACT with COD—that is, retention in treat-
ment, self-report measures of substance
abuse, and stable housing (although both
groups improved). Drake notes that “drift”
occurred in the comparison group; that is,
elements of ACT were incorporated gradually
into the standard case management model,
which made it difficult to determine the dif-
ferential effectiveness of ACT. Further analy-
ses indicated that clients in high-fidelity ACT
programs showed greater reductions in alco-
hol and drug use and attained higher rates of
remissions in substance use disorders than
clients in low-fidelity programs (McHugo et
al. 1999). Nevertheless, ACT is a recommend-
ed treatment model for clients with COD,
especially those with serious mental disor-
ders, based on the weight of evidence. 
Intensive case management
The earliest model of case management was pri-
marily a brokerage model, in which linkages to
services were forged based on the individual
needs of each client, but the case
manager did not provide formal
clinical services. Over time, it
became apparent that clinicians
could provide more effective case
management services; conse-
quently, clinical case management
largely supplanted the brokerage
model. ICM emerged as a strategy
in the late 1980s and early 1990s.
It was designed as a thorough,
long-term service to assist clients
with SMI (particularly those with
mental and functional disabilities
and a history of not adhering to
prescribed outpatient treatment)
by establishing and maintaining
linkages with community-based
service providers. 
ICM is not a precisely defined
term, but rather is used in the lit-
erature to describe an alternative
to both traditional case manage-
ment and ACT. The goals of the
ICM model are to engage individ-
uals in a trusting relationship, assist in meeting
their basic needs (e.g., housing), and help them
access and use brokered services in the commu-
nity. The fundamental element of ICM is a low
caseload per case manager, which translates
into more intensive and consistent services for
each client. TIP 27, Comprehensive Case
Management for Substance Abuse Treatment
(CSAT 1998b), contains more information on
the history of case management, both how it
has developed to meet the needs of clients in
substance abuse treatment (including clients
with COD) and specific guidelines about how to
implement case management services.
Program model
ICM programs typically involve outreach and
engagement activities, brokering of community-
based services, direct provision of some sup-
port/counseling services, and a higher intensity
of services than standard case management.
The intensive case manager assists the client in
selecting services, facilitates access to these ser-
Advice to Administrators:
Treatment Principles From ACT
• Provide intensive outreach activities.
• Use active and continued engagement techniques with
clients.
• Employ a multidisciplinary team with expertise in sub-
stance abuse treatment and mental health.
• Provide practical assistance in life management (e.g.,
housing), as well as direct treatment.
• Emphasize shared decisionmaking with the client.
• Provide close monitoring (e.g., medication manage-
ment).
• Maintain the capacity to intensify services as needed
(including 24-hour on-call, multiple visits per week).
• Foster team cohesion and communication; ensure that all
members of the team are familiar with all clients on the
caseload.
• Use treatment strategies that are related to the client’s
motivation and readiness for treatment, and provide
motivational enhancements as needed.  
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vices, and monitors the client’s progress
through services provided by others (inside or
outside the program structure and/or by a
team). Client roles in this model include serving
as a partner in selecting treatment components.
In some instances, the ICM model uses multi-
disciplinary teams similar to ACT. The compo-
sition of the ICM team is determined by the
resources available in the agency implementing
the programs. The team often includes a clus-
ter-set of case managers rather than the spe-
cialists prescribed as standard components of
the treatment model. The ICM team may offer
services provided by ACT teams, including
practical assistance in life management (e.g.,
housing) and some direct counseling or other
forms of treatment. Caseloads are kept smaller
than those in other community-based treatment
models (typically, the client-to-counselor ratio
ranges from 15:1 to 25:1), but larger than those
in the ACT model. Because the case manage-
ment responsibilities are so wide ranging and
require a broad knowledge of local treatment
services and systems, a typically trained coun-
selor may require some retraining and/or close,
instructive supervision in order to serve effec-
tively as a case manager.
Treatment activities and
interventions
Examples of ICM activities and interventions
include
•Engaging the client in an alliance to facili-
tate the process and connecting the client
with community-based treatment programs
•Assessing needs, identifying barriers to
treatment, and facilitating access to treat-
ment 
•Offering practical assistance in life man-
agement and facilitating linkages with sup-
port services in the community
•Making referrals to treatment programs
and services provided by others in the com-
munity (see TIP 27 [CSAT 1998b] for guid-
ance on establishing linkages for service
provision and interagency cooperation) 
•Advocating for the client with treatment
providers and service delivery systems
•Monitoring progress
•Providing counseling and support to help
the client maintain stability in the commu-
nity
•Crisis intervention 
•Assisting in integrating treatment services
by facilitating communication between ser-
vice providers
Key modifications of ICM for
co-occurring disorders 
Key ICM modifications from basic case man-
agement for clients with COD include
•Using direct interventions for clients with
COD, such as enhancing motivation for treat-
ment and discussing the interactive effects of
mental and substance use disorders 
•Making referrals to providers of integrated
substance abuse and mental health services
or, if integrated services are not available or
accessible, facilitating communication
between separate brokered mental health
and substance abuse service providers
•Coordinating with community-based services
to support the client’s involvement in mutual
self-help groups and outpatient treatment
activities
Empirical evidence
The empirical study of ICM for COD is not as
extensive or as clarifying as the research on
ACT; however, some studies do provide
empirical support. ICM has been shown to be
effective in engaging and retaining clients with
COD in outpatient services and to reduce
rates of hospitalization (Morse et al. 1992).
Further, treatments combining substance
abuse counseling with intensive case manage-
ment services have been found to reduce sub-
stance use behaviors for this population in
terms of days of drug use, remission from
alcohol use, and reduced consequences of
substance use (Bartels et al. 1995; Drake et
al. 1993, 1997; Godley et al. 1994). The con-
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tinued use and further develop-
ment of ICM for COD is indicat-
ed based on its overall utility
and modest empirical base. 
Comparison of ACT
and ICM
Similarities between ACT
and ICM
Both ACT and ICM share the fol-
lowing key activities and inter-
ventions:
•Focus on increased treatment
participation
•Client management
•Abstinence as a long-term goal,
with short-term supports 
•Stagewise motivational interventions 
•Psychoeducational instruction
•Cognitive–behavioral relapse prevention
•Encouraging participation in 12-Step 
programs
•Supportive services 
•Skills training
•Crisis intervention
•Individual counseling
Differences between 
ACT and ICM
ACT is more intensive than most ICM
approaches. The ACT emphasis is on develop-
ing a therapeutic alliance with the client and
delivery of service components in the client’s
home, on the street, or in program offices
(based on the client’s preference). ACT ser-
vices, as described by NAMI (1999), are pro-
vided predominantly by the multidisciplinary
staff of the ACT team (typically, 75 percent of
services are team provided), and the program
often is located in the community. Most ACT
programs provide services 16 hours a day on
weekdays, 8 hours a day on weekends, plus on-
call crisis intervention, including visits to the
client’s home at any time, day or night, with
the capacity to make multiple visits to a client
on any given day. Caseloads usually are 12:1.
ICM programs typically include fewer hours of
direct treatment, though they may include 24-
hour crisis intervention; the focus of ICM is on
brokering community-based services for the
client. ICM caseloads range up to 25:1.
The ACT multidisciplinary team has shared
responsibility for the entire defined caseload of
clients and meets frequently (ideally, teams
meet daily) to ensure that all members are fully
up-to-date on clinical issues. While team mem-
bers may play different roles, all are familiar
with every client on the caseload. The nature of
ICM team functioning is not as defined, and
cohesion is not necessarily a focus of team func-
tioning; the ICM team can operate as a loose
federation of independent case managers or as
a cohesive unit in a manner similar to ACT.
Also, the ACT model has been developed to
include the clients’ family and friends within
treatment services (Wingerson and Ries 1999),
which is not necessarily true for ICM models.
ICM most frequently involves the coordina-
tion of services across different systems
and/or over extended periods of time, while
ACT integrates and provides treatment for
COD within the team. As a consequence,
while advocacy with other providers is a
major component of ICM, advocacy in ACT
focuses on ancillary services. Additionally,
Advice to Administrators: 
Treatment Principles From ICM
• Select clients with greater mental and functional disabili-
ties who are resistant to traditional outpatient treatment
approaches.
• Employ low caseload per case manager to accommodate
more intensive services.
• Assist in meeting basic needs (e.g., housing).
• Facilitate access to and utilization of brokered communi-
ty-based services.
• Provide long-term support, such as counseling services.
• Monitor the client’s progress through services provided
by others.
• Use multidisciplinary teams.
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the ACT multidisciplinary team approach to
treatment places greater emphasis on provid-
ing integrated treatment for clients with COD
directly, assuming that the team members
include both mental health and substance
abuse treatment counselors and are fully
trained in both approaches.
Recommendations for
extending ACT and ICM in
substance abuse treatment
settings
It is not self-evident that ACT and ICM models
translate easily to substance abuse settings. The
consensus panel offers the following six key rec-
ommendations for successful use of ACT and
ICM in substance abuse settings with clients
who have COD:
1. Use ACT and ICM for clients who require
considerable supervision and support.
ACT is a treatment alternative for those
clients with COD who have a history of
sporadic adherence with continuing care
or outpatient services and who require
extended monitoring and supervision (e.g.,
medication monitoring or dispensing) and
intensive onsite treatment supports to sus-
tain their tenure in the community (e.g.,
criminal justice clients). For this subset of
the COD population, ACT provides acces-
sible treatment supports without requiring
return to a residential setting. The typical
ICM program is capable of providing less
intense levels of monitoring and supports,
but can still provide these services in the
client’s home on a more limited basis.
2. Develop ACT and/or ICM programs selec-
tively to address the needs of clients with
SMI who have difficulty adhering to treat-
ment regimens most effectively. ACT,
which is a more complex and expensive
treatment model to implement compared
with ICM, has been used for clients with
SMI who have difficulty adhering to a
treatment regimen. Typically, these are
among the highest users of expensive (e.g.,
emergency room, hospital) services. ICM
programs can be used with treatment-
resistant clients who are clinically and
functionally capable of progressing with
much less intensive onsite counseling and
less extensive monitoring.
3. Extend and modify ACT and ICM for
other clients with COD in substance abuse
treatment. With their strong tradition in
the mental health field, particularly for
clients with SMI, ACT and ICM are attrac-
tive, accessible, and flexible treatment
approaches that can be adapted for indi-
viduals with COD. Components of these
programs can be integrated into substance
abuse treatment programs.
4. Add substance abuse treatment compo-
nents to existing ACT and ICM programs.
Incorporating methods from the substance
abuse treatment field, such as substance
abuse education, peer mutual self-help,
and greater personal responsibility, can
continue to strengthen the ACT approach
as applied to clients with COD. The degree
of integration of substance abuse and men-
tal health components within ACT and
ICM is dependent upon the ability of the
individual case manager/counselor or the
team to provide both services directly or
with coordination.
5. Extend the empirical base of ACT and
ICM to further establish their effectiveness
for clients with COD in substance abuse
treatment settings. The empirical base for
ACT derives largely from its application
among people with SMI and needs to be
extended to establish firm support for the
use of ACT across the entire COD popula-
tion. In particular, adding an evaluation
component to new ACT programs in sub-
stance abuse settings can provide docu-
mentation currently lacking in the field
concerning the effectiveness and cost bene-
fit of ACT in treating the person who
abuses substances with co-occurring men-
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tal disorders in substance abuse treatment
settings. The limitations of ICM have been
listed above. The use of ACT or ICM
should turn on the assessed needs of the
client.
Residential Substance
Abuse Treatment
Programs for Clients
With COD
Background and Effectiveness
Residential treatment for substance abuse
comes in a variety of forms, including long-
term (12 months or more) residential treatment
facilities, criminal justice-based programs,
halfway houses, and short-term residential pro-
grams. The long-term residential substance
abuse treatment facility is the primary treat-
ment site and the focus of this section of the
TIP. Historically, residential substance abuse
treatment facilities have provided treatment to
clients with more serious and active substance
use disorders but with less SMI. Most providers
now agree that the prevalence of people with
SMI entering residential substance abuse treat-
ment facilities has risen.
Prevalence
As noted, mental disorders have been observed
in an increasing proportion of clients in many
substance abuse treatment settings (De Leon
1989; Rounsaville et al. 1982a). Compared to
the rates found in clients in the outpatient pro-
grams of DATOS, slightly higher rates of anti-
social personality disorder, and roughly similar
rates of major depressive episode and general-
ized anxiety disorder, were found among adult
clients admitted to the long-term residential
programs that were part of DATOS (Flynn et
al. 1996; see also Figure 1-2 in chapter 1 of this
TIP). Of course, those admitted to long-term
residential care tended to have more severe
substance abuse problems. Additionally, in the
year prior to admission to treatment, clients in
long-term residential care reported the highest
rate of past suicidal thoughts or attempts (23.6
percent) as compared to outpatient drug-free
(19.3 percent) and outpatient methadone treat-
ment (16.6 percent). Only the suicide thoughts
and attempts rate for clients admitted to short-
term inpatient treatment was higher (31.0 per-
cent) (Hubbard et al. 1997, Table 2). This evi-
dence points to the need for a programmatic
response to the problems posed by those with
COD who enter residential treatment settings. 
Empirical evidence of 
effectiveness
Evidence from a number of large-scale, longitu-
dinal, national, multisite treatment studies has
established the effectiveness of residential sub-
stance abuse treatment (Fletcher et al. 1997;
Hubbard et al. 1989). In general, these studies
have shown that residential substance abuse
treatment results in
significant improve-
ment in drug use,
crime, and employ-
ment.
The most recent of
these national
efforts is NIDA’s
DATOS (Fletcher et
al. 1997). The
DATOS study
involved a total of
10,010 adult clients,
including many
minorities, admitted
between 1991 and
1993 to short-term
inpatient substance
abuse treatment
programs, residen-
tial TCs, outpatient
drug-free programs,
or outpatient
methadone mainte-
nance programs
across 11 cities
(Chicago, Houston,
Miami,
Minneapolis,
Historically, res-
idential sub-
stance abuse
treatment facili-
ties have provid-
ed treatment to
clients with
more serious
and active 
substance use
disorders but
with less SMI.
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Newark, New Orleans, New York, Phoenix,
Pittsburgh, Portland, and San Jose). Of the
4,229 clients eligible for follow-up and inter-
viewed at intake, 2,966 were re-interviewed
successfully after treatment (Hubbard et al.
1997).
Encouragingly, even with this high prevalence
of clients with COD, DATOS study partici-
pants displayed positive outcomes for sub-
stance use and other maladaptive behaviors
in the first year after treatment. Because
studies of populations that abuse substances
have shown that those who remain in treat-
ment for at least 3 months have more favor-
able outcomes, a critical retention threshold
of at least 90 days has been established for
residential programs (Condelli and Hubbard
1994; Simpson et al. 1997b, 1999). Persons
admitted to residential programs likely have
the most severe problems, and those remain-
ing beyond the 90-day threshold have the
most favorable outcomes (Simpson et al.
1999).
Legal pressure and internal motivation among
clients in residential programs have been
associated with retention beyond the 90-day
threshold (Knight et al. 2000). This relation-
ship between legal pressure and retention
supports practices that encourage court refer-
rals to residential treatment for drug-involved
persons (Hiller et al. 1998). Broome and col-
leagues (1999) found that hostility was related
to a lower likelihood of staying in residential
treatment beyond the 90-day threshold, but
depression was associated with a greater like-
lihood of retention beyond the threshold.
Designing Residential
Programs for Clients With
COD
To design and develop services for clients with
COD, a series of interrelated program activities
must be undertaken, as discussed below. While
the MTC described in detail later in this chap-
ter is used frequently as a frame of reference
throughout this discussion, these observations
are applicable both to such TCs and to other
residential programs that might be developed
for COD.
Intake
Chapter 4 provides a full discussion of screen-
ing and assessment. This section will address
intake procedures relevant to persons with
COD in residential substance abuse treatment
settings. The four interrelated steps of the rele-
vant intake process include:
1. Written referral. Referral information from
other programs or services can include the
client’s psychiatric diagnosis, history, cur-
rent level of mental functioning, medical
status (including results of screening for
tuberculosis, HIV, STDs, and hepatitis),
and assessment of functional level. Referrals
also may include a psychosocial history and
a physical examination.
2. Intake interview. An intake interview is
conducted at the program site by a coun-
selor or clinical team. At this time, the
referral material is reviewed for accuracy
and completeness, and each client is inter-
viewed to determine if the referral is
appropriate in terms of the history of men-
tal and substance abuse problems. The
client’s residential and treatment history is
reviewed to assess the adequacy of past
treatment attempts. Finally, each client’s
motivation and readiness for change are
assessed, and the client’s willingness to
accept the current placement as part of
the recovery process is evaluated.
Screening instruments, such as those
described in chapter 4, can be used in con-
junction with this intake interview.
3. Program review. Each client should
receive a complete description of the pro-
gram and a tour of the facility to ensure
that both are acceptable. This review
includes a description of the daily opera-
tion of the program in terms of groups,
activities, and responsibilities; a tour of
the physical site (including sleeping
arrangements and communal areas); and
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an introduction to some of the clients who
are already enrolled in the program.
4. Team meeting. At the end of the intake
interview and program review, the team
meets with the client to arrive at a decision
concerning whether the referred client
should be admitted to the program. The
client’s receptivity to the program is con-
sidered and additional information (e.g.,
involvement with the justice system, sui-
cide attempts) is obtained as needed. It
should be noted that the decisionmaking
process is inclusive; that is, a program
accepts referrals as long as they meet the
eligibility criteria, are not currently a dan-
ger to self or others, do not refuse medica-
tion, express a readiness and motivation
for treatment, and accept the placement
and the program as part of their recovery
process.
Assessment 
Once accepted into the program, the client goes
through an assessment process that should
include five areas:
1. Substance abuse evaluation. The sub-
stance abuse evaluation consists of assess-
ing age at first use, primary drugs used,
patterns of drug and alcohol use, and
treatment episodes. This information can
be augmented by some basic standard data
collection method such as the Addiction
Severity Index (ASI).
2. Mental health evaluation. Upon placement
in a residential facility, it is desirable to
have a psychiatrist, psychologist, or other
qualified mental health professional evalu-
ate each client’s mental status, cognitive
functioning, diagnosis, medication require-
ments, and the need for individual mental
health services. If individual treatment is
indicated, it is integrated with residential
treatment via contact among the client, the
case manager, and the therapist.
3. Health and medical evaluation. Referral
information contains the results of recent
medical examinations required for place-
ment. All outstanding medical, dental, and
other health issues, including infectious
diseases, especially HIV and hepatitis,
should be addressed early in the program
through affiliation agreements with
licensed medical facilities. Each client
should receive a complete medical evalua-
tion within 30 days of entry into the pro-
gram.
4. Entitlements. The counselor should assess
the status of each client’s entitlements
(e.g., Supplemental Security Income
[SSI], Medicaid, etc.) and assist clients in
completing all necessary paperwork to
ensure maximum benefits. However, care
must be taken
not to jeopardize
a client’s eligibil-
ity for SSI by
inadvertently
mischaracteriz-
ing the client’s
disability as sub-
stance abuse pri-
mary.
5. Client status.
Staff members
assess clients’
status as they
enter treatment,
including per-
sonal strengths,
goals, family,
and social sup-
ports. A key
assessment
weighs the
client’s readiness and motivation for
change.
Engagement
The critical issue for clients with COD is
engaging them in treatment so that they can
make use of the available services. A success-
ful engagement program helps clients to view
the treatment facility as an important
resource. To accomplish this, the program
must meet essential needs and ensure psychi-
atric stabilization. Residential treatment pro-
grams can accomplish this by offering a wide
A successful
engagement pro-
gram helps
clients to view
the treatment
facility as an
important
resource. 
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range of services that include both targeted
services for mental disorders and substance
abuse and a variety of other “wraparound”
services including medical, social, and work-
related activities. The extensiveness of resi-
dential services has been well documented
(Etheridge et al. 1997; McLellan et al. 1993;
Simpson et al. 1997a).
The interventions to promote engagement
described in Figure 6-1 incorporate therapeu-
tic community-oriented methods described in
other studies (Items 1, 3, 5–7) (De Leon
1995), as well as strategies employed and
found clinically useful in non-TC programs
(Items 2 and 4). This approach holds promise
for expanding treatment protocols for TC and
many non-TC programs to permit wider
treatment applicability.
Continuing care
Returning to life in the community after resi-
dential placement is a major undertaking for
clients with COD, with relapse an ever-pre-
sent danger. The long-term nature of mental
disorders and substance abuse requires conti-
nuity of care for a considerable duration of
time—at least 24 months (see, e.g., Drake et
al. 1996b, 1998b). The goals of continuing
care programming are sustaining abstinence,
continuing recovery, mastering community
living, developing vocational skills, obtaining
gainful employment, deepening psychological
understanding, increasing assumption of
responsibility, resolving family difficulties,
and consolidating changes in values and iden-
tity. The key services are life skills education,
relapse prevention, 12-Step or double trouble
groups, case management (especially for
housing) and vocational training and employ-
ment. A recent study (Sacks et al. 2003a) pro-
vided preliminary evidence that a continuing
care strategy using TC-oriented supported
housing stabilizes gains in drug use and crime
prevention, and is associated with incremen-
tal improvement in psychological functioning
and employment.
Discharge planning
Discharge planning follows many of the same
procedures discussed in the section on outpa-
tient treatment. However, there are several
other important points for residential pro-
grams:
•Discharge planning begins upon entry into
the program. 
•The latter phases of residential placement
should be devoted to developing with the
client a specific discharge plan and beginning
to follow some of its features. 
•Discharge planning often involves continuing
in treatment as part of continuity of care. 
•Obtaining housing, where needed, is an inte-
gral part of discharge planning. 
Implementing Residential
Programs
The literature contains many descriptions of
programs that are employed in the various
agencies but far fewer descriptions of how to
design and implement these programs. Figure
6-2 (p. 166) identifies some principles found
effective in designing and implementing resi-
dential programs. 
Staffing
Developing a new treatment model places
unique demands on staff. Staff for clients with
COD should contain a substantial proportion
of both mental health and substance abuse
treatment providers, include both recovering
and nonrecovering staff, and be culturally
competent with regard to the population in
treatment. A typical 25-bed residential pro-
gram should consist of about 15 staff, as fol-
lows: 
•Program director (preferably with an
advanced degree in the human service field
or with at least 5 years’ experience in sub-
stance abuse treatment, including at least 3
years of supervisory experience), a secretary,
a program supervisor (preferably with a
165Traditional Settings and Models
Figure 6-1
Engagement Interventions
Item Element Description
1 Client Assistance Counseling •Emphasizes client responsibility, coaching and
guiding the client, and using the client’s senior
peers to provide assistance 
2 Medication •Begins with mental health assessment and med-
ication prescription, then monitors for medica-
tion adherence, side effects, and effectiveness
3 Active Outreach and Continuous Orientation •Builds relationships and enhances program
compliance and acceptance through multiple
staff contacts 
4 Token Economy •Awards points (redeemable for tangible
rewards such as phone cards, candy, toiletries)
for positive behaviors including medication
adherence, abstinence, attendance at program
activities, follow-through on referrals, com-
pleting assignments, and various other activi-
ties essential to the development of commit-
ment
5 Pioneers—Creating a Positive Peer Culture • Facilitates program launch by forming a
seedling group of selected residents (pioneers)
to transmit the peer mutual self-help culture
and to encourage newly admitted clients to
make full use of the program
6 Client Action Plan • Formulated by clients and staff to specify,
monitor, and document client short-term goals
under the premise that substantial accomplish-
ments are achieved by attaining smaller objec-
tives 
7 Preparation for Housing •Entitlements are obtained—a Section 8 appli-
cation for housing is filed, available treatment
and housing options are explored, work readi-
ness skills are developed, and household man-
agement skills are taught 
Source: Adapted from Sacks et al. 2002.
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bachelor’s degree), and 10 line staff (with
high school diplomas or associate’s degrees)
•A clinical coordinator, a nurse practitioner
(half-time), an entitlements counselor (half-
time), and a vocational rehabilitation coun-
selor (half-time)
•Consultive and/or collaborative arrangements
for medical, psychiatric, and psychological
input or care
The optimal staffing ratio for morning, after-
noon, and night shifts is 3:1, 3:1, and 8:1,
respectively. The critical position is the clinical
coordinator who will direct program implemen-
tation.
Training
Initial training
To implement a new initiative such as the
multicomponent MTC requires both initial
training and continuing technical assistance.
Learning should be both a didactic and expe-
riential activity. The initial training for an
MTC, conducted at the program site for 5
days before program launch, provides a
model of structure and process that can be
applied in other TC and non-TC settings. The
training includes an overview of the philoso-
phy, history, and background of the TC
approach; a review of structure, including the
daily regimen, role of staff, role of peers,
peer work structure, privileges, and sanc-
tions; and a review of treatment process,
including a description of the stages and
phases of treatment. This curriculum also
includes special training in the assessment
and treatment of clients with COD and in the
key modifications of the TC for clients with
COD (see Figure 6-3). Once established, the
flagship program becomes the model for sub-
sequent experiential training.
Figure 6-2
Principles of Implementation
How to organize
•Identify the key person responsible for the successful implementation of the program.
•Use a field demonstration framework in which there is cross-fertilization between program design and empirical
data.
How to integrate with a system
•Follow system policy, guidelines, and constraints.
•Involve system stakeholders.
How to integrate in an agency
•Select an agency that displays organizational readiness and encourages program change.
•Form collaborative relationships at all levels of the organization, including both program and executive staff.
How to design, launch, and implement
•Develop a planning group of key stakeholders that meets regularly.
•Ensure client and staff orientation to all program elements.
•Provide training and technical assistance in the context of implementation.
Source: Adapted from Sacks et al. 1997b.
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Figure 6-3
Sample Training and Technical Assistance Curriculum
What is a TC? • Describes the theory, principles, and methods of the TC 
• Presents the TC perspective of four views: person, disorder, recovery, and
“right living”
• Describes the fundamentals of the TC approach with an emphasis on commu-
nity-as-method; i.e., the community is the healing agent
What do we know about the
treatment of people with
COD?
•Reviews the literature on the increased prevalence of clients with COD in the
mental health services, substance abuse treatment, and criminal justice sys-
tems 
•Presents a selected review and classification of treatment approaches and
principles; provides a review of the research literature and its implications
for practice
•Describes research establishing the effectiveness of MTCs for clients with
COD
What is an MTC? • Describes the seven main modifications of the TC for clients with COD
• Elaborates key changes in structure, process, and interventions of MTCs for
clients with COD
How do we assess/diagnose
the client with COD?
•Describes the main signs and symptoms of SMI for schizophrenia, major
depression, and mania 
•Presents critical differences between Axis I and Axis II disorders (see the
DSM-IV-TR) and their implications for program design
•Describes the 10 main characteristics of populations of people with substance
use disorders
•Presents a classification of criminal behavior and criminal thinking
•Presents three clinical instruments for assessing mental disorders, substance
abuse, and danger profile
•Presents empirical data on profiles of clients with COD
How do we start/implement
the program?
•Presents six guidelines for successful program implementation
•Provides practical advice on how to recruit, select, and initially evaluate
•Emphasizes how to establish the TC culture
•Describes six techniques for engaging the client in treatment
•Presents empirical data from staff studies on the process of change 
•Develops a sequence for implementing the core TC elements
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Ongoing training and technical
assistance
Training and technical assistance take place in
the field; both are direct and immediate. Staff
members learn exactly how to carry out pro-
gram activities by participating in the activities.
Technical assistance begins with a discussion of
TC methods over a period of time (usually sev-
eral weeks) before implementation, followed by
active illustration during the initiation period
(several weeks to several months). Supervisors
hold briefing and debriefing sessions before
and after each group activity, a process that
continues for several months. As staff members
begin to lead new activities, technical assistance
staff members provide guidance for a period of
several weeks. Monitoring continues until staff
demonstrate competency (which takes several
weeks, on average), as established by supervi-
sory ratings. Thereafter, quarterly reviews
ensure continued staff competency and fidelity
of program elements to TC principles and
methods. Training in the MTC model and its
implementation has been conducted nationally
by National Development and Research
Institutes as a part of grant supported activities
on NIDA- and SAMHSA-funded projects at no
cost to the provider agencies. Other TC agen-
cies (e.g., Gaudenzia, Odyssey House in New
York) have also developed this model and
either provide training or have the capacity to
provide training. SAMHSA’s Co-Occurring
Center for Excellence affords a unique oppor-
tunity for training and the further dissemina-
tion of the MTC and other evidence- and con-
sensus-based practices recommended by the
consensus panel. See also appendix I for a list
of training resources.
Figure 6-3 (continued)
Sample Training and Technical Assistance Curriculum
What are the main inter-
ventions and activities of
the TC?
•Provides a complete list and brief discussion of all TC interventions in four
areas: community enhancement (e.g., morning meeting), therapeutic/educative
(e.g., conflict resolution groups, interpersonal skills training, medication/medi-
cation monitoring), community/clinical management (e.g., learning experi-
ences), and work/other (e.g., peer work hierarchy)
•Delineates the interventions for both the residential and continuing care 
components
•Uses illustrations to teach three main interventions
How do clients change? •Presents the stages and phases of TC programs
•Describes the domains and dimensions of change
•Describes an instrument for measuring change
•Presents empirical data from staff studies on the process of change
What is the role of the
staff?
•Describes the staffing patterns and job responsibilities of TC staff
•Discusses the role of mental health, substance abuse, and criminal justice staff
•Uses exercises to establish teamwork and “esprit de corps”
•Provides the major cross-training experiences
What is it like to be in a
TC?
•Discusses the “nuts and bolts” of TC operations 
•Provides a description of a typical day in the life of a TC resident
•Demonstrates a typical schedule for a TC day/week 
•Addresses the concerns and issues of non-TC trained staff 
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Evaluating Residential
Programs 
The model outlined in the section on outpatient
services can be applied here. Program evalua-
tion for use by administrators to improve their
programs also can consist of assessing perfor-
mance standards such as bed or occupancy
rates, program retention, average duration of
stay, existence of service plans, and referral
rates to continuing care. These will be evaluat-
ed by comparing standards (to be established
by each program) to actual data. Such mea-
sures are available in almost all programs and
require very little in the way of additional
resources. In addition, client satisfaction sur-
veys and focus groups are useful in providing
feedback from the perspective of the client and
his or her family.
The efficacy of programs can be evaluated by
determining change from pre- to post-treatment
on basic measures of substance abuse and psy-
chological functioning. Chapter 4 outlines a
variety of measures that are available for this
purpose including the ASI (McLellan et al.
1985), the Global Appraisal of Individual
Needs (Dennis 2000), the Symptom Checklist-
90 (Derogatis and Spencer 1982; Derogatis et
al. 1973) and the Beck Depression Inventory
(Beck and Steer 1987). These measures are rel-
atively easy to use and can be employed even in
substance abuse treatment programs with limit-
ed resources. The highest level of evaluation
involves systematic research study; such efforts
Special Issue: The Use of Confrontation in Residential
Substance Abuse Treatment
Confrontation is used commonly in residential substance abuse treatment. De Leon (2000b) presents a full
description of confrontation that serves as the basis of this discussion. De Leon defines confrontation as a
form of interpersonal exchange in which individuals present to each other their observations of, and reac-
tions to, behaviors and attitudes that are matters of concern and that should change. In TC-oriented pro-
grams, confrontation is used informally in peer interactions, and formally in the encounter group process.
The primary objective of confrontational communication simply is to raise the individual’s awareness of how
his or her behavior and attitudes affect others. Compassionate conversation, mutual sharing, and other sup-
portive communications and interactions balance properly implemented confrontational exchanges.
Confrontation presents “reality” to individuals. Reality in this sense consists of peer reactions to each other’s
behavior and attitudes: teaching clients to say it as they see it and to say it honestly. Peer reactions include
thoughts as well as the expression of honest feelings that enhance the credibility of the observations. These
emotional expressions may be uncomfortable (e.g., hurt, anger, disappointment, fear, sadness) or comfort-
able (e.g., love, hope, happiness, encouragement, optimism). Appropriate intensity of emotions always is
delivered with responsible concern. Thus, the observations and reactions of a confrontation may address neg-
ative “reality” and also affirm the “reality” of positive changes in behaviors and attitudes in individuals as
they are perceived by others.
Confrontation skills and their application in encounter group are learned through staff training. There are
tools and rules that enhance the therapeutic utility of confrontation in particular and the encounter group
process in general. Thus, clients and staff must be trained in the proper use of confrontation.
The consensus panel notes that in working with individuals who have COD, the conflict resolution group
replaces the encounter group, and the conflict resolution group is described below in the section on MTCs. In
brief, the conflict resolution group has many of the same goals as the encounter group but modifies some of
the features (especially the degree of emotional intensity) that characterize the confrontation employed in
standard encounter groups as described by De Leon above. 
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usually require partnerships with research
investigators.
Sustaining Residential
Programs
One important vehicle for sustaining the resi-
dential program is through the development of
a Continuous Quality Improvement (CQI) plan.
The goal of CQI is to assess and ensure that the
program meets
established stan-
dards. It is a partici-
patory process led
by internal program
staff with consulta-
tion from experts
who use both quan-
titative and qualita-
tive information to
monitor and review
program status and
to develop action
plans for program
improvements and
refinements. For
quality control, the
CQI staff uses obser-
vation, key infor-
mant interviews,
resident focus
groups, standard-
ized instruments,
and staff review.
CQI is a manage-
ment plan for sus-
taining program
quality, for ensuring
that programs are
responsive to client
needs, and for main-
taining performance
standards. 
A sample CQI plan for an MTC in residential
facilities, applicable with modified instruments
to other residential programs, is as follows: 
•Fidelity of program implementation to pro-
gram design and TC standards. Program
fidelity (i.e., assurance that the key ele-
ments/interventions of the TC are present)
may be tested by administration of the TC
Scale of Essential Elements Questionnaire
(SEEQ) (Melnick and De Leon 1999). Any
scores that fall below the level of “meets the
standard” will trigger discussion and appro-
priate adjustments.
•Delivery of actual program activities/ele-
ments. Appropriate measures for success
include (1) the delivery of an established
number of program hours per day or week,
as measured by a review of staff schedules
and information systems report; (2) the
delivery of an established level of specific
groups and activities, as assessed by pro-
gram schedules and program management
information system activity reports; and (3)
satisfactory concordance rate between pro-
gram activities as designed and as deliv-
ered. This rate may be assessed using the
Program Monitoring Form and the TC
Scale of Essential Elements Questionnaire
(Melnick and De Leon 1999).
•Presence of a therapeutic environment. The
use of community as the healing agent, the
existence of trust in interpersonal relation-
ships, and the perception of the TC pro-
gram as a place to facilitate recovery and
change, together constitute a therapeutic
environment. The extent to which these ele-
ments exist may be established by partici-
pant observation, interviews, and focus
groups.
Therapeutic Communities
The goals of the TC are to promote absti-
nence from alcohol and illicit drug use, to
decrease antisocial behavior, and to effect a
global change in lifestyle, including attitudes
and values. The TC views drug abuse as a
disorder of the whole person, reflecting prob-
lems in conduct, attitudes, moods, values,
and emotional management. Treatment focus-
es on drug abstinence, coupled with social
and psychological change that requires a mul-
tidimensional effort, involving intensive
mutual self-help typically in a residential set-
The goals of the
TC are to pro-
mote abstinence
from alcohol
and illicit drug
use, to decrease
antisocial
behavior, and to
effect a global
change in
lifestyle, includ-
ing attitudes and
values.
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ting. At the time of this writing, the duration
of residential TC treatment typically is about
12 months, although treatment duration has
been decreasing under the influence of man-
aged care and other factors. In a definitive
book titled The Therapeutic Community:
Theory, Model, and Method, De Leon (2000b)
has provided a full description of the TC for
substance abuse treatment to advance
research and guide training, practice, and
program development.
The effectiveness of TCs in reducing drug use
and criminality has been well documented in
a number of program-based and multisite
evaluations. In general, positive outcomes are
related directly to increased length of stay in
treatment (De Leon 1984; Hubbard et al.
1984; Simpson and Sells 1982). Short- and
long-term follow-up studies show significant
decreases in alcohol and illicit drug use,
reduced criminality, improved psychological
functioning, and increased employment
(Condelli and Hubbard 1994; De Leon 1984;
Hubbard et al. 1997; Simpson and Sells
1982).
In terms of psychological functioning, clients
demonstrate improvement in psychological
well-being after treatment (Brook and
Whitehead 1980; Carroll and McGinley 1998;
De Leon 1984, 1989; De Leon and Jainchill
1982; Kennard and Wilson 1979). Research
findings indicate that psychological status
improves during treatment, with larger
changes in self-esteem, ego strength, socializa-
tion, and depression, and smaller changes in
long-standing characteristics such as person-
ality disorders (De Leon and Jainchill 1982).
Modified therapeutic commu-
nities for clients with COD
The MTC approach adapts the principles and
methods of the TC to the circumstances of the
COD client. The illustrative work in this area
has been done with people with COD, both
men and women, providing treatment based
on community-as-method—that is, the com-
munity is the healing agent. This section
focuses on the MTC as the potent residential
model developed within the substance abuse
treatment field; most of this section applies to
both TC and other residential substance
abuse treatment programs. A complete
description of the MTC for clients with COD,
including treatment manuals and guides to
implementation, can be found in other writ-
ings (e.g., De Leon 1993a; Sacks et al. 1997a,
b, 1999).
Treatment activities/interventions
All program activities and interactions, singly
and in combination, are designed to produce
change. Interventions are grouped into four
categories—community enhancement (to pro-
mote affiliation with the TC community), thera-
peutic/educative (to promote expression and
instruction), community/clinical management
(to maintain personal and physical safety), and
vocational (to operate the facility and prepare
clients for employment). Implementation of the
groups and activities listed in Figure 6-4 
(p. 172) establishes the TC community.
Although each intervention has specific individ-
ual functions, all share community, therapeu-
tic, and educational purposes.
Key modifications
The MTC alters the traditional TC approach in
response to the client’s psychiatric symptoms,
cognitive impairments, reduced level of func-
tioning, short attention span, and poor urge
control. A noteworthy alteration is the change
from encounter group to conflict resolution
group. Conflict resolution groups have the fol-
lowing features:
• They are staff led and guided throughout.
•They have three highly structured and often
formalized phases—(1) feedback on behavior
from one participant to another, (2) opportu-
nity for both participants to explain their
position, and (3) resolution between partici-
pants with plans for behavior change.
•There is substantially reduced emotional
intensity and an emphasis on instruction and
the learning of new behaviors.
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Figure 6-4
Residential Interventions
Community Enhancement
Morning Meeting Increases motivation for the day’s activities and creates a positive family
atmosphere.
Concept Seminars Review the concept of the day.
General Interest Seminars Provide information in areas of general interest (e.g., current events).
Program-Related Seminars Address issues of particular relevance (e.g., homelessness, HIV preven-
tion, and psychotropic medication).
Orientation Seminars Orient new members and introduce all new activities.
Evening Meetings Review house business for the day, outline plans for the next day, and
monitor the emotional tone of the house.
General Meetings Provide public review of critical events.
Therapeutic/Educative
Individual Counseling Incorporates both traditional mental health and unique M TC goals and
methods.
Psychoeducational Classes Are predominant, using a format to facilitate learning among clients with
COD; address topics such as entitlements/money management, positive
relationship skills training, triple trouble group, and feelings manage-
ment.
Conflict Resolution Groups Modified encounter groups designed specifically for clients with COD.
Medication/Medication Monitoring Begins with mental health assessment and medication prescription; con-
tinues with psychoeducation classes concerning the use and value of medi-
cation; and then monitors, using counselor observation, the peer commu-
nity, and group reporting for medication adherence, side effects, and
effectiveness. (See chapter 1, subsection titled “Pharmacological
advances,” and chapter 5, subsection titled “Monitor Psychiatric
Symptoms” for more details on the role of the counselor and the peer-
community in monitoring mental disorder symptoms and medication.)
Gender-Specific Groups Combine features of “rap groups” and therapy groups focusing on gen-
der-based issues.
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•There is a persuasive appeal for personal
honesty, truthfulness in dealing with others,
and responsible behavior to self and others. 
In general, to create the MTC program for
clients with COD, three fundamental alter-
ations were applied within the TC structure:
• Increased flexibility
• Decreased intensity
• Greater individualization
Nevertheless, the central TC feature remains;
the MTC, like all TC programs, seeks to devel-
op a culture in which clients learn through
mutual self-help and affiliation with the com-
munity to foster change in themselves and oth-
ers. Respect for ethnic, racial, and gender dif-
ferences is a basic tenet of all TC programs and
is part of teaching the general lesson of respect
for self and others. 
Figure 6-5 (p. 174) summarizes the key modifi-
cations necessary to address the unique needs
of clients with COD.
Role of the family
While many MTC clients come from highly
impaired and disrupted family situations and
find in the MTC program a new reference and
support group, some clients do have available
Figure 6-4 (continued)
Residential Interventions
Community and Clinical
Management Policies
A system of rules and regulations to maintain the physical and psychologi-
cal safety of the environment, ensuring that resident life is orderly and
productive, strengthening the community as a context for social learning.
Social Learning Consequence A set of required behaviors prescribed as a response to unacceptable
behavior, designed to enhance individual and community learning by
transforming negative events into learning opportunities.
Vocational
Peer Work Hierarchy A rotating assignment of residents to jobs necessary to the day-to-day
functioning of the facility, serving to diversify and develop clients’ work
skills and experience.
World of Work A psychoeducational class providing instruction in applications and inter-
views, time and attendance, relationships with others at work, employers’
expectations, discipline, promotion, etc.
Recovery and World of Work A psychoeducational class that addresses issues of mental disorders, sub-
stance abuse, and so on, in a work context.
Peer Advocate Training A program for suitable clients offering role model, group facilitator, and
individual counseling training.
Work Performance Evaluation Provides regular, systematic feedback on work performance.
Job Selection and Placement Individual counseling after 6 months to establish direction and to deter-
mine future employment.
Source: Sacks et al. 1999.
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Figure 6-5
TC Modifications for Persons With COD
Modifications to Structure Modifications to Process Modifications to Elements
(Interventions)
There is increased flexibility in pro-
gram activities.
Sanctions are fewer with greater
opportunity for corrective
learning experiences.
Orientation and instruction are
emphasized in programming and
planning.
Meetings and activities are shorter. Individual counseling is provided
more frequently to enable clients to
absorb the TC experience.
There is greatly reduced intensity of
interpersonal interaction.
Engagement and stabilization
receive more time and effort.
Task assignments are individual-
ized.
More explicit affirmation is given
for achievements.
Breaks are offered frequently dur-
ing work tasks.
Greater sensitivity is shown to indi-
vidual differences.
Progression through the pro-
gram is paced individually,
according to the client’s rate of
learning.
Individual counseling and instruc-
tion are more immediately provided
in work-related activities.
There is greater responsiveness to
the special developmental needs of
the individual.
Engagement is emphasized through-
out treatment.
More staff guidance is given in the
implementation of activities; many
activities remain staff assisted for a
considerable period of time.
Criteria for moving to the next
phase are flexible to allow
lower-functioning clients to
move through the program
phase system.
Activities are designed to overlap.
There is greater staff responsibility
to act as role models and guides.
Activities proceed at a slower pace.
Smaller units of information are
presented gradually and are fully
discussed.
Live-out re-entry (continuing
care) is an essential component
of the treatment process.
Individual counseling is used to
assist in the effective use of the com-
munity.
Greater emphasis is placed on
assisting individuals.
The conflict resolution group
replaces the encounter group.
Increased emphasis is placed on
providing instruction, practice, and
assistance.
Clients can return to earlier
phases to solidify gains as neces-
sary.
Source: Sacks et al. 1999.
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intact families or family members who can be
highly supportive. In those cases, MTC pro-
grams offer a variety of family-centered activi-
ties that include special family weekend visit-
ing, family education and counseling sessions,
and, where children are involved, classes
focused on prevention. All these activities are
designed in the latter part of treatment to facil-
itate the client’s reintegration into the family
and to mainstream living. 
Empirical evidence
A series of studies has established that
•Homeless persons with COD have multiple
impairments requiring multifaceted treat-
ment (Sacks et al. 1997b, 1998a), and the
homeless population with COD contains dis-
tinctive subgroups (De Leon et al. 1999).
•Residential MTCs for people with COD,
including women, produce significantly
greater positive outcomes for substance use
and employment than treatment as custom-
arily provided (De Leon et al. 2000c). A
parallel study (Rahav et al. 1995) also
demonstrated significantly improved psy-
chological functioning (e.g., lower depres-
sion) for an MTC group as
compared to a “low demand”
community residence pro-
gram.
•Preliminary evidence shows
that TC-oriented supported
housing stabilizes the gains
from the residential program
(Sacks et al. 2003a).
•The cost of providing effective
treatment through the MTC is
no more than the cost of pro-
viding less effective treatment
delivered through customarily
available services (French et
al. 1999; McGeary et al.
2000).
•MTC treatment produces $6 in
benefit for every dollar spent
(French et al. 2002).
•Initial evidence indicates that
those with both a mental and
substance use disorder in an
MTC group show significantly lower rein-
carceration rates than a group receiving
regular mental health services (Sacks et al.
2004).
Current applications
The MTC model has been adopted successfully
in community residence programs for serious
and persistent mental illness (Sacks et al.
1998a), general hospitals (Galanter et al. 1993),
and substance abuse treatment programs, both
nationally (Caroll 1990) and internationally. It
has spread particularly within TC agencies
such as Phoenix House, Walden House
(Guydish et al. 1994), Odyssey House,
Gaudenzia, and Second Genesis. 
Manuals have been developed that describe the
MTC programs (Sacks et al. 1998b, 2002) and
principles of implementation (Sacks et al.
1999). In addition, there are procedures that
ensure the quality control of new applications
(see section on “Continuous Quality
Improvement” above). This information is use-
ful to providers planning to develop MTC pro-
grams. A representative example of such MTC
programs from Gaudenzia is provided on pages
176–178.
Advice to Administrators:
Recommended Treatment and Services 
From the MTC Model
In addition to all the guidelines for treatment cited in
chapter 1, the following treatment recommendations
are derived from MTC work and are applicable across all
models.
• Treat the whole person.
• Provide a highly structured daily regimen.
• Use peers to help one another.
• Rely on a network or community for both support and 
healing.
• Regard all interactions as opportunities for change.
• Foster positive growth and development.
• Promote change in behavior, attitudes, values, and
lifestyle. 
• Teach, honor, and respect cultural values, beliefs, and 
differences.
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Gaudenzia, Inc., Pennsylvania
Overview
Gaudenzia, Inc. is a substance abuse treatment organization that provides a range of services at a number of dif-
ferent facilities. It is the largest nonprofit provider of substance abuse treatment services in the State of
Pennsylvania, and it has more than 30 different facilities located across the State. Most programs are based on
TC or MTC principles and methods. The entire agency has about 550 staff consisting of administrative manage-
ment, clinical management, front line clinical, administrative, operational support, and nursing personnel. Most
of the funding for these programs comes from municipal and State Offices of Mental Health. 
While Gaudenzia has facilities in a variety of different areas (urban, suburban, rural), all of the programs
described below are in urban areas. Urban locations can support more specialized programs because they serve
a larger population, with substantial concentrations of particular subgroups. Six of its facilities were developed
as MTC programs to exclusively or primarily serve clients with COD, and a seventh has become a facility for
people with HIV/AIDS and COD. They share a common perspective, principles, and methods, which are
described below.
Gaudenzia House Broad Street
Gaudenzia House Broad Street is a 30-bed residential treatment program for adult men and women, 18 years or
older, who have been diagnosed with both substance use disorders and co-occurring chronic and persistent men-
tal disorders. This facility was opened as a response to the closure of Byberry, Philadelphia’s State Hospital, to
provide community-based treatment for people with COD. Broad Street is a drug and alcohol and mental health
residential program dually licensed by the Commonwealth of Pennsylvania Bureau of Drug and Alcohol
Programs as a residential treatment program and by the Office of Mental Health as a residential treatment facili-
ty. The program also is accredited by the Joint Commission on Accreditation of Healthcare Organizations. The
program uses an MTC approach to treat substance abuse, provides onsite mental health services for co-occur-
ring mental disorders, and integrates substance abuse treatment and mental health services. Program services
include individual counseling, work therapy, life skills training, group therapy, educational seminars on sub-
stance abuse and mental health, 12-Step and Double Trouble meetings, family counseling, and mental health
treatment.
Focus House
Focus House is a long-term (9 months to 2 years) residential substance abuse treatment and mental health ser-
vices program for men ages 18 and over who have chronic COD. This 12-bed facility provides substance abuse
counseling, community residential rehabilitation, and transitional living arrangements for clients with severe and
persistent mental illness. Focus House teaches clients the essential life skills they will need to live independent
and productive lives in the community, to cease the substance abuse that complicates their mental illness, and to
promote self-motivated involvement in the mental health service system. This program is used as a step-down
from a more intensive residential inpatient program. All of the clients attend day programs at the local mental
health center. In-house program services include group therapy, relapse prevention, individual counseling,
socialization skill training, and life skills training.
New Beginnings
Gaudenzia’s New Beginnings is an 18-bed residential program that provides long-term residential care for
homeless men and women who are chronically mentally ill and have co-occurring substance use disorders.
The program initially is a “low-demand” environment that first addresses essential needs and then helps res-
idents change the dysfunctional patterns that contribute to chronic homelessness and aggravate their mental
disorders. It is called a “progressive demand facility,” which recognizes the need to meet clients where they
are, but expects individuals to reach their potential through layering services and expectations in a logical
building block manner.
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Joy of Living
Gaudenzia’s Joy of Living is a 14-bed program that provides long-term (9 to 18 months) residential services for
homeless men and women who have COD. The facility provides residents with shelter, support for recovery from
substance abuse, and assistance in stabilizing the symptoms of chronic mental disorders. Clients at both the Joy
of Living and New Beginnings programs (see above) arrive typically from a hospital or through interventions by
city outreach workers or as a next step residence for those who have completed longer-term treatment but are not
able to sustain themselves. They generally are not motivated for treatment and have many pressing needs that
must be met before they are capable of engaging in a treatment program. Mental health treatment services are
not provided onsite because the majority of the clients are in partial-hospital day programs off-site. Case manage-
ment services are provided to help coordinate services based on clients’ abilities to engage in these services.
The facility is considered a specialized progressive demand residence that engages people into formal treatment
services by intervention and referral to outside services as needed, such as mental health care, medical services,
and vocational/educational programs. Onsite substance abuse treatment includes individual and group counsel-
ing, treatment planning, life skills training, medication management, and 12-Step programs.
Progress House
Gaudenzia’s Progress House is a 14-bed moderate care community residential rehabilitation program for clients
with COD. The facility has six apartments; one is an office and the other five are residences shared by the clients.
The program provides semi-independent living for clients who have completed treatment at one of Gaudenzia’s
other programs. Staff is onsite 16 hours a day, and residents are provided with counseling for mental health and
substance abuse issues. All clients go to mental health service programs, vocational programs, or sheltered work-
shops during the day. Program services include life skills training, vocational guidance, 12-Step meetings, and
transitional living services.
New View
Gaudenzia’s New View was established to provide community residential rehabilitation services to adult residents
(both men and women) of Dauphin County who have SMI and a history of drug and alcohol problems. The pro-
gram can last up to 2 years depending on a client’s clinical progress. The eight-bed program has the features of
an MTC, with a strong emphasis on community reintegration. The goal for the majority of the clients is to obtain
employment in the community during the later stages of treatment. There also is a strong family component and a
weekly continuing care group for clients who have completed inpatient care and are making the transition to
independent living.
People With Hope 
This program is an MTC 23-bed facility for adult men and women who have AIDS (and are symptomatic) with a
variable length of treatment (3 to 9 months); the majority of these clients have co-occurring substance abuse and
mental disorders. The goal is to provide substance abuse treatment, shelter, medical care, seminars on HIV dis-
ease, and educational services that are designed to enhance the quality of life for the individual. The services dur-
ing the intensive phase of treatment include individual and group therapy, work therapy, GED/literacy classes,
and daily seminars that focus on life skills, AIDS-related issues, parenting, sexual orientation, nutrition, relapse
prevention, budgeting, and socialization. The re-entry and continuing care phases of the program include a tran-
sitional living component and a strong emphasis on 12-Step participation. For those clients who have a co-occur-
ring disorder, ongoing mental health services such as medication evaluation and monitoring are arranged through
the nearby community mental health center. People With Hope has a nursing staff onsite providing medication
management and health care case management.
Together House
Together House consists of three distinct programs in the same building licensed by the Commonwealth of
Pennsylvania under one umbrella to provide residential treatment for three distinct populations. Among the
three tracks, a total of 57 clients are served. The three programs are (1) Men’s Forensic Intensive Recovery pro-
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Recommendations
A considerable research base exists for the
MTC approach, and the consensus panel rec-
ommends the MTC as an effective model for
treating persons with COD, including those
with SMI. Recently, the MTC has been rated as
one of a few promising practices for COD by
the National Registry of Effective Programs
and Practices (NREPP), as part of NREPP’s
ongoing evaluation of COD strategies and mod-
els. However, although improved psychological
functioning has been reported, differential
improvement in mental health functioning
using the MTC approach in comparison to
more standard treatment has yet to be demon-
strated. The TC and MTC approach, although
demonstrably effective with various popula-
tions of people who use drugs, including those
with COD, encounters difficulty in achieving
more widespread acceptance. To accomplish
greater receptivity to TC and application of its
methods, several developments are necessary:
•The principles, methods, and empirical data
on MTC approaches need better articulation
and broader dissemination to the mental
health and other treatment fields. The devel-
opment of MTCs in mainstream mental
health programs is one useful approach
(Galanter et al. 1993).
•The application of MTC methods for COD in
non-TC medical and mental health settings
needs to be established more firmly. It is
especially important to ascertain whether,
and to what extent, these methods can be
separated from their TC framework and
made “portable” as services to be used by
other systems and approaches.
•As MTC programs continue to adapt for spe-
cific populations (e.g., adolescents, prison
gram (MFIR), (2) Women’s Forensic Intensive Recovery program (WFIR), and (3) Short-Term Program (STP).
MFIR and WFIR each provide residential treatment for 24 adults with COD who have been referred through
the City of Philadelphia Forensic network. The majority of these clients come directly to Together House from
the city prison system where they have been incarcerated for drug- or alcohol-related offenses. 
This program represents a major effort by the city of Philadelphia to provide treatment instead of incarceration
to individuals with substance use disorders, recognizing the special needs of the person with COD. The STP
serves nine men and women who have HIV, are homeless, and have COD. They must have issues of addiction
and also have a co-existing mental disorder. The purpose of STP is engagement, stabilization, thorough assess-
ment, and referral for longer-term treatment. Maximum length of stay is 4 to 6 weeks. In each track, all services
are provided onsite, including a full nursing staff, medical management, mental health services, individual and
group counseling, life skills education, health and mental health education, vocational planning, onsite 12-Step
meetings, and recreational programming.
FIRst Program 
The Department of Corrections FIRst (Forensic Intensive Recovery state) is located in the Together House com-
plex and provides a community corrections transitional living program for men coming from incarceration in the
State penal system with SMI and substance abuse issues. Started in the summer of 1999, this program was a
response to a gaping lack of support for men who were returning to their communities after serving lengthy sen-
tences for what was often a drug- or alcohol-related offense. Their SMI presented a particular problem for early
release, hence the FIRst program was indeed a first effort to aid in transition from incarceration to community
living. 
There are 24 men in residence for 9 to 12 months, with a thorough initial evaluation and stabilization period,
followed by increasing reliance on services in the community, decreasing dependence on the program, and grad-
ual re-introduction to the world of work, if possible. Onsite counseling (group and individual), nursing support,
mental health services, vocational assessment and referral, recreation, and resocialization classes are all provid-
ed. However, after initial engagement, community services are utilized to aid in practicing accessing outside sup-
ports in planning a return to outside life. 12-Step meetings are provided onsite and through outside groups.
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inmates, people with COD, women and chil-
dren), their longer term effectiveness after
treatment needs to be evaluated.
•Quality assurance of MTC programs is essen-
tial. The theory-based work of De Leon and
his colleagues for standard TCs provides the
necessary tools for this effort. Specifically,
the development of an instrument for mea-
suring the essential elements of TC programs
(Melnick and De Leon 1999) and the develop-
ment of standards for TC prison programs
(with Therapeutic Communities of America
1999) enable the service and research com-
munities to assess to what extent TC pro-
grams contain the essential elements and
meet applicable standards. Further work is
needed in adapting these instruments for
MTC programs. 
Additional Residential Models
A variety of other residential models have been
adapted for COD. Two representative models
are the Na’nizhoozi model in the Southwest,
designed for American Indians with alcohol
problems, with the recent incorporation of ser-
vices for COD (p. 180); and the Foundations
Associates model that integrates short-term res-
idential treatment with outpatient services (pp.
181–182).
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The Na’nizhoozi Center, Inc. (NCI)
Overview
The NCI has facilities in the town of Gallup, New Mexico (population 20,000), and serves clients throughout a
largely rural region of some 450,000 square miles, spanning two States and multiple counties within those States.
(In fact, because of the unique nature of the services it offers, the program has accepted clients from across the
United States.) The population in the area served by the program predominantly is American Indian.
In 1992, the Navajo Nation, the City of Gallup, the Zuni Pueblo, and McKinley County created NCI to address
a significant public intoxication problem in Gallup and in McKinley County, New Mexico. In the 1980s, Gallup
alone had more than 34,000 people placed into protective custody for public drunkenness; in 1999, this number
had decreased to 14,600.
Clients
The client population is 95 percent American Indian with the great majority (approximately 93 percent) being
members of the Navajo Nation. The program has a 150-bed residential facility built to provide service primarily
to clients in protective custody (a form of criminal justice sanction that does not involve felony or misdemeanor
or other criminal charge in a minimum-security setting, meaning that all doors are locked and the units are seg-
regated).
The primary substance abused by clients entering NCI is alcohol, and the majority of clients (70 percent) is
male. Clients exhibit an array of psychological problems and mental disorders. The incidence of COD with the
protective custody population is 20 percent. Posttraumatic stress disorder, major affective disorders, and per-
sonality disorders are seen most commonly at NCI.
NCI also has a 3-week short-term residential program that is based on American-Indian philosophy. The NCI
averages 12 clients per day, of whom 25 percent are admitted from the protective custody residential unit.
Services
NCI’s 28-day residential program consists of 150 beds and provides services that are based largely on practices
from both Dine’ (Navajo) and intertribal traditions. Treatment literature emphasizes culturally appropriate
interventions and NCI has made a major effort toward accomplishing this with the American-Indian population
it serves. Sweat lodge ceremonies, Talking Circles, language, appropriate individual and group counseling, and
culture-based treatment curricula are a few of the initiatives used. Sweat lodge ceremonies are nondenomina-
tional group activities with a strong spiritual component. Participants discuss problems or successes in life and
receive feedback from other participants. Talking Circles often have a greater number of participants than the
sweat lodge ceremonies with less interaction between the speaker and others in the circle. An important factor
associated with both activities is that they often are conducted in the native language with Navajo values empha-
sized in the dialog. Because more than one tribe is served at NCI, the services are designed to meet the needs of
different tribal cultures in the southwestern region.
The program has been increasing its services for clients with COD, which include referral to psychiatric assess-
ment, medication, and case management. NCI provides residential and shelter services to support psychiatric
interventions by monitoring medication use and providing crisis intervention services within the context of the
facility. 
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Foundations Associates
Foundations Associates in Nashville, Tennessee offers a residential program and a fully integrated continuum of
care for clients with COD. Foundations’ residential model employs a TC-like structure modified to incorporate
best practice concepts for COD. Foundations’ program has been recognized as a national leader in serving
clients with co-occurring substance abuse and SMI, such as schizophrenia.
Clients
Foundations typically serves clients diagnosed with substance dependence and SMI. Approximately 70 percent
of Foundations’ residents are diagnosed with schizophrenia, schizo-affective, or mood disorders with psychotic
features. Typical substance abuse problems include crack/cocaine, alcohol, and cannabis. Fifty percent of
Foundations’ consumers are women, and 80 percent are referred from primary substance abuse or mental
health treatment programs, typically after referring staff recognize the presence of a second (co-occurring) dis-
order.
Assessment
Substance abuse, mental health, physical health, vocational/educational, financial, housing/life skills, spiritual,
and recreational/social needs are assessed prior to program enrollment. Individualized therapy and case man-
agement plans are developed and service matching is determined through the assessment (using ASAM Patient
Placement Criteria, Second Edition, Revised). Based on the assessment, clients are assigned to appropriate ser-
vices.
Services
Core residential services include Dual Diagnosis Enhanced Therapeutic Community, Halfway House, and
Independent Living levels of care. Clients progress through the residential program in a series of five stages,
based on clinical progress and earned privilege. All clinical activities, including treatment team staffing, are fully
integrated to blend treatment for substance use and mental disorders. Program services are comprehensive to
meet the complex needs of clients, and frequently include case management, vocational rehabilitation, individu-
al/family/group therapy, and skills training.
Evaluation
Initial findings from a 3-year CSAT-funded evaluation of Foundations’ residential program indicated abstinence
in 70 to 80 percent of Foundations’ clients up to 1 year following treatment. Severity of psychiatric symptoms
was reduced by 60 percent, with corresponding improvements in quality of life. Perhaps most notably, high-cost
service utilization dropped substantially following integrated treatment, with 80 to 90 percent reductions in
inpatient and emergency room (ER) visits related to substance use or mental health problems. Likewise, inpa-
tient and ER visits for general health care declined by 50 to 60 percent. Service profiles showed an increase in
appropriate, cost-effective utilization of community supports and services. These results suggest that the pro-
gram model of integrated and continuous treatment breaks the repetitive cycle of traditional substance abuse
and mental health treatment for consumers with COD.
Best Practices
Best practice integrated treatment concepts serve as the basis for all program activities, including
•Continuous cross-training of professional and nonprofessional staff
•Empowerment of clients to engage fully in their own treatment
•Reliance upon motivational enhancement concepts
•Culturally appropriate services
•A long-term, stagewise perspective addressing all phases of recovery and relapse
•Strong therapeutic alliance to facilitate initial engagement and retention
Foundations Associates (continued)
•Group-based interventions as a forum for peer support, psychoeducation, and mutual self-help activities
•A side-by-side approach to life skills training, education, and support
•Community-based services to attend to clinical, housing, social, or other needs
•Fundamental optimism regarding “hope in recovery” by all staff
These principles reflect best practice concepts for COD, but the challenge lies in day-to-day program implemen-
tation. To facilitate broader adoption of integrated practices, Foundations Associates will make available upon
request implementation guides, program manuals, and clinical curricula for programs interested in adapting this
model to their community.
Contact information, detailed program materials, and research findings may be obtained via Foundations’ Web
site at www.dualdiagnosis.org.
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7 Special Settings and
Specific Populations
In This
Chapter…
Acute Care and
Other Medical
Settings
Dual Recovery
Mutual Self-Help
Programs
Specific
Populations
Overview
Building on the programmatic perspective of chapter 6, this chapter
describes substance abuse treatment for co-occurring disorders (COD)
within special settings and with specific populations. The chapter begins
with a discussion of treatment in acute care and other medical settings.
While not devoted to drug treatment, important substance abuse treat-
ment does occur there, hence their inclusion in the TIP. Two examples of
medical settings in which care is provided for clients with COD are pre-
sented: the Harborview Medical Center of Seattle, Washington, a teach-
ing and research county hospital that serves a number of clients with
serious mental illness (SMI) and severe substance abuse; and the HIV
Integration Project (HIP), run out of The CORE Center, an ambulatory
infectious disease clinic in Chicago, Illinois. HIP provides integrated
care to persons living with HIV/AIDS who also are diagnosed with co-
occurring mental and substance use disorders.
This chapter then turns to a description of the emerging dual recovery
mutual self-help programs, and the work of various advocacy groups
is highlighted. Finally, specific populations of clients with COD are
discussed, including the homeless, women, and those in criminal jus-
tice settings. This section highlights the treatment strategies that have
proven effective in responding to the needs of these populations.
Several examples of programs designed to serve such populations are
cited, including a variety of models for trauma. Two such programs
for specific populations are illustrated: the Clackamas County pro-
grams (Oregon City, Oregon) for persons with COD who are under
electronic surveillance or in jail and the Triad Women’s Project,
located in a semi-rural area of Florida that spans three counties. The
latter program was designed to provide integrated services for women
with histories of trauma and abuse who have COD. 
Additionally, this chapter contains Advice to the Counselor boxes, to
provide readers who have basic backgrounds with the most immediate
practical guidance. (For a full listing of these boxes see the table of
contents.)
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Acute Care and Other
Medical Settings
Background
Although not substance abuse treatment set-
tings per se, acute care and other medical set-
tings are included here because important
substance abuse and mental health treatment
do occur in medical units. Acute care refers
to short-term care provided in intensive care
units, brief hospital stays, and emergency
rooms (ERs). Providers in acute care settings
usually are not concerned with treating sub-
stance use disorders beyond detoxification,
stabilization, and/or referral. In other medi-
cal settings, such as primary care offices,
providers generally lack the resources to pro-
vide any kind of extensive substance abuse
treatment, but may be able to provide brief
interventions (for more information see TIP
24, A Guide to Substance Abuse Services for
Primary Care Clinicians [Center for
Substance Abuse Treatment (CSAT) 1997a]).
Exceptions are programs for chronic physical
illnesses such as HIV/AIDS, which may have
the staff and resources to provide some types
of ongoing treatment for mental illness and/or
substance abuse. TIP 37, Substance Abuse
Treatment for Persons With HIV/AIDS
(CSAT 2000e), provides comprehensive infor-
mation on substance abuse treatment for this
population, including integrated treatment
for people who have substance use disorders
and HIV/AIDS as well as co-occurring mental
disorders. 
The integration of substance abuse treatment
with primary medical care can be effective in
reducing both medical problems and levels of
substance abuse. More clients can be engaged
and retained in substance abuse treatment if
that treatment is integrated with medical care
than if clients are referred to a separate sub-
stance abuse treatment program (Willenbring
and Olson 1999). While extensive treatment
for substance abuse and co-occurring mental
disorders may not be available in acute care
settings given the constraints on time and
resources, brief assessments, referrals, and
interventions can be effective in moving a
client to the next level of treatment.
More information on particular issues relat-
ing to substance abuse screening and treat-
ment in acute and medical care settings can
be found in TIP 16, Alcohol and Other Drug
Screening of Hospitalized Trauma Patients
(CSAT 1995a); TIP 19, Detoxification From
Alcohol and Other Drugs (CSAT 1995c); and
TIP 24 (CSAT 1997a). More information on
the use and value of brief interventions can
be found in TIP 34, Brief Interventions and
Brief Therapies for Substance Abuse (CSAT
1999a).
Examples of Programs
Because acute care and primary care clinics
are seeing chronic physical diseases in combi-
nation with substance abuse and psychologi-
cal illness (Wells et al. 1989b), treatment
models appropriate to medical settings are
emerging. Two programs, the Harborview
Medical Center’s Crisis Triage Unit (CTU) in
Seattle and The CORE Center (an ambulato-
ry facility for the prevention, care, and
research of infectious disease) in Chicago, are
examples of two different medical settings in
which COD treatment has been effectively
integrated. (For a full description of these
programs, see the text boxes on pages 185 and
186.) The consensus panel notes that the pro-
grams selected have advantages over more
typical situations—the Harborview Medical
Setting is a teaching and research hospital
run by the county and The CORE Center has
the support of a research grant. Nonetheless,
program features are suggestive of the range
of services that can be offered.
The programs featured above typify the “no
wrong door” to treatment approach (CSAT
2000a). These providers have the capacity to
meet and respond to the client at the location
where care is requested, ensuring that each dis-
order is addressed in the treatment plan.
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Providing Treatment to Clients
With COD in Acute Care and
Other Medical Settings
Programs that rely on identification (i.e.,
screening and assessment) and referral have a
particular service niche within the treatment
system; to be successful, they must have a clear
view of their treatment goals and limitations.
Effective linkages with various community-
based substance abuse treatment facilities are
essential to ensure an appropriate response to
client needs and to facilitate access to addition-
al services when clients are ready. This section
highlights the essential features of providing
treatment to clients with COD in acute care
and other medical settings.
Harborview Medical Center’s Crisis Triage Unit, 
Seattle, Washington
Overview
The Harborview Medical Center is a teaching and research county hospital owned by King County and man-
aged by the University of Washington. As the major trauma center facility in the Seattle area, it receives clients
from throughout the Pacific Northwest. The Center has by far the busiest ER in the region, part of which is
dedicated to the Crisis Triage Unit for clients with substance abuse and/or mental illness–related emergencies.
Across the street from the program is a walk-in crisis center for persons with less severe psychological or sub-
stance-related disorders and drug-related emergencies.
Clients Served
The type of clients seen differs at each of the Center’s locations. Although clients representative of each of the
four quadrants are served, those seen in the ER fall generally into quadrant IV of the four-quadrant model,
that is, those with SMI and severe substance abuse problems (see chapters 2, 3, and 4 for more information
about the four-quadrant system).
Services
The focus of services at the CTU is on acute care. Primary goals are to ensure safety, assessment, stabilization,
and, as needed, triage to another level of care (either within the facility or outside). The CTU’s treatment can
involve intensive medical interventions (which may mean that the client is sent back to the medical/surgical ER),
psychiatric interventions (which may include engagement, assessment, acute medications, and even use of
restraints), substance abuse–related interventions (emergency detoxification, treatment for withdrawal, and
HIV screening and counseling), and holding and referral activities. Clients’ needs vary greatly; while some may
only receive a brief crisis intervention, others will require medical care and medication, and still others need
social services such as referral to housing.
The Crisis Triage Unit has a 23-hour holding area in the ER where clients can be held long enough to be evalu-
ated (the average length of stay is 4.5 hours). About 1,000 clients come through the CTU each month and close
to half of these have co-occurring substance use and mental disorders. Based on the client’s needs, disposition
can range from brief evaluation and referral to involuntary acute inpatient hospitalization.
Over the years, staff providing integrated treatment for people with COD have been placed (1) in the CTU, (2)
on all three inpatient acute psychiatric units, (3) in the mental health center outpatient program, (4) at the off-
site substance abuse treatment detoxification unit, and (5) at the regional substance abuse treatment residential
center. Most of the larger mental health centers in the area have developed treatment tracks for persons with
COD, and several of the larger substance abuse treatment agencies have hired onsite, part-time psychiatrists.
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Screening and assessment 
(in acute and other medical
settings)
Clients entering acute care or other medical
facilities generally are not seeking substance
abuse treatment. Often, treatment providers
(primary care and mental health) are not famil-
iar with substance use disorders. Their lack of
expertise can lead to unrealistic expectations or
frustrations, which may be directed inappro-
priately toward the client.
The CORE Center serves as a good example
of effective screening and assessment. To
facilitate early identification of substance
abuse and mental disorders within the HIV
client population, The CORE Center attempts
routine screening of all new clients accessing
primary care. Treatment begins at the screen-
ing or assessment phase; the triad assesses not
only psychological functioning and substance
abuse severity, but also readiness for change.
The provider will offer only those services
that the client is willing to accept. Examples
include literature to educate the client on his
disorders, case management to address hous-
ing or other needs, or referral for detoxifica-
tion. Next, the triad tries to engage the client,
creating a positive experience that encourages
The HIV Integration Project of The CORE Center, 
Chicago, Illinois
Overview
The HIV Integration Project (HIP) is run out of The CORE Center, an ambulatory infectious disease clinic in
Chicago, Illinois. It is part of a cooperative agreement funded by six Federal agencies. The goal of this project is
to evaluate the impact of the integration of primary care, mental health, and substance abuse treatment services
on the healthcare costs, treatment adherence, and health outcomes of persons living with HIV/AIDS who also
are diagnosed with co-occurring mental health and substance use disorders.
Clients Served
The center serves more than 3,000 HIV-infected clients annually. Clients predominantly are economically disad-
vantaged minorities, and include 33 percent women, 73 percent African Americans, 14 percent
Hispanics/Latinos, and 12 percent Caucasians. Approximately one-third of the clients present with co-occurring
mental health and substance use disorders.
Services
Many settings, despite close proximity, may deliver “co-located” care but not fully integrated care. The HIP
model focuses on developing a behavioral science triad that consists of a mental health counselor, a substance
abuse treatment counselor, and a case manager. Both medical and social service providers are present during
outpatient HIV clinic sessions and clients are screened for eligibility onsite. The triad works together to assess,
engage, and facilitate clinically appropriate services for clients with HIV and COD. If clients need immediate
services—such as housing, psychiatric hospitalization, or detoxification—the appropriate triad member will
facilitate linkage and coordination of care. Outpatient mental health care and substance abuse treatment are
offered at the same center where clients receive their primary care.
The triads meet jointly with their clients. They develop joint assessments and treatment plans, communicating
regularly with medical providers. Emphasis is placed on facilitating six processes among mental health, chemical
dependency, case management, and medical providers: (1) interdisciplinary team identity building, (2) coordi-
nation and communication, (3) cross-disciplinary learning, (4) outreach for clients who do not engage initially or
sustain mental health or substance abuse care, (5) mental health services, and (6) specialized training in the
care of triply diagnosed clients.
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return visits. Since continuity of care is
important, the triad attempts to follow clients
while hospitalized and to work with inpatient
medical staff in the same manner as with out-
patient staff.
A majority of clients do return to The CORE
Center for their primary care treatment.
Primary care providers keep the triad
informed of client visits so that counselors
can build a trusting working relationship with
clients that facilitates engagement in mental
health or substance abuse care. After meeting
with clients, the triad briefs the medical
providers on the clinical disposition and
treatment strategy. Often, these briefing ses-
sions serve as an opportunity for cross-disci-
plinary learning. The CORE Center frames
its treatment philosophy as holistic, and in
one setting treats both the physical and emo-
tional problems the client is experiencing. 
At Harborview, clients are given a multidisci-
plinary evaluation that has medical, mental
health, substance abuse, and social work
components. Harborview does not employ
any dedicated staff for performing evalua-
tion, but rather trains a variety of staff to
perform each part of the evaluation. Because
of the nature of the setting (the fast-paced
world of an emergency room), the basic
assessments usually can be performed in 30
minutes, but may take longer in more compli-
cated cases (e.g., if a client cannot communi-
cate because of a speech disorder and infor-
mation can be gathered only from records or
family). Chapter 4 contains a full description
of screening and assessment procedures and
instruments applicable to COD.
Accessing services
The CORE Clinic offers clinical interventions
focused on crisis counseling, single session
treatment, motivational enhancement, short-
term mental health services and substance
abuse treatment counseling, and psychoeduca-
tion as appropriate while the client is in The
CORE Center. Primary care providers some-
times are asked to help reinforce treatment rec-
ommendations and to join in being “one unified
voice” that the client hears.
Given the diversity among people with COD,
treatment referrals from The CORE Center
are varied, ranging from residential sub-
stance abuse treatment to acute psychiatric
hospitalization; solid working relationships
with treatment communities are needed
across settings. When the client is ready for
more intensive treatment, the triad provides a
critical triage function to the larger substance
abuse treatment and mental health services
communities.
When Harborview set up its CTU program,
part of its contract required that the county
mental health and substance abuse treatment
systems provide “back door” staff with the
authority to ensure client access to other
required services. At least one of these staff is
onsite 16 hours each day to make referrals
for clients being discharged from the CTU.
This service has proven extremely important
for ensuring both that continuing care for
COD is provided to clients leaving the unit
and that disposition of CTU clients is effi-
cient.
Implementation
Administrators who may be considering inte-
grating substance abuse treatment and/or men-
tal health services within existing medical set-
tings should realize that they are introducing a
new model of care. The systems and operating
culture in place may view changes as unneces-
sary. Similar to the way in which providers
assess a client’s readiness for change (i.e.,
readiness for treatment), administrators should
assess organizational readiness for change
prior to implementing a plan of integrated
care. This assessment should consider space for
additional staff, establish a clear organizational
reporting structure, and allow time for
providers to work in partnership with other
disciplines. 
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The assessment will inform the planning pro-
cess. In developing a plan, administrators
should:
• Seek input from all stakeholders, especially
the clients, a necessary prerequisite to devel-
oping or offering services. This information
can be gathered through archival data, focus
groups, and provider interviews.
•Clarify the role of each of the primary care,
substance abuse treatment, and mental
health treatment providers.
•Clearly specify the desired outcome(s) for
mental health and substance abuse treatment
services.
•Outline and pilot both formal and informal
communication mechanisms prior to full
implementation of services. 
When developing and implanting the program,
administrators should not minimize or ignore
the fact that the medical and social service cul-
tures are very different; opportunities must be
provided for relationship and team building
(ideally in informal settings). Finally, continued
monitoring and flexibility in the development of
the model are critical.
Staffing, supervision, and
training
Cross-training/cross-disciplinary
learning
Cross-training of staff in acute care settings
may be more difficult than in other settings
because of the greater variety of staff present,
but these activities are no less essential. For
example, in the Harborview program, staff
members include numerous doctors, nurses,
physician assistants, psychiatric residents in
training, medical students, social workers,
social work students, substance abuse treat-
ment counselors, and security officers. Such
settings have a greater number of stakehold-
ers than dedicated substance abuse treatment
programs—all of whom will need to be
involved, at some level, in the development
and implementation of a program for clients
with COD. Moreover, staff assigned to inte-
grated settings will have varying degrees of
commitment to integrated care. Staff also will
come into these settings with different defini-
tions of integrated care. They may have vary-
ing treatment approaches or may use disci-
pline-specific language that inadvertently can
become a barrier to integration. Time and
other resource limitations can also pose an
obstacle. The CORE Center’s medical care
providers cite time constraints as a major
impediment to close working relationships
with social service staff.
The CORE Center’s staff training program
serves to illustrate the potential of cross-
training. Staff who work in The CORE
Center have begun to look at cross-training
more as cross-disciplinary learning. They are
discovering what each discipline does, its lan-
guage and beliefs, and the role of that disci-
pline in the client’s treatment. For example,
even though a substance abuse treatment
counselor may never serve as a primary care
provider, the counselor can appreciate how
this provider contributes to the client’s well-
being. Likewise, primary care providers can
learn from case managers about the chal-
lenges of finding housing for clients with
COD. Social service staff wear lab coats that
identify their discipline and team affiliation
during clinic sessions; this simple but notice-
able change helps social service staff feel a
sense of belonging and supports team-building
efforts. Mutual respect for the disciplines and
a deeper understanding of the interrelated-
ness of the various staff functions develop
over time.
Team building
Staff training and consultation can help bring
all staff on board and unify treatment
approaches. To foster team building, The
CORE Center has incorporated key compo-
nents of competent care teams as discussed in
the geriatric and oncology literature
(Wadsworth and Fall Creek 1999). This effort
includes formal and informal team building,
training on working in an integrated healthcare
team, and clear communication mechanisms.
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Effective integrated care teams take time to
develop, and a number of institutional and dis-
ciplinary barriers make it difficult for staff
from different areas of expertise to work
together. For instance, differences in philoso-
phies of treatment and traditions of care, as
well as differences in how language is used to
describe and discuss disorders, can lead to
major communication problems. Thus, staff
need opportunities to become familiar with the
vocabulary of substance abuse treatment, men-
tal health services, and medical treatment.
Types of training
Specific training needs will vary depending on
the type of program, but some mechanism for
cross-training activities in acute care settings
needs to be in place. The CORE Center has
found it useful to have formal training activi-
ties where an instructor is invited into the
facility (which, in their experience, works
better than sending staff out of the facility for
training). This strategy may be used in combi-
nation with informal training mechanisms,
such as providing feedback to medical staff
concerning The CORE Center program so
they can better understand how medical deci-
sions affect clients’ success in substance abuse
treatment and mental health services.
Continuing care and transi-
tion issues
Since medical care is continuous for clients
with chronic medical conditions, continuing
care (also called aftercare) or transition
issues can become blurred for both clients
and providers. The CORE Center attempts to
facilitate linkage to more intensive services,
but realizes that chronically ill clients do not
make status transitions in the traditional
sense, but rather enter periods of stability
when little intervention is required. Because
episodic use of services by these clients is the
norm, staff need to be flexible and to realize
that these clients are likely to return to The
CORE Center when in crisis. This reality
underscores the requirement for strong link-
ages to other services for clients who need a
more intensive level of care than is available
in acute or outpatient care.
Program evaluation
In developing programs such as the HIV
Integration Project or Harborview, it is criti-
cal to incorporate program evaluation activi-
ties that examine
both process and
outcome. The evalu-
ation of these pro-
grams can prove
challenging. Logic
models that
describe the interre-
lationship between
the conceptual
framework, client
demographics,
treatment services,
and expected out-
comes are useful to
guide evaluation
efforts and to iden-
tify immediate,
short-, and long-
term outcomes.
Evaluators should
add measures such
as increased treat-
ment and medica-
tion adherence,
quality of life, and
physical health to
the more standard
outcome measures
such as abstinence
or remission of psy-
chiatric symptoms.
Since many of the
gains involve
improvement in
quality of life and
physical well-being,
evaluations that incorporate quantitative and
qualitative methods have the best success in
capturing the impact of these integrated ser-
vices. Given the high cost of medical care,
Administrators
who may be
considering inte-
grating sub-
stance abuse
treatment
and/or mental
health services
within existing
medical settings
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economic analyses of the cost and benefits
associated with treatment are essential.
Sustaining Programs for
Clients With COD in Acute
Care Settings
Acute care and other medical care settings
generally will rely on very different funding
streams than are available to outpatient or
residential substance abuse treatment pro-
grams. These funding sources will vary
depending on the type of program. At
Harborview, for example, most funds come
from the medical and mental health systems;
very little substance abuse treatment money is
involved. The program at Harborview has
been highly visible and has a number of key
county stakeholders (e.g., Department of
Mental Health, Department of Alcohol and
Drugs, County Hospital), which helps avoid
budget cuts. Harborview also has clearly
positioned itself as the program of last resort
in the region and has developed its programs
accordingly. Further, it has created a state-
of-the-art integrated information system (each
assessment generates a database entry); this
enables staff to prepare detailed quality and
clinical reports, which are of value to the
entire system.
Initial funding for The CORE Center came
from the Substance Abuse and Mental Health
Services Administration (SAMHSA) through
the AIDS demonstration program of
SAMHSA’s Center for Mental Health Services
(CMHS). Additional funding was provided
through other grants through CSAT. Funding
from the Health Resources and Services
Administration through the Ryan White Care
Act supports opportunities to offer more
intensive integrated services. Other funding
mechanisms, such as private foundation
grants, serve as vehicles to secure financial
support for these unique integrated services.
At present, it is difficult to secure sustained
funding from sources such as Medicare or
Medicaid. Continuing funding comes from the
Ryan White Care Act with some additional
funds from the county.
Dual Recovery Mutual
Self-Help Programs
The dual recovery mutual self-help movement
is emerging from two cultures: the 12-Step fel-
lowship recovery movement and, more recent-
ly, the culture of the mental health consumer
movement. This section describes both, as well
as other, consumer-driven psychoeducational
efforts.
Background
During the past decade, mutual self-help
approaches have emerged for individuals
affected by COD. Mutual self-help programs
apply a broad spectrum of personal responsi-
bility and peer support principles, usually
including 12-Step methods that prescribe a
planned regimen of change. These programs
are gaining recognition as more meetings are
being held in both agency and community set-
tings throughout the United States, Canada,
and abroad.
In recent years, dual recovery mutual self-
help organizations have emerged as a source
of support for people in recovery from COD
(DuPont 1994; Ryglewicz and Pepper 1996).
Such groups sometimes have been described
as special needs groups for people in recovery
from substance use disorders (Hendrickson et
al. 1996; White 1996). Mental health advoca-
cy organizations—including the National
Alliance for the Mentally Ill and the National
Mental Health Association—have published
articles that have identified dual recovery
mutual self-help organizations (Goldfinger
2000; Hamilton 2000). At the Federal level,
SAMHSA also has produced documents iden-
tifying dual recovery mutual self-help organi-
zations (CMHS 1998; CSAT 1994a).
The new dual recovery mutual self-help orga-
nizations are important signs of progress in
several respects: First, they encourage men
and women who are affected by COD to take
responsibility for their personal recovery.
Second, they reflect a growing trend toward
consumer empowerment (Hendrickson et al.
191Special Settings and Specific Populations
1994). Finally, they reflect recognition of the
importance of peer support in sustained
recovery.
Several issues serve as the rationale for estab-
lishing dual recovery programs as additions to
previously existing 12-Step community groups.
To paraphrase Hamilton’s review (Hamilton
2001):
•Stigma and Prejudice: Stigma related to
both substance abuse and mental illness
continues to be problematic, despite the
efforts of many advocacy organizations.
Unfortunately, these negative attitudes may
surface within a meeting. When this occurs,
people in dual recovery may find it difficult
to maintain a level of trust and safety in the
group setting.
•Inappropriate Advice (Confused Bias):
Many members of substance abuse recovery
groups recognize the real problem of cross-
addiction and are aware that people do use
certain prescription medications as intoxi-
cating drugs. Confusion about the appro-
priate role of psychiatric medication exists,
and as a result, some members may offer
well-intended, but inappropriate, advice by
cautioning newcomers against using medica-
tions. Clearly, confused bias against medi-
cations may create either of two problems.
First, newcomers may follow inappropriate
advice and stop taking their medications,
causing a recurrence of symptoms. Second,
newcomers quickly may recognize confused
bias against medications within a meeting,
feel uncomfortable, and keep a significant
aspect of their recovery a secret.
•Direction for Recovery: A strength of tradi-
tional 12-Step fellowships is their ability to
offer direction for recovery that is based on
years of collective experience. The new dual
recovery programs offer an opportunity to
begin drawing on the experiences that mem-
bers have encountered during both the pro-
gression of their COD and the process of
their dual recovery. In turn, that body of
experience can be shared with fellow mem-
bers and newcomers to provide direction
into the pathways to dual recovery.
• Acceptance:
Twelve-Step fel-
lowships provide
meetings that
offer settings for
recovery. Dual
recovery meetings
may offer mem-
bers and new-
comers a setting
of emotional
acceptance, sup-
port, and empow-
erment. This con-
dition provides
opportunities to
develop a level of
group trust in
which people can
feel safe and able
to share their
ideas and feelings
honestly while
focusing on recovery from both illnesses.
Dual Recovery Mutual Self-
Help Approaches
Dual recovery 12-Step fellowship groups recog-
nize the unique value of people in recovery
sharing their personal experiences, strengths,
and hope to help other people in recovery. This
section provides an overview of emerging self-
help fellowships and describes a model self-help
psychoeducational group.
Self-Help Groups
Four dual recovery mutual self-help organiza-
tions have gained recognition in the field, as
represented in the literature cited in this sec-
tion. Each of these fellowships is an indepen-
dent and autonomous membership organiza-
tion that is guided by the principles of its own
steps and traditions (for more information on
specific steps, see appendix J for each organi-
zation’s contact information). Dual recovery
fellowship members are free to interpret, use,
or follow the 12 steps in a way that meets
Dual recovery
meetings may
offer members
and newcomers
a setting of
emotional
acceptance,
support, and
empowerment. 
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their own needs. Members use the steps to
learn how to manage their addiction and men-
tal disorders together. The following section
provides additional information on each of
these specific organizations and the supported
mutual self-help model.
1. Double Trouble in Recovery (DTR). This
organization provides 12 steps that are
based on a traditional adaptation of the
original 12 steps. For example, the identi-
fied problem in step one is changed to
COD, and the population to be assisted is
changed in step 12 accordingly. The orga-
nization provides a format for meetings
that are chaired by members of the fellow-
ship.
2. Dual Disorders Anonymous. This organi-
zation follows a similar format to DTR.
Like other dual recovery fellowships, the
organization provides a meeting format
that is used by group members who chair
the meetings.
3. Dual Recovery Anonymous. This organiza-
tion provides 12 steps that are an adapted
and expanded version of the traditional 12
steps, similar to those used by DTR and
Dual Disorders Anonymous. The terms
“assets” and “liabilities” are used instead
of the traditional term “character
defects.” In addition, it incorporates affir-
mations into three of the 12 steps. Similar
to other dual recovery fellowships, this
organization provides a suggested meeting
format that is used by group members who
chair the meetings.
4. Dual Diagnosis Anonymous. This organi-
zation provides a hybrid approach that
uses 5 additional steps in conjunction with
the traditional 12 steps. The five steps dif-
fer from those of other dual recovery
groups in underscoring the potential need
for medical management, clinical interven-
tions, and therapies. Similar to other dual
recovery fellowships, this organization
provides a meeting format that is used by
group members who chair the meetings. 
The dual recovery fellowships are member-
ship organizations rather than consumer ser-
vice delivery programs. The fellowships func-
tion as autonomous networks, providing a
system of support parallel to traditional clini-
cal or psychosocial services. Meetings are
facilitated by members, who are empowered,
responsible, and take turns “chairing” or
“leading” the meetings for fellow members
and newcomers. Meetings are not led by pro-
fessional counselors (unless a member hap-
pens to be a professional counselor and takes
a turn at leading a meeting), nor are members
paid to lead meetings. However, the fellow-
ships may develop informal working relation-
ships or linkages with professional providers
and consumer organizations. 
In keeping with traditional 12-Step principles
and traditions, dual recovery 12-Step fellow-
ships do not provide specific clinical or coun-
seling interventions, classes on psychiatric
symptoms, or any services similar to case
management. Dual recovery fellowships main-
tain a primary purpose of members helping
one another achieve and maintain dual recov-
ery, prevent relapse, and carry the message
of recovery to others who experience dual dis-
orders. Dual recovery 12-Step members who
take turns chairing their meetings are mem-
bers of their fellowship as a whole.
Anonymity of meeting attendees is preserved
because group facilitators do not record the
names of their fellow members or newcomers.
Fellowship members carry out the primary
purpose through the service work of their
groups and meetings, some of which are
described below.
Groups provide various types of meetings,
such as step study meetings, in which the dis-
cussion revolves around ways to use the fel-
lowship’s steps for personal recovery.
Another type of meeting is a topic discussion
meeting, in which members present topics
related to dual recovery and discuss how they
cope with situations by applying the recovery
principles and steps of their fellowship.
Hospital and institutional meetings may be
provided by fellowship members to individu-
als currently in hospitals, treatment pro-
grams, or correctional facilities.
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Fellowship members who are experienced in
recovery may act as sponsors to newer mem-
bers. Newcomers may ask a member they
view as experienced to help them learn to use
the fellowship’s recovery principles and steps.
Outreach by fellowship members may provide
information about their organization to agen-
cies and institutions through in-service pro-
grams, workshops, or other types of presenta-
tions.
Access and linkage
The fellowships are independent organiza-
tions based on 12-Step principles and tradi-
tions that generally develop cooperative and
informal relationships with service providers
and other organizations. The fellowships can
be seen as providing a source of support that
is parallel to formal services, that is, partici-
pation while receiving treatment and after-
care services.
Referral to dual recovery fellowships is infor-
mal:
•An agency may provide a “host setting” for
one of the fellowships to hold its meetings.
The agency may arrange for its clients to
attend the scheduled meeting.
•An agency may provide transportation for its
clients to attend a community meeting pro-
vided by one of the fellowships.
•An agency may offer a schedule of community
meetings provided by one of the fellowships
as a support to referral for clients.
Common features of dual
recovery mutual self-help 
fellowships
Dual recovery fellowships tend to have the fol-
lowing in common:
•A perspective describing co-occurring disor-
ders and dual recovery.
•A series of steps that provides a plan to
achieve and maintain dual recovery, prevent
relapse, and organize resources.
•Literature describ-
ing the program
for members and
the public.
•A format to struc-
ture and conduct
meetings in a way
that provides a
setting of accep-
tance and support.
•Plans for establish-
ing an organiza-
tional structure to
guide the growth
of the member-
ship, that is, a cen-
tral office, fellow-
ship network of
area intergroups,
groups, and meet-
ings. An “inter-
group” is an
assembly of people
made up of dele-
gates from several
groups in an area.
It functions as a
communications
link upward to the
central office or
offices and out-
ward to all the
area groups it
serves.
Empirical evidence
Empirical evidence suggests that participation
in DTR contributes substantially to members’
progress in dual recovery and should be
encouraged. Specifically, studies found the fol-
lowing positive outcomes:
•A process analysis indicated that DTR
involvement at baseline predicted greater lev-
els of subsequent mutual self-help processes
(e.g., helper-therapy and reciprocal learning
experiences), which were associated with bet-
ter drug/alcohol abstinence outcomes
(Magura et al. 2003).
Dual recovery
12-Step 
fellowship
groups 
recognize the
unique value of
people in 
recovery shar-
ing their person-
al experiences,
strengths, and
hope to help
other people in
recovery. 
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•An examination of the associations between
DTR attendance, psychiatric medication
adherence, and mental health outcomes indi-
cated that consistent DTR attendance was
associated with better adherence to medica-
tion, controlling for other relevant variables.
Better adherence to medication was, in turn,
associated with lower symptom severity at
followup and no psychiatric hospitalization
during the follow-up period (Magura et al.
2002).
Supported mutual self-help
for dual recovery
Support Together for Emotional/Mental
Serenity and Sobriety (STEMSS) is a support-
ed self-help model for people with co-occurring
disorders. It is a psychoeducational group
intervention rather than a fellowship or mem-
bership organization; therefore it has no “par-
ent organization.” STEMSS uses trained facili-
tators to initiate,
implement, and
maintain support
groups for clients.
Facilitators may
include professional
counselors or
trained clinicians,
therapists, nurses,
or paraprofession-
als who are
employed at various
institutions, treat-
ment programs,
hospitals, or com-
munity agencies. In
some instances,
groups may be
started and facilitat-
ed by other individ-
uals trained in the
STEMSS model. 
The six steps of the
program and the
support groups are
intended to comple-
ment participation
in traditional 12-Step programs. Facilitators
generally are providers who have received
training in the theoretical concepts, the six
steps for recovery, psychoeducational con-
tent, and group approaches. They are
encouraged to work with the model in a flexi-
ble way, encouraging clients to develop lead-
ership skills to help groups make the transi-
tion from psychoeducational groups to
sources of mutual self-help. Facilitators may
modify the approach, incorporate additional
content, develop their own exercises, or
incorporate the model into the treatment sys-
tem. Roles commonly filled by the facilitator
include
• Psychoeducation: The facilitator provides
information related to recovery topics, psy-
chiatric symptoms, medications, symptom
management, coping skills, and other top-
ics.
•Exercises: The facilitator may develop
group exercises to stimulate discussions and
group interaction, as well as to help main-
tain the recovery focus.
•Step discussion: Facilitators initiate discus-
sions regarding the STEMSS six-step
approach to recovery.
The STEMSS model may be incorporated into
the milieu of an agency’s services or may be
an autonomous group established in a com-
munity setting; thus, STEMSS groups are
supported mutual self-help approaches rather
than fellowships or consumer service delivery
organizations. Due to the anonymous nature
of the groups and the way in which an agency
uses the model, linkages to STEMSS groups
would be established on a group-by-group
basis. For more detail about the STEMSS
model see TAP 17, Treating Alcohol and
Other Drug Abusers in Rural and Frontier
Areas (CSAT 1995e).
Advocating for Dual Recovery
At this writing, advocacy organizations are at
various stages of developing information mate-
rials, engaging in advocacy efforts to increase
public awareness, coalition building to develop
Empirical 
evidence sug-
gests that partic-
ipation in DTR
contributes sub-
stantially to
members’
progress in dual
recovery and
should be
encouraged.
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consensus for services, and providing support
for dual recovery mutual self-help organiza-
tions. For contact information on each organi-
zation, see appendix J.
Dual Diagnosis Recovery
Network (DDRN)
The DDRN is a program of Foundations
Associates that derives part of its funding from
the Tennessee Department of Mental Health
and Developmental Disabilities and part from
the Tennessee Department of Health, Bureau
of Alcohol and Drug Abuse Services. DDRN
provides
•Dual recovery mutual self-help information
for all areas of the services that are offered
•Education and training through community
programs, inservice training, and work-
shops, and through State, regional, and
national conferences
•Advocacy and coalition building through
networking and coordinating a statewide
task force that engages chemical dependen-
cy and mental health professionals, clients,
and family members
•Information dissemination through the Dual
Network quarterly journal and through the
resource and information clearinghouse
Dual Recovery Empowerment
Foundation (DREF)
The DREF provides training programs and
materials to assist treatment providers, con-
sumer-run programs, and consumer advocacy
organizations in developing education pro-
grams for clients, consumers, and family
members. One DREF program is Dual
Recovery Self-Help, which encompasses
information on dual recovery 12-Step fellow-
ships, 12-Step principles for personal recov-
ery, coping and life skills, and forming dual
recovery 12-Step groups and meetings. DREF
also offers Recovery Cultural Cross Training,
which provides a cultural competency
approach to reframe “philosophical barriers”
and explore the histories, common goals,
diversity, and accomplishments of both the
substance abuse recovery culture and the
mental health consumer recovery culture.
National Mental Health
Association
The National Mental Health Association
(NMHA) has expanded its mission to include
COD. In 1999 the NMHA board of directors
adopted a position statement that affirmed
NMHA’s commitment to advocacy, public
education, and service delivery for consumers
with co-occurring substance use and mental
disorders. NMHA focuses its efforts in four
major areas—prevention, treatment,
research, and policy—and is committed to
providing leadership in the substance abuse
and mental health fields in the area of COD.
The organization has a designated area on its
Web site—Alcohol and Drug Abuse,
Addiction and Co-Occurring Disorders—that
contains information, facts, resources, and
links to help mental health consumer advo-
cates increase their knowledge about the key
issues in COD (www.nmha.org/substance/
index.cfm).
National Council on
Alcoholism and Drug
Dependence
The National Council on Alcoholism and Drug
Dependence, Inc. (NCADD) was founded in
1944 and works at the national level on policy
issues related to barriers in education, preven-
tion, and treatment for people with substance
use disorders and their families. NCADD has a
nationwide network of nearly 100 affiliates.
These affiliates provide information and refer-
rals to local services, including counseling and
treatment. NCADD also offers a variety of pub-
lications and resources. For more information,
visit www.ncadd.org.
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Mental health consumer
advocacy organizations
The consumer advocacy movement has a his-
tory separate from the substance abuse recov-
ery and 12-Step recovery movements. The
historical roots of the mental health recovery
movement, to a great extent, are related
directly to issues in
the delivery of men-
tal health services.
The modern move-
ment formed in
response to con-
cerns about the
quality of care,
availability of ser-
vices, and lack of
coordination during
and following dein-
stitutionalization.
The term “mental
health consumer,”
though controver-
sial to many people
in the movement,
clearly reflects both
a personal and col-
lective relationship
to issues related to
mental health care
services and sup-
port. On the other
hand, individuals
in substance abuse
recovery and those
in 12-Step programs do not identify them-
selves in language that is related to treatment
services. 
The mental health recovery movement and
the substance abuse recovery movement can
develop ways to collaborate in an effort to
support people affected by COD. In order to
collaborate, the movements must engage in a
coalition building process that involves
•Shared goals and visions of the movement
•Histories: identifying and valuing diversity
•Experience, strengths, and skills
•Accomplishments and progress
•Shared goals and visions for dual recovery
Consumer Organization and
Networking Technical
Assistance Center (CONTAC)
The West Virginia Mental Health Consumer’s
Association’s CONTAC, which receives funding
through SAMHSA’s CMHS, serves as a
resource center for consumers/survivors/
ex-patients and consumer-run organizations
across the United States, promoting self-help,
recovery, and empowerment (see
www.contac.org/the.htm). The services that
CONTAC provides include informational mate-
rials, onsite training and skills-building curric-
ula, and networking and customized activities
promoting self-help, recovery, leadership, busi-
ness management, and empowerment. 
CONTAC also offers the Leadership Academy,
a training program that is designed to help
clients learn how to engage in and develop con-
sumer services (www.contac.org/WVMHCA/
wvla/index.htm).
National Empowerment
Center
The National Empowerment Center has pre-
pared an information packet that includes a
series of journal articles, newspaper articles,
and a listing of organizations and Federal agen-
cies that provide information, resources, and
technical assistance related to substance abuse
and dependence, COD, services, and mutual
self-help support.
The consumer
advocacy move-
ment has a his-
tory separate
from the sub-
stance abuse
recovery and
12-Step recov-
ery movements. 
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Specific Populations
In recent years, awareness of COD in subpop-
ulations (such as the homeless, criminal jus-
tice clients, women with children, adoles-
cents, and those with HIV/AIDS) and concern
about its implications has been growing. This
section focuses on three of these subgroups:
the homeless, those in criminal justice set-
tings, and women. A complete description of
these clients and related programs is beyond
the scope of this TIP. However, relevant
information can be found in a number of
other TIPs, including TIP 17, Planning for
Alcohol and Other Drug Abuse Treatment for
Adults in the Criminal Justice System (CSAT
1995d); TIP 21, Combining Alcohol and
Other Drug Abuse Treatment With Diversion
for Juveniles in the Justice System (CSAT
1995b); TIP 30, Continuity of Offender
Treatment for Substance Use Disorders From
Institution to Community (CSAT 1998c); and
the forthcoming TIPs Substance Abuse
Treatment for Adults in the Criminal Justice
System (CSAT in development e) and
Substance Abuse Treatment: Addressing the
Specific Needs of Women (CSAT in develop-
ment b). This section provides background
information on the problem of COD in these
specific populations, describes some model
programs and Federal initiatives, and offers
recommendations for programs and services.
The purpose of this section is to highlight the
emergence of specific-population COD groups
and the potential impact of these specialized
populations on COD treatment.
Homeless Persons With COD
Homelessness
Homelessness continues to be one of the
United States’ most intractable and complex
social problems. The Urban Institute esti-
mates that 2.3 to 3.5 million people are home-
less annually and 842,000 were homeless in
February 1996 (Burt and Aron 2000). In New
York City alone, more than 33,800 New
Yorkers use the city shelter system each night
(Bernstein 2002). Despite these statistics, an
understanding of the diversity of this popula-
tion and its service needs is incomplete, and
treatment options are still meager.
Homeless people have a variety of medical
problems (Institute of Medicine 1988), includ-
ing HIV (CSAT 2000e). They are frequent
victims of and participants in crime (Rahav
and Link 1995). They also are disproportion-
ately likely to use substances (Fischer and
Breakey 1987) and to have some form of men-
tal illness (Rossi 1990).
Homelessness and COD
Homeless persons with COD are a particularly
problematic subgroup, one that places unique
demands on the mental health and substance
abuse treatment systems. The number of home-
less persons with COD has been estimated to
range from 82,215 to 168,000 in any given week
(Rahav et al. 1995).
For most, if not all, homeless clients with
COD, the impact of substance abuse and
mental illness bears a direct relationship to
their homeless status. The ability to maintain
housing is affected profoundly by substance
abuse (Hurlburt et al. 1996). Approximately
70 percent of participants in recent National
Institute on Alcohol Abuse and Alcoholism
demonstration projects identified substance
abuse problems as the primary reason for
their homelessness in both the first and most
recent episodes (Leaf et al. 1993; Stevens et
al. 1993). Among those in shelters, 86 percent
are estimated to have alcohol problems and
more than 60 percent have problems with
illicit drugs (Fischer and Breakey 1991).
The importance of housing
Results from the homelessness prevention
cooperative agreement funded by SAMHSA’s
CMHS and CSAT suggest the importance of
providing interventions that address housing.
Those that ensured housing by “control of
housing stock” (i.e., programs that make
housing available or ensure housing) are of
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particular interest. This study explored the
interactions among housing, treatment, and
outcomes for persons with COD who are
homeless. Researchers noted that after 6
months, the intervention group for whom
housing was made available had 12 more days
of stable housing (during the 6-month period)
than the comparison group. After 1 year, the
intervention group had 17 more such days
(Williams et al. 2001). Among participants
who had guaranteed access to housing,
improvements were even greater: At 6 months
and at 1 year, participants who had guaran-
teed access to housing showed significant
short-term and longer-term improvements (on
all residential measures) compared to a con-
trol group who did not have access to hous-
ing. The change in the stable housing measure
represents a 40-day increase from baseline at
6 months and a 41-day increase at 1 year. In
contrast, the comparison group showed
decreases in housing stability. At 6 months
they had 14 fewer days of homelessness, and
at 1 year, 7 days. These results are signifi-
cant, underlining the contribution of stable
housing to recovery of individuals with COD
(Williams et al. 2001).
Another study examined the cost of providing
supportive housing versus allowing homeless
people to continue in the homeless assistance
system, including the cost to the mental
health, substance abuse treatment, shelter,
hospital, criminal justice, and other public
systems. The study reported that psychiatric
hospital stays were reduced by 28.2 days (49
percent) for each placement in supportive
housing. The study found that supportive
housing dramatically reduced use of other
public systems by people who were homeless
and had SMI, including many who also had
substance abuse problems (Culhane et al.
2001).
Service models for homeless
persons with COD
The treatment community has responded posi-
tively to the needs of this population. It has
developed several models for homeless clients
with COD.
Supportive housing 
Supportive housing typically is housing com-
bined with access to services and supports to
address the needs of homeless individuals so
that they may live independently in the com-
munity. Generally, it is considered an option
for individuals and families who have either
lived on the streets for longer periods of time
and/or who have needs that can be best met
by services accessed through their housing.
Although the evidence base consists of a small
number of studies that vary in methodological
rigor and population focus, the results indi-
cate that housing with supports in any form is
a powerful intervention that improves the
housing stability of individuals with substance
abuse and mental disorders, including those
who have been homeless (Hurlburt et al.
1996; Rog and Gutman 1997; Shinn et al.
1991). However, many of the same studies
also indicate that substance abuse is a major
cause of housing loss and that individuals
with COD fare less well in housing than those
with other disabilities (Shern et al. 1997).
The Pathways to Housing program developed
by Tsemberis (Tsemberis et al. 2003;
Tsemberis and Eisenberg 2000) is a form of
supportive housing designed to serve a highly
visible and vulnerable segment of New York’s
homeless population (persons with COD who
live in the streets, parks, subway tunnels, and
similar places). The Pathways program
adopts a client perspective and offers clients
the option of moving from the streets directly
into a furnished apartment of their own
(Tsemberis and Eisenberg 2000). However,
clients must agree to receive case management
and accept a representative payee to ensure
that rent/utilities are paid and for resource
management. Pathways also uses Assertive
Community Treatment teams to offer clients
their choice of a wide array of support ser-
vices in twice-monthly sessions. Vocational,
health, psychiatric, substance abuse, and
other services are among the options.
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A 2-year longitudinal, random assignment,
clinical trial study evaluating the effectiveness
of the Pathways program as compared to con-
tinuum of care programs (i.e., programs
where clients move from one level of housing
to the next least restrictive level) was con-
ducted with 225 individuals who were home-
less and had mental disabilities; 90 percent
also had co-occurring substance use disor-
ders. Housing outcomes were significantly
better for the Pathways group at the 6-, 12-,
18-, and 24-month followup points. For exam-
ple, between 18 and 24 months the Pathways
group members spent 4 percent of their time
literally homeless, compared to 23 percent for
the continuum group; they also spent 74 per-
cent of their time in stable housing, compared
to 34 percent for the continuum group. In
addition, Pathways participants were not
more symptomatic at any point, and they did
not differ from the continuum group on use of
alcohol or other substances. However, the
greater effectiveness of the Pathways program
in comparison with other programs for the
substance abuse, mental health, and other
problems of these homeless clients with COD
remains to be established.
Housing contingent on 
treatment
Milby and colleagues (1996) found promise in
an intervention that added contingent work
therapy and housing to a regular day treat-
ment regimen. They compared a standard
treatment that featured twice-weekly treat-
ment sessions and referrals for housing and
vocational services with an enhanced treat-
ment program that included weekday day
treatment (for 5.5 hours per day) and a work
therapy component that provided clients with
a salary great enough to afford subsidized
housing (contingent upon drug-free urine
samples). Clients in day treatment with the
housing and vocational component had 36
percent fewer cocaine-positive urine toxicolo-
gies at 2 months after treatment and 18 per-
cent fewer at 6 months compared to clients in
the standard outpa-
tient program.
However, the study
did not focus solely
on clients with
COD; in fact, it
excluded clients
with active psy-
chosis (Milby et al.
1996).
In a later study,
Milby and col-
leagues (2000) com-
pared two different
day treatment pro-
grams, one that
added abstinent
contingent employ-
ment and housing
and one that did
not. Although the
study excluded
clients with psy-
chotic disorders,
three fourths met
Axis I diagnostic
criteria for other
mental disorders.
Those who received
the extra vocational and housing services
achieved longer periods of abstinence than
those who did not (the former having a medi-
an of approximately 9 consecutive weeks of
abstinence out of 24 weeks, and the latter
only 3–4 consecutive weeks during the same
period). The clients who received these added
services also showed greater gains in mea-
sures of homelessness and employment (Milby
et al. 2000).
Housing and treatment 
integrated
In New York City two specialized shelters are
addressing the needs of people who are home-
less and who have COD: the Greenhouse
Program and the Salvation Army shelter. The
For most, if not
all, homeless
clients with
COD, the
impact of sub-
stance abuse
and mental ill-
ness bears a
direct relation-
ship to their
homeless status. 
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Greenhouse Program is a 28-bed modified
therapeutic community (TC) shelter for hard-
to-reach homeless persons with COD. Staff at
the program are trained to address both men-
tal and substance use disorder issues.
Developed in 1991 by Bellevue Hospital, this
was one of the first specialized shelter pro-
grams in the City to treat this population
(Galanter et al. 1993; Silberstein et al. 1997).
The second is the Salvation Army shelter.
Developed in 1998 by the Salvation Army in
association with National Development and
Research Institutes, Inc., “Kingsboro
New Beginnings” is a modified TC for
engagement and retention in an 80-bed
shelter. Designed for hard-to-reach peo-
ple who are homeless and have co-occur-
ring mental and substance use disor-
ders—those who are seeking shelter, but
not necessarily treatment—this program
brought people with COD who were
homeless into a specialized shelter set-
ting, using strategies to engage them in
mental health services and substance
abuse treatment and prepare them for
housing (Sacks et al. 2002). 
In a series of papers, Sacks and col-
leagues report on a system of care for
people who are homeless that uses a
modified therapeutic community (MTC)
approach (see chapter 6 for additional
information on the MTC model). Clients
move from a residential facility to co-
located supportive housing as they progress
though stages of treatment. Engagement, pri-
mary treatment, and planning for re-entry
take place in the residential facility; re-entry
takes place in the supportive housing pro-
gram. The research indicated that these
clients made significant improvement (com-
pared to treatment-as-usual) on measures of
substance use and employment during resi-
dential treatment (De Leon et al. 1999,
2000c). These gains appeared to stabilize dur-
ing the supportive housing phase (Sacks et al.
2003a). The authors concluded:
These pilot findings suggest that the positive
behavioral change associated with completion
of 12 months of residential treatment can be
sustained and, in some cases, strengthened by
the use of TC-oriented supported housing as
an aftercare strategy. The particular gains in
employment and symptom relief are notewor-
thy in that they speak to core problems of the
homeless MICA [mentally ill chemical abus-
ing] population. Combined with the capacity
to maintain low levels of crime and substance
use, supported housing can be seen as an
important and effective way of achieving con-
tinuing progress for this population (Sacks et
al. 2003a).
Criminal Justice Populations
Prevalence of COD
Estimates of the rates of severe mental and
substance use disorders in jail and prison
populations have varied between 3 and 16
percent (Peters and Hills 1993; Regier et al.
1990; Steadman et al. 1987). A U.S.
Department of Justice special report (Ditton
1999) estimated that 16 percent of State
prison inmates, 7 percent of Federal inmates,
16 percent of those in local jails, and about
16 percent of probationers reported either a
mental disorder or an overnight stay in a
mental hospital during their lifetime (Ditton
Advice to the Counselor:
Working With Homeless Clients 
With COD
The consensus panel recommends the following in
working with homeless clients with COD:
• Address the housing needs of clients.
• Help clients obtain housing.
• Teach clients skills for maintaining housing.
• Work closely with shelter workers and other
providers of services to the homeless.
• Address real-life issues in addition to housing, such as
substance abuse treatment, legal and pending crimi-
nal justice issues, Supplemental Security
Insurance/entitlement applications, issues related to
children, healthcare needs, and so on.
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1999). Substance abuse is also common in the
criminal justice population. Offenders in the
U.S. Department of Justice Survey report a
high incidence of drug and alcohol abuse.
One third were alcohol dependent, while 6 in
10 were under the influence of alcohol or
drugs at the time of offense (Ditton 1999). 
Rationale for treatment
The rationale for providing substance abuse
treatment in prisons is based on the well-
established relationship between substance
abuse and criminal behavior. According to
Ditton (1999), offenders with mental illness
were likely to be using substances when they
committed their convicting offense and likely
to be incarcerated for a violent crime. On the
other hand, the majority of probationers with
mental disorders (approximately three quar-
ters) have not been involved in violent crime.
The overall goal of substance abuse treatment
for criminal offenders, especially for those
who are violent, is to reduce criminality.
Treatment features and
approaches
Several features distinguish the programs cur-
rently in place to treat inmates with COD from
other substance abuse treatment programs:
•Staff are trained and experienced in treating
both mental illness and substance abuse.
•Both disorders are treated as “primary.”
•Treatment services are integrated whenever
possible.
•Comprehensive treatment is flexible and indi-
vidualized.
•The focus of the treatment is long-term.
Treatment approaches used with other popu-
lations (e.g., TCs, interventions using cogni-
tive–behavioral approaches, relapse preven-
tion strategies, and support groups) can be
adapted to suit the particular needs of offend-
ers with COD. Common modifications
described in the literature (Edens et al. 1997;
Peters and Hills 1997; Peters and Steinberg
2000; Sacks and Peters 2002) include
•Smaller caseloads
•Shorter and simplified meetings
•Special attention to criminal thinking
•Education about medication and COD
•An effort to minimize confrontation
The importance of post-
release treatment and 
followup
In the last decade, a number of studies have
established the importance of linking institu-
tional services to community services (of vari-
ous kinds). The initial rationale for providing
aftercare subsequent to prison-based treat-
ment was to ease the abrupt transition of the
offender from prison to community, thus pro-
moting reintegration while monitoring the
offender’s behavior in a semi-controlled envi-
ronment (Clear and Braga 1995; McCarthy
and McCarthy 1997). Significant reductions
in recidivism were obtained; reductions were
larger and sustained for longer periods of
time when institutional care was integrated
with aftercare programs. Examples are TC
work-release (Butzin et al. 2002; Inciardi et
al. 2001; Martin et al. 1999) or other commu-
nity-based treatment such as post-prison TC
(Griffith et al. 1999; Hiller et al. 1999; Knight
et al. 1997; Wexler et al. 1999) or cognitive–
behavioral programs (Johnson and Hunter
1995; Peters et al. 1993; Ross et al. 1988).
Longer-term followup studies of TC in-prison
plus aftercare programs have reported find-
ings indicating that treatment effects produc-
ing lower rates of return to custody may per-
sist for up to 5 years (Prendergast et al.
2004).
Recently, the National Institute on Drug
Abuse has established the Criminal Justice
Drug Abuse Treatment System. This initiative
funds regional research centers that are
intended to forge partnerships between sub-
stance abuse service providers and the crimi-
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nal justice system to design and test
approaches to the better integration of in-
prison treatment and post-prison services. 
Examples of programs in
prisons
The Clackamas County program
(Oregon City, Oregon)
Clackamas County offers two related programs
for persons in jails. While incarcerated,
inmates are offered pretreatment services in
which psychoeducational and preliminary
treatment issues are discussed. Discussion ses-
sions are staffed by both a substance abuse
treatment counselor, employed by the Mental
Health Center, and a corrections counselor
who is certified to provide substance abuse
treatment services. Inmates are housed in a
separate unit, creating some milieu interven-
tion factors. 
Many of these inmates are transferred to the
Center’s Corrections Substance Abuse
Program, when space is available. The
Corrections Substance Abuse Program is a
residential treatment program within a work
release setting. During the first phase clients
stay in-house exclusively. With successful
progress, they are allowed to seek work in the
community. On completion of the program,
clients are transitioned to outpatient care in
the community with continued monitoring by
probation or parole.
Clackamas County also offers intensive out-
patient programs focused on different client
needs. Through close consultation with the
local criminal justice system, offenders under
electronic surveillance receive intensive out-
patient care. Programming is gender based,
with parallel programming for men and
women. Sufficient progress transitions the
client to less intensive outpatient care.
The Clackamas County program for offenders
under electronic surveillance was developed
in close consultation with the criminal justice
system, with staff members from that system
serving as co-facilitators for treatment groups
in the program. The highest incidence of per-
sonality disorders of any clients in Clackamas
County’s substance abuse treatment programs
have been found in this particular population
of offenders. Consequently, skills building to
address such mental health issues as identify-
ing thinking errors, anger management, and
conflict resolution are emphasized and form
an integral part of this intervention. A sub-
program (“Bridges”) works
specifically with clients who have
COD, providing case manage-
ment and treatment services.
Most Bridges clients have severe
and persistent mental illness
with histories of school and work
failures; consequently, the inter-
vention is intensive, stepwise,
and structured, with the oppor-
tunity for support in developing
social and work skills.
Another effort coordinated with
criminal justice has been the
intensive outpatient subpro-
gram, drug court. To partici-
pate, clients must be of non-
felony status and can have their
Advice to the Counselor:
Providing Community Supervision 
for Offenders With COD
The panel recommends the following strategies for com-
munity supervision of offenders with COD:
• Recognize special service needs.
• Give positive reinforcement for small successes and
progress.
• Clarify expectations regarding response to supervision.
• Use flexible responses to infractions.
• Give concrete (i.e., not abstract) directions.
• Design highly structured activities.
• Provide ongoing monitoring of symptoms.
Source: Adapted from Peters and Hills 1997.
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misdemeanor charges expunged by comple-
tion of the year-long program. This program,
too, is conceived as a stepwise intervention.
The Colorado Prison program
In response to the increasing number of
inmates with SMI, the Colorado Department of
Corrections contracted with a private not-for-
profit agency during the mid-1990s to develop
Personal Reflections, a modified TC program.
A separate 32-bed unit with a planned stay of
15 months, Personal Reflections is located in
Pueblo at the San Carlos Correctional Facility,
which houses only inmates with mental illness.
The goal of the program is to foster personal
change and to reduce the incidence of return
to a criminal lifestyle. Personal Reflections
uses TC principles and methods as the foun-
dation for recovery and to provide the struc-
ture for a cognitive–behavioral curriculum
focused on the triple issues of substance
abuse, mental illness, and criminal thinking
and activity. At the same time, as is central to
TC programming, a positive peer culture is
employed to facilitate behavior change.
The Personal Reflections modified TC uses
psychoeducational classes to increase an
inmate’s understanding of mental illness,
addiction, the nature of COD, drugs of use
and abuse, and the connection between
thoughts and behavior. These classes also
teach emotional and behavioral coping skills.
Therapeutic interventions in the modified TC
include (1) core groups to process personal
issues, (2) modified encounter groups that
address maladaptive behaviors and personal
responsibility, and (3) peer groups to provide
feedback and support.
Empirical evidence
The Personal Reflections program is being
evaluated by a study design that randomly
assigned and compared two groups, modified
TC and services-as-usual (i.e., a mental health
services approach). The results obtained from
an intent-to-treat analysis of all study entries
showed that inmates randomized into the MTC
group had significantly lower rates of reincar-
ceration compared to those in the mental
health services only group (Sacks et al. 2004). 
Because of the stigma associated with the
combination of substance abuse, co-occurring
mental illness, and a criminal record, this
group of offenders will face barriers to being
accepted into an aftercare program. They
also will have difficulty locating effective pro-
grams for their complex problems that
require specialized treatment (Broner et al.
2002). 
Women
Women with co-occurring disorders can be
served in the same types of mixed-gender co-
occurring programs and with the strategies
mentioned elsewhere in this TIP. However,
specialized programs for women with COD
have been developed primarily to address
pregnancy and childcare issues as well as cer-
tain kinds of trauma, violence, and victimiza-
tion that may best be dealt with in women-
only programs. 
Responsibility for care of dependent children
is one of the most important barriers to enter-
ing treatment according to a major survey of
public alcohol dependence authorities, treat-
ment programs, and gatekeepers in 39 com-
munities (CSAT 2001). Women who enter
treatment sometimes risk losing public assis-
tance support and custody of their children,
making the decision to begin treatment a diffi-
cult one (Blume 1997). Women accompanied
by their children into treatment can be suc-
cessful in treatment. A CSAT study of 50
grantees in the Residential Women and
Children and Pregnant and Postpartum
Women programs reported that the 6- to 12-
month treatment program had positive results
according to a number of outcome measures
(CSAT 2001).
Few women-centered or women-only outpa-
tient co-occurring programs have been
described, and most outpatient groups are
mixed gender. However, Comtois and Ries
(1995) concluded that gender-specific special-
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ized programming may make very significant
differences. They found that before special-
ized programming, women only accounted for
20 percent of group attendance, yet made up
40 percent of census in a large integrated
COD treatment program for those with SMI.
After women-only specialized programming
was developed, the 40 percent census then
accounted for 50 percent of group visits.
Women attendees commented that they did
not feel comfortable in mixed groups, espe-
cially in the early phases of treatment, but
felt very differently when they had their own
groups. 
It is the responsibility of the program to
address the specific needs of women, and
mixed-gender programs need to be made
more responsive to women’s needs. Women in
mixed-gender outpatient programs require
very careful and appropriate counselor
matching and the availability of specialized
women-only groups to address sensitive issues
such as trauma, parenting, stigma, and self-
esteem. Strong administrative policies per-
taining to sexual harassment, safety, and lan-
guage must be clearly stated and upheld.
These same issues occur in residential pro-
grams designed for women who have multiple
and complex needs and require a safe envi-
ronment for stabilization, intensive treat-
ment, and an intensive recovery support
structure. Residential treatment for pregnant
women with co-occurring disorders should
provide integrated co-occurring treatment
and primary medical care, as well as atten-
tion to other related problems and disorders.
The needs of women in residential care
depend in part on the severity and complexity
of their co-occurring mental disorders. Other
issues meriting attention include past or pre-
sent history of domestic violence or sexual
abuse, physical health, and pregnancy or
parental status.
Substance abuse and mental
health problems in women
While alcohol, marijuana, and cocaine contin-
ue to be problems, heroin, methamphetamine,
and new drugs like OxyContin® have gained
popularity among women. In general, drugs of
abuse today are more available and less expen-
sive than in the past. The previously lower rate
of addictions in women compared to men
appears to be vanishing, as the rate of sub-
stance abuse among young females has become
almost equivalent to that of young males. For
example, according to SAMHSA’s 2002
National Survey on Drug Use and Health, past-
month use of methamphetamine reported by
women was 0.2 percent, versus 0.3 percent
reported by men (Office of Applied Studies
2003b).
Women and men have differing coping mecha-
nisms and symptom profiles. As compared to
their male counterparts, women with sub-
stance use disorders have more mental disor-
ders (depression, anxiety, eating disorders,
and posttraumatic stress disorder [PTSD])
and lower self-esteem. While women with sub-
stance use disorders have more difficulty with
emotional problems, their male counterparts
have more trouble with functioning (e.g.,
work, money, legal problems). See the TIP
Substance Abuse Treatment: Addressing the
Specific Needs of Women (CSAT in develop-
ment b) for more on the psychological impact
of substance abuse on women.
Treatment for substance abuse in women
should emphasize the importance of relation-
ships, the link between relationships and sub-
stance abuse (many women continue to use
with a partner), and the importance of rela-
tionships with children as a motivator in
treatment. The stigma attached to females
who abuse substances functions as a barrier
to treatment, as does the lack of provision for
children.
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Pregnancy and co-occurring
disorders
Pregnancy can aggravate or diminish the symp-
toms of co-occurring mental illness. Worsening
symptoms of mental illness can result from hor-
monal changes that occur during pregnancy;
lactation; medications given during pregnancy
or delivery; the stresses of pregnancy, labor,
and delivery; and adjusting to and bonding
with a newborn (Grella 1997). Women with co-
occurring disorders sometimes avoid early pre-
natal care, have difficulty complying with
healthcare providers’ instructions, and are
unable to plan for their babies or care for them
when they arrive. According to the literature,
women with anxiety disorders or personality
disorders are at increased risk for postpartum
depression (Grella 1997).
Many pregnant women with co-occurring dis-
orders are distrustful of substance abuse
treatment and mental health service
providers, yet they are in need of multiple
services (Grella 1997). One concern is
whether the mother can care adequately for
her newborn. For her to do so requires fami-
ly-centered, coordinated efforts from such
caregivers as social workers, child welfare
professionals, and the foster care system.
Issues to address with co-occurring
mental illness
It is particularly important to make careful
treatment plans during pregnancy for women
with mental disorders that include planning for
childbirth and infant care. Women often are
concerned about the effect of their medication
on their fetuses. Treatment programs should
work to maintain medical and mental stability
during the client’s pregnancy and collaborate
with other healthcare providers to ensure that
treatment is coordinated. 
When women are parenting, it can often
retrigger their own childhood traumas.
Therefore, providers need to balance growth
and healing with coping and safety. Focusing
on the woman’s interest in and desire to be a
good mother, the sensitive counselor will be
alert to the inevitable guilt, shame, denial,
and resistance to dealing with these issues, as
the recovering woman increases her aware-
ness of effective parenting skills. Providers
also need to allow for evaluation over time for
women with COD. Reassessments should
occur as mothers progress through treatment. 
Pharmacologic considerations
From a clinical standpoint, before giving any
medications to pregnant women it is of vital
importance that they understand the risks
and benefits of taking these medications and
that they sign informed consent forms verify-
ing that they have received and understand
the information provided to them. Certain
psychoactive medications may be associated
with birth defects, especially in the first
trimester of pregnancy, and weighing poten-
tial risk/benefit is important. In most cases, a
sensible direction can be found; however, this
needs expert advice and consideration by a
physician and pharmacist familiar with work-
ing with pregnant women with mental disor-
ders. Since pregnant women often present to
treatment in mid to late second trimester and
polydrug use is the norm rather than the
exception (Jones et al. 1999), it is important
first to screen these women for dependence on
the classes of substances that can produce a
life-threatening withdrawal for the mother:
alcohol, benzodiazepines, and barbiturates.
These substances, as well as opioids, can
cause a withdrawal syndrome in the baby,
who may need treatment. Pregnant women
should be made aware of any and all wrap-
around services to assist them in managing
newborn issues, including food, shelter, medi-
cal clinics for innoculations, etc., as well as
programs that can help with developmental or
physical issues the infant may experience as a
result of alcohol/drug exposure. For more on
pharmacologic considerations for pregnant
women, see appendix F.
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Postpartum depression
The term “postpartum depression” encompass-
es:
•Postpartum or maternity “blues,” which
affects up to 85 percent of new mothers 
•Postpartum depression, which affects
between 10 and 15 percent of new mothers
•Postpartum psychosis, which develops follow-
ing about one per 500–1,000 births, accord-
ing to some studies (Steiner 1998)
Postpartum “blues” is transient depression
occurring most commonly within 3–10 days
after delivery. There is evidence that the
“blues” are precipitated by progesterone
withdrawal (Harris et al. 1994). Prominent in
its causes are a woman’s emotional letdown
following the excitement and fears of preg-
nancy and delivery, the discomforts of the
period immediately after giving birth, fatigue
from loss of sleep during labor and while hos-
pitalized, energy expenditure at labor, anxi-
eties about her ability to care for her child at
home, and fears that she may be unattractive
to her partner. Symptoms include weepiness,
insomnia, depression, anxiety, poor concen-
tration, moodiness, and irritability. These
symptoms tend to be mild and transient, and
women usually recover completely with rest
and reassurance. Anticipation and preventive
reassurance throughout pregnancy can pre-
vent postpartum blues from becoming a prob-
lem. Women with sleep deprivation should be
assisted in getting proper rest. Followup care
should ensure that the woman is making suffi-
cient progress and not heading toward a
relapse to substance use.
Figure 7-1 lists the criteria for major depres-
sive episode, of which postpartum onset is one
specifier. Not all instances of postpartum
depression meet the criteria for major depres-
sive episode; they may have fewer than five
symptoms. 
According to the DSM-IV-TR (APA 2000), for
a depressive episode to be characterized
“with postpartum onset,” it must begin within
4 weeks postpartum. Risk factors for postpar-
tum depression include prior history of non-
postpartum depression or psychological dis-
tress during pregnancy, other prepregnancy
mental diagnosis, or family history of mental
disorder (American Psychiatric Association
[APA] 2001; Nielsen Forman et al. 2000;
Steiner 2002; Webster et al. 2000). Prospects
for recovery from postpartum depression are
good with supportive psychological counseling
Figure 7-1
Criteria for Major Depressive Episode
At least five of the following symptoms present during the same 2-week period, representing a change from pre-
vious functioning; one of the symptoms is either depressed mood or loss of interest or pleasure:
•Depressed mood most of the day, nearly every day
•Diminished interest or pleasure in activities
•Significant weight loss
•Insomnia or hypersomnia nearly every day
•Psychomotor agitation or retardation nearly every day
•Fatigue or loss of energy
•Feelings of worthlessness or excessive or inappropriate guilt
•Diminished ability to think or concentrate, or indecisiveness
•Recurrent thoughts of death, recurrent suicidal ideation, or a suicide attempt
Source: APA 2000.
207Special Settings and Specific Populations
accompanied as needed by pharmacological
therapy (Chabrol et al. 2002; Cohen et al.
2001; O’Hara et al. 2000). Antidepressants,
anxiolytic medications, and even electrocon-
vulsive therapy have all been successful in
treating postpartum depression (Griffiths et
al. 1989; Oates 1989; Varan et al. 1985).
Because some medications pass into breast
milk and can cause infant sedation, it is best
to consult an experienced psychiatrist or
pharmacist for details. Patients with postpar-
tum depression need to be monitored for
thoughts of suicide, infanticide, and progres-
sion of psychosis in addition to their response
to treatment.
Postpartum psychosis is a serious mental dis-
order. Women with this disorder may lose
touch with reality and experience delusions,
hallucinations, and/or disorganized speech or
behavior. Women most likely to be diagnosed
with postpartum psychosis are those with pre-
vious diagnoses of bipolar disorder,
schizophrenia, or schizoaffective disorder or
women who had a major depression in the
year preceding the birth (Kumar et al. 1993).
Other studies reviewed by Marks and col-
leagues (1991) indicate that other risk factors
for postpartum psychosis include previous
depressive illness or postpartum psychosis,
first pregnancy, and family history of mental
illness. Recurrence of postpartum psychosis
in the next pregnancy occurs in 30–50 percent
of women (APA 2000). Peak onset is 10–14
days after delivery but can occur any time
within 6 months. The severity of the symp-
toms mandates pharmacological treatment in
most cases, and sometimes, hospitalization.
The risk of self-harm and/or harm to the
baby needs to be assessed, and monitoring of
mother–infant pairs by trained personnel can
limit these risks.
Women, trauma, and 
violence
It is estimated that between 55 and 99 percent
of women in substance abuse treatment have
had traumatic experiences, typically child-
hood physical or sexual abuse, domestic vio-
lence, or rape. Of these, between 33 and 59
percent have been found to be experiencing
current PTSD; yet, historically, few sub-
stance abuse treatment programs assess for,
treat, or educate clients about trauma
(Najavits 2000). This deficiency is a serious
one, given the multiplying consequences of
failure to address this problem. Greater vio-
lence leads to more serious substance abuse
and other addictions (e.g., eating disorders,
sexual addiction, and compulsive exercise),
along with higher rates of depression, self-
mutilation, and suicidal impulses. Addiction
places women at higher risk of future trauma,
through their associations with dangerous
people and lowered self-protection when using
substances (e.g., going home with a stranger
after drinking).
Models for women’s trauma 
recovery
Clearly, effective ways of addressing the trau-
ma-specific needs of women with COD are
essential. Fortunately, a number of models are
emerging, many with data demonstrating their
efficacy. Harris and Fallot have described the
core elements of a trauma-informed addictions
program as follows (2001, p. 63):
•“The program must have a commitment to
teaching explanations that integrate trauma
and substance use.” The authors stress the
need to help clients understand the interac-
tion between trauma and substance use.
They encourage the use of “self-soothing
mechanisms” to help trauma survivors deal
with symptoms such as flashbacks without
resorting to substance use. (See “Grounding”
in the discussion of PTSD, appendix D.)
•“The milieu must promote consumer empow-
erment and relationship building as well as
healing.” The authors stress the importance
of building strengths, providing an opportu-
nity for caring connections through group
work and informal sharing, and establishing
a milieu that is “warm, friendly, and nurtur-
ing.”
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•“Each woman must be encouraged to devel-
op certain crossover skills that are equally
important in recovery from trauma and
chemical dependency.” Examples of such
skills include enhancing self regulation,
limit setting, and building self-trust. 
•“A series of ancillary services help a woman
to continue her recovery once she leaves a
structured program.” Examples of areas to
be addressed include legal services (e.g.,
child custody issues, childcare issues), safe
housing (e.g., housing that accepts chil-
dren), and health care (e.g., prenatal care,
gynecology, pediatrics).
•“The program avoids the use of recovery
tactics that are contraindicated for women
recovering from physical and sexual vio-
lence.” For many women, these include
shaming, moral inventories, confrontation,
emphasis on a higher power, and intrusive
monitoring. Many practitioners find that
alternatives to the 12-Step model are help-
ful for some women (Kasl 1992; Women for
Sobriety 1993). On the other hand, many
women have benefited from 12-Step pro-
grams. Gender-specific 12-Step meetings
may compensate for the shortcoming of
mixed gender or predominantly male 
programs.
While a detailed description of trauma recov-
ery model programs is beyond the scope of this
TIP, readers should be aware that there are a
number of emerging models available for use.
Many are supported by published materials,
such as workbooks with session guides that aid
in implementation. Examples include the fol-
lowing:
•The Trauma Recovery and Empowerment
Model (TREM) is a group approach to heal-
ing from the effects of trauma. TREM com-
bines the elements of social skills training,
psychoeducational and psychodynamic
techniques, and emphasizes peer support,
which have proven to be highly effective
approaches with survivors. A 33-session
guide book for clinicians is available
(Harris and Community Connections
Trauma Work Group 1998).
•Seeking Safety offers a manual-based, cog-
nitive–behavioral therapy model consisting
of 25 sessions which has been used in a
number of studies with women who have
substance dependence and co-occurring
PTSD (Najavits 2000, 2002).
•Helping Women Recover: A Program for
Treating Addiction is an integrated pro-
gram with a separate version for women in
the criminal justice system. This model inte-
grates theoretical perspectives of substance
abuse and dependence, women’s psychologi-
cal development, and trauma (Covington
1999).
•The Addiction and Trauma Recovery
Integration Model is designed to assess and
intervene at the body, mind, and spiritual
levels to address key issues linked to trau-
ma and substance abuse experiences (Miller
and Guidry 2001).
•Trauma Adaptive Recovery Group
Education and Therapy (TARGET) aims to
help clients replace their stress responses
with a positive approach to personal and
relational empowerment. TARGET has
been adapted for deaf clients and for those
whose primary language is Spanish or
Dutch (Ford et al. 2000).
For more detailed information, including
individual and other models of trauma heal-
ing, see the forthcoming TIPs Substance
Abuse Treatment: Addressing the Specific
Needs of Women (CSAT in development b)
and Substance Abuse Treatment and Trauma
(CSAT in development d).
The women, co-occurring 
disorders, and violence study 
Three SAMHSA Centers—CSAT, CMHS, and
the Center for Substance Abuse Prevention—
collaborated on a nine-site study to develop
systems of care for women with co-occurring
disorders who also were survivors of violence
(www.wcdvs.com) (the study ended in 2003).
Each site was charged with implementing an
intervention that models integrated care and
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conducting a qualitative evaluation of the
methods used. The work clearly underlined
the need for integrated services, the need to
address trauma and violence, and the need to
include children with their mothers in treat-
ment. Two of the the participating sites are
featured below.
The sites also have identified many issues for
children whose mothers had co-occurring dis-
orders. In four of the nine sites in this study,
an additional subset study focused on the
children of women who participated in the
study. The “Cooperative Agreement to Study
Children of Women with Alcohol, Drug Abuse
and Mental Health (ADM) Disorders who
Have Histories of Violence” sought to gener-
ate and apply empirical knowledge about the
effectiveness of trauma-informed, culturally
relevant, age-specific intervention models for
children 5 to 10 years of age
(www.wcdvs.com/children). The intervention
was driven by concern for children who expe-
rienced stress as a result of witnessing vio-
lence and were at risk for a multitude of
problems as they grew older, including COD. 
Community Connections
Community Connections is a comprehensive
nonprofit human services agency serving an
urban population in Washington, D.C.
Community Connections was the lead agency
in the District of Columbia Trauma
Collaboration Study (DCTCS), one of nine
sites in the SAMHSA research effort to exam-
ine the effectiveness of services for female
trauma survivors with COD. The DCTCS
served more than 150 women in the experi-
mental condition at two agencies in
Washington, D.C. All had histories of sexual
and/or physical abuse and had co-occurring
substance use and mental disorders.
For the past decade, Community Connections
has focused both clinical and research efforts
on the needs of trauma survivors. The agency
has developed trauma-specific services, exam-
ined the prevalence and impact of trauma in
the lives of individuals diagnosed with serious
mental disorders, and developed training and
consultation models addressing trauma. In
the first 2 years of the SAMHSA project,
Community Connections developed a compre-
hensive, integrated, trauma-focused network
of services. A quasi-experimental research
project that occurred from 2000 to 2003
assessed the impact of the key intervention
components: 
1. TREM groups. The TREM group treat-
ment intervention was developed by clini-
cians at Community Connections with con-
siderable input from consumers. TREM is
a 33-session intervention that uses a psy-
choeducational focus and skill-building
approach, emphasizes survivor empower-
ment and peer support, and teaches tech-
niques for self-soothing, boundary mainte-
nance, and current problemsolving. A
more abbreviated version (24 sessions) was
developed for agencies to use in a 3- to 6-
month time frame. TREM has been pub-
lished as a fully manualized leader’s guide
(Harris and Community Connections
Trauma Work Group 1998), and in a self-
help workbook format titled Healing the
Trauma of Abuse (Copeland and Harris
2000).
2. Integrated Trauma Services Teams
(ITSTs). ITSTs provide an integrated,
comprehensive package of services,
include consumer/survivor/recovering per-
sons (C/S/Rs) in central roles, and are
responsive to issues of gender and culture.
Embedded in an integrated network of
programs offering a full range of necessary
support services, ITSTs are composed of
primary clinicians cross-trained in trau-
ma, mental health, and substance abuse
domains. The teams provide services
addressing these domains and the complex
interactions among them simultaneously
and in a closely coordinated way.
3. Collateral Groups. Several additional
trauma-informed groups have been devel-
oped for women in the study. These mod-
ules are explicitly integrative, addressing
the relationships among trauma, mental
health, and substance abuse concerns.
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Group modules are: Trauma Informed
Addictions Treatment, Parenting Issues,
Spirituality and Trauma Recovery,
Domestic Violence, Trauma Issues
Associated with HIV Infection, and
Introduction to Trauma Issues for Women
on Inpatient or Short-Stay Units.
4. Women’s Support and Empowerment
Center (peer support). Project C/S/Rs
developed and offer a variety of peer-run
services, including a Peer Representative
program providing support, companion-
ship, and advocacy within a women’s peer
center, open 5 days a week to women in
the program. 
Data from the DCTCS suggested that this
TREM-based integrative approach was effec-
tive in facilitating recovery from substance use
disorders and other mental illness. Pilot data
from four different clinical sites indicate
TREM’s potential benefits in several domains:
mental health symptom reduction, decreased
utilization of intensive services such as inpa-
tient hospitalization and emergency room vis-
its, decreases in high-risk behavior, and
enhanced overall functioning.
Advice to the Counselor:
Treatment Principles and Services for Women With COD
The panel recommends the following treatment principles and services for women.
A report from the National Women’s Resource Center (Finkelstein et al. 1997) reviews the litera-
ture on women’s programs and finds that these models have many basic tenets in common. The
overarching principle is that the provision of comprehensive services and treatment needs to be
in accord with the context and needs of women’s daily lives. Recommendations based on the
Center’s review include:
• Identify and build on each woman’s strengths.
• Avoid confrontational approaches (or, as has been stated previously, supportive interventions are
preferred to confrontational interventions for persons with COD, especially in the early stages of
treatment).
• Teach coping strategies, based on a woman’s experiences, with a willingness to explore the
woman’s individual appraisals of stressful situations.
• Arrange to meet the daily needs of women, such as childcare and transportation.
• Have a strong female presence on staff.
• Promote bonding among women.
In addition, the consensus panel adds the following advice:
• Offer program components that help women reduce the stress associated with parenting, and
teach parenting skills.
• Develop programs for both women and children.
• Provide interventions that focus on trauma and abuse.
• Foster family reintegration and build positive ties with the extended/kinship family.
• Build healthy support networks with shared family goals.
• Make prevention and emotional support programs available for children.
Source: Adapted from Finkelstein et al. 1997.
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The Triad Women’s Project
This project, featured in the text box above,
has found, consistent with the Diagnostic and
Statistical Manual of Mental Disorders, 4th
edition, that the prevalence of depression and
anxiety disorders, especially PTSD, is higher
among women than men, and that the inci-
dence of borderline personality disorder also
is higher (APA 2000). 
Need for increased empirical
information
Knowledge about, and understanding of,
women with COD needs to be expanded, par-
ticularly for those women who experience
SMI. The knowledge base should include
accurate information on the rates of incidence
of COD among women who have SMI, their
profiles, and their use of services. In addi-
The Triad Women’s Project: A Cooperative Agreement
Network
Overview
The Triad Women’s Project was developed in 1998 with funds from a SAMHSA collaborative grant on Women,
Co-Occurring Disorders, and Violence. The project was designed to provide integrated services for women with
histories of trauma and abuse who have COD. Clients were frequent users of mental health and substance abuse
treatment services in a semirural area of Florida that spans three counties. Services in the area previously had
been delivered by different agencies in a nonintegrated system.
Clients
The program served up to 175 women, many of whom were mandated to treatment by the court.
Services
The three main service components were
•Triad Specialists. The Triad Specialists who provided case management services were located in and fund-
ed by their respective mental health or substance abuse treatment programs. They were cross-trained in
mental health, substance abuse, and trauma/violence/abuse issues. (A cross-training package was devel-
oped on a video that features 16 hours of instruction.) The Triad Specialists met regularly to share infor-
mation and resources. Caseloads were restricted to 25 clients, all of whom had histories of abuse and were
diagnosed with COD. The Triad Specialist became a woman’s case manager at the client’s entrance into
the “gateway” agency. The specialist continued to work with her even if she used other services.
•Triad Women’s Group. This component was developed to assist triply diagnosed women with their sub-
stance abuse, mental health, and trauma issues. This integrated intervention was designed as a 16-week
therapy group, employing a manualized skill development curriculum that could be used in outpatient or
residential settings.
•Peer Support Group. The peer support group, called Women of Wisdom, was run by consumers/survivors
and served both as a support group for women in treatment and as a continuing support group for those
who had left. The groups were based on a 12-Step model for trauma survivors, but addressed substance
abuse and mental health recovery issues. They met in community settings and were open to all women in
the community.
Preliminary Empirical Evidence
A formal evaluation of the project began in October 2000. Data have shown reductions in mental disorder
symptoms, reductions in symptoms related to child sexual abuse, and improvements in “approach or active”
coping responses related to substance abuse recovery (as measured by the Coping Responses Inventory
[Moos 1993]) as a result of the group intervention. 
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tion, COD outcome studies need to focus on
gender differences to further improve treat-
ment protocols for women. Research efforts
should address the following questions:
•Medication—Do the problems that women in
general have with prescribed psychoactive
medication (e.g., concerns about weight gain
affecting adherence) hold for women with
COD, especially those who have SMI?
•HIV/AIDS risk—Is the current popularity
of heroin or methamphetamine translating
to increased HIV/AIDS in this subpopula-
tion of women? Are there increasing rates of
transmission of HIV/AIDS among females
who abuse substances?
•Populations—What differences exist among
different populations (e.g. women, teens,
lesbian/gay/bisexual, rural, older adults)?
•Drug use—Is the current decline in crack
cocaine use reflected in the drug habits of
these women?
•Networks—Do social networks of women
with COD support recovery, or do they trig-
ger relapse?
•Trauma—Does the severity of mental illness
affect the experience of trauma, violence,
and victimization? What are the effects of
trauma, violence, and abuse on the course
of treatment for women with COD?
•Systems—Do existing models meet the com-
plicated service needs of women with COD?
Do these models achieve effective linkages
with supports based in the community? Do
these structures support women with SMI?
•Community connections—How are linkages
established and maintained?
•Treatment—What treatment components
are effective for women with COD, particu-
larly those who have severe mental disor-
ders?
•Outcomes—Are various treatments differ-
entially effective for women? How do exist-
ing strategies and models for the treatment
of COD need to be modified to produce the
best outcomes for women? (Adapted from
Alexander 1996)
8 A Brief Overview of
Specific Mental
Disorders and Cross-
Cutting IssuesIn This
Chapter…
Cross-Cutting
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Personality
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Mood Disorders
and Anxiety
Disorders
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Other Psychotic
Disorders
Attention-Deficit/
Hyperactivity
Disorder (AD/HD)
Posttraumatic
Stress Disorder
(PTSD)
Eating Disorders
Pathological
Gambling
Conclusion
Overview
This chapter provides a brief overview for working with substance
abuse treatment clients who also have specific mental disorders. It is
presented in concise form so that the counselor can refer to this one
chapter to obtain basic information. Appendix D contains more in-
depth information on suicidality, nicotine dependence, and each of the
disorders addressed in this chapter. The material included is not a
complete review of all disorders in the Diagnostic and Statistical
Manual of Mental Disorders, 4th edition (DSM-IV), but updates the
material from TIP 9 (Center for Substance Abuse Treatment 1994a)
(i.e., personality disorders, mood disorders, anxiety disorders, and
psychotic disorders), adding other mental disorders with special rele-
vance to co-occurring disorders (COD) not covered in TIP 9 (i.e.,
attention deficit/hyperactivity disorder, posttraumatic stress disorder,
eating disorders, and pathological gambling). The consensus panel
acknowledges that people with COD may have multiple combinations
of the various mental disorders presented in this chapter (e.g., a per-
son with a substance use disorder, schizophrenia, and a pathological
gambling problem). However, for purposes of clarity and brevity the
panel chose to focus the discussion on the main disorders and not
explore the multitude of possible combinations.
The chapter begins with a brief description of cross-cutting issues—
suicidality and nicotine dependency. While suicidality is not a DSM-IV
diagnosed mental disorder per se, it is a high-risk behavior associated
with COD. Nicotine dependency is recognized as a disorder in DSM-
IV, and as such a client with nicotine dependency and a mental disor-
der could be considered to have a co-occurring disorder. Though this
is the case, an important difference between tobacco addiction and
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other addictions is that tobacco’s chief effects
are medical rather than behavioral, and, as
such, it is not conceptualized and presented
as a typical co-occurring addiction disorder.
However, because of the high proportion of
the COD population addicted to nicotine, as
well as the devastating health consequences of
tobacco use, nicotine dependency is treated as
an important cross-cutting issue for people
with substance use disorders and mental ill-
ness. 
The discussions of suicidality and nicotine
dependency highlight key information coun-
selors should know about that disorder in
combination with substance abuse. This sec-
tion offers factual information (e.g., preva-
lence data), commonly agreed-upon clinical
practices, and other general information that
may be best characterized as “working for-
mulations.”
A brief description of selected disorders and
their diagnostic criteria follows. This material
has been extracted from DSM-IV-TR (Text
Revision, American Psychiatric Association
[APA] 2000) and highlights the descriptive
features, diagnostic features, and symptom
clusters of each mental disorder. The consen-
sus panel elected to take this material directly
from DSM-IV-TR to provide easy access to
the material that is not typically available in
the substance abuse treatment field. Use of a
specialized dictionary that includes terminol-
ogy related to mental disorders may be need-
ed to understand terms in the quoted material
from DSM-IV-TR, though the main features
of each disorder should still be clear. 
Because of the greater availability of case his-
tories from the mental health literature, the
illustrative material in the next section has a
greater emphasis on the mental disorder.
Wherever possible case histories were selected
to illustrate the interaction of the mental and
substance use disorders. Finally, each section
contains an Advice to the Counselor box.
The consensus panel recognizes that no one
chapter can replace the comprehensive train-
ing necessary for diagnosing and treating
clients with specific mental disorders co-
occurring with substance use disorders and
that the Advice to the Counselor understates
the complexity involved in treating clients
with these disorders. The Advice to the
Counselor boxes are designed to distill for the
counselor the main actions and approaches
that they can take in working with substance
abuse treatment clients who have the specific
mental disorder being discussed (see the table
of contents for a full listing of these boxes
throughout the TIP).
The consensus panel also recognizes the chap-
ter cannot possibly cover each mental disor-
der exhaustively and that addiction coun-
selors are not expected to diagnose mental
disorders. The limited goals of the panel in
providing this material are to increase sub-
stance abuse treatment counselors’ familiarity
with mental disorders terminology and crite-
ria, as well as to provide advice on how to
proceed with clients who demonstrate these
disorders. It is also the purpose of this chap-
ter and appendix D to stimulate further work
in this area and to make this research accessi-
ble to the addiction field.
Cross-Cutting Issues
Suicidality
Suicidality is not a mental disorder in and of
itself, but rather a high-risk behavior associ-
ated with COD, especially (though not limited
to) serious mood disorders. Research shows
that most people who kill themselves have a
diagnosable mental or substance use disorder
or both, and that the majority of them have
depressive illness. Studies indicate that the
most promising way to prevent suicide and
suicidal behavior is through the early recogni-
tion and treatment of substance abuse and
mental illnesses. This is especially true of
clients who have serious depression (U.S.
Public Health Service 1999). Substance-
induced or exacerbated suicidal ideations,
intentions, and behaviors are an ever-present
215A Brief Overview of Specific Mental Disorders and Cross-Cutting Issues
possible complication of sub-
stance use disorders, especially
for clients with co-occurring
mental disorders.
The topic of suicidality is critical
for substance abuse treatment
counselors working with clients
with COD. Substance use disor-
ders alone increase suicidality,
while the added presence of some
mental disorders doubles an
already heightened risk.
Counselors should be aware that
the risk of suicide is greatest
when relapse occurs after a sub-
stantial period of abstinence—
especially if there is concurrent
financial or psychosocial loss.
Every agency that offers counsel-
ing for substance abuse also
must have a clear protocol in
place that addresses the recogni-
tion and treatment (or referral)
of persons who may be suicidal.
What counselors
should know about
suicide and 
substance abuse
Counselors should be aware of the
following facts about the associa-
tion between suicide and sub-
stance abuse:
•Abuse of alcohol or drugs is a
major risk factor in suicide, both for people
with COD and for the general population.
•Alcohol abuse is associated with 25 to 50 per-
cent of suicides. Between 5 and 27 percent of
all deaths of people who abuse alcohol are
caused by suicide, with the lifetime risk for
suicide among people who abuse alcohol esti-
mated to be 15 percent.
•There is a particularly strong relationship
between substance abuse and suicide among
young people.
•Comorbidity of alcoholism and depression
increases suicide risk.
•The association between alcohol use and sui-
cide also may relate to the capacity of alcohol
to remove inhibitions, leading to poor judg-
ment, mood instability, and impulsiveness. 
•Substance intoxication is associated with
increased violence, both toward others and
self.
Advice to the Counselor:
Counseling a Client Who Is Suicidal
• Screen for suicidal thoughts or plans with anyone who
makes suicidal references, appears seriously depressed, or
who has a history of suicide attempts. Treat all suicide
threats with seriousness.
• Assess the client’s risk of self-harm by asking about what
is wrong, why now, whether specific plans have been
made to commit suicide, past attempts, current feelings,
and protective factors. (See the discussion of suicidality in
appendix D for a model risk assessment protocol.)
• Develop a safety and risk management process with the
client that involves a commitment on the client’s part to
follow advice, remove the means to commit suicide (e.g.,
a gun), and agree to seek help and treatment. Avoid sole
reliance on “no suicide contracts.”
• Assess the client’s risk of harm to others.
• Provide availability of contact 24 hours per day until psy-
chiatric referral can be realized. Refer those clients with
a serious plan, previous attempt, or serious mental illness
for psychiatric intervention or obtain the assistance of a
psychiatric consultant for the management of these
clients.
• Monitor and develop strategies to ensure medication
adherence.
• Develop long-term recovery plans to treat substance
abuse.
• Review all such situations with the supervisor and/or
treatment team members.
• Document thoroughly all client reports and counselor
suggestions.
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Case study: counseling a sub-
stance abuse treatment
client who is suicidal
Beth M., an American-Indian woman, comes
to the substance abuse treatment center com-
plaining that drinking too much causes prob-
lems for her. She has tried to stop drinking
before but always relapses. The counselor
finds that she is not sleeping, has been eating
poorly, and has been calling in sick to work.
She spends much of the day crying and think-
ing of how alcohol,
which has cost her
her latest signifi-
cant relationship,
has ruined her life.
She also has been
taking painkillers
for a recurring
back problem,
which has added to
her problems. The
counselor tells her
about a group
therapy opportuni-
ty at the center
that seems right for
her, tells her how
to register, and
makes arrange-
ments for some
individual counsel-
ing to set her on
the right path. The
counselor tells her
she has done the
right thing by coming in for help and gives
her encouragement about her ability to stop
drinking.
Beth M. does not arrive for her next appoint-
ment, and when the counselor calls home, he
learns from her roommate that Beth made an
attempt on her life after leaving the substance
abuse treatment center. She took an overdose
of opioids (painkillers) and is recovering in
the hospital. The emergency room staff found
that Beth M. was under the influence of alco-
hol when she took the opioids.
Discussion: Although Beth M. provided
information that showed she was depressed,
the counselor did not explore the possibility
of suicidal thinking. Counselors always
should ask if the client has been thinking of
suicide, whether or not the client mentions
depression. An American-Indian client, in
particular, may not answer a very direct
question, or may hint at something darker
without mentioning it directly. Interpreting
the client’s response requires sensitivity on
the part of the counselor. It is important to
realize that such questions do not increase the
likelihood of suicide. Clients who, in fact, are
contemplating suicide are more likely to feel
relieved that the subject has now been
brought into the light and can be addressed
with help from someone who cares.
It is important to note that the client reports
taking alcohol and pain medications. Alcohol
impairs judgment and, like pain medications,
depresses brain and body functions. The
combination of substances increases the risk
of suicide or accidental overdose. Readers are
encouraged to think through this case and
apply the assessment strategy included in the
discussion of suicidality in appendix D, imag-
ining what kind of answers the counselor
might have received. Then, readers could
consider interventions and referrals that
would have been possible in their treatment
settings.
Nicotine Dependence
In 2003 an estimated 29.8 percent of the gen-
eral population aged 12 or older report cur-
rent (past month) use of a tobacco product
(National Survey on Drug Use and Health
2003c). The latest report of the Surgeon
General on the Health Consequences of
Smoking (U.S. Public Health Service Office
of the Surgeon General 2004) provides a
startling picture of the damage caused by
tobacco. Tobacco smoking injures almost
every organ in the body, causes many dis-
Counselors
always should
ask if the client
has been 
thinking of 
suicide, whether
or not the client
mentions
depression.
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eases, reduces health in general, and leads to
reduced life span and death. Tobacco depen-
dence also has serious consequences to non-
smokers through environmental tobacco
smoke (secondhand smoke) and the negative
effects on unborn children. Fortunately quit-
ting smoking has immediate as well as long-
term benefits (U.S. Public Health Service
Office of the Surgeon General 2004).
Evidence suggests that people with mental dis-
orders and/or dependency on other drugs are
more likely to have a tobacco addiction. In
fact, most people with a mental illness or
another addiction are tobacco dependent—
about 50 to 95 percent, depending on the sub-
group (Anthony and Echeagaray-Wagner
2000; Centers for Disease Control and
Prevention 2001; National Institute on Drug
Abuse 1999a; Richter 2001; Stark and
Campbell 1993b). Smokers with mental disor-
ders consume nearly half of all the cigarettes
sold in the United States (Lasser et al. 2000).
A study of individuals doing well in recovery
from alcohol dependence found that those
who smoked lived 12 fewer years because of
their tobacco dependence and the quality of
their lives was affected by other tobacco-
caused medical illnesses (Hurt et al. 1996). 
There is increasing recognition of the impor-
tance of integrating tobacco dependence
treatment and management into mental health
services and addiction treatment settings.
Although tobacco dependence treatment
works for smokers with mental illness and
other addictions, only recently have clinicians
been given training to address this serious
public health and addiction treatment con-
cern. It is increasingly recognized that all
clients deserve access to effective treatments
for tobacco addiction, and that smokers and
their families should be educated about the
considerable risks of smoking as well as the
benefits of tobacco dependence treatment. All
current tobacco dependence clinical practice
guidelines strongly recommend addressing
tobacco during any clinical contact with
smokers and suggest the use of one or more of
the six Food and Drug Administration (FDA)-
approved medications as first-line treatments
(e.g., bupropion SR/zyban and the nicotine
patch, gum, nasal spray, inhaler, and
lozenge). 
Tobacco use and dependence should be
assessed and documented in all clinical base-
line assessments, treatment plans, and treat-
ment efforts. A motivation-based treatment
model allows for a wider range of treatment
goals and interventions that match the
patient’s motivation to change. Like other
addictions, tobacco dependence is a chronic
disease that may require multiple treatment
attempts for many individuals and there is a
range of effective clinical interventions,
including medications, patient/family educa-
tion, and stage-based psychosocial treat-
ments. Recent evidence-based treatment
guidelines have been published for the man-
agement of tobacco dependence and this
information can be a primary guide for
addressing tobacco. Few recognize how ignor-
ing tobacco perpetuates the stigma associated
with mental illness and addiction when some
ask, “Why should tobacco be addressed in
mental health or addiction settings?” or
“Other than increased morbidity and mortali-
ty, why should we encourage and help this
group to quit?” or “What else are they going
to do if they cannot smoke?” 
What counselors should
know about nicotine 
dependence
•Tobacco dependence is common in clients
with other substance use disorders and men-
tal illnesses.
•Like patients in primary care settings,
clients in mental health services and addic-
tion treatment settings should be screened
for tobacco use and encouraged to quit.
•The U.S. Public Health Service Guidelines
encourage the use of the “5 A’s” (Ask,
Advise, Assess, Assist, Arrange Followup)
as an easy road map to guide clinicians to
help their patients who smoke:
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– Ask about tobacco use and document in
chart.
– Advise to quit in a clear, strong, and
personal message.
– Assess willingness to make a quit
attempt and consider motivational inter-
ventions for the lower motivated and
assist those ready to quit.
– Assist in a quit attempt by providing
practical counseling, setting a quit date,
helping them to anticipate the challenges
they will face, recommending the use of
tobacco dependence treatment medica-
tions, and discussing options for psy-
chosocial treatment, including individu-
al, group, telephone, and Internet coun-
seling options.
– Arrange followup to enhance motiva-
tion, support success, manage relapses,
and assess medication use and the need
for more intensive treatment if neces-
sary.
•Assessment of tobacco use includes assessing
the amount and type of tobacco products
used (cigarettes, cigars, chew, snuff, etc.),
current motivation to quit, prior quit
attempts (what treatment, how long absti-
nent, and why relapsed), withdrawal symp-
toms, common triggers, social supports and
barriers, and preference for treatment.
•Behavioral health professionals already
have many of the skills necessary to provide
tobacco dependence psychosocial interven-
tions.
•Smokers with mental illness and/or another
addiction can quit with basic tobacco
dependence treatment, but may also
require motivational interventions and
treatment approaches that integrate medi-
cations and psychosocial treatments. 
•Tobacco treatment is cost-effective, feasible,
and draws on principles of addictions and
co-occurring disorders treatment.
•The current U.S. Clinical Practice
Guidelines indicate that all patients trying
to quit smoking should use first-line phar-
macotherapy, except in cases where there
may be contraindications (Fiore 2000). 
•Currently there are six FDA-approved
treatments for tobacco dependence treat-
ment: bupropion SR and five Nicotine
Replacement Treatments (NRTs): nicotine
polacrilex (gum), nicotine transdermal
patch, nicotine inhaler, nicotine nasal
spray, and nicotine lozenge. 
•Tobacco treatment medications are effective
even in the absence of psychosocial treat-
ments, but adding psychosocial treatments
to medications enhances outcomes by at
least 50 percent.
•Specific coping skills should be addressed to
help smokers with mental or substance use
disorders to cope with cravings associated
with smoking cues in treatment settings
where smoking is likely to be ubiquitous.
•When clients with serious mental illnesses
attempt to quit smoking, watch for changes
in mental status, medication side effects,
and the need to lower some psychiatric
medication dosages due to tobacco smoke
interaction.
Program-level changes 
As with other COD, the most effective strate-
gies to address tobacco include both enhanc-
ing clinician skills and making program and
system changes. Effective steps for addressing
tobacco at the treatment program level are
listed in an outline in the text box on page
219. These steps have been developed at the
University of Medicine and Dentistry of New
Jersey Tobacco Program and used effectively
to address tobacco in hundreds of mental
health and addiction treatment settings
(Ziedonis and Williams 2003a). The necessary
steps include developing comprehensive
tobacco dependence assessments; providing
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treatment, patient education, and continuing
care planning; making self-help groups such
as Nicotine Anonymous available to clients
and their families; providing nicotine depen-
dence treatment to interested staff; and mak-
ing policy changes related to tobacco. Such
changes should include documentation forms
in clinical charts that contain more tobacco
related questions, labeling smoker’s charts,
not referring to breaks in the program’s
schedule as “smoking breaks,” forbidding
staff and patients to smoke together, provid-
ing patient education brochures, and provid-
ing NRT for all clients in smoke-free residen-
tial treatment settings (Ziedonis and Williams
2003a). 
Case study: addressing tobac-
co in an individual with
panic disorder and alcohol
dependence 
Tammy T. is a 47-year-old widow who has
been treated in a substance abuse outpatient
program for co-occurring alcohol dependence
and panic disorder. She is about 9 months
abstinent from alcohol and states that she is
now ready to address her tobacco addiction.
When she first entered treatment she was not
ready to quit tobacco. Her substance abuse
counselor recognized her ambivalence and
implemented some motivational interventions
and followup on this topic over the course of
the 9 months of her initial recovery. This per-
sistence was perceived as expressing empathy
and concern, and Tammy T. eventually recog-
nized the need to quit smoking as part of a
long-term recovery plan. She was now ready
to set a quit date.
Tammy T. started smoking at age 17. Her
only period of abstinence was during her
pregnancy. She quickly resumed smoking
after giving birth. She cut back from 30
cigarettes per day (1.5 packs) to 20 cigarettes
per day (1 pack) in the last year but has been
unable to quit completely. She lives with her
brother, who also smokes. Her panic disorder
is well controlled by sertraline (Zoloft), and
she sees a counselor monthly and a psychia-
trist four times a year for medication manage-
ment. She works full time in a medical office
as an office manager and must leave the
building to smoke during work hours. Tammy
T. drank alcohol heavily for many years, con-
suming up to 10 beers 3 to 5 times per week
Steps for Addressing Tobacco Within Treatment Programs
1. Acknowledge the challenge.
2. Establish a leadership group and commit to change.
3. Create a change plan and implementation timeline.
4. Start with easy system changes.
5. Assess and document in charts nicotine use, dependence, and prior treatments. 
6. Incorporate tobacco issues into client education curriculum. 
7. Provide medications for nicotine dependence treatment and required abstinence. 
8. Conduct staff training. 
9. Provide treatment and recovery assistance for interested nicotine-dependent staff.
10. Integrate motivation-based treatments throughout the system. 
11. Develop addressing tobacco policies that are site specific.
12. Establish ongoing communication with 12-Step recovery groups, professional colleagues, and referral
sources about system changes.
Source: Ziedonis et al. 2003.
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until about 1 year ago. At the advice of her
physician, who initiated treatment for panic
attacks, she was able to quit using alcohol
completely. She was encouraged by her suc-
cess in stopping drinking, but has been dis-
couraged about continuing to smoke.
In creating a quit plan for Tammy T., it was
important for the counselor to determine
what supports she has available to help her to
quit. Encouraging her brother to quit at the
same time was seen as a useful strategy, as it
would help to remove smoking from the home
environment. Tammy T. was willing to attend
a 10-week group treatment intervention to get
additional support, education, and assistance
with quitting. Some clients may desire indi-
vidual treatment that is integrated into their
ongoing mental health or addiction treatment,
or the use of a telephone counseling service
might be explored since it is convenient and is
becoming more widely available. In discussing
medication options, Tammy T. indicated that
she was willing to use the nicotine inhaler.
Medication education enhanced compliance
with the product and increased its effective-
ness. She was encouraged to set a quit date
and to use nicotine replacement starting at
the quit date and in an adequate dose.
Tammy T. was taking sertraline for her panic
disorder (a selective serotonin reuptake
inhibitor [SSRI]) and therefore another med-
ication option might be to add bupropion SR
(not an SSRI) to her current medications for
a period of 12 weeks, specifically to address
smoking if another quit attempt is needed in
the future. If she had not been successful in
this attempt, it would have been important to
motivate her for future quit attempts and
consider increasing the dose and/or duration
of the medication or psychosocial treatment.
In this case the group treatment, 6 months of
NRT inhaler, and eliciting her brother’s
agreement to refrain from smoking in the
house resulted in a successful quit attempt, as
well as continued success in her recovery
from co-occurring panic disorder and alcohol
dependence. 
Personality Disorders
These are the disorders seen most commonly by
addiction counselors and in quadrant II sub-
stance abuse treatment settings.
Personality disorders (PDs) are rigid, inflexi-
ble, and maladaptive behavior patterns of
sufficient severity to cause internal distress or
significant impairment in functioning. PDs
are enduring and persistent styles of behavior
and thought, rather than rare or unusual
events in someone’s life. Furthermore, rather
than showing these thoughts and behaviors in
response to a particular set of circumstances
or particular stressors, people with PDs 
carry with them these destructive patterns of
thinking, feeling, and behaving as their way
of being and interacting with the world and
others. 
Those who have PDs tend to have difficulty
forming a genuinely positive therapeutic
alliance. They tend to frame reality in terms
of their own needs and perceptions and not to
understand the perspectives of others. Also,
most clients with PDs tend to be limited in
terms of their ability to receive, accept, or
benefit from corrective feedback.
A further difficulty is the strong counter-
transference clinicians can have in working
with these clients, who are adept at “pulling
others’ chains” in a variety of ways. Specific
concerns will, however, vary according to the
specific PD and other individual circum-
stances.
Borderline Personality
Disorder
What counselors should
know about substance abuse
and borderline personality
disorders 
The essential feature of borderline personality
disorder (BPD) is a pervasive pattern of insta-
bility of interpersonal relationships, self-image,
and affects, along with marked impulsivity,
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that begins by early adulthood and is present
in a variety of contexts. Counselors should be
aware that
•People with BPD may use drugs in a variety
of ways and settings.
•At the beginning of a crisis episode, a client
with this disorder might take a drink or a dif-
ferent drug in an attempt to quell the growing
sense of tension or loss of control.
•People with BPD may well use the same
drugs of choice, route of administration, and
frequency as the individuals with whom they
are interacting.
•People with BPD often use substances in
idiosyncratic and unpredictable patterns.
•Polydrug use is common, which may involve
alcohol and other sedative-hypnotics taken
for self-medication.
•Individuals with BPD often are skilled in
seeking multiple sources of medication that
they favor, such as benzodiazepines. Once
they are prescribed this medication in a men-
tal health system, they may demand to be
continued on the medication to avoid danger-
ous withdrawal.
Diagnostic Features of Personality Disorders
The essential feature of a personality disorder is an enduring pattern of inner experience and behavior that
deviates markedly from the expectations of the individual’s culture and is manifested in at least two of the
following areas: cognition, affectivity, interpersonal functioning, or impulse control (Criterion A). This
enduring pattern is inflexible and pervasive across a broad range of personal and social situations
(Criterion B) and leads to clinically significant distress or impairment in social, occupational, or other
important areas of functioning (Criterion C). The pattern is stable and of long duration, and its onset can
be traced back at least to adolescence or early adulthood (Criterion D). The pattern is not better accounted
for as a manifestation or consequence of another mental disorder (Criterion E) and is not due to the direct
physiological effects of a substance (e.g., a drug of abuse, a medication, exposure to a toxin) or a general
medical condition (e.g., head trauma) (Criterion F).
General diagnostic criteria for a personality disorder
A. An enduring pattern of inner experience and behavior that deviates markedly from the expectations of the
individual’s culture. This pattern is manifested in two (or more) of the following areas:
(1) Cognition (i.e., ways of perceiving and interpreting self, other people, and events)
(2) Affectivity (i.e., the range, intensity, lability, and appropriateness of emotional response)
(3) Interpersonal functioning
(4) Impulse control
B. The enduring pattern is inflexible and pervasive across a broad range of personal and social situations.
C. The enduring pattern leads to clinically significant distress or impairment in social, occupational, or other
important areas of functioning.
D. The pattern is stable and of long duration, and its onset can be traced back at least to adolescence or early
adulthood.
E. The enduring pattern is not better accounted for as a manifestation or consequence of another mental disor-
der.
F. The enduring pattern is not due to the direct physiological effects of a substance (e.g., a drug of abuse, a
medication) or a general medical condition (e.g., head trauma).
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Case Study: Counseling a
Substance Abuse Treatment
Client With Borderline
Personality Disorder
Ming L., an Asian female, was 32 years old
when she was taken by ambulance to the local
hospital’s emergency room. Ming L. had
taken 80 Tylenol capsules and an unknown
amount of Ativan in a suicide attempt. Once
medically stable, Ming L. was evaluated by
the hospital’s social worker to determine her
clinical needs.
The social worker asked Ming L. about her
family of origin. Ming L. gave a cold stare
and said, “I don’t talk about that.” Asked if
she had ever been sexually abused, Ming L.
replied, “I don’t remember.” Ming L.
acknowledged previous suicide attempts as
well as a history of cutting her arm with a
razor blade during stressful episodes. She
reported that the cutting “helps the pain.”
Ming L. denied having “a problem” with sub-
stances but admitted taking “medication” and
“drinking socially.” A review of Ming L.’s
medications revealed the use of Ativan “when
I need it.” It soon became clear that Ming L.
was using a variety of benzodiazepines (anti-
anxiety medications) prescribed by several
doctors and probably was taking a daily dose
indicative of serious dependence. She report-
ed using alcohol “on weekends with friends”
but was vague about the amount. Ming L. did
acknowledge that before her suicide attempts,
she drank alone in her apartment. This last
suicide attempt was a response to a breakup
with her boyfriend. Ming L.’s insurance com-
pany is pushing for immediate discharge and
has referred her to the substance abuse treat-
ment counselor to “address the addictions
problem.”
The counselor reads through notes from an
evaluating psychiatrist and reviews the social
worker’s report of his interview with Ming.
She notes that the psychiatrist describes the
client as having a severe borderline personali-
ty disorder, major recurrent depression, and
dependence on both benzodiazepines and
alcohol. The counselor advises the insurance
company that unless the client’s co-occurring
disorders also are addressed, there is little
that substance abuse treatment
counseling will be able to accom-
plish.
Discussion: While it is impor-
tant not to refuse treatment for
clients with co-occurring disor-
ders, it is also important to
know the limits of what a sub-
stance abuse treatment coun-
selor or agency can and cannot
do realistically. A client with
problems this serious is unlikely
to do well in standard substance
abuse treatment unless she also
is enrolled in a program quali-
fied to provide treatment to
clients with borderline personal-
ity disorders, and preferably in
a program that offers treatment
designed specially for this disor-
der such as Dialectical Behavior
Therapy (Linehan et al. 1999)
Advice to the Counselor:
Counseling a Client With Borderline 
Personality Disorder
• Anticipate that client progress will be slow and uneven.
• Assess the risk of self-harm by asking about what is
wrong, why now, whether the client has specific plans
for suicide, past attempts, current feelings, and protec-
tive factors. (See the discussion of suicidality in appendix
D for a risk assessment protocol.)
• Maintain a positive but neutral professional relationship,
avoid overinvolvement in the client’s perceptions, and
monitor the counseling process frequently with supervi-
sors and colleagues.
• Set clear boundaries and expectations regarding limits
and requirements in roles and behavior.
• Assist the client in developing skills (e.g., deep breathing,
meditation, cognitive restructuring) to manage negative
memories and emotions.
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Diagnostic Features of Borderline Personality Disorder
The essential feature of borderline personality disorder is a pervasive pattern of instability of interpersonal
relationships, self-image, and affects, along with marked impulsivity that begins by early adulthood and is
present in a variety of contexts. Individuals with borderline personality disorder make frantic efforts to
avoid real or imagined abandonment (Criterion 1). Individuals with borderline personality disorder have a
pattern of unstable and intense relationships (Criterion 2). There may be an identity disturbance character-
ized by markedly and persistently unstable self-image or sense of self (Criterion 3). Individuals with this dis-
order display impulsivity in at least two areas that are potentially self-damaging (Criterion 4). Individuals
with borderline personality disorder display recurrent suicidal behavior, gestures, or threats, or self-muti-
lating behavior (Criterion 5). Individuals with borderline personality disorder may display affective insta-
bility that is due to a marked reactivity of mood (e.g., intense episodic dysphoria, irritability, or anxiety
usually lasting a few hours and only rarely more than a few days) (Criterion 6). Individuals with borderline
personality disorder may be troubled by chronic feelings of emptiness (Criterion 7). Individuals with bor-
derline personality disorder frequently express inappropriate, intense anger or have difficulty controlling
their anger (Criterion 8). During periods of extreme stress, transient paranoid ideation or dissociative
symptoms (e.g., depersonalization) may occur (Criterion 9), but these are generally of insufficient severity
or duration to warrant an additional 
diagnosis.
Diagnostic criteria for borderline personality disorder
A pervasive pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity
beginning by early adulthood and present in a variety of contexts, as indicated by five (or more) of the follow-
ing:
(1) Frantic efforts to avoid real or imagined abandonment. Note: Do not include suicidal or self-mutilating
behavior covered in Criterion 5.
(2) A pattern of unstable and intense interpersonal relationships characterized by alternating between
extremes of idealization and devaluation.
(3) Identity disturbance: markedly and persistently unstable self-image or sense of self.
(4) Impulsivity in at least two areas that are potentially self-damaging (e.g., spending, sex, substance abuse,
reckless driving, binge eating). Note: Do not include suicidal or self-mutilating behavior covered in
Criterion 5.
(5) Recurrent suicidal behavior, gestures, or threats, or self-mutilating behavior.
(6) Affective instability due to a marked reactivity of mood (e.g., intense episodic dysphoria, irritability, or
anxiety usually lasting a few hours and only rarely more than a few days).
(7) Chronic feelings of emptiness.
(8) Inappropriate, intense anger or difficulty controlling anger (e.g., frequent displays of temper, constant
anger, recurrent physical fights).
(9) Transient, stress-related paranoid ideation or severe dissociative symptoms.
Source: Reprinted with permission from DSM-IV-TR (APA 2000, pp. 706–708, 710).
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(although substance abuse treatment pro-
grams are increasingly developing their
capacities to address specialized mental disor-
ders). She is likely to need complicated detox-
ification either on an inpatient basis or in a
long-term outpatient program that knows how
to enclose the kinds of behavioral chaos that
borderline clients often experience.
Antisocial Personality
Disorder
The two essential features of antisocial person-
ality disorder (APD) are: (1) a pervasive disre-
gard for and violation of the rights of others,
and (2) an inability to form meaningful inter-
personal relationships.
What counselors should
know about substance abuse
and APD
The prevalence of antisocial personality disor-
der and substance abuse is high:
•Much of substance abuse treatment is partic-
ularly targeted to those with APD, and sub-
stance abuse treatment alone has been partic-
ularly effective for these disorders.
•The majority of people with substance use
disorders are not sociopathic except as a
result of their addiction.
•Most people diagnosed as having APD are not
true psychopaths—that is, predators who use
manipulation, intimidation, and violence to
control others and to satisfy their own needs.
•Many people with APD use substances in a
polydrug pattern involving alcohol, marijua-
na, heroin, cocaine, and methamphetamine.
•People with APD may be excited by the illegal
drug culture and may have considerable
pride in their ability to thrive in the face of
the dangers of that culture. They often are in
trouble with the law. Those who are more
effective may limit themselves to exploitative
or manipulative behaviors that do not make
them as vulnerable to criminal sanctions.
Case study: counseling a 
substance abuse treatment
client with antisocial 
personality disorder
Mark R., a Hispanic/Latino male, was 27 years
old when he was arrested for driving while
intoxicated. Mark R. presented himself to the
court counselor for evaluation of the possible
need for substance abuse treatment. Mark R.
was on time for the appointment and was
slightly irritated at having to wait 20 minutes
due to the counselor’s schedule. Mark R. was
wearing a suit (which had seen better days) and
was trying to present himself in a positive light.
Mark R. denied any “problems with alcohol”
and reported having “smoked some pot as a
kid.” He denied any history of suicidal think-
ing or behavior except for a short period fol-
lowing his arrest. He acknowledged that he
did have a “bit of a temper” and that he took
pride in the ability to “kick ass and take
names” when the situation required. Mark R.
denied any childhood trauma and described
his mother as a “saint.” He described his
father as “a real jerk” and refused to give
any other information.
In describing the situation that preceded his
arrest, Mark R. tended to see himself as the
victim, using statements such as “The bar-
tender should not have let me drink so
much,” “I wasn’t driving that bad,” and
“The cop had it in for me.” Mark R. tended
to minimize his own responsibility throughout
the interview. Mark R. had been married
once but only briefly. His only comment
about the marriage was, “She talked me into
it but I got even with her.” Mark R. has no
children and lives alone in a studio apart-
ment. Mark R. has attended two meetings of
Alcoholics Anonymous (AA) “a couple of
years ago before I learned how to control my
drinking.”
The counselor coordinates closely with the
parole officer and arranges several three-way
meetings. He carefully reviews details of the
court contract and conditions of parole and
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keeps court records up to date. His work with
Mark R. centers on clarifying expectations.
Discussion. It is likely that Mark R. has 
antisocial personality disorder. Clients with
this disorder usually are very hard to engage
in individual treatment and are best managed
through strict limits with clear consequences.
With such an individual, it is important to
maximize the interaction with the court,
parole officers, or other legal limit setters.
This enforces the limits of treatment, and
prevents the client from criticizing and blam-
ing one agency representative to the other.
People with this disorder are best managed in
group treatment that addresses both their
substance abuse and antisocial personality
disorder. In such groups the approach is to
hold the clients responsible for their behavior
and its consequences and to confront dishon-
est and antisocial behavior directly and firm-
ly and stress immediate learning experiences
that teach corrective responses.
It is important to differentiate true antisocial
personality from substance-related antisocial
behavior. This can best be done by looking at
how the person relates to others throughout
Diagnostic Features of Antisocial Personality Disorder
The essential feature of antisocial personality disorder is a pervasive pattern of disregard for, and violation
of, the rights of others that begins in childhood or early adolescence and continues into adulthood. This pat-
tern also has been referred to as psychopathy, sociopathy, or dyssocial personality disorder. Because deceit
and manipulation are central features of antisocial personality disorder, it may be especially helpful to inte-
grate information acquired from systematic clinical assessment with information collected from collateral
sources. For this diagnosis to be given, the individual must be at least age 18 (Criterion B) and must have had
a history of some symptoms of conduct disorder before age 15 (Criterion C).
Diagnostic criteria for antisocial personality disorder
A. There is a pervasive pattern of disregard for and violation of the rights of others occurring since age 15, as
indicated by three (or more) of the following:
(1) Failure to conform to social norms with respect to lawful behaviors as indicated by repeatedly perform-
ing acts that are grounds for arrest
(2) Deceitfulness, as indicated by repeated lying, use of aliases, or conning others for personal profit or
pleasure
(3) Impulsivity or failure to plan ahead
(4) Irritability and aggressiveness, as indicated by repeated physical fights or assaults
(5) Reckless disregard for safety of self or others
(6) Consistent irresponsibility, as indicated by repeated failure to sustain consistent work behavior or
honor financial obligations
(7) Lack of remorse, as indicated by being indifferent to or rationalizing having hurt, mistreated, or stolen
from another
B. The individual is at least age 18.
C. There is evidence of Conduct Disorder (see APA 2000, p. 98) with onset before age 15.
D. The occurrence of antisocial behavior is not exclusively during the course of Schizophrenia or a Manic
Episode.
Source: Reprinted with permission from DSM-IV-TR (APA 2000, pp. 701, 702, 706).
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the course of his or her life. Persons with this
disorder will have evidence of antisocial
behavior preceding substance use and even
during periods of enforced abstinence. It also
is important to recognize that people with
substance-related antisocial behavior may be
more likely to have major depression than
other typical personality disorders. However,
the type and character of depressions that
may be experienced by those with true APD
have been less well characterized, and their
treatment is unclear.
Mood Disorders and
Anxiety Disorders
Because of the striking similarities in under-
standing and serving clients with mood and
anxiety disorders, the sections have been com-
bined to address both disorders. (It should be
noted, however, that two disorder types are
separated in DSM-IV-TR [APA 2000].)
What Counselors Should
Know About Mood and
Anxiety Disorders and
Substance Abuse
Counselors should be aware of the following:
•Approximately one quarter of United States
residents are likely to have some anxiety dis-
order during their lifetime, and the preva-
lence is higher among women than men.
•About one half of individuals with a sub-
stance use disorder have an affective or anxi-
ety disorder at some time in their lives.
•Among women with a substance use disor-
der, mood disorders may be prevalent.
Women are more likely than men to be clin-
ically depressed and/or to have posttrau-
matic stress disorder.
•Certain populations are at risk for anxiety
and mood disorders (e.g., clients with HIV,
clients maintained on methadone, and older
adults).
•Older adults may be the group at highest
risk for combined mood disorder and sub-
stance problems. Episodes of mood distur-
bance generally increase in frequency with
age. Older adults with concurrent mood
and substance use disorders tend to have
more mood episodes as they get older, even
when their substance use is controlled.
•Both substance use and discontinuance may
be associated with depressive symptoms.
•Acute manic symptoms may be induced or
mimicked by intoxication with stimulants,
steroids, hallucinogens, or polydrug combi-
nations.
•Withdrawal from depressants, opioids, and
stimulants invariably includes potent anxi-
ety symptoms. During the first months of
sobriety, many people with substance use
disorders may exhibit symptoms of depres-
sion that fade over time and that are relat-
ed to acute withdrawal.
•Medical problems and medications can pro-
duce symptoms of anxiety and mood disor-
ders. About a quarter of individuals who
have chronic or serious general medical
conditions, such as diabetes or stroke,
develop major depressive disorder.
•People with co-occurring mood or anxiety
disorders and a substance use disorder typ-
ically use a variety of drugs.
•Though there may be some preference for
those with depression to favor stimulation
and those with anxieties to favor sedation,
there appears to be considerable overlap.
The use of alcohol, perhaps because of its
availability and legality, is ubiquitous.
•It is now believed that substance use is more
often a cause of anxiety symptoms rather
than an effort to cure these symptoms.
•Since mood and anxiety symptoms may
result from substance use disorders, not an
underlying mental disorder, careful and
continuous assessment is essential.
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Diagnostic Features of Mood Disorders
The mood disorders are divided into the depressive disorders (“unipolar depression”), the bipolar disorders,
and two disorders based on etiology—mood disorder due to a general medical condition and substance-induced
mood disorder. The depressive disorders (i.e., major depressive disorder, dysthymic disorder, and depressive
disorder not otherwise specified) are distinguished from the bipolar disorders by the fact that there is no history
of ever having had a manic, mixed, or hypomanic episode. The bipolar disorders (i.e., bipolar I disorder, bipo-
lar II disorder, cyclothymic disorder, and bipolar disorder not otherwise specified) involve the presence (or his-
tory) of manic episodes, mixed episodes, or hypomanic episodes, usually accompanied by the presence (or histo-
ry) of major depressive episodes.
The section below describes mood episodes (major depressive episode, manic episode) which are not diag-
nosed as separate entities, but serve as the building block for the mood disorder diagnoses.
Major Depressive Episode
Episode features
The essential feature of a Major Depressive Episode is a period of at least 2 weeks during which there is either
depressed mood or the loss of interest or pleasure in nearly all activities. In children and adolescents, the mood
may be irritable rather than sad. The individual also must experience at least four additional symptoms drawn
from a list that includes changes in appetite or weight, sleep, and psychomotor activity; decreased energy; feel-
ings of worthlessness or guilt; difficulty thinking, concentrating, or making decisions; or recurrent thoughts of
death or suicidal ideation, plans, or attempts. To count toward a Major Depressive Episode, a symptom must
either be newly present or must have clearly worsened compared with the person’s pre-episode status. The
symptoms must persist for most of the day, nearly every day, for at least 2 consecutive weeks. The episode must
be accompanied by clinically significant distress or impairment in social, occupational, or other important areas
of functioning. For some individuals with milder episodes, functioning may appear to be normal but requires
markedly increased effort.
Criteria for major depressive episode
Five (or more) of the following symptoms have been present during the same 2-week period and represent a
change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of inter-
est or pleasure. 
Note: Do not include symptoms that are clearly due to a general medical condition, or mood-incongruent delu-
sions or hallucinations.
(1) Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g.,
feels sad or empty) or observation made by others (e.g., appears tearful). Note: In children and ado-
lescents, can be irritable mood.
(2) Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every
day (as indicated by either subjective account or observation made by others).
(3) Significant weight loss when not dieting or weight gain (e.g., a change of more than 5 percent of body
weight in a month), or decrease or increase in appetite nearly every day. Note: In children, consider
failure to make expected weight gains.
(4) Insomnia or hypersomnia nearly every day.
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(5) Psychomotor agitation or retardation nearly every day (observable by others, not merely subjective
feelings of restlessness or being slowed down).
(6) Fatigue or loss of energy nearly every day.
(7) Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every
day (not merely self-reproach or guilt about being sick).
(8) Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective
account or as observed by others).
(9) Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific
plan, or a suicide attempt or a specific plan for committing suicide.
B. The symptoms do not meet criteria for a Mixed Episode (see APA 2000, p. 365).
C. The symptoms cause clinically significant distress or impairment in social, occupational, or other important
areas of functioning.
D. The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medica-
tion) or a general medical condition (e.g., hypothyroidism).
E. The symptoms are not better accounted for by Bereavement, i.e., after the loss of a loved one; the symptoms
persist for longer than 2 months or are characterized by marked functional impairment, morbid preoccupa-
tion with worthlessness, suicidal ideation, psychotic symptoms, or psychomotor retardation.
Manic Episode
Episode features
A Manic Episode is defined by a distinct period during which there is an abnormally and persistently elevat-
ed, expansive, or irritable mood. This period of abnormal mood must last at least 1 week (or less if hospital-
ization is required) (Criterion A). The mood disturbance must be accompanied by at least three additional
symptoms from a list that includes inflated self-esteem or grandiosity, decreased need for sleep, pressure of
speech, flight of ideas, distractibility, increased involvement in goal-directed activities or psychomotor agita-
tion, and excessive involvement in pleasurable activities with a high potential for painful consequences. If
the mood is irritable (rather than elevated or expansive), at least four of the above symptoms must be pre-
sent (Criterion B). The symptoms do not meet criteria for a Mixed Episode, which is characterized by the
symptoms of both a Manic Episode and a Major Depressive Episode occurring nearly every day for at least
a 1-week period (Criterion C). The disturbance must be sufficiently severe to cause marked impairment in
social or occupational functioning or to require hospitalization, or it is characterized by the presence of psy-
chotic features (Criterion D). The episode must not be due to the direct physiological effects of a drug of
abuse, a medication, other somatic treatments for depression (e.g., electroconvulsive therapy or light thera-
py), or toxin exposure. The episode also must not be due to the direct physiological effects of a general med-
ical condition (e.g., multiple sclerosis, brain tumor) (Criterion E).
Criteria for manic episodes
A. A distinct period of abnormally and persistently elevated, expansive, or irritable mood, lasting at least 1
week (or any duration if hospitalization is necessary).
B. During the period of mood disturbance, three (or more) of the following symptoms have persisted (four if the
mood is only irritable) and have been present to a significant degree:
(1) Inflated self-esteem or grandiosity
(2) Decreased need for sleep (e.g., feels rested after only 3 hours of sleep)
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Case Study:
Counseling a
Substance Abuse
Treatment Client With
Bipolar Disorder
John W. is a 30-year-old African-
American man with diagnoses of
bipolar disorder and alcohol
dependence. He has a history of
hospitalizations, both psychiatric
and substance-related; after the
most recent extended psychiatric
hospitalization, he was referred
for substance abuse treatment. He
told the counselor he used alcohol
to facilitate social contact, as well
as deal with boredom, since he
had not been able to work for
some time. The counselor learned
that during his early twenties,
John W. achieved full-time
employment and established an
intimate relationship with a non-
drinking woman; however, his
drinking led to the loss of both. 
(3) More talkative than usual or pressure to keep talking
(4) Flight of ideas or subjective experience that thoughts are racing
(5) Distractibility (i.e., attention too easily drawn to unimportant or irrelevant external stimuli)
(6) Increase in goal-directed activity (either socially, at work or school, or sexually) or psychomotor agi-
tation
(7) Excessive involvement in pleasurable activities that have a high potential for painful consequences
(e.g., engaging in unrestrained buying sprees, sexual indiscretions, or foolish business investments)
C. The symptoms do not meet criteria for a Mixed Episode (see APA 2000, p. 365).
D. The mood disturbance is sufficiently severe to cause marked impairment in occupational functioning or in
usual social activities or relationships with others, or to necessitate hospitalization to prevent harm to self or
others, or there are psychotic features.
E. The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medica-
tion, or other treatment) or a general medical condition (e.g., hyperthyroidism).
Note: Manic-like episodes that are clearly caused by somatic antidepressant treatment (e.g., medication,
electroconvulsive therapy, light therapy) should not count toward a diagnosis of Bipolar I Disorder.
Source: Reprinted with permission from DSM-IV-TR (APA 2000, pp. 349, 356, 357, 362).
Advice to the Counselor: 
Counseling a Client With a Mood or 
Anxiety Disorder
• Differentiate among the following: mood and anxiety
disorders; commonplace expressions of anxiety and
depression; and anxiety and depression associated with
more serious mental illness, medical conditions and med-
ication side effects, and substance-induced changes.
• Although true for most counseling situations, it is espe-
cially important to maintain a calm demeanor and a
reassuring presence with these clients.
• Start low, go slow (that is, start “low” with general and
nonprovocative topics and proceed gradually as clients
become more comfortable talking about issues).
• Monitor symptoms and respond immediately to any
intensification of symptoms.
• Understand the special sensitivities of phobic clients to
social situations.
• Gradually introduce and teach skills for participation in
mutual self-help groups.
• Combine addiction counseling with medication and men-
tal health treatment.
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Diagnostic Features of Generalized Anxiety Disorder
The essential feature of generalized anxiety disorder is excessive anxiety and worry (apprehensive expectation),
occurring more days than not for a period of at least 6 months, about a number of events or activities (Criterion
A). The individual finds it difficult to control the worry (Criterion B). The anxiety and worry are accompanied
by at least three additional symptoms from a list that includes restlessness, being easily fatigued, difficulty con-
centrating, irritability, muscle tension, and disturbed sleep (only one additional symptom is required in chil-
dren) (Criterion C). The focus of the anxiety and worry is not confined to features of another Axis I disorder
such as having a panic attack (as in panic disorder), being embarrassed in public (as in social phobia), being
contaminated (as in obsessive-compulsive disorder), being away from home or close relatives (as in separation
anxiety disorder), losing weight (as in anorexia nervosa), having multiple physical complaints (as in somatiza-
tion disorder), or having a serious illness (as in hypochondriasis), and the anxiety and worry do not occur
exclusively during posttraumatic stress disorder (Criterion D). Although individuals with generalized anxiety
disorder may not always identify the worries as “excessive,” they report subjective distress due to constant
worry, have difficulty controlling the worry, or experience related impairment in social, occupational, or other
important areas of functioning (Criterion E). The disturbance is not due to the direct physiological effects of a
substance (i.e., a drug of abuse, a medication, or toxin exposure) or a general medical condition and does not
occur exclusively during a mood disorder, a psychotic disorder, or a pervasive developmental disorder
(Criterion F).
Diagnostic criteria for generalized anxiety disorder
A. Excessive anxiety and worry (apprehensive expectation), occurring more days than not for at least 6 months,
about a number of events or activities (such as work or school performance).
B. The person finds it difficult to control the worry.
C. The anxiety and worry are associated with three (or more) of the following six symptoms (with at least some
symptoms present for more days than not for the past 6 months). Note: Only one item is required in chil-
dren.
(1) Restlessness or feeling keyed up or on edge
(2) Being easily fatigued
(3) Difficulty concentrating or mind going blank
(4) Irritability
(5) Muscle tension
(6) Sleep disturbance (difficulty falling or staying asleep, or restless unsatisfying sleep)
D. The focus of the anxiety and worry is not confined to features of an Axis I disorder, e.g., the anxiety or
worry is not about having a Panic Attack (as in Panic Disorder), being embarrassed in public (as in Social
Phobia), being contaminated (as in Obsessive-Compulsive Disorder), being away from home or close relatives
(as in Separation Anxiety Disorder), losing weight (as in Anorexia Nervosa), having multiple physical com-
plaints (as in Somatization Disorder), or having a serious illness (as in Hypochondriasis), and the anxiety
and worry do not occur exclusively during Posttraumatic Stress Disorder.
E. The anxiety, worry, or physical symptoms cause clinically significant distress or impairment in social, occu-
pational, or other important areas of functioning.
F. The disturbance is not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medica-
tion) or a general medical condition (e.g., hyperthyroidism) and does not occur exclusively during a Mood
Disorder, a Psychotic Disorder, or a Pervasive Developmental Disorder.
Source: Reprinted with permission from DSM-IV-TR (APA 2000, pp. 472, 473, 476).
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During one of his alcohol treatments, he
developed florid manic symptoms, believing
himself to be a prophet with the power to heal
others. He was transferred to a closed psychi-
atric unit, where he eventually stabilized on a
combination of antipsychotic medications
(risperdal) and lithium. Since that time he
has had two episodes of worsening psychiatric
symptoms leading to hospitalization; each of
these began with drinking, which then led to
stopping his medications, then florid mania
and psychiatric commitment. However, when
he is taking his medications and is sober,
John W. has a normal mental status and
relates normally to others. Recently, following
a series of stressors, John W. left his girl-
friend, quit his job, and began using alcohol
heavily again. He rapidly relapsed to active
mania, did not adhere to a medication regi-
men, and was rehospitalized.
At the point John W. is introduced to the sub-
stance abuse treatment counselor, his mental
status is fairly normal; however, he warns the
counselor that after manic episodes he tends
to get somewhat depressed, even when he is
taking medications. In taking an addiction
history, the counselor finds that though John
W. has had several periods of a year or two
during which he was abstinent from both
alcohol and drugs of abuse, he has never
become involved with either ongoing alcohol
treatment or AA meetings. John W. replies to
his questions about this with, “Well, if I just
take my meds and don’t drink, I’m fine. So
why do I need those meetings?”
Using a motivational approach, the counselor
helps John W. analyze what has worked best
for him in dealing with both addiction and
mental problems, as well as what has not
worked well for him. John W. is tired of the
merry-go-round of his life; he certainly
acknowledges that he has a major mental dis-
order, but thinks his drinking is only sec-
ondary to the mania. When the counselor
gently points out that each of the episodes in
which his mental disorder led to hospitaliza-
tion began with an alcohol relapse, John W.
begins to listen. In a group for clients with co-
occurring disorders at the substance abuse
treatment agency, John W. is introduced to
another recovering manic patient with alcohol
problems who tells his personal story and how
he discovered that both of his problems need
primary attention. This client agrees to be
John W.’s temporary sponsor. The counselor
calls John W.’s case manager, who works at
the mental health center where John W. gets
his medication, and describes the treatment
plan. She then makes arrangements for a
monthly meeting involving the counselor, case
manager, and John W. 
Discussion: The substance abuse treatment
counselor has taken the wise step of taking a
detailed history and attempting to establish
the linkage between co-occurring disorders.
The counselor tries to appreciate the client’s
own understanding of the relationship
between the two. She uses motivational
approaches to analyze what John W. did in
his previous partially successful attempts to
deal with the problem and helps develop con-
nections with other recovering clients to
increase motivation. Lastly, she is working
closely with the case manager to ensure a
coordinated approach to management of each
disorder.
Schizophrenia and
Other Psychotic
Disorders
What Counselors Should
Know About Substance Abuse
and Psychotic Disorders
There are different types of psychotic disorders
or disorders that have psychotic features.
Schizophrenia, a relatively common type of
psychotic disorder, is featured in this section.
Counselors should be aware of the following:
•There is evidence of increasing use of alcohol
and drugs by persons with schizophrenia
(from 14 to 22 percent in the 1960s and 1970s
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Descriptive Features
The term “psychotic” historically has received a number of different definitions, none of which has achieved
universal acceptance. The narrowest definition of psychotic is restricted to delusions or prominent halluci-
nations, with the hallucinations occurring in the absence of insight into their pathological nature. A slightly
less restrictive definition also would include prominent hallucinations that the individual realizes are hallu-
cinatory experiences. Broader still is a definition that also includes other positive symptoms of schizophre-
nia (i.e., disorganized speech, or grossly disorganized or catatonic behavior). Unlike these definitions based
on symptoms, the definition used in earlier classifications (e.g., DSM-II and ICD-9) probably was far too
inclusive and focused on the severity of functional impairment. In that context, a mental disorder was
termed “psychotic” if it resulted in “impairment that grossly interferes with the capacity to meet ordinary
demands of life.” The term also has previously been defined as a “loss of ego boundaries” or a “gross
impairment in reality testing.”
Schizophrenia is a disorder that lasts for at least 6 months and includes at least 1 month of active-phase
symptoms (i.e., two or more) of the following: delusions, hallucinations, disorganized speech, grossly disor-
ganized or catatonic behavior, negative symptoms. Definitions for the schizophrenia subtypes (paranoid,
disorganized, catatonic, undifferentiated, and residual) are also included in this section.
Diagnostic criteria for schizophrenia
A. Characteristic symptoms: Two (or more) of the following, each present for a significant portion of time
during a 1-month period (or less if successfully treated):
(1) Delusions
(2) Hallucinations
(3) Disorganized speech (e.g., frequent derailment or incoherence)
(4) Grossly disorganized or catatonic behavior
(5) Negative symptoms, i.e., affective flattening, alogia, or avolition
Note: Only one Criterion A symptom is required if delusions are bizarre or hallucinations consist of a voice
keeping up a running commentary on the person’s behavior or thoughts, or two or more voices conversing with
each other.
B. Social/occupational dysfunction: For a significant portion of the time since the onset of the disturbance,
one or more major areas of functioning such as work, interpersonal relations, or self-care are markedly
below the level achieved prior to the onset (or when the onset is in childhood or adolescence, failure to
achieve expected level of interpersonal, academic, or occupational achievement).
C. Duration: Continuous signs of the disturbance persist for at least 6 months. This 6-month period must
include at least 1 month of symptoms (or less if successfully treated) that meet Criterion A (i.e., active-
phase symptoms) and may include periods of prodromal or residual symptoms. During these prodromal
or residual periods, the signs of the disturbance may be manifested by only negative symptoms or two or
more symptoms listed in Criterion A present in an attenuated form (e.g., odd beliefs, unusual perceptual
experiences).
D. Schizoaffective and Mood Disorder exclusion: Schizoaffective Disorder and Mood Disorder With
Psychotic Features have been ruled out because either (1) no Major Depressive, Manic, or Mixed
Episodes have occurred concurrently with the active-phase symptoms; or (2) if mood episodes have
occurred during active-phase symptoms, their total duration has been brief relative to the duration of
the active and residual periods.
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to 25 to 50 percent in the 1990s) (Fowler et
al. 1998).
•There is no clear pattern of drug choice
among clients with schizophrenia. Instead,
it is likely that whatever substances happen
to be available or in vogue will be the sub-
stances used most typically.
•What looks like resistance or denial may in
reality be a manifestation of negative symp-
toms of schizophrenia.
•An accurate understanding of the role of
substance use disorders in the client’s psy-
chosis requires a multiple-contact, longitu-
dinal assessment.
•Clients with a co-occurring mental disorder
involving psychosis have a higher risk for
self-destructive and violent behaviors.
•Clients with a co-occurring mental disorder
involving psychosis are particularly vulner-
able to homelessness, housing instability,
victimization, poor nutrition, and inade-
quate financial resources.
•Both psychotic and substance use disorders
tend to be chronic disorders with multiple
relapses and remissions, supporting the
need for long-term treatment. For clients
with co-occurring disorders involving psy-
chosis, a long-term approach is imperative.
It is important that the program philosophy be
based on a multidisciplinary team approach.
Ideally, team members should be cross-trained,
and there should be representatives from the
medical, mental health, and addiction systems.
The overall goals of long-term management
should include (1) providing comprehensive
and integrated services for both the mental and
substance use disorders, and (2) doing so with
a long-term focus that addresses biopsychoso-
cial issues in accord with a treatment plan with
goals specific to a client’s situation. 
Case Study: Counseling a
Substance Abuse Treatment
Client With Schizophrenia
Adolfo M. is a 40-year-old Hispanic male who
began using marijuana and alcohol when he
was 15. He was diagnosed as having
schizophrenia when he was 18 and began
using cocaine at 19. Sometimes he lives with
his sister or with temporary girlfriends; some-
times he lives on the street. He has never had
a sustained relationship, and he has never
held a steady job. He has few close friends.
He wears long hair, tattoos, torn jeans, and t-
shirts with skulls or similar images. Although
he has had periods of abstinence and freedom
E. Substance/general medical condition exclusion: The disturbance is not due to the direct physiological
effects of a substance (e.g., a drug of abuse, a medication) or a general medical condition.
F. Relationship to a Pervasive Developmental Disorder: If there is a history of Autistic Disorder or another
Pervasive Developmental Disorder, the additional diagnosis of Schizophrenia is made only if prominent
delusions or hallucinations also are present for at least a month (or less if successfully treated).
Classification of longitudinal course (can be applied only after at least 1 year has elapsed since the initial
onset of active-phase symptoms):
•Episodic With Interepisode Residual Symptoms (episodes are defined by the reemergence of prominent
psychotic symptoms); also specify if: With Prominent Negative Symptoms
•Episodic With No Interepisode Residual Symptoms
•Continuous (prominent psychotic symptoms are present throughout the period of observation); also spec-
ify if: With Prominent Negative Symptoms
•Single Episode In Partial Remission; also specify if: With Prominent Negative Symptoms
•Single Episode In Full Remission
•Other or Unspecified Pattern
Source: Reprinted with permission from DSM-IV-TR (APA 2000, pp. 298–302, 312–313).
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from hallucinations and major delusions, he
generally has unusual views of the world that
emerge quickly in conversation.
Adolfo M. has been referred to the substance
abuse treatment counselor, who was hired by
the mental health center to do most of the
group and individual drug/alcohol work with
clients. The first step the counselor takes is to
meet with Adolfo M. and his case manager
together. This provides a clinical linkage as
well as a method to get the best history. The
clinical history reveals that Adolfo M. does
best when he is sober and on medications, but
there are times when he will be
sober and not adhere to a medi-
cal regimen, or when he is both
taking medications and drinking
(though these periods are becom-
ing shorter in duration and less
frequent). His case manager
often is able to redirect him
toward renewed sobriety and
adherence to medications, but
Adolfo M. and the case manager
agree that the cycle of relapse
and the work of pulling things
back together is wearing them
both out. After the meeting, the
case manager, counselor, and
Adolfo M. agree to meet weekly
for a while to see what they can
do together to increase the stable
periods and decrease the relapse
periods. After a month of these
planning meetings, the following
plan emerges. Adolfo M. will
attend substance abuse treat-
ment groups for persons with
COD (run by the counselor three
times a week at the clinic), see
the team psychiatrist, and attend
local dual disorder AA meetings.
The substance abuse treatment
group he will be joining is one
that addresses not only addiction
issues, but also issues with treat-
ment follow through, life prob-
lems, ways of dealing with stress,
and the need for social support
for clients trying to get sober.
When and if relapse happens, Adolfo M. will
be accepted back without prejudice and sup-
ported in recovery and treatment of both his
substance abuse and mental disorders; how-
ever, part of the plan is to analyze relapses
with the group. His goal is to have as many
sober days as possible with as many days
adhering to a medical regimen as possible.
Another aspect of the group is that monthly,
90-day, 6-month, and yearly sobriety birth-
days are celebrated with both AA coins and
refreshments. Part of the employment pro-
gram at the center is that clients need to have
Advice to the Counselor:
Counseling a Client With a 
Psychotic Disorder
• Obtain a working knowledge of the signs and symptoms
of the disorder.
• Work closely with a psychiatrist or mental health profes-
sional.
• Expect crises associated with the mental disorder and
have available resources (i.e., crisis intervention, psychi-
atric consultation) to facilitate stabilization.
• Assist the client to obtain entitlements and other social
services.
• Make available psychoeducation on the psychiatric con-
dition and use of medication.
• Monitor medication and promote medication adherence.
• Provide frequent breaks and shorter sessions or meet-
ings.
• Employ structure and support.
• Present material in simple, concrete terms with examples
and use multimedia methods.
• Encourage participation in social clubs with recreational
activities.
• Teach the client skills for detecting early signs of relapse
for both mental illness and substance abuse.
• Involve family in psychoeducational groups that specifi-
cally focus on education about substance use disorders
and psychosis; establish support groups of families and
significant others.
• Monitor clients for signs of substance abuse relapse and
a return of psychotic symptoms.
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a minimum of 3 months of sobriety before
they will be placed in a supported work situa-
tion, so this becomes an incentive for sobriety
as well. 
Discussion: Substance abuse treatment
counselors working within mental health cen-
ters should be aware of the need not only to
work with the client, but also to form solid
working relationships with case managers, the
psychiatrist, and other personnel. Seeing
clients with case managers and other team
members is a good way to establish important
linkages and a united view of the treatment
plan. In Adolfo M.’s case, the counselor used
his ties with the case manager to good effect
and also is using relapse prevention and con-
tingency management strategies appropriately
(see chapter 5 for a discussion of these tech-
niques).
Attention Deficit/
Hyperactivity Disorder
(AD/HD)
What Counselors Should
Know About Substance Abuse
and AD/HD
The essential feature of AD/HD is a persistent
pattern of inattention and/or hyperactivity-
impulsivity that is displayed more frequently
and more serious than is observed typically in
individuals at a comparable level of develop-
ment (APA 2000). Counselors should be aware
of the following:
•Studies of the adult substance abuse treat-
ment population have found AD/HD in 5 to
25 percent of persons (Clure et al. 1999;
King et al. 1999; Levin et al. 1998;
Schubiner et al. 2000; Weiss et al. 1998).
•Approximately one third of adults with
AD/HD have histories of alcohol abuse or
dependence, and approximately one in five
has other drug abuse or dependence histo-
ries.
•Adults with AD/HD have been found pri-
marily to use alcohol, with marijuana being
the second most common drug of abuse.
•The history of a typical AD/HD substance
abuse treatment client may show early
school problems before substance abuse
began.
•The client may use self-medication for
AD/HD as an excuse for drug use.
•The most common attention problems in
substance abuse treatment populations are
secondary to short-term toxic effects of sub-
stances, and these should be substantially
better with each month of sobriety.
•The presence of AD/HD complicates the
treatment of substance abuse, since clients
with these COD may have more difficulty
engaging in treatment and learning absti-
nence skills, be at greater risk for relapse,
and have poorer substance use outcomes. 
Case Study: Counseling a
Substance Abuse Treatment
Client With AD/HD
John R., a 29-year-old African-American
man, is seeking treatment. He has been in
several treatment programs but always
dropped out after the first 4 weeks. He tells
the counselor he dropped out because he
would get cravings and that he just could not
concentrate in the treatment sessions. He
mentions the difficulty of staying focused dur-
ing 3-hour intensive group sessions. A con-
tributing factor in his quitting treatment was
that group leaders always seemed to scold him
for talking to others. The clinician evaluating
him asks how John R. did in school and finds
that he had difficulty in his classwork years
before he started using alcohol and drugs; he
was restless and easily distracted. He had
been evaluated for a learning disability and
AD/HD and took Ritalin for about 2 years (in
the 5th and 6th grades), then stopped. He was
not sure why, but he did terribly in school,
eventually dropping out about the time he
started using drugs regularly in the 8th grade.
236 A Brief Overview of Specific Mental Disorders and Cross-Cutting Issues
Diagnostic Features of AD/HD
The essential feature of attention-deficit/hyperactivity disorder is a persistent pattern of inattention and/or
hyperactivity-impulsivity that is more frequently displayed and more severe than is typically observed in
individuals at a comparable level of development (see Criterion A below). Some hyperactive-impulsive or
inattentive symptoms that cause impairment must have been present before age 7, although many individu-
als are diagnosed after the symptoms have been present for a number of years, especially in the case of indi-
viduals with the predominantly inattentive type (Criterion B). Some impairment from the symptoms must be
present in at least two settings (e.g., at home and at school or work) (Criterion C). There must be clear evi-
dence of interference with developmentally appropriate social, academic, or occupational functioning
(Criterion D). The disturbance does not occur exclusively during the course of a pervasive developmental
disorder, schizophrenia, or other psychotic disorder and is not better accounted for by another mental dis-
order (e.g., a mood disorder, anxiety disorder, dissociative disorder, or personality disorder) (Criterion E).
Diagnostic criteria for AD/HD
A. Either (1) or (2):
(1) Six (or more) of the following symptoms of inattention have persisted for at least 6 months to a degree
that is maladaptive and inconsistent with developmental level:
Inattention
(a) Often fails to give close attention to details or makes careless mistakes in schoolwork, work, or
other activities
(b) Often has difficulty sustaining attention in tasks or play activities
(c) Often does not seem to listen when spoken to directly
(d) Often does not follow through on instructions and fails to finish schoolwork, chores, or duties in
the workplace (not due to oppositional behavior or failure to understand instructions)
(e) Often has difficulty organizing tasks and activities
(f) Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (such
as schoolwork or homework)
(g) Often loses things necessary for tasks or activities (e.g., toys, school assignments, pencils, books,
or tools)
(h) Is often easily distracted by extraneous stimuli
(i) Is often forgetful in daily activities
(2) Six (or more) of the following symptoms of hyperactivity-impulsivity have persisted for at least 6
months to a degree that is maladaptive and inconsistent with developmental level:
Hyperactivity
(a) Often fidgets with hands or feet or squirms in seat
(b) Often leaves seat in classroom or in other situations in which remaining seated is expected
(c) Often runs about or climbs excessively in situations in which it is inappropriate (in adolescents or
adults, may be limited to subjective feelings of restlessness)
(d) Often has difficulty playing or engaging in leisure activities quietly; is often “on the go” or often
acts as if “driven by a motor”
(e) Often talks excessively
Impulsivity
(a) Often blurts out answers before questions have been completed
(b) Often has difficulty awaiting turn
(c) Often interrupts or intrudes on others (e.g., butts into conversations or games)
237A Brief Overview of Specific Mental Disorders and Cross-Cutting Issues
Discussion: The substance abuse treatment
clinician reviewed John R.’s learning history
and asked about anxiety or depressive disor-
ders. The clinician referred him to the team’s
psychiatrist, who uncovered more history
about the AD/HD and also contacted John
R.’s mother. When the clinician
reviewed a list of features com-
monly associated with AD/HD,
she agreed that John R. had
many of these features and that
she had noticed them in child-
hood. John R. was started on
bupropion medication and
moved to a less intensive level of
care (1 hour of group therapy,
30 minutes of individual coun-
seling, and AA meetings three times weekly).
Over the next 2 months, John R.’s ability to
tolerate a more intensive treatment improved.
Although he was still somewhat intrusive to
others, he was able to benefit from more
intensive group treatment.
B. Some hyperactive-impulsive or inattentive symptoms that caused impairment were present before age 7. 
C. Some impairment from the symptoms is present in two or more settings (e.g., at school or work and at
home). 
D. There must be clear evidence of clinically significant impairment in social, academic, or occupational func-
tioning. 
E. The symptoms do not occur exclusively during the course of a Pervasive Developmental Disorder,
Schizophrenia, or other Psychotic Disorder and are not better accounted for by another mental disorder
(e.g., Mood Disorder, Anxiety Disorder, Dissociative Disorder, or a Personality Disorder).
Code based on type:
• Attention-Deficit/Hyperactivity Disorder, Combined Type: if both Criteria A1 and A2 are met for the
past 6 months
• Attention-Deficit/Hyperactivity Disorder, Predominantly Hyperactive-Impulsive Type: if Criterion A2
is met but Criterion A1 is not met for the past 6 months
Coding note: For individuals (especially adolescents and adults) who currently have symptoms that no
longer meet full criteria, “In Partial Remission” should be specified.
Source: Reprinted with permission from DSM-IV-TR (APA 2000, pp. 85–87, 92–93).
Advice to the Counselor:
Counseling a Client Who Has AD/HD
• Clarify for the client repeatedly what elements of a ques-
tion he or she has responded to and what remains to be
addressed.
• Eliminate distracting stimuli from the environment.
• Use visual aids to convey information.
• Reduce the time of meetings and length of verbal
exchanges.
• Encourage the client to use tools (e.g., activity journals,
written schedules, and “to do” lists) to organize impor-
tant events and information.
• Refer the client for evaluation of the need for medica-
tion.
• Focus on enhancing the client’s knowledge about AD/HD
and substance abuse. Examine with the client any false
beliefs about the history of both AD/HD and substance
abuse difficulties.
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Posttraumatic Stress
Disorder (PTSD)
What Counselors Should
Know About Substance Abuse
and PTSD
PTSD is classified in DSM-IV-TR as one type
of anxiety disorder. It is treated separately in
this TIP because of its special relationship to
substance abuse and the growing literature on
PTSD and its treatment.
The essential feature of PTSD is the develop-
ment of characteristic symptoms following
exposure to an extreme traumatic stressor
involving direct personal experience of an
event that involves actual or threatened death
or serious injury, or other threat to one’s phys-
ical integrity; or witnessing an event that
involves death, injury, or a threat to the physi-
cal integrity of another person; or learning
about unexpected or violent death, serious
harm, or threat of death or injury experienced
by a family member or other close associate
(APA 2000, p. 463). Counselors should be
aware that
•The lifetime prevalence of PTSD among
adults in the United States is about 8 per-
cent.
•Among high-risk individuals (those who
have survived rape, military combat, and
captivity or ethnically or politically moti-
vated internment and genocide), the pro-
portion of those with PTSD ranges from
one-third to one-half.
•Among clients in substance abuse treatment,
PTSD is two to three times more common in
women than in men.
•The rate of PTSD among people with sub-
stance use disorders is 12 to 34 percent; for
women with substance use disorders, it is 30
to 59 percent (Brown and Wolfe 1994).
•Women with substance abuse problems
report a lifetime history of physical and/or
sexual abuse ranging from 55 to 99 percent
(Najavits et al. 1997).
•Most women with this co-occurring disorder
experienced childhood physical and/or sex-
ual abuse; men with both disorders typical-
ly experienced crime victimization or war
trauma.
•Clinicians are advised not to overlook the
possibility of PTSD in men. 
•People with PTSD and substance abuse are
more likely to experience further trauma
than people with substance abuse alone.
•Because repeated trauma is common in
domestic violence, child abuse, and some
substance-using lifestyles (e.g., the drug
trade), helping the client protect against
future trauma may be an important part of
work in treatment.
•People with PTSD tend to abuse the most
serious substances (cocaine and opioids);
however, abuse of prescription medications,
marijuana, and alcohol also are common.
•From the client’s perspective, PTSD symp-
toms are a common trigger for substance
use.
•While under the influence of substances, a
person may be more vulnerable to trau-
ma—for example, a woman drinking at a
bar may go home with a stranger and be
assaulted.
•As a counselor, it is important to recognize,
and help clients understand, that becoming
abstinent from substances does not resolve
PTSD; both disorders must be addressed in
treatment.
Case Study: Counseling a
Substance Abuse Treatment
Client Who Binge Drinks and
Has PTSD
Caitlin P. is a 17-year-old American-Indian
female who was admitted to an inpatient sub-
stance abuse treatment program after she tried
to kill herself during a drunken episode. She
has been binge drinking since age 12 and also
has tried a wide variety of pills without caring
what she is taking. She has a history of depres-
sion and burning her arms with cigarettes. She
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Diagnostic Features of PTSD
The essential feature of posttraumatic stress disorder is the development of characteristic symptoms follow-
ing exposure to an extreme traumatic stressor involving direct personal experience of an event that involves
actual or threatened death or serious injury, or other threat to one’s physical integrity; or witnessing an
event that involves death, injury, or a threat to the physical integrity of another person; or learning about
unexpected or violent death, serious harm, or threat of death or injury experienced by a family member or
other close associate (Criterion A1). The person’s response to the event must involve intense fear, helpless-
ness, or horror (or in children, the response must involve disorganized or agitated behavior) (Criterion A2).
The characteristic symptoms resulting from the exposure to the extreme trauma include persistent reexperi-
encing of the traumatic event (Criterion B), persistent avoidance of stimuli associated with the trauma and
numbing of general responsiveness (Criterion C), and persistent symptoms of increased arousal (Criterion
D). The full symptom picture must be present for more than 1 month (Criterion E), and the disturbance
must cause clinically significant distress or impairment in social, occupational, or other important areas of
functioning (Criterion F).
Diagnostic criteria for PTSD
A. The person has been exposed to a traumatic event in which both of the following were present:
(1) The person experienced, witnessed, or was confronted with an event or events that involved actual or
threatened death or serious injury, or a threat to the physical integrity of self or others.
(2) The person’s response involved intense fear, helplessness, or horror. Note: In children, this may be
expressed instead by disorganized or agitated behavior.
B. The traumatic event is persistently reexperienced in one (or more) of the following ways:
(1) Recurrent and intrusive distressing recollections of the event, including images, thoughts, or percep-
tions. Note: In young children, repetitive play may occur in which themes or aspects of the trauma
are expressed.
(2) Recurrent distressing dreams of the event. Note: In children, there may be frightening dreams with-
out recognizable content.
(3) Acting or feeling as if the traumatic event were recurring (includes a sense of reliving the experience,
illusions, hallucinations, and dissociative flashback episodes, including those that occur on awaken-
ing or when intoxicated). Note: In young children, trauma-specific reenactment may occur.
(4) Intense psychological distress at exposure to internal or external cues that symbolize or resemble an
aspect of the traumatic event.
(5) Physiological reactivity on exposure to internal or external cues that symbolize or resemble an aspect
of the traumatic event.
C. Persistent avoidance of stimuli associated with the trauma and numbing of general responsiveness (not pre-
sent before the trauma), as indicated by three (or more) of the following:
(1) Efforts to avoid thoughts, feelings, or conversations associated with the trauma
(2) Efforts to avoid activities, places, or people that arouse recollections of the trauma
(3) Inability to recall an important aspect of the trauma
(4) Markedly diminished interest or participation in significant activities
(5) Feeling of detachment or estrangement from others
(6) Restricted range of affect (e.g., unable to have loving feelings)
(7) Sense of a foreshortened future (e.g., does not expect to have a career, marriage, children, or a nor-
mal life span)
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was date-raped at age 15 and did not tell any-
one except a close friend. She was afraid to tell
her family for fear that they would think less of
her for not preventing or fighting off the
attack.
In treatment, she worked with staff to try to
gain control over her repeated self-destruc-
tive behavior. Together they worked on devel-
oping compassion for herself, created a safety
plan to encourage her to reach out for help
when in distress, and began a log to help her
identify her PTSD symptoms so that she
could recognize them more clearly. When she
had the urge to drink, drug, or burn herself,
she was guided to try to “bring down” the
feelings through grounding, rethink the situa-
tion, and reassure herself that she could get
through it. She began to see that her sub-
stance use had been a way to numb the pain.
Discussion: Counselors can be very impor-
tant in helping clients gain control over PTSD
symptoms and self-destructive behavior asso-
ciated with trauma. Providing specific coping
strategies and a lot of encouragement typical-
ly are well received by PTSD/substance abuse
treatment clients, who may want to learn how
to be able to overcome the emotional roller
coaster of the disorders. Notice that in such
early-phase treatment, detailed exploration of
the past is not generally advised.
Eating Disorders
What Counselors Should
Know About Substance Abuse
and Eating Disorders
The essential features of anorexia nervosa are
that the individual refuses to maintain a mini-
mal normal body weight, is intensely afraid of
gaining weight, and exhibits a significant dis-
turbance in the perception of the shape or size
of his or her body. The essential features of
bulimia nervosa are binge eating and inappro-
priate compensatory methods to prevent weight
gain. In dealing with persons who have either
disorder, counselors should be aware of the fol-
lowing:
• The prevalence of bulimia nervosa is elevated
in women presenting for substance abuse
treatment.
D. Persistent symptoms of increased arousal (not present before the trauma), as indicated by two (or more) of
the following:
(1) Difficulty falling or staying asleep
(2) Irritability or outbursts of anger
(3) Difficulty concentrating
(4) Hypervigilance
(5) Exaggerated startle response
E. Duration of the disturbance (symptoms in Criteria B, C, and D) is more than 1 month.
F. The disturbance causes clinically significant distress or impairment in social, occupational, or other impor-
tant areas of functioning.
Specify if:
Acute: duration of symptoms is less than 3 months
Chronic: duration of symptoms is 3 months or more
Specify if:
With Delayed Onset: onset of symptoms is at least 6 months after the stressor
Source: Reprinted with permission from DSM-IV-TR (APA 2000, pp. 463, 467, 468).
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• Studies of individuals in inpa-
tient substance abuse treatment
centers (as assessed via ques-
tionnaire) suggest that approxi-
mately 15 percent of women and
1 percent of men had a DSM-
III-R eating disorder (primarily
bulimia nervosa) in their life-
time (Hudson et al. 1992).
• Substance abuse is more com-
mon in bulimia nervosa than in
anorexia nervosa.
• Individuals with eating disor-
ders are significantly more like-
ly to use stimulants and signifi-
cantly less likely to use opioids
than other individuals undergo-
ing substance abuse treatment
who do not have a co-occurring
eating disorder.
• Many individuals alternate
between substance abuse and
eating disorders.
• Alcohol and drugs such as mari-
juana can disinhibit appetite
(i.e., remove normal restraints
on eating) and increase the risk
of binge eating as well as relapse
in individuals with bulimia ner-
vosa.
• Individuals with eating disor-
ders experience craving, tolerance, and with-
drawal from drugs associated with purging,
such as laxatives and diuretics.
• Women with eating disorders often abuse
pharmacological agents ingested for the pur-
pose of weight loss, appetite suppression, and
purging. Among these drugs are prescription
and over-the-counter diet pills, laxatives,
diuretics, and emetics. Nicotine and caffeine
also must be considered when assessing sub-
stance abuse in women with eating disorders.
• Several studies have suggested that the pres-
ence of co-occurring substance-related disor-
ders does not affect treatment outcome
adversely for bulimia nervosa.
• Further studies are required to assess how
the presence of an eating disorder affects
substance abuse treatment and how best to
integrate treatment for those with both condi-
tions. This condition is quite serious and can
be fatal. Treat it accordingly.
• Individuals with eating disorders experience
urges (or cravings) for binge foods similar to
urges for drugs.
Advice to the Counselor:
Counseling a Client With PTSD
• Anticipate proceeding slowly with a client who is diag-
nosed with or has symptoms of PTSD. Consider the effect
of a trauma history on the client’s current emotional
state, such as an increased level of fear or irritability.
• Develop a plan for increased safety where warranted.
• Establish both perceived and real trust.
• Respond more to the client’s behavior than her words.
• Limit questioning about details of trauma.
• Recognize that trauma injures an individual’s capacity for
attachment. The establishment of a trusting treatment
relationship will be a goal of treatment, not a starting
point.
• Recognize the importance of one’s own trauma history
and countertransference.
• Help the client learn to de-escalate intense emotions.
• Help the client to link PTSD and substance abuse.
• Provide psychoeducation about PTSD and substance
abuse.
• Teach coping skills to control PTSD symptoms.
• Recognize that PTSD/substance abuse treatment clients
may have a more difficult time in treatment and that
treatment for PTSD may be long term, especially for
those who have a history of serious trauma.
• Help the client access long-term PTSD treatment and
refer to trauma experts for trauma exploratory work.
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Case Study: The History of a
Substance Abuse Treatment
Client With an Eating Disorder
Mandy H. was 28 years old, Caucasian, 5’10”
and 106 pounds when she first presented to
the eating disorders service. She reported 4
years of untreated bingeing and self-induced
vomiting. In the months prior to presentation
she had quit her job and was spending days
locked in her mother’s house doing nothing
but bingeing and vomiting, up to 20 times per
day. She had large ulcers and infected
scrapes in her mouth as a result of inserting
objects down her throat to induce vomiting.
She denied the use of alcohol, drugs, or other
substances to induce purging. Her mother
and boyfriend had substantial difficulties
with alcohol abuse. She was admitted to the
hospital and had great difficulties complying
with unit rules. Vomitus was found hidden in
her room and other clients’ rooms; she was
caught smoking numerous times in the non-
smoking ward. She stole objects from staff
and other clients to insert down her throat to
induce vomiting.
Although she was able to gain 10 pounds dur-
ing her hospital stay, very little progress was
made with the cognitive features of her bulim-
ia nervosa. During subsequent outpatient fol-
lowup, she managed to normalize her eating
and reach a high weight of 125; however, she
soon dropped out of treatment. One year
later she presented again to the emergency
room, this time weighing 103 pounds and
intoxicated. Although she had managed to
stop bingeing and purging, she had been
restricting her food intake severely to about
250 calories per day from food (not including
the amount of calories she took in the form of
alcohol). She had been drinking excessively
and smoking marijuana with her boyfriend.
Her therapist searched for a treatment pro-
gram for uninsured individuals that special-
ized in substance abuse and that could
address the added complexity of co-occurring
disordered eating.
Mandy H.’s therapist found a residential sub-
stance abuse treatment program that consid-
ered itself to have a balanced substance abuse
and mental health approach, with a special-
ized dual disorders program for women who
met American Society of Addiction Medicine
Dual Diagnosis Enhanced criteria. The pro-
gram offered group and individual counseling
using the Dialectical Behavior Therapy (DBT)
method. The therapist’s use of DBT included
psychosocial groups for skills training, indi-
vidual psychotherapy to strengthen individu-
al skills and increase motivation, and tele-
phone contact with the therapist when needed
to foster generalization of skills to everyday
life outside the treatment context (Linehan et
al. 1999). The woman in charge of the DBT
component of the treatment services was
delighted to form a collaborative relationship
with Mandy H.’s eating disorder therapist.
Once during Mandy H.’s treatment (with
Mandy H.’s permission, and the permission of
the DBT group), Mandy H.’s eating disorders
therapist sat in on the substance abuse treat-
ment agency’s team treatment meeting and
observed the DBT group counseling session
that day. Mandy H.’s eating disorders thera-
pist also was able to help Mandy H. get
Medicaid coverage for her residential sub-
stance abuse treatment under the State’s pro-
gram for clients with severe and persistent
mental illness by demonstrating the persis-
tence of Mandy H.’s COD based on her hospi-
tal stay the prior year and her current
severe, complex, co-occurring conditions.
Mandy H. did very well during her residential
stay, and she responded positively to AA.
From the extensive intake information and
collateral reports from relatives, Mandy H.’s
substance abuse treatment counselor learned
that Mandy H.’s family tree was filled with
people who had developed alcoholism, includ-
ing a grandmother who might well have devel-
oped an addiction to sleeping pills and/or
tranquilizers in the 1960s. Since the sub-
stance abuse treatment counselor also had a
family tree with many people with chemical
dependencies, the counselor could under-
stand how Mandy H. could identify closely
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Anorexia Nervosa
Diagnostic features
The essential features of anorexia nervosa are that the individual refuses to maintain a minimally normal body
weight, is intensely afraid of gaining weight, and exhibits a significant disturbance in the perception of the shape
or size of his or her body (see below Criterion A). In addition, postmenarcheal females with this disorder are
amenorrheic. (The term anorexia is a misnomer because loss of appetite is rare.) Individuals with this disorder
intensely fear gaining weight or becoming fat (Criterion B). This intense fear of becoming fat is usually not alle-
viated by the weight loss. In fact, concern about weight gain often increases even as actual weight continues to
decrease. The experience and significance of body weight and shape are distorted in these individuals (Criterion
C). In postmenarcheal females, amenorrhea (due to abnormally low levels of estrogen secretion that are due in
turn to diminished pituitary secretion of follicle-stimulating hormone and luteinizing hormone) is an indicator of
physiological dysfunction in Anorexia Nervosa (Criterion D).
Diagnostic criteria for anorexia nervosa
A. Refusal to maintain body weight at or above a minimally normal weight for age and height (e.g., weight loss
leading to maintenance of body weight less than 85 percent of that expected; or failure to make expected
weight gain during period of growth, leading to body weight less than 85 percent of that expected).
B. Intense fear of gaining weight or becoming fat, even though underweight.
C. Disturbance in the way in which one’s body weight or shape is experienced, undue influence of body weight
or shape on self-evaluation, or denial of the seriousness of the current low body weight.
D. In postmenarcheal females, amenorrhea, i.e., the absence of at least three consecutive menstrual cycles. (A
woman is considered to have amenorrhea if her periods occur only following hormone, e.g., estrogen, admin-
istration.)
Specify type:
Restricting Type: During the current episode of Anorexia Nervosa, the person has not regularly
engaged in binge-eating or purging behavior (i.e., self-induced vomiting or the misuse of laxatives,
diuretics, or enemas).
Binge-Eating/Purging Type: During the current episode of Anorexia Nervosa, the person has regularly
engaged in binge-eating or purging behavior (i.e., self-induced vomiting or the misuse of laxatives,
diuretics, or enemas).
Bulimia Nervosa
Diagnostic features
The essential features of bulimia nervosa are binge eating and inappropriate compensatory methods to prevent
weight gain. In addition, the self-evaluation of individuals with bulimia nervosa is excessively influenced by
body shape and weight. To qualify for the diagnosis, the binge eating and the inappropriate compensatory
behaviors must occur, on average, at least twice a week for 3 months (Criterion C). An episode of binge eating is
also accompanied by a sense of lack of control (Criterion A2). Another essential feature of bulimia nervosa is
the recurrent use of inappropriate compensatory behaviors to prevent weight gain (Criterion B).
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with what people had to say at AA meetings,
even without a lengthy history of heavy alco-
hol use. Mandy H. found that the strong
attachment to alcohol expressed by others
was what she was already experiencing,
including her finding that until she knew
where her drinking would be able to occur
during the day, not much else could keep her
attention. Mandy H. felt she had a similar
addictive response to marijuana.
The substance abuse treatment program
directed Mandy H. to AA meetings that other
people with co-occurring disorders attended.
Mandy H. was able to find a sponsor who
herself had a co-occurring depressive disor-
der, one that had been handled successfully
with maintenance antidepressant medication.
Mandy H. did well throughout treatment, and
by the time she was in her sixth month of out-
patient continuing care, she had gained 12
pounds. At that point Mandy H. began to
struggle with urges to binge and thoughts of
inducing vomiting. Her eating disorders ther-
apist contacted her continuing care substance
abuse treatment counselor (the same woman
who handled the DBT parts of the residential
program). After discussing Mandy H.’s situa-
tion and improvement, the substance abuse
treatment counselor agreed with the eating
disorders counselor’s recommendation that
Mandy H. see the substance abuse treatment
program’s psychiatric consultant for possible
use of an antidepressant to help with the
emerging bingeing and purging concerns. The
psychiatrist consultant saw Mandy H. and
then called another psychiatrist who Mandy
Individuals with bulimia nervosa place an excessive emphasis on body shape and weight in their self-evaluation,
and these factors are typically the most important ones in determining self-esteem (Criterion D). However, a
diagnosis of bulimia nervosa should not be given when the disturbance occurs only during episodes of anorexia
nervosa (Criterion E).
Diagnostic criteria for bulimia nervosa
A. Recurrent episodes of binge eating. An episode of binge eating is characterized by both of the following:
(1) Eating, in a discrete period of time (e.g., within any 2-hour period), an amount of food that is definitely
larger than most people would eat during a similar period of time and under similar circumstances
(2) A sense of lack of control over eating during the episode (e.g., a feeling that one cannot stop eating or
control what or how much one is eating)
B. Recurrent inappropriate compensatory behavior in order to prevent weight gain, such as self-induced vomit-
ing; misuse of laxatives, diuretics, enemas, or other medications; fasting; or excessive exercise.
C. The binge eating and inappropriate compensatory behaviors both occur, on average, at least twice a week
for 3 months.
D. Self-evaluation is unduly influenced by body shape and weight.
E. The disturbance does not occur exclusively during episodes of Anorexia Nervosa.
Specify type:
Purging Type: during the current episode of Bulimia Nervosa, the person has regularly engaged in self-
induced vomiting or the misuse of laxatives, diuretics, or enemas.
Nonpurging Type: during the current episode of Bulimia Nervosa, the person has used other inappro-
priate compensatory behaviors, such as fasting or excessive exercise, but has not regularly engaged in
self-induced vomiting or the misuse of laxatives, diuretics, or enemas.
Source: Reprinted with permission from DSM-IV-TR (APA 2000, pp. 583, 584, 589-591, 594)
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H.’s eating disorder therapist
used regularly. After a brief dis-
cussion with the other psychia-
trist, the psychiatrist treating
Mandy H. prescribed 20 mg of
fluoxetine and discussed with
Mandy H. what to expect.
It was helpful to Mandy H. to see
the medication as part of how
she could be empowered to take
care of herself and to take care
of her recovery. Mandy H. fully
embraced the idea of being pow-
erless over her use of alcohol,
marijuana, or euphoria-produc-
ing drugs, as she saw that as a
great help to her both in terms of
averting thoughts about her
weight and in terms of thoughts
about whether just to smoke
marijuana or have just a little
wine, Mandy H.’s sponsor was
able to share with Mandy H. her
“research” with “just a little
wine.”
Mandy H.’s COD were a diag-
nostic challenge for the treat-
ment team. Her DBT counselor
thought she had an additional borderline per-
sonality disorder, but the treatment team
thought she should be re-evaluated after 3 to
6 months of both sobriety and healthy eating,
especially as Mandy H. had had regular but
slow progress the prior year until she
dropped out of treatment and began to drink
and smoke marijuana. 
Indeed, with a year of sobriety and strong
feelings of a new lease on life through 12-Step
living, Mandy H. was eligible for State voca-
tional rehabilitation assistance and entered
college. Mandy H. still went to AA once a
month, or more if she or her sponsor thought
it wise, and she stayed in touch about once a
week with her sponsor. Mandy H. attended
monthly continuing care groups, and she saw
her eating disorders therapist every other
month. Mandy H. also continued to see the
psychiatrist for medication management, and
she had unproblematic increases in her medi-
cation to a full therapeutic dose appropriate
for her. On rare occasions Mandy H. had
thoughts about foregoing her medication, but
with her counselor’s help she realized that
such thoughts were akin to “stinking think-
ing” and often connected to some other reac-
tions or concerns going on in other areas of
her life.
Discussion: How would Mandy H. have 
fared without comprehensive and integrated
treatment? Mandy H.’s case history highlights
the importance of assisting clients in thera-
peutic and extra-therapeutic ways, such as
assisting with Medicaid and vocational reha-
bilitation eligibilities. Also, the importance of
Mandy H.’s particular background and the
reactions it engendered to AA is taken into
consideration, while nonacute concerns about
diagnostic concerns were put in abeyance.
Advice to the Counselor: 
Counseling a Client With an 
Eating Disorder
• Where possible, work closely with a professional who spe-
cializes in eating disorders.
• Document through a comprehensive assessment the indi-
vidual’s full repertoire of weight loss behaviors since peo-
ple with eating disorders will often go to dangerous
extremes to lose weight.
• Conduct a behavioral analysis of the foods and substances
of choice; high-risk times and situations for engaging in
disordered eating and substance abuse behaviors; and
the nature, pattern, and interrelationship of disordered
eating and substance use.
• Develop a treatment plan for both the eating and sub-
stance use disorder.
• Employ psychoeducation and cognitive–behavioral tech-
niques for bulimia nervosa.
• Use adjunctive strategies such as nutritional consultation,
the setting of a weight range goal, and observations at
and between meal times for disordered eating behaviors.
• Incorporate relapse prevention strategies to plan for a
long course of treatment and several treatment episodes.
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Last, the united front between the substance
abuse counselor and persons involved in
treatment of her mental disorder regarding
medications and other aspects of treatment
was helpful to Mandy H. maintaining her
dual recovery.
Pathological Gambling 
What Counselors Should
Know About Substance Abuse
and Pathological Gambling
The essential feature of pathological gambling
is persistent and recurrent maladaptive gam-
bling behavior that disrupts personal, family,
or vocational pursuits. Counselors should be
aware that
•Prevalence data for gambling regularly
makes distinctions among “pathological”
gamblers (the most severe category) and
levels of “problem” gambling (less severe to
moderate levels of difficulty). Recent gener-
al estimates (Gerstein et al. 1999; Shaffer et
al. 1997) indicate about 1 percent of the
U.S. general population could be classified
as having pathological gambling, according
to the diagnostic criteria below. Cogent con-
siderations regarding prevalence are given
in the DSM-IV-TR regarding variations due
to the availability of gambling and seeming-
ly greater rates in certain locations (e.g.,
Puerto Rico, Australia), which have been
reported to be as high as 7 percent. Higher
prevalence rates also have been reported in
adolescents and college students, ranging
from 2.8 to 8 percent (APA 2000). The gen-
eral past-year estimate for pathological and
problem gambling combined is roughly 3
percent. This can be compared to past year
estimates of alcohol abuse/dependence of
9.7 percent and drug abuse/dependence of
3.6 percent.
•The rate of co-occurrence of pathological
gambling among people with substance use
disorders has been reported as ranging
from 9 to 30 percent and the rate of sub-
stance abuse among individuals with patho-
logical gambling has been estimated at 25 to
63 percent.
•Among pathological gamblers, alcohol has
been found to be the most common sub-
stance of abuse. At minimum, the rate of
problem gambling among people with sub-
stance use disorders is four to five times
that found in the general population.
•It is important to recognize that even
though pathological gambling often is
viewed as an addictive disorder, clinicians
cannot assume that their knowledge or
experience in substance abuse treatment
qualifies them automatically to treat people
with a pathological gambling problem.
•With clients with substance use disorders
who are pathological gamblers, it often is
essential to identify specific triggers for
each addiction. It is also helpful to identify
ways in which use of addictive substances
or addictive activities such as gambling act
as mutual triggers.
In individuals with COD, it is particularly
important to evaluate patterns of substance use
and gambling. The following bullets provide
several examples:
•Cocaine use and gambling may coexist as
part of a broader antisocial lifestyle.
•Someone who is addicted to cocaine may see
gambling as a way of getting money to sup-
port drug use.
•A pathological gambler may use cocaine to
maintain energy levels and focus during
gambling and sell drugs to obtain gambling
money.
•Cocaine may artificially inflate a gambler’s
sense of certainty of winning and gambling
skill, contributing to taking greater gam-
bling risks.
•The gambler may use drugs or alcohol as a
way of celebrating a win or relieving
depression.
•One of the more common patterns that has
been seen clinically is that of a sequential
addiction. A frequent pattern is that some-
one who has had a history of alcohol depen-
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dence—often with many years of recovery
and AA attendance—develops a gambling
problem.
Case Study: Counseling a
Substance Abuse Treatment
Client With a Pathological
Gambling Disorder
Louis Q. is a 56-year-old, divorced Caucasian
male who presented through the emergency
room, where he had gone complaining of
chest pain. After cardiovascular problems
were ruled out, he was asked about stressors
that may have contributed to chest pain.
Louis Q. reported frequent gambling and sig-
nificant debt. However, he has never sought
any help for gambling problems.
The medical staff found that Louis Q. had a
30-year history of alcohol abuse, with a sig-
nificant period of meeting criteria for alcohol
dependence. He began gambling at age 13.
Currently, he meets criteria for both alcohol
dependence and pathological gambling. He
has attended AA a few times in the past for
very limited periods. 
He was referred to a local substance abuse
treatment agency. Assessment indicated that
drinking was a trigger for gambling, as well as
a futile attempt at self-medication to manage
depression related to gambling losses. The
precipitating event for seeking help was anxi-
ety related to embezzling money from his job
and fear that his embezzlement was going to
be found by an upcoming audit. 
Diagnostic Features of Pathological Gambling
The essential feature of pathological gambling is persistent and recurrent maladaptive gambling behavior
(Criterion A) that disrupts personal, family, or vocational pursuits. The diagnosis is not made if the gambling
behavior is better accounted for by a manic episode (Criterion B).
Diagnostic criteria
A. Persistent and recurrent maladaptive gambling behavior as indicated by five (or more) of the following:
(1) Is preoccupied with gambling (e.g., preoccupied with reliving past gambling experiences, handicap-
ping or planning the next venture, or thinking of ways to get money with which to gamble)
(2) Needs to gamble with increasing amounts of money in order to achieve the desired excitement
(3) Has repeated unsuccessful efforts to control, cut back, or stop gambling
(4) Is restless or irritable when attempting to cut down or stop gambling
(5) Gambles as a way of escaping from problems or of relieving a dysphoric mood (e.g., feelings of help-
lessness, guilt, anxiety, depression)
(6) After losing money gambling, often returns another day to get even (“chasing” one’s losses)
(7) Lies to family members, therapist, or others to conceal the extent of involvement with gambling
(8) Has committed illegal acts such as forgery, fraud, theft, or embezzlement to finance gambling
(9) Has jeopardized or lost a significant relationship, job, or educational or career opportunity because
of gambling
(10) Relies on others to provide money to relieve a desperate financial situation caused by gambling
B. The gambling behavior is not better accounted for by a Manic Episode.
Source: Reprinted with permission from DSM-IV-TR (APA 2000, pp. 671, 674).
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During the evaluation, it became clear that
treatment would have to address both his
gambling as well as his alcohol dependence,
since these were so intertwined. Education
was provided on both disorders, using stan-
dard information at the substance abuse
treatment agency as well as materials from
Gamblers Anonymous (GA). Group and indi-
vidual therapy repeatedly pointed out the
interaction between the disorders and the
triggers for each, emphasizing the develop-
ment of coping skills and relapse prevention
strategies for both disorders. Louis Q. also
was referred to a local GA meeting and was
fortunate to have another member of his
addictions group to guide him there. The fam-
ily was involved in treatment planning and
money management, including efforts to orga-
nize, structure, and monitor debt repayment.
Legal assistance was obtained to advise him
on potential legal charges due to embezzle-
ment at work. He began attending both AA
and GA meetings, obtaining sponsors in both
programs.
Discussion: The counselor 
takes time to establish the rela-
tionship of the two disorders. He
takes the gambling problem seri-
ously as a disorder in itself,
rather than assuming it would go
away when the addiction was
treated. Even though his agency
did not specialize in gambling
addiction treatment, he was able
to use available community
resources (e.g., GA) as a source
of educational material and a
referral. He recognized the
importance of regular group
involvement for Louis Q. and
also knew it was critical to sup-
port the family in working
through existing problems and
trying to avoid new ones.
Conclusion
The information contained in
this chapter can serve as a quick
reference for the substance
abuse counselor when working
with clients who have the mental disorders
described or who may be suicidal. As noted
above, appendix D provides more extensive
information. The limited aims of the panel in
providing this material are to increase sub-
stance abuse treatment counselors’ familiarity
with mental disorders terminology and crite-
ria, as well as to provide advice on how to
proceed with clients who demonstrate these
disorders. The panel encourages counselors
to continue to increase their understanding of
mental disorders by using the resource mate-
rial referenced in each section, attending
courses and conferences in these areas, and
engaging in dialog with mental health profes-
sionals who are involved in treatment. At the
same time, the panel urges continued work to
develop improved treatment approaches that
address substance use in combination with
specific mental disorders, as well as better
translation of that work to make it more
accessible to the substance abuse field.
Advice to the Counselor:
Counseling a Client With Pathological
Gambling Disorder
• Carefully assess use and frequency of sports events,
scratch tickets, games of chance, and bets.
• Ask if the client is at any physical risk regarding owing
money to people who collect on such debts.
• Treat the disorders as separate but interacting problems.
• Become fluent in the languages of substance abuse and
of gambling.
• Understand the similarities and differences of substance
use disorders and pathological gambling.
• Utilize all available 12-Step and other mutual support
groups.
• Recognize that a client’s motivation level may be at dif-
ferent points for dealing with each disorder.
• Use treatments that combine 12-Step, psychoeducation,
group therapy and cognitive–behavioral approaches.
• Use separate support groups for gambling and for alco-
hol and/or drug dependence. While the groups can sup-
plement each other, they cannot substitute for each
other.
9 Substance-Induced
Disorders
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Identifying
Disorders
Overview
The toxic effects of substances can mimic mental illness in ways that can
be difficult to distinguish from mental illness. This chapter focuses on
symptoms of mental illness that are the result of substance abuse—a
condition referred to as “substance-induced mental disorders.” 
Description
As defined in the Diagnostic and Statistical Manual of Mental
Disorders, 4th edition, Text Revision (American Psychiatric
Association [APA] 2000) (DSM-IV-TR), substance-induced disorders
include: 
• Substance-induced delirium
• Substance-induced persisting dementia
• Substance-induced persisting amnestic disorder
• Substance-induced psychotic disorder
• Substance-induced mood disorder
• Substance-induced anxiety disorder
• Hallucinogen persisting perceptual disorder
• Substance-induced sexual dysfunction
• Substance-induced sleep disorder
Substance-induced disorders are distinct from independent co-occur-
ring mental disorders in that all or most of the psychiatric symptoms
are the direct result of substance use. This is not to state that sub-
stance-induced disorders preclude co-occurring mental disorders,
only that the specific symptom cluster at a specific point in time is
more likely the result of substance use, abuse, intoxication, or with-
drawal than of underlying mental illness. A client might even have
both independent and substance-induced mental disorders. For exam-
ple, a client may present with well-established independent and con-
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trolled bipolar disorder and alcohol depen-
dence in remission, but the same client could
be experiencing amphetamine-induced audi-
tory hallucinations and paranoia from an
amphetamine abuse relapse over the last 3
weeks.
Symptoms of substance-induced disorders
run the gamut from mild anxiety and depres-
sion (these are the most common across all
substances) to full-blown manic and other
psychotic reactions (much less common). The
“teeter-totter principle”—i.e., what goes up
must come down—is useful to predict what
kind of syndrome or symptoms might be
caused by what substances. For example,
acute withdrawal symptoms from physiologi-
cal depressants such as alcohol and benzodi-
azepines are hyperactivity, elevated blood
pressure, agitation, and anxiety (i.e., the
shakes). On the other hand, those who
“crash” from stimulants are tired, with-
drawn, and depressed. Virtually any sub-
stance taken in very large quantities over a
long enough period can lead to a psychotic
state. 
Because clients vary greatly in how they
respond to both intoxication and withdrawal
given the same exposure to the same sub-
stance, and also because different substances
may be taken at the same time, prediction of
any particular substance-related syndrome
has its limits. What is most important is to
continue to evaluate psychiatric symptoms
and their relationship to abstinence or ongo-
ing substance abuse over time. Most sub-
stance-induced symptoms begin to improve
within hours or days after substance use has
stopped. Notable exceptions to this are psy-
chotic symptoms caused by heavy and long-
term amphetamine abuse and the dementia
(problems with memory, concentration, and
problemsolving) caused by using substances
directly toxic to the brain, which most com-
monly include alcohol, inhalants like gasoline,
and again amphetamines. Following is an
overview of the most common classes of sub-
stances of abuse and the accompanying psy-
chiatric symptoms seen in intoxication, with-
drawal, or chronic use.
Alcohol
In most people, moderate to heavy consump-
tion is associated with euphoria, mood labili-
ty, decreased impulse control, and increased
social confidence (i.e., getting high). Such
symptoms might even appear “hypomanic.”
However these often are followed with next-
day mild fatigue, nausea, and dysphoria (i.e.,
a hangover). In a person who has many life
stresses, losses, and struggles, which is often
the case as addiction to alcohol proceeds, the
mood lability and lowered impulse control
can lead to increased rates of violence toward
others and self. Prolonged drinking increases
the incidence of dysphoria, anxiety, and such
violence potential. Symptoms of alcohol with-
drawal include agitation, anxiety, tremor,
malaise, hyperreflexia (exaggeration of reflex-
es), mild tachycardia (rapid heart beat),
increasing blood pressure, sweating, insom-
nia, nausea or vomiting, and perceptual dis-
tortions. 
Following acute withdrawal (a few days),
some people will experience continued mood
instability, fatigue, insomnia, reduced sexual
interest, and hostility for weeks, so called
“protracted withdrawal.” Differentiating pro-
tracted withdrawal from a major depression
or anxiety disorder is often difficult. More
severe withdrawal is characterized by severe
instability in vital signs, agitation, hallucina-
tions, delusions, and often seizures. The best
predictor of whether this type of withdrawal
may happen again is if it happened before.
Alcohol-induced deliriums after high-dose
drinking are characterized by fluctuating
mental status, confusion, and disorientation
and are reversible once both alcohol and its
withdrawal symptoms are gone, while by defi-
nition, alcohol dementias are associated with
brain damage and are not entirely reversible
even with sobriety.
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Caffeine
When consumed in large quantities, caffeine
can cause mild to moderate anxiety, though
the amount of caffeine that leads to anxiety
varies. Caffeine is also associated with an
increase in the number of panic attacks in
individuals who are predisposed to them.
Cocaine and Amphetamines
Mild to moderate intoxication from cocaine,
methamphetamine, or other stimulants is
associated with euphoria, and a sense of
internal well-being, and perceived increased
powers of thought, strength, and accomplish-
ment. In fact, low to moderate doses of
amphetamines may actually increase certain
test-taking skills temporarily in those with
attention deficit disorders (see this in
appendix D) and even in people who do not
have attention deficit disorders. However, as
more substance is used and intoxication
increases, attention, ability to concentrate,
and function decrease. 
With street cocaine and methamphetamines,
dosing is almost always beyond the functional
window. As dosage increases, the chances of
impulsive dangerous behaviors, which may
involve violence, promiscuous sexual activity,
and others, also increases. Many who become
chronic heavy users go on to experience tem-
porary paranoid delusional states. As men-
tioned above, with methamphetamines, these
psychotic states may last for weeks, months,
and even years. Unlike schizophrenic psy-
chotic states, the client experiencing a para-
noid state induced by cocaine more likely has
intact abstract reasoning and linear thinking
and the delusions are more likely paranoid
and less bizarre (Mendoza and Miller 1992).
After intoxication comes a crash in which the
person is desperately fatigued, depressed,
and often craves more stimulant to relieve
these withdrawal symptoms. This dynamic is
why it is thought that people who abuse stim-
ulants often go on week- or month-long binges
and have a hard time stopping. At some point
the ability of stimulants to push the person
back into a high is lost (probably through
washing out of neurotransmitters), and then a
serious crash ensues. 
Even with several weeks of abstinence, many
people who are addicted to stimulants report
a dysphoric state that is marked by anhedo-
nia (absence of pleasure) and/or anxiety, but
which may not meet the symptom severity cri-
teria to qualify as DSM-IV Major Depression
(Rounsaville et al. 1991). These anhedonic
states can persist for weeks. As mentioned
above, heavy, long-term amphetamine use
appears to cause long-term changes in the
functional structure of the brain, and this is
accompanied by long-term problems with con-
centration, memory, and, at times, psychotic
symptoms. Month-long methamphetamine
binges followed by week- or month-long alco-
hol binges, a not uncommon pattern, might
appear to be “bipolar” disorder if the drug
use is not discovered. For more information,
see the National Institute on Drug Abuse Web
site (www.nida.nih.gov).
Hallucinogens
Hallucinogens produce visual distortions and
frank hallucinations. Some people who use
hallucinogens experience a marked distortion
of their sense of time and feelings of deper-
sonalization. Hallucinogens may also be asso-
ciated with drug-induced panic, paranoia,
and even delusional states in addition to the
hallucinations. Hallucinogen hallucinations
usually are more visual (e.g., enhanced colors
and shapes) as compared to schizophrenic-
type hallucinations, which tend to be more
auditory (e.g., voices). The existence of a
marijuana-induced psychotic state has been
debated (Gruber and Pope 1994), although a
review of the research suggests that there is
no such entity. A few people who use hallu-
cinogens experience chronic reactions, involv-
ing prolonged psychotic reactions, depres-
sion, exacerbations of preexisting mental dis-
orders, and flashbacks. The latter are symp-
toms that occur after one or more psychedelic
“trips” and consist of flashes of light and
after-image prolongation in the periphery.
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The DSM-IV defines flashbacks as a “hallu-
cinogen persisting perception disorder.” A
diagnosis requires that they be distressing or
impairing to the client (APA 1994, p. 234).
Nicotine
Clients who are dependent on nicotine are
more likely to experience depression than
people who are not addicted to it; however, it
is unclear how much this is cause or effect. In
some cases, the client may use nicotine to reg-
ulate mood. Whether there is a causal rela-
tionship between nicotine use and the symp-
toms of depression remains to be seen. At
present, it can be said that many persons who
quit smoking do experience both craving and
depressive symptoms to varying degrees,
which are relieved by resumption of nicotine
use (see chapter 8 for more information on
nicotine dependence).
Opioids
Opioid intoxication is characterized by
intense euphoria and well-being. Withdrawal
results in agitation, severe body aches, gas-
trointestinal symptoms, dysphoria, and crav-
ing to use more opioids. Symptoms during
withdrawal vary—some will become acutely
anxious and agitated, while others will experi-
ence depression and anhedonia. Even with
abstinence, anxiety, depression, and sleep
disturbance can persist for weeks as a pro-
tracted withdrawal syndrome. Again, differ-
entiating this from major depression or anxi-
ety is difficult and many clinicians may just
treat the ongoing symptom cluster. For many
people who become opioid dependent, and
then try abstinence, these ongoing withdrawal
symptoms are so powerful that relapse occurs
even with the best of treatments and client
motivation. For these clients, opioid replace-
ment therapy (methadone, suboxone, etc.)
becomes necessary and many times life sav-
ing. There are reports of an atypical opioid
withdrawal syndrome characterized by deliri-
um after abrupt cessation of methadone
(Levinson et al. 1995). Such clients do not
appear to have the autonomic symptoms typi-
cally seen in opioid withdrawal. Long-term
use of opioids is commonly associated with
moderate to severe depression.
Phencyclidine (PCP) causes dissociative and
delusional symptoms, and may lead to violent
behavior and amnesia of the intoxication.
Zukin and Zukin (1992) report that people
who use PCP and who exhibit an acute psy-
chotic state with PCP are more likely to expe-
rience another with repeated use.
Sedatives
Acute intoxication with sedatives like
diazepam is similar to what is experienced
with alcohol. Withdrawal symptoms are also
similar to alcohol and include mood instabili-
ty with anxiety and/or depression, sleep dis-
turbance, autonomic hyperactivity, tremor,
nausea or vomiting, and, in more severe
cases, transient hallucinations or illusions
and grand mal seizures. There are reports of
a protracted withdrawal syndrome character-
ized by anxiety, depression, paresthesias,
perceptual distortions, muscle pain and
twitching, tinnitus, dizziness, headache, dere-
alization and depersonalization, and
impaired concentration. Most symptoms
resolve within weeks, though some symptoms,
such as anxiety, depression, tinnitus (ringing
in the ears), and paresthesias (sensations such
as prickling, burning, etc.), have been report-
ed to last a year or more after withdrawal in
rare cases. No chronic dementia-type syn-
dromes have been characterized with chronic
use; however, many people who use sedatives
chronically seem to experience difficulty with
anxiety symptoms, which respond poorly to
other anxiety treatments.
Diagnostic
Considerations
Diagnoses of substance-induced mental disor-
ders will typically be provisional and will
require reevaluation—sometimes repeatedly.
Many apparent acute mental disorders may
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really be substance-induced disorders, such
as in those clients who use substances and
who are acutely suicidal (see chapter 8 and
appendix D for more on suicidality and drug
use). 
Some people who have what appear to be sub-
stance-induced disorders may turn out to
have both a substance-induced disorder and
an independent mental disorder. For most
people who are addicted to substances, drugs
eventually become more important than jobs,
friends, family, and even children. These
changes in priorities often look, sound, and
feel like a personality disorder, but diagnostic
clarity regarding personality disorders in gen-
eral is difficult, and in clients with substance-
related disorders the true diagnostic picture
might not emerge or reveal itself for weeks or
months. Moreover, it is not unusual for the
symptoms of a personality disorder to clear
with abstinence—sometimes even fairly early
in recovery. Preexisting mood state, personal
expectations, drug dosage, and environmental
surroundings all warrant consideration in
developing an understanding of how a partic-
ular client might experience a substance-
induced disorder. Treatment of the substance
use disorder and an abstinent period of weeks
or months may be required for a definitive
diagnosis of an independent, co-occurring
mental disorder. As described in chapter 4 on
assessment, substance abuse treatment pro-
grams and clinical staff can concentrate on
screening for mental disorders and determin-
ing the severity and acuity of symptoms,
along with an understanding of the client’s
support network and overall life situation.
The text box above provides an example of
the diagnostic criteria for one substance-
induced disorder—substance-induced mood
disorders. 
Case Studies:
Identifying Disorders 
George M. is a 37-year-old divorced male who
was brought into the emergency room intoxi-
cated. His blood alcohol level was .152, and
the toxicology screen was positive for cocaine.
He was also suicidal (“I’m going to do it right
this time!”). He has a history of three psychi-
atric hospitalizations and two inpatient sub-
stance abuse treatments. Each psychiatric
admission was preceded by substance use.
George M. has never followed through with
mental health care. He has intermittently
attended Alcoholics Anonymous, but not
recently.
Teresa G. is a 37-year-old divorced female
who was brought into a detoxification unit 4
days ago with a blood alcohol level of .150.
She is observed to be depressed, withdrawn,
with little energy, fleeting suicidal thoughts,
and poor concentration, but states she is just
fine, not depressed, and life was good last
week before her relapse. She has never used
drugs (other than alcohol), and began drink-
Criteria for Diagnosis of Substance-Induced Mood Disorders
1. A prominent and persistent disturbance in mood predominates, characterized by (a) a depressed mood or
markedly diminished interest or pleasure in activities, or (b) an elevated, expansive, or irritable mood.
2. There is evidence from the history, physical examination, or laboratory findings that the symptoms devel-
oped during or within a month after substance intoxication or withdrawal, or medication use, is etiologically
related to the mood disturbance.
3. The disturbance is not better explained by a mood disorder.
4. The disturbance did not occur exclusively during a delirium.
5. The symptoms cause clinically significant distress or impairment.
Source: APA 1994.
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ing alcohol only 3 years ago. However, she
has had several alcohol-related problems
since then. She has a history of three psychi-
atric hospitalizations for depression, at ages
19, 23, and 32. She reports a positive
response to antidepressants. She is currently
not receiving mental health services or sub-
stance abuse treatment. She is diagnosed with
alcohol dependence (relapse) and substance-
induced mood disorder, with a likely history
of, but not active, major depression.
Discussion
Many factors must be examined when making
initial diagnostic and treatment decisions. For
example, if George M.’s psychiatric admis-
sions were 2 or 3 days long, usually with dis-
charges related to leaving against medical
advice, decisions about diagnosis and treat-
ment would be different (i.e., it is likely this
is a substance-induced suicidal state and
referral at discharge should be to a substance
abuse treatment agency rather than a mental
health center) than if two of his psychiatric
admissions were 2 or 3 weeks long with clear-
ly defined manic and psychotic symptoms
continuing throughout the course, despite
aggressive use of mental health care and med-
ication (this is more likely a person with both
bipolar disorder and alcohol dependence who
requires integrated treatment for both his
severe alcoholism and bipolar disorder).
Similarly, if Teresa G. had become increas-
ingly depressed and withdrawn over the past
3 months, and had for a month experienced
disordered sleep, poor concentration, and
suicidal thoughts, she would be best diag-
nosed with major depression with an acute
alcohol relapse rather than substance-
induced mood disorder secondary to her alco-
hol relapse.
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Appendix B:
Acronyms
AA Alcoholics Anonymous
AAAP American Academy of Addiction Psychiatry
AACP American Association of Community Psychiatrists 
ACA Adult Children of Alcoholics 
ACT Assertive Community Treatment
AD/HD attention deficit/hyperactivity disorder
ADM Alcohol, Drug Abuse or Mental Disorders
AHRQ Agency for Healthcare Research and Quality (formerly
AHCPR)
AIDS acquired immunodeficiency syndrome
AOD alcohol and other drugs
AOS addiction only services 
APA American Psychological Association; American Psychiatric
Association
APD antisocial personality disorder
APPI American Psychiatric Publishing, Inc.
ASAM American Society of Addiction Medicine
ASI Addiction Severity Index
ATTC Addiction Technology Transfer Center
AUDIT Alcohol Use Disorders Identification Test
AUS Alcohol Use Scale
309
310 Acronyms
BAI Beck Anxiety Inventory
BDI Beck Depression Inventory
BED binge-eating disorder
BPD borderline personality disorder
BSI-18 Brief Symptom Inventory-18
CA Cocaine Anonymous
CAMI chemically abusing mentally ill,
or chemically addicted and men-
tally ill
CBT cognitive–behavioral therapy
CCISC Comprehensive Continuous
Integrated System of Care 
CINA Clinical Institute Narcotic
Assessment
CIWA-Ar Clinical Institute Withdrawal
Assessment
CM Contingency Management
CMHS Center for Mental Health
Services (SAMHSA)
COD co-occurring disorders (in this
TIP, specifically co-occurring
substance abuse and one or more
mental health disorders)
CONTAC Consumer Organization and
Networking Technical Assistance
Center
CQI Continuous Quality Improvement
CSAP Center for Substance Abuse
Prevention (SAMHSA);
Corrections Substance Abuse
Program
CSAT Center for Substance Abuse
Treatment (SAMHSA)
CTU Crisis Triage Unit
DALI Dartmouth Assessment of
Lifestyle Inventory
DAST Drug Abuse Screening Test
DATOS Drug Abuse Treatment Outcome
Studies
DBT Dialectical Behavior Therapy
DDC dual diagnosis capable
DDE dual diagnosis enhanced
DDRN Dual Diagnosis Recovery
Network
DID dissociative identity disorder, 
formerly known as multiple per-
sonality disorder
DIS Diagnostic Interview Schedule
DSM-IV Diagnostic and Statistical Manual
of Mental Disorders, 4th Edition
DTR Double Trouble in Recovery
DUI driving under the influence
DUS Drug Use Scale
EAP employee assistance program
ECA Epidemiological Catchment Area
ER emergency room
FY fiscal year
GA Gamblers Anonymous
GAD general anxiety disorder
GAIN Global Appraisal of Individual
Needs
HIP HIV Integration Project
HIPAA Health Insurance Portability and
Accountability Act
HIV human immunodeficiency virus
ICM Intensive Case Management
ICOPSD individuals with co-occurring
psychiatric and substance disor-
ders
311Acronyms
IOM Institute of Medicine
LOCUS Level of Care Utilization System
MAST Michigan Alcoholism Screen Test 
MATCH Matching Alcoholism Treatment
to Client Heterogeneity
MDDA Manic Depressive and Depressive
Association
MET Motivational Enhancement
Techniques
MFIR Men’s Forensic Intensive
Recovery
MHSF-III Mental Health Screening Form-
III
MI Motivational Interviewing
MICA mentally ill chemically addicted
or affected, mentally ill chemical
abusing, or mentally ill chemical
abuser 
MICD mentally ill chemically dependent
MIDAS Mental Illness Drug and Alcohol
Screening
MINI Mini-International
Neuropsychiatric Interview
MISA mentally ill substance abuser
MISU mentally ill substance using
MMPI Minnesota Multiphasic
Personality Inventory
MTC Modified Therapeutic
Community 
NA Narcotics Anonymous
NAADAC National Association of
Alcoholism and Drug Abuse
Counselors
NAC National Advisory Council
NAMI National Alliance for the Mentally
Ill
NASADAD National Association of State
Alcohol and Drug Abuse
Directors
NASMHPD National Association of State
Mental Health Program Directors
NCADI National Clearinghouse for
Alcohol and Drug Information
NCI Na’nizhoozi Center, Inc.
NCS National Comorbidity Study
NIAAA National Institute on Alcohol
Abuse and Alcoholism
NIDA National Institute on Drug Abuse
NIH National Institutes of Health
NIMH National Institute of Mental
Health
NLAES National Longitudinal Alcohol
Epidemiologic Study
NMHA National Mental Health
Association
NRC National Research Council
NTIES National Treatment Improvement
Evaluation Study
OCD obsessive-compulsive disorder
ONDCP Office of National Drug Control
Policy
PCP phencyclidine
PD personality disorder
PG pathological gambling
PIC Practice Improvement
Collaboratives 
PPC patient placement criteria
PRISM Psychiatric Research Interview
for Substance and Mental
Disorders
PTSD posttraumatic stress disorder
312 Acronyms
RPT Relapse Prevention Therapy
SADAP State Alcohol and Drug Abuse
Profiles
SAMHSA Substance Abuse and Mental
Health Services Administration
SAMI substance abusing mentally ill
SAMM Substance Abuse Management
Module
SCID Structured Clinical Interview for
Diagnosis
SDS Symptom Distress Scale
SMI severely mentally ill
SOGS South Oaks Gambling Screen
SPMI serious and persistent mental 
illness 
SSI-SA Simple Screening Instrument for
Substance Abuse
SSRI selective serotonin reuptake
inhibitor (a type of antidepres-
sant)
STD sexually transmitted disease
STEMSS Support Together for
Emotional/Mental Serenity and
Sobriety
STP Short-Term Program
TC therapeutic community
TIP Treatment Improvement Protocol
TREM Trauma Recovery and
Empowerment Model
UFDS Uniform Facility Data Set
URICA University of Rhode Island
Change Assessment Scale 
WFIR Women’s Forensic Intensive
Recovery
Appendix C:
Glossary of Terms
Note to the reader: The definitions of many of these terms have been
taken verbatim from the Diagnostic and Statistical Manual of Mental
Disorders, 4th edition, text revision (DSM-IV-TR) (American Psychiatric
Association 2000). Such definitions have been presented and properly
attributed in the text of this TIP. See appendix B, Acronyms, for
acronym definitions.
Abstinent
Not using substances of abuse at any time.
Acculturated
Mentally and physically in harmony with and connected to the cul-
ture in which one lives.
ACT
See Assertive Community Treatment
Acute care
Short-term care provided in intensive care units, brief hospital
stays, and emergency rooms for those who are severely intoxicated
or dangerously ill.
Addiction
Physical dependence on a substance of abuse. Inability to cease use of
a substance without experiencing withdrawal symptoms. Sometimes
used interchangeably with the term substance dependence.
AD/HD
See attention deficit/hyperactivity disorder
Addiction-only services
Programs that by law or regulation, by choice, or for lack of
resources cannot accommodate patients who have psychiatric ill-
nesses that require ongoing treatment, however stable the illness and
however well-functioning the patient.
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Advanced program
A treatment program that has the capacity
to provide integrated substance abuse and
mental health treatment for clients with
COD. These programs address COD using
an integrated perspective and provide ser-
vices for both disorders.
Agitation
A restless inability to keep still. Agitation is
most often psychomotor agitation, that is,
having emotional and physical components.
Agitation can be caused by anxiety, over-
stimulation, or withdrawal from depres-
sants and stimulants.
Anorexia nervosa
A disorder in which the individual refuses
to maintain a minimal normal body weight,
is intensely afraid of gaining weight, and
exhibits a significant disturbance in the
perception of the shape or size of his or her
body.
Antiretroviral combination therapy
Treatment for HIV/AIDS infection that
employs several medications in combina-
tion to suppress the HIV virus or delay
both the development of resistant viruses
and the appearance of AIDS symptoms.
Antisocial personality disorder
An illness whose two essential features are:
(1) a pervasive disregard for and violation
of the rights of others and (2) an inability
to form meaningful interpersonal relation-
ships. Deceit and manipulation are impor-
tant manifestations of antisocial personality
disorder.
Anxiety disorder
An illness whose essential feature is exces-
sive anxiety and worry. The individual with
anxiety disorder finds it difficult to control
the worry, and the anxiety and worry are
accompanied by additional symptoms from
a list that includes restlessness, being easily
fatigued, difficulty concentrating, irritabili-
ty, muscle tension, and disturbed sleep,
among other signs and symptoms.
Assertive Community Treatment (ACT)
A form of treatment that typically employs
intensive outreach activities, continuous
24-hour responsibility for client’s welfare,
active and continued engagement with
clients, a high intensity of services, as well
as the provision of services by multidisci-
plinary teams. ACT emphasizes shared
decisionmaking with the client as essential
to the client’s engagement process.
Assessment
A basic assessment consists of gathering
key information and engaging in a process
with the client that enables the counselor to
understand the client’s readiness for
change, problem areas, COD diagnosis,
disabilities, and strengths. An assessment
typically involves a clinical examination of
the functioning and well-being of the client
and includes a number of tests and written
and oral exercises. The COD diagnosis is
established by referral to a psychiatrist or
clinical psychologist. Assessment of the
client with COD is an ongoing process that
should be repeated over time to capture the
changing nature of the client’s status.
Attention deficit/hyperactivity disorder
(AD/HD)
A persistent pattern of inattention and/or
hyperactivity-impulsivity that is more fre-
quently displayed and more serious than is
typically observed in individuals at a com-
parable level of development.
Basic program
A treatment program with the capacity to
provide treatment for one disorder, but
thatalso screens for other disorders and is
able to access necessary consultations.
Blackout
A blackout consists of a period of amnesia
or memory loss, typically caused by chron-
ic, high-dose substance abuse. The person
later cannot remember the blackout peri-
od. Blackouts are most often caused by
sedative-hypnotics such as alcohol and the
benzodiazepines.
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Borderline personality disorder
An illness whose essential feature is a per-
vasive pattern of instability of interperson-
al relationships, self-image, and affects,
along with marked impulsivity that begins
by early adulthood and is present in a vari-
ety of contexts.
Bulimia nervosa
An illness whose essential feature is binge
eating and inappropriate compensatory
methods to prevent weight gain. In addi-
tion, the self-evaluation of individuals with
bulimia nervosa is excessively influenced
by body shape and weight.
CAGE questionnaire
A brief alcoholism screening tool asking
subjects about attempts to Cut down on
drinking, Annoyance over others’ criticism
of the subject’s drinking, Guilt related to
drinking, and use of an alcoholic drink as
an Eye opener.
CBT
See cognitive–behavioral therapy
CCISC
See Comprehensive Continuous Integrated
System of Care
CM
See contingency management
COD
See co-occurring disorders
Coerced
Legally forced or compelled.
Cognitive
Pertaining to the mind’s capacity to under-
stand concepts and ideas.
Cognitive–behavioral therapy (CBT)
A therapeutic approach that seeks to modi-
fy negative or self-defeating thoughts and
behavior. CBT is aimed at both thought
and behavior change—that is, coping by
thinking differently and coping by acting
differently.
Coke bugs
Slang term for tactile hallucinations (also
called formications) that feel like bugs
crawling on or under the skin. Chronic and
high-dose stimulant abuse can cause these
hallucinations.
Collaboration
In the context of treatment programs, col-
laboration is distinguished from consulta-
tion by the formal quality of the collabora-
tive agreement, such as a memorandum of
understanding or a service contract, which
documents the roles and responsibilities
each party will assume in a continuing rela-
tionship.
Combined psychopharmacological
intervention
Treatment episodes in which a client
receives medications both to reduce crav-
ings for substances and to medicate a men-
tal disorder.
Comorbid disorders
See co-occurring disorders
Competency
An ability, capacity, skill, or set of skills.
Comprehensive Continuous Integrated
System of Care (CCISC)
A theoretical method for bringing the men-
tal health and substance abuse treatment
systems (and other systems, potentially)
into an integrated planning process to
develop a comprehensive, integrated sys-
tem of care. The CCISC is based on an
awareness that co-occurring disorders are
to be expected in clients throughout the
service system.
Concomitant treatment
Treatment of two or more mental or physi-
cal disorders at the same time.
Confrontation
A form of interpersonal exchange in which
individuals present to each other their
observations of, and reactions to, behav-
iors and attitudes that are matters of con-
cern and should be changed. Confrontation
316 Glossary of Terms
presents “reality” to individuals. The goal
of confrontation is feedback on behavior
and the compelling appeal to the client for
personal honesty, truthfulness in dealing
with others, and responsible behavior.
Constricted pupils (pinpoint pupils)
Pupils that are temporarily narrowed or
closed. This is usually a sign of opioid
abuse.
Consultation
In the context of treatment programs, con-
sultation is a traditional type of informal
relationship among treatment providers,
such as a referral or a request for exchang-
ing information.
Contingency management (CM)
An approach to treatment that maintains
that the form or frequency of behavior can
be altered through a planned and orga-
nized system of positive and negative conse-
quences. CM assumes that neurobiological
and environmental factors influence sub-
stance use behaviors and that the consis-
tent application of reinforcing environmen-
tal consequences can change these behav-
iors.
Continuing care
Care that supports a client’s progress,
monitors his or her condition, and can
respond to a return to substance use or a
return of symptoms of mental disorder. It
is both a process of post-treatment moni-
toring and a form of treatment itself.
Sometimes referred to as aftercare.
Convulsion
A symptom of a seizure, characterized 
by twitching and jerking of the limbs. 
A seizure is a sudden episode of uncon-
trolled electrical activity in the brain. If
the abnormal electrical activity spreads
throughout the brain, the result may be
loss of consciousness and a grand mal
seizure. Seizures may occur as the result of
head injury, infection, cerebrovascular
accidents, withdrawal from sedative-hyp-
notic drugs, or high doses of stimulants.
Co-occurring disorders (COD)
Refers to co-occurring substance use
(abuse or dependence) and mental disor-
ders. Clients said to have COD have one or
more mental disorders as well as one or
more disorders relating to the use of alco-
hol and/or other drugs. See dually disor-
dered.
Countertransference
The feelings, reactions, biases, and images
from the past that the clinician may project
onto the client with COD.
Crack
Cocaine (cocaine hydrochloride) that has
been chemically modified so that it will
become a gas vapor when heated at rela-
tively low temperatures. Also called “rock”
cocaine.
Cross-training
The simultaneous provision of material and
training to persons from more than one dis-
cipline (for example, to substance abuse
and social work counselors or to substance
abuse counselors and corrections officers).
Cultural competence
The capacity of a service provider or an
organization to understand and work effec-
tively in accordance with the cultural
beliefs and practices of persons from a
given ethnic/racial group. Also includes an
ability to examine and understand nuances
and exercise full cultural empathy.
Cultural destructiveness
Practices or actions through which an indi-
vidual shows that he or she regards other
cultures as inferior to the dominant culture,
through cultural incapacity and blindness
to more positive attitudes and greater levels
of skill.
Cultural proficiency
The highest level of cultural capacity, which
implies an ability to perceive the nuances of
a culture in depth and a willingness to work
to advance in proficiency through leader-
ship, research, and outreach.
317Glossary of Terms
Cultural sensitivity
The capacity and willingness of a clinician
or other service provider to be open to
working with issues of culture and diversity.
Culturally competent treatment
Biopsychosocial or other treatment that is
adapted to suit the special cultural beliefs,
practices, and needs of a client.
DDC
See dual diagnosis capable
DDE
See dual diagnosis enhanced
Deficit
In the context of substance abuse treat-
ment, disability, or inability to function
fully.
Detoxification
A clearing of toxins from the body. The
medical and biopsychosocial procedure
that assists a person who is dependent on
one or more substances to withdraw from
dependence on all substances of abuse.
Dilated pupils
Pupils that have become temporarily
enlarged. 
Disorder
An illness or a disruption of some mental
or physical process.
Domestic violence
The use of emotional, psychological, sexual,
or physical force by one family member or
intimate partner to control another. Violent
acts include verbal, emotional, and physical
intimidation; destruction of the victim’s
possessions; maiming or killing pets;
threats; forced sex; and slapping, punching,
kicking, choking, burning, stabbing, shoot-
ing, and killing victims. Spouses, parents,
stepparents, children, siblings, elderly rela-
tives, and intimate partners may all be tar-
gets of domestic violence. 
Downers
Slang term for drugs that exert a depres-
sant effect on the central nervous system.
In general, downers are sedative-hypnotic
drugs, such as benzodiazepines and barbi-
turates.
Dual diagnosis capable (DDC)
Of or pertaining to programs that address
co-occurring mental and substance-related
disorders in their policies and procedures,
assessment, treatment planning, program
content, and discharge planning.
Dual diagnosis enhanced (DDE)
Of or pertaining to programs that have a
higher than average level of integration of
substance abuse and mental health treat-
ment services. These programs are able to
provide primary substance abuse treat-
ment to clients who are, compared with
those treatable in DDC programs, more
symptomatic and/or functionally impaired
as a result of their co-occurring mental dis-
order.
Dually disordered
Having been diagnosed with two disorders,
for example a substance use disorder and a
mental health disorder.
Dual recovery groups
Therapy groups in which recovery skills
for co-occurring disorders are discussed.
DTs
Delirium tremens, a state of confusion
accompanied by trembling and vivid hallu-
cinations. Symptoms may include restless-
ness, agitation, trembling, sleeplessness,
rapid heartbeat, and possibly convulsions.
Delirium tremens often occurs in people
with alcohol use disorders after withdrawal
or abstinence from alcohol.
Ecstasy
Slang term for methylenedioxymetham-
phetamine (MDMA), a member of the
amphetamine family (for example, speed).
At lower doses, MDMA causes distortions
of emotional perceptions. At higher doses,
it causes potent stimulation typical of the
amphetamines.
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Empirical
Relying on observation or experience rather
than theoretical principles or theory.
Engagement
A client’s commitment to and maintenance
of treatment in all of its forms. A successful
engagement program helps clients view the
treatment facility as an important
resource.
Formal collaboration
Formal collaboration occurs when the
nature of the client’s disabilities requires
more specific information and more com-
plex and targeted intervention. This level
of working relationship ensures that
providers give attention to both mental
health and substance abuse disorders in
the treatment regimen. An example of such
collaboration is an interagency staffing
conference where representatives of both
mental health and substance abuse agencies
take part in the development and imple-
mentation of a specific treatment program
for clients with co-occurring disorders.
Focus is placed on the creation of an indi-
vidualized treatment plan that is imple-
mented under the auspices of one system or
the other. (See also collaboration and ser-
vice integration.)
Fully integrated program
A treatment program that actively com-
bines substance abuse and mental health
interventions to treat disorders, related
problems, and the whole person more
effectively. 
Functional
Pertaining to a person’s ability to carry out
tasks. Also, working, able to work.
Grounding
The use of strategies that soothe and dis-
tract the client who is experiencing intense
pain or other strong emotions, helping the
client anchor in the present and in reality.
Grounding techniques direct the mental
focus outward to the external world, rather
than inward toward the self. Also can be
referred to as “centering,” “looking out-
ward,” “distraction,” or “healthy detach-
ment.”
Habilitation
Initial learning and the acquisition of skills
necessary for everyday life.
Hallucinogens
A broad group of drugs that cause distor-
tions of sensory perception. The prototype
hallucinogen is lysergic acid diethylamide
(LSD). LSD can cause potent sensory per-
ceptions, such as visual, auditory, and tac-
tile hallucinations. Related hallucinogens
include peyote and mescaline. 
Hepatitis
An inflammation of the liver, with accom-
panying liver cell damage and risk of
death. Hepatitis may be of limited duration
or a chronic condition. It may be caused by
viral infection, or by chronic exposure to
poisons, chemicals, or drugs of abuse, such
as alcohol.
Ice
Slang term for smokeable metham-
phetamine. Just as cocaine can be modified
into a smokeable state (crack cocaine),
methamphetamine can be prepared so that
it produces a gas vapor when heated at rel-
atively low temperatures. When smoked,
ice methamphetamine produces an
extremely potent and long-lasting euphoria,
an extended period of high energy and pos-
sible agitation, followed by an extended
period of deep depression.
ICM
See Intensive Case Management
Impaired
Hampered or held back from being able to
do some mental or physical task.
Infectious
Able to spread by an agent such as a virus
or bacterium.
Informal collaboration
Informal collaboration ensures that both
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mental illness and substance abuse prob-
lems are sufficiently understood by all par-
ticipating providers to allow effective
identification, engagement, prevention, and
early intervention. An example of this type
of collaboration is a telephone request for
information or general advice regarding the
origins and clinical course of depression in
a person abusing alcohol or drugs. Discus-
sion of a particular client usually does not
occur, or occurs at a relatively general
level. (See also collaboration, service inte-
gration.)
Integrated competencies
The possession of specific attitudes, values,
knowledge, and skills required to provide
appropriate services to individuals with
COD in the context of their actual job and
program setting.
Integrated interventions
Specific treatment strategies or therapeutic
techniques in which interventions for two
or more disorders are combined in a single
session or interaction, or in a series of
interactions or multiple sessions.
Integrated treatment
Any mechanism by which treatment inter-
ventions for co-occurring disorders are
combined within the context of a primary
treatment relationship or service setting. It
recognizes the need for a unified treatment
approach to meet the substance abuse,
mental health, and related needs of a
client, and is the preferred model of treat-
ment.
Integration
As defined by NASMHPD and NASADAD
in the context of treatment programs,
denotes relationships among mental health
and substance abuse providers in which
the contributions of professionals in both
fields are moved into a single treatment set-
ting and treatment regimen.
Intensive Case Management (ICM)
A thorough, long-term service to assist
clients with serious mental illness (particu-
larly those with psychiatric and functional
disabilities and a history of not adhering to
prescribed outpatient treatment) by estab-
lishing and maintaining linkages with com-
munity-based service providers. ICM typi-
cally provides referrals to treatment pro-
grams, maintains advocacy for clients, pro-
vides counseling and crisis intervention,
and assists in a wide variety of other basic
services.
Intermediate program
A treatment program that focuses primari-
ly on one disorder without substantial mod-
ification to its usual treatment, but also
with the capacity to explicitly address spe-
cific needs of another disorder.
Intersystem linkages
Connections between substance abuse
treatment and mental health systems that
allow collaboration. Necessary because
these are the primary care systems for per-
sons with COD.
Intervention
Encompasses the specific treatment strate-
gies, therapies, or techniques that are used
to treat one or more disorders.
Legal problems
People who abuse substances are at a high-
er risk for engaging in behaviors that are
high risk and illegal. These behaviors may
result in arrest and other problems with
the criminal justice system. Examples of
such behaviors include driving while intoxi-
cated, writing bad checks to obtain money
for drugs, failure to pay bills and credit
card debts, possession or sale of drugs,
evictions, and drug-related violence.
Locus
A place or a setting for some activity.
Marijuana
The Indian hemp plant cannabis sativa;
also called “pot” and “weed.” The dried
leaves and flowering tops can be smoked or
prepared in a tea or food. Marijuana has
two significant effects. In the person with
320 Glossary of Terms
no tolerance for it, marijuana can produce
distortions of sensory perception, some-
times including hallucinations. Marijuana
also has depressant effects and is partially
cross-tolerant with sedative-hypnotic drugs
such as alcohol. Hashish (or “hash”) is a
combination of the dried resins and com-
pressed flowers of the female plant.
Mental health program
An organized array of services and inter-
ventions with a primary focus on treating
mental health disorders, whether providing
acute stabilization or ongoing treatment.
Mental health treatment system
A broad array of services and programs
intended to treat a wide range of mental
health disorders.
MI
See motivational interviewing
Modified Therapeutic Community (MTC)
A therapeutic community whose approach
to treatment adapts the principles and
methods of the therapeutic community to
the circumstances of the COD client. The
MTC employs interventions that have spe-
cial functions, all of which share commu-
nity, therapeutic, and educational purpos-
es. All interventions are grouped into four
categories: community enhancement, ther-
apeutic/ educative, community/clinical
management, and vocational.
Mood disorders
Include the depressive disorders (“unipolar
depression”), the bipolar disorders, and
two disorders based on etiology—mood dis-
order due to a general medical condition
and substance-induced mood disorder. 
Motivational interviewing (MI)
A client-centered, directive method for
enhancing intrinsic motivation to change by
exploring and resolving ambivalence.
MTC
See Modified Therapeutic Community
Mutual self-help
An approach to recovery from substance
use disorders that emphasizes personal
responsibility, self-management, and
clients’ helping one another. Such pro-
grams apply a broad spectrum of personal
responsibility and peer support principles,
usually including 12-Step methods that pre-
scribe a planned regimen of change.
Nodding out
Slang term for the early stages of depres-
sant-induced sleep. Opioids and sedative-
hypnotics induce depression of the central
nervous system, causing mental and behav-
ioral activity to become sluggish. As the
nervous system becomes profoundly
depressed, symptoms may range from
sleepiness to coma and death. Typically,
“nodding out” refers to fading in and out
of a sleepy state.
National Mental Health Association
(NMHA)
A policymaking and educational association
that holds workshops and has an annual
conference for clinicians working with per-
sons with mental health problems, includ-
ing persons with COD. The organization
continues to develop resources, documents,
publications, and a COD-designated section
on its Web site.
Neuroleptic medication
A drug used to treat psychosis, especially
schizophrenia.
NMHA
See National Mental Health Association
Opioid
A type of depressant drug that diminishes
pain and central nervous system activity.
Prescription opioids include morphine,
meperidine (Demerol), methadone, codeine,
and various opioid drugs for coughing and
pain. Illicit opioids include heroin, also
called “smack,” “horse,” and “boy.”
Organization
An entity that provides mental health ser-
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vices in two or three service settings (inpa-
tient, residential, or outpatient) and is not
classified as a psychiatric or general hospi-
tal or as a residential treatment center.
Outreach strategies
Approaches that actively seek out persons
in a community who may have substance
use disorders and engage them in substance
abuse treatment.
Paranoia
A type of delusion, or false idea, that is
unchanged by reasoned argument or proof
to the contrary. Clinical paranoia involves
the delusion that people or events are in
some way specially related to oneself.
People who are paranoid may believe that
others are talking about them, plotting
devious plans about them, or planning to
hurt them. Paranoia often occurs during
episodes of high-dose chronic stimulant use
and may occur during withdrawal from
sedative-hypnotics such as alcohol.
Paraphernalia
A broad term that describes objects used
during the chemical preparation or use of
drugs. These include syringes, syringe nee-
dles, roach clips, and marijuana or crack
pipes.
Pathological gambling
An illness whose essential feature is persis-
tent and recurrent maladaptive gambling
behavior that disrupts personal, family, or
vocational pursuits.
Personality disorders
Rigid, inflexible, and maladaptive behavior
patterns of sufficient severity to cause
internal distress or significant impairment
in functioning. Personality disorders are
enduring and persistent styles of behavior
and thought, rather than rare or unusual
events in someone’s life.
Posttraumatic stress disorder (PTSD)
An illness whose essential feature is the
development of characteristic symptoms fol-
lowing exposure to an extreme traumatic
stressor involving direct personal experience
of an event that involves actual or threat-
ened death or serious injury, or other threat
to one’s physical integrity; or witnessing an
event that involves death, injury, or a threat
to the physical integrity of another person;
or learning about unexpected or violent
death, serious harm, or threat of death or
injury experienced by a family member or
other close friend or relative. 
Practice Improvement Collaboratives
Community-based initiatives that link
treatment providers, researchers, and poli-
cymakers in order to build a strong foun-
dation to effect action.
Prescribing Onsite Psychiatrist Model
A model for a substance abuse treatment
agency that includes on its staff a psychia-
trist who works onsite from 4 to 16 hours a
week. The onsite psychiatrist brings diag-
nostic, behavioral, and medication services
directly to where the clients are based for
the major part of their treatment.
Prognosis
A clinician’s judgment or estimate of how
well a disorder will respond to treatment.
Program
Currently, substance abuse treatment pro-
grams use the Service Delivery Unit (SDU)
as their program definition for the National
Survey of Substance Abuse Treatment
Services. Mental health treatment pro-
grams use facility or organization in report-
ing for the Survey of Mental Health
Organizations, General Hospital Mental
Health Services, and Managed Behavioral
Health Care Organization (SMHD).
Protease inhibitor
Protease is an enzyme used by the HIV to
process new copies of the virus after it has
reproduced. Protease inhibitors are medi-
cations used to treat HIV; they interfere
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with the action of this enzyme, thus inter-
fering with viral reproduction.
Psychopharmacological
Pertaining to medications used to treat
mental illnesses.
Psychosis
A mental disorder that is characterized by
distinct distortions of a person’s mental
capacity, ability to recognize reality, and
relationships to others to such a degree that
it interferes with that person’s ability to
function in everyday life.
Psychosocial
Involving a person’s psychological well-
being, as well as housing, employment,
family, and other social aspects of life cir-
cumstances.
PTSD
See posttraumatic stress disorder
Psychotropic medication
A drug that has an effect on the mind and
sometimes affects behavior as well.
Quadrants of care
A conceptual framework that classifies set-
tings within which clients with COD are
treated. The four quadrants are based on
relative symptom severity, rather than by
diagnosis.
Referral
A process for facilitating client/consumer
access to specialized treatments and ser-
vices through linkage with, or directing
clients/consumers to, agencies that can
meet their needs. For COD, referrals are
frequently made for detoxification, assess-
ment, special treatment, and medications.
Relapse
A breakdown or setback in a person’s
attempt to change or modify any particular
behavior. An unfolding process in which
the resumption of substance abuse is the
last event in a series of maladaptive
responses to internal or external stressors
or stimuli.
Relapse prevention therapy (RPT)
A variety of interventions designed to teach
individuals who are trying to maintain
health behavior changes how to anticipate
and cope with the problem of relapse. RPT
strategies can be placed in five categories:
Assessment Procedures, Insight/Awareness
Raising Techniques, Coping Skills
Training, Cognitive Strategies, and
Lifestyle Modification.
Remission
A state in which a mental or physical disor-
der has been overcome or a disease process
halted.
RPT
See relapse prevention therapy
Schizophrenia
A type of psychosis. Persons diagnosed
with schizophrenia are subject to halluci-
nations occurring in the absence of insight
into their pathological nature, as well as
disorganized speech and grossly disorga-
nized or catatonic behavior. The disorder
lasts for at least 6 months and includes at
least 1 month of active-phase symptoms
including two or more of the following:
delusions, hallucinations, disorganized
speech, grossly disorganized or catatonic
behavior, negative symptoms.
Screening
A formal process of testing to determine
whether a client warrants further attention
at the current time for a particular disor-
der and, in this context, the possibility of a
co-occurring substance or mental disorder.
The screening process for co-occurring
disorders seeks to answer a “yes” or “no”
question: Does the substance abuse [or
mental health] client being screened show
signs of a possible mental health [or sub-
stance abuse] problem? Note that the
screening process does not necessarily iden-
tify what kind of problem the person might
have or how serious it might be but deter-
mines whether further assessment is 
warranted.
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Service integration
No one set of treatment interventions con-
stitutes integrated treatment. The term
refers to the availability and delivery of a
comprehensive array of appropriate men-
tal health and substance abuse services and
interventions that are identified within a
single treatment plan, coordinated by a sin-
gle treatment team, and both effective and
responsive to the high degree of severity of
both mental illness and substance abuse
experienced by the client. Under the “no
wrong door” approach, integrated services
should be available, as necessary, through
both mental health and substance abuse
treatment systems. (See also collaboration
and informal collaboration.)
Single State Agencies
Systems that organize statewide services.
Skin abscess
A collection of pus formed as a result of
bacterial infection. Abscesses close to the
skin usually cause inflammation, with red-
ness, increased skin temperature, and ten-
derness. Abscesses may be caused by
injecting drugs and impurities into the
body.
Slurred speech
A sign of depressant intoxication. When
people consume significant amounts of
sedative-hypnotics and opioids, their
speech may become garbled, mumbled,
and slow.
Stigma
A negative association attached to some
activity or condition. A cause of shame or
embarrassment.
Substance abuse
A maladaptive pattern of substance use
manifested by recurrent and significant
adverse consequences related to the repeat-
ed use of substances. Sometimes used inter-
changeably with the term substance depen-
dence.
Substance abuse treatment program
An organized array of services and inter-
ventions with a primary focus on treating
substance use disorders, providing both
acute stabilization and ongoing treatment.
Substance abuse treatment system
A broad array of services organized into
programs intended to treat substance use
disorders. It also includes services orga-
nized in accord with a particular treatment
approach or philosophy (e.g., methadone
treatment or therapeutic community).
Substance dependence
A maladaptive pattern of substance use
leading to clinically significant impairment
or distress, as manifested by a need for
increasing amounts of the substance to
achieve intoxication, markedly diminished
effect of the substance with continued use,
the need to continue to take the substance
in order to avoid withdrawal symptoms,
and other serious behavioral effects,
occurring at any time in the same 12-
month period.
Substance use disorders
A class of substance-related disorders that
includes both substance abuse and sub-
stance dependence.
Suicidality
A measure or estimate of a person’s likeli-
hood of committing suicide. A high-risk
behavior associated with COD, especially
(although not limited to) serious mood dis-
orders.
System
An organization of a number of different
treatment programs and related services in
order to implement a specific mission and
common goals.
Therapeutic alliance
A type of relationship between client and
clinician in which both are working coop-
eratively toward the same goals, with
mutual respect and understanding; also
called “helping alliance.” The bond of
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trust formed between client and clinician
during therapeutic work that makes heal-
ing possible.
Therapeutic community (TC)
A social environment or residential treat-
ment setting in which the social and group
process is harnessed with therapeutic
intent. The TC promotes abstinence from
alcohol and illicit drug use, and seeks to
decrease antisocial behavior and to effect a
global change in lifestyle, including atti-
tudes and values. The TC employs the
community itself as the agent of healing.
The TC views drug abuse as a disorder of
the whole person, reflecting problems in
conduct, attitudes, moods, values, and
emotional management. Treatment focuses
on drug abstinence, coupled with social
and psychological change that requires a
multidimensional effort involving intensive
mutual self-help typically in a residential
setting.
Toxicity
Poisonous nature; poisonous quality.
Transference
The feelings, reactions, biases, and images
from the past that the client with COD may
project onto the clinician.
Trauma
Violent mental or physical harm to a per-
son, damage to an organ, etc.
Treatment
Substance abuse treatment is an organized
array of services and interventions with a
primary focus on treating substance abuse
disorders. For the Treatment Episode Data
Set, the Center for Substance Abuse
Treatment defines treatment to include the
following general categories: hospital, short-
and long-term residential, and outpatient.
Mental health treatment is an organized
array of services and interventions with a
primary focus on treating mental disorders,
whether providing acute stabilization or
ongoing treatment. These programs may
exist in a variety of settings, such as tradi-
tional outpatient mental health centers
(including outpatient clinics and psychoso-
cial rehabilitation programs) or more inten-
sive inpatient treatment units. 
Treatment retention
Keeping clients involved in treatment activ-
ities and receiving required services.
Tremor
An involuntary and rhythmic movement in
the muscles, most often in the hands, feet,
jaw, tongue, or head. Tremors may be
caused by stimulants such as
amphetamines and caffeine, as well as by
withdrawal from depressants. 
TC
See therapeutic community
Unsteady gait
Crooked, meandering, and uncoordinated
walk, typical of alcohol-impaired people.
Uppers
Slang term used to describe drugs that
have a stimulating effect on the central ner-
vous system. Examples include cocaine,
caffeine, and amphetamines.
Wraparound services
Aspects of a treatment program that
address difficult-to-treat problems, such as
finding childcare while in treatment,
arranging for proper housing, and finding
employment. 
Appendix D:
Specific Mental
Disorders: Additional
Guidance for the
Counselor
Overview
While substance abuse treatment counselors do not always have the
advantage of an accurate diagnosis of every disorder for each of their
clients with co-occurring disorders (COD), the consensus panel believes
it is useful to have a working knowledge of the most common disorders
seen in substance abuse treatment settings. In cases in which a diagnosis
has not been made, the counselor may be able to detect a pattern of
behavior that suggests further assessment is needed. For clients current-
ly receiving care, the counselor’s appreciation of the features and issues
associated with each known disorder may improve coordination and
mutual understanding between substance abuse treatment services and
the mental health providers. Moreover, some knowledge of the disorder
also will help the counselor understand the role of addiction within the
framework of the client’s experience and to see how the client’s disorders
are interrelated. This understanding may be helpful in relapse preven-
tion. In addition, a general appreciation of the features of the disorder
will help the counselor adapt the treatment strategy in meaningful ways
that are more likely to be effective for the particular client. The consen-
sus panel also acknowledges that people with COD may have multiple
combinations of the various mental disorders presented in this appendix
(e.g., a person with a substance use disorder, schizophrenia, and a
pathological gambling problem). However, for purposes of clarity and
brevity the panel chose to focus the discussion on the main disorders and
not explore the multitude of possible combinations.
Known diagnoses should be documented. Such records will help the
treatment agency gain a better understanding of this aspect of client
demographics. If the substance abuse treatment agency seeks supple-
mental funding for its work with clients who have COD, it will be help-
ful, if not essential, to report the number and profile of such clients.
Chapter 8 cites the diagnostic criteria used to identify many mental dis-
orders by the standard diagnostic tool for professionals, Diagnostic and
Statistical Manual of Mental Disorders, 4th Edition, Text Revision
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Suicidality
Nicotine Dependency
Personality Disorders
(Overview)
Borderline Personality
Disorder
Antisocial Personality
Disorder
Mood and Anxiety
Disorders
Schizophrenia and
Other Psychotic
Disorders
Attention Deficit/
Hyperactivity
Disorder (AD/HD)
Posttraumatic Stress
Disorder
Eating Disorders
Pathological Gambling
(DSM-IV-TR) (American Psychiatric
Association [APA] 2000). These criteria are not
duplicated in this appendix.
The disorders in this chapter are discussed
mainly within the following framework of top-
ics: 
• Description of the disorder
• Differential Diagnosis for the disorder,
including how to distinguish this mental dis-
order from substance-related disorders or
medical conditions that present in a similar
way
• Prevalence
• Substance Use Among People With This
Disorder
• Key Issues and Concerns that arise in work-
ing with clients who have this disorder
• Strategies, Tools, and Techniques, including
those relevant to engagement, assessment,
crisis stabilization, short-term care and treat-
ment, and longer term care
Case studies are presented when illustrative
information is useful to the counselor. See
appendix F for medications commonly used to
treat various disorders and observations on
appropriate management of pharmacology with
clients who have substance use disorders.
Readers should also consult the introduction to
chapter 8 for an overview of the aims and limi-
tations of both chapter 8 and this appendix. 
Suicidality
Description
Though not a DSM-IV diagnosed mental disor-
der, per se, suicidality is a high-risk behavior
associated with COD, especially serious mood
disorders. Suicide is a complex behavior usual-
ly caused by a combination of factors.
Research shows that most people who kill
themselves have a diagnosable mental or sub-
stance use disorder, or both, and that the
majority of them have depressive illness.
Studies indicate that the most promising way
to prevent suicide and suicidal behavior is
through the early recognition and treatment of
substance abuse and mental illnesses, especial-
ly depression (U.S. Public Health Service
1999). A wide range of self-harm and severely
negative feelings and beliefs about the self can
be induced or exacerbated by substance use.
As a result, suicidal ideations, intentions, and
behaviors can be potentially lethal complica-
tions of substance use disorders, especially for
clients with co-occurring mental disorders.
Self-harm, often called parasuicide, can be
expressed in a less extreme form than suicide,
such as self-cutting, self-burning, and other
self-mutilation behaviors. Poussaint and
Alexander (2000) include “victim-precipitated
homicide” as a form of suicidal behavior and
recognize that drug and alcohol abuse often
play a part in such tragic events. Researchers
von der Stein and Podoll (1999) found that
self-cutting acts were not accompanied by
frank suicidal ideation in 18 percent of 100
male clients with alcoholism hospitalized for
detoxification.
Differential Diagnosis
Suicide or suicide attempts can be the result of
any substance use or mental disorder; however,
suicide is more common in some disorders and
more likely to be lethal with particular disor-
ders. Acute suicidal planning or behavior
requires immediate intervention; sorting out
the differential diagnosis can occur later, once
the client is safe. Note that being suicidal does
not, in itself, mean that the person has an inde-
pendent mental disorder.
Prevalence
A recent report from the Centers for Disease
Control and Prevention’s National Center for
Health Statistics indicates that in 2002, suicide
was the eleventh leading cause of death for all
Americans and the third leading cause of death
for people ages 15 to 24 (Kochanek and Smith
2004). Males are four times more likely to die
of suicide than are females; however, females
are more likely to attempt suicide than are
males (U.S. Public Health Service 1999). There
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are an estimated 16 attempted suicides for each
completed suicide. The ratio is lower in women
and youth and higher in men and the elderly.
Women and youth try more often and with less
success than men; men and the elderly succeed
more frequently. In recent years, rates for
young adults have soared. Significantly, 50 per-
cent of people who commit suicide have alcohol
in their blood (U.S. Public Health Service
1999).
Suicide rates increase with age and are highest
among Caucasian males aged 65 and older.
Older suicide victims are likely to have lived
alone, have been widowed, and have had a
physical illness (U.S. Public Health Service
1999). Other population groups also have ele-
vated rates of suicide. Many communities of
American Indians and Alaska Natives have ele-
vated suicide rates. Between 1980 and 1996,
the rate of suicide among African-American
males ages 15–19 increased 105 percent (U.S.
Public Health Service 1999).
Risk factors
It has been estimated that “25 to 30 percent of
ambulatory clients in general medical practices
have a diagnosable psychiatric condition, and a
further 10 to 15 percent of people suffering
from major psychiatric illnesses such as affec-
tive disorder, schizophrenia, and alcoholism
will end their lives by suicide” (Blumenthal
1988, p. 937). Suicide rates are particularly
high among persons with the following mental
disorders (Blumenthal 1988, pp. 944–946):
• Bipolar disorder, particularly at the time of
the switch from depression to mania or vice
versa (as high as 20 percent)
• Schizophrenia—15 percent end life by sui-
cide
• Antisocial personality disorder—5 percent
die by suicide and as many as 46 percent
attempt it
• Borderline personality disorder—5 to 10 per-
cent eventually commit suicide, though they
may also engage in self-destructive behavior
without lethal intent
• Major depression—6 percent 
• Substance-induced depression—7 percent
Suicide is also more likely among those with the
personality traits of impulsivity, hopelessness,
or cognitive rigidity (Blumenthal 1988).
Substance use disorders alone increase suici-
dality (Inskip et al. 1998), and rates of suicide
among persons with the above mental disorders
are even higher (roughly doubled) if co-occur-
ring substance use disorders are present. In
particular, there is a heightened risk of suicide
when relapse occurs after a substantial period
of abstinence—especially if there is concurrent
financial or psychosocial loss.
Suicidality and chronic 
medical illness
The presence of a chronic medical illness also is
a major risk factor, possibly by causing depres-
sion or by producing an organic disorder.
Individuals at particular risk include people
with epilepsy (who have a suicide rate of four
times that of the population as a whole), people
with cancer, people with peptic ulcers (proba-
bly because of the association of alcoholism
with the formation of these ulcers), clients
undergoing renal dialysis, people with
Huntington’s chorea (their suicide rate is six
times greater), and
people with AIDS. It
appears that “severe
or incapacitating
medical status when
associated with
depression, alco-
holism, organicity,
and neurological
impairment are
important contribut-
ing factors leading to
diminished judgment
and increased impul-
sivity in medically ill
clients” (Blumenthal
1988, p. 951).
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Suicidality is a
high-risk behavior
associated with
COD, especially
serious mood 
disorders.
Suicidality and family history
A family history of suicide is a significant risk
factor, and there is some evidence that biologi-
cal factors, such as reduced serotonergic func-
tion, contribute to a likelihood of violence
against oneself or others (Blumenthal 1988).
Substance Use Among Suicidal
Persons
Alcohol and other drug abuse is a major risk
factor in suicide, both for those with co-occur-
ring mental disorders and for the general popu-
lation. Alcohol abuse is associated with 25 to 50
percent of suicides; between 5 and 27 percent
of all deaths of people with substance use disor-
ders are caused by suicide, with the lifetime
risk for suicide estimated to be 15 percent
(Blumenthal 1988). There is a particularly
strong relationship between substance abuse
and suicide among young people. One study
found that as many as 70 percent of adolescent
suicide victims had alcohol or substance abuse
problems. For people with substance use disor-
ders, the incidence of suicide is 20 times greater
than the general population (Blumenthal 1988).
Comorbidity of alcoholism and depression
increases suicide risk (Clark and Fawcett
1992), perhaps because these agents exacer-
bate personality
and cognitive prob-
lems, and add to
environmental
stressors. Alcohol
also can impair cog-
nitive functioning
(Rogers 1992).
Using alcohol in
attempts to relieve
depression, anxiety,
and fear often cre-
ates more depres-
sion and psycholog-
ical distress, an
effect labeled alco-
hol myopia (Steele
and Josephs 1990).
Alcohol myopia
involves narrowing or impaired perception
that interferes with inferential thought and
makes one “the captive of an impoverished
version of reality in which the breadth,
depth, and time line of our understanding is
constrained” (Steele and Josephs 1990, p. 923).
Thus, the link between alcohol use and suicide
goes beyond the pharmacological and interper-
sonal effects. The association also may be a
function of the capacity of alcohol to restrict
attention to immediate situations, inhibit the
ability to solve current problems, and limit
hope for the future (Rogers 1992). “Alcohol
and substance use and abuse exacerbate other
environmental problems and lessen the ability
to cope” (Westefeld et al. 2000, p. 453). 
Key Issues and Concerns
The following are key elements of effective sui-
cide prevention.
• All substance abuse treatment clients should
receive at least a basic screening for suicidali-
ty. All substance abuse treatment profession-
als should know how to conduct at least basic
screening and triage.
• The counselor should know his or her own
skills and limitations in engaging, screening,
assessing, and intervening with suicidal
clients. Work out these issues before an emer-
gency.
• Providers are advised to develop clear
answers to the following questions: Do you or
your agency have the knowledge, tools, skills,
and personnel for crisis stabilization and/or
ongoing work with suicidal clients? How sui-
cidal can clients be and still be retained in
your practice or agency? What about suici-
dality that emerges later in treatment or in
conjunction with a relapse?
• The counselor should know what immediate
onsite and offsite resources are available to
help with someone identified as suicidal.
• Establish standardized protocols and staff
training around suicide screening, assess-
ment, intervention, and/or triage: (1) Who
asks? (2) What is asked? (3) When is this
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All substance
abuse treatment
clients should
receive at least a
brief screening 
for suicide.
done? (4) Where does this take place? (5)
How are findings documented? (6) What is
done with the results?
• Suicide “contracts” are written statements in
which the person who is suicidal states that
he will not kill himself, but rather call for
help, go to an emergency room (ER), etc., if
he becomes suicidal. These contracts are not
effective as the sole intervention for a client
who is suicidal. While such contracts often
help to make the client and therapist less
anxious about a suicidal condition, studies
have never shown these contracts to be effec-
tive at preventing suicide. What good con-
tracts really do is help to focus on the key
elements that are most likely to keep clients
safe, such as agreeing to remove the means a
client is most likely to use to commit suicide.
Strategies, Tools, and
Techniques
Engagement
It is possible, though uncommon, for people
with suicidality as their primary complaint to
present to substance abuse treatment profes-
sionals; it is more likely for them to go to men-
tal health agencies or ERs. Nonetheless, sub-
stance abuse treatment counselors should be
prepared to detect suicidality. During the
course of substance abuse assessment, the sui-
cidal client may appear withdrawn, depressed,
or even angry or agitated. It is important to
inquire about these symptoms as they appear.
For example
• “You know, you seem to be pretty down.
How depressed are you?”
• The issue may arise in response to general
questions: “Crack? No, I don’t use that much
any more. I get really down when I’m coming
off it.” The counselor might then ask, “How
down have you gotten? Were you ever suici-
dal? How are you doing now?”
At issue is the principle that the suicidal client
is more likely to engage with the counselor and
reveal his or her suicidality if the counselor
responds to clues given by the client and
inquires sensitively about them. To say to an
agitated client, “You seem pretty nervous and
uncomfortable—is there something I can do to
help?” opens a door to further assessment.
Screening and assessment
Screening
All substance abuse treatment clients should
receive at least a brief screening for suicide,
such as: “In the past, have you ever been suici-
dal or made a suicide attempt? Do you have
any of those feelings now?” All substance abuse
treatment staff should be able to screen for sui-
cidality and basic mental disorders. It is
expected that those at the intermediate or
advanced levels of COD competence will have
additional knowledge and skills.
Risk assessment
No generally accepted and standardized suicide
assessment has been shown to be reliable and
valid, but most established suicide assessments
contain similar elements. A particularly easy-
to-use method has been developed by the QPR
Institute for Suicide Prevention. Further infor-
mation and training is available at their Web
site (www.qprinstitute.com/).
The QPR Institute’s risk assessment interview
is designed to elicit information about the indi-
vidual’s current risk of suicide, which then can
be used to match the level of care with the level
of risk (Quinnett and Bratcher 1996). The
authors note that “client answers to an initial
seven questions provide the database for clini-
cal decision making, while the client’s level of
commitment to a safety/treatment management
plan determines the level of care, e.g., outpa-
tient, inpatient, evaluation for involuntary
admission.” See Figure D-1 (p. 330).
While the entire protocol includes 13 questions,
the seven questions in Figure D-1 provide rich
data that provide a basis for making clinical
decisions.
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Figure D-1
Key Questions in a Suicide Risk Review
What is wrong?
• Personal narrative about how bad things are and the nature of the problem(s)
• Personal construction of reasons for suicide
• Personal measure of psychological pain and suffering
Why now?
• Elements of the current crisis
• History of real or imagined losses or rejections
• Sudden and unacceptable changes in life circumstances; for example, the client just received a 
serious or terminal diagnosis, relapse, onset of possible symptoms (e.g., sleeplessness)
With what?
• The means of suicide under consideration
• Access to the means selected
Where and when?
• Possible location and timing of a suicide attempt
• Degree of planning
• Possible anniversary phenomena
When and with what in the past?
• Past history of suicidal behavior
• Past history of intense suicidal ideation and/or planning
• Whether rescue was avoided
• Timing of past attempts
• Social response to past attempts
• Potential protective factors (reasons for living)
• Comparison of current method versus old method
Who’s involved?
• Others who may know or be involved
• Persons who may or may not be helpful in managing the client
• Names of potentially helpful third parties
• Possible presence of a suicide pact or murder-suicide plan
Why not now?
• One or more protective factors (reasons for living)
• Spiritual or religious prohibitions
Instead of the common “no-suicide” contracts
(e.g., “I will go to the ER before taking an
overdose”), this protocol recommends a more
complete informed consent, safety, and risk
management process that requires the client’s
consent to six key elements. These are
• To remain clean and sober
• To follow medical advice
• To see to the removal of the means of suicide
• To commit to personal safety
• To seek help in case of emergency
• To follow through on referral and/or treat-
ment (Quinnett and Bratcher 1996)
By using this evaluation format or other suicide
evaluation tools, the clinician needs to deter-
mine whether the risk of imminent suicide is
mild, moderate, or high. The clinician must
also determine to what degree the client is will-
ing and able to follow through with a set of
interventions to keep safe.
Using many of the same indicators, counselors
should also be prepared to probe the client’s
likelihood of inflicting harm on another person.
Specifically
• On a scale of 0 to 10, with 0 meaning “not
likely at all,” how likely are you to harm this
person in the next week?
• Do you have a plan for how you would do
this?
• Would you be willing to agree not to harm
this person during the next week?
• Would you be willing to agree to tell someone
before you do this?
• How confident are you that you can remain
sober over the next week? What can you do
to increase the chances you will remain
sober? (e.g., use of 12-Step meetings, sup-
ports, or treatment).
Screening personnel should also assess whether
suicidal feelings are transitory or reflect a
chronic condition. Factors that may predispose
a client toward suicide and should be consid-
ered in client evaluation can be seen in “Risk
Factors” above.
Documentation
In today’s managed care environment, intakes
are often preprinted with yes/no or other check-
off items. For example, some State versions of
the Addiction Severity Index (ASI) may include
only whether the client has ever had psychiatric
care (yes/no) and whether the client is on psychi-
atric medications (yes/no) or some other abbre-
viated psychiatric inventory. As noted, it is the
view of the consensus panel that because suici-
dality is common in the substance abuse treat-
ment population, all substance abuse treatment
clients should receive at least a brief screening
for suicide. If the screen is positive, the client
should receive a more thorough assessment as
discussed previously. Further screening/assess-
ment should be documented to protect both the
client and the counselor. This means writing
information on evaluation forms or making
additional notes, even if suicide-related items
are not included on the form used.
Crisis stabilization
The first steps in suicide intervention, and thus
crisis stabilization, are contained in the process
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Figure D-1 (continued)
Key Questions in a Suicide Risk Review
• Duties to others or pets
• Residual tasks to be completed before the attempt; for example, making out a will
Source: Quinnett and Bratcher 1996.
of a good engagement and evaluation. Asking
suicide-related questions, exploring the context
of those impulses, evaluating support systems,
considering the lethality of means, and assess-
ing the client’s motivation to seek help are in
themselves an intervention. Such an interview
will often elicit the client’s own insight and
problem solving and may result in a decrease in
suicidal impulses.
If, however, the client experiences little or no
relief after this process, then it is clear that
psychiatric intervention is required. This is
especially true if it emerges that the client has a
co-occurring mental disorder or medical disor-
der in which the risk of suicide is elevated (see
“Risk Factors” above) or if the client has a his-
tory of suicide attempts. If either or both is
true, arrangements should be made for trans-
fer to a facility that is capable of more intensive
psychiatric evaluation and treatment.
Emergency procedures should be in place so
the counselor can accomplish this transfer even
when a psychiatrist or clinical supervisor/direc-
tor are not available. Once the client is stabi-
lized and is safe to return to a less restrictive
setting, he or she should return to the pro-
gram.
Short-term care and 
treatment
Treatment for the client who is suicidal should
include supportive care aimed at helping the
client vent feelings, discover alternatives,
improve relationships, change negative think-
ing, and focus on the future (Blumenthal 1988).
The clinician should be caring and supportive.
The seriously suicidal client should have some-
one to contact 24 hours a day, and frequent
telephone contact between the client and the
contact person usually is indicated.
Management of a client who is suicidal “usually
requires the assistance of a psychiatric consul-
tant and is clearly indicated for all clients who
have a serious plan for suicide or who have
made an attempt” (Blumenthal 1988, p. 958).
At a minimum, “consultation with a psychiatric
colleague who has specialty training in the diag-
nosis of mental illness is often indicated and
may be particularly helpful in the assessment
and management of acutely suicidal persons”
(Blumenthal 1988, p. 959). The client should
be evaluated by a psychiatrist onsite immedi-
ately, or a case manager or counselor should
escort the client to emergency psychiatric ser-
vices. Where available, mobile crisis service,
which includes a psychiatrist, is another quick
response resource for the management of the
client who is suicidal.
Case management
Interventions should seek to increase support
available to the client from the family and com-
munity, and should provide immediate inter-
ventions, including medication to stabilize the
client’s mental state, if needed.
Psychoeducation
Families and individuals often benefit from
education about depression and suicidality,
including warning signs, resources for help,
and the importance of addressing this problem.
Education often provides individuals with a
sense of hope and realistic expectations. Many
individuals will have passive suicidal ideation
at one point in their lives. Some individuals will
feel reassured to know their feelings are not
uncommon and be more willing to share their
feelings about their thoughts.
Adapting mental health/substance
abuse treatment approaches to
specific disorder subtypes
The co-occurrence of substance abuse and sui-
cidal thoughts increases the risk of suicide and
requires clinicians to be more active in their
management of the problem. People with
chronic substance use disorders may need to
undergo detoxification and may have cognitive
limitations secondary to chronic usage.
Longer term care
Suicidality is not in itself a disease; rather, it is
a short-term, acute, and potentially lethal
behavior or set of behaviors. Longer term
treatment issues for a client who has been suici-
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dal focus on long-term treatment strategies for
COD or on other risk factors that have culmi-
nated in a suicidal event. In this case, treat-
ment becomes long-term prevention. Some per-
sons who are chronically suicidal need special
programs that can handle this chronic behavior
(American Society of Addiction Medicine 2001).
Among clients with dependence on alcohol,
“suicide frequently occurs late in the disease,
often in relation to rejection or some interper-
sonal loss as well as to the onset of medical
complications of the illness” (Blumenthal 1988,
p. 945). Particular attention should be given to
people with long-term dependence on alcohol
who are developing medical symptoms, who are
experiencing a personal loss or crisis, or who
have had a relapse. It is wise to check for suici-
dal ideation regularly as it can recur. Since
relapse is far and away the most dangerous sui-
cide risk in long-term substance abuse treat-
ment clients, the consensus panel recommends
a solid long-term recovery plan as the best
approach to suicide prevention. In persons
with serious and persistent mental disorders,
such as bipolar disorder, long-term medication
compliance is a key element in preventing sui-
cide. Just as essential as medication and medi-
cation compliance, however, is the need to
rebuild a sense of hope in the future and
engender the belief that recovery from co-
occurring disorders is possible and that one has
a sense of purpose, value, empowerment, and
role in one’s own recovery.
Nicotine Dependence
Tobacco dependence is the most common sub-
stance use disorder in the United States, and
cigarette smoking is the primary preventable
cause of disease and deaths in the United
States. Smoking causes approximately 450,000
premature deaths among people who use tobac-
co and an additional 50,000 deaths in non-
smokers from exposure to environmental
tobacco smoke (U.S. Public Health Service,
Office of the Surgeon General 2004; Ziedonis
and Fiester 2003). 
Tobacco dependence
is present in most
clients in mental
health and addiction
treatment settings.
Individuals with
behavioral health dis-
orders spend about
$214 billion annually
on tobacco, and
account for 44 per-
cent of all cigarettes
smoked in the United
States (Lasser et al.
2000). More people
with alcohol use disor-
ders die from smok-
ing-related diseases
than from alcohol-
related diseases (Hurt
et al. 1996). Smoking is also linked to depres-
sion and substance use disorders. Research
repeatedly has shown that, compared with the
general population, people who smoke are
more likely to abuse substances, and people
who abuse substances are more likely to smoke
cigarettes. Those who abuse alcohol are two to
three times more likely to smoke than the gen-
eral population (Anthony and Echeagaray-
Wagner 2000; Gilbert 1995), and up to seven
times more likely to smoke heavily (Collins and
Marks 1995). There is no simple reason why so
many clients in mental health or substance
abuse treatment smoke. As with other addictive
disorders, it is likely a combination of complex
biological and psychosocial factors (Ziedonis
and Fiester 2003).
Nicotine dependence was first included as a
substance use disorder in the Diagnostic and
Statistical Manual of Mental Disorders, Third
Edition (DSM-III) in 1980. The diagnostic cri-
teria for dependence are the same as other sub-
stance use disorders. Of note, unlike all other
substances, the DSM only recognizes nicotine
dependence (there is no diagnosis of nicotine
abuse) because most individuals transition
quickly and directly from use to dependence
and meet criteria of tolerance and withdrawal.
The nicotine withdrawal syndrome develops
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Tobacco depen-
dence is the most
common substance
use disorder in the
United States.
after abrupt cessation of or a reduction in the
use of nicotine products and is accompanied by
four of the following signs and symptoms: (1)
dysphoria or depressed mood; (2) insomnia; (3)
irritability, frustration, or anger; (4) anxiety;
(5) difficulty concentrating; (6) restlessness or
impatience; (7) decreased heart rate; and (8)
increased appetite or weight gain (APA 2000, p.
266). The withdrawal symptoms also must
cause clinically significant distress or impair-
ment in social, occupational, or other impor-
tant areas of functioning. 
Although nicotine is thought to be the primary
addictive component in tobacco, it is important
to remember that not all forms of nicotine are
equivalent. The pharmacology and potential
for addiction to nicotine is dependent on its
route of entry into the body. Smoking is an
extremely efficient route of administration, and
delivers the fastest and highest-spiking arterial
dose of nicotine. Nicotine delivery from smok-
ing produces levels of nicotine in the body that
are many times higher than those achieved with
use of nicotine replacement therapies (NRT).
Therefore, NRT products do not replicate the
perceived effect of smoking.
NRT has been found to be safe in cardiovascu-
lar disease and safe in persons who use it while
continuing to smoke. Several forms are avail-
able without pre-
scription (patches,
gum, lozenge), since
nicotine is not a car-
cinogen and there is
little abuse potential
for nicotine when it
is administered in
forms other than
smoking. Nicotine
has a pH of 8, mak-
ing oral absorption
poor. NRT products
rely on administra-
tion through the
skin, or buccal
(cheek) or nasal
mucosa, and are
buffered to increase
alkalinity and absorption. Nicotine absorption
in the mouth is markedly reduced when it is
administered with acidic beverages like sodas,
coffee, and juices. Simple instructions not to
use the gum, lozenge, or inhaler in conjunction
with these beverages can greatly increase the
nicotine absorption. 
Research has demonstrated that the vast
majority of harm associated with cigarettes is
attributable to the byproducts of smoking
rather than to the effects of nicotine (Slade
1999). In addition to nicotine, unprocessed
tobacco smoke includes more than 2,500 com-
pounds, and when manufactured additives and
other compounds are taken into account, about
4,000 compounds are present (U.S.
Department of Health and Human Services
1988). Smoking is the cause of 90 percent of all
lung cancers and nearly all cases of chronic
obstructive pulmonary disease, and is associat-
ed with a two times greater risk of death from
stroke and coronary heart disease. It is also
associated with an increased incidence of can-
cer at a number of other sites, including the
larynx, oral cavity, esophagus, cervix, bladder,
pancreas, and kidney, and is associated with
complications of pregnancy and negative effects
on the fetus, including low birth weight
(Ziedonis and Fiester 2003; U.S. Public Health
Service Office of the Surgeon General 2004).
Why do individuals with mental illness or
addiction die? Most die of smoking-caused dis-
eases, including cardiac and pulmonary prob-
lems, infections, and cancer. Among people
who are addicted to narcotics who are in sub-
stance abuse treatment, the death rate of smok-
ers is four times that of nonsmokers (Hser et al.
1994). Among people who are in recovery for
alcohol abuse who die, 51 percent of mortality
is attributed to smoking-related illness, and at
20-year followup the cumulative mortality was
48 percent versus 19 percent expected if a per-
son never smoked (Hurt et al. 1994).
Differential Diagnosis
Unsuccessful quit attempts, difficulty control-
ling use, and previous withdrawal symptoms
during abstinence are criteria for nicotine
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dependence in both the DSM-IV (APA 1994)
and the ICD-10 (World Health Organization
1992). These sources provide useful descrip-
tions of clinically observed phenomena, and
clinicians are advised to familiarize themselves
with diagnostic criteria and withdrawal symp-
toms (see Figure D-2, p. 341). However, unlike
other mental disorders, tobacco dependence
diagnostic criteria are rarely used in clinical or
research settings. Instead, tobacco dependence
is usually conceptualized dimensionally rather
than categorically. It should be noted that cate-
gorical diagnostic schemes based on DSM crite-
ria are not highly correlated with dimensional
assessments, such as the Fagerstrom Test for
Nicotine Dependence (Moolchan et al. 2002). 
Differential diagnosis is a less pressing clinical
issue with tobacco dependence than with other
substance use and mental disorders.
Approximately 80 percent of all people who
smoke, and virtually all people who smoke
daily, are nicotine dependent. DSM-IV diag-
nostic criteria are identical to those for other
substance use disorders, although DSM does
not recognize Nicotine Abuse as a diagnostic
category.
Prevalence
Although tobacco dependence is the most com-
mon substance use disorder, there are sub-
groups of individuals with particularly high
rates of tobacco dependence. Individuals with
mental illness and other substance use disor-
ders are the most common subgroup; however,
other important subgroups are known. The
prevalence of cigarette smoking is higher at
lower socioeconomic levels. Slightly more males
than females smoke, although more males than
females are successful in stopping smoking.
There is evidence that the number of cigarettes
smoked per person is increasing, leaving a
more hard core and, potentially, more depen-
dent group of people who smoke. There has
also been a recent increase in the rate of smok-
ing among adolescents, particularly in the num-
ber of teenage girls smoking. This increased
smoking rate among adolescents is particularly
alarming, as people who smoke typically start
smoking at an early age, with more than 60
percent beginning by age 14, and nearly all by
age 18 (Ziedonis and Fiester 2003).
Tobacco Dependence Among
Individuals With Another
Substance Use Disorder
Rates of smoking in people with substance use
disorders consistently have been shown to be
three to four times higher than in the general
population (Berger 1972; Richter et al. 2000;
Stark and Campbell 1993b), with heavier
smoking linked to increased drug or alcohol
severity (Hughes 1996; Sussman 2002). More
than two thirds of people who abuse drugs
smoke tobacco regularly, a rate double that of
the rest of the population (Zickler 2000). 
An 80 to 90 percent rate of smoking has been
found in persons with active alcoholism (Patten
et al. 1996). Similar results have been found in
people who use illicit drugs, with recent studies
finding smoking rates as high as 90 percent
among outpatient substance abuse clients
(Clarke et al. 2001; Clemney et al. 1997; Stark
and Campbell 1993b). Heavy smoking is partic-
ularly linked with drinking, with 72 percent of
people in treatment for alcohol use disorders
smoking heavily, versus 9 percent of the gener-
al population (Hughes 1995). Smoking also has
been shown to be a predictor of greater prob-
lem severity and poorer treatment response
(Krejci et al. 2003).
People who smoke and have a history of an
alcohol problem find nicotine more reinforcing,
and meet more nicotine dependence criteria
and withdrawal symptoms (Hughes et al. 2000;
2002). This may make consideration of phar-
macological approaches crucial, although some
clients in recovery from another addiction pre-
fer to quit without medications. There is grow-
ing evidence to suggest that many people in
substance abuse treatment are interested in
smoking cessation treatment simultaneously
(Joseph et al. 2002; Saxon et al. 1997),
although there is still some debate as to the best
time for tobacco treatment during substance
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abuse treatment. A recent study by Joseph and
colleagues (2003), comparing the timing of
tobacco dependence treatment, showed no dif-
ference in number of quit attempts, smoking
abstinence, or use of NRT between those who
received tobacco treatment concurrent with
substance abuse treatment, and tobacco treat-
ment that was delayed for 6 months after initi-
ating intensive substance abuse treatment. The
overall quit rates were comparable to the gen-
eral population, with about 18 percent achiev-
ing abstinence at 1 year. 
Surveys have reported that prevalence rates of
smoking in clients in methadone maintenance
programs are between 85 and 98 percent
(Berger 1972; Stark and Campbell 1993a).
Smoking status is predictive of illicit substance
use in methadone programs and increases in a
stepwise fashion from people who do not smoke,
to people who smoke but are nondependent, to
people who smoke heavily (Frosch et al. 2002).
There is a significant positive relationship dur-
ing treatment between rates of change in heroin
use and rates of change in tobacco use.
Tobacco Dependence Among
Individuals With Mental
Illness
The prevalence of smoking is high among peo-
ple with all types of mental illnesses, including
schizophrenia (70 to 90 percent), affective dis-
orders (42 to 70 percent), and anxiety disor-
ders, especially agoraphobia and panic disor-
der. Conversely, there is also evidence that
affective, anxiety, and substance use disorders
may be more common in individuals who
smoke than in those who do not or in those who
have never smoked. The presence of depressive
symptoms during withdrawal is also associated
with failed cessation attempts (APA 1996;
Ziedonis and Fiester 2003). 
Smokers with schizophrenia are more likely to
be current smokers (58 to 88 percent versus 23
percent) (Centers for Disease Control and
Prevention 2001; National Institute on Drug
Abuse [NIDA] 1999), to smoke more (Kelly and
McCreadie 1999), and to have ever smoked
daily (De Leon et al. 2002). They also smoke
more “efficiently” by inhaling more deeply and
smoking more of each cigarette (Olincy et al.
1997). People with schizophrenia are less suc-
cessful in quitting smoking, both in naturalistic
settings (Lasser et al. 2000) and in tobacco-
dependence treatment trials (Williams and
Hughes 2003). Although smoking rates are ele-
vated among all people with mental disorders,
individuals with schizophrenia are more likely
to smoke than those with other mental disorder
diagnoses (De Leon et al. 2002). In addition,
smokers with schizophrenia are more likely to
experience smoking-related morbidity and
mortality than the general population of smok-
ers (Brown et al. 2000; Dalack et al. 1998). The
effect of tobacco is that medications are metab-
olized faster and are cleared from the body
more efficiently, causing smokers with
schizophrenia to be prescribed higher medica-
tion doses. As a result, these people also experi-
ence greater medication side effects such as
tremor (Kelly and McCreadie 1999), rigidity
(Gideon et al. 1994), and possibly tardive dys-
kinesia (Nilsson et al. 1997). 
Key Issues and Concerns
Timing of the quit attempt
A major clinical issue is the timing of the quit
attempt. Should an individual try to quit all
substances at the same time? Clinicians tend to
endorse this strategy for all substances but
tobacco. Although there is debate about the
best time for tobacco treatment for people in
substance abuse treatment, studies suggest that
tobacco treatment does not jeopardize recovery
from other substances and might improve the
outcomes for the other substance use disorder. 
Should nicotine dependence treatment be timed
to a specific stage of recovery from a mental
disorder? There are very limited data to guide
this decision other than clinical judgment.
Clinical experience suggests that treating tobac-
co dependence during outpatient treatment
when mental disorder symptoms are somewhat
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stable appears to be an excellent time to target
interventions. Of note, managing tobacco
dependence through forced abstinence because
of environmental tobacco smoke concerns is
necessary, and addressing this issue with
appropriate dosages of NRT is warranted. 
Effect of tobacco abstinence
on psychiatric medication
blood levels
Tobacco (not nicotine) is metabolized in the
liver by the P450/1a2 isoenzyme, and tobacco’s
metabolism actually increases the metabolism
rate of certain psychiatric medications such as
haloperidol, fluphenazine, olanzapine, and
clozapine. When an individual stops smoking
tobacco, the liver enzymes P450/1a2 become
less active and metabolize the psychiatric medi-
cations at a slower rate. Therefore there will be
an increase in the blood levels of those medica-
tions, potentially causing an increase in the
medication’s side effects or other adverse
events, including noncompliance with the medi-
cation due to the side effects (APA 1996;
Ziedonis and Fiester 2003). 
Effect of tobacco abstinence
on mental disorders
Some clinicians are concerned about whether
tobacco abstinence will worsen mental illness or
jeopardize recovery from other substances.
This is an important area that needs more
research; however, research and clinical expe-
rience support the ability of people to quit and
not induce relapses or severe worsening of their
mental illness. The studies to date report that
nicotine dependence treatment for this popula-
tion is safe and usually well tolerated.
However, there have been reports of some
increases in psychiatric symptoms during the
acute detoxification phase (APA 1996; Ziedonis
and Williams 2003b).
Effect of trying to quit 
smoking on recovery from
other addictions
Until recently, substance abuse treatment clini-
cians generally have not addressed the issue of
tobacco dependence or provided treatment
largely because of the belief that the added
stress of quitting smoking would jeopardize the
recovery from alcohol or other substances.
Research has not confirmed this belief. One
study evaluated the progress of residents in an
alcoholism treatment facility who were concur-
rently undergoing a standard smoking cessation
program (i.e., experimental group) (Hurt et al.
1994). A comparison
group of people with
alcohol use disorders
who smoked partici-
pated in the same pro-
gram but without
undergoing the smok-
ing cessation pro-
gram. One year after
treatment, results
indicated that the
smoking cessation
program had no effect
on abstinence from
alcohol or other
drugs. In addition, 12
percent of the sub-
jects in the experi-
mental group, but
none of the subjects in
the comparison group, had stopped smoking.
Some data suggest that addiction recovery may
facilitate nicotine abstinence. In one study,
clients participating in concurrent treatment
for nicotine addiction during residential treat-
ment for alcohol and other drug abuse
achieved at least a temporary reduction in
smoking and an increased motivation to quit
smoking (Joseph et al. 1990).
Following the lead of other health facilities,
many substance abuse treatment facilities are
becoming smoke free, providing a “natural
experiment” on the effectiveness of dual recov-
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ery programs. Initial evaluations suggest that
no-smoking policies are feasible in this setting
(Martin et al. 1997). However, no outcome
studies have been performed, and additional
research is needed. 
Effect of tobacco use on
craving and other drugs
Researchers have found that craving for tobac-
co appears to increase craving for illicit drugs
among people with substance use disorders who
also smoke tobacco. This relationship suggests
that people who smoke and are in drug treat-
ment programs may be less successful in stay-
ing off drugs than people who do not smoke.
Recent research has found that cues that elicit-
ed craving for tobac-
co also elicited crav-
ing for the person’s
drug of choice. This
suggests that situa-
tions that produce
tobacco craving also
may result in crav-
ing for drugs of
abuse (Taylor et al.
2000). The findings
suggest that sub-
stance abuse treat-
ment efforts will
benefit from a more
complete under-
standing of the
interrelationships
between tobacco and
drug craving (Taylor
et al. 2000). In a study among patients on
methadone maintenance, tobacco craving and
heavy smoking appeared to contribute to
increased use of cocaine and heroin (Frosch et
al. 2000). In a study of people with alcohol use
disorders, researchers at Purdue University
concluded that alcohol alone can prompt peo-
ple who smoke to crave a cigarette. In a study
of rats, Canadian scientists found evidence that
the nicotine in cigarettes can induce a craving
for alcohol (Le et al. 2000) among rats trained
to drink alcohol. Alcohol consumption
increased 20 percent after nicotine exposure
and consumption decreased 30 percent after
mecamylamine exposure. The researchers
hypothesized that nicotine receptors are
involved in alcohol consumption and/or self-
administration (Le et al. 2000).
Motivation to quit among
individuals with substance
use or mental disorders
Many people in mental disorder and substance
abuse treatment settings are interested in quit-
ting tobacco, even if the interest is not immedi-
ate. In one study 75 percent of substance abuse
treatment inpatients accepted the offer of
smoking cessation treatment (Seidner et al.
1996). In another study, 53 percent of outpa-
tients reported moderate interest in quitting
(Kozlowski et al. 1989). Further, one study of
methadone maintenance patients found that 61
percent planned to quit within 6 months, 57
percent were very interested in an on-site ces-
sation program, and 80 percent were interested
in nicotine replacement products (Clemmey et
al. 1997). Still another study found that 72 to
94 percent of outpatients were not yet ready to
quit (Abrams et al. 1996). In conclusion, there
often is interest in quitting tobacco, but there is
variability in the interest level and there is a
need to provide encouragement and support to
those who are considering quitting smoking.
Realistic expectations:
Tobacco dependence is like
other addictions
Nicotine dependence, like other substance use
disorders, can be thought of as a chronic,
relapsing illness with a course of intermittent
episodes alternating with periods of remission
for most people who smoke. Only about 3 per-
cent of quit attempts without formal treatment
are successful, and in recent years about 30 per-
cent of people who smoke and who want to quit
are seeking treatment. Outcomes for nicotine
dependence treatment vary by the type of treat-
ment and the intensity of treatment, with specif-
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ic reports of 1-year abstinence rates following
treatment ranging from about 15 to 45 percent.
Cessation attempts result in high relapse rates,
with the relapse curve for smoking cessation
paralleling that for opioids. Most individuals
relapse during the first 3 days of withdrawal and
most others will relapse within the first 3 months
(APA 1996; Ziedonis and Fiester 2003). Like any
other substance, individuals can relapse to
tobacco in any stage of recovery.
Strategies, Tools, and
Techniques
Engagement
People entering treatment for substance use or
mental disorders rarely intend to receive treat-
ment for nicotine dependence. They may be
surprised or even annoyed by questions about
their smoking. It is important to initially inte-
grate assessment questions about nicotine
dependence into an overall assessment and
treatment plan, and to be prepared to revisit
the topic throughout the course of treatment.
This should be done in an empathic and non-
judgmental manner, emphasizing the clinician’s
concern for the client’s general health and well-
being. Initial interventions should be tailored
to the client’s stage of change (Prochaska et al.
1992), with a focus in the earlier stages on pro-
viding information, exploring ambivalence,
eliciting client concerns, and beginning to envi-
sion the possibility of quitting. 
For people who smoke who are not yet ready to
quit, the clinician can do effective motivational
interventions that will keep the client thinking
about quitting at some time in the future.
Discussing reasons for the person to consider
quitting—for example, carbon monoxide (CO)
monitor readings, costs, short- and long-term
health consequences of smoking, benefits of
quitting specific to the individual, and the fac-
tors that may have prevented an attempt—is
important. Written materials about tobacco
dependence and treatment options with brief
advice to quit is one method of providing such
information and increasing motivation.
Another is to follow the “5 Rs” as outlined in
the Surgeon General’s guidelines (U.S. Public
Health Service, Office of the Surgeon General
2004):
• Relevance: Encourage the client to indicate
why quitting could be personally relevant,
being as specific as possible. 
• Risks: Motivational information has the
greatest impact if it is relevant to a client’s
disease status or risk, family or social situa-
tion (e.g., having children in the home),
health concerns, age, gender, and other
important client characteristics (e.g., prior
quitting experience, personal barriers to ces-
sation).
• Rewards: Elicit from clients possible benefits
of quitting, with a particular focus on identi-
fying short-term benefits that they will notice
immediately.
• Roadblocks: Help the client to identify barri-
ers or impediments to quitting. Typical barri-
ers might include withdrawal symptoms, fear
of failure, weight gain, lack of support,
depression, or enjoyment of tobacco.
• Repetition: The motivational intervention
should be repeated every time an unmotivat-
ed client visits the clinical setting. People who
use tobacco and who have failed in previous
quit attempts should be informed that most
people make repeated quit attempts before
they are successful.
Preparation for quitting may include self-moni-
toring or keeping a diary of smoking, planning
rewards for successful abstinence, seeking
additional information about treatment, pur-
chasing the medication to aid in quitting,
attempting to not smoke in certain situations or
locations (such as the car, in the house) to
enhance perceived self-control over smoking,
and making a list of reasons for and potential
benefits of quitting. Sources of social support
should also be identified.
Screening and assessment
All clients should be screened for tobacco use
beginning with an assessment of current and
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past patterns of tobacco use (number of
cigarettes smoked per day, times during the
day, location, and circumstances). For individ-
uals who currently smoke, a more comprehen-
sive assessment should be completed (see text
box below).
In addition to self-reported amount of tobacco
use, the amount of tobacco usage can be
assessed more objectively through cotinine or
CO levels. Cotinine levels can be obtained from
the urine, blood, or saliva to assess the amount
of nicotine ingested. Cotinine is a primary
metabolite of nicotine and remains in the body
for several weeks. The expired-air test for a CO
level is inexpensive and can be obtained within
a minute by any clinician with a CO meter. The
CO meter is useful at intake and to monitor for
relapse. Higher cotinine and CO levels are
associated with a higher number of cigarettes
per day and also severity of nicotine withdraw-
al. Despite the usefulness of these biochemical
measures, they are frequently unavailable in
clinical settings.
Assessment of tobacco withdrawal symptoms in
the past and during the early abstinence period
can be helpful. Clients can be educated that
these symptoms will reduce substantially after
2 weeks (see Figure D-2).
The severity of nicotine dependence can be
assessed with the Fagerstrom Test for Nicotine
Dependence (FTND) (see Figure D-3, p. 342), a
six-item, self-report measure that has been
shown to predict withdrawal symptom and
craving severity (Payne et al. 1994). Two ques-
tions from the FTND that assess the number of
cigarettes per day and time elapsed before the
first cigarette have been shown to perform
about as well as the full scale (Hajek et al.
2001; Kozlowski et al. 2004). As a clinical
guideline, those who smoke at least 10
cigarettes per day have moderate nicotine
dependence, while those who smoke more than
20 cigarettes per day have high nicotine depen-
dence. Similarly, those who smoke within 60
minutes of waking can be considered to have
moderate dependence, and those who smoke
within 30 minutes of waking can be considered
to have high dependence. Because of the
unique social circumstances of people with
schizophrenia, the FTND may not be an ideal
measure of nicotine dependence for this popu-
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Assessing Nicotine Use and Nicotine Dependence
• Current and past patterns of tobacco use (include multiple sources of nicotine)
• Severity of tobacco dependence (e.g., Fagerstrom Scale)
• Current motivation to quit
• Breath CO level or cotinine level (saliva, blood, urine)
• Assess prior quit attempts (number of attempts and what happened in the more recent attempts), why
the client quit, how long the client was abstinent, why the client relapsed, what treatment did the client use
(how was it used and for how long)
• Assess withdrawal symptoms 
• Psychiatric and substance use histories
• Medical conditions
• Common triggers (car, people, moods, home, phone calls, meals, etc.)
• Perceived barriers against quitting and supports for treatment success 
• Preference for treatment strategy
Source: Ziedonis and Fiester 2003.
lation. For example, items intended to assess
the need to smoke in response to overnight
abstinence may elicit artificially low scores
among people who smoke who are not permit-
ted to smoke first thing in the morning by
group home staff, day treatment staff, or fami-
ly members with whom they live (Steinberg et
al. 2004a). 
Assessment of a client’s prior tobacco treatment
and cessation attempts should include the
nature of the prior treatments, length of absti-
nence, timing of relapse, and factors specifically
related to relapse (e.g., environmental or inter-
personal triggers). Assessing prior treatments
includes assessing medications and psychosocial
treatments. Important information about medi-
cations includes asking about the dose level of
medications and for how long they were taken;
any side effects that developed; and how the
client actually took the medication.
Psychosocial treatments might include group or
individual treatment, American Lung
Association and other community support
groups, hypnosis, acupuncture, or attendance
at Nicotine Anonymous meetings. A history of
specific withdrawal symptoms and their severity
and duration is critical, as is an assessment of
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Figure D-2
DSM-IV Criteria for Nicotine Withdrawal
A. Daily use of nicotine for at least several weeks.
B. Abrupt cessation of nicotine use, or reduction in the amount of nicotine used, followed within 24 hours
by four (or more) of the following:
(1) dysphoric or depressed mood
(2) insomnia
(3) irritability, frustration, or anger
(4) anxiety
(5) difficulty concentrating 
(6) restlessness
(7) decreased heart rate
(8) increased appetite or weight gain
C. The symptoms in criterion B cause clinically significant distress or impairment in social, occupational,
or other important areas of functioning.
The symptoms are not due to a general medical condition and are not better accounted for by another
mental disorder. 
Associated features:
• Craving for nicotine
• Desire for sweets
• Impaired performance on tasks requiring vigilance
• EEG slowing
• Decrease in catecholamine and cortisol levels
• Decreased metabolism of medications and other substances
Source: APA 2000, p. 266. Reprinted with permission.
the person’s social and environmental contexts;
for example, whether other household members
smoke and the availability of family and social
supports (Ziedonis and Fiester 2003).
An assessment should be made of the person’s
reasons for quitting and his or her motivation,
commitment, and self-efficacy (perceived abili-
ty to quit). The individual’s stage of readiness
for stopping smoking is also important; that is,
whether the person is not yet seriously consid-
ering stopping smoking (precontemplation), is
considering attempting to quit but not for sev-
eral months (contemplation), is seriously con-
sidering quitting in the next month and has
begun to think about the necessary steps to
stop smoking (preparation), or is actually
attempting to stop smoking (action). 
Patient motivation: Although 70 percent of
people who smoke express an interest in quit-
ting, only 8 percent are planning to make a
quit attempt in the next month (Wewers et al.
2003). Stages of change can be assessed using
the following simple algorithm:
• Client is not planning to quit in the next 6
months (precontemplation)
• Client is planning to quit in the next 6
months, but not the next month (contempla-
tion)
• Client is planning to quit in the next month
(preparation)
Client self-efficacy: Clients with little confi-
dence in their ability to quit are less likely to
make a quit attempt and less likely to succeed if
they do. 
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Figure D-3
The Fagerstrom Test For Nicotine Dependence
Question Answer Score
How soon after you wake up do you smoke your first
cigarette?
Within 5 minutes
6–30 minutes
31–60 minutes
> 60 minutes
3
2
1
0
Do you find it difficult to refrain from smoking in places
where it is forbidden? 
Yes
No
1
0
Which cigarette would you hate to give up the most? The first one in the 
morning 
Others
1
0
How many cigarettes per day do you smoke? < 10
11–20
21–30
> 31
0
1
2
3
Do you smoke more frequently during the first hours after
waking than during the rest of the day? 
Yes
No
1
0
Do you smoke if you are so ill that you are in bed most of
the day?
Yes
No
1
0
Scores are totaled to yield a single value, with scores of 6 or more indicating high nicotine dependence.
Environmental factors and social support:
People who smoke find it harder to quit when
they live and work alongside other people who
smoke, have a high current stress level, or have
a history of mental disorders. This is particu-
larly true in mental disorder treatment settings
or communal living arrangements where clients
are commonly exposed to staff and other clients
who smoke. 
Client beliefs about smoking and quitting: For
example, older adults who smoke may believe
that they are less likely to be able to quit, or
that they will experience few health benefits if
they do so. In fact, most studies find the oppo-
site—that older adults who smoke, (i.e., who
have smoked the longest) have a higher proba-
bility of success on any given quit attempt
(Stapleton et al. 1995). Similarly, some clients
and clinicians believe that nicotine causes can-
cer and that NRTs are dangerous. This is clear-
ly not the case, and addressing this common
misconception can help to increase motivation
to quit.
Interventions
The U.S. Public Health Service Clinical
Practice Guideline on Treating Tobacco Use
and Dependence (Fiore et al. 2000a) advises
clinicians to use the “5 A’s” (Ask, Advise,
Assess, Assist, Arrange Followup) with every
person who uses tobacco who shows a willing-
ness to quit (see chapter 8 for more informa-
tion). The 5 A’s are a brief and simple tobacco
intervention that has been shown to increase
the quit rates in primary care settings (Katz et
al. 2002). Unfortunately, they are rarely imple-
mented by clinicians treating clients in behav-
ioral healthcare settings. This may be because
clinicians are unsure how to implement them in
daily practice, or because the guideline gives
little information on the assessment of tobacco
use in these complex clients. 
Treatment Planning 
All clients who smoke should have tobacco
dependence as a problem listed in their treat-
ment plans and motivation-based treatment
plans written to match their motivation to
address tobacco. Those with less motivation
can receive written information and motiva-
tional interventions. For clients interested in
tobacco dependence treatment a “quit date”
should be selected. After cessation, close moni-
toring should occur during the early period of
abstinence. Before the quit date, the person
should be encouraged to explore and organize
social support for the self-attempt. Plans to
minimize cues associated with smoking (e.g.,
avoiding circumstances likely to contribute to
relapse) are important, as is considering alter-
native coping behaviors for situations with a
higher potential for relapse. A telephone or
face-to-face followup during the first few days
after cessation is critical because this is the time
that withdrawal symptoms are most severe, 
and 65 percent of patients relapse within 1
week. A followup face-to-face meeting within 1
to 2 weeks allows a discussion of problems that
have occurred (e.g., difficulties managing crav-
ing) and serves as an opportunity to provide
reinforcement for ongoing abstinence. Even
after the early period of abstinence, periodic
telephone or face-to-face contacts can provide
continued encouragement to maintain absti-
nence, allow problems with maintaining absti-
nence to be addressed, and provide feedback
regarding the health benefits of abstinence.
Figure D-4, p. 344, provides several strategies
for counselors to use in helping clients stop
smoking.
How To Treat Tobacco
Dependence
Before making a quit attempt, clients should
know the psychopharmacological options (i.e.,
NRT and bupropion) and what to expect while
trying to quit. This knowledge may inoculate
people who smoke from the frustration they
might otherwise experience with the discomfort
of quitting. Clients should know about the
withdrawal symptoms they may experience, the
fact that many people quit several times before
quitting successfully, and the potential for
minor weight gain. Clinicians should also dis-
cuss the timing of the quit attempt to maximize
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Figure D-4
Brief Strategies for Smoking Cessation
Action Strategies for Implementation
Help the client with a quit
plan.
A client’s preparations for quitting
• Set a quit date—ideally, the quit date should be within 2 weeks.
• Tell family, friends, and coworkers about quitting and request understanding
and support.
• Anticipate challenges to planned quit attempt, particularly during the critical
first few weeks. These include nicotine withdrawal symptoms.
• Remove tobacco products from your environment. Prior to quitting, avoid
smoking in places where you spend a lot of time (e.g., work, home, car).
Provide practical counsel-
ing (problem solving/skills
training).
Abstinence—Total abstinence is essential. “Not even a single puff after the quit
date.”
Past quit experience—Identify what helped and what hurt in previous quit
attempts.
Anticipate triggers or challenges in upcoming attempt—Discuss challenges/trig-
gers and how client will successfully overcome them.
Alcohol—Since alcohol can cause relapse, the client should consider abstaining
from alcohol while quitting.
Other smokers in the household—Quitting is more difficult when there is anoth-
er smoker in the household. Clients should encourage housemates to quit with
them or not smoke in their presence.
Provide intra-treatment
social support.
Provide a supportive clinical environment while encouraging the client in his or
her quit attempt. “My office staff and I are available to assist you.”
Help client obtain extra-
treatment social support.
Help client develop social support for his or her quit attempt in his or her envi-
ronments outside of treatment. Have the client ask his or her spouse/partner,
friends, and coworkers to support the client in the quit attempt.
Recommend the use of
approved pharmacothera-
py, except in special cir-
cumstances.
Recommend the use of pharmacotherapies found to be effective in this guide-
line. Explain how these medications increase smoking cessation success and
reduce withdrawal symptoms. The first-line pharmacotherapy medications
include bupropion SR, nicotine gum, nicotine inhaler, nicotine nasal spray, and
nicotine patch.
Provide supplementary
materials.
Sources—Federal agencies, nonprofit agencies, or local/State health 
departments.
Type—Culturally/racially/educationally/age appropriate for the client.
Location—Readily available at every clinician’s workstation.
Source Fiore et al. 2000a, b.
the chances for success. In contrast to other
drugs of abuse, it is recommended that people
who smoke take 2 to 4 weeks to prepare for the
quit date. Clients with few mental health prob-
lems may be ready in 2 weeks, while people with
more serious mental illnesses should take longer
to prepare. Once a quit date is set, a decision
must be made regarding making an abrupt or
gradual change. Making a gradual change has
the disadvantage of making each cigarette more
enjoyable as the number of cigarettes decreases,
with the result that the last few cigarettes may
be very difficult to give up.
Other preparatory strategies include using
“behavioral disconnects,” publicizing the
planned quit attempt, and creating a detailed
coping plan for dealing with cravings after the
quit date. Behavioral disconnects involve using
the preparation time to practice not smoking in
the client’s usual contexts. For example, if the
client is accustomed to smoking while speaking
on the telephone, he or she can practice speak-
ing on the phone without smoking cigarettes.
This strategy has the dual benefit of increasing
self-efficacy if done successfully and of decreas-
ing psychological cravings in the presence of
the client’s usual smoking cues.
By publicizing the planned quit attempt, the
client is likely to feel more committed to follow-
ing through on the quit day. It is helpful to tell
as many significant others as possible, includ-
ing all friends, family, coworkers, and so on.
Telling other treatment staff is also important,
as supportive treatment staff can play a key
role in encouraging the change. The client
should also be informed of the potential effects
of smoking on psychotropic medications, as
aromatic hydrocarbons (tar) in the tobacco
smoke increases the metabolism of many of the
medications the client may be taking. Upon
quitting smoking, the medications may need to
be adjusted accordingly.
Publicizing the planned quit attempt will also
help in gathering the social support needed to
be successful. Significant others who do not
smoke are likely to be supportive, and those
who do smoke can be put on notice that they
should not offer cigarettes or sabotage the quit
attempt. The detailed coping plan should
include having a reference sheet with several
individualized reasons for quitting, names and
phone numbers of supportive others to call,
and a list of distracting activities, preferably
those that are inconsistent with smoking (e.g.,
exercising, playing with children).
As the quit date approaches, stimulus control
techniques should be implemented, such as
removing all tobacco product cues (e.g.,
cigarettes, lighters, ashtrays) from the client’s
environment. The client should also make sure
others do not smoke in the home, be prepared
to sit in non-smoking areas, and avoid smoking
cues that can be avoided.
Avoiding smoking cues is often difficult for peo-
ple who smoke and have other substance use or
mental disorders. Clients with other substance
use disorders may be faced with smoke-filled
12-Step program meetings, sponsors who
smoke, or even sponsors who discourage them
from quitting. Clients with mental disorders
may be faced with group home housemates who
smoke and day treatment programs populated
by people who smoke. It is helpful to have
other supportive treatment staff to intervene in
these circumstances to facilitate the quit
attempt. Regardless of the co-occurring disor-
der, it is important to take into account the
specific deficits or circumstances secondary to
the disorder.
An in-person or telephone followup contact
should occur within 2 days of the quit date.
Clinicians and clients should have an action
plan for managing a lapse or relapse, and this
plan should be activated if the client slips and
has a cigarette. After the client has quit,
relapse prevention strategies should be used.
Popularized by Marlatt and Gordon (1985),
relapse prevention is a well-established, empiri-
cally based approach using cognitive–behav-
ioral therapy techniques to teach people to
avoid and/or cope with triggers to use addictive
substances. Since cravings or urges to use
addictive substances are common issues for
clients seeking treatment for substance use dis-
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orders (including nicotine dependence), clients
are taught how to manage and cope with these
feelings and avoid smoking cues whenever pos-
sible. Common cues for smoking include the
people, places, and things associated with
tobacco use as well as negative mood states like
anger or sadness. These cues can trigger smok-
ing behavior and can be lessened through psy-
chosocial interventions.
Medications for nicotine
dependence treatment
Six medications have received Food and Drug
Administration (FDA) approval for nicotine
dependence treatment, and the practice guide-
lines recognize these medications as first-line
treatments (Fiore et al. 2000a). These treat-
ments are effective for about 25 to 30 percent
of people in the general population who smoke
on any one attempt, and this rate increases
with combined psychosocial treatment. These
medications have similar success rates but have
side effect differences. 
The five types of NRTs are administered in a
variety of ways: nicotine polacrilex (gum), nico-
tine transdermal patch, nicotine inhaler, nico-
tine nasal spray, and the nicotine lozenge.
These medications are similar in how they
reduce nicotine
withdrawal and urge
to smoke, and
improve abstinence
rates and client sat-
isfaction. The only
FDA-approved non-
nicotine treatment is
bupropion SR (mar-
keted as Zyban SR)
for tobacco addic-
tion and Wellbutrin
SR for treatment of
depression.
Bupropion’s effect
on tobacco depen-
dence, however, is
independent of
depression status.
Bupropion SR has proven effectiveness in
clients with or without past depression medica-
tion treatment. 
Most people who smoke and who have mental
disorders smoke heavily. People who smoke
heavily usually have higher CO and cotinine
levels, higher Fagerstrom nicotine dependence
scores, more nicotine withdrawal symptoms,
and experience mood difficulties during with-
drawal. There is some evidence to suggest
titrating the dosage of NRT to the cotinine lev-
els in the client. People who smoke heavily may
have improved outcomes with higher NRT
dosages (multiple NRTs simultaneously, multi-
ple NRT patches), adding bupropion SR, and
integrating behavioral therapies. There is one
report that high-dose patch treatment resulted
in 40 percent fewer withdrawal symptoms and
2.5 times greater reductions in craving in a
pilot study of people with schizophrenia who
smoked, and was well tolerated, although larg-
er trials are needed. 
Specific psychosocial 
treatments for tobacco
dependence
Psychosocial treatments for nicotine depen-
dence are among the first-line treatments in
several practice guidelines (APA 1996; Fiore et
al. 2000a). Because behavioral health treatment
providers (i.e., those treating substance use
and/or mental disorders) possess many of the
skills needed to provide tobacco dependence
services, intensive interventions may be well
suited to a mental or substance use disorder
treatment setting. Data support the use of psy-
chosocial interventions for tobacco dependence
as provided by various counselor disciplines
(e.g., physicians or nonphysicians), and via
multiple treatment modalities (e.g., telephone,
group, and individual counseling). Although
there is a clear dose-response relationship
between counseling intensity and success, even
very brief counseling can increase quit rates
(Fiore et al. 2000a). 
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Relapse 
prevention uses
social skills train-
ing to teach drug
refusal skills.
Despite the strong evidence that psychosocial
treatments are effective for treating tobacco
dependence, only 5 percent of people who smoke
who make a 24-hour quit attempt receive coun-
seling as part of their treatment (Zhu et al.
2000). Clients who are motivated to quit smok-
ing should be taught general problemsolving
skills, provided with social support as part of
counseling, and assisted in gaining social support
from family and friends for their quit attempt.
Psychosocial interventions have been success-
fully adapted for people with schizophrenia who
smoke (Addington et al. 1998; George et al.
2000; Steinberg et al. 2004a; Ziedonis and
George 1997), depression (Hall et al. 1994,
1995, 1996, 1998, 1999), and substance use dis-
orders (e.g., Burling et al. 2001; Patten et al.
1998, 2001). Successful adaptation involves
blending traditional mental health services with
tobacco dependence treatments while address-
ing the unique problems associated with the spe-
cific mental disorder. Integrating medications
with these psychosocial treatments is also very
important, since these groups are often highly
dependent on tobacco.
While clinicians are often hesitant to help
clients with serious mental illness who smoke to
quit smoking, the Clinical Practice Guideline
(Fiore et al. 2000a) recommends that tobacco
use be addressed in all clients who smoke.
While many excuse smoking in this population,
it should be recognized that smoking exacer-
bates many existing problems. When compared
with people who do not smoke, those with
schizophrenia who smoke exhibited more posi-
tive symptoms of schizophrenia (Goff et al.
1992; Ziedonis et al. 1994) and experienced
more hospitalizations than their counterparts
who did not smoke (Goff et al. 1992; Kelly and
McCreadie 1999). People with schizophrenia
who smoke often are prescribed more antipsy-
chotic medication than people with schizophre-
nia who do not smoke, due to an increased
metabolism of many psychiatric medications
secondary to the “tar” or aromatic polynuclear
hydrocarbons—not due to nicotine (Goff 1992;
Hughes 1993; Ziedonis 1994). They also experi-
ence greater medication side effects such as
tremor (Kelly and McCreadie 1999), rigidity
(Ziedonis et al. 1994), and possibly tardive
dyskinesia (Nilsson et al. 1997). Tobacco use
also depletes their already scarce financial
resources. Cigarettes may constitute up to 27
percent of the monthly budget for people with
schizophrenia who smoke (Steinberg et al.
2004a). A recent study indicated that a brief
motivational interviewing intervention was
effective in motivating people with schizophre-
nia who smoked to seek formal tobacco depen-
dence treatment (Steinberg et al. 2004b).
Relapse prevention also uses social skills train-
ing to teach drug refusal skills. Since seeing
others smoke is a strong predictor for relapse,
this approach is very important for those living
in a group home or attending a substance abuse
treatment or mental health services setting
where smoking may be ubiquitous. Specialized
treatments for this group should incorporate
techniques for reducing the appeal of smoke
breaks and learning to avoid “bumming”
cigarettes or accepting an offered cigarette.
Interactive teaching through role playing can
enhance this type of learning and allow for
real-world practicing. Raising awareness of the
stigma related to these drug-seeking and drug-
use behaviors can also help to change behavior.
Creating a relapse analysis is helpful to under-
stand the role of “seemingly irrelevant deci-
sions” in the path toward a relapse. An exam-
ple of a “seemingly irrelevant decision” might
be a relapse to smoking after dining in the
smoking section of a restaurant rather than sit-
ting in the nonsmoking section.
Relapse prevention also distinguishes between
a “lapse” and a “relapse” as a matter of degree
and severity. There is a focus on trying to
avoid letting a “lapse” become a “relapse” by
quickly managing the situation and framing it
as a learning opportunity in an effort to return
to abstinence. This model allows for some mis-
takes as the client is working toward a goal of
abstinence. Figure D-5 (p. 348) presents
strategies for helping clients address situations
that may lead to relapse.
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Personality Disorders
(Overview)
Description
Personality disorders (PD) are rigid, inflexible,
and maladaptive behavior patterns of sufficient
severity to cause significant impairment in
functioning or internal distress. Personality
disorders are enduring and persistent styles of
behavior and thought, rather than rare or
unusual events in someone’s life. Furthermore,
as opposed to a response to a particular set of
circumstances or particular stressors, people
with personality disorders carry with them
these destructive patterns of thinking, feeling,
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Figure D-5
Brief Strategies 2. Components of Prescriptive Relapse Prevention
During prescriptive relapse prevention, a client might identify a problem that threatens his or her abstinence.
Specific problems likely to be reported by clients and potential responses follow: 
Problems Responses
Lack of support for cessa-
tion
Negative mood or depres-
sion
• Schedule followup visits or telephone calls with the client.
• Help the client identify sources of support within his or her environment.
• Refer the client to an appropriate organization that offers cessation counsel-
ing or support.
• If significant, provide counseling, prescribe appropriate medications, or refer
the client to a specialist.
• If the client reports prolonged craving or other withdrawal symptoms, consid-
er extending the use of an approved pharmacotherapy or adding/combining
pharmacological medications to reduce strong withdrawal symptoms.
Strong or prolonged with-
drawal symptoms
• If the client reports prolonged craving or other withdrawal symptoms, consid-
er extending the use of an approved pharmacotherapy or adding/combining
pharmacological medications to reduce strong withdrawal symptoms.
Weight gain • Recommend starting or increasing physical activity; discourage strict dieting.
• Reassure the client that some weight gain after quitting is common and
appears to be self-limiting.
• Emphasize the importance of a healthy diet.
• Maintain the client on pharmacotherapy known to delay weight gain (e.g.,
bupropion SR and NRTs, particularly nicotine gum).
• Refer the client to a specialist or program.
Flagging motivation/feeling
deprived
• Reassure the client that these feelings are common.
• Recommend rewarding activities.
• Probe to ensure that the client is not engaged in periodic tobacco use.
• Emphasize that beginning to smoke (even a puff) will increase urges and make
quitting more difficult.
Source: Fiore et al. 2000a, b.
and behaving as their way of being and inter-
acting with the world and others. 
Though sudden stressful circumstances might
worsen the response of a client with a PD, such
a client experiences the disorder regularly and
often pervasively. Clients with PDs frequently
are unaware of the impact of the disorder on
their personality, behaviors, and interactions
with others. Sometimes clients with PDs blame
others or the world for misery that they clearly
bring upon themselves.
The course and severity of PDs can be wors-
ened by the presence of other mental disorders
such as mood, anxiety, and psychotic disor-
ders. Furthermore, of the roughly 10 different
types of PDs that can be described, people with
any one of the disorders are at an increased
likelihood of having another—that is, though
the different PDs can be discussed as if they
were separate entities, in clinical practice,
clients often have more than one PD and might
well have features of many.
“Mixed personality disorder,” the mental
health equivalent of “polysubstance abuse,”
describes individuals who meet the diagnostic
criteria for more than one PD. This TIP pro-
vides details about two of the PDs—borderline
personality disorders (BPDs) and antisocial
personality disorders (APDs). Before exploring
BPD and APD in detail, a brief overview of the
other PDs follows. However, the reader should
keep in mind that the diagnostic approach to
personality disorders is slated for significant
change and refinement, as there have been
numerous concerns expressed about the mean-
ingfulness and utility of the current system for
diagnosing personality disorders (see footnote1
for more information). 
Personality disorders grouped
into clusters A, B, or C
The PDs include paranoid, schizoid, schizoty-
pal, histrionic, narcissistic, antisocial, border-
line, avoidant, dependent, and obsessive-com-
pulsive. In the DSM-IV-TR (pp. 690–730), PDs
are conceptualized as three distinct clusters,
“A,” “B,” and “C:”
• Cluster A: Paranoid PD; Schizoid PD; and
Schizotypal PD
• Cluster B: Antisocial PD; Borderline PD;
Histrionic PD; and Narcissistic PD
• Cluster C: Avoidant PD; Dependent PD; and
Obsessive-Compulsive PD
Cluster A
Cluster A PDs describe clients who may be seen
as “odd-eccentric.”
People with paranoid personality disorder are
pervasively distrustful and suspicious to a
degree that routinely interferes with their form-
ing a correct perception of the motives and
beliefs of others, and with their successfully
forming positive relationships with others.
They may interpret other people as trying to
threaten, demean, or intimidate them, even
when such behavior is not exhibited.
Schizoid personality disorder is descriptive of a
person whom others often see as a “loner” and
who commonly exhibits an indifference to the
views and feelings of others. People with a
schizoid personality disorder have a restricted
range of emotional experience and expression.
People with a schizotypal personality disorder
often behave in ways others see as weird, with
possible peculiarities of speech, dress, and/or
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1A group of clinicians committed to a research agenda for the development of DSM-V have given the following assess-
ment of the status of personality disorders within the DSM-IV-TR (APA 2000): “… there is notable dissatisfaction with
the current conceptualization and definition of the DSM-IV-TR (APA 2000). Problems identified by both researchers
and clinicians include confusion regarding the relationship between the DSM-IV-TR personality disorders (especially
those that are chronic and have their onset in childhood or adolescence); excessive comorbidity among the DSM-IV-TR
personality disorder; arbitrary distinction between normal personality, personality traits, and personality disorders;
and limited coverage (the most common diagnosed personality disorder is the residual diagnosis of personality disorder
not otherwise specified)” (First et al. 2002).
beliefs. These strange or markedly unusual
characteristics often produce avoidance or
wariness in others, and the resulting difficulties
in interpersonal relations may lead to anxieties
and depression.
Cluster B
Cluster B PDs include histrionic PDs and nar-
cissistic PDs, in addition to the borderline and
antisocial PDs (which are discussed in detail in
following sections). The general characteriza-
tion of the Cluster B dimensions is “dramatic-
emotional.”
Histrionic personality disorder is expressed in
excessive emotionality and attention seeking,
often including inappropriate sexually seduc-
tive behaviors.
Clients with narcissistic personality disorder
exhibit a “pervasive pattern of grandiosity,
need for admiration, and lack of empathy”
(APA 2000, p. 714). While a certain self-cen-
teredness and falsity are common with addic-
tive disease, a client with a true narcissistic dis-
order displays a grandiosity, over-inflates the
value of his or her own abilities, and displays a
superiority that is so distorted as to impair his
or her judgment. People with narcissistic PD
and substance use disorders will exhibit these
features even after achieving and maintaining
abstinence. 
Antisocial personality disorder involves a histo-
ry of chronic antisocial behavior that begins
before the age of 15 and continues into adult-
hood (though the diagnosis cannot be made
officially unless a person is at least 18 years
old). The disorder is manifested by a pattern of
irresponsible and antisocial behavior indicated
by illegal activities, recklessness, impulsive
behavior, academic failure, and poor job per-
formance. Other features often include dyspho-
ria, an inability to tolerate boredom, feeling vic-
timized, and a diminished capacity for intimacy.
Borderline personality disorder is character-
ized by unstable mood and self-image, and
unstable and intense interpersonal relation-
ships. These people often display extremes of
overidealization and devaluation, marked
shifts from baseline to an extreme mood or
anxiety state, and impulsiveness.
Though people with APD are more likely to be
male and those with BPD female, APD and
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Figure D-6
Characteristics of People With Antisocial and Borderline Personality Disorders
Characteristic Antisocial Borderline
Affect Angry intimidation Angry self-harm
World view If you don’t do what I want, you’ll be
sorry.
I deserve it all.
They’re the ones with the problem.
I’ve got to get you before you get me.
I don’t deserve to exist.
Help me, help me, but you can’t.
Presenting problem Legal difficulties, polysubstance abuse and
dependence, parasitic relationships
Self-harm, impulsive behavior, episodic
polysubstance abuse, hot-and-cold rela-
tionships
Social functioning Episodic achievement Gross dysfunctioning
Motivation Self-esteem Safety
Defenses Rationalization, projection Splitting, projection
BPD have a number of features in common.
Both disorders tend to diminish in intensity
with age, and sometimes even remit after a
client reaches age 40 or so. People with APD
or BPD are likely to show features of other
PDs. Both APD and BPD are commonly asso-
ciated with a co-occurring substance use disor-
der as well as with other significant (Axis I)
mental health complaints. Characteristics of
people with APD and BPD are presented in
Figure D-6. 
Cluster C
Cluster C PDs include avoidant PD, dependent
PD, and obsessive-compulsive PD and describe
clients who are “anxious-fearful.”
People with avoidant personality disorder show
extreme hypersensitivity to others, social dis-
comfort, and timidity, often with accompanying
depression, anxiety, and anger for failing to
develop social relations.
People with obsessive-compulsive personality
disorder display a preoccupation with orderli-
ness, perfectionism, and control, and they may
appear excessively conscientious, moralistic,
scrupulous, and judgmental. Symptoms may
include distress associated with indecisiveness
and difficulty in expressing tender feelings,
feelings of depression, and anger about feeling
controlled by others.
Clients with dependent personality disorder
live with a pervasive and excessive need to have
others take care of them. Individuals with a
dependent PD typically have severely low self-
esteem, and their behavior often is submissive
and clinging. Such individuals are at risk of
forming abusive relationship and even of failing
to protect their children from abuse.
Differential Diagnosis 
The clinical situation often is challenging when
working with clients who have both a PD and a
substance use disorder. PDs should not be
diagnosed during substance use or withdrawal
as misdiagnosis can easily occur if the current
and historical roles of substance use are not
properly assessed. A period of abstinence is
often required before the co-occurrence of a
PD with a substance use disorder can be deter-
mined. If a PD coexists with substance use, the
PD will remain during abstinence. When a
bona fide co-occurring PD exists, during absti-
nence and recovery the PD symptoms can get
worse and the functioning level of the client
might even deteriorate, though over time
improvement and greater stability are possible
for the client with co-occurring personality dis-
order and substance use disorder who receives
effective care for both.
Some criteria that describe PDs (e.g., depen-
dency or insensitivity) are also characteristic of
other Axis I disorders. Three PDs—paranoid,
schizoid, and schizotypal—may be distin-
guished from psychotic disorders by being
observed when the client is clearly not experi-
encing a psychotic episode (APA 2000).
Counselors are cautioned to take into account
the individual’s ethnic, cultural, and social
background when judgments are made about
personality functions. To make a sound judg-
ment when working with a client who has an
unfamiliar cultural background, it is a good
idea to consult with someone who is familiar
with that culture to gain a sense of norms and
alternative, culturally consonant explanations
of observed behaviors.
Prevalence
Nace (1990) contends that the prevalence of
PDs is at least 50 percent in substance-abusing
populations. Brooner et al. (1997) found that
35 percent of the 716 consecutive admissions to
a methadone maintenance program had a per-
sonality disorder, while Flynn et al. (1996) in
the large Drug Abuse Treatment Outcome
Study of over 7,400 clients with substance
dependence found antisocial personality disor-
der in 34.7 percent for alcohol-only clients, 27
percent for heroin only, 30.4 percent for
cocaine only, percentages in the mid-40 percent
range for clients dependent on two of these
three drugs, and 59.8 percent for clients
dependent on all three drugs. As noted, howev-
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er, no diagnosis should be made during the
acute phase of detoxification. The early phases
of treatment involve addressing behaviors that
may appear to be symptoms of PDs, especially
BPD. Thus, counselors should exercise care
not to rush to conclude that a patient or client
has BPD.
Among Cluster A disorders (“odd-eccentric”),
paranoid PD has been reported to be 0.5 to 2.5
percent in the general population, as high as 10
to 30 percent among those in inpatient mental
health settings, and 2 to 10 percent among
those in outpatient mental health clinics (APA
2000). One study found 44 percent of persons
in treatment for alcoholism to have this disor-
der (Dowson and Grounds 1995). Another
study (Verheul et al. 2000) found through semi-
structured interviews that 13.2 percent of a
group of 370 patients in treatment for sub-
stance abuse warranted a diagnosis of a para-
noid personality disorder. Schizoid PD is
believed to be uncommon in clinical settings
(APA 2000). Similarly, although up to 3 per-
cent of the general population may be affected
by schizotypal PD (APA 2000, p. 699), the
prevalence rate even in substance abuse treat-
ment programs that treat clients with COD
appears to be quite low.
Among Cluster B disorders (“dramatic/emo-
tional”), about 1 percent of females and 3 per-
cent of males in the general population are
believed to have antisocial PD. In clinical set-
tings, the prevalence is estimated to be any-
where from 3 percent to as high as 30 percent,
with especially high prevalence in substance
abuse treatment and prison settings (APA
2000). Among the male prison population, 20
percent or more may have antisocial PD.
Borderline PD also is relatively common in
mental health settings. Although only about 2
percent of the general population has this dis-
order, its incidence is about 10 percent of men-
tal health clinic outpatients and 20 percent of
mental health inpatients. From 30 to 60 per-
cent of other clinical populations may have this
disorder. One study of 370 clients in substance
abuse treatment (Verheul et al. 2000) found
that more had Cluster B diagnoses (27 percent
antisocial PD and 18.4 percent borderline PD)
than either Cluster A (13.2 percent) and
Cluster C (18.4 percent avoidant).
The DSM-IV suggests prevalence rates of 2 to 3
percent for histrionic PD in the general popu-
lation and 10 to 15 percent in mental health
settings; there is reason to believe the 10 to 15
percent estimate would also be true of sub-
stance abuse treatment settings (APA 2000).
Prevalence rates for narcissistic PD are esti-
mated to be roughly similar to those for histri-
onic PD—from 2 to 16 percent in the clinical
population (APA 2000) and about 10 to 15 per-
cent in the clinical practice of a substance
abuse counselor.
Among Cluster C disorders (“anxious/fearful”),
avoidant PD and obsessive-compulsive PD
probably each make up at most 10 percent of
clients at mental health clinics. With a rate in
the general population of less than 1 percent for
each, substance abuse counselors seldom see
pure forms of these types of PDs in clinical prac-
tice. On the other hand, persons with dependent
PD are “among the most frequently… encoun-
tered in mental health clinics” (APA 1994).
Again, the reader is cautioned that the utility
and meaningfulness of the Cluster groupings
and/or the distinctiveness of the 10 separate
“personality disorders” is in doubt. Bohn and
Meyer (1999) report that frequencies of antiso-
cial PD “in samples of alcoholic patients have
ranged from 16 to 49 percent. Somewhat higher
rates have been detected among opioid- and
other drug-abusing populations. The frequency
of occurrence of ASPD [antisocial PD] varies
depending on the type of sample and the diag-
nostic criteria used [emphasis added]
(Hesselbrock et al. 1985; Rounsaville et al.
1983). The higher reported prevalence rates of
ASPD among substance-dependent patients
since 1980 … are likely a function of the broad
diagnostic criteria applied to this disorder by
DSM-III, DMS-III-R, and DSM-IV, rather than
of a real change in the patient population”
(Bohn and Meyer 1999, p. 99). In fact, North
and colleagues found that antisocial PD
appeared to change little over 20 years within
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the homeless population, with 10 to 20 percent
of homeless women and 20 to 25 of homeless
men receiving diagnoses of antisocial PD (see
North et al. 2004).
Substance Use Among People
With Personality Disorders
Substance use may trigger or worsen personali-
ty disordered behaviors. No single pattern of
substance use or abuse can be identified for
any one PD; the drug or drugs of abuse depend
on many factors beyond the presence of a spe-
cific PD. For example, individuals with para-
noid PD may prefer stimulants to augment
their need to be vigilant or they may seek opi-
oids to reduce the severe tension generated by
their fear and distrust.
Plans to place the diagnosis of PDs on a solid
research foundation (including the ever-grow-
ing body of neurobiological knowledge) that
will yield diagnoses useful for clinical practice
(Kupfer et al. 2002) envision significant
changes to the DSM-IV-TR presentation of
PDs. In brief, it seems that a more complex
and psychometrically based set of categories
and measurement dimensions will be utilized
instead of 3 clusters and 10 PDs. The meaning-
ful and useful relationships among the behav-
iors and treatment considerations relevant for
people with personality disorders may well
match up with categories and dimensions that
are not clearly enough represented by the cur-
rent schema to yield treatment decisionmaking
information. Perhaps the future understanding
of people with personality disorders and DSM-
V will be useful to enhance the treatment
responses of these individuals, as the one thing
that is already clear from the available
research is that these individuals can change
and profit from treatment.
Key Issues and Concerns
Clients with PDs tend to have difficulty form-
ing a genuinely positive therapeutic alliance.
They tend to frame reality in terms of their
own needs and perceptions and to be unable to
understand the per-
spectives of others.
Also, most clients with
PDs are limited in
terms of their ability
to receive, accept, or
benefit from correc-
tive feedback. A fur-
ther difficulty is the
strong countertrans-
ference clinicians can
have in working with
these clients, who are
adept at “pulling oth-
ers’ chains” in a vari-
ety of ways. Specific
concerns will, howev-
er, vary according to
the PD and other
individual circumstances. In general, group
therapies, therapeutic communities, and more
rationally oriented, directive, behavioral forms
of treatment have been thought to be particu-
larly appropriate for people with PDs.
Borderline Personality
Disorder
Description
One of the most prominent features of people
with BPD is instability. Their relationships
with others are likely to be unstable, with
reports of how wonderful an individual is one
day and expressions of intense anger, disap-
proval, condemnation, and even hate toward
that same individual a week later. Then a
month later the person with BPD is once again
singing the praises of the same person. These
reactions can be unsettling for a counselor,
especially if it is the counselor who is being held
in high esteem one minute and accused of every
form of deceit the next. The severe instability
experienced by the person with BPD includes
fluctuating views and feelings about him- or
herself. Those with BPD often feel quite good
about themselves and their progress and opti-
mistic about their future for a few days or
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Substance use 
may trigger 
or worsen person-
ality disordered 
behaviors.
weeks, only to have a seemingly minor experi-
ence turn their world upside-down with con-
comitant plunging self-esteem and depressing
hopelessness.
Basic instability extends to work and school,
where it sometimes seems that people with BPD
“snatch failure out of the jaws of success.”
Individuals with BPD might well be engaging
and attempt to please initially, then become
demanding, hostile, and exhausting. When
experiencing emotional states they cannot han-
dle, clients with BPD can be at risk of suicidal,
self-mutilating, and/or brief psychotic states.
Since people with BPD typically seek mental
health or substance abuse treatment based on
their current life conditions and emotional
state, it is likely that the person with BPD who
seeks mental health treatment is acutely emo-
tionally distraught, needing some relief from
how she or he feels. Similarly, the client with
BPD who chooses (or is directed to choose) a
substance abuse treatment program probably
is experiencing the substance use disorder as
the immediate target for treatment.
Consequently, the average admission of a per-
son with BPD to a mental health environment
might, in general, be considerably different
from the average admission of a person with
BPD to a substance abuse treatment setting.
Evidence is accumulating that BPD, posttrau-
matic stress disorder (PTSD), and a history of
childhood abuse occur with regularity among
women in substance abuse treatment (Gil-Rivas
et al. 1996; Sullivan and Evans 1994). Women
with BPD are more likely to have eating disor-
ders or PTSD, while men are more likely to
have co-occurring substance use disorders,
along with PTSD and other personality disor-
ders (Johnson et al. 2003).
Substance Use Among People
With BPD
Individuals with BPD are often skilled in seek-
ing multiple sources of medication that they
favor, such as benzodiazepines. Once this med-
ication has been prescribed in a mental health
system, they may demand that it be continued.
Confrontation or pressure to engage in detoxifi-
cation or outpatient withdrawal can precipitate
intense rage and various levels of client crises.
Individuals with BPD may well associate drugs
with social interaction and use the same drugs
of choice, route of administration, and fre-
quency as the individuals with whom they are
interacting. On the other hand, they often use
substances in chaotic and unpredictable pat-
terns. Polydrug use is common and may
involve alcohol and other sedative-hypnotics
taken for self-medication.
People with BPD usually have big appetites;
they experience powerful, emotion-driven
needs for something outside of themselves. If
they do give up alcohol and other drugs, per-
haps because they are experiencing a positive
relationship to a service provider or a group,
they are extraordinarily vulnerable to meeting
their needs through other compulsive behav-
iors. Newly abstinent individuals with BPD
must be monitored for compulsive sexual
behavior, compulsive gambling, compulsive
spending/shopping, or other out-of-control
behaviors that result in negative or even dan-
gerous consequences.
At the beginning of a crisis episode, a client
with BPD might take a drink or a different
drug in an attempt to quell the growing sense
of tension or loss of control. What the client
needs to learn is twofold: (1) that a drink/
drug at that point increases the harm and
real loss of control, and (2) that at the point
where a drug/drink is desired some other,
positive coping strategy needs to be put into
play immediately.
Key Issues and Concerns
Progress with clients who have BPD can be
slow. Therapists should be realistic in their
expectations and know that clients will try to
test them. To respond to such tests, therapists
should maintain a matter-of-fact, businesslike
attitude, and remember that people with PDs
often display maladaptive behaviors that have
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helped them to survive in difficult situations,
sometimes called “survivor behaviors.” (See
TIP 36, Substance Abuse Treatment for
Persons With Child Abuse and Neglect Issues
[Center for Substance Abuse Treatment
(CSAT) 2000d].)
It is important to educate clients about their
substance use and mental disorders. Clients
should learn that treatment for and recovery
from their substance use disorder may progress
at a different rate than their treatment for and
recovery from BPD. In addition, while many
clients appear to fully recover from their sub-
stance use disorders, the degree of long-term
recovery from BPD is less understood and
characterized. Written and oral contracts that
are simple, clear, direct, and time-limited can
be a useful part of the treatment plan.
Contracts can help clients create safe environ-
ments for themselves, prevent relapse, or pro-
mote appropriate behavior in therapy sessions
and in self-help meetings.
Treatment of people with BPD requires atten-
tion to several issues, such as violence to self or
others, transference and countertransference,
boundaries, treatment resistance, symptom
substitution, and somatic complaints.
Strategies, Tools, and
Techniques
Engagement
Safety is an anchor for clients with BPD, for
whom abandonment and fear of rejection often
are core issues. Counselors should recognize
that acting-out behavior common to people
with BPD is a maladaptive survivor response
that expresses a need for safety. Indeed, the
client’s primary motivation for treatment may
be a desire for safety. Therapists should discov-
er what safety means to the client. 
Soon after entering into a therapeutic alliance,
the reliability of the counselor can have strong
symbolic importance to the client and the
strengthening of the relationship between client
and counselor. Showing up on time, being there
throughout the time period expected, and not
allowing interruptions can have a strong and
positive effect on the client and the client’s
response to treatment. Alternatively, disrup-
tions in the sense of the counselor’s reliability
and trust can have negative fallout. Even what
might seem to the counselor to be a minor event
can be a blow to a client’s shaky emotional
state and interfere with the client–counselor
relationship. The therapist’s absence, even for
brief periods, can prompt acting-out behavior.
Therapists can learn how clients create their
own feelings of safety by asking them about
safe spots, magic getaway places, closet-sitting,
rocking or other repetitive movements, or
other techniques the client may use to generate
a sense of security. To help clients with BPD
establish and maintain a sense of safety, coun-
selors regularly should ask clients: “What do
you need right now?” “What do you want right
now?” Counselors can also help clients to
develop a list of the conditions that they need
to feel safe. Counselors might ask clients,
“What would have been helpful (in a specific
situation) to make you feel safe?” Through
teaching cognitive skills to promote a client’s
sense of safety, counselors can help clients with
BPD assume personal responsibility for their
own safety. (See TIP 36, chapter 4, for a com-
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Key Issues and Concerns in
the Treatment of Borderline
Personality Disorders
• Slow progress in therapy
• Suicidal behavior
• Self-injury or harming behavior
• Client contracting
• Transference and countertransference
• Clear boundaries
• Resistance
• Subacute withdrawal
• Symptom substitution
• Somatic complaints
• Therapist well-being
plete discussion about counseling issues related
to those clients with BPD and a history of
childhood trauma [CSAT 2000d].)
Written and verbal contracts can identify spe-
cific ways to help clients stay safe physically
and emotionally and to prevent relapse.
Contracts for safety should be developed dur-
ing the assessment process with simple and
clear behavioral responses regarding the man-
agement of unsafe feelings and behaviors.
These contracts can be very simple and direct:
• “If I feel like I want to get drunk, I will call
my sponsor.”
• “If I feel like getting high, I will go to the next
NA meeting.”
• “If I feel like hurting myself, I will call a cri-
sis hotline and go to my sister’s house.”
• “I will report self-harm thoughts and behav-
iors to the therapist at the next session.”
A discrepancy between the client and his or her
clinical record or other source of information
can reflect the client’s inclination to deny, mini-
mize, or hide what the service provider is try-
ing to diagnose. Similarly, few addicted individ-
uals come into an assessment and treatment
planning session prepared to make a full disclo-
sure of their patterns of substance use and the
harm that results
from such use.
Similarly, few indi-
viduals with BPD
acknowledge their
maladaptive and
provocative behav-
iors. Both disorders
are misrepresented
by client self-report
and involve the
client’s insistence
that the real prob-
lem lies elsewhere,
usually in how they
are being treated by
others. Diagnosis
and understanding
of both disorders
must come from observation, interpretation,
extrapolation, information from objective
instruments (e.g., assessment tools, urinalysis),
and outside sources (e.g., family).
Screening and assessment 
Gathering historical information affords an
opportunity to examine a client’s strengths and
weaknesses, which are especially important for
clients with BPD. When things are going well,
clients with BPD might have exceptional skills
in various areas. Consequently, a discussion of
what the client sees as weaknesses can be
revealing. Any history of psychotic-like think-
ing that occurred under intense stress or that
was drug-related should be noted. For exam-
ple, a client may state, “I really believed the
walls were bleeding.”
The assessment of clients with BPD should elic-
it any history of self-harm, which is common
among these clients. It is important to explore
when and how such episodes, if any, occurred.
Specifically, determine what is remembered
about the period of time before, during, and
after any episodes of self-harm. A list of poten-
tial means available to clients to injure them-
selves in their own homes, such as a large sup-
ply of medication, warrants review for clients
with BPD who have any history of self-harm.
Assessment also should establish any history or
evidence of dissociative experiences, such as
trance states, rocking, flashbacks, or night-
mares. Anniversary reactions also are common
to survivors of abuse, whose memories or feel-
ings may be triggered by certain dates, events,
or objects. For no apparent reason, the sur-
vivor may become sick or suicidal when faced
with a situation similar to a past reminder of
abuse. The history of fugue states and losing
time may also be significant. For example,
clients with BPD might start watching a movie
and suddenly reorient later in the middle of
another movie, with no clear memory of the
elapsed time.
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Progress with
clients who have
BPD can be slow,
and therapists
should be realistic
in their 
expectations.
Crisis stabilization
Safety issues are at the core of crisis stabiliza-
tion. To ensure the client’s safety or to detoxi-
fy a client, a brief psychiatric hospitalization
may be necessary. Issues to be addressed dur-
ing crisis stabilization might include an unwill-
ingness or inability to contract for safety. A
written release of medical information is
important to coordinate care with physicians
and substance abuse treatment counselors.
At this stage, counselors should avoid psycho-
dynamic confrontations with clients and
should not engage clients in further therapy
for abuse or trauma. The treatment focus
should be on addressing the client’s need for
safety, which is especially important with
clients who have BPD. More complicated and
emotionally charged material should be
deferred until the client has better skills to
manage emotional pain.
It may be helpful to describe out-of-control
crisis behavior as a survivor response.
Counselors and clients should avoid rigid
black-or-white thinking. For example,
describing events or issues as being more or
less helpful may circumvent the inflexibility of
seeing life’s challenges and problems only as
good or bad, while ignoring the numerous
gray areas of experience.
The family should take part in this process. It
may be useful to encourage written and verbal
contracts with family members. These con-
tracts can dissuade family members from
assuming dysfunctional roles such as the vic-
tim, the persecutor, and the rescuer. The fam-
ily should learn how to set boundaries with
the client and avoid playing certain roles,
especially that of rescuer. 
Short-term care and 
treatment 
Theorists and clinicians with expertise in PDs
agree that BPD requires long-term, compre-
hensive, integrated treatment. 
Recommendations for the early stages of treat-
ment include developing “skills for managing
negative emotions and memories, such as deep
breathing, using time-outs, and centering
through the senses” (Sullivan and Evans 1994,
p. 374), focusing on emotional regulation,
enhancing motivation, discussing what inter-
feres with treatment (Dimeff et al. 1998), and
carefully considering all medication issues
(including the possible genuine need for assis-
tance with pain control through medication or
other techniques).
Group therapy
There are particular issues of concern when
working with people with BPD in group thera-
py. Since group counseling regularly begins
early in treatment, counselors should consider
the following group-related issues in both short-
and long-term treatment:
• Making contracts for all members to stay in
the room.
• Making contracts for group rules that pro-
mote safe behavior.
• Discussing thoughts and feelings about other
group members as they arise.
• Mentioning the time limits at the start of each
session.
• Making mini-contracts for those who have
issues to work on in each session.
• Having group members sign contracts for
abstinence and reporting self-harm and sub-
stance use to the group.
• Making contracts for confidentiality.2
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2Confidentiality is governed by the Federal “Confidentiality of Alcohol and Drug Abuse Patient Records” regulations (42
C.F.R. Part 2) and the Federal “Standards for Privacy of Individually Identifiable Health Information” (45 C.F.R.
Parts 160 and 164).
• Disallowing participants to form intimate or
exclusive relationships with one another.
Supportive activities, such as calling one
another during crises or attending 12-Step
meetings together, are acceptable and should
be encouraged.
• Evaluating safety issues in screening people
with BPD for group therapy. Clients should
be safe from the predatory, manipulative
behavior of others, and should not engage in
such behaviors themselves.
• Promoting same-sex groups.
Longer term care
Individual counseling, continuing group thera-
py, 12-Step participation, and continuum of
care components are the major forms of inter-
vention for comprehensive treatment of clients
with BPD. Dimeff et al. (1998) recommend that
individual and group counseling concentrate on
the development of new skills, balancing tolera-
tion of distress with how to change life circum-
stances (what they see as a “dialectical” inter-
play of the opposites of an emphasis on change
and an emphasis on acceptance of things as
they are), and targeting specific areas where
control is lacking, such as impulsivity or suici-
dality.
People with BPD may benefit from skills devel-
opment in anger management (Reilly et al.
1994). Linehan and colleagues’ (1999) dialecti-
cal behavior therapy (DBT) solidly intertwines
group counseling with the unique DBT termi-
nology and therapeutic strategies. Linehan and
her colleagues offer 2-day workshops that train
counselors to use their skills training tech-
niques in leading group counseling for clients
with BPD and substance use disorders. 
Individual counseling 
Issues stemming both from BPD and substance
use may emerge in individual therapy. Issues
related to unsafe behavior or substance use will
continue to be important. Longer term care is a
stage in which teaching the client skills such as
assertiveness and boundary setting can be useful.
There is no pressing need for the discussion of
early memories; rather the focus of therapy
should be on behavior (Sullivan and Evans
1994). Complications at this stage can include a
variety of compulsive and impulsive behaviors,
such as eating disorders (obesity, anorexia,
bulimia), compulsive spending and money mis-
management, relationship problems, inappro-
priate sexual behaviors, and unprotected sex
(in regard to sexually transmitted diseases and
pregnancy). Other maladaptive behaviors
include sexual impulsiveness, which can cause
confusion about sexual identity dramatized in
experimental sexual relationships, adding to
the crisis and drama to which people with BPD
often seem drawn.
Counselors may want to avoid educational
material about adult children of alcoholics or
general self-help books for clients with BPD, as
reading such material may be detrimental to
some clients’ recovery. For some clients, self-
labeling can become counterproductive and in
worst-case scenarios, it can lead to self-fulfill-
ing prophecies. For example, books suggesting
that some people self-mutilate in order to
relieve pain may teach clients with BPD to self-
mutilate. Some books offering “inner-child
work” lead the client through age-regressive
exercises that can cause an overwhelming flood
of feelings the abused client may not yet be
ready to manage.
Counselors should remember that progress in
treating clients with BPD and substance abuse
problems may be slow and may have many set-
backs. Rather than looking for enormous
changes in personality or behavior, counselors
should look for small, observable signs of
improvement.
In addition, counselors may want to consider
the following in treating clients with BPD:
• Use mini-contracts for each session to
encourage the client to stay focused.
• Immediately ask clients about any crises that
have occurred and review the entire week,
not just a particular day.
• State the purpose of each session.
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• Run through a checklist that might include
homework, failing tests, arguments with oth-
ers, interactions with the criminal justice sys-
tem, problems in school or work life, family
relationships and friends, relapses, thoughts
of self-harm, nightmares, flashbacks, painful
situations, and bad memories. Questions
should be specific.
• Keep and date all correspondence and notes
from telephone conversations. Documenting
conversations can help remind the client of
earlier agreements and conversations.
Mutual self-help group 
participation
Although mutual self-help groups can be
important for clients with BPD, some may not
be able to attend them right away. Some indi-
viduals with BPD may find it helpful to partici-
pate in self-help group practice sessions. For
example, for clients planning to attend a 12-
Step meeting, they should be helped to organize
their thoughts, to practice saying their name or
“pass” for their first few 12-Step meetings.
Counselors may want to use the step work
handout (see Figure D-7, p. 360) as a treatment
tool for working with people with BPD (see
chapter 7 on the use of 12-Step programs and
the use of other mutual support meetings).
Other mutual self-help groups would require
their own types of preparation.
Because of their problems with intimacy and
trauma, and their own impulsiveness, clients
with BPD should be encouraged to join same-
sex mutual self-help groups when possible.
People with BPD may find it helpful to use
same-sex sponsors as guides to recovery. When
possible, counselors should educate the sponsor
about survivor behaviors. Since antidepres-
sants or lithium may be an important part of
the client’s recovery, the sponsor might attend
a counseling session to learn why the client is
taking medications. Explaining how medica-
tions are helpful can enable sponsors to help
improve medication compliance. 
Sponsors who have problems setting bound-
aries or become overly angry when doing so
should not be paired with clients with BPD. If
such pairing does
occur, the sponsor
needs to understand
how important
boundaries are to
help clients with BPD
feel safe. Under-
standing this may
keep them from tak-
ing on those with
BPD, who may be
more than the spon-
sor can handle.
Material in the step
program should be
limited to the here-
and-now. As previous-
ly stated, clients with
BPD should not be
asked to address sexu-
al abuse issues until they are ready.
Longer term care should include specialized 12-
Step work. In using step one (“We admitted we
were powerless over alcohol/our addiction, that
our lives had become unmanageable”) with
clients who have BPD, counselors should
encourage clients to recognize that “powerless-
ness” does not mean “helplessness.” Instead,
clients should focus on gaining personal control
over the tools for recovery. Faith and hope
concepts used in 12-Step work may also be dif-
ficult for this group to comprehend or inte-
grate.
Figure D-7 shows a recovery model for treat-
ment of BPD.
Antisocial Personality
Disorder
Description
The essential diagnostic feature of APD is the
pervasive disregard for and violation of the
rights of others. Since most clients who are
actively using substances display behaviors at
one time or another that show disregard for the
rights of others, it is not surprising that the dis-
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Issues stemming
both from BPD
and substance use
may emerge in
individual 
therapy.
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Figure D-7
Step Work Handout for Clients With BPD
Step One: “We admitted we were powerless over alcohol, that our lives had become unmanageable.”
• Describe five situations where you suffered negative consequences as a result of drinking or using other
drugs.
• List at least five “rules” that you have developed to try to control your use of alcohol or other drugs.
(Example: “I never drink alone.”)
• Give one example describing how and when you broke each rule.
• Check the following that apply to you:
___ I sometimes drink or use drugs more than I plan.
___ I sometimes lie about my use of alcohol or drugs.
___ I have hidden or stashed away alcohol or drugs so I could use them alone or at a later time.
___ I have had memory losses when drinking or using drugs.
___ I have tried to hurt myself when drinking or using drugs.
___ I can drink or use more than I used to, without feeling drunk or high.
___ My personality changes when I drink or use drugs.
___ I have school or work problems related to using alcohol or drugs.
___ I have family problems related to my use of alcohol or drugs.
___ I have legal problems related to my use of alcohol or drugs.
• Give two examples for each item that you checked.
Step Two: “We came to believe that a Power greater than ourselves could restore us to sanity.”
• Give three examples of how your drinking or use of drugs was “insane.” (One definition of insanity is to keep
repeating the same mistake and expecting a different outcome.)
• Check which of the following mistakes or thinking errors that you use:
___ Blaming
___ Lying
___ Manipulating
___ Excuse making
___ Beating up yourself with “I should have” statements
___ Self-mutilation (cutting on yourself when angry)
___ Negative self-talk
___ Using angry behavior to control others
___ Thinking “I’m unique”
• Explain how each thinking error you checked above is harmful to you and others.
• Give two examples of something that has happened since you stopped drinking or using drugs that shows 
you how your situation is improving.
• Who or what is your Higher Power?
• Why do you think your Higher Power can be helpful to you?
tinction between addictive diseases and APD
has been a difficult one for both the mental
health and the substance abuse treatment
fields.
Individuals with APD exhibit signs of antisocial
behavior from 15 to 18 years of age, such as
unlawful behavior, deceitfulness, consistent
irresponsibility, and lack of remorse. Often
there is evidence of similar behaviors even
before the person turns 15. When antisocial
behavior occurs without any signs of it during
adolescence, the DSM-IV diagnosis is Adult
Antisocial Behavior to distinguish the person
who engages in such behaviors after 18 years of
age—perhaps because of an alcohol-induced
state or the development of substance depen-
dency—from someone with a genuine APD. It
is now widely recognized that “...although
many delinquent youth abuse alcohol as part of
their antisocial behavior, and some become
alcoholic, the majority of alcoholics are not
sociopathic except as a result of their addic-
tion” (Vaillant 1995, p. 88).
One stigmatizing aspect of having a co-occur-
ring APD is that the history of the terms socio-
pathic, psychopathic, and antisocial carry
extremely negative connotations that might well
be accurate in only a small percentage of those
people with substance use disorders and a cur-
rent DSM-IV-TR diagnosis of APD. Hare
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Figure D-7 (continued)
Step Work Handout for Clients With BPD
Step Three: “We made a decision to turn our will and our lives over to the care of God as we understood Him.”
• Explain how and why you decided to turn your will over to a Higher Power.
• Give two examples of things or situations you have “turned over” in the last week.
• List two current resentments you have, and explain why it is important for you to turn them over to your
Higher Power.
• How do you go about “turning over” a resentment?
• What does it mean to turn your will and life over to your Higher Power?
• Explain how and why you have turned your will and life over to a Power greater than yourself
Step Four: “We made a searching and fearless moral inventory of ourselves.”
• List five things you like about yourself.
• Give five examples of situations where you have been helpful to others.
• Give three examples of sexual behaviors related to your drinking or use of other drugs, which have occurred
in the last 5 years, about which you feel bad.
• Describe how beating yourself up for old drinking and drug-using behaviors is not helpful to you now.
• List five current resentments you have, and explain how holding on to these resentments hurts your recov-
ery.
• List all laws you have broken related to your drinking and use of other drugs.
• List three new behaviors you have learned that are helpful to your recovery.
• List all current fears you are experiencing, and discuss how working the first three Steps can help dissolve
them.
• Give an example of a current situation you are handling poorly.
• Discuss how you plan to handle this situation differently the next time the situation arises.
Source: Adapted with permission from Evans and Sullivan 1990. 
(1998) differentiates
between more severe
cases of APD by
using the term psy-
chopaths, or
“predators who use
charm, manipula-
tion, intimidation,
and violence to con-
trol others and to
satisfy their own
needs” (p. 104).
Hare is careful to
point out that prob-
ably only 1 percent
of the general popu-
lation can be classi-
fied as psychopaths
according to his cri-
teria and that most people with antisocial per-
sonality disorder are not psychopaths.
Consequently, the number of individuals with
both a co-occurring substance use disorder and
psychopathy is quite small, and substance
abuse treatment counselors are unlikely to see
such clients outside of criminal justice settings
(Hare 1998; Windle 1999). (See also the forth-
coming TIP Substance Abuse Treatment for
Adults in the Criminal Justice System [CSAT in
development e] for a full discussion of psy-
chopathy and its relationship to APD.)
More men than women are diagnosed with
APD, although some women with APD may be
misdiagnosed as BPD. Determining the type
and extent of antisocial symptoms for women is
not easy (Rutherford et al. 1999), but it is
important because of the high prevalence of
neglectful parenting in women with substance
use disorders and APD (Goldstein et al. 1999).
Substance Use Among People
With APD
Many people with APD use substances in a
polydrug pattern involving alcohol, marijuana,
heroin, cocaine, and methamphetamine. The
illicit drug culture can correspond with their
view of the world as fast-paced and dramatic,
which supports their need for a heightened self-
image. Consequently, they may be involved in
crime and other sensation-seeking, high-risk
behavior. Some may have extreme antisocial
symptoms—for example, rapists with severe
APD may use alcohol to justify conquest, and
the small number of these individuals might
warrant Hare’s designation as psychopaths.
APD appears to be a failure to attach. The
people with this diagnosis appear deficient in
their ability to experience shared or reciprocal
emotions such as guilt or love. Individuals with
APD disdain society’s rules; they know right
from wrong but they do not care. They may be
excited by the illicit drug culture and may have
considerable pride in their ability to thrive in
the face of the dangers of that culture. They
are often in trouble with the law. If they are
more effective, they may limit themselves to
exploitive or manipulative behavior that does
not make them so vulnerable to spending time
in jail.
Key Issues and Concerns
As with co-occurring disorders in general, indi-
viduals with both a substance use disorder and
APD have been perceived as exceptionally hard
to treat, having poor prognoses, and warrant-
ing exclusion from treatment programs and/or
group counseling.
These negative stereotypes do not hold up well
on examination (Messina et al. 1999). It is true
that as a group substance abuse clients with
APD do worse than substance abuse clients
who do not have APD. Indeed, many articles
begin by correctly describing clients with both
disorders as having a “worse” response to
treatment or a “poor prognosis.” Nonetheless,
research suggests that clients with APD and
substance use disorders can and do respond to
treatment. Seivewright and Daly (1997) note
that clients with APD “progress reasonably sat-
isfactorily in methadone maintenance” (p.
247), and Vaillant (1995) found in his longitudi-
nal study that after 10 to 15 years, 48 percent
of men from an inner-city environment who
had been classified as both alcoholic and socio-
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The substance abuse
treatment system
encounters many
people with APD
and has developed
effective treatment
methods for them.
pathic were abstinent. This is about the same
percentage as an advantaged comparison group
of college men without APD and a significantly
higher percentage than the rate of 28 percent
found in an inner city group of men who
abused alcohol but did not have APD. 
The substance abuse treatment system encoun-
ters many individuals with substance abuse and
APD and has developed effective treatment
methods for clients with this mental disorder.
Key issues and concerns in the treatment of
people with APD include
• Countertransference and transference
• Counselor/therapist well-being
• Resistance
• Contracting
Countertransference and
transference
In working with clients with APD, counter-
transference issues might be of equal or greater
concern than transference issues. That is,
although it is usually of more clinical concern
how the client reacts to, interprets, and misin-
terprets the counselor, when working with
clients with APD, it is also important how the
counselor reacts to, interprets, or misinterprets
the client. Some clients with APD can be fright-
ening to work with; some engage in behaviors
that counselors may reject as criminal and
antisocial; a few have histories of acts that
counselors may abhor. Counselors should be
wary of those clients with APD who can be
charming and underhanded. The reactions of
counselors to working with clients with APD in
general, and each specific client with APD in
particular, requires regular self-examination
and supervision. (Again, the reader is referred
to chapter 4 of TIP 36 [CSAT 2000d].)
Counselor well-being
Counselor well-being is critical for counselors
serving individuals with substance use disor-
ders and APD; counselors who are not provid-
ed with an environment that supports a sense
of well-being are subject to burnout. A sense of
well-being can be fostered by the availability of
supervision, the coordination of duties in a
team structure, and a clear understanding of
roles and responsibilities for standard and cri-
sis situations.
Carlson and Baker (1998) report briefly on
efforts at the Portland Veterans Affairs Medical
Center to establish a system to assist staff and
improve care when managing clients who are
dangerous, difficult, demanding, or drug-seek-
ing. They describe a coordinated and focused
approach with multidisciplinary meetings of
administrators, clinicians, and others that
serve to support consistent and systemwide
methods of handling these types of situations.
In examining 36 consecutive cases under the
system, they noted that the 36 individuals com-
mitted 47 incidents of violence during the year
prior to the implementation of their program,
whereas the number of incidents dropped to 4
in the year following implementation.
Moreover, their evaluations documented
increased staff morale and confidence.
Although not specifically targeting clients with
substance use disorders and APD, their coordi-
nated, top-to-bottom system for team-handling
such stressful client–staff interactions is appli-
cable to these clients.
Resistance
Clients with APD are often said to “act out”
tension or conflict. Behaviors that interfere
with treatment, which might even result in a
client being sent immediately to jail, are seen
by therapists as a form of resistance to whatev-
er happens to be the focus of therapy at the
time. Substance abuse treatment counselors
working with clients with APD often sense
resistance to substance abuse treatment and its
goals. The counselor should not buy into this
negative or pessimistic outlook. Instead, coun-
selors can focus on how much better the client’s
life will be with successful treatment, and
explain to the client that treatment can succeed
without the client’s complete commitment at the
beginning.
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It can be hard for a counselor not to blame the
client for failing to seek a better life and better
behavior. Counselors who fall into this counter-
transference reaction expect that the client sim-
ply has a choice he fails to make. Interestingly,
some research (Raine et al. 2000) shows lower
prefrontal gray matter volumes in clients with
APD (compared to healthy controls, individu-
als with substance dependence, and other men-
tal disorders). Thus, the extent of actual con-
trol clients with APD have over their responses
and resistance might well be less than others
due to this physiological deficit. 
Contracting
Contracting is essential in working with clients
with APD. Without contracts and clear expec-
tations of what is to be done, when, how, and
the consequences of failing to comply, the ther-
apeutic relationship can become a constant
argument about why something was not done
and why it is unfair to be punished for an
infraction or omission. As a general rule, when
working with individuals with substance use
disorders and APD, it is advised to put every-
thing into writing. 
Strategies, Tools, and
Techniques
Engagement
In engaging the client with APD, it is useful to
remain neutral toward the client’s world view,
which may include a need for control and a
sense of entitlement. In this context, entitle-
ment refers to people who believe their needs
are more important than the needs of others.
Entitlement may include rationalization of neg-
ative behavior (such as robbery or lying).
People with APD may evidence little empathy
for their victims. If incarcerated, they may
believe they should be released immediately. In
a substance abuse treatment program, they
may describe themselves as being unique and
requiring special treatment.
The primary motivation of the client with APD
is to be right and to be successful. It is useful to
work with this motivation, not against it.
Although this motivation may not reflect social-
ly acceptable reasons for changing behavior, it
does offer a point from which to begin treat-
ment. Wanting to be clean and sober, to keep a
job, to avoid jail, and to become the chair of an
Alcoholics Anonymous (AA) meeting are rea-
sonable goals, despite a self-serving appear-
ance. Counselors can help clients with APD by
working with clients’ world views, rather than
by trying to change their value systems to
match those of the therapist or of society. Of
course, in therapeutic communities the expec-
tation of eventually having a change in values
and in self is part and parcel of the structure of
the community, but early in a client’s treatment
those aspects of the program might well be kept
on the “back burner.”
Contracting is another effective strategy.
Contracts establish rules for conduct during
treatment and clarify the clients’ role in the
therapeutic process. The contract should state
explicitly all expectations and rules of conduct
and should be honored by all parties. Such an
approach can be useful with people with APD,
who often view relationships as unfair con-
tracts in which one person attempts to take
advantage of the other. Counselors may find
that once a level of interpersonal respect has
been established, working with antisocial
clients can lead to important gains for the
client.
Screening and assessment
In addition to an objective psychosocial and
criminal history, the following steps may be
useful in assessing the antisocial client:
• Taking a thorough family history.
• Finding out whether the client set fires as a
child, abused animals, or was a bed-wetter.
• Taking a thorough sexual history that
includes questions about animals and objects.
Asking about any unusual or out-of-the-ordi-
nary sexual experiences may serve as a lead-
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in and as a means to gauge how the client
responds to questions about such personal
areas.
• Taking a history of the client’s ability to bond
with others. Counselors can ask, “Who was
your first best friend?” “When was the last
time you saw him or her?” “Do you know
how he or she is?” “Is there any authority
figure who has ever been helpful to you?”
• Asking questions to find out about possible
parasitic relationships and taking a history of
exploitation of self and others. In this con-
text, parasitic refers to a relationship in
which one person uses and manipulates
another until the first has gotten everything
he or she wants, then abandons the relation-
ship.
• Taking a history of head injuries, fighting,
and being hit. It may be useful to refer for
neuropsychological testing.
• Testing urine for recent substance use.
• HIV testing.
The assessment should consider criminal think-
ing patterns, such as rationalization and justifi-
cation for maladaptive behaviors. There is a
special need to establish collateral contacts and
to assess for criminal history and the relation-
ship of substance use to behavior. Useful
assessment instruments include
• The Minnesota Multiphasic Personality
Inventory - 2 (MMPI-2)
• The Millon Clinical Multiaxial Inventory
(MCMI), and Nadeau et al. 1999
• The PCL-R (Hare Psychopathy Checklist-
Revised), and the forthcoming TIP
Substance Abuse Treatment for Adults in the
Criminal Justice System (CSAT in develop-
ment e)
Crisis stabilization
People with APD may enter treatment pro-
foundly depressed, feeling that all systems have
failed them. Often, their scams and lofty ideas
have failed. They feel exposed and have no ego
strength. They are at risk for suicide, especial-
ly during intoxication or acute withdrawal, and
may require psychiatric hospitalization and
detoxification. Containment in the form of a
brief hospitalization may be indicated for
clients experiencing acute paranoid reactions to
avoid acting out against others. When paranoid
reactions are less acute, counselors should
avoid cornering clients, disengage from any
power struggle, offer lower stimulus levels, and
explore options, especially those suggested by
the client. During this phase, clarification with-
out harsh confrontation is recommended. 
Counselors should be especially cautious when
working with APD clients in crisis. These
clients may engage in dangerous physical
behavior to avoid unpleasant situations or
activities. Counselors are advised avoid angry
confrontations.
Short-term care and 
treatment
O’Connell (1998, pp. 123–124), acknowledging
the historical contributions of Doren (1987)
and Barley (1986), advises counselors to be
prepared to be “amused by these clients, out-
raged by their lack of conscience, intrigued
with the glamour of their high-risk lifestyle, or
flattered by their praise of the therapist’s skills
and knowledge ...
excessively fascinated
by the course of ther-
apy.” He recommends
developing strategies
to (1) get reliable
information from oth-
ers to counter misrep-
resentation of facts,
(2) avoid being
manipulated or hav-
ing any intense inter-
est in any of the
client’s escapades or
old war stories, and
(3) confront intimida-
tion, criticism, and
flattery through
supervision and/or a
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In engaging the
client with APD, it
is useful to remain
neutral toward the
client’s world view.
team approach. Confronting antisocial behav-
ior and its relationship to substance use is, of
course, an ever-present part of treating clients
with substance use disorders and APD.
Group therapy
In group therapy, clients with APD can learn
to identify errors not only in their own thinking
but in the thinking of others, as well as think-
ing that makes them vulnerable to relapse. For
example, when an individual begins to glamor-
ize stories of substance use or criminal and act-
ing-out behaviors, the group can help to limit
that grandiosity. Counselors may also ask peo-
ple with APD to discuss feelings associated with
the behavior being glamorized.
Clients with APD may be asked to sign con-
tracts that establish healthy and nonparasitic
relationships with other group members. This
means not becoming romantically involved with
other members, not borrowing money from
them, and not developing exploitive relation-
ships. Role-play exercises can be useful tools in
group counseling; however, counselors should
be careful to prevent clients with APD from
using newly learned skills to exploit or control
other group members. In group therapy, clients
with APD can be encouraged to model proso-
cial behaviors and to learn by practicing them.
Role-play exercises can help these clients focus
on their own shortcomings rather than on the
faults of others.
Greene and McVinney (1997) describe anger,
group cohesion, dependency/counterdependen-
cy, and overdeveloped/underdeveloped strate-
gies as significant areas requiring the coun-
selor’s attention when running outpatient
groups for male clients with Cluster B person-
ality disorders and chemical dependency. They
emphasize the importance of interrupting anger
and hostility early in group formation by
encouraging the clients to “talk through the
therapist” rather than directly to each other,
and by having members learn to monitor trig-
gers and understand why some behaviors elicit
a hostile response. Group cohesion can be
threatened unless clients with PD also have
individual counseling that helps them manage
their reactions to the group and group mem-
bership. For clients with APD, issues related to
dependency and counterdependency are likely
to be long-term group issues, and group work
will focus on overdeveloped combativeness,
exploitiveness, and predation and underdevel-
oped strategies of empathy, reciprocity, and
social sensitivity. Many theorists and clinicians
employ cognitive–behavioral and “reality ther-
apy” orientations for clients with APD, both
with and without substance use disorders.
Fisher (1995) offers an outline of Group
Leadership Actions for a 4-week, 15-session
cognitive–behavioral therapy group for clients
with substance use disorders and APD.
Longer term care
Individual counseling
It is helpful to view working with clients with
APD as a process of adaptation of thinking,
rather than the restructuring of a client into a
person whose morals and values match those of
the therapist or society. Counselors may benefit
from modifying their own expectations of treat-
ment outcomes, realizing that they may not be
able to help certain clients develop empathic
and loving personalities—it is enough to guide
clients to lead lives that follow society’s rules.
Figure D-8 offers tips for counseling clients
with APD.
Individual counseling offers the counselor an
opportunity to point out clients’ errors in
thinking without causing them to feel humiliat-
ed in the presence of the group. Other issues
for individual counseling may include contin-
ued relapse management and identity of empa-
thy. Three key words summarize a strategy for
working with people with APD: corral, con-
front, and consequences.
1. Corral. Corralling with regard to clients
with APD means coordinating treatment with
other professionals, establishing a system of
communications with other professionals and
with clients, contracting clients to be responsi-
ble for their substance use in the recovery pro-
gram, monitoring information about clients,
and working toward specific treatment goals.
366 Specific Mental Disorders: Additional Guidance for the Counselor
Clients may benefit by signing agreements to
comply with the treatment plan and by receiv-
ing written clarification of what is being done
and why. Interventions and interactions should
be linked to original treatment goals. One
approach to treatment that adds to the notion
of “corralling” is to “expand the system.”
Spouses, family members, friends, and treat-
ment professionals may be invited to partici-
pate in counseling sessions as a way to provide
collateral data. This is sometimes called “net-
work therapy.”
2. Confront. In confronting clients who are
antisocial, counselors can be direct and firm.
They can be clear in pointing out antisocial
thinking patterns. They can remark on contra-
dictions between what clients say and what
clients do. Random testing for substances is
essential for monitoring clients with APD.
Honest reporting of substance use should be an
active part of treatment.
3. Consequences. Clients should bear the
responsibility for the consequences of their
behavior. For instance, violation of probation or
rules should be recorded. Clients who are
offenders should be encouraged to report behav-
ior that violates probation, thus taking responsi-
bility for their own actions. Positive conse-
quences that demonstrate to clients the benefits
of appropriate behavior should also be designed
and incorporated into the treatment plan. 
Case management
Case management may involve coordinating
care with a variety of other professionals and
individuals, including those in the criminal jus-
tice system, mental health providers, and fami-
ly members. Clients need to understand that
the counselor must talk to other providers and
to family members. It is helpful for clients to
sign consents for the release of information for
all people involved in their treatment.
Terminating counseling
The question of terminating counseling can be
puzzling for counselors treating clients with
APD. Clients with APD frequently express a
desire to end treatment. This desire should be
closely examined to determine whether it is a
manifestation of client resistance or a valid
request. Reasons for termination on the coun-
selors’ part can include noncompliance with
treatment, continued drug use without
improvement, any aggressive behavior, para-
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Figure D-8
Counseling Tips for Clients With APD
Corral: • Coordinate treatment.
• Communicate with other providers.
• Make contracts with clients.
Confront: • Be direct and firm.
• Identify antisocial thinking.
• Conduct random substance testing.
Consequences: • Make clients responsible for their behavior.
• Record violations of rules.
• Allow clients to experience consequences of their behavior.
• Designate positive consequences for prosocial behavior.
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Figure D-9
Antisocial Thinking-Error Work
The group facilitator presents thinking errors and then asks each group member to identify two thinking-
error examples that apply to him or her and to choose one to focus on with the group’s help.
1. Excuse making. Excuses can be made for anything and everything. Excuses are a way to justify behavior.
For example: “I drink because my mother nags me,” “My family was poor,” “My family was rich.”
2. Blaming. Blaming is an excuse to avoid solving a problem and is used to excuse behavior and build up
resentment toward someone else for “causing” whatever has happened. For example: “They forced me to
drink it!”
3. Justifying. To justify an antisocial behavior is to find a reason to support it. For example: “If you can, I
can,” “I deserve to get high, I’ve been clean for 30 days.”
4. Redefining. Redefining is shifting the focus on an issue to avoid solving a problem. Redefining is used as a
power play to get the focus off the person in question. For example: “I didn’t violate my probation. The
language is confusing and the order is full of typos.”
5. Superoptimism. “I think; therefore it is.” Example: “I don’t have to go to AA. I can stay sober on my own.”
6. Lying. There are three basic kinds of lies: (1) lies of commission, or making things up that are simply not
true; (2) lies of omission, or saying partly what is true but leaving out major sections; and (3) lies of
assent, or pretending to agree with other people or approving of their ideas despite disagreement or hav-
ing no intention of supporting the idea.
7. “I’m unique.” Thinking one is special and that rules should not apply to oneself.
8. Ingratiating. Being nice to others, and going out of one’s way to act interested in other people, can be used
to try to control situations or get the focus off a problem. Also known as “apple polishing.”
9. Fragmented personality. Some people may attend church on Sunday, get drunk or loaded on Tuesday, and
then attend church again on Wednesday. They rarely consider the inconsistency between these behaviors.
They may feel that they have the right to do whatever they want and that their behaviors are justified.
10.Minimizing. Minimizing behavior and action by talking about it in such a way that it seems insignificant.
For example: “I only had one beer. Does that count as a relapse?”
11.Vagueness. This strategy is to be unclear and nonspecific to avoid being pinned down on any particular
issue. Vague words or phrases such as: “I more or less think so,” “I guess,” “Probably,” “Maybe,” “I
might,” “I’m not sure about this,” “It possibly was,” etc.
12.Power play. This strategy is to use power plays whenever one isn’t getting one’s way in a situation.
Examples include walking out of a room during a disagreement, threatening to call an attorney or to
report the group facilitator to higher-ups.
13.Victim playing. The victim player transacts with others to invite either criticism or rescue from those
around him.
14.Grandiosity. Grandiosity is minimizing or maximizing the significance of an issue, and it justifies not solv-
ing the problem. For example: “I was too scared to do anything else but sit,” “I’m the best there is, so no
one else can get in my way.”
15.Intellectualizing. Using an emotionally detached, data-gathering approach to avoid responsibility. For
example, when faced with a positive urine drug screen the client states, “When was the last time the labo-
ratory had its equipment calibrated?” or “What is the percentage of error in this testing procedure?”
Adapted with permission from Evans and Sullivan 1990.
sitic relationship with other clients, or any
unsafe behavior.
Breaking the rules
Clients with APD compulsively try to break
rules. If a treatment plan is not devised to work
with a person who wants to redefine rules, ter-
mination should be considered and transfer to
more appropriate care arranged.
Continuum of care
A key to treating people with APD is to be flexi-
ble within an array of containment interven-
tions. Counselors should have the ability to
move a client quickly from a less controlled
environment to a more controlled environment.
Clients benefit from sanctions that match the
degree of severity of behavior. Sanctions should
not be “punishments” but responses to the
need for containment and more intensive treat-
ment. Clients with APD need a range of treat-
ment and other services, from residential to
outpatient treatment, from vocational educa-
tion to participation in long-term relapse pre-
vention support groups, and from jail to 12-
Step programs.
Thinking-error work
Continued thinking-error work, as described in
Figure D-9, may help clients identify various
types of rationalizations that they may use
regarding their behaviors. Ball (1998) and Ball
and Young (2000) developed a 24-week manual
guided cognitive–behavioral approach for peo-
ple with substance use and PDs; research with
an opioid-dependent group is being supported
by NIDA.
Mood and Anxiety
Disorders
Description
Mood disturbance and anxiety are ever-present
features of many people in treatment for sub-
stance use disorders. A substance-abusing
lifestyle regularly brings with it great cause for
worries and sadness. Often, in recovery, these
negative feeling states are, in time, replaced
with hopefulness, a sense of renewal, and a
general level of well-being. Many substances
also cause mood and anxiety disorders through
biochemical changes that may be alleviated
when the client is no longer using. Sometimes,
however, clients have anxiety and/or mood dis-
orders that require treatment, both for their
resolution and to remove the threats to recov-
ery associated with these disorders.
Mood episodes
A mood episode is a cluster of symptoms that
occur together for a discrete period of time,
including
• Changes in appetite or weight, sleep, and
psychomotor activity. The individual may
report loss of interest in eating or may crave
foods such as sweets or carbohydrates; the
person may seem agitated or action may seem
slowed down—for example, slowed speech
and body movements. Frequently, the person
has difficulty sleeping or sleeps too much.
Waking up 90 minutes to 2 hours before
usual and being unable to go back to sleep
(“early morning awakening”) and difficulty
falling asleep are common manifestations of
sleep problems.
• Decreased energy. Sometimes the person also
reports decreased efficiency in performing
tasks.
• Feelings of worthlessness or guilt. The indi-
vidual may be preoccupied with past feelings
and dwell on personal defects, often with cog-
nitive distortion such as strong feelings of not
living up to her or his potential even though
the person has been very productive and oth-
ers think well of her or his work.
• Difficulty thinking, concentrating, or espe-
cially making decisions. Sometimes people
are easily distracted, have difficulty with
memory, or perform normally but feel that it
requires increased effort to do so.
• Recurrent thoughts of death, suicidal
ideations, and/or suicidal plans or attempts.
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Mood disorders
Bipolar I, bipolar II, and
cyclothymia
While Bipolar I and II are classified in the
DSM-IV as mood disorders, mania and bipolar
disorders are addressed in the next section on
schizophrenia and psychosis. The fundamental
difference diagnostically between bipolar I and
bipolar II disorders relates to whether the indi-
vidual has experienced a manic episode. If a
person has never experienced a manic episode,
but has both periods of major depression and
periods of at least 4 days of hypomanic states,
the diagnosis is one of bipolar II disorder.
Though seemingly minor, the difference carries
considerable prognostic value—people who
experience a true manic episode along with
alternating episodes of major depression have
an extremely high probability of having anoth-
er manic episode. Usually, the manic episode
will occur immediately before or immediately
after a major depressive episode (APA 2000).
Thus, what can seem to be a small diagnostic
matter can be significant, and in this case it is
likely that bipolar I and bipolar II represent
meaningfully distinct clinical entities.
Cyclothymic disorder is a mood disorder that
involves fluctuating moods from above normal
to below normal, but never has symptoms so
severe or persistent as to meet the diagnostic
criteria for a bipolar disorder. To be consid-
ered a disorder, the disturbance must reach a
level great enough to have a negative impact on
someone’s interpersonal or vocational life.
With a co-occurring substance use disorder, all
forms of mood disorders can worsen acutely
over the long run.
Major depression
Symptoms of major depression may occur at
mild or moderate levels of severity. Major
depression typically is experienced as a more
intense and acute depression, often with strong
physiological changes in appetite, sleep, energy
level, and ability to think, as well as excessive
feelings of worthlessness with possible suicidal
ideation or plans. Though two thirds of people
who experience a major depressive episode
recover fully (APA 2000), one third may recov-
er only partially and a number of individuals
develop a persistent major depressive disorder,
often meeting criteria for evidence of severe
and/or persistent mental illness. 
Severe depressive episodes can include psy-
chotic features, such as an auditory hallucina-
tion of a voice saying that the person is “horri-
ble,” a visual hallucination of a lost relative
mocking the person, or a delusion that one’s
internal body parts have rotted away.
However, most people who have a major
depressive episode do not exhibit psychotic
symptoms even when the depression is severe
(for more information see the next section on
schizophrenia and psychosis).
Chapter 8 contains a full description of the
characteristics of a Major Depressive Episode.
Dysthymia and generalized
anxiety disorder (GAD)
GAD and dysthymia are, respectively, preva-
lent anxiety and mood disorders. Both are per-
sistent disorders. GAD is characterized by at
least 6 months of persistent and excessive anxi-
ety and worry (APA 2000). Dysthymic disorder
“is characterized by a depressed mood for most
of the day, for more days than not, for at least
2 years” (APA 2000, p. 380). Dysthymic symp-
toms can include feelings of inadequacy, loss of
interest and social withdrawal, irritability,
excessive anger, and lethargy. At some time in
their lives 5 percent of people will have GAD
and 6 percent will have dysthymic disorder
(APA 2000). Consequently, substance abuse
counselors need to be alert to GAD or dys-
thymic disorder in their clients. The term anxi-
ety refers to the sensations of nervousness, ten-
sion, apprehension, and fear. In GAD there is
no specific focus to the anxiety—it is said to be
“free-floating.” Other common anxiety disor-
ders are panic disorder, specific phobia, and
social phobia; obsessive-compulsive disorder;
and PTSD and acute stress disorder.
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Anxiety disorders
Panic attack, panic disorder, specif-
ic phobia, and social phobia
A panic attack is a distinct period of intense
fear or discomfort that develops abruptly, usu-
ally reaching a crescendo within a few minutes
or less. Physical symptoms may include hyper-
ventilation, palpitations, trembling, sweating,
dizziness, hot flashes or chills, numbness or
tingling, and the sensation or fear of nausea or
choking. Psychological symptoms may include
depersonalization and derealization (feeling as
if things are not real) and fear of fainting,
dying, doing something uncontrolled, or losing
one’s mind.
A panic disorder consists of episodes of panic
attacks followed by a period of persistent fear
of the recurrence of more panic attacks.
Sometimes panic attacks are associated with
fears of going places where rapid exit would be
difficult or embarrassing, such as over bridges,
in airplanes, or in stores or markets. When the
focus of anxiety is an activity, person, or situa-
tion that is dreaded, feared, and probably
avoided, the anxiety disorder is called a pho-
bia. Panic disorders often are underdiagnosed
at the beginning of treatment, or else are seen
as secondary to the more significant disorders,
which are the primary focus of treatment.
However, panic disorders can impede signifi-
cantly a person’s ability to do the tasks of
recovery, such as getting on a bus to go to a
meeting or sitting in a 12-Step meeting.
Sometimes these can erroneously be identified
as manipulative or treatment-resistant behav-
iors.
Phobia-inspired avoidance behavior, with its
associated travel and activity restrictions, may
become intense and incapacitating. The pho-
bias include agoraphobia, social phobia, and
simple or specific phobia; panic attacks and
panic disorders often are involved, but not nec-
essarily. Specific phobia, also called single or
simple phobia, describes the onset of intense,
excessive, or unreasonable fear stimulated by
the presence or anticipation of a specific object
or situation. The causes may be naturally
occurring (e.g., animals, insects, thunder,
water), situational (such as heights or riding in
elevators), or related to receiving injections or
giving blood. Social phobia describes the per-
sistent and recognizably irrational fear of
embarrassment and humiliation in social situa-
tions. The social phobia may be quite specific
(e.g., public speaking) or may become general-
ized to all social situations.
Though panic disor-
ders, phobias, and
social phobias may
seem relatively
straightforward, they
are quite complex, as
they often are histori-
cally intertwined for
each and every per-
son. For example, the
client who says he or
she is “claustropho-
bic” and fears getting
into an elevator may
have had a few panic
attacks 20 years
beforehand, has suc-
cessfully avoided
going into any eleva-
tors in the past 2
decades, and may barely remember the panic
symptoms associated with the original reaction
to elevators that led to the avoidant behavior.
There is considerable evidence that both non-
medication behavioral approaches and medica-
tions can be useful, either alone or in combina-
tion in the treatment of these mental disorders.
Obsessive-compulsive disorder
(OCD)
OCD is an anxiety disorder involving obses-
sions or compulsive rituals, or both. Obsessions
are repetitive and intrusive thoughts, impulses,
or images that cause marked anxiety. They
often involve transgressing social norms, harm-
ing others, and becoming contaminated, but
they are more intense than excessive worries
about real problems. Compulsions are repeti-
tive rituals and acts that people are driven to
perform and which they perform reluctantly to
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Mood disturbances
and anxiety are
ever-present
features of many
people in
substance abuse
treatment.
prevent or reduce distress. The frequency and
duration of their repetition make them incon-
venient and often incapacitating. Examples
include ritualistic behaviors (such as hand
washing and rechecking) and mental acts (e.g.,
counting and repeating words silently).
Obsessions are often time consuming and inter-
fere significantly with daily functioning.
PTSD and acute stress disorder
Although PTSD is one of the anxiety disorders
and many of the possible symptoms of PTSD
are anxiety-like symptoms, PTSD has been
identified as so prevalent in populations with
COD that it is described in full in the following
section. There is only a diagnostic difference
between PTSD and acute stress disorder in
that PTSD cannot be diagnosed until and
unless a person experiences the symptoms for a
month; therefore, if the symptoms last less than
1 month or it has been less than 1 month since
the traumatic event, then acute stress disorder
rather than PTSD would be diagnosed.
Except for these timeframe criteria, the symp-
toms of acute stress disorder that follow a trau-
matic event are, by and large, the same types of
symptoms as PTSD. The client may have a
subjective sense of “being in a daze” with emo-
tional detachment, inability to recall aspects of
the event, feeling as if things are not real (dere-
alization), feeling that one is not oneself or dis-
connected from feeling oneself (depersonaliza-
tion). The client may also report the phenome-
na of re-experiencing the event, avoidant
behavior, increased arousal, distress, and
interference with functioning. See the section
on PTSD for a thorough description.
Differential Diagnosis
It comes as no surprise to the substance abuse
treatment counselor that licit and illicit drugs
of abuse cause symptoms that are identical to
the depression and anxiety symptoms that have
been discussed. In addition, many medications,
toxins, and medical procedures can cause or
are associated with an eruption of an anxiety
and/or depressive reaction. Moreover, these
reactions run the gamut from mild manifesta-
tions of short-lived symptoms to full-blown
manic and other psychotic reactions, which are
not necessarily short-lived.
For substance abuse counselors and clinicians,
the role of personality, preexisting mood state,
personal expectations, drug dosage, and envi-
ronmental surroundings all warrant considera-
tion in developing an understanding of how a
particular client might experience a substance-
induced disorder. While many people with sub-
stance use disorders will experience sensory
and perceptual distortions, some will experi-
ence euphoric religious or spiritual states that
may resemble aspects of a manic or psychotic
episode. Others may have a deeply troubling
introspective experience, causing symptoms of
depression. Some may have a positive experi-
ence that they seek to repeat.
Diagnostic process
Diagnoses of mental disorders should be provi-
sional and reevaluated constantly. Many
apparent mental disorders are really sub-
stance-induced disorders that are caused by
substance use. Treatment of the substance use
disorder and an abstinent period of weeks or
months may be required for a definitive diag-
nosis of an independent, co-occurring mental
disorder. As described in chapter 4 on assess-
ment, substance abuse treatment programs and
clinical staff can concentrate on screening for
mental disorders and determining the severity
and acuity of symptoms, along with an under-
standing of the client’s support network and
overall life situation.
Anxiety and mood distur-
bance in other disorders
Anxiety and mood disturbance, often a regular
part of the life of people with substance use dis-
orders, are common, ubiquitous components of
almost all mental disorders. People with
schizophrenia or PDs, for example, typically
experience ups and downs in anxiety, as well as
waxing and waning of mood disturbance.
Therefore, not only is it difficult to tell when
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someone enters substance abuse treatment
whether the person has a co-occurring mood or
anxiety disorder that is separate from the sub-
stance use disorder, it is also hard to determine
whether the symptoms of mood or anxiety dis-
orders are part of the manifestations of anoth-
er mental disorder or constitute a separate dis-
order.
Many psychiatric conditions can mimic mood
disorders. Disorders that can complicate diag-
nosis include schizophrenia, brief reactive psy-
chosis, and anxiety disorders. Clients with
PDs, especially of the borderline, narcissistic,
and antisocial types, frequently manifest symp-
toms of mood disorders. These symptoms often
are fluid and may not meet the diagnostic crite-
rion of persistence over time. In addition, all of
the mental disorders noted here can coexist
with substance use and mood disorders.
To make the initial evaluative situation even
more challenging, discriminating between an
acute anxiety disorder and an acute mood dis-
order can be difficult. Of course, where severe
and acute symptoms exist, treatment personnel
move ahead with treatment for all the present-
ing problems while awaiting the ultimate reso-
lution over time of the diagnostic specifics. As
noted in chapter 4, this is a major reason to
repeat screening and assessment periodically as
recovery proceeds.
Anxiety and mood distur-
bances versus substance use
Symptoms that look like anxiety or mood dis-
turbances may appear either during use or
withdrawal. Withdrawal from depressants, opi-
oids, and stimulants invariably includes potent
anxiety symptoms (see Figure D-10). During
the first months of abstinence, many people
with substance use disorders may exhibit symp-
toms of depression that fade over time and are
related to acute withdrawal. Since depressive
symptoms during withdrawal and early recov-
ery may result from substance use disorders
and not an underlying depression, a period of
time should elapse before depression is diag-
nosed. Overall, the process of addiction per se
can result in biopsychosocial disintegration,
leading to chronic dysthymia or depression
often lasting from months to years.
Acute manic symptoms may be induced or
mimicked by intoxication with stimulants,
steroids, hallucinogens, or polydrug combina-
tions. They may also be caused by withdrawal
from depressants such as alcohol. Individuals
experiencing acute mania with its accompany-
ing hyperactivity, psychosis, and often aggres-
sive and impulsive behavior should be referred
to emergency mental health professionals. This
is true whatever the causes may appear to be.
Substance-induced mood alterations can result
from acute and chronic drug use as well as
from drug withdrawal. Substance-induced
mood disorders, most notably acute depression
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Figure D-10
Drugs That Precipitate or Mimic Mood Disorders
Mood Disorders During Use (Intoxication) After Use (Withdrawal)
Depression and dys-
thymia
Alcohol, benzodiazepines, opioids, barbi-
turates, cannabis, steroids (chronic), stim-
ulants (chronic)
Alcohol, benzodiazepines, barbiturates,
opioids, steroids (chronic), stimulants
(chronic)
Mania and
cyclothymia
Stimulants, alcohol, hallucinogens,
inhalants (organic solvents), steroids
(chronic, acute) 
Alcohol, benzodiazepines, barbiturates,
opioids, steroids (chronic)
lasting from hours to days, can result from
sedative-hypnotic intoxication. Similarly, pro-
longed or subacute withdrawal, lasting from
weeks to months, can cause episodes of depres-
sion, and sometimes is accompanied by suicidal
ideation or attempts. Figure D-10 provides an
overview of drugs that precipitate or mimic
mood disorders.
Stimulant withdrawal
Stimulant withdrawal may provoke episodes of
depression lasting from hours to days, especial-
ly following high-dose, chronic use. Stimulant-
induced episodes of mania may include symp-
toms of paranoia lasting from hours to days.
Stimulants such as cocaine and amphetamines
cause potent psychomotor stimulation.
Stimulant intoxication generally includes
increased mental and physical energy, feelings
of well-being and grandiosity, and rapid pres-
sured speech. Chronic, high-dose stimulant
intoxication, especially when combined with
sleep deprivation, may prompt an episode of
mania. Symptoms may include euphoric,
expansive, or irritable mood, often with flight
of ideas, severe impairment of social function-
ing, and insomnia.
Acute stimulant withdrawal generally lasts
from several hours to 1 week and is character-
ized by depressed mood, agitation, fatigue,
voracious appetite, and insomnia or hypersom-
nia (oversleeping). Depression resulting from
stimulant withdrawal may be severe and can be
worsened by the individual’s awareness of sub-
stance-abuse–related adverse consequences.
Symptoms of craving for stimulants are likely
and suicide is possible.
Protracted stimulant withdrawal often includes
sustained episodes of anhedonia (absence of
pleasure) and lethargy with frequent rumina-
tions and dreams about stimulant use. There
may be bursts of dysphoria, intense depres-
sion, insomnia, and agitation for several
months following stimulant cessation. These
symptoms may be either worsened or lessened
by the quality of the client’s recovery program.
Mood and anxiety disorders
versus medical conditions
and medication-induced
symptoms
Medical problems and medications can produce
symptoms of anxiety and mood disorders. For
example, acute cardiac disorders can produce
symptoms that suggest generalized anxiety or
panic disorders. Similarly, both prescribed and
over-the-counter medications can precipitate
depression. Diet pills and other over-the-
counter medications can lead to mania. It is
important to distinguish between the symptoms
of a mental disorder and those accompanying a
medical disorder or those associated with an
over-the-counter or prescription medication.
The counselor should be aware of these possi-
bilities and seek information that helps make
an accurate determination. 
Prevalence
Approximately one quarter of U.S. residents
are likely to have some anxiety disorder during
their lifetime, and the prevalence is higher
among women (30.5 percent) than men (19.2
percent) (Kessler et al. 1994). Estimates of life-
time prevalence for major depression range
from 10 to 25 percent for women and half that
for men. For dysthymic disorder, estimates are
6 percent for both women and men (APA
2000).
Data from the National Comorbidity Study
indicate that about one half (41 to 65 percent)
of individuals with a substance use disorder
have an affective or anxiety disorder at some
time in their lives (Kessler et al. 1996b). Among
women with a substance use disorder, mood
disorders may be prevalent, and women are
more likely than men to be clinically depressed
and/or to have PTSD. Research suggests that
4.5 percent of clients with substance use disor-
ders have panic disorder and 16 percent of
panic disorder clients have a co-occurring sub-
stance use disorder (DuPont 1997).
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Certain populations are at risk for anxiety and
mood disorders. American Indians, clients with
HIV, clients maintained on methadone, and
older adults may all have a higher risk for
depression. The elderly may be the group at
highest risk for combined mood disorder and
substance problems (see TIP 26, Substance
Abuse Among Older Adults [CSAT 1998d]).
Episodes of mood disturbance generally
increase in frequency with age. Older adults
with concurrent mood and substance disorders
tend to have more mood episodes as they get
older, even when their substance use is con-
trolled. Also, from 20 to 25 percent of individu-
als who have chronic or severe general medical
conditions, such as diabetes or stroke, develop
major depressive disorder. The data on high
prevalence of these disorders and the informa-
tion on the most vulnerable groups point to the
need for counselors to consider in treatment
planning that the observed behavior of depres-
sion, anxiety, and elation may likely be associ-
ated with a mental disorder.
Substance Use Among People
With Mood or Anxiety
Disorders
People with co-occurring mood or anxiety dis-
orders and a substance use disorder probably
have used many substances. Though those with
depression may favor stimulation while those
with anxieties may favor sedation, considerable
overlap is apparent. The use of alcohol, per-
haps because of its availability and legality, is
ubiquitous.
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Assessment Case Studies: George M. and Teresa G.
George M.
George M. is a 37-year-old divorced male who was brought into the emergency room intoxicated. His blood
alcohol level was .152, and the toxicology screen was positive for cocaine. He was also suicidal (“I’m going to
do it right this time!”). He has a history of three psychiatric hospitalizations and two inpatient substance
abuse treatments. Each psychiatric admission was preceded by substance use. George M. has never followed
through with psychiatric treatment. He has intermittently attended AA, but not recently.
Teresa G.
Teresa G. is a 37-year-old divorced female who was brought into a detoxification unit with a blood alcohol
level of .150. She was observed to be depressed and withdrawn. She has never used drugs (other than alco-
hol), and began drinking alcohol only 3 years ago. However, she has had several alcohol-related problems
since then. She has a history of three psychiatric hospitalizations for depression, at ages 19, 23, and 32. She
reports a positive response to antidepressants. She is currently not receiving mental health services or sub-
stance abuse treatment.
Differential diagnostic issues for case examples. Many factors must be examined when making initial diagnos-
tic and treatment decisions. For example, if George M.’s psychiatric admissions were 2 or 3 days long, usually
with discharges related to leaving against medical advice, decisions about diagnosis and treatment would be
different if than if two of his psychiatric admissions were 4 to 6 weeks long with clearly defined manic and
psychotic symptoms continuing throughout the course, despite aggressive use of psychiatric treatment and
medication.
Similarly, if Teresa G. had abstained from alcohol for 6 months “on her own,” had relapsed the night before
while thinking about killing herself, had become increasingly depressed and withdrawn over the past 3
months, and had suffered from disordered sleep, poor concentration, and suicidal thoughts, a different
diagnostic picture would emerge. 
The notion that substance use disorders are
caused, in whole or part, by an individual’s
attempts to “self-medicate” specific symptoms
with alcohol or illicit drugs has been a source of
debate. Many prominent researchers and clini-
cians have concluded that substance use is a
cause rather than an attempt to cure symp-
toms. Vaillant, for example, noted that
“depression is a symptom caused by alcoholism
more often than the reverse” (Vaillant 1995, p.
80). Both Brower and colleagues (2001) and
Raimo (1998) point out that insomnia, depres-
sion, and other “psychiatric” symptoms often
are more likely substance-use related, thus self-
medication in this case becomes using alcohol
(or other drugs) to block acute or protracted
substance withdrawal symptoms. 
The “self-medication hypothesis” first pro-
posed by Khantzian (1997) did not focus on
withdrawal symptoms, but proposed that those
who abuse drugs do so to deal with core psy-
chopathology that might range from anger to
mania. While an attractive theory, research
does not entirely support this hypothesis. For
example, adolescents with attention deficit dis-
order should likely prefer to abuse stimulants
such as cocaine or amphetamines; however,
marijuana is by far the most commonly abuse
drug in this population (Flory et al. 2003) and
it has been demon-
strated to make
attention issues
worse. Likewise,
patients with bipolar
disorder in either
depressed or manic
states should corre-
spondingly use stim-
ulants or depres-
sives, but
Strakowski and col-
leagues (1998), after
following such
patients for a year
after acute hospital-
ization, could find
no pattern to their
use, nor types of
substances used. In
addition, there have been negative studies on
schizophrenia (Scheller-Gilkey et al. 2003), and
the only symptom/diagnosis in which data
appear to support that core mental disorder
symptoms lead to substance use, and substance
use leads to decreased symptoms, is that of
social anxiety, as demonstrated by Thomas and
colleagues (Thomas et al. 2003), though even in
this case there have been negative studies (e.g.,
Ham and Hope 2003).
The consensus panel cautions that the term
“self-medication” should not be used, as it
equates drugs of abuse (which usually worsen
health) with true medications (which are
designed to improve health). Equating sub-
stances of abuse with medications can be taken
quite concretely by some patients, especially
those who are either psychotic or are looking
for a clever rationalization for their addictive
behavior. Thus, such patients might conclude,
“Well, I’ll use the doctor’s medications during
the week, but my ‘medications’ on the weekend
(didn’t the doctor say ‘self-medication with
alcohol?’).” 
Key Issues and Concerns
The key issues and concerns for the client with
mild-to-moderate mood and/or anxiety disor-
ders center on making the client comfortable
with, or at least able to tolerate, the treatment
environment. Often, the specific type of disor-
der and its symptoms need to be examined in
light of treatment demands. How does the
client get to the meeting? Are there any aspects
of the treatment environment that duplicate or
remind a client of a prior trauma experience?
Can a client who wakes up 2 hours earlier than
normal, say 5:00 a.m., develop some non-mal-
adaptive way of coping with the monotony that
can feed the client’s feelings of depression? Do
other clients make fun of the obsessive-compul-
sive rituals of a client? An insightful counselor
and a dedicated staff can go a long way in
assisting the anxious or depressed client.
The majority of clients receiving treatment for
combined mood or anxiety disorders and sub-
stance use disorders improve in response to
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Clients with severe
and persistent
substance use and
mood disorders
should not be seen
as resistant,
manipulative, or
unmotivated.
treatment. When they don’t improve, a re-eval-
uation of the treatment plan is warranted. A
client receiving antidepressant medication who
is abstinent from substances but anhedonic
requires a careful evaluation and assessment to
identify resistant psychiatric conditions that
require treatment. Based on assessment, an
additional treatment service such as psy-
chotherapy may be added. Indeed, psychother-
apy has been shown to improve the efficacy of
substance abuse treatment and of mental
health services that involve antidepressant
medication.
When clients do not improve as expected, it is
not necessarily because of treatment failure or
client noncompliance. Clients may be compliant
and plans may be adequate, but disease pro-
cesses remain resistant. Clients with severe and
persistent substance use and mood disorders
should not be seen as resistant, manipulative,
or unmotivated, but as extremely ill and in
need of intensive support.
Strategies, Tools, and
Techniques
Engagement
As observed in the section above on
“Differential Diagnosis,” a client who shows
severe and acute levels of anxiety and mood
disturbance may have another psychological
disorder, such as psychosis, PTSD, or a PD.
The client may also have a history of suicidality
or may be suicidal currently. When this is the
case, see the pertinent portions of the
“Differential Diagnosis” section and the
“Suicidality” section.
In general, counselors can engage clients with
mood or anxiety difficulties by gathering
enough information to empathize with the
clients’ experience and acknowledge the legiti-
macy of the client’s feelings. Worried clients
tend to know they are overly concerned com-
pared to other people, and depressed clients
often feel that they should not be depressed.
Depressed clients may view depression as a
personal shortcoming and imagine that they are
bringing others down with them.
A model of engagement that can be instructive
is the sympathetic physician who has seen it all
before and is calm in the face of what she or he
knows others find upsetting. That is, a sub-
stance abuse treatment counselor can attend to
the symptoms and their effects on the client,
while remaining an observant distance from the
worry itself or the depressed mood. For exam-
ple, the counselor could tell a client that he or
she recognizes how painful and nerve-racking it
is for the client to be so concerned about the
possible loss of employment, while avoiding get-
ting into the details of either the worst possible
outcomes or the worries. Such a strategy can
help with engagement.
Cognitive–behavioral therapy might help a
client see how he or she has developed a way of
viewing mainly the worst possible outcomes of
events, or how he or she tends to emphasize the
most negative aspect of a situation. However,
the client’s ability to recognize these patterns of
behavior may be a long-term goal that can only
be accomplished through time and trust.
Trying too soon to address such entrenched
habits of perception is not likely to be an effec-
tive engagement strategy. “Start low, go slow” is
a cliché physicians use to describe beginning
with a small amount of a medication to gauge
side effects, then slowly increasing the medica-
tion to a therapeutically effective dose. A simi-
lar approach can help with the engagement
phase of working with clients who have mood
and anxiety concerns.
Screening and assessment
Medical assessment
Clients with mood/anxiety disorders, particu-
larly older adults, may have life-threatening
medical conditions, including hypoglycemia
(insulin overdose), stroke, or infections. These
conditions, as well as withdrawal and toxic
drug reactions, always must be considered and
require a thorough physical examination and
laboratory assessment. Clinical staff should
make appropriate referrals for medical assess-
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ment and treatment. Facilities that have no
medical component should train assessment
staff in triage and referral, especially as part of
the intake process.
Assessing mood and anxiety 
symptoms
During initial screening sessions, clients with
substance use disorders may overemphasize or
underemphasize their psychiatric symptoms.
For instance, clients who feel depressed during
the assessment may distort their past psychi-
atric experiences and unwittingly exaggerate
the intensity or frequency of past depressive
episodes. Some clients experience feelings of
guilt that are excessive and inappropriate.
Other clients do not accurately label their
depression and fail to remember that they have
experienced depression before. Since clients
frequently confuse depression with sadness and
other emotions, it is important to obtain collat-
eral information from other people and from
documents such as medical and psychiatric
records. It is critical to continue the process of
evaluation past the period of drug withdrawal.
For anxiety and mood symptoms especially,
observation is an important component of
screening and assessment. Does the client seem
calm and relaxed or nervous and distraught?
Often, with training in screening or assessment,
the counselor will learn to recognize some of
the features that provide clues to a client’s
mental status, such as rate of speech, affective
tone, cooperativeness, and so on.
Assessment instruments
A differential diagnostic evaluation can include
the clinical application of the DSM-IV, perhaps
in the form of a structured clinical interview.
Some specific and general standardized assess-
ment measures are available for anxiety and
mood disorders. The Beck Depression
Inventory-II (BDI-II) (and its predecessor) has
been used in a wide variety of settings for the
past 25 years, and a Beck Anxiety Inventory is
available; both have English and Spanish ver-
sions and are proprietary. Substance abuse
treatment agencies need to provide training in
the use of assessment instruments so that coun-
seling staff can take full advantage of the infor-
mation and can play the most effective roles
possible in assessment processes.
Discussion of the case study (p. 379): While
many clients are depressed and anxious at the
onset of treatment—and someone in Jim R.’s
position might well be expected to have these
symptoms—it is still important to consider the
possibility that the depression or anxiety might
be a co-occurring mental disorder. The coun-
selor notes the indications of depression and
formally screens for depression using the BDI-
II. Upon review at the next session the coun-
selor notes and evaluates the increase in
depression and refers the client to a psychia-
trist when the symptoms persist and intensify.
The psychiatrist establishes the co-occurring
mental diagnosis and, with the counselor,
develops a treatment plan that involves medica-
tion, cognitive–behavioral mental health coun-
seling and continued substance abuse treatment
and monitoring of medication. With this inte-
grated treatment approach, based on a sound
observation, rapid referral, and accurate diag-
nosis, the client begins making good progress in
treatment.
Psychosocial assessment
A comprehensive psychosocial assessment,
including an evaluation of the client’s support
system, is an important aspect of the overall
assessment. Such information is essential for
understanding the full context of anxiety and
mood troubles. Effective treatment planning
for both disorders depends on understanding
the total life situation of the client.
Crisis stabilization
When a mood and anxiety disturbance is at
mild or moderate levels, crisis stabilization
should not be needed. Substance abuse coun-
selors should use their clinical skills and be
responsive to signs of an impending serious cri-
sis, such as a moderately depressed client who
has given away his or her belongings or who
has begun to talk about wills or contacting old
friends.
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In terms of anxiety disorders, an immediate
episode of panic (and to some degree a dissocia-
tive state) can represent a crisis. In some cases,
the counselor may have to make arrangements
for a client to get home. Two of the acute anxi-
ety conditions most commonly encountered in
emergency room settings are panic attacks and
dissociative states that may resemble psychosis.
However, some anxious clients misinterpret
their symptoms of chronic anxiety as symptoms
of an acute anxiety episode. Their misinterpre-
tation may predispose the therapist to make the
same misinterpretation.
Interventions for acute anxiety conditions
include calming reassurance, reality orienta-
tions, breathing management, and when need-
ed, sedative medications such as benzodi-
azepines. These interventions are nearly identi-
cal to those used for the two most common sub-
stance-related anxiety emergencies: withdrawal
from sedative-hypnotics (including alcohol) and
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Case Study: Assessment of Mood and Anxiety Disorders
Jim R. enters the substance abuse treatment center after detoxification at the hospital. He was admitted
following a drinking and driving incident in which he hit the side of a building, fortunately injuring no one.
The counselor immediately sees that Jim R. is depressed and somewhat anxious. He talks about how he has
screwed up, will probably lose his license, and will then not be able to work. He says he has tried repeatedly
to stop drinking and cannot succeed; his life is hopeless.
Jim R. is not thinking of suicide, but he has lost a great deal of weight recently, has difficulty concentrating,
feels worthless, moves suddenly in an agitated way (he shifts his position in the chair continually), and
admits to difficulty sleeping. The counselor senses that the client may be depressed and notes the indications
of depression in the record. To obtain further collaboration, the counselor immediately uses the BDI-II and
finds that Jim R. scores 15. A score of 15 represents a moderate level of depression, but the treatment pro-
gram’s protocol for the use of the BDI-II by counselors calls for weekly monitoring of moderately scoring
clients with repeat administrations of the BDI-II. In the next session, the counselor notes signs of increased
depression and reevaluates the symptoms. He finds that Jim R. now scores 40 on the BDI-II. According to
the established protocol, he now refers him to a psychiatrist, suggesting that Jim R. may be in need of medi-
cation and a differential diagnosis.
The psychiatrist does a longitudinal assessment in which she explores Jim R.’s drinking and establishes a
diagnosis of alcohol abuse disorder. The psychiatrist also explores when Jim remembers being depressed and
gauges the severity and persistence of these depressions. Finding a pattern of persistent depression with anx-
ious features, such as excessive worry, that precedes Jim R.’s drinking, she prescribes an antidepressant
with a calming effect. She tells Jim R. the pills should help him feel less worried and sleep better even though
the pills are neither tranquilizers nor sleeping pills, and she stresses the importance of taking them regularly.
Noting that Jim R. is a college graduate, she prescribes a workbook on depression (David Burns, The
Feeling Good Handbook) to help him learn about the disease. The psychiatrist informs the substance abuse
treatment counselor of her action and asks the counselor to continue monitoring the client’s depression. She
also refers Jim R. for cognitive–behavioral sessions with a mental health clinician to help him overcome his
negative thinking and regain his sense of worth.
On Jim R.’s next visit, the substance abuse treatment counselor checks Jim R.’s pill box and finds that many
of the pills have not been taken. He uses motivational therapy techniques to encourage Jim R. to take the
pills regularly. He also reinforces the work of the mental health counselor, pointing out that the “stinking
thinking” discussed in AA as a bad rationale for drinking is similar to the thought patterns that drive his
depression. Gradually, Jim R. is able to manage his disorder through medication and improved thought pat-
terns.
intoxication from stimulants (including
cocaine). While the use of benzodiazepines gen-
erally is not problematic during acute with-
drawal, their use may become a problem for
abstinent, recovering people. Such people may
have abused benzodiazepines before they
became abstinent, and the use of benzodi-
azepines to calm the anxiety disorder may lead
to relapse of the addictive behavior.
Interventions for acute anxiety conditions
should include behavioral, cognitive, and
relaxation therapies, often in combination with
long-term serotonergic and depressant medica-
tions. 
During an acute panic attack, people often
believe that they are having a heart attack, feel
dizzy, and are unable to catch their breath.
Enforced regular breathing through the use of
a paper bag helps to regulate breathing and
diminish excess release of carbon dioxide. Such
breathing exercises, education about symp-
toms, and reassurance will diminish panic
symptoms for many clients. These clients also
should be examined by a medical professional
such as a nurse to identify any person who may
be having an actual heart attack.
Short-term care and 
treatment
The acronym MASST, defined in the text box
below, is a reminder for counselors of the areas
of substance abuse recovery that need to be
continually assessed.
In terms of mood and anxiety problems,
MASST can be used to incorporate specific
strategies within the client’s overall recovery
efforts. Though there are many interventions
for anxiety and mood disorders other than
medications, medications often are a significant
part of such treatment efforts. For clients with
more than mild levels of disturbance, medica-
tions can be essential. 
For many clients in early recovery from sub-
stance abuse, treatment of anxiety disorders
can be postponed unless a certain or verifiable
history shows that the anxiety preceded the
addiction or is incapacitating. If symptoms are
mild and do not interfere with functioning,
including participation in treatment, it is judi-
cious to wait to see if the symptoms resolve as
the substance abuse treatment progresses.
Antecedent traumas, as well as dysfunctional
family situations that have been identified dur-
ing the assessments, should be addressed in a
supportive and calming manner. However,
affect-liberating therapies probably should be
deferred until the client is stable with respect to
substance abuse and acute anxiety has been
established. Issues of importance to the client
and raised by the client should not be ignored,
but exploration of underlying trauma should
not be encouraged until the client is stabilized.
Supportive, cognitive, behavioral, and dynamic
therapies all can be used, but in early recovery,
clients need significant support and will have
limited tolerance for anxiety and depression.
The emphasis should be on supporting recov-
ery, attending 12-Step meetings, and participat-
ing in other self-help and group therapies.
Insight-oriented treatments must be measured
carefully and limited early on by their potential
to increase anxiety and trigger relapse. When
psychotherapy is immediately essential, clients
should be referred to recovery-oriented psy-
chotherapists who will integrate psychotherapy
with mutual self-help approaches.
Clients may overuse medications or relapse to
illicit drugs. Certain medications that do not
produce physical dependence or withdrawal
and have much lower potential for abuse have
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MASST Areas of Recovery
for Assessment
M: Meetings (12-Step or other recovery-oriented
self-help)
A: Abstinence goals
S: Sponsor and other helping people
S: Social support systems
T: Treatment efforts
been found to be effective for treating anxiety
disorders. Many are as effective as the benzodi-
azepines but without the abuse liability. The
antidepressants fluoxetine (Prozac) and sertra-
line (Zoloft) and the antianxiety medication
buspirone (BuSpar) are medications that can
be used to treat symptoms of anxiety disorders,
have good safety profiles, are not euphorigenic
(producing euphoria), and have few drug inter-
action cautions. They can be used in the man-
agement of subacute withdrawal states. When
these drugs do not produce the desired results,
the tricyclic and monoamine oxidase inhibitor
antidepressants may be used. (See appendix F
for a discussion of psychiatric medications.)
Medications should be used in combination
with nondrug treatment approaches. Although
studies are still underway, acupuncture, aero-
bic exercise, stress reduction techniques, and
visualization techniques may be useful compo-
nents of treatment and recovery. These tools
can be valuable adjuncts for the reduction of
stress. Clients should be taught that efforts to
improve their general health, such as eating
more healthful foods and exercising regularly,
can lead to better mental health.
It is beyond the scope of this TIP to provide
comprehensive review on the use of psy-
chotherapeutic treatment. However, there are
numerous resources regarding counseling and
psychotherapy for depression and anxiety
(e.g., Barlow 2002).
Longer term care
Always foremost in longer term COD treatment
are the issues of diagnosis and re-diagnosis.
Once a patient has engaged in treatment and
has been abstinent for over a month, most of
the substance-induced depression/anxiety
symptoms caused by either the substance or its
withdrawal should have abated. This allows for
the diagnosis of ongoing symptoms to be more
certain. It should be recognized that just
because psychiatric symptoms abate with absti-
nence and addiction treatment alone doesn’t
mean that such symptoms may not re-occur
later and need specific mental health services,
such as medications. It does, however, make
this much less likely. If a patient is diagnosed
with COD, is in active addiction treatment, but
has been started on a psychiatric medication
for depression, anxiety, or both by an outside
prescriber (either a psychiatrist or primary
care physician), then the substance abuse
counselor should refer to chapter 5 of this TIP
(the section titled “Monitor Psychiatric
Symptoms”) to identify strategies for monitor-
ing symptoms and supporting medications. 
While medications are useful for anxiety disor-
ders, they are not a substitute for substance
abuse treatment or other activities related to
recovery. Cognitive and behavioral techniques
used in substance abuse treatment often are as
effective as medications in treatment of anxiety
disorders, though they generally take longer to
achieve an equivalent response for the mental
illness component of the disorder.
It should also be noted that certain depressions
may become so severe that they can cause
symptoms of mental disorders, such as delu-
sions (e.g., “I’m so evil that I was responsible
for starting World War II”) or hallucinations
(e.g., “When I’m alone I hear my name being
called and the voices tell me that I am bad”).
These types of depression need immediate psy-
chiatric consultation and medication treatment.
Patients who are significantly anxious or
depressed should always be evaluated for sui-
cide: Counselors are referred to chapter 5, the
subsection “Potential for harm to self or oth-
ers” within the section titled “Monitor
Psychiatric Symptoms,” as well as to the suici-
dality sections in chapter 8 and this appendix,
for details on evaluation and management.
The consumption of foods containing stimu-
lants should not be overlooked. People who
consume significant amounts of caffeine and
sugar may have a higher risk for episodes of
anxiety and depressive symptoms. Chocolate,
large quantities of refined carbohydrates, and
any diets that cause significant variations in
blood sugar levels should be avoided, since this
condition will tend to aggravate or induce both
mood and anxiety states. It is important to be
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sure that eating habits do not imitate the rushes
and crashes of substance abuse.
Use of 12-Step and other mutual
self-help programs
Participation in 12-Step programs provides
valuable therapeutic experiences for many
recovering people who have mood or anxiety
disorders. People who have a social phobia and
the fear of public speaking often are extremely
resistant to attending self-help meetings. Yet,
such people can make tremendous recovery
gains in terms of anxiety desensitization and
substance abuse recovery.
Few situations are as safe, supportive, pre-
dictable, and undemanding as the average 12-
Step group meeting. For this reason, groups
such as AA and Narcotics Anonymous (NA)
provide constructive opportunities to help
clients desensitize social fears. However, anx-
ious clients must not simply be thrust unpre-
pared into 12-Step group meetings. Counselors
should educate and prepare such clients
regarding the process and approach of 12-Step
and other self-help group meetings.
A stepwise approach to using
mutual self-help
It is important for substance abuse treatment
staff to appreciate the difficulty and distress
that are experienced by people who have social
phobias and fears of speaking in public. Staff
who assist such clients with 12-Step group par-
ticipation should become knowledgeable about
the signs and symptoms, course, and treatment
of generalized anxiety disorder, panic disorder,
and the phobias, especially social phobia and
other anxieties related to public speaking and
social situations.
Staff can help socially anxious clients partici-
pate in 12-Step group meetings by using a step-
wise approach of progressively active exposure
and participation based somewhat on the prin-
ciples of systematic desensitization: 
• One of the least intense levels of preparation
involves the use of mock AA/NA meetings
consisting of staff and clients. This process
makes it possible to stop the meeting fre-
quently, discuss various meeting components,
examine group methods, and allow potential
participants to observe and practice. 
• The next level of intensity involves attending
a 12-Step group meeting as a nonspeaking
observer. Staff should help clients to under-
stand that being a nonspeaking observer is a
transitional phase and is not a substitute for
active participation. For this reason, it may
be helpful to limit nonspeaking observation
by the client to a specific number of meet-
ings. At first clients can attend meetings with
someone they know and trust, and they can
stay in the back of the meeting room close to
an exit door.
• The next level of intensity involves clients
attending a limited number of 12-Step meet-
ings during which they identify themselves
but do not talk about themselves. The coun-
selor can give assistance by providing easily
rehearsable suggestions for self-introductions
such as, “Hi, my name is Mary. I’m an alco-
holic and I am glad to be here, although I am
a little nervous.”
Since the mutual support associated with the
12-Step group meetings can occur outside of
the meeting, anxious clients should be encour-
aged to do more than merely attend and partic-
ipate in the meetings. Rather, they should
arrive before the meeting begins and should
linger and mingle with others following the
meeting. Clients can be encouraged to volun-
teer to help set up the room, make the coffee,
or clean up afterward. In particular, socially
phobic clients can be encouraged to join others
for coffee and conversation after the meetings
on a more one-to-one basis, a traditional aspect
of 12-Step group involvement.
By participating in step-by-step, rehearsed
activities, many anxious and depressed clients
seem to break through an internal barrier. As
they do, participation in self-help group meet-
ings becomes an integral aspect of recovery
from substance use disorders and mental
health problems.
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The stepwise approach described for clients
with anxiety disorders can be adapted for
clients who are depressed. Anxious clients often
avoid group participation and public speaking,
saying to themselves, “If I talk or if I am
noticed, I will freak out.” Similarly, depressed
clients often avoid group participation and
other recovery activities, perhaps thinking, “I
just don’t have the energy to go. Why bother?”
The counselor must elicit comments, under-
stand them, and help clients to reverse these
internal barriers to recovery and participation
in group and other social activities.
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Case Study: Phobia, Tranquilizers, and Alcohol
Lan S. has been referred to the substance abuse treatment clinic by her physician because of abuse of pre-
scribed tranquilizing drugs and alcohol. The counselor finds Lan S. somewhat nervous but apparently in
stable condition and willing to discuss her substance abuse problems. During the course of conversation, she
mentions her discomfort in restaurants and malls. When the counselor refers her to a 12-Step group, Lan S.
seems hesitant and uncomfortable. The counselor identifies her symptoms as resistance to treatment and
strongly emphasizes the importance of attendance if she wants to change.
In future sessions, however, the counselor finds her refusal to go to group remains steadfast. After confer-
ring with a mental health counselor, she probes Lan S.’s discomfort about going to group and explores the
possibility of other similar problems. She finds that Lan S. orders all her clothes online to avoid going to
stores and that she rarely appears in public. Coming to the counseling session is an ordeal made possible
only by the fact that her mother takes her to the clinic and waits for her in the counseling center.
The counselor refers Lan S. to the psychiatrist, who finds that Lan S. has a social phobia. He prescribes
Zoloft, a selective serotonin reuptake inhibitor (SSRI) antidepressant, and arranges for a course of treat-
ment with a mental health counselor who specializes in phobias. He asks the substance abuse treatment
counselor to coordinate closely with the mental health counselor to develop a strategy to enable Lan S. to
attend meetings. Together, they work out a phased approach to regular attendance at meetings in which she
first attends a meeting at the clinic, then is escorted to a meeting at another part of town. The counselors
also provide psychoeducation for both Lan S. and her mother to help them understand her mental disorder.
The substance abuse treatment counselor works with Lan S.’s sponsor to ensure understanding of her limi-
tations. Gradually, Lan S. is able to attend AA regularly on her own.
Discussion: Counselors should be aware that some “resistance” may actually indicate a mental disorder.
Until the disorder is treated, this obstacle will remain in the client’s path and deter recovery. At the same
time, some clients with social phobia or other anxiety disorders may choose not to attend 12-Step groups;
this is a legitimate choice. Such clients should be offered alternatives, such as increased amounts of individu-
al therapy. As long as they can engage in such treatment alternatives, it is important not to convey to clients
that they are “wrong” or “bad” or “not doing recovery right” by choosing not to attend 12-Step groups.
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Case Study: GAD and Protracted Withdrawal
Ray Y., a 50-year-old husband and father of teenagers, is going through protracted alcohol withdrawal. He
appears “edgy” and irritable, sometimes sad, and complains to his substance abuse treatment counselor of
insomnia, headaches, and an upset stomach. He tells the counselor he can barely stand not to drink: “I’m
jumping out of my skin.” Although these symptoms are common during protracted withdrawal, because they
have persisted for over a month, the counselor begins a more detailed exploration.
The counselor asks Ray Y. whether he had these symptoms before he used alcohol and Ray Y. says he’s
“always been this way.” He worries about everything, even events that are weeks away. His family vacations
are nightmares because every aspect of vacation planning troubles him and keeps him awake. During family
therapy, it becomes apparent that his daughter deeply resents his controlling and distrustful behavior, as
well as his overprotective stance toward all her social commitments. The counselor refers Ray Y. to the psy-
chiatrist, who diagnoses generalized anxiety disorder and begins a course of medication and initiates mental
health counseling. The family receives help coping with Ray Y.’s disorder and the daughter is referred for
short-term counseling to help her address the mental problems she is beginning to develop as a result of her
father’s excessive control.
Discussion: Even though anxiety symptoms are quite common during protracted withdrawal, counselors are
advised to consider the possibility that an anxiety disorder is sometimes indicated. Symptoms should be
tracked to see whether they persist beyond the normal time that might be expected for protracted withdraw-
al (about a month). Counselors should also be aware of the effect of such disorders on close family members.
Children and adolescents may not understand that a parent has a mental disorder and may be relieved to
have a way of understanding and coping with difficult behavior.
Case Study: OCD and Alcohol
Marla W. is a 40-year-old woman with a secret: She has been compulsively washing her hands for many
years, and cannot stop. She began drinking to try to relax, but found herself gradually drinking more and
more in an attempt to cope with what she knew was very unhealthy behavior. She feels triggered to wash her
hands whenever she thinks of “germs,” and feels that she cannot get them clean enough. She sometimes
washes up to 100 times a day, and has constricted her life so others will not see her. When she drinks, she is
alone.
The substance abuse treatment counselor discovers Marla W.’s obsession when she notices Marla W.’s
repeated trips to the rest room. She discusses Marla W.’s symptoms and assures her that some medication
and therapies may be able to help her overcome the disorder. She refers Marla W. to the psychiatrist for
assistance.
Discussion: Substance abuse treatment counselors often consider compulsive behaviors (gambling, shopping,
overeating, sex, work, etc.) to be addictions. However, they should also consider that some compulsive
behaviors may be part of an OCD and clients may benefit by having further evaluation and the knowledge
that specific medication and therapies are available to assist them.
Schizophrenia and
Other Psychotic
Disorders
Description
Psychosis is the term for a severely incapacitat-
ed mental and emotional state involving a per-
son’s thinking, perception, and emotional con-
trol. Psychosis refers to distorted thoughts in
which an individual has false beliefs, sensations
or perceptions that are imagined, and/or very
extreme and unusual emotional states along
with deterioration in thinking, judgment, self-
control, or understanding. In everyday terms,
people who are acutely psychotic cannot tell
the difference between what is real and what is
not, but this common distinction is too simplis-
tic to be clinically useful. Psychosis usually is
expressed clinically as a combination of one or
more of the following symptoms:
• Belief in delusions (such as that one is being
followed by people from Mars, or that one is
a very important person whom the President
wants to talk to right away, or that one is
eternally damned).
• Hearing or seeing things that are not there
(hallucinations) and being unable to recog-
nize that what is being experienced is not
real, such as hearing voices that say self-con-
demning or other disturbing things, or seeing
a mocking or threatening face of the Devil.
• Severe emotional excitement, which can man-
ifest as a “manic” state with feelings of exu-
berance, invincibility, grandiosity. Often this
state is accompanied by poor judgment and
prolonged functioning with little sleep, as is
seen in people with bipolar disorder during
the manic phase. Alternatively, an emotional
state reflecting psychosis may manifest as
severe agitation, sometimes with vaguely
expressed worries or fears and/or with tears
and depressive consternation. 
• On rare occasions, a very different type of
psychotic reaction can occur, one that mani-
fests as immobility, stupor, or rigid body
position over extended periods of time. This
is known as catalepsy, one of several forms of
catatonic states that occur during certain
types of schizophrenic episodes.
Although schizophrenia is the illness most
strongly associated with psychotic disorders,
people with bipolar disorder (or what used to
be termed “manic-depressive illness”) may
experience psychotic states during periods of
mania—the heightened state of excitement, lit-
tle or no sleep, and poor judgment described
above. Other conditions also can be accompa-
nied by a psychotic state, including toxic poi-
soning, other metabolic difficulties (infections
[e.g., late-stage AIDS]), and other mental dis-
orders (major depression, dementia, alcohol
withdrawal states, brief reactive psychoses,
and others).
For the purpose of this TIP, the focus will be
on schizophrenia and bipolar disorder.
Although schizophrenia is a “thought” disorder
and bipolar disorder is a “mood” or “affective”
disorder, these often are the diagnoses that
States and/or other funding agencies use to
establish special programs for people with
“severe and persistent mental illness” or the
“severely mentally ill.” In practice, however,
eligibility for such programs often is more
largely determined by the mental health prob-
lems and their impact on the basics of the
client’s life—living arrangements, employment,
hospitalizations, ability to care for self—than
by the client’s specific diagnosis.
Substance abuse treatment counselors typically
do not see clients in the throes of an acute psy-
chotic episode, as such psychotic patients more
likely present, or are referred to, ERs and
mental health treatment facilities. Counselors
are more likely to encounter such clients in a
“residual” or later and less active phase of the
illness, the time at which these individuals may
receive treatment for their substance use disor-
ders in an addiction treatment agency. Even if
the substance abuse treatment counselor never
sees a client during an actively psychotic peri-
od, knowing what the client experiences as a
psychotic episode will enable the counselor to
understand and assist the client more effective-
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ly. On the other hand, counselors are increas-
ingly treating clients with methamphetamine
dependence who often have residual paranoid
and psychotic symptoms, and may need
antipsychotic medications. These clients may
continue with such psychotic symptoms for
months, or even years (Chen et al. 2003).
Schizophrenia
Schizophrenia is best understood as a group of
disorders that can be divided into subtypes: (1)
paranoid type, in which delusions or hallucina-
tions predominate; (2) disorganized type, in
which speech and behavior peculiarities pre-
dominate; (3) catatonic type, in which catalep-
sy or stupor, extreme agitation, extreme nega-
tivism or mutism, peculiarities of voluntary
movement or stereotyped movements predomi-
nate; (4) undifferentiated type, in which no sin-
gle clinical presentation predominates; and (5)
residual type, in which prominent psychotic
symptoms no longer predominate.
Symptoms of schizophrenia include delusions,
hallucinations, disorganized speech (e.g., fre-
quent derailment or incoherence), grossly dis-
organized or catatonic behavior, and deficits in
certain areas of functioning—for example, the
inability to initiate and persist in goal-directed
activities. These symptoms regularly develop
before the first episode of a schizophrenic
breakdown, sometimes stretching back years
and often intensifying prior to reactivations of
an active, acutely psychotic state.
Relatively subtle indicators may exist. For
example, a clinician may notice a client’s ten-
dency toward loose associations, a symptom
that is exhibited when ideas expressed appear
to be disconnected or only very loosely con-
nected. A similar disturbance, called tangen-
tiality or tangential thinking, occurs when a
client gets lost in telling a story and cannot get
to the point. As with many of the behaviors dis-
cussed, isolated occurrences of these phenome-
na are unremarkable, but their repetition can
be a cause for concern.
Clinicians generally divide the symptoms of
schizophrenia into two types: positive and neg-
ative symptoms. Acute course schizophrenia is
characterized by positive symptoms, such as
hallucinations, delusions, excitement, and dis-
organized speech; motor manifestations such as
agitated behavior or catatonia; relatively minor
thought disturbances; and a positive response
to neuroleptic medication. Chronic course
schizophrenia is characterized by negative
symptoms, such as lack of any enjoyments
(“anhedonia”), apathy, very little emotional
expressiveness (“flat affect”), and social isola-
tion. Some clients will live their entire lives
exhibiting only a single psychotic episode; oth-
ers may have repeated episodes separated by
varying durations of time.
Brief reactive psychosis describes a condition
in which an individual develops psychotic
symptoms after being confronted by over-
whelming stress.
Bipolar disorder
Bipolar disorder, formerly termed “manic-
depressive illness,” is meant to characterize the
fluctuations in mood from one end or “pole” to
the other—severe depression to mania. Unlike
schizophrenia, bipolar illness might have little
effect on the client’s ability to think; that is, it
does not necessarily include the symptoms of a
“thought disorder,” whereas schizophrenia at
some point always shows disturbances of
thought (such as delusions, bizarre beliefs, or
loose associations).
Depressive phases in bipolar clients are similar
to those in clients who are severely depressed—
that is, the person feels sad; might feel life is
not worthwhile; gets little or no enjoyment
from anything, even from involvement with
children or family/friends; and has altered
appetite and sleep needs, for example, waking
up early in the morning almost 2 hours before
normal or oversleeping. Similarly, the client
may overeat or have little or no appetite. The
person might experience lethargy; fatigue easi-
ly; have feelings of guilt or worthlessness (some-
times for seemingly trivial things) or show
386 Specific Mental Disorders: Additional Guidance for the Counselor
strong feelings disproportional to the acts or
thoughts involved; and experience recurrent
thoughts of death, illness, or manifest suicidal
thoughts, plans, or attempts.
Manic episodes for someone with bipolar disor-
der also vary in intensity. Full-blown, intense
mania (during which a client might, for exam-
ple, take off all his or her clothes and run to a
church to declare that the secrets of the uni-
verse have been revealed) is relatively rare
and, especially with medication, usually short-
lived. An evolving manic episode might be hard
to detect, especially in someone who is drinking
and/or using drugs; some people with mania
can get by on a day-to-day basis, partying and
barely sleeping, telling tall tales others might
ignore, and even being intact enough to per-
suade others that their delusion of vast wealth
is true. People in a manic state have been
known to get yachts to take to sea for a trial
run or to run up thousands in bills at expensive
hotels before anyone recognizes that the indi-
vidual has not changed clothes in 6 days and
cannot carry on a conversation without stating
outlandish impossibilities (such as owning
Nebraska or being married to the queen of
England).
In between the extremes of elation and depres-
sion, some clients with bipolar disorder are
likely to struggle almost all the time with mild-
to-moderate depression and, on occasion, with
“hypomanic” (mildly elevated) states that can
carry deterioration in judgment, leading to
legal trouble, financial loss, or relapse to abus-
ing substances. For the 20 to 30 percent of peo-
ple with bipolar illness who are not fully func-
tional between episodes of mania and/or
depression, the residual phase is usually char-
acterized by mood instability, interpersonal
problems, and/or occupational difficulties
(APA 2000). However, clients with bipolar dis-
order who are successfully treated frequently
return to positive and productive lives without
any future disruption.
Differential Diagnosis
Psychosis versus substance-
induced psychotic disorder
Differential diagnosis among psychotic disor-
ders can be challenging, even for experienced
clinicians and diagnosticians, especially when
drugs and alcohol are involved. When a client
presents in a psychotic state, any immediate or
recent substance use is difficult to determine,
and it may be impossible to discern whether the
hallucinations or delusions are caused by alco-
hol or other drug use. If the hallucinations or
delusions can be attributed to substance use,
but are prominent and beyond what one might
expect from intoxication alone, the episode
would be described as a “substance-induced
psychotic disorder.” Hallucinations that the
person knows are solely the result of substance
use are not considered indicative of a psychotic
episode; instead, they are considered part of
what DSM-IV-TR calls Substance Intoxication.
Psychedelic, hallucinogenic, and stimulant
drugs can produce reactions with psychotic fea-
tures, especially in clients with co-occurring
schizophrenia and bipolar disorders. People
who use phencyclidine
(PCP) and who expe-
rience one psychotic
episode are “more
likely to develop
another with repeated
use” (Goldsmith and
Ries 1998, p. 971). In
addition, withdrawal
from some sub-
stances, especially
alcohol, can produce
states that can mimic
psychosis. Consider
the following descrip-
tions by Goldsmith
and Ries (1998, p.
970) of the known
concomitants of with-
drawal:
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Schizophrenia is 
a “thought” 
disorder and 
bipolar disorder is
a “mood” 
or “affective” 
disorder.
• Sedatives: “A protracted withdrawal syn-
drome has been reported to include anxiety,
depression, paresthesias [a tingling, prick-
ling, or burning sensation on the skin], per-
ceptual distortions ... headache, derealiza-
tion and depersonalization, and impaired
concentration.”
• Amphetamines: Many people who abuse stim-
ulants report a state of hopelessness, discom-
fort, and unhappiness that includes little or
no pleasure. This state may persist for weeks.
“Some stimulant addicts report hallucinatory
symptoms that are visual (e.g., coke snow)
and tactile (e.g., coke bugs). Sleep distur-
bances are prominent in the intoxicated and
withdrawal states, as is sexual dysfunction.”
• Opioids: “There are reports of an atypical
opiate withdrawal syndrome consisting of
delirium following the abrupt discontinuation
of methadone.”
• Alcohol: “A few chronic heavy drinkers expe-
rience hallucinations, delusions, and anxiety
during acute withdrawal, and some have
grand mal seizures. Brain damage of several
types is associated with alcohol-induced
dementias and deliriums.”
Some clinicians have developed clues to differ-
entially discriminate one type of disorder from
another. For example, DSM-IV (APA 2000, p.
300) advises that “certain types of auditory hal-
lucinations (i.e., two or more voices conversing
with one another or voices maintaining a run-
ning commentary on the person’s thoughts or
behavior) have been considered to be particu-
larly characteristic of schizophrenia....”
Mendoza and Miller (1992) suggest that people
who abuse cocaine and become paranoid main-
tain their abstract thinking and basic clear
thinking; they have delusions that are poorly
developed and of a non-bizarre nature
(Goldsmith and Ries 1998). Fortunately, both
the substance abuse treatment clinician and the
physician responsible for the management of a
client with psychotic-like symptoms can attend
directly to the symptoms presented and begin
by treating those symptoms without requiring
an exact diagnosis beforehand.
Physical illnesses and 
reactions to medication
Any number of physical illnesses or medication
reactions, from brain tumors to steroid side
effects, can cause a psychotic episode or psy-
chotic behavior. These are situations when the
thorough diagnostician, one who follows a
client until the details of the disorder and the
correct differential diagnosis are clear, earns
his or her keep.
Schizophrenia versus bipolar
disorder
Detailed and complex strategies for conducting
a differential diagnosis take into consideration
the typical “natural” histories of both sub-
stance use disorders and schizophrenia or
bipolar disorder and the pattern of presenting
symptoms (see, e.g., Rosenthal and Miner
1997). Often, continued input from the sub-
stance abuse counselor and treatment team
staff will help clarify the diagnosis or lead a
psychiatrist to change a diagnosis from
schizophrenia to bipolar disorder. This may
also lead the psychiatrist to switch a client’s
medication from one of the “antipsychotic”
medications to a “mood stabilizer” such as
lithium.
Collateral information can be important in
making an accurate diagnosis. For example,
Sloan and colleagues (2000) found that a self-
report of having been hospitalized with a diag-
nosis of bipolar disorder and/or a report of a
prior positive therapeutic response to a mood
stabilizer were better measures of bipolar dis-
order than questions about symptoms. Some
types of delusions brought on by drinking
(often delusions of jealousy) or by metham-
phetamine use can be recognized easily with
input from collateral sources that clarify the
situation. Without such information, staff can
be misled into believing the delusion is true.
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Prevalence
Schizophrenia
The lifetime prevalence rate for adults with
schizophrenia is between 0.5 and 1.5 percent
(APA 2000). The Epidemiologic Catchment
Area (ECA) studies reported that among clients
with schizophrenia, 47 percent met criteria for
some form of a substance use disorder (Regier
et al. 1990). Fifteen years earlier, McLellan and
Druley (1977) also found that about half of
male inpatients with schizophrenia could be
expected to have a co-occurring addiction to
amphetamines, alcohol, or hallucinogens.
Research by Fowler et al. (1998) reviewed
prior studies and assessed 194 Australian out-
patients with schizophrenia, finding similar
results with more than 59 percent of the group
having lifetime alcohol abuse/dependence. In
an almost all-male study of the medical records
of 1,027 veterans treated for some form of
schizophrenia, Bailey and colleagues (1997)
found that 50.8 percent of the clients had
received a diagnosis of a substance use disorder.
Bipolar disorder
The lifetime prevalence of bipolar disorder also
is roughly 1 percent of the general U.S. popula-
tion (APA 2000), so both schizophrenia and
bipolar disorder are relatively rare compared
to major depressive illness, which has lifetime
incidences in the general population of 10 to 25
percent for women and 5 to 12 percent for men
(APA 2000). People with bipolar disorder also
are subject to high rates of co-occurring sub-
stance abuse and dependence, with even higher
rates in specific populations. In the ECA study,
nearly 90 percent of those with bipolar disor-
der in a prison population had a co-occurring
substance use disorder (Regier et al. 1990).
Substance Use Among People
With Bipolar Disorder or
Schizophrenia
The search for specific patterns of use among
clients with schizophrenia or bipolar disorder
has not led to any clear pattern of drug choice.
Instead, there appears a strong likelihood that
whatever substances happen to be available
will be the substances used most typically
(Galanter et al. 1988). In research on the sub-
stance use of Australian and American patients
with schizophrenia, Fowler and coworkers
(1998) attributed the “slightly different pattern
of substances abused (i.e., absence of cocaine)”
to the “relative differences in the availability
[of] certain drugs” (p. 443).
There is evidence of increasing use of alcohol
and drugs among persons with schizophrenia.
Fowler and colleagues reviewed studies on the
substance use of people with schizophrenia,
concluding that alcohol abuse and dependence
increased “from 14 to 22 percent in the 1960s
and 1970s ... to 25 to 50 percent in the 1990s”
(1998, p. 444). The same analysis showed that
stimulant abuse or dependence also may have
nearly doubled from the 1970s to the 1990s,
from about 13 percent to between 17 percent
and 31 percent, respectively. However, Fowler
and coworkers also
found that hallucino-
gen abuse or depen-
dence declined from
roughly 12.5 percent
in the 1970s to 7 per-
cent in the 1990s, and
they estimate that
cannabis use has
remained stable at an
estimated range of
12.5 to 35.8 percent.
Sonne and Brady
(1999, p. 611) report
that some individuals
with bipolar disorder
use cocaine to “inten-
sify and lengthen
euphoric mood states
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Family members
and community
supports, when
appropriate,
should be included
in a client’s overall
treatment process.
rather than to self-medicate depressive
episodes.” However, other clinicians see the use
of alcohol by people with manic behaviors as
their way of trying to sedate the heightened
emotional state. Many authors report that
clients will claim to use substances to counter-
act feelings of hopelessness or other symptoms
of illness, but a majority of clients report that
they use drugs or alcohol in a manner similar
to persons who are not mentally ill—that is, to
“get high” and/or to be sociable and fit in with
others. It seems likely that clients can be con-
fused about their substance use. Addington and
Duchak (1997) report that clients state they use
substances to feel less depressed—even though
65 percent of them indicated that alcohol
increased their symptoms of depression. 
Key Issues and Concerns
Suicide and suicidal behaviors are major, ongo-
ing concerns for this client population, and the
substance abuse counselor should have a thor-
ough understanding of her or his role in pre-
venting suicide. Medication compliance should
be emphasized strongly and monitored at every
session. The cyclical nature of bipolar disorder,
frequently punctuated by bouts of deliberate
medication noncompliance, can test a coun-
selor’s patience, and it is crucial to cultivate
and convey an understanding of the allure of
the manic episode. 
Individuals with bipolar disorder do not have
the same cognitive limitations as individuals
with schizophrenia. Therefore, people with
bipolar disorder can function at a high level in
the work environment, and the maintenance of
their work position can be a key factor in their
long-term, successful treatment. Consequently,
quick attention to signs of depression or mania
can be critical, especially as medication might
be able to ward off the worsening of the client’s
condition. For developing mania, which is vir-
tually nonresponsive to psychosocial interven-
tions, a variety of mood stabilizers have
demonstrated remarkable efficacy. Their time-
ly use can avert potentially life-altering, nega-
tive events.
Family members and community supports,
when appropriate, should be considered for
inclusion in the overall treatment process for
these clients. The psychoeducational compo-
nent of treatment should include both mental
health and substance use disorder information,
from causes and the natural histories of the dis-
orders to the recovery process and how the ill-
nesses can interact.
A recovery perspective and a compassionate
attitude toward clients can convey hope and
allow them to envision significant recovery and
improvement in their lives. For example, in a
focus group study of 18 clients with schizophre-
nia and a substance use disorder, 16 had
received a course of individual therapy, and all
cited contact with their individual therapist as
“...helpful in their efforts to change substance
abuse patterns.” Many of the focus group par-
ticipants stressed the importance of the human-
to-human nature of their relationship with the
therapist and the key role of family members
and friends (Maisto et al. 1999, p. 223).
Strategies, Tools, and
Techniques
Engagement
For clients with psychosis, as for others with
co-occurring disorders, it is essential to build a
relationship. Actively helping them to secure
basic needs such as medical assistance and
housing helps with the engagement process, and
also helps create the level of stability needed
for treatment to proceed successfully (see
Figure D-11). It also is helpful to increase client
motivation for treatment through involvement
of the client’s family.
Screening and assessment
Clinicians experience a common difficulty in
determining whether psychotic symptoms rep-
resent a primary mental disorder or are sec-
ondary to substance use. In the early phase of
assessment, the goal is to stabilize the crisis
rather than to establish a diagnosis, which is
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often best determined during a multiple-con-
tact, longitudinal assessment process. The best
assessments include direct client interviews,
collateral data, observations of the client, and
a review of available documented history.
Especially with clients who have bipolar or
schizophrenic disorders, the counselor will
profit from always actively inquiring how they
are feeling and how things have been going.
These clients might sometimes inexplicably fail
to describe the most significant events or
changes spontaneously, even though they are
forthright and open about such matters when
asked.
Assessment of high-risk conditions
The initial step of every assessment is to deter-
mine whether the individual has an imminent
life-threatening condition. Three domains of
high risk require assessment: biological (or
medical), psychological, and social. At any
given time, one aspect of this biopsychosocial
approach may be more urgent than the others.
Medical risks
The goal of medical or biological assessment is
to ensure that clients do not have life-threaten-
ing disorders such as substance-induced toxic
states or withdrawal, delirium tremens, or
delirium.
Clients may exhibit symptoms that represent an
exacerbation of their underlying chronic men-
tal illness. Their symptoms may be due to an
aggravation of medical problems such as neuro-
logical disorders (e.g., brain hemorrhage,
seizure disorder), infections (central nervous
system infection, pneumonia, AIDS-related
complications), and endocrine disorders (dia-
betes, hyperthyroidism). The presence of cog-
nitive impairment (such as acute confusion,
disorientation, or memory impairment), unusu-
al hallucinations (such as visual, olfactory, or
tactile), or signs of physical illness (such as
fever, marked weight loss, or slurred speech)
show a high risk for an acute medical illness.
Clients who exhibit this degree of risk need to
be referred immediately for a comprehensive
medical assessment.
Social risks
The primary goal is to ensure that clients have
access to adequate supports and that their basic
needs are met. Clients with COD involving psy-
chosis are particularly vulnerable to homeless-
ness, housing instability, victimization, poor
nutrition, and inadequate financial resources.
Clients who lack basic supports may require
aggressive crisis intervention, such as the provi-
sion of food and assistance with locating a safe
shelter. Lack of these social supports can be life
threatening and can exacerbate and intensify
both medical and psychiatric emergencies.
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Figure D-11
Engaging the Client With Chronic Psychosis
Positive Engagement Techniques Coercive Engagement Techniques
• Assistance obtaining food, shelter, and clothing
• Assistance obtaining entitlements and social 
services
• Drop-in centers as entry to treatment
• Recreational activities
• Low-stress, nonconfrontational approaches
• Outreach to client’s community
• Involuntary commitment
• Use of a representative payee
• Mandated medications
Psychological risks
The primary goal of psychological assessments
must be an evaluation of the danger to self or
others and other manifestations of violent or
impulsive behavior. Clients with COD involving
psychosis have a higher risk for self-destructive
and violent behaviors, and should be assessed
for plans, intents, and means of carrying out
dangerous intent. Clients who are imminently
suicidal, homicidal, or otherwise pose a danger
need to be placed in a secure setting for further
assessment and treatment (see Figure D-12).
Some clients may have a cognitive impairment
related to their disorder and be unable to
attend adequately to basic needs. An assess-
ment for these types of problems need to be
conducted by appropriately trained and expe-
rienced graduate-level professionals. When a
substance abuse counselor participates in these
assessment processes, he or she can provide
vital information on the client’s behavior and
emotional state.
Clinician’s observations
The clinician’s observations are an important
aspect of the assessment. The clinician should
make careful note of the client’s overall behav-
ior, appearance, hygiene, speech, and gait. Of
particular interest are any acute changes in
these behaviors, as well as the emergence of
disorganized or bizarre thinking and behavior.
A long-term therapeutic relationship with the
client increases the opportunity to make clini-
cal observations that assist in making the dif-
ferential diagnosis. Within this context, clini-
cians can better understand the relationships
between the substance use and the symptoms of
mental disorders.
Collateral resources
As previously mentioned, data obtained from
direct interviews and self-reports, as well as
observational data, are limited. One important
way of augmenting these approaches is to
obtain information from collateral sources by
direct interviews with family members and sig-
nificant others concerning the psychiatric and
substance-related behavior of clients. The fam-
ily interview can also be a useful means of
obtaining further information regarding a fam-
ily history of psychiatric and substance use dis-
orders.
Useful documentation includes medical and
criminal justice records, as well as information
gathered from other sources such as landlords,
housing settings, social services, and employ-
ers. Case managers are in a unique position to
compile aggregate reports from these various
sources, since they follow clients over an
extended period of time in a variety of settings.
Laboratory tests
Laboratory tests for drug detection can be
valuable both in documenting substance use
and in assessing substance use in relation to
psychotic symptoms. Objective urine and blood
toxicology screens and alcohol Breathalyzer
tests can be useful. Besides being a diagnostic
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Figure D-12
Biopsychosocial Assessment of High-Risk Conditions
Biological risks: Assess for life-threatening medical problems
Psychological risks: Assess for violent and impulsive behaviors
Social risks: Assess basic needs and life supports
Clients should be asked direct questions about past and current access to basic needs such as food, shelter,
money, medication, or clothing. Clients should be assessed for past and recent episodes of victimization and
of exchanging sex for money, drugs, and shelter.
tool, data from urine screens may be particu-
larly important for clients who deny regular
use of substances and who can benefit from
objective evidence of substance use. Toxicology
screens that document the absence of drug use
can provide positive feedback for abstinent
clients who are actively working to maintain
sobriety.
Social issues
While psychiatric, medical, or substance-
induced disorders may be more visible to the
clinician than social problems, the latter can
contribute significantly to the elaboration of
the disorder and to the client’s receptivity to
treatment. Indeed, the client with a co-occur-
ring substance use disorder is more likely than
not to have significant impairment in the social
area. Thus, identifying the problem areas of a
specific client’s social life becomes a core com-
ponent of the service or treatment plan.
Primary health care
A current or recent comprehensive medical
evaluation is an essential aspect of the overall
assessment for clients with psychotic disorders,
since they generally have a high prevalence of
medical problems. It is also important to evalu-
ate the relationships between clients’ medical
problems and their psychotic and substance
use disorders. For example, medical problems
may: (1) coexist with co-occurring disorders,
(2) prompt or exacerbate psychotic and/or sub-
stance use disorders, or (3) be the direct or
indirect result of perpetuating co-occurring dis-
orders.
It is especially important for these clients to
have easy access to treatment for medical con-
ditions that are strongly associated with sub-
stance use, such as tuberculosis, hepatitis, dia-
betes, and HIV/AIDS. They should also have
easy access to primary care treatment for basic
medical needs, such as hypertension, as well as
cardiovascular, respiratory, and neurological
disorders. Prenatal care and monitoring should
be available to pregnant women who may be
especially at risk for relapse when her regular
antipsychotic medication regimen is contraindi-
cated.
For clients who are taking prescribed medica-
tions, it is important to assess the types of med-
ications, whether the medications are being
taken as prescribed, and the types of side
effects they may cause. Clients should be asked
specifically about the frequency, dosage, and
duration of any prescription medication.
Medication noncompliance is the rule, not the
exception, for people with co-occurring disor-
ders. Psychiatric medication noncompliance is
particularly associated with co-occurring disor-
ders that involve psychosis, and has a signifi-
cant impact on presenting symptoms and level
of function. Because of this common association
between substance use and noncompliance, and
the limited utility of self-reports in this area,
prescribing physicians often order serum drug
level tests for psychiatric medications.
In addition to considering substance use as a
primary factor that affects the use of psychi-
atric medications, it is also important to consid-
er the potential role of psychiatric medications
in subsequent substance use. For example, side
effects such as akathisia (severe restlessness) or
sedation may be caused by antipsychotic medi-
cations, and clients may take alcohol and/or
other drugs in an attempt to medicate these
unwanted side effects.
Frequently, clients spend money on psychoac-
tive substances rather than on adequate and
nutritious food; the resulting nutritional
impairment can lead to impaired cognition. A
lack of regular meals and poor nutrition are
common occurrences among clients with COD;
therefore, access to regular meals should be
assessed. Acute dental problems as well as reg-
ular periodic dental care also should be
assessed. Because this group frequently experi-
ences financial difficulties, dental care often is
limited or nonexistent. Attention should be
given to the social and emotional consequences
of poor dental health, such as poor self-esteem
and diminished social interaction.
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Crisis stabilization
The most important initial step in treatment is
to identify high-risk conditions that require
immediate attention. Within the area of acute
management it is useful to differentiate between
acute management of crises and the resolution
of subacute problems that may be severe but
not life threatening.
High-risk conditions
The initial critical consideration for high-risk
conditions is to determine if a client requires
emergency medical treatment, psychiatric
treatment, or both. If the client is found to
require hospitalization, it is then necessary to
determine the type of treatment that is
required (e.g., primary health care, detoxifica-
tion, or psychiatric care). Such determinations
necessarily involve medical assessment and
intervention. Coordination with emergency
mental health services and the local police
department may be necessary to ensure the
immediate safety of the client and others.
Substance abuse treatment programs should
have clear and readily available policies and
procedures for addressing these situations, and
staff members should be thoroughly familiar
with their roles and responsibilities.
With regard to high-
risk social condi-
tions (homelessness,
housing instability,
victimization, and
unmet basic needs),
the priority is to
implement aggres-
sive case manage-
ment. Meeting
clients’ basic needs
is critical to the
treatment of COD,
including psychosis.
High-risk conditions
may be related to
medical, substance
use disorder, and/or
psychiatric crises,
and often will
require followup upon hospital discharge.
Regardless of the priority of the immediate
needs, the overall biopsychosocial needs of
clients must be addressed in a holistic manner,
considering both the psychosis and the sub-
stance use disorder. The approach must be
integrated and comprehensive despite the high-
er visibility of one of the disorders at a given
time.
Therapeutic coercion
Those clients with severe mental or substance
use disorders who do not respond to these ini-
tial attempts at engagement in the treatment
process may require the use of therapeutic
coercive approaches. Clients with severe COD
may have gross cognitive impairment due to
substance dependence and may be severely dis-
organized due to mental illness. They may be
impulsive, exhibit extremely poor judgment, or
be subject to repeated episodes in which they
are dangerous to themselves or others. Without
therapeutic coercive interventions, some of
these clients may be at substantial risk of catas-
trophic outcomes, including death, injury, vio-
lent behavior, or long-term incarceration.
Examples of therapeutic coercive approaches
include the appointment of a representative
payee, guardian, or conservator, and the use of
parole or probation. Legal advocacy by a case
manager for court-mandated treatment services
may be essential for engaging in and maintain-
ing treatment services. Other mechanisms
include commitment to outpatient treatment
services, conditional discharge, and commit-
ment to appropriate inpatient treatment.
Therapeutic coercive efforts should be tempo-
rary and reserved for clients for whom other
interventions have failed. The long-term goal
for these clients is to regain control over their
lives. Even when coercion is necessary, the
counselor can focus on the dangerous or harm-
ful circumstances and avoid having the client
take commitment or other coercion as a sign of
personal failure, or as an indication of the
counselor rejecting the client. Although at the
time the client may protest, claiming to be mis-
treated and misunderstood, he or she often
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Clients with severe
or persistent men-
tal and substance
use disorders
require dually
focused, integrated
treatment.
later expresses appreciation to the counselor
for the concern shown in seeing that the client’s
basic needs were met. This turnabout especial-
ly is likely when the counselor is able to convey
compassion and understanding (though not
agreement) throughout the process involving
coercive elements.
Short-term care and 
treatment
Following the resolution of the acute crisis,
subacute conditions must be addressed before
long-term management can occur. (Subacute
conditions can also occur as a precursor to
acute relapse of psychiatric symptomatology or
substance use.) Examples of specific manage-
ment issues that may arise in regard to suba-
cute conditions include resuming or adjusting
psychotropic medication, clients’ comfort with
the medication, medication compliance,
addressing acute psychiatric symptoms, estab-
lishing early substance abuse treatment inter-
vention, and establishing or sustaining clients’
connection with support systems and services
for obtaining housing and meeting basic needs.
The subacute phase offers an opportunity to
reassess the diagnosis and overall treatment
needs. The ultimate goal should be to establish
a long-term treatment plan, avert imminent
decompensation or relapse, and plan to
address long-term needs. Both short-term and
long-term plans should be developed with the
client and should be subject to periodic review
and revision.
Group treatment
Group process is a core element of substance
abuse and mental health treatment. However,
for clients with psychosis, group treatment
should be modified and provided in coordina-
tion with a comprehensive service plan. Clients
who have accepted the goal of abstinence, have
maintained mental health stability, and have
essential social skills may benefit from carefully
selected traditional 12-Step programs that are
sensitive to the needs of people with serious
mental illness. However, during the early phas-
es of treatment, an unfacilitated referral to tra-
ditional 12-Step programs could result in a
poor response. Fortunately, the growing move-
ment for dual recovery mutual self-help groups
(as described in chapter 7) is providing an
attractive alternative for clients with COD. The
core approach should include psychoeduca-
tional, supportive, behaviorally oriented, and
skill-building activities.
Longer term care
The overall goal of long-term management
should involve: (1) providing comprehensive
and integrated services for both the mental and
substance use disorders, and (2) doing so with
a long-term focus that addresses biopsychoso-
cial issues in accord with a treatment plan with
goals specific to a client’s situation. The follow-
ing cases exemplify some of the diverse issues
that may arise in treatment planning.
Discussion of case examples
Louisa F. and James T. (see text box, p. 396)
have different long-term needs. Louisa F.’s
brief reactive psychosis and depression may
never recur, but the relationship between her
alcohol use and mental disorder symptoms
should be explored. James T.’s chronic psy-
chosis and frequent substance abuse episodes
are woven together intricately and require
combined treatment.
These case examples are valuable to demon-
strate how the absence of a dual-focus
approach can lead to treatment failure. While
Louisa F.’s psychotic episode was related to
overwhelming stress, her alcohol use might be
underemphasized in a traditional mental health
setting. Doing so may obscure the possibility
that her drinking severely deepened her
depression, increased daytime agitation, and
exacerbated the psychotic episode.
While James T. has ongoing psychosis and sub-
stance abuse problems, focusing on only one set
of these problems means that he bounces back
and forth between the mental health and sub-
stance abuse treatment programs, depending on
his current symptoms. His involvement with the
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local medical clinic for treatment of physical
injuries that are sustained during episodes of
impaired thinking often complicates his already
uncoordinated treatment, especially if he is
given psychoactive agents for pain relief or what
seems to the medical clinic staff to be anxiety.
As these case examples illustrate, clients who
experience psychosis and substance abuse or
dependency often are highly symptomatic and
may have multiple psychosocial and behavioral
problems. It is common for such clients to have
undergone different approaches to treatment
by different providers without long-term suc-
cess. Furthermore, clarifying the diagnosis and
“underlying disorder” is extremely complicated
in the early phases of assessment. The first step
in treatment of a person with COD is an assess-
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Case Studies: The Importance of a Dual Recovery Approach
for Two Clients With Psychosis
Louisa F.
Married for more than 15 years, Louisa F. was responsible for most of the duties related to raising four chil-
dren and maintaining the home. In the past, she had been treated for an episode of postpartum psychosis,
but until recently she had not required any psychiatric medications or mental health services.
Her husband, a successful businessman, was the family’s only source of financial support and was emotion-
ally distant. While Louisa F. believed that her husband was frequently out of town on business trips, he was
actually nearby having an affair with a woman whom Louisa F. had known for many years. One day, he
abruptly informed Louisa F. of the affair and moved out of the house.
During the next 3 days, Louisa F. was intensely depressed and agitated. Her normally infrequent and low-
dose alcohol use escalated as she attempted to diminish her agitation and insomnia. During this time, she ate
and slept very little. She began to feel extremely guilty for even the smallest problem experienced by her
four children. She felt burdened by what she called her “transgressions, faults, and sins.” She expressed
fears about being doomed to “eternal damnation.” Loudly and inconsolably, she declared that she “had lost
her soul” and would have to repent for the rest of her life. While being taken to a nearby clinic for evalua-
tion, she passionately described a conspiracy by members of the Catholic Church to steal her soul.
James T.
In his inner-city neighborhood, James T. was well known by the local medical clinic, the substance abuse
treatment program, and the community mental health program. During the day he spent much of his time
walking around the neighborhood, frequently talking to himself or arguing with an unseen individual. He
spent most of his evenings in the park in a wooded area away from other people, except in the winter when
he slept in community-run shelters.
James T. has a prominent scar in the center of his forehead. When asked about it, he described in great
detail his “third eye,” and how he could see into the future through the eye. When asked about his stated
reluctance to live in an apartment, he described an aversion to “electromagnetic fields” that drain his “life
force” and make it difficult for him to “think about good things.” For extended periods lasting several
months, James T. appeared disheveled and agitated, and he could be seen drinking heavily or using whatev-
er drugs were available. During other periods, he did not use drugs and alcohol heavily and appeared well-
groomed.
In general, James T. was pleasant and well-liked, although he was known to become hostile and potentially
violent when he used substances.
ment that addresses biological, psychological,
and social issues.
Clients with severe or persistent mental and
substance use disorders, such as James T.,
require dually focused, integrated treatment.
Clients like Louisa F., who have mild or brief
symptoms of mental illness, may benefit from
consultations, collaborations, and mutual self-
help groups.
Long-term perspective
Both psychotic and substance use disorders
tend to be chronic disorders with multiple
relapses and remissions, supporting the need
for long-term treatment. For clients with COD
involving psychosis, a long-term approach is
imperative. Research has shown that individu-
als become abstinent and gain control over psy-
chiatric symptoms through a process that fre-
quently takes years, not days or months.
Front-loaded, intensive, expensive, and highly
stimulating short-term treatment modalities are
likely to have limited success with this group of
clients. Also, an accurate diagnosis and an
assessment of the role of substances in the
client’s psychosis necessitate a multiple-contact,
longitudinal assessment and treatment perspec-
tive.
Treatment teams
Especially for programs that treat clients with
psychotic and substance use disorders, it is
important that the program philosophy be
based on a multidisciplinary team approach.
Ideally, team members should be cross-trained,
and the team should include representatives
from the medical, mental health, and substance
abuse treatment systems. All staff members—
clinical, administrative, and operational—
should learn to use gentle or indirect con-
frontation techniques with these clients when
necessary. Many clients with co-occurring
schizophrenia require a temperate approach all
the time, and some people with bipolar disor-
der can take any criticism as an extreme insult,
particularly if they are experiencing the
grandiosity that often accompanies hypomanic,
manic, or residual states of the illness.
Assertive case management
Team members should endorse an assertive
case management approach, wherein the case
manager is expected to provide services to
clients in their own environments as well as at
the treatment site. The case manager must not
attempt to be the sole broker of treatment ser-
vices or the exclusive provider of office-based
treatment. A supportive and psychotherapeutic
approach to individual, group, and family
work should be employed.
Flexible hours are necessary to provide ser-
vices to these clients. Services need to be avail-
able during evening and weekend hours when
crises frequently occur. In addition, alternative
social activities and peer group activities often
take place in the evening and on weekends.
Using a behavioral and psychoedu-
cational perspective
The individual and group programs for clients
whose COD involves psychosis should be based
on a behavioral and psychoeducational per-
spective, not a psychodynamic approach.
Educational information should be repeated
often and presented in concrete terms using a
multimedia format. Programs should be modi-
fied to include frequent breaks and shorter ses-
sions than normal.
Special care should be taken with regard to
client education and group discussion about
“Higher Power” issues. If a program has this
focus, staff members should be trained to teach
clients and lead group discussions about spiri-
tuality and the concept of a Higher Power.
Staff members should understand the differ-
ence between spirituality and religion, and
especially the differences between spirituality,
religion, and delusional systems that have a
religious or spiritual content.
Associated psychosocial needs
Even intensive, carefully designed substance
abuse treatment is likely to have limited success
if the extensive psychosocial problems faced by
the client are not addressed concurrently.
Common psychosocial concerns of this group
include housing, finances and entitlements,
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legal services, job assistance, and access to ade-
quate food, clothing, and medication.
A particularly common complication of clients
with psychosis and substance use disorders is
housing instability and homelessness. Among
the possible housing services that may be par-
ticularly useful are shelters, supervised housing
settings, congregated living settings, treatment
milieu settings, and therapeutic communities.
Ideally, residential options and placements
should be long term, with the goal of promoting
independent, stable, and safe housing.
However, short-term options that are less than
ideal should be explored to ensure the client’s
basic safety from weather and violence. 
Vocational services
Vocational services also are essential for long-
term stabilization and recovery. Both sub-
stance abuse and mental health services have
traditionally referred clients to generic voca-
tional rehabilitation services; however, to be
effective these services must be integrated and
modified for the specialized needs of the indi-
vidual with psychosis and substance use disor-
ders. Temporary hire placements and job
coaching options are important elements to
incorporate into rehabilitation services for this
group.
Alternative support groups
An essential part of treatment for clients is the
development of alternative peer group relation-
ships that do not include substance use.
Developing these non–substance-using social
networks can be enhanced by programs that
provide social club activities, recreational
activities, and drop-in centers onsite, as well as
linkages to other community-based social pro-
grams. At the same time, clients should be
encouraged to establish and maintain relation-
ships, including family relationships, that are
supportive of treatment goals.
Family
Treatment can be substantially supported and
enhanced by direct involvement of the client’s
family. Services can include family psychoedu-
cational groups that focus on education about
substance use disorders and psychosis, includ-
ing those multifamily treatment groups that the
individual with the COD attends with his or her
family members.
Families also may be helpful in identifying
early signs of mental disorder or substance
use relapse symptoms. They can work with the
treatment team in initiating acute relapse pre-
vention and intervention. Confidentiality3
needs to be addressed at the beginning of
treatment, with the goal of identifying a signif-
icant support person who has the client’s per-
mission to be involved in the long-term treat-
ment process.
Relapse prevention
An essential component of relapse prevention
and relapse management is close monitoring of
clients for signs of substance abuse relapse and
a return of psychotic symptoms. Relapse pre-
vention also includes closely monitoring the
development of clients’ substance refusal skills
and their recognition of early signs of psychi-
atric problems and substance use. The goals of
relapse prevention are (1) identification of
clients’ relapse signs, (2) identification of the
causes of relapse, and (3) development of spe-
cific intervention strategies to interrupt the
relapse process.
Close monitoring involves the long-term obser-
vation of clients for early signs of impending
psychiatric relapse. Such signs may include the
emergence of paranoid symptoms and symp-
toms related to substance use, such as hostile
or disorganized behavior. For example, a sign
of paranoid symptoms may be the client’s sud-
den and constant use of sunglasses. Additional
important clues may involve changes in daily
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3Confidentiality is governed by the Federal “Confidentiality of Alcohol and Drug Abuse Patient Records” regulations (42
C.F.R. Part 2) and the Federal “Standards for Privacy of Individually Identifiable Health Information” (45 C.F.R.
Parts 160 and 164).
routine, changes in social setting, loss of daily
structure, irritation with friends, and rejection
of help. Family members who reside with the
client often are the first to detect early signs of
psychotic or substance use relapse. Even rou-
tine daily stressors may have an intense impact
on the client with chronic psychosis and may
prompt relapse.
Objective laboratory tests also may be useful in
detecting relapse. These include the use of ran-
dom urine toxicology screens, current noninva-
sive measures of alcohol use (e.g., saliva or
breath analysis), and blood tests to detect
street drugs. As medication noncompliance is
associated strongly with both substance use and
psychotic relapse, blood medication levels
(including antipsychotic and lithium levels)
particularly may be useful. Finally, the use of
intramuscular forms of antipsychotic medica-
tions may be particularly useful with very diffi-
cult noncompliant clients for ensuring long-
term compliance with antipsychotic medica-
tions.
In addition to close monitoring by healthcare
professionals, family members, and significant
others, an important component of relapse pre-
vention is assisting the client with developing
skills to anticipate the early warning signs of
mental and substance use disorders. These
skills can be acquired through direct individual
psychoeducation and participation in role-play
exercises and psychoeducation groups. These
clients should be trained in substance refusal
skills and to recognize situations that place
them at risk for substance use.
Similarly, these clients may benefit significantly
from behavioral therapy; development of relax-
ation, meditation, and biofeedback skills; exer-
cise; use of visualization techniques; and use of
relapse prevention workbooks. Pharmacologic
strategies may include the use of disulfiram or
naltrexone for certain clients.
Weiss and colleagues (1999) have developed a
promising relapse prevention model for group
therapy with persons who have a bipolar disor-
der. The treatment consists of 20 weekly therapy
groups, each of which focuses on a topic rele-
vant to both disor-
ders. Topics include
(1) denial, ambiva-
lence, and acceptance;
(2) self-help groups;
and (3) identifying and
fighting triggers. The
group is based on a
relapse prevention
model, which was
adapted to integrate
the treatment of bipo-
lar and substance use
disorders by focusing
on similarities between
the recovery and
relapse processes for
each. For instance,
just as many people
with substance use dis-
orders are tempted to abandon attempts at
abstinence after a “slip,” those with bipolar dis-
order may feel like stopping their medications
after experiencing a mood episode despite medi-
cation compliance. The group reviews strategies
for coping with a temporary setback in either
disorder, emphasizing the role of thoughts and
behaviors that can either improve or worsen
such a situation in either disorder. (For a more
detailed account of this approach see Weiss et al.
1999.)
Medication
With clients who have COD that involve psy-
chosis, lack of attention to medication issues is a
common provider mistake that often leads to
mental disorder or substance use relapse. Most
important, treatment programs must provide
aggressive treatment of medication side effects,
as ignoring the side effects of prescribed medica-
tion often results in clients using substances to
diminish such effects.
Equally important, clients should be educated
and thoroughly informed about (1) the specific
medication being prescribed, (2) the expected
results, (3) the medication’s time course, (4) pos-
sible medication side effects, and (5) the expect-
ed results of combined medication and sub-
stance use. Whenever possible, family members
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An important com-
ponent of relapse
prevention is helping
the client learn to
anticipate the early
warning signs of
mental and sub-
stance use disorders.
and significant others should be educated about
the medication.
Medication should not simply be prescribed or
provided to the client with psychosis. Rather, it
is critical to discuss with clients (1) their under-
standing of the purpose for the medication, (2)
their beliefs about the meaning of medication,
and (3) their understanding of the meaning of
compliance. It is important to ask clients what
they expect from the medication and what they
have been told about the medication. Overall, it
is important to understand the use of medication
from the client’s perspective. Indeed, informed
consent relative to a client’s use of medication
requires that the client have a thorough under-
standing of the medication as described above.
It also is important to help clients prepare for
peer reaction to the use of medication during
participation in certain 12-Step programs.
Clients should be taught to educate other people
who may have biases against prescription medi-
cations or who may be misinformed about
antipsychotic medications.
Ideally, clients receiving medication should par-
ticipate in professionally led medication educa-
tion groups and medication-specific peer sup-
port groups. These groups will help clients to
manage the emotional and social aspects of med-
ication, promote medication compliance, and
help clinicians and clients identify and address
early noncompliance and side-effect problems.
Overall, a specific and aggressive treatment
strategy that helps make medication use simple
and comfortable is essential. The scheduling
and administration of medication should be
simple and convenient for clients. The ideal
schedule for oral medications is once per day.
The use of depot scheduling may be the most
comfortable and effective option for some
clients with COD involving psychosis.
Case Studies
Individuals with psychosis and substance use
disorders more often present for treatment in
the mental health setting. However, in some sit-
uations individuals with psychosis will report to
substance abuse treatment settings. For exam-
ple, counselors may encounter a paranoid dis-
order that does not become apparent until the
client has been in treatment for some time, as
in the case study “A Hidden Psychosis.”
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Case Study: A Hidden Psychosis
John R. was a 33-year-old client who had been treated for about 2 months in the substance abuse treatment
clinic. He was mostly quiet in treatment groups and had limited, though appropriate, social interaction with
his peers. His affect was somewhat restricted, but he initially denied a history of mental health services. He
was single, attended community college part time, and lived with his parents. During the first 2 months he
complained about somatic symptoms and cravings. During discussions in group treatment, he started to
become more vocal. He laughed inappropriately at times and often appeared to be laughing quietly at his own
jokes. Later, he confided in his therapist that he thought he was ugly and that his nose was disfigured because
he lied. He was also focused on the fact that he was 5 feet 5 inches; he wanted to have a surgical procedure to
increase his height because he would never get a girlfriend if he wasn’t taller.
Discussion: Some cases of schizophrenia are mild and are only uncovered over time. A case this mild might be
treatable in the substance abuse treatment setting, with a consultation with the psychiatrist to evaluate the
need for medication.
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Case Study: Denial of Psychosis
Bob K. was a 31-year-old client who was homeless and living in and out of shelters. He stated that he loved
smoking pot but that the cocaine was taking a toll on him. Cocaine binges would cause him to hear voices
and become suspicious of others. Bob K. presented disheveled, with poor hygiene. He denied prior mental
health services and refused to see the psychiatrist because he didn’t want to be put on any medications. He
admitted later that he had some mental health services previously, but didn’t agree with the therapist’s diag-
nosis of schizophrenia. He did have periods of hallucinations and paranoia even when he had not used
cocaine for several weeks. He stated that the voices he heard were due to a bad LSD trip when he was 21
years old and that since then God has been punishing him for doing drugs and not listening to his mother.
Discussion: With an unmotivated client like Bob K., it is best to go easy and not challenge his belief system
head-on. The initial goal is to keep him in treatment, not to insist on his acceptance of the label of
“schizophrenic.” It would be best to assure him, for example, that even if his symptoms are a result of drug
use, medication could be helpful. The psychiatrist would do well to start him at a low dose of medication,
because he might bolt from treatment if he experienced side effects.
Case Study: Aftereffects of Drug Use
Sue P. was a 24-year-old who became extremely frightened and agitated upon returning from a “rave”
party. Her mother brought her to the emergency room because of her daughter’s strange behaviors and odd
comments. Sue was a college graduate who was working in sales and living at home. She wanted to stay in a
fetal position, was fearful of others, and worried that the police had planted listening devices in her home.
After about 48 hours Sue was less paranoid and more relaxed. She then was able to admit to doing ecstasy
and ketamine at the rave.
Discussion: Sue will probably recover well in a quiet room with supervision, possibly from her mother or
possibly as an inpatient. She should have a low dose of antipsychotic medication for about a week and
should be carefully assessed for suicidal tendencies. She should be told clearly that the effects she is experi-
encing are the result of drug use.
Case Study: Counseling a Binge Drinker With Bipolar
Disorder
Francisco H. has come for treatment after losing his job because of binge drinking. Francisco H. has little
energy and his voice is so low the counselor can barely hear it. Probing for depression, the counselor learns
that Francisco H. has at least five symptoms of depression and has previously been diagnosed as having
bipolar disorder. He says he sometimes drinks to calm down “when he’s flying too fast.” However, he has
not taken his medication regularly and believes if he can just stop drinking he will be fine. He has been
attending AA meetings sporadically and has been told that medication is just another form of drug.
The counselor gives Francisco H. a brochure from AA on medication for mental illness (Alcoholics
Anonymous World Services 1984). He points out that acceptance of medication is an important step in
recovery, suggesting that Francisco H.’s bipolar disorder and alcohol abuse interact with each other. Using 
Attention
Deficit/Hyperactivity
Disorder (AD/HD)
Description
AD/HD is “a persistent pattern of inattention
and/or hyperactivity-impulsivity that is more
frequently displayed and more severe than typ-
ically is observed in individuals at a compara-
ble level of development” (APA 2000, p. 85).
People with AD/HD may fail to give close atten-
tion to details, be easily distracted, shift among
activities without completing tasks, have disor-
ganized work habits, and forget obligations.
Hyperactivity may be indicated by “fidgeti-
ness,” difficulty engaging in quiet activities,
and general restlessness. Individuals with
AD/HD may be impatient and engage in dan-
gerous activities without thinking of the conse-
quences. Strictly speaking, those with attention
deficit do not have a deficit in attention but “a
lack of consistency in direction and control.”
They have been described as “attending to
everything” (Waid et al. 1998, p. 394). Often,
individuals with AD/HD have poor self-
esteem, are demoralized, and may be rejected
by their peers.
Symptoms of this disorder are most likely to be
evident in a group setting. Usually symptoms
lessen as children mature, though adults may
continue to have difficulty participating in
sedentary activities. Many adults diagnosed
with AD/HD complain of having a hot temper,
low self-esteem, inability to relax, inability to
complete tasks, poor driving skills, family vio-
lence, and difficulty sustaining jobs or relation-
ships. Their key “neuropsychological weak-
ness” has been termed “executive dysfunction,”
which includes difficulties with planning,
sequencing, and organizing activities. Some
adults with AD/HD learn to channel their ener-
gy into sports-related activities or find other
means of coping with the disorder.
There are three types of AD/HD: a “combined
type” in which a person has both difficulty
paying attention and hyperactivity, a type that
is “predominantly inattentive,” and a type that
is “predominantly hyperactive-impulsive.” It is
important to note that “the validity of the diag-
nosis of AD/HD, particularly in adults, has
been questioned” (Waid et al. 1998, p. 393).
However, AD/HD is now recognized as a disor-
der by DSM-IV, the standard guidance on diag-
nosis for mental disorders (APA 2000).
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Case Study: Counseling a Binge Drinker With Bipolar
Disorder (continued)
motivational interviewing techniques, he finds that Francisco H.’s major concern is his need for work; his
wife is pregnant, and his loss of a job has put the family in a precarious position. He suggests that taking the
medication will help Francisco H. level out mentally and enable him to seek employment. If he uses the med-
ication consistently along with other recovery supports, including a 12-Step group that meets at the center,
he may be able to break the interactive cycle between the two disorders. The counselor cautions that 3 or 4
weeks may be needed to feel the full effects of the medication and alerts him to the possibility of side effects,
which should be reported immediately. He lets him know, however, that if Francisco H. does experience side
effects with one antidepressant, he may be able to take others. Francisco H. accepts a consultation with the
psychiatrist to explore the possibility of medication.
Discussion: Often, a client is motivated to address one disorder but not the other. The counselor should help
the client recognize the possible relationship between the two. When the use of medication is a concern, the
counselor should be prepared to explain the difference between drugging or drinking to get high and using a
prescription drug to stay at a normal level of functioning. AA literature that addresses this topic is often
helpful (see appendix J for information).
Symptom clusters for inattention and for
hyperactivity-impulsivity are illustrated in
Figures D-13 and D-14.
Differential Diagnosis
A number of other mental disorders may pro-
duce symptoms similar to AD/HD, including
substance-related cognitive impairment, bipo-
lar disorder, major depression, anxiety disor-
der, dissociative identity disorders, social pho-
bia, and personality disorders, especially
obsessive-compulsive personality disorder.
AD/HD must also be distinguished from per-
sonality change that may occur as a result of a
medical condition, such as a stroke, head trau-
ma, or hypothyroidism. Both alcohol and mari-
juana abuse can produce symptoms that mimic
AD/HD. 
It is important to rule out other causes of inat-
tention or hyperactivity. People with substance
use disorders who are newly abstinent or those
in active or protracted withdrawal may experi-
ence some impairments similar to AD/HD.
Some persons with low IQs may also exhibit
AD/HD symptoms.
Further adequate assessment and treatment for
potential withdrawal syndromes should occur
before concluding that the client is either cogni-
tively impaired or has AD/HD (see also TIP 29,
Substance Use Disorder Treatment for People
with Physical and Cognitive Disabilities [CSAT
1998e]). Keys to reliable diagnosis of AD/HD in
adults include the following:
• Childhood history
• Corroboration by an outside source
• Proof of impairment, such as problems with
certain types of work or study
• Persistence of symptoms over time without
fluctuation
• Taking into account the effect of the context
(e.g., inability to focus on reading matter in a
crowded, noisy subway car does not imply
AD/HD)
• Cognitive testing
• Questionnaires
Prevalence
A recent review reports the prevalence of
AD/HD among children as wide as 2 to 19 per-
cent (Rowland et al. 2002). Between 10 and 65
percent of individuals who have AD/HD as chil-
dren continue to have debilitating symptoms of
the disorder as adults (Waid et al. 1998).
Studies of the adult substance abuse treatment
population have found AD/HD in 5 to 25 per-
cent of persons, suggesting that about one in six
clients may have this co-occurring problem
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Figure D-14
AD/HD Symptom Cluster:
Hyperactivity-Impulsivity
• Fidgets, squirms
• Unable to remain seated
• Runs or climbs excessively (restless in adults)
• Inability to play (relax) quietly
• “On the go,” “driven by a motor”
• Talks excessively
• Blurts out answers
• Can’t wait for turn
• Interrupts, intrudes
Figure D-13
AD/HD Symptom Cluster:
Inattention
• Failure to attend to detail, careless mistakes
• Difficulty sustaining attention
• Does not listen
• Poor follow through, failure to finish
• Difficulty organizing tasks and activities
• Avoidance of effort-demanding tasks
• Losing things
• Easily distracted
• Forgetful in daily activities
(Clure et al. 1999; King et al. 1999; Levin et al.
1998; Schubiner et al. 2000; Weiss et al. 1998).
Waid and colleagues (1998) estimate that 33
percent of adults with AD/HD have histories of
alcohol abuse or dependence, and 20 percent
have other drug abuse or dependence histories.
A history of childhood AD/HD has been found
in 17 to 50 percent of people with substance use
disorders and from 17 to 45 percent in people
who abuse cocaine and opioids (Waid et al.
1998). Adults with persistent symptoms of
AD/HD who have a history of conduct disorder
or have co-occurring APD are at the highest
risk for having substance use disorders as well.
Substance Abuse and
Dependence Among Adults
With AD/HD
Adults with AD/HD have been found to abuse
primarily alcohol, with marijuana being the
second most common drug of abuse (Waid et al.
1998). While early studies hypothesized that
these clients used stimulants in an effort to self-
medicate, their preferences seem to be the same
as those of the general population (Waid et al.
1998). The relationship between AD/HD and
substance use disorders is important because
“clients with these combined disorders may
require and respond differentially to various
therapeutic approaches” (Waid et al. 1998, p.
393). The presence of AD/HD complicates the
treatment of substance abuse, since clients with
these co-occurring disorders have “more treat-
ment difficulties, poorer substance abuse treat-
ment outcomes, and a greater risk for relapse
than clients diagnosed with substance use dis-
order alone” (Waid et al. 1998, p. 412).
Obviously, such clients have more trouble in
didactic, lengthy sessions that require focus
and sustained attention.
Key Issues and Concerns
Though controversial, AD/HD appears to be a
real disorder and must be considered seriously
as a possibility for clients who show the symp-
tom clusters depicted in Figures D-13 and D-14
(p. 403).
Though stimulants are the pharmacological
treatment of choice for AD/HD in children,
clinicians should be aware that antidepressants
such as bupropion or desipramine are prefer-
able for chemically dependent adults.
Research is lacking on longer term outcomes,
and better biopsychosocial treatments remain
to be developed.
Strategies, Tools, and
Techniques
Engagement
During engagement, a problem can emerge if
the client divulges a previous AD/HD diagnosis
to a counselor who does not believe the prob-
lem exists. Another problem can occur if the
client has the hyperactive version of AD/HD,
which makes interaction difficult, and poses
many of the same challenges as hypomanic
clients. Such clients have trouble staying
focused and maintaining a dialogue. Eliciting
information and keeping the client on task for
the duration of the intake interview is difficult.
These clients may have a “short fuse” and
become irritable when the counselor has to
bring them back to the intake process repeat-
edly. During group, this type of behavior and
habitual side conversations can lead to intra-
group conflict.
These engagement problems are in fact the
beginning stages of differential diagnosis and
assessment. Adult AD/HD has not been widely
recognized or accepted in either the substance
abuse or mental health treatment communities,
but occupies a position similar to that of PTSD
in the last decade—clients with complaints, a
small amount of research, and often active
resistance by therapists to acknowledging that
AD/HD is a real disorder. Substance abuse
treatment counselors who hear clients say, “I
was just self-medicating my AD/HD with
cocaine,” as a convenient rationalization for
substance abuse may be even more suspicious,
but about one in six of these “rationalizers”
may have real attention deficit problems that
undermine their treatment and abstinence. At
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this stage, the best engagement strategy for
such clients is to keep an open mind to the pos-
sibility the client does have AD/HD and devel-
op services or referrals for clients who are
legitimately affected by AD/HD.
Engaging the hyperactive client
The counselor may use an adapted form of
motivational techniques for the invasive,
talkative, hyperactive client. The counselor
might tell the client which elements of discus-
sion he or she has successfully completed, then
reframe the remainder. For example, during
the initial intake question concerning what it
was that brought the client to the clinic, a client
may begin to talk about his alcohol and mari-
juana use, but rapidly move into a discussion
of the argument he and his wife have been hav-
ing about his poor work history (he gets jobs
but then loses them), then switch to talking
about what is wrong with the automobile indus-
try in the United States and pollution control.
After a few attempts to redirect, the counselor
is left thinking, “How can I get this guy to
focus? Why does he talk so fast and always
ends up off-topic? Is this denial, resistance,
hypomania, or attention deficit disorder?”
In such a situation, the counselor might
respond, “You sure pack a lot of information
into one answer. It’s hard for me to keep up!
So can we take things a bit slower? Now, let’s
go back to when you first started to use alco-
hol.” In this case, the client with AD/HD will
more likely be able to focus with frequent gen-
tle reminders. The hypomanic client will most
likely keep “revving up” and require more
active management. The school histories of
these two clients should be different, with the
client with AD/HD showing early school prob-
lems before substance abuse began.
Screening and assessment
Strictly speaking, it is not possible to diagnose
an adult as having AD/HD unless there is a
childhood history of the disorder. Basic screen-
ing for this possibility can be as simple as ask-
ing, “When you were in grade school, before
you used drugs or alcohol, did you have learn-
ing or behavior problems? Were you ever diag-
nosed with AD/HD? Did you ever take medica-
tions for this? How much did the medications
help?”
The clinician is advised to “focus on the prima-
ry symptoms of inattention, impulsivity, and
hyperactivity because secondary symptoms
such as procrastination, disorganization, for-
getfulness, chronic lateness, or underachieve-
ment do not necessarily indicate that the client
suffers from AD/HD” (Waid et al. 1998, p.
406).
Since people with substance use disorders are
not always good historians, whenever possible
it is useful to interview others who knew them
well as children. Evidence should also be
sought “via review of records, reports from
parents or significant others, and use of behav-
ioral checklists and questionnaires” (Waid et
al. 1998, p. 412). Scales and checklists current-
ly available for use in assessing behavioral
symptoms of AD/HD include the Hyperkinesis-
Minimal Brain Dysfunction Childhood
Symptom Checklist, the Wender Utah Rating
Scale (Ward et al. 1993), the Client Behavior
Checklist, and the Conners Abbreviated
Symptom Questionnaire. When using these
instruments, the clinician should be aware that
they have not been
validated for use in
substance-abusing
populations.
There is no “definitive
test battery” to assess
the neuropsychologi-
cal impairments asso-
ciated with AD/HD,
but much can be
learned by observing
clients’ behavior in
testing situations.
Frequent false starts,
off-task behavior, and
concentration prob-
lems are suggestive
(Waid et al. 1998),
and continuous per-
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The presence 
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complicates the
treatment of 
substance abuse.
formance tests—the
Gordon Diagnostic
System (GDS), the
Test of Variables of
Attention (TOVA),
and the Conners
Continuous
Performance Test—
can be used to mea-
sure distractibility.
The most common
attention problems
in people with sub-
stance use disorders
occur as a result of
short-term toxic
effects of substances.
Such difficulties
should improve with
each month of abstinence. With this in mind,
Waid and colleagues suggest that “frequent
reassessments as abstinence is maintained may
result in the detection or disappearance of
other psychiatric and cognitive disorders,
including learning disabilities” (Waid et al.
1998, p. 415). If attention symptoms do not
improve over time, the client should be
referred for further assessment.
Crisis stabilization
Adult AD/HD is not an emergency condition.
Rather, it usually is chronic, subtle, and diffi-
cult to separate from the client’s substance use
or its consequences. The most likely crisis that
might emerge is from the significant abuse of
prescription stimulants obtained illegally or
from a doctor outside the client’s established
healthcare providers. For example, a client
might arrive at a group intoxicated, on stimu-
lants, hyperactive, and evasive. The client
might have a positive urine test, but refuse to
accept the incident as serious because “the
medication was prescribed.” The second part
of the crisis would then require consultation
with the outside prescribing doctor; the client
must sign a consent form for the release of
information held by this doctor.
If the client is found to be taking psychoactive
and abusable prescription medications such as
amphetamines, Ritalin, and pemoline outside
of the substance abuse treatment agency treat-
ment plan, an immediate treatment conference
is needed to determine and discuss
• Client safety: Does the client need hospital-
ization or detoxification?
• If not, is the client willing to discontinue the
outside medications and continue substance
abuse treatment?
Preferably, medical personnel at the substance
abuse treatment agency will obtain the appro-
priate consent from the client, contact the out-
side doctor, discuss the case, and make the best
clinical decisions around the welfare of the
client. This typically includes consideration of
other, nonabusable AD/HD medications such
as bupropion or desipramine, preferably pre-
scribed by internal agency substance abuse
treatment staff (if available).
Short-term care and 
treatment
Unless the client already has been diagnosed
with valid AD/HD, which is possible but rare,
AD/HD cognitive and behavioral problems
begin to become apparent during this initial
phase of treatment. Poor attention and impul-
sive behavior are most likely due to continued
substance use or withdrawal; however, if the
client is found to be clean and has no history of
a mental disorder, then AD/HD should be con-
sidered, and the client should be referred to an
expert diagnostician. Since AD/HD expert diag-
nosticians are rare, especially as available to
substance abuse treatment agencies, the field
faces a serious challenge. Individual clinicians
need to do the best they can with their limited
resources.
Factors leading to underdiagnosis of AD/HD at
this stage include
• Reluctance on the part of staff or the client to
considering or accepting the diagnosis, or
lack of familiarity with the disorder.
406 Specific Mental Disorders: Additional Guidance for the Counselor
Education about
AD/HD may be
useful and 
enlightening to
many clients.
• Difficulties stemming from the client’s lack of
recall or having no family to help with the
diagnosis of a childhood AD/HD condition,
whether or not the diagnosis was made offi-
cially.
• The client’s life habits have compensated
partially for AD/HD symptoms, though
AD/HD was present in childhood and symp-
toms may emerge in the treatment process.
Factors leading to overdiagnosis include
• Attributing cognitive or behavioral abnor-
malities prematurely to AD/HD, rather than
considering the most usual causes (continued
substance use, withdrawal, or other disor-
ders noted above).
• Using results of standardized screens such as
the AD/HD Behavior Checklist for Adults
without considering that many positive
responses can be caused by substance use or
other mental disorders.
Assuming that the AD/HD diagnosis is reason-
ably and accurately made, sensible treatment
for adults with co-occurring substance depen-
dence and AD/HD include the following:
• Abstinence from substances of abuse or
dependence.
• A psychosocial treatment plan that takes into
account the client’s AD/HD profile—for
example, an increased use of visual aids
(Dansereau et al. 1995; Dees et al. 1994).
• The use of medications to increase attention.
Though substance-dependent AD/HD clients
may be able to take abusable stimulants in high-
ly monitored clinics, much as opioid-dependent
clients can take methadone in highly controlled
clinics, this approach should not be attempted
by other substance abuse treatment clinics.
Rather, when medication is indicated, bupropi-
on, tricyclics such as desipramine, or other
antidepressants should be used. These medica-
tions have been found to be about as effective as
stimulants, but are not abusable and have little
if any street value. The substance abuse treat-
ment counselor helps to monitor compliance,
asks about side effects, and communicates any
clinical responses to the prescriber.
Case management
Case management of suspected adult AD/HD
begins by arranging adequate diagnostic assess-
ment. If AD/HD is confirmed as the co-occur-
ring disorder, the counselor should employ the
elements of treatment as discussed below in this
section (see “Adapting Mental Health and
Substance Abuse Treatment Approaches”) and
monitor outcomes over time.
Psychoeducation
Education about AD/HD may be useful and
enlightening to many clients; self-help books
and AD/HD support groups also can be very
helpful (Waid et al. 1998). Waid and colleagues
suggest that “modalities other than
auditory/verbal ones may be constructive in
this population” (Waid et al. 1998, p. 413). For
example, consider the use of pamphlets (espe-
cially those with diagrams and pictographs)
and dramatic videos. In fact, many of the typi-
cal alternatives used in standard substance
abuse treatment—Alcoholics Anonymous meet-
ings (60 to 90 minutes versus all-day classes),
dramatic videos (versus textbooks), relapse
diagrams, and standardized short group check-
ins—help to focus those with impaired atten-
tion rather than overwhelm them with details.
Adapting mental health and sub-
stance abuse treatment approaches
Waid and colleagues recommend “structured
and goal-directed sessions, with the therapist
actively enhancing the client’s knowledge about
AD/HD and substance abuse and examining
false beliefs about the history of his or her diffi-
culties” to “serve as the framework for an
effective intervention” (Waid et al. 1998, p.
413). They caution that “long verbal
exchanges, extended group therapy, and over-
stimulating environments should be avoided, as
they often overtax the AD/HD substance abus-
ing client” (Waid et al. 1998, p. 413). Frequent
brief sessions are preferable to a few long
intense ones. The usual 3 hours, three times
weekly in Intensive Outpatient Programs will
be difficult for many people with AD/HD, even
when the AD/HD is being treated. These clients
should be assigned to therapists knowledgeable
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about both disorders so that appropriate
adjustments in treatment strategies can be
made as needed.
Longer term care
Even if response to medications and structure
occurs, the effects may be subtle and slow to
develop—it is primarily in longer term care
that the real benefit of integrated AD/HD care
emerges. The client will be more likely to stay
sober and in treatment within the framework of
longer term care. Gradually, the impulsiveness
and inattention should lessen. Coaching about
how to handle taking medications while attend-
ing 12-Step or other mutual self-help programs
also may be advisable.
Posttraumatic Stress
Disorder
Description
PTSD follows the experience of a psychologi-
cally traumatic stressor such as witnessing
death, being threatened with death or injury,
or being sexually abused. At the time of the
stressful event, the individual experiences
intense fear, helplessness, or horror. PTSD
entails three sets of symptoms that last longer
than 1 month and result in a decline in func-
tioning (e.g., work, social):
• Intrusion: a persistent reexperiencing of the
trauma in the form of intrusive images and
thoughts, recurrent nightmares, or experi-
encing episodes during which the trauma is
relived, as in flashbacks
• Avoidance: persistent avoidance of stimuli
related to the trauma such as activities, feel-
ings, and thoughts associated with the trau-
matic event
• Arousal: persistent symptoms of increased
arousal such as insomnia, irritability, hyper-
vigilance, and exaggerated startle response
Many physical, cognitive, and emotional dis-
ruptions can occur in response to an acute
traumatic event and/or PTSD. The DSM-IV-
TR (APA 2000, p. 465) lists the following asso-
ciated descriptive features:
• Impaired affect modulation
• Self-destructive and impulsive behavior
• Dissociative symptoms (Note: Dissociation
represents a psychic defense in which a per-
son is so overwhelmed by a traumatic memo-
ry or feeling that the mind simply “shuts
down,” literally removing itself [disassociat-
ing] from the present reality. The person may
become suddenly quiet, or stare into space,
as if they have entered a trance. Patients
have described dissociation as “being out of
it,” “losing time,” or “floating away.”)
• Somatic complaints
• Feelings of ineffectiveness, shame, despair, or
hopelessness
• Feeling permanently damaged
• A loss of previously sustained beliefs
• Hostility
• Social withdrawal
• Feeling constantly threatened
• Impaired relationships with others
• Change from the individual’s previous per-
sonality characteristics
The two conditions may coexist for decades,
particularly if both disorders are not addressed
adequately in treatment. Interest in the role of
trauma and PTSD have increased with the
recognition that they are common among sub-
stance abuse clients. This co-occurring disor-
der is particularly prevalent among women,
who typically experienced childhood physical
or sexual abuse. It also is prevalent in combat
veterans and many veterans’ hospitals have
PTSD treatment units (Forbes et al. 2003;
Steindl et al. 2003). The Department of
Veterans Affairs’ National Center for PTSD
has been a leading clinical and research
resource for both the trauma and substance
abuse fields (see www.ncptsd.org and the forth-
coming TIP Substance Abuse Treatment and
Trauma [CSAT in development d]).
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Prevalence
Community-based studies indicate the lifetime
prevalence of PTSD among adults in the
United States is about 8 percent (APA 2000).
Among high-risk individuals (those who have
survived “rape, military combat and captivity”
or “ethnically or politically motivated intern-
ment and genocide”), the proportion of those
with PTSD ranges from one-third to one-half
(APA 2000, p. 466).
Among clients in substance abuse treatment,
this co-occurring disorder is two to three times
more common in women than in men (Brown
and Wolfe 1994). The rate of PTSD among peo-
ple with substance use disorders is 12 to 34 per-
cent; for women who abuse substances, it is 30
to 59 percent. A review of the literature found
that PTSD often goes undetected due to lack of
screening (Leskin et al. 1999). See below for
suggestions on conducting a basic screening for
PTSD.
Most women with this co-occurring disorder
experienced childhood physical and/or sexual
abuse; men with both disorders typically expe-
rienced crime victimization or war trauma
(Kessler et al. 1995). Clients sometimes are per-
ceived as “crazy,” “lazy,” or “bad” by others
and by themselves (Najavits 2002). They may
carry a great burden of shame and guilt, as
both PTSD and substance abuse may be associ-
ated with keeping secrets and denial. Clinicians
are advised not to overlook the possibility of
PTSD in men; in Kessler’s major study of a
community sample, rates for men were higher
than for women (Kessler et al. 1995).
People with PTSD and substance abuse also are
more likely to experience another trauma than
people with substance abuse alone (Dansky et
al. 1998). Repeated trauma is common in
domestic violence, child abuse, and some sub-
stance abuse lifestyles (e.g., the drug trade).
Helping protect the client against future trauma
may be an important part of work in treatment.
It is also noteworthy that in a high percentage
of rape cases (37.9 percent), those who perpe-
trated the violent assault were using substances
at the time (Bureau of Justice Statistics 2002).
Substance Abuse and
Dependence Among People
With PTSD
People with PTSD tend to abuse the most
addictive substances (cocaine and opioids);
however, abuse of prescription medications,
marijuana, and alcohol also is common.
Substance abuse often is viewed as “self-medi-
cation” to cope with the overwhelming emotion-
al pain of PTSD (Chilcoat and Breslau 1998b;
Cottler et al. 1992; Goldenberg et al. 1995;
Grice et al. 1995; Najavits et al. 1997). From
the client’s perspective, PTSD symptoms are a
common trigger of
substance use (Brown
et al. 1995). The com-
bination of PTSD and
substance abuse may
present in combat vet-
erans, those with
acute PTSD related to
terrorist attacks,
those with chronic
PTSD related to
childhood events, and
others (Breslau et al.
2003; Forbes et al.
2003; Grieger et al.
2003; Riggs et al.
2003; Simpson 2003;
Steindl et al. 2003).
While under the influ-
ence of substances, a
person may be more
vulnerable to trauma—for example, the woman
drinking at a bar who goes home with a
stranger and is assaulted.
As a counselor, it is important to recognize—
and help clients to understand—that becoming
abstinent from substances does not resolve
PTSD; indeed, some PTSD symptoms might
become worse with abstinence at first (Brady et
al. 1994; Kofoed et al. 1993; Root 1989). As
clients give up substance use, they may be
overwhelmed by a flood of memories and feel-
ings that their substance use had kept at bay.
“You will feel better once you are clean and
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sober” is not an accurate message to give a
client with PTSD and substance use disorders.
A more accurate statement would be, “Getting
clean and sober will help you, but initially you
may find yourself facing feelings and memories
of your trauma. We can get through this togeth-
er, and eventually you can achieve recovery
from both the substance abuse and PTSD
issues.”
A variety of medications are used in the treat-
ment of PTSD, and since other anxiety disor-
ders (often panic, generalized anxiety) and
mood disorders (major depression, dysthymia,
bipolar II) often accompany PTSD, patients
can be on several medications at once, most
often an antidepressant, such as a sertraline or
paroxetine (SSRIs—see appendix F, Common
Medications for Disorders), which is frequently
combined with a sedative medication, such as
an anticonvulsant, or even an antipsychotic
(Ballenger et al. 2004; Davidson 2004).
Especially as a client with PTSD becomes absti-
nent, medications targeting mood, anxiety, or
severe nightmares may be of crucial impor-
tance. While benzodiazepines such as clon-
azepam and alprazolam often have been pre-
scribed to such clients for anxiety, and though a
few case reports exist that document the safe
use of these medications, the consensus panel
recommends that
benzodiazepines usu-
ally be avoided, as
panel members have
observed a great
many problems with
the use of benzodi-
azepines. Consensus
panel members
reported their own
experiences with
clients who abused
benzodiazepines—
clients experienced
escalating tolerance,
had periods of con-
fusion, and became
dependent on a med-
ication that is among
the most dangerous
in its withdrawal symptoms (seizures, etc.),
especially if used along with alcohol, as it often
is. Recent research has found both prazocin
and propranolol, which are older, generic anti-
hypertensives that decrease overactivity in the
autonomic nervous system, to hold great
promise in decreasing nightmares and flash-
backs (Raskind et al. 2002, 2003; Vaiva et al.
2003).
Key Issues and Concerns
Treatment of PTSD with co-occurring sub-
stance use disorders requires careful planning
and supervision. As the client faces painful
trauma memories, the desire for intoxication
can be overwhelming. By exploring trauma
memories, well-intentioned counselors inadver-
tently may drive a client back to the substance
by urging her to “tell her story” or “let out the
abuse.” Even if a client wants to talk about
trauma and seems safe during the session,
after-effects may well ensue, including a flood
of memories she is not prepared to handle,
increased suicidality, and “retraumatization”
where she feels as though she is reliving the
event. Such treatment approaches should be
undertaken only with adequate formal training
in both PTSD and substance abuse and only
under careful clinical supervision.
These clients need stability in their primary
therapeutic relationship; hence, this work
should not be undertaken in settings with high
staff turnover, and should never be undertaken
without training and supervision. The sub-
stance abuse counselor should not try to pro-
vide trauma-exploration treatment, in view of
the potential for highly destabilizing effects
(including worsening of substance use).
However, the substance counselor can play an
important role in helping to identify PTSD and
in providing present-focused psychoeducation
about PSTD, such as teaching the client to rec-
ognize symptoms of the disorder and how to
cope with them. For severe cases of PTSD,
treatment typically is long term.
Several well-developed, research-based, and
clinically tested models of treatment exist for
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Several 
well-developed, 
research-based,
and clinically 
tested models of
treatment exist for
PTSD.
PTSD (for example and reviews, see Foa et al.
2000; Follette et al. 1998; Yehuda 2002). Some
of these models are particularly suited for use
with clients who also have a substance use dis-
order (such as the Seeking Safety model dis-
cussed below). For example, the Trauma
Adaptive Recovery Group Education and
Therapy (TARGET) (Ford et al. 2000) has
developed a strengths-based approach to edu-
cation and skills training for trauma survivors
that presents a seven-step approach both for
changing the PTSD alarm response and for
relapse prevention during each of the sessions.
Other models (e.g., Abueg and Fairbank 1992;
Klever and Brom 1992) are eclectic—that is,
they mix a variety of strategies, techniques,
and models. Several of these eclectic approach-
es and various research studies focus on specif-
ic interventions or problems, such as Meisler
(1999) on group therapy for PTSD with alcohol
abuse; Brady et al. (1995) on the possible use
of sertraline; and Nishith et al. (2003) regard-
ing alcohol use for sleep by female rape victims.
Of course, this brief review of models barely
begins to cover the immense amount of work
related to trauma and substance abuse. Many
people working with clients on issues of child-
hood abuses have long known of the impor-
tance of including substance abuse in treatment
(e.g., Covington 2003; Evans and Sullivan
1995; Trotter 1992). For more information, see
the forthcoming TIP Substance Abuse
Treatment and Trauma (CSAT in development d).
The following sections are based on the Seeking
Safety (Najavits 2002) model, which the con-
sensus panel deems a practical and helpful
approach for most counselors. While Seeking
Safety was developed for women, the consensus
panel feels it is broadly appropriate for both
men and women with PTSD and co-occurring
substance use disorders. Several issues need to
be considered when working with PTSD/sub-
stance abuse treatment clients:
• Develop a plan for increased safety where
appropriate (e.g., this is less critical for
chronic PTSD secondary to childhood trau-
ma or war trauma)
• Establish trust
• “Listen” to a client’s behavior even more
than his or her words
• Recognize that a client with PTSD and sub-
stance use disorder may have a more difficult
time in treatment
• Help the client access treatment for PTSD
• Recognize the importance of one’s own trau-
ma history
• Help the client learn to de-escalate intense
emotions
• Reinforce the taking of appropriate medica-
tions
Develop a plan for increased safety. Some
clients with PTSD have a variety of safety
issues, including risk for further trauma, suici-
dality, and self-destructive behavior (e.g., self-
harm such as cutting, unsafe sex that may lead
to HIV, and involvement with people who
exploit them). Helping the client become aware
of these patterns, and identifying concrete
actions the client can use to cope with them,
may be highly beneficial. For example, a client
who is living with a partner who is battering
her (domestic violence) needs careful assis-
tance, often through consultation with a domes-
tic violence hotline or other expert who can
help advise on this difficult situation (see TIP
25, Substance Abuse Treatment and Domestic
Violence [CSAT 1997c]). See below for specific
treatment resources for safety-oriented work
with people with PTSD.
Establish trust. Sometimes clients who have
lived through trauma have difficulty trusting
others. The trauma may have been a violation
of an important relationship (e.g., in child
abuse or domestic violence), or the trauma may
have felt like something that could not be
talked about (e.g., war, rape). Substance
abuse, too, may have isolated the client.
Therefore, a key element of successful treat-
ment involves helping the client build trust,
never forcing her to talk about something she
does not want to, asking permission to talk
about sensitive issues, conveying respect and
empathy in tone, avoiding harsh confrontation,
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and generally acting as her advocate and ally,
even when difficult behaviors arise.
“Listen” to a client’s behavior even more than
words. Clients with PTSD often are not fully
conscious of the depth of their inner feelings.
They may be prone to internal “splitting” as
well, where their feeling-states are not integrat-
ed (e.g., they shift between anger and depres-
sion). They may find themselves acting in ways
that suddenly “happen,” rather than acting in
ways that are chosen. They also may keep their
feelings to themselves out of the fear of burden-
ing others. Monitoring the client’s actual
behaviors is key: Is she using substances more
or less? Is he showing up for treatment? Is she
able to follow through on commitments?
Recognize that a client with PTSD and sub-
stance use disorders may have a more difficult
time in treatment. Treatment outcomes for
clients with PTSD and substance use disorders
typically are worse than for other clients with
COD, and worse than for clients with substance
use disorders alone (Ouimette et al. 1998,
1999). Moreover, as compared to clients with
substance use disorders alone, clients whose
substance use disorder co-occurs with PTSD
have more problems in general (e.g., other Axis
I and II disorders, interpersonal and medical
problems, HIV risk) (Brady et al. 1994; Brown
and Wolfe 1994), and their treatment may be
more fragile and prone to relapse, unstable
alliances, and erratic attendance (Root 1989;
Triffleman 1998). If the counselor is to work
effectively with such clients, extra support and
encouragement is needed, along with a positive,
optimistic tone and strong outreach.
Help the client access treatment for PTSD. It is
recognized widely that integrated treatment—
treatment of both PTSD and substance
abuse—is likely to be more successful and more
sensitive to clients’ needs than substance abuse
treatment alone. Yet most clients with PTSD
receive only substance abuse treatment, despite
the fact that they prefer treatment for both
(Brown et al. 1998). The counselor should
inquire whether the client would like to address
her PTSD, and if so, the counselor can play a
pivotal role in providing a referral to such
treatment and the encouragement to partici-
pate. To help locate a PTSD specialist, the
International Society for Traumatic Stress
Studies has a listing of members (www.istss.org).
Recognize the importance of one’s own trauma
history. Counselors may have their own histo-
ries of trauma, which can have an impact on
their work both for better (increased empathy)
and worse (feeling triggered by clients). Honest
self-evaluation and self-care skills are impor-
tant, as well as seeking supervision and support
as needed.
Help the client learn to de-escalate intense emo-
tions. The nature of PTSD and substance use is
a frequent experience of overwhelming feelings.
Clients may find a seemingly small comment or
event to be a trigger, which can set off a crav-
ing to use substances. Teaching the client to do
grounding and to soothe himself can be an
important means to regain control. Grounding
(also called “centering,” “looking outward,”
“distraction,” or “healthy detachment”) uses a
set of simple strategies that facilitate detach-
ment from emotional pain, such as drug crav-
ings, self-harm impulses, anger, and sadness.
The technique distracts one from the impulse
to use substances or to hurt oneself by directing
the mental focus outward to the external world,
rather than inward toward the self. Figure D-
15 provides a basic overview of what is
involved in grounding. (For a lesson plan and
other materials on grounding, see Najavits
2002.)
Strategies, Tools, and
Techniques
It may be difficult for clients with PTSD to
form a trusting therapeutic alliance. They often
have great shame about both their illnesses and
may hide, minimize, or even lie about their
past as a means of psychological self-protec-
tion. Particularly in the case of people with
severe PTSD arising from child abuse, distrust
of others and fragile treatment alliances are
common. Clients often are full of anger, which
can be directed at self or at others, including
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Figure D-15
Grounding: A Coping Skill for Clients With Emotional Pain
Three major ways of grounding will be described—mental, physical, and soothing. “Mental” means focus-
ing your mind; “physical” means focusing on your senses (e.g., touch, hearing); and “soothing” means talk-
ing to yourself in a very kind way. You may find that one type works better for you, or all types may be
helpful. Note that grounding is different from relaxation training or meditation. In grounding, it is essen-
tial to keep your eyes open the entire time and to keep talking out loud. These strategies keep you focused
on the outside world.
Mental Grounding
• Describe your environment in detail using all your senses. For example, “The walls are white, there are
five pink chairs, there is a wooden bookshelf against the wall...” Describe objects, sounds, textures, col-
ors, smells, shapes, numbers, and temperature. You can do this anywhere. For example, on the subway:
“I’m on the subway. I’ll see the river soon. Those are the windows. This is the bench. The metal bar is
silver. The subway map has four colors...”
• Play a “categories” game with yourself. Try to name “types of dogs,” “jazz musicians,” “States that begin
with ‘A’,” “cars,” “TV shows,” “writers,” “sports,” “songs,” or “cities.”
• Do an age progression. If you have regressed to a younger age (e.g., 8 years old), you can slowly work
your way back up (e.g., “I’m now 9,” “I’m now 10,” “I’m now 11”…) until you are back to your current
age.
• Describe an everyday activity in great detail. For example, describe a meal that you cook (e.g., “First I
peel the potatoes and cut them into quarters, then I boil the water; I make an herb marinade of oregano,
basil, garlic, and olive oil…”).
• Imagine. Use an image: Glide along on skates away from your pain; change the TV channel to get to a
better show; think of a wall as a buffer between you and your pain.
• Say a safety statement. “My name is ____; I am safe right now. I am in the present, not the past. I am
located in _____; the date is _____.”
• Read something, saying each word to yourself. Or read each letter backward so that you focus on the let-
ters and not on the meaning of words.
• Use humor. Think of something funny to jolt yourself out of your mood.
• Count to 10 or say the alphabet, very s..l..o..w..l..y.
Physical Grounding
• Run cool or warm water over your hands.
• Grab onto your chair as hard as you can.
• Touch various objects around you: a pen, keys, your clothing, the table, the walls. Notice textures, col-
ors, materials, weight, temperature. Compare objects you touch: Is one colder? Lighter?
• Dig your heels into the floor-literally “grounding” them. Notice the tension centered in your heels as you
do this. Remind yourself that you are connected to the ground.
• Carry a grounding object in your pocket—a small object (a small rock, clay, ring, piece of cloth or yarn)
that you can touch whenever you feel triggered.
• Jump up and down.
counselors. They are likely to engage in power
struggles, especially when they feel helpless.
Counselors must try to maintain professional-
ism, composure, and empathy in working with
such clients, no matter how difficult. If the
counselor can stay calm, clear, and understand
the relational problems in light of the PTSD,
the client is likely to become engaged. However,
if the clinician argues, gives ultimatums, or
tries to coerce clients, clients are more likely to
drop out of treatment prematurely. Harsh con-
frontation, particularly for PTSD clients, can
feel like a reexperiencing of childhood trauma
and emotional abuse.
The counselor’s role in reinforcing medications
has been discussed extensively in chapter 5 and
will not be repeated here.
414 Specific Mental Disorders: Additional Guidance for the Counselor
Figure D-15 (continued)
Grounding: A Coping Skill for Clients With Emotional Pain
• Notice your body: The weight of your body in the chair; wiggling your toes in your socks; the feel of your
back against the chair. You are connected to the world.
• Stretch. Extend your fingers, arms or legs as far as you can; roll your head around.
• Clench and release your fists.
• Walk slowly, noticing each footstep, saying “left” and then “right,” with each step.
• Eat something, describing the flavors in detail to yourself.
• Focus on your breathing, noticing each inhale and exhale. Repeat a pleasant word to yourself on each
inhale (e.g., a favorite color or a soothing word such as “safe” or “easy”).
Soothing Grounding
• Say kind statements, as if you were talking to a small child. For example, “You are a good person going
through a hard time. You’ll get through this.”
• Think of favorites. Think of your favorite color, animal, season, food, time of day, or TV show.
• Picture people you care about (e.g., your children), and look at photographs of them.
• Remember the words to an inspiring song, quotation, or poem that makes you feel better, such as the
Serenity Prayer.
• Remember a safe place. Describe a place that you find very soothing (perhaps the beach or mountains, or
a favorite room); focus on everything about that place—the sounds, colors, shapes, objects, and textures.
• Say a coping statement. “I can handle this.” “This feeling will pass.”
• Plan out a safe treat for yourself, such as a piece of candy, a nice dinner, or a warm bath.
• Think of things you are looking forward to in the next week, perhaps time with a friend, going to a
movie, or going on a hike.
• Create a cassette tape of a grounding message that you can play when needed; consider asking your ther-
apist or someone close to you to record it if you want to hear someone else’s voice.
• Think about why grounding works. Why might it be that by focusing on the external world, you become
more aware of an inner peacefulness? Notice the methods that work for you-—why might those be more
powerful for you than other methods?
• Don’t give up.
Screening and assessment
It is important to emphasize that, in obtaining
a preliminary diagnosis of PTSD, it can be
damaging to ask the client to describe traumat-
ic events in detail. When screening it is impor-
tant to limit questioning to very brief and gen-
eral questions, such as “Have you ever experi-
enced childhood physical abuse? Sexual abuse?
A natural disaster such as a hurricane or tor-
nado? A serious accident? Violence or the
threat of it? Seeing a dead body?” Once a brief
and general identification of such traumas has
occurred, the substance counselor should not
seek to obtain detailed description of such
events, which can be extremely destabilizing
for the client and is unnecessary for screening
purposes. Indeed, it has been found that having
the client complete a written questionnaire leads
to higher reporting of traumas and may be less
upsetting for clients (Najavits et al. 1998).
Assuming the client has a trauma, the Modified
PTSD Symptom Scale (Falsetti et al. 1993) is a
good screening instrument. The scale asks
about each of the DSM-IV symptoms for PTSD
and is useful for monitoring and tracking
PTSD over time. Although it is relatively rare
for clients to become upset when answering a
written questionnaire about trauma, if such a
questionnaire is used, the client should know
how to locate clinical staff for help if the pro-
cess becomes too upsetting. Both childhood and
adult traumas should be identified; for exam-
ple, a rape experience within the last year and
early childhood incest both could lead to the
development of anxiety disorders. Because peo-
ple living in violent situations, such as prosti-
tutes who have been raped, can manifest anxi-
ety symptoms, it is a mistake to ignore proximal
violence and look solely at early traumas. Abuse
of males as well as females must be considered,
as the issue of physical and sexual abuse of
males historically has been overlooked.
Crisis stabilization
Danger to self is a particular risk for clients
with PTSD and substance abuse; the self-harm
may include suicidality, which is common in
this population, as well as self-injurious behav-
ior such as cutting or burning. People in disso-
ciated states may put themselves in danger to
which they remain unaware, thus may require
involuntary commitment. Finally, the potential
for harm to others needs to be considered, par-
ticularly in clients with PTSD who show high
levels of aggression and poor impulse control.
The clinician should establish a written plan
that details what the client will do if he feels
the impulse to act out any self-harm behavior;
this plan should include who to call after hours
(for outpatient care), as well as strategies that
may help the client reduce the impulse. The
client and the clinician should each keep a
copy of the plan.
Short-term care and 
treatment
Safety-oriented, skill-building
treatment
For clients with PTSD and substance abuse,
providing psychoeducation about the disorders
and teaching coping skills to gain control over
the symptoms usually form an essential founda-
tion of treatment. For example, the client with
PTSD can learn to identify symptoms of “intru-
sion, avoidance, and arousal” and be trained to
use grounding to manage these symptoms.
Other skills include rethinking, activity schedul-
ing, seeking out interpersonal support, identify-
ing and fighting PTSD and substance abuse
triggers, and learning to communicate with oth-
ers. Helping clients understand the link between
their PTSD and substance use is also part of
such treatment; specifically, how each may trig-
ger the other, and how mastery of one disorder
can help with overcoming the other.
Notice that such treatment directly addresses
PTSD but doesn’t push the client to describe
or explore trauma memories. It is considered
the safest and most essential “first-stage”
approach, and is likely the best choice for most
substance abuse treatment settings, particular-
ly those that are short-term, have clients with
PTSD and substance use disorders with acute
suicidality or self-harm, and/or have staff who
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have not undergone formal training in PTSD
treatment. For treatment manuals, see
Najavits’ Seeking Safety model (2002), which
has undergone empirical testing, and two man-
uals in the 12-Step tradition, Evans and
Sullivan (1995) and Trotter (1992).
Trauma exploration work
This type of treatment involves having clients
face their painful trauma memories, telling the
story of what happened, and facing the associ-
ated intense emotions. These treatments, all
initially developed on clients who did not abuse
substances, include exposure therapy (Foa and
Rothbaum 1998), mourning (Herman 1997),
eye movement desensitization reprocessing
(Shapiro 1989), and the counting method
(Ochberg 1996). Such treatments are consid-
ered high-risk for substance abuse clients and
should be conducted (or at least supervised)
only by providers with formal training in
PTSD, and then only when the client is ready.
Readiness for such work depends on a variety
of factors, including the context of treatment
(i.e., length of stay), the client’s safety level,
and the availability of staff to manage the
intense feelings that surface (often after hours).
As noted above, even if the client wants to talk
about trauma, he or she may not be ready to
do so safely and may underestimate the desta-
bilizing effect such work will have.
Only a few pilot studies so far have evaluated
trauma-exploration therapies in substance
abuse clients (Brady et al. 2001; Triffleman
2000). While some positive results have been
found, generally it is believed that more work is
needed to define which clients, under what con-
ditions, and with what staff training, are need-
ed for this type of work. 
Longer term care
For clients with a severe trauma history, treat-
ment is likely to be long term. If possible, refer
the client with PTSD to an individual therapist
who can work with the client consistently over
a long period. Individual therapy generally is
needed (in addition to the standard group
treatments typical of substance abuse treat-
ment programs) to permit confidential discus-
sion of, and adequate attention to, trauma.
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Case Study: Counseling a Client with Polysubstance Abuse
and PTSD
Carlos F. is a 34-year-old man who repeatedly has been admitted to detoxification and substance abuse
treatment for polysubstance abuse. He appears aggressive and defensive and tends to isolate. Since child-
hood, he has a long history of starting fights, and does not like to talk about his past. He was not assessed
for PTSD until the present admission, where a counselor found out that he was physically and sexually
abused by his mother during childhood. Carlos F. had never heard of PTSD, but when presented with edu-
cation about the symptoms he was able to recognize them in himself immediately. Carlos F. stated, “I always
thought there was just something wrong with me—bad genes, or just a bad attitude. It is a relief to know
there’s a reason why I feel and act the way I do.”
Discussion: Counselors often are more likely to diagnose PTSD in women, with the single exception being
soldiers or survivors of kidnapping or torture. It is important to screen for PTSD for all clients—men and
women—and for all types of trauma. For more information on PTSD and trauma, see the forthcoming TIP
Substance Abuse Treatment and Trauma (CSAT in development d).
Eating Disorders
Description
Dieting and concern about body weight and
shape are ever-present among people (especial-
ly women) in Western cultures. Young women
who are of normal weight report high rates of
dissatisfaction with their body weight and size.
Dieting, which is nearly universal among
female youth, often is the first step toward
developing an eating disorder; however, only a
small percentage of women who diet actually
progress to an eating disorder. The primary
eating disorders are anorexia nervosa and
bulimia nervosa; however, the classification
system has not yet been perfected, as the
majority of individuals who seek treatment for
an eating disorder fall under the diagnostic
heading of “eating disorders not otherwise
specified.”
Anorexia nervosa
Anorexia nervosa, the most visible eating disor-
der, is marked by a refusal to maintain body
weight above the minimally normal weight for
age and height (currently operationalized as 85
percent of expected weight for height).
Anorexia nervosa (“nervous loss of appetite”)
is a misnomer. Only in extreme stages of inani-
tion (i.e., exhaustion as a result of lack of
nutrients in the blood) is appetite actually lost.
Individuals with anorexia nervosa have a
dogged determination to lose weight and can
achieve this in several ways. Individuals with
the classic restricting subtype of anorexia ner-
vosa achieve this weight loss solely through
severe food restriction, exercise, and fasting.
Others augment their dieting with vomiting,
laxative use, diuretic use, diet pills, and other
methods of purging. In addition to these purg-
ing behaviors, women with the bulimic subtype
also exhibit binge eating.
Individuals with anorexia nervosa have an
intense fear of gaining weight even when emaci-
ated, place undue importance on weight and
shape in terms of self-evaluation, deny the seri-
ousness of their illness, and may experience a
distortion of the manner in which they perceive
their own body size (i.e., they may see them-
selves as fat even when emaciated). In women,
the cessation of menstrual periods for 3 or
more months officially is required to diagnose
anorexia nervosa; however, this criterion
should be viewed with caution because there is
great variation in the reproductive system’s
response to starvation.
The age of onset of anorexia nervosa usually is
during the teenage years (Lucas et al. 1991).
However, it can occur earlier and may emerge
at any time.
Bulimia nervosa
The core symptoms of bulimia nervosa are
bingeing and purging. A binge is regarded as
the rapid consumption of an unusually large
amount of food by comparison with social
“norms” in a discrete period of time. Integral
to the notion of a binge is feeling out of control.
An individual with bulimia may state that he or
she is unable to postpone the binge or stop eat-
ing willfully once the binge has begun. The
binge may only end when she is interrupted,
out of food, exhausted, or physically unable to
consume more. Although the current DSM-IV
diagnostic criteria require the presence of binge
eating at least twice per week for at least 3
months (see chapter 8), bingeing and purging
clearly are unhealthy behaviors and should not
be ignored when present at lesser frequencies.
The second feature of bulimia nervosa is purg-
ing. There are many different ways that indi-
viduals with bulimia nervosa compensate for
overeating. Between 81 and 88 percent of
women with bulimia self-induce vomiting (Hoek
and van Hoeken 2003; Johnson et al. 1982;
Mitchell et al. 1985; Rome 2003; Sigman 2003).
Other methods of purgation include the abuse
of laxatives, diuretics and emetics, saunas,
excessive exercise, fasting, and other idiosyn-
cratic methods that people believe will lead to
weight loss. Many of these auxiliary methods
are dangerous and ineffective as they promote
loss of water and valuable electrolytes (see the
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section on crisis stabilization below). Finally,
individuals with bulimia nervosa place undue
emphasis on shape and weight in their sense of
identity.
The age of onset of bulimia nervosa is generally
somewhat later than for anorexia nervosa;
however, many women have bulimia for up to 5
years prior to seeking treatment.
Other eating disorders
There are several alternative and subthreshold
presentations of disordered eating. Among
these are individuals who purge in the absence
of binge eating, as well as individuals who meet
some but not all formal diagnostic criteria for
anorexia or bulimia nervosa. Binge-Eating
Disorder (BED) is being scrutinized as a poten-
tial third discrete eating disorder. BED is asso-
ciated with binge eating in the absence of com-
pensatory behaviors and commonly is associat-
ed with obesity.
Prevalence
Anorexia nervosa primarily is a disorder of
females, with a gender ratio of approximately
10:1. The disorder is found across social classes
and ethnic groups. Epidemiological studies sug-
gest a prevalence of between 0.1 to 0.7 percent
of females, although subclinical conditions are
more prevalent (Hoek 1991; Hoek and van
Hoeken 2003; Rome 2003; Sigman 2003).
Anorexia nervosa is more prevalent in sports
and professions that value thinness (e.g., jock-
eys, ballet dancers, gymnasts). Males who
develop the disorder have presenting symptoms
and clinical profiles similar to females.
The gender ratio for bulimia nervosa is also
approximately 10:1, with higher prevalence in
females. Epidemiological studies suggest that
the prevalence of bulimia nervosa is somewhere
between 1 and 3 percent across a range of
Western cultures (Bushnell et al. 1990;
Drewnowski et al. 1988; Garfinkel et al. 1995;
Johnson-Sabine et al. 1988; Kendler et al.
1991; King 1986; Rand and Kuldau 1992;
Schotte and Stunkard 1987). Again, subclinical
forms of the disorder are more prevalent.
Bulimia is found across all ethnic groups and
social classes. Indeed, recent epidemiological
evidence suggests that binge eating may be
becoming more common in the lower socioeco-
nomic classes and that the gender disparity
may be diminishing.
Substance abuse and 
dependence among people
with eating disorders
Estimates of the prevalence of co-occurring
substance abuse and/or dependence in clinical
samples of women with bulimia nervosa have
varied widely. The prevalence of comorbid sub-
stance abuse ranges between 3 percent and 49
percent. A review of 25 studies of the preva-
lence of substance abuse in women with bulimia
nervosa in clinical samples calculated a median
prevalence of 23 percent (Corcos et al. 2001;
Holderness et al. 1994; Specker and
Westermeyer 2000; Westermeyer and Specker
1999). Parameters affecting the estimates differ
according to the nature of the clinical service
(inpatient versus outpatient), the definition of
the disorder, assessment procedures for both
eating disorders and substance dependence,
whether current or lifetime diagnoses are
assessed, the distorting effects of any exclusion
criteria for clinical trials, and the age of clients
seen.
Overall, the majority of studies have observed
an elevated prevalence of substance abuse in
clinical samples of women with bulimia ner-
vosa. Most studies have observed comorbidity
that exceeds that expected in the general popu-
lation of women of similar age, as well as higher
rates than in women with major depression.
Population-based studies also have observed
elevated substance abuse in women with bulim-
ia nervosa (although not as extreme as in clini-
cal samples), suggesting that the observed co-
occurrence is not merely the result of focusing
studies on treatment-seeking populations.
The frequently observed co-occurrence of sub-
stance abuse in women with bulimia nervosa
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warrants routine screening for the presence of
substance abuse when women with bulimia ner-
vosa are assessed. The screening ideally would
address both current and lifetime presence of
alcohol and other substance use disorders and
would seek to develop an indepth understand-
ing of the relation between the eating disorder
and substance use.
Substance abuse appears to be much less fre-
quent in women with the restricting subtype of
anorexia nervosa than in other subtypes of eat-
ing disorders (Corcos et al. 2001; Specker and
Westermeyer 2000; Westermeyer and Specker
1999). In most studies, the prevalence of sub-
stance abuse in women with anorexia nervosa
was less than in women with bulimia nervosa
and not significantly different from women in
the general population. Substance use disor-
ders are observed primarily in women with the
bulimic subtype of anorexia. Across studies,
the prevalence of substance-related disorders
in anorectic women with bulimic features
appear to be comparable to or exceed those of
women with normal weight bulimia nervosa
(Corcos et al. 2001; Specker and Westermeyer
2000; Westermeyer and Specker 1999). 
In summarizing the data regarding the preva-
lence of substance abuse in clinical samples of
women with eating disorders, several issues
must be considered. First, although the preva-
lence of comorbid substance abuse is high, it is
not the most frequently diagnosed comorbid
condition. Most studies have reported more
frequent lifetime comorbid affective and anxi-
ety disorders. Thus, comorbidity of a range of
disorders, not just substance abuse, commonly
is observed in women with bulimia nervosa.
In addition, with some exceptions, most studies
have been cross-sectional and have determined
the eating disorder diagnosis based on current
clinical presentation. This approach is concep-
tually problematic as the boundary between
anorexia and bulimia nervosa often is fluid.
Although a percentage of women with the
restricting subtype of anorexia never binge or
purge, between 37 and 48 percent of clinical
samples of women with anorexia nervosa dis-
play features of
bulimia nervosa at
some point during
their illness. The dis-
tinction between cur-
rent anorexia nervosa
with or without cur-
rent bulimic symp-
toms has been codi-
fied in the DSM-IV
into “restricting” and
“binge-eating/purg-
ing” types. It is diffi-
cult, if not impossible,
to predict accurately
which women are
likely to recover,
maintain a chronic
course of restricting
anorexia, or develop
bulimia nervosa. Therefore, when examining
the prevalence of substance abuse in women
with eating disorders, counselors must be
mindful that the clinical features on which
groups are defined are multifaceted, and that a
cross-sectional examination of the same sample
at a later date may yield different groupings,
and therefore, different estimates of the preva-
lence of comorbidity.
Eating disorders among 
individuals with substance
use disorders
To what extent are eating disorders a problem
in individuals with primary substance use dis-
orders? Studies examining prevalence of eating
disorders in substance-dependent treatment
samples have used both questionnaires and
interview designs. With some exceptions, the
prevalence of bulimia nervosa is elevated in
women presenting for treatment of substance
dependence (Corcos et al. 2001; Specker and
Westermeyer 2000; Westermeyer and Specker
1999). The characteristics of people with sub-
stance use disorders and bulimia included
younger age at presentation, onset of problem
drinking at an earlier age, higher self-report
scores on eating pathology, decreased chance of
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Eating disorders
and disordered eat-
ing appear to be
overrepresented in
clinical samples of
women presenting
for treatment of
substance abuse.
a family history of alcoholism, and heavier
weight.
A study of callers to a national cocaine hotline
(122 men and 137 women) via a structured tele-
phone interview found that 22 percent of
callers met DSM-III criteria for bulimia, 7 per-
cent for anorexia and bulimia, 2 percent
anorexia nervosa, and 9 percent met criteria
for bulimia plus vomiting. Among female
callers, 23 percent met criteria for bulimia and
13 percent met criteria for bulimia with purg-
ing (Jonas et al. 1987).
Studies of individuals in inpatient substance
abuse treatment centers suggest that approxi-
mately 15 percent of women and 1 percent of
men had a DSM-III-R eating disorder (primari-
ly bulimia nervosa) in their lifetime as assessed
via questionnaire (Hudson et al. 1992).
Individuals with eating disorders were signifi-
cantly more likely to use stimulants and signifi-
cantly less likely to use opioids than individuals
undergoing substance abuse treatment without
comorbid eating disorders.
In summary, eating disorders and disordered
eating appear to be overrepresented in clinical
samples of women presenting for treatment of
substance abuse. Further studies are required
to assess how the presence of an eating disorder
affects treatment for substance abuse and how
best to integrate treatment for those with both
conditions.
Substance Use Among
Individuals With Eating
Disorders
Studies of bulimic women with co-occurring
alcohol use disorders often have used retro-
spective interviews to determine the chronology
of the onset of both disorders. Patterns vary,
with approximately one third of women recall-
ing bulimia beginning first, one third recalling
the alcohol abuse beginning first, and one third
recalling onset of both problems within the
same year (Bulik et al. 1997).
Several investigations have found no differ-
ences in the core clinical features of bulimia
nervosa (i.e., frequency of bingeing and purg-
ing) in women with and without co-occurring
substance use disorders (Bulik et al. 1997),
although those with comorbid substance use
disorders showed greater use of diuretics and
laxatives, more food restriction, greater disrup-
tion in financial and work areas, more stealing,
more suicide attempts, and more inpatient
treatment (Hatsukami et al. 1986).
Personality differences also appear to exist
between bulimic women with and without sub-
stance use disorders. Women with bulimia ner-
vosa and substance dependence also report
higher novelty seeking and lower cooperative-
ness, higher impulsivity, and a tendency to use
more immature defenses. Overall, women with
bulimia nervosa and alcohol dependence exhib-
ited a pattern of greater impulsiveness across a
broad array of response domains (Bulik et al.
1997).
The subgroup of women with bulimia who
exhibit these traits have been referred to as
“multi-impulsive bulimics,” defined as a combi-
nation of bulimia plus other impulsive behav-
iors such as excessive alcohol use, regular
street drug use, stealing, overdosing, self-harm,
borderline features, and sexual promiscuity
(Lacey 1993). Approximately 40 percent of
bulimic women seen in clinical settings display
substance abuse, stealing, overdosing, or self-
harm (Lacey 1993). This group of individuals
requires higher clinical vigilance and is at high-
er risk for self-harming and parasuicidal
behaviors.
In summary, the core clinical features of the
eating disorder (i.e., frequency of bingeing and
purging) do not appear to differ significantly
whether substance abuse or dependence is pre-
sent. Individuals with the comorbid pattern do
appear to display more frequent impulsive
behaviors, use of other drugs, and possibly
more Axis II pathology. These data suggest that
it is important to consider the critical role of
impulsivity in the development of both eating
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disorders and substance abuse in this group of
women. See Figure D-16 for a summary of how
eating and substance use disorders are related.
Key Issues and Concerns
In addition to “traditional” drugs of abuse and
alcohol, women with eating disorders are
unique in their abuse of pharmacological
agents ingested for the purpose of weight loss,
appetite suppression, and purging. Among
these drugs are prescription and over-the-
counter diet pills, laxatives, diuretics, and
emetics. Nicotine and caffeine also must be
considered when assessing substance abuse in
women with eating disorders.
Drugs related to purging, such as diuretics, lax-
atives, and emetics, have been shown to be
ineffective and potentially dangerous methods
of accomplishing weight loss or maintenance.
The literature suggests that, like more common
drugs of abuse, tolerance and withdrawal occur
with laxatives, diuretics, and possibly diet pills
and emetics.
A critical message for clinicians is that women
with eating disorders often will go to dangerous
extremes to lose weight and a comprehensive
assessment must document the individual’s full
repertoire of weight-loss behaviors. Clinicians
also must be mindful of excessive consumption
of sugar substitutes, as the long-term effect of
consumption of large quantities of these sub-
stances in humans is yet to be determined.
Strategies, Tools, and
Techniques
Though the presence of a history of alcohol
abuse or dependence appears not to affect out-
come in trials of cognitive–behavioral or phar-
macological therapy for bulimia nervosa, much
less is known regarding the effects of current
substance use on treatment outcome for bulim-
ia nervosa. Practically, the management of
individuals with concurrent active bulimia and
substance abuse can be challenging. Given that
few treatment programs specialize in the treat-
ment of concurrent eating and substance abuse
problems, the phenomenon of treatment ping-
pong often is observed. Individuals may alter-
nate between eating disorders and substance
abuse treatment programs without ever benefit-
ing from treatment that targets both problems
simultaneously.
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Figure D-16
How Are Eating Disorders and Substance Use Disorders Related?
• Individuals with eating disorders experience urges (or cravings) for binge-foods similar to urges for drug
or alcohol use.
• Many individuals alternate between substance abuse and eating disorders.
• Bingeing and purging can be secretive and shameful behaviors.
• Relapse prevention is critical for individuals with bulimia nervosa.
• Abstinence from bingeing and purging is an essential treatment goal.
• For individuals with bulimia nervosa, alcohol and drugs such as marijuana can diminish normal appetite
restraints and increase the risk of binge-eating as well as relapse.
• Individuals with eating disorders experience cravings, tolerance, and withdrawal from drugs associated
with purging, such as laxatives and diuretics.
• There is an increased risk of alcohol and drug abuse and dependence in family members of individuals
with bulimia nervosa.
Engagement
No controlled trials have yet been conducted to
determine the optimal intervention strategy for
women with co-occurring eating disorders and
substance use disorders, although a variety of
treatments have been described (Bergh et al.
2003; McElroy et al. 2003; Trotzky 2002;
Weiner 1998). Few specialist services exist that
are designed to treat eating disorders and sub-
stance abuse concurrently. In the absence of
such services, staff on specialty services for
substance use or eating disorders should have
specific training in working with individuals
with this particular pattern of comorbidity.
Even less is known about men with eating dis-
orders, and almost nothing has been written
recently about their treatment (Mangweth et al.
2004).
Screening and assessment
Even though a client may not have an eating
disorder currently, the past presence of bulimia
or anorexia could become a factor in the suc-
cessful treatment of her substance abuse, or
vice versa. To detect this possibility, clinical
interviews may be supplemented with struc-
tured eating disorders interviews such as the
Eating Disorders Examination. A number of
medical investigations might be warranted,
depending on the findings on physical examina-
tion and based on the nature and severity of
the substance-related disorder.
Figure D-17 suggests general and specific
screening questions that may be used to probe
the possibility that the client has an eating dis-
order. The general questions simply explore the
individual’s attitudes toward shape, weight,
and dieting. Sometimes it is best to start with
such questions rather than begin immediately
with questions focused specifically on the
behavior patterns associated with anorexia and
bulimia because clients may feel shame about
these behaviors. Easing into the topic some-
times is the best approach.
Once the co-occurrence of eating and substance
use disorders has been established, then a com-
plete behavioral analysis can be informative, if
consistent with the philosophy and approach of
the treatment service. The critical questions to
be addressed in this portion of the assessment
include foods and substances of choice, high-
risk times and situations for engaging in disor-
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Figure D-17
General and Specific Screening Questions for Persons With Possible
Eating Disorders
General Screening Questions
•How satisfied are you with your weight and shape?
•How often do you try to lose or gain weight?
•How often have you been dieting?
•What other sorts of methods do you use to lose weight?
Specific Screening Questions
•Have you ever lost a lot of weight and weighed less than other people thought you should weigh?
•Have you had eating binges where you eat a large amount of food in a short period of time?
•Do you ever feel out of control when eating?
•Have you ever vomited to lose weight or to get rid of food that you have eaten?
•What other sorts of methods have you used to lose weight or to get rid of food?
dered eating and substance abuse behaviors,
and the nature, pattern, and relationship of
disordered eating and substance use. Examples
of appropriate areas of inquiry are
• What sorts of situations could prompt the
client to diet/binge/drink?
• What times of the day are high-risk times for
each behavior?
• What are the cues that prompt disordered
eating behavior/substance use?
In addition, counselors must address how diet-
ing and bingeing are related to substance
abuse. For example, does the client drink or
use drugs to curb appetite when dieting? What
is the effect of drinking on eating behavior?
Does alcohol use lead to unrestrained eating?
From the client’s perspective, do bingeing and
drinking serve similar or different “functions?”
Crisis stabilization
Crisis situations differ somewhat between
women with anorexia and bulimia nervosa. In
both cases, the presence of substance abuse
intensifies the crisis. Presenting symptoms
include dehydration, electrolyte abnormalities,
cardiac or gastrointestinal complications, sec-
ondary to extreme inanition, and suicidality.
Women with bulimia nervosa may present in
crisis with dehydration, electrolyte abnormali-
ties, gastrointestinal crises secondary to purg-
ing (e.g., esophageal ruptures or instruments
used for purging lodged in the throat), or suici-
dality.
In the case of both disorders, medical stabiliza-
tion is of primary importance. Anorexia ner-
vosa, in particular, is the most lethal of all
mental disorders, with a mortality rate of
approximately 6 percent per decade (Sullivan
1995). Deaths associated with anorexia nervosa
are most commonly complications of starvation
followed closely by suicide. Hospital admission
with vigilant monitoring for disordered eating
behaviors (e.g. bingeing, purging, excessive
exercising) is critical. In their terror of weight
gain, clients might attempt to engage in disor-
dered eating behaviors in the hospital and
sneak substances such as laxatives and diuret-
ics into treatment facilities.
Short-term care and 
treatment
Once a diagnosis has been established and the
behavioral parameters identified, three poten-
tial approaches have been outlined for the
treatment of the individual with eating disor-
ders and substance abuse. First, both disorders
can be treated concomitantly on a unit special-
izing in this particular pattern of COD.
Second, detoxification and treatment for sub-
stance abuse can be completed first, followed
by specialized treatment for the eating disor-
der. Third, specialized treatment for the eating
disorder can be followed by specialized treat-
ment for the substance abuse.
There are several factors that can dictate
which of these approaches is followed; howev-
er, no empirical data exist to inform the deci-
sion. Specialty services for clients with COD
are scarce and hence the opportunity for con-
current treatment is limited. In the absence of
such a service, counselors must attempt to
determine which disorder currently is most
troublesome and requires the most immediate
attention. Perhaps the most important treat-
ment goal is to encourage the client to complete
treatment for both disorders, although detoxifi-
cation is an essential first step for some individ-
uals. Completion should be emphasized
throughout the treatment process.
Whichever treatment approach is chosen, the
other disorder cannot be compartmentalized
and ignored. It is critical to address the pres-
ence of the eating problem, even if the sub-
stance-related problem is the initial target of
treatment. Failure to integrate treatment leads
to the “ping-pong” phenomenon where clients
bounce back and forth between eating and sub-
stance abuse treatment services, never address-
ing the relation between the two disorders. The
re-emergence of binge eating following detoxifi-
cation from opioids and alcohol has been
observed. It has also been noted clinically that
the frequent behavioral pairing between disor-
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dered eating behaviors and substance abuse
can lead to a situation in which relapse in one
domain fuels relapse in the other. Thus, an
integrated relapse prevention plan that
acknowledges the similarities and differences in
relapse risk for each behavior is essential.
Individuals with eating disorders who are being
treated in substance abuse treatment facilities
should participate fully in the substance abuse
treatment program. Their treatment may be
augmented with nutritional consultation, the
setting of a weight range goal, and observations
at and between meal times for disordered eat-
ing behaviors. If a treatment program has suf-
ficient numbers of clients who have eating dis-
orders or disordered eating behavior, special
eating disorders psychoeducation or basic cog-
nitive–behavioral strategy groups can be used
to augment the substance abuse treatment
plan.
The available literature supports the inclusion
of clients with past or current mild or moderate
substance-related disorders in eating disorders
treatment programs. Cognitive–behavioral
techniques targeted toward bulimic symptoms
such as psychoeducation, identification of auto-
matic thoughts, thought restructuring, chain-
ing, and relapse prevention, often generalize to
substance-related problems.
Treatment of individuals with severe substance-
related disorders and eating disorders poses a
more significant clinical challenge. In addition
to traditional cognitive–behavioral approaches,
many individuals find 12-Step approaches ben-
eficial in controlling their drinking or drug use
and disordered eating behavior. Traditionally,
the 12-Step approach of Overeaters
Anonymous focuses on abstinence from high-
risk foods (i.e., sugar, wheat), which are
believed to have the ability to trigger a binge.
In direct contrast, the cognitive–behavioral
approach emphasizes empowerment over food
and minimizes avoidance.
Although it is possible to abstain from alcohol
and drugs, it is virtually impossible to abstain
from foods, given their obvious relationship to
survival and the frequency with which high-
risk foods are encountered in daily life. In an
integrated model that tries to merge
cognitive–behavioral techniques with the bene-
ficial 12-Step approach, one can encourage
clients to abstain from high-risk behaviors (i.e.,
dieting or bingeing) rather than high-risk
foods. Empirical data are required to substan-
tiate the efficacy of this approach; however, it
holds intuitive appeal for those individuals who
find a 12-Step approach beneficial and who see
similarities between their disordered eating and
substance-related problems.
Pharmacological approaches to treatment also
may be considered. The SSRI fluoxetine has
been shown to be of some efficacy in the treat-
ment of bulimia nervosa (Fluoxetine Bulimia
Nervosa Collaborative Study Group 1992),
although its specific efficacy in individuals with
comorbid substance use disorders has not been
documented. The opioid antagonist naltrexone
appears to decrease the reinforcing efficacy of
alcohol and has been approved by the Food
and Drug Administration for the treatment of
alcohol dependence because of its efficacy in
reducing alcoholic relapse. Preliminary data
suggest that naltrexone may decrease the fre-
quency of bingeing and purging and the preoc-
cupation with food in women with bulimia
(Jonas and Gold 1988). The possible utility of
naltrexone in the treatment of individuals with
comorbid bulimia nervosa and alcohol depen-
dence is an empirical question worthy of fur-
ther investigation.
No clinical trials exist that identify the optimal
approach to the treatment of comorbid eating
disorders and substance-related disorders.
Such trials clearly are needed to determine the
most effective approach to individuals who pre-
sent with severe co-occurring eating and sub-
stance-related disorders.
Longer term care and 
treatment
Relapse is a major concern in eating disorders.
Anorexia nervosa is particularly difficult to
treat, with the average duration of treatment
being 5 years. Even women who have recov-
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ered from anorexia nervosa continue to main-
tain relatively low body weight and retain cog-
nitive features of the disorder.
Although relatively successful treatments for
bulimia nervosa have been developed (primari-
ly cognitive–behavioral therapy), which lead to
abstinence in between half and two thirds of
clients, relapse is common within the first year
following therapy. Thus, concrete relapse pre-
vention strategies are critical both to prevent
the re-emergence of disordered eating symp-
toms as well as to prevent the ping-pong effect
in symptom expression. Techniques that can be
incorporated into a successful relapse preven-
tion program include
• Booster therapy sessions
• Participation in both 12-Step groups and
more unstructured support groups for eating
disorders and for substance abuse
• Use of self-help manuals and programs when
slips occur and regularly throughout the
recovery intervals
• Development of strategies that enhance self-
awareness of imminent slips and relapses
Pathological Gambling
Description
Pathological gambling (PG) has been best
described as “a progressive disorder character-
ized by a continuous or periodic loss of control
over gambling; a preoccupation with gambling
or obtaining money with which to gamble; irra-
tional thinking, and a continuation of the
behavior despite adverse consequences”
(Rosenthal 1992). The American Psychiatric
Association’s criteria for the diagnosis of PG
(DSM-IV-TR) (APA 2000) are in many ways
similar to those for alcohol and other drug
dependence (see Figure D-18, p. 426).
Many clients with PG display what amounts to
tolerance, needing to gamble with increasing
amounts of money (or make increasingly risky
bets with what money is available to them) to
achieve the desired effect. For some gamblers,
often referred to as “action” gamblers, this
effect may be excitement (Cocco et al. 1995;
Lesieur and Rosenthal 1991). For other gam-
blers, thought of as “escape” gamblers, the
sought-for effect is relief from painful emotions
or stress. Consequently, gambling may act as a
stimulant such as amphetamine or cocaine for
some clients with PG, while acting as a sedative
or tranquilizer for others. (See Figure D-19 on
p. 427 for a list of differences between action
and escape gamblers.)
Pathological gamblers often report withdrawal-
like symptoms when attempting to stop gam-
bling. These may include symptoms such as
irritability, problems focusing or concentrating,
difficulty sleeping, and even physical symptoms
such as nausea, vomiting, headaches, and mus-
cular pain (Rosenthal and Lesieur 1992; Wray
and Dickerson 1981). Currently, there are no
DSM criteria for gambling disorders that com-
pare directly to criteria for substance use dis-
orders. However, in practice, the term “prob-
lem gambling” is most commonly considered to
apply to those individuals who meet one to four
of the DSM-IV criteria for pathological gam-
bling (National Research Council [NRC] 1999).
Problem gamblers are individuals who do not
meet full criteria to be diagnosed as pathologi-
cal gamblers, but who meet some of the criteria
and indicate that gambling is contributing to
some level of disruption in their lives.
While there are similarities between PG and
substance use disorders, there are some signifi-
cant differences between these disorders.
Research comparing individuals diagnosed with
PG to individuals with substance use disorders
is still in early stages, but there have been clini-
cal reports on such differences. To begin with,
it may be more difficult to define what consti-
tutes gambling than to define a drug or an alco-
holic drink. Gambling can encompass a variety
of behaviors: buying lottery tickets, playing
cards for money (even in friendly family
games), investing in the stock market, partici-
pating in a charity raffle, betting on a golf
game, betting on horse races, or playing
scratch-off games to win money at a fast food
restaurant.
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Figure D-18
Diagnostic Criteria for Pathological Gambling Compared to Substance
Dependence Criteria
Diagnostic Criteria for Pathological Gambling Comparable Substance Dependence Criteria
Persistent and recurrent maladaptive gambling
behavior as indicated by five (or more) of the fol-
lowing:
Maladaptive pattern of substance use, leading to clinical-
ly significant impairment of distress, as manifested by
three (or more) of the following, occurring at any time in
the same 12-month period:
• Is preoccupied with gambling (e.g., preoccupied
with reliving past gambling experiences, handi-
capping or planning the next venture, or think-
ing of ways to get money with which to gamble)
• A great deal of time is spent in activities necessary to
obtain the substance (e.g., visiting multiple doctors or
driving long distances), use the substance (e.g., chain
smoking), or recover from its effects
• Needs to gamble with increasing amounts of
money to achieve the desired excitement
• Tolerance
• Has repeated unsuccessful efforts to control, cut
back, or stop gambling
• There is a persistent desire or unsuccessful efforts to cut
down or control substance use
• Is restless or irritable when attempting to cut
down or stop gambling
• Withdrawal
• Gambles as a way of escaping from problems or
of relieving a dysphoric mood (e.g., feelings of
helplessness, guilt, anxiety, depression)
• N/A
• After losing money gambling, often returns
another day to get even (“chasing” one’s losses)
• The substance is often taken in larger amounts or over a
longer period than was intended
• Lies to family members, therapist, or others to
conceal the extent of involvement with gambling
• The substance use is continued despite knowledge of
having persistent or recurrent physical or psychological
problem that is likely to have been caused or exacerbat-
ed by the substance• Has committed illegal acts such as forgery,
fraud, theft, or embezzlement to finance gam-
bling
• Relies on others to provide money to relieve a
desperate financial situation caused by gambling 
• Has jeopardized or lost a significant relation-
ship, job, or educational or career opportunity
because of gambling
• Important social, occupational, or recreational activities
are given up or reduced because of substance use
Source: APA 2000.
One of the main differences between PG and
substance use disorders is that there is no bio-
logical test to screen for PG. The absence of a
clear physical sign of the disorder enables a
person to hide gambling behavior for longer
periods of time. This also may contribute to the
severe and entrenched lying and deception that
are included in the diagnostic criteria for PG.
Because no substance is being ingested, often it
is very difficult for individuals diagnosed with
PG and their families/significant others to
accept PG as a medical disorder. Research is
beginning to establish a biological/genetic pre-
disposition to PG that is similar to that found
in severe alcohol and drug addictions, and that
gambling may affect the central nervous system
in ways similar to substance use (Breiter et al.
2001; Comings et al. 1996; Potenza 2001;
Slutske et al. 2000). However, it is still difficult
for individuals with PG, as well as the general
public, to accept a medical model for this disor-
der. It is easier to accept that people with sub-
stance use disorders may behave badly (become
aggressive or violent) while intoxicated than for
gamblers to accept that their harmful behavior
can be attributed to their gambling. This possi-
bility could exacerbate the gambler’s sense of
shame and guilt and contribute to the develop-
ment of rigid defense mechanisms to ward off
these feelings and to allow gambling to persist.
These hypothesized differences need to be
investigated empirically.
Prevalence
Legalized gambling is available in 47 States and
the District of Columbia. The great majority of
adults (81 percent) have gambled sometime
during their life. This compares to recent stud-
ies of alcohol use in the United States that esti-
mate 91 percent of adults have drunk alcohol.
Between 1974 and 1995, the amount of money
spent on legal gambling increased 3,100 percent
in the United States, from $17.4 billion to $550
billion. A national study estimated the lifetime
prevalence of pathological gambling among
adults in the United States to be 1.1 percent,
while the past-year estimate for problem or
pathological gambling combined was 2.9 per-
cent. This can be compared to past-year esti-
mates of alcohol abuse/dependence of 9.7 per-
cent and drug abuse/dependence of 3.6 percent
(NRC 1999).
Information on the prevalence of pathological
gambling among adolescents has been contro-
versial, with reported rates higher than for
adults (Shaffer et al. 1997). However, adoles-
cent rates of problem or pathological gambling,
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Figure D-19
Comparison of Action and Escape Pathological Gamblers
Action Escape
• Gambles for excitement, competition
• More likely to engage in “skilled” forms of gam-
bling such as poker, horse racing, sports
• More likely to have early onset of gambling
• Longer progression from regular gambling to
addictive/out of control gambling
• More likely to be male
• More likely to present narcissistic or antisocial
traits
• Gambles for relief, escape from stress or negative affect
• More likely to engage in “luck” forms of gambling such
as lottery, slots, video poker, bingo
• Later onset of gambling
• Shorter progression from regular gambling to
addictive/out of control gambling
• More likely to be female
• More likely to be dysthymic 
which range from 9 to 23 percent in various
studies, are comparable to rates of adolescent
alcohol use (8 to 23 percent). Also, past-year
adolescent pathological gambling rates of 1 to 6
percent are comparable to past-month rates of
marijuana use of 3 to 9 percent (NRC 1999).
Gambling prevalence studies also illuminate
demographic variables and risk for gambling
problems. As suggested above, younger age
seems to be a risk factor. Adults under the age
of 30 report higher proportions of gambling
problems. Men, ethnic minorities, and para-
doxically, those with household incomes below
$25,000 also tend to be overrepresented among
problem/pathological gamblers. Employment
status did not seem to have any relationship to
risk for gambling problems. However, educa-
tional level had a moderate relationship with
problem gambling, with those with a high
school education or less being at higher risk for
gambling problems (NRC 1999).
The rate of co-occurrence of PG among people
with substance use disorders has been reported
as ranging from 9 to 16 percent (Crockford and
el-Guebaly 1998; Lesieur et al. 1986;
McCormick 1993). Among pathological gam-
blers, alcohol has been found to be the most
common substance of abuse. At a minimum,
the rate of problem
gambling among
people with sub-
stance use disorders
is 4 to 5 times that
found in the general
population.
People with sub-
stance use disorders
and co-occurring
PG have been com-
pared to people with
substance use disor-
ders without PG.
While some findings
appear contradicto-
ry, there is some evi-
dence that people
with co-occurring
substance use and PG may have higher levels
of negative affect, overall psychiatric distress,
impulsivity, higher rates of antisocial personali-
ty disorder, AD/HD, and risky sexual behav-
iors (APA 2000; Crockford and el-Guebaly
1998; Langenbucher et al. 2001; McCormick
1993; Petry 2000b, c). The high rates of co-
occurrence of substance use disorders and
gambling problems clearly emphasize the need
for screening and assessment of gambling prob-
lems in substance-abusing populations.
Key Issues and Concerns
Despite the high prevalence, treatment services
for PG are limited or lacking in many areas.
According to a survey conducted by the
National Council on Problem Gambling, only
21 States provide some level of funding for
addressing problem and pathological gambling.
According to the Association of Problem
Gambling Service Administrators
(www.apgsa.org), only 16 States provide some
public funding specifically for gambling treat-
ment. Additionally, only about 1,000 Gamblers
Anonymous meetings are held in the United
States, fewer than the number of AA meetings
found in some major metropolitan areas. 
It is important to recognize that even though
PG often is viewed as an addictive disorder,
clinicians cannot assume that their knowledge
or experience in substance abuse treatment
qualifies them to treat persons with a PG prob-
lem. Training and supervision should be
obtained to work with pathological gamblers,
or referral should be made to specific gambling
treatment programs.
A second consideration is that clients with PG
problems seeking treatment have high rates of
legal problems. Research has shown that in
most settings, two thirds of people with PG
problems report engaging in illegal activities to
obtain money for gambling or to repay gambling
debts. Pathological gamblers often fail to report
such activities as embezzling from their job as
an illegal activity. In their own minds they label
what they are doing as borrowing rather than
stealing, as they are certain that they will make
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In individuals 
with COD, it is
particularly
important to 
evaluate patterns
of substance use
and gambling.
a winning bet and be able to pay the money
back. Persons with substance use disorders also
have many of these same problems.
Transference and countertransference issues in
the treatment of pathological gambling can have
a significant impact. Competitive, action-orient-
ed gamblers may attempt to make treatment a
competitive sport, and clinicians may become
distracted by debating and arguing. Relapsing
may become a way for the pathological gambler
to “beat” the therapist. The lack of physical
signs or biological tests for gambling can con-
tribute to countertransference reactions, such
as the therapist becoming overly zealous in try-
ing to “catch” gamblers in their lies or overly
accepting of self-reports. Either extreme can
impede the therapeutic relationship.
Strategies, Tools, and
Techniques
Engagement
In an initial contact with a pathological gam-
bler, it is important to begin developing rap-
port quickly. Counselors should remember that
when a pathological gambler makes an initial
phone call to access treatment or comes in for
an initial evaluation, he or she is likely to be
feeling a great deal of shame, guilt, anxiety, or
anger. To acknowledge gambling problems is to
admit to being a “loser,” an extremely difficult
admission for most gamblers. The gambler
whose family and friends have failed to
acknowledge that he or she has a legitimate dis-
order also is likely to be sensitive about being
judged, criticized, and condemned.
Consequently, the clinician must demonstrate
knowledge of the signs, symptoms, and course
of pathological gambling; present a nonjudg-
mental attitude and empathy regarding the
emotional, financial, social, and legal conse-
quences of gambling; and convey hope regard-
ing the potential for recovery.
It is also important for the clinician to under-
stand how and when to probe for greater detail
regarding the severity of the gambling disorder
and its consequences, since as with substance
abuse, the gambling client is likely to minimize
the negative impact of gambling. Clients with
COD are likely to minimize or deny the disor-
der for which help is not being sought.
Screening and assessment
There are several valid and reliable instru-
ments that have been developed for the screen-
ing and assessment of pathological gambling.
Screening
The South Oaks Gambling Screen (SOGS)
(Lesieur and Blume 1987) is one of the most
widely researched instruments. This is a 20-
item questionnaire designed to screen for gam-
bling problems and has been found to be effec-
tive in substance abuse populations. It can be
conducted as a structured interview or a self-
report questionnaire in both lifetime and past
6-month versions. The drawbacks are its length
and the fact that the items are not specifically
based on DSM-IV criteria, which precludes its
use as a diagnostic instrument. Someone who
scores above the cut-off on the SOGS would
then require a more detailed diagnostic assess-
ment.
A brief screening tool, the Lie/Bet Question-
naire, has been found to be effective in identi-
fying probable pathological gamblers (Johnson
et al. 1997). The questionnaire consists of two
questions:
1. Have you ever felt the need to bet more and
more money?
2. Have you ever had to lie to people who are
important to you about how much you gamble?
A “yes” response to either question suggests
potential problem gambling. Again, this instru-
ment is likely to over-identify individuals with
gambling problems and a positive screen needs
to be followed by a more detailed clinical/diag-
nostic interview.
A computerized problem gambling screening
tool that may be particularly useful in criminal
justice populations is the Gambler Assessment
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Index (GAI), which incorporates a problem
gambling scale as one of seven scales—truthful-
ness, attitude, gambler, alcohol, drugs, suicide,
and stress). It takes about 20 minutes to com-
plete and includes a descriptive computerized
printout of risk levels for all scales (Behavior
Data Systems 2000).
Assessment
A more comprehensive problem gambling
assessment needs to be part of a broader
biopsychosocial and spiritual evaluation. Only
two instruments have been studied and used to
evaluate issues of problem gambling severity.
An addendum to the ASI, the Gambling
Severity Index has been developed and validat-
ed (Lesieur and Blume 1991). Another instru-
ment that has been found to be valid and reli-
able is the Gambling Treatment Outcome
Monitoring System, or GAMTOMS (Stinchfield
et al. 2001). This is a battery of four question-
naires designed to be used in assessment of
problem gambling and in treatment outcome
evaluation.
The Gambling Treatment Admission
Questionnaire (GTAQ) is particularly useful. A
162-item self-report questionnaire that incor-
porates the SOGS and DSM-IV criteria, the
GTAQ evaluates the range of gambling behav-
iors and frequency of gambling, gambling debt,
treatment history, substance use, and gam-
bling-related financial, legal, occupational, and
psychosocial problems.
Structured interviews for the diagnosis of
pathological gambling based on DSM-IV crite-
ria currently are being researched and devel-
oped, but are not yet publicly available
(Cunningham-Williams 2001; Potenza 2001).
Most clinicians conduct a clinical interview
based on DSM-IV criteria to establish the diag-
nosis of pathological gambling.
In individuals with COD, it is particularly
important to evaluate patterns of substance use
and gambling. Among those who abuse cocaine,
for example, there seem to be several common
patterns of interaction between gambling and
drug use. Cocaine use and gambling may coex-
ist as part of a broader antisocial lifestyle.
Someone who is addicted to cocaine may see
gambling as a way of getting money to support
drug use. A pathological gambler may use
cocaine to maintain energy levels and focus
during gambling and sell drugs to obtain gam-
bling money. Cocaine may artificially inflate a
gambler’s sense of certainty of winning and
gambling skill, contributing to taking greater
gambling risks. Cocaine may be viewed by the
gambler as a way of celebrating a win or may
be used to relieve depression following losses.
Cocaine and pathological gambling may be con-
current or sequential addictions. With cocaine
in particular, it often is difficult to have enough
money for both disorders at the same time.
There is no clear evidence that one addiction is
likely to precede another, although one recent
study reported that in a population of people
with substance use disorders who are in treat-
ment, the onset of gambling behavior was likely
to precede the use of addictive substances (Hall
et al. 2000).
Several patterns of interaction may emerge for
individuals who are alcohol dependent and are
pathological gamblers. One of the more com-
mon clinically observed patterns is sequential
addiction; for example, someone who has had a
history of alcohol dependence—often with
many years of recovery and AA attendance—
who develops a gambling problem. Such indi-
viduals often report that they did not realize
their gambling was becoming another addic-
tion, or that gambling could be as addictive as
alcohol and drugs. It is not uncommon for such
individuals to seek treatment only after a
relapse to alcohol (or recognizing they are close
to a relapse), secondary to the gambling-related
stresses. Other individuals have developed
alcohol problems only after their gambling has
begun to create serious adverse consequences;
they begin using drinking as a response to such
problems. Since alcohol is readily available
(and often free) in most gambling settings,
drinking and gambling may simply “go togeth-
er” for some individuals.
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It often is helpful, if not critical, to obtain col-
lateral information from family and significant
others. One scale that is helpful in this process,
the Victorian Problem Gambling Family Impact
Scale, is undergoing validation (Research
Evaluates Gambling’s Impact 1998).
Obtaining collateral information often can be
challenging, as the gambler may want to control
both what the clinician knows and what the
family knows. The gambler may not want the
clinician to know how angry and devastated the
family is feeling, or the gambler may not want
the family to know the extent of his or her gam-
bling and gambling debt. Also, the gambler may
give specific instructions to family members
about what to tell or not to tell the clinician.
This may be related to gambling or finances,
but it also may relate to substance use.
Therefore, while it is advisable to involve family
members as early as possible in the assessment
and treatment process, it may take time to
develop a trusting clinical relationship with the
gambler before he or she gives consent to family
involvement. The clinician needs to consider
carefully the best way to involve family mem-
bers or significant others in the assessment and
treatment process. Initial sessions with both the
gambler and family present may help to allevi-
ate the gambler’s anxiety. Such sessions can be
followed up with meetings without the gambler
present. It is essential that the therapist not be
viewed as taking sides in this process.
Crisis stabilization
Pathological gamblers frequently come into
treatment in a state of panic and crisis. The
attempted suicide rate among gamblers in
treatment is high (20 percent) (NRC 1999),
which makes a careful evaluation of suicide
potential essential. A common suicide plan for
PG clients is to have an automobile accident so
that family can collect life insurance to pay off
gambling debts. Concurrent substance use adds
to the risk potential for self-harm, so it is
important that the gambler who is at risk for
suicide contracts not to use any mind-altering
substances in addition to not endangering
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Case Study: Pathological Gambling Assessment 
A 36-year-old, married male, Andy J. entered treatment for pathological gambling. An initial assessment
involving questionnaires and structured diagnostic interviews found indications of excessive alcohol use and
use of cocaine. On a family assessment interview, Andy J.’s wife denied knowledge of any excessive alcohol
use or any cocaine use on her husband’s part.
As treatment proceeded, it became apparent that Andy J.’s substance use was more extensive and problem-
atic than first presented. Staff members were particularly concerned about his apparent hiding of his sub-
stance use from his spouse. Andy J. became angry and agitated, threatening to discontinue treatment when
staff indicated that the issue of his substance abuse needed to be addressed at the next family session. Andy
J. was given the choice of communicating the extent of his substance use to his wife prior to the session or
waiting until the session.
Andy J. initially withdrew consent to communicate with his wife. However, after intensive group and indi-
vidual work focusing on relapse potential, dishonesty as a relapse risk factor, and assessment of further neg-
ative consequences, he decided to tell his wife. In the next joint session, his wife expressed relief and report-
ed that she had been aware of and concerned about his substance use. She had lied at the initial assessment
at her husband’s request, as he had convinced her that it would be best for his treatment not to get the ther-
apist distracted by his substance use so that he could fully focus on his gambling problem. Andy J., once the
initial anger and anxiety had subsided, acknowledged that he was holding onto his substance use for fear of
living life without an addiction to fall back on. He realized that continued substance dependence would con-
tinue to maintain all the problems he was attributing only to his gambling.
him/herself or others. (However, as noted in
the discussion of suicide, counselors should not
rely solely on such contracts.) Placement in a
structured environment, inpatient, or residen-
tial setting may be necessary in some cases.
Addressing financial and legal
issues
Financial crises may involve eviction and
homelessness; inability to pay for food or utili-
ties; or families discovering that savings
accounts, college funds, and so on are totally
depleted. It is important in handling financial
crises to make sure the basics of food and shel-
ter are met for the gambler and his family. This
may mean referring the family to homeless
shelters or finding temporary living quarters
with extended family. Resolving the entire
extent of financial problems takes more time;
however, in the crisis situation it is essential to
convey to the gambler and family that coping
with financial stress is a part of treatment, and
to outline the process for addressing the prob-
lems. It is important to help the gambler and
family prioritize immediate needs (i.e., food,
shelter) separately from those that can be man-
aged later to relieve the feelings of being over-
whelmed. The counselor can help the client
make specific lists of what can be done now and
what can wait until later. For example, if the
family is being evicted, the clinician could pro-
vide a list of shelters to call or have the client
call shelters from the clinician’s office.
Legal issues can create an additional crisis for
the pathological gambler and the family.
Embezzling from an employer or writing bad
checks are two common illegal practices of
pathological gamblers. When facing potential
legal charges for such activities, the gambler
often is in a state of panic, looking for money to
borrow from family or friends to pay off the
checks or pay the employer back to avoid legal
consequences. It often is difficult for the family
or friends of the gambler to refuse such
requests when they fear the result will be send-
ing the gambler to jail. In such cases, the clini-
cian needs to direct the gambler to obtain legal
counsel prior to making impulsive decisions.
The clinician needs to work with both the gam-
bler and potential “bail out” sources to explore
other options.
Financial and legal issues also can trigger
domestic violence. The pathological gambler
may face physical violence from a spouse or
significant other when he or she confesses to
the extent of gambling debt. Alternatively, a
spouse or significant other may face violence if
he or she attempts to withhold money from the
pathological gambler. The clinician needs to
assess the history of domestic violence or poten-
tial for violence very carefully before suggesting
any plan for dealing with money management
or financial disclosure.
Self-banning
To assist a client with a PG problem to abstain
from gambling, some gambling venues (mainly
casinos and some race tracks) offer “self-ban-
ning.” This is a process of completing a written
document indicating a desire to be prohibited
from entering a casino or race track. Some
States have made this a legal process with crim-
inal consequences if a gambler who has self-
banned is found gambling at the banned loca-
tion. Information on this process can be
obtained from the gambling venue’s responsible
gaming office, from State Councils on Problem
Gambling, or from State-funded problem gam-
bling treatment programs.
Short-term care and 
treatment
This section will first discuss specific treatments
that have been used in the treatment of patho-
logical gambling, then explore how this knowl-
edge can be applied to the pathological gambler
with a substance use disorder. Although a broad
range of treatment modalities have been applied
to the treatment of pathological gamblers, to
date there has been little research to support
one type of treatment over another.
Psychodynamic therapies
Some of the earliest clinical writing on the suc-
cessful treatment of pathological gambling was
based on psychodynamic approaches. Such
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approaches emphasize identifying the underly-
ing conflicts and psychological defenses that
contribute to addictive gambling. Therapy
involves helping the gambler gain insight into
the psychological meaning of his or her gam-
bling (Rosenthal and Rugle 1994), decreasing
defenses that support denial and irrational
thinking, and developing more adaptive coping
skills to resolve internal conflicts. Such dynam-
ic therapies generally are incorporated into a
comprehensive treatment approach with the
therapist taking a more active and directive
role than in traditional dynamic approaches.
Cognitive–behavioral treatment
While early reports of behavioral treatment of
pathological gambling focused exclusively on
gambling behaviors using aversive conditioning
and systematic desensitization, more recent
approaches involve a range of cognitive as well
as behavioral interventions. Similar to
approaches to substance use disorders, these
include relapse prevention strategies, social
skills training, problem solving, and cognitive
restructuring (Sharpe 1998).
A component that is specific to pathological
gambling in this strategy involves modifying
irrational beliefs about gambling and the odds
of winning. Research repeatedly has shown
that gamblers hold beliefs in “the illusion of
control,” biased evaluation, and the gambler’s
fallacy (Ladouceur and Walker 1998).
• The illusion of control is the belief that one
can control or influence random or unpre-
dictable events, such as picking winning lot-
tery numbers or controlling the fall of the
dice by how they are thrown.
• Biased evaluation involves attributing wins to
one’s special skill or luck, while losses are
blamed on external circumstances.
• The gambler’s fallacy is the misunderstand-
ing of independent probabilities. For exam-
ple, if a coin is tossed 10 times resulting in 10
heads, one would think it more likely to get a
tail on the next toss, rather than realizing the
odds of a head or tail is the same for any one
toss.
Cognitive–behavioral interventions are targeted
at identifying and correcting such irrational
thinking and erroneous beliefs.
As with substance abuse, relapse prevention
includes identifying gambling-related internal
and external triggers. Money is a common trig-
ger and interventions generally involve remov-
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Case Example: Counseling a Pathological Gambler 
Michael B. was a gambler who relished the competitiveness of card playing and had developed a reputation
as a tough player and as a winner early in his gambling career. His gambling gradually became out of control
and it was clear that he was unable to stop gambling until he had lost all his money. However, when he
attempted to abstain from gambling he would feel depressed. In treatment he confessed to feeling increasing
anxiety when he was winning, and to feel relief only when he had lost everything.
Michael B.’s father had been a successful business executive who had been very demanding and critical of
Michael B. throughout his life. Michael B. had been determined to “beat his father at his own game” and
become even more successful. While Michael B. had developed many businesses, they always seemed to col-
lapse after an initial success, a pattern that mimicked his gambling. In therapy, it became clear that Michael
B. felt guilty at thoughts of “beating” his father, which contributed to the destructive pattern of his gambling
and of his unsuccessful businesses.
Treatment helped Michael B. let go of his guilt-producing fantasy of spectacular success and focus on how he
could enjoy his life without feeling a need to compete with his father. He was able to set more realistic goals
to achieve a sense of accomplishment and was able to abstain from gambling without feeling depressed and
inadequate.
ing money from the gambler’s control. This can
include removing the gambler’s name from
joint checking and savings accounts, limiting
the amount of cash the gambler carries, discon-
tinuing credit cards, and choosing a trusted
family member or friend to become the gam-
bler’s money manager. As might be anticipated,
this can be a difficult and conflictual process;
successful use requires creativity and sensitivi-
ty to issues of power and control. The goal is
not only to remove the trigger of money from
the gambler, but also to protect the gambler’s
and the family’s finances. It can be helpful if
this is explained as a process of assisting the
gambler in regaining financial control of his or
her life. Negotiating a workable and tolerable
system of financial accountability and safety is
a key therapeutic task in the treatment of
pathological gamblers, regardless of therapeu-
tic approach.
With clients with co-occurring PG and sub-
stance use disorders, it often is essential to
identify specific triggers for each disorder. It
also is helpful to identify ways in which use of
addictive substances or addictive activities such
as gambling act as mutual triggers.
Increasing evidence supports the effectiveness
of treatment approaches with the goal of
reduced or limited gambling, particularly for
problem gamblers who do not meet all criteria
for a diagnosis of pathological gambling or
who are low-severity pathological gamblers.
This approach generally involves money man-
agement along with cognitive–behavioral inter-
ventions to set and achieve goals for con-
trolled or limited gambling. Manuals are avail-
able to guide this type of treatment, and a
self-help manual also has been published
(Blaszczynski 1998).
Psychopharmacological treatment
Two main types of medication have been
reported to reduce gambling cravings and gam-
bling behavior: SSRIs, such as fluvoxamine
(Luvox), and opiate antagonists, such as nal-
trexone, which has also been found to be effec-
tive in treating people with substance use dis-
orders (Hollander et al. 2000; Kim et al. 2001).
As people with co-occurring substance use and
PG disorders may be more likely to experi-
ence a broad range of additional mental disor-
ders, psychiatric medication to address affec-
tive disorders, anxiety disorders, and atten-
tion deficit hyperactivity disorder may some-
times be needed.
Integrated multimodal treatment
Treatments combining 12-Step, psychoeduca-
tion, group therapy, and cognitive–behavioral
approaches have been found to be effective in
the treatment of pathological gamblers with co-
occurring substance use and mental disorders
(Lesieur and Blume 1991; Taber et al. 1987).
Gamblers Anonymous
It is advisable for persons with substance use
and PG disorders to attend separate support
groups for gambling and for alcohol and/or
drug dependence. While the groups can supple-
ment each other, they cannot substitute for
each other.
It may be difficult for some individuals to
adjust to both types of groups, as Gamblers
Anonymous (GA) meetings can be different
from AA. It is not uncommon for people with
substance use disorders who have had exten-
sive experience with AA, Narcotics
Anonymous, or Cocaine Anonymous to find
fault with GA groups. While GA often places
less emphasis on step work, sponsorship, and
structure than other 12-Step programs, it still
provides a unique fellowship to address gam-
bling issues. GA also can be useful in helping
gamblers and their families cope with money
management, debt, and restitution issues
through a process called “Pressure Relief.”
Clinicians new to the treatment of pathological
gambling are advised to attend open GA and
Gam-anon meetings in their area to gain a bet-
ter understanding of this support system.
The experience of some clinicians is that initial-
ly, limited gambling may be an approach for
those with substance use disorders and gam-
bling problems who are willing to work on
abstinence goals for their substance use, but
who are less motivated to abstain from gam-
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bling. Rather than distracting from the sub-
stance abuse treatment, the clinician can sug-
gest either a limited gambling approach or a
time-limited period of abstinence from gam-
bling. These may be presented as experiments.
Cravings for both gambling and substances can
be monitored in either approach to help clients
understand the potential interactions of both
disorders and to make better informed deci-
sions about whether they can gamble at all.
The same can be done with the client who is
motivated to abstain from gambling but more
ambivalent about the need to reduce his or her
substance use or abuse. This approach may
help minimize a client’s defensiveness toward
treatment in general and reduce the risk of
dropping out of treatment or denying a prob-
lem altogether.
Longer term treatment
PG, like substance use disorders, may be con-
ceptualized as a chronic, recurring disorder.
Potential for lapses and relapses must be recog-
nized for both disorders—and perhaps partic-
ularly for people with both disorders. It is
important to educate clients about this possibil-
ity, if not likelihood, and to develop a plan for
re-engaging in treatment if a lapse or a relapse
occurs. Professionally facilitated continuing-
care groups that focus on recovery mainte-
nance skills can be effective, particularly in
combination with mutual self-help groups.
Continuing-care groups often can be facilitated
by peer counselors or treatment program alum-
ni with several years of abstinence. Such contin-
uing-care groups particularly may be useful for
clients with COD to maintain contact with ther-
apy resources, to help “catch” a relapse in the
making, and to supplement limited availability
of GA in many communities. Development of a
treatment alumni network also can be a useful
strategy to maintain contact with clients over
longer periods of time and to increase the likeli-
hood of using supportive resources in times of
stress, vulnerability, or crisis.
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Case Study: Counseling the Client With Pathological
Gambling and Substance Use Disorders
Jan T. is a 32-year-old divorced, single parent with a history of cocaine and marijuana dependence, alcohol
abuse, and two prior treatments for her substance use disorders. She entered treatment following a bout of
heavy drinking resulting in a citation for Driving Under the Influence (DUI). During assessment, she
screened positive on the SOGS for probable pathological gambling. She had been going to casinos several
evenings per week, losing on average $200 to $500 per week playing video poker. Her rent and utilities were
past due, and she feared losing her job due to tardiness and inefficiency because often she would go to work
after staying up all night gambling. She had begun drinking while gambling after a 2-year abstinence from
substances, and her drinking had increased as her gambling problems progressed.
Jan T.’s DUI occurred while driving home from an all-night gambling episode. Her gambling had begun to
increase following her first substance abuse treatment and she acknowledged that her alcohol relapse after
her first treatment was related to her gambling, as was her current relapse. She reported having increased
her gambling due to feelings of stress and loneliness. As her gambling increased, she discontinued going to
continuing care and AA and Cocaine Anonymous meetings. However, in her second substance abuse treat-
ment, no one had asked her about her gambling and she did not recognize it as a problem at the time.
Current treatment emphasized her gambling problems as well as substance abuse. She attended gambling-spe-
cific education and therapy groups as well as AA, Cocaine Anonymous, and GA meetings. Due to serious, con-
tinuing financial problems and debt, Jan T. moved in with an older sister who had a 12-year history of absti-
nence from alcohol and attended AA meetings regularly. This sister also agreed to be her money manager.
Since Gam-anon groups are even less prevalent
than GA groups, continuing-care groups for
family members or for family members and PG
clients jointly particularly can be useful to pro-
vide support for coping with financial issues
that may persist for many years despite gam-
bling abstinence.
Resolving financial problems and accomplish-
ing debt repayment also can be a relapse trig-
ger for pathological gamblers, so often it is
important to schedule a “check up” visit
around the anticipated time when gambling
debts may be paid off. In general, it may be
advisable to attempt to maintain therapeutic
contact beyond the gambler’s 1-year anniver-
sary of abstinence, since often this seems to be
a time of vulnerability, overconfidence, and
complacency regarding recovery.
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Appendix E:
Emerging Models
Part I of this appendix provides information on where to seek further
information for models referenced in the main body of the TIP. Part II
describes models of care for people with COD that were evaluated or are
currently being evaluated with funding by the Substance Abuse and
Mental Health Services Administration (SAMHSA) or other Federal
agencies. Because these models are undergoing evaluation, they are not
endorsed by the consensus panel as consensus-based practices. Rather,
the models are intended to augment those described in the main body of
the TIP and to represent some initiatives. It is hoped that these models
will suggest ways in which readers working with a variety of client popu-
lations, disorders, or severities in different settings can improve their
capacities to assess and treat clients with COD.
Material for this chapter was derived from responses to a request for
information sent to programs listed in SAMHSA initiatives in 2002. The
programs were invited to describe essential aspects of their programs
and empirical information on outcome data. All initiatives canvassed are
listed at the end of this appendix. The models included in this appendix
are from programs that responded to the request. 
Part I: Addresses for Models
Referenced in the Text
Arapahoe House 
Michael W. Kirby, Jr., Ph.D.
CEO
Arapahoe House, Inc.
8801 Lipan Street
Thornton, CO 80260
Phone: (303) 657-3700
E-mail: mick@ahinc.org
437
Ellen Brown, Ph.D.
Same address and telephone number
E-mail: ellen@ahinc.org
Clackamas County Mental
Health Center 
Clackamas County Mental Health Center
Alcohol and Drug Program Manager
524 Main Street
Oregon City, OR 97045
CMHS/CSAT Collaborative
Program to Prevent
Homelessness
Colleen Clark, Ph.D.
Principal Investigator
Boley Centers for Behavioral Health Care, Inc.
St. Petersburg, FL 33713
Phone: (727) 821-4819 
Fax: (727) 822-6240
Web site: www.boleycenters.org
Community Connections
Rebecca Wolfson Berley, M.S.W.
Director of Trauma Education
Community Connections
801 Pennsylvania Avenue, SE
Suite 201
Washington, DC 20003
Phone: (202) 608-4735
Fax: (202) 608-4286
E-mail: rwolfson@communityconnectionsdc.org
Web site: www.communityconnectionsdc.org
(For more description see Part II of this
appendix.)
The Dual Assessment and
Recovery Track (DART)
Stanley Sacks, Ph.D., Principal Investigator
Center for the Integration of Research and 
Practice
National Development and Research Institutes,
Inc. 
71 West 23 Street, 8th Floor
New York, NY 10010
Phone: (212) 845-4648
Fax: (917) 438-0894
Evaluation of a Treatment
Model for Co-Occurring and
Traumatic Stress Disorder
Linda K. Frisman, Ph.D.
Principal Investigator
Connecticut Department of Mental Health and 
Addiction Services
Hartford, CT 06134
Phone: (860) 418-6788 
Fax: (860) 418-6692
E-mail: Frisman@uconnvm.uconn.edu
Foundations Associates
Contact information, detailed program materi-
als, and research findings may be obtained via 
Foundations’ Web site at
www.dualdiagnosis.org.
Gaudenzia, Inc.
Karen Griffin, Director of Administration
Gaudenzia Corporate Offices
106 W. Main Street 
Norristown, PA 19401
Phone: (610) 239-9600 x 231 
E-mail: kgriffin@Gaudenzia.org
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Harborview Medical Center’s
Crisis Triage Unit (CTU)
Rick Ries, Director of Outpatient Psychiatry, 
Addictions, and Dual Disorders Services
Harborview Medical Center
Box 359911
325 Ninth Avenue
Seattle, WA 98104
Phone: (206) 341-4216
Fax: (206) 731-3236
E-mail: rries@u.washington.edu
HIV Integration Project of the
CORE Center
Director, Behavioral Sciences
The CORE Center
2020 W. Harrison Street
Chicago, IL 60612
Phone: (312) 633-4915
Homelessness Prevention TC
for Addicted Mothers
Jo Ann Sacks, Ph.D., Principal Investigator
Center for the Integration of Research & 
Practice 
National Development & Research Institutes, 
Inc. 
71 W 23rd St., 8th Floor
New York, NY 10010
Phone: (212) 845-4648
Fax: (917) 438-0894
Na’nizhoozi Center, Inc.
Raymond Daw, M.A., Executive Director
Na’nizhoozi Center, Inc.
2205 East Boyd Drive
Gallup, NM 87301
Phone: (505) 722-2177
Fax: (505) 722-5961
E-mail: raydaw@aol.com
Project SPIRIT: Seeking
Pathways Into Receiving
Integrated Treatment
Roy M. Gabriel, Ph.D., Principal Investigator
RMC Research Corporation
522 SW Fifth Avenue, Suite 1407
Portland, OR 97204
Phone: (800) 788-1887 or (503) 223-8248
Fax: (503) 223-8399
E-mail: roy_gabriel@rmccorp.com
Triad Women’s Project
For more information on the Triad Women’s
Project, consult the following Web site:
www.fmhi.usf.edu/cmh/research/exemplary/
triad.html.
Part II: Other Emerging
Models
Case Management for Rural
Substance Abuse
This project evaluates the effectiveness of case
management with adult clients in residential
treatment for drug abuse. The results of this
study will be helpful to service providers and
policy developers as they plan drug treatment
interventions, especially in rural areas.
Contact information
James Hall, Ph.D., LISW
Principal Investigator
University of Iowa
Iowa City, IA 52242
Description of intervention
The overall goal of this study is to provide
insight into the development of case manage-
ment models for substance abuse treatment 
and to improve quality of life for rural sub-
stance abuse clients. The purpose of this pro-
ject is to conduct a full study of case manage-
ment treatment services and to evaluate the
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effectiveness of three case management models:
brokerage (IBCM), comprehensive (ICCM),
and standard treatment (SCM). The conceptual
model used is the health services framework of
Aday et al. (1993). In this framework, the pop-
ulation at risk is evaluated for predisposing,
enabling, and need variables.
Setting
Clients were recruited for the study from the
residential program at the Mid-Eastern Council
on Chemical Abuse (MECCA), which was also
the site for our earlier study on case manage-
ment. As a facility receiving State funds,
MECCA participates in the State-funded man-
aged care program. MECCA has a catchment
area comprising four counties and is governed
by community representatives from the four-
county area. MECCA’s main office is in Iowa
City, IA, with satellite offices in Coralville,
Marengo, and Washington, IA. Total popula-
tion for MECCA’s catchment area is 148,000
(1990 census), comprising 90 percent white, 2
percent African American, and 3 percent other
races. Roughly 75 percent of MECCA’s clients
are insured by a source that falls under the
IDPH managed care plan.
MECCA has a 20-bed residential unit with
additional beds in a halfway house, a detoxifi-
cation unit, and outpatient and educational
programs for adults and adolescents. Adult
clients are referred to MECCA from a variety
of sources, including hospitals (7 percent),
other health and social service agencies (7 per-
cent), the legal system (30 percent), family and
friends (6 percent), committals (10 percent),
and self-referrals (40 percent). Approximately
2,400 people are evaluated in person by
MECCA intake counselors annually to deter-
mine a treatment recommendation. The intake
screening uses Iowa’s Level of Care (LOC
Determination Form), which determines treat-
ment placement according to American Society
of Addiction Medicine (ASAM) Criteria.
Client characteristics
The target population for this study of rural
clients in substance abuse treatment is residen-
tial clients of one Midwestern not-for-profit
substance abuse treatment center, MECCA.
Approximately 380 clients per year meet crite-
ria required for an admission to MECCA’s
adult residential program. Clients in the resi-
dential program may receive up to 50 hours of
treatment services weekly, including group and
individual therapy, life skills training, and
other education classes. The average age of
MECCA residential clients is 33.9. Forty-two
percent are female, 84 percent are white, 12
percent are African American, 4 percent are
other races. Fifty-eight percent are unem-
ployed. Sixty-one percent have no health insur-
ance, 19 percent have Medicaid, Medicare, or
other public coverage. Eight percent are home-
less. Forty-nine percent of residential clients
have been diagnosed with a psychiatric condi-
tion prior to the admission. Ninety percent
have used alcohol steadily for at least 1 year in
their lifetime, 70 percent have used marijuana,
47 percent have used cocaine, and 48 percent
have used amphetamines. Residential clients
have been arrested an average 7.8 times in
their lifetime. Data collected at MECCA during
our previous study indicates that 49 percent of
female and 13 percent of male residential
clients have been sexually abused in their life-
time; 72 percent of female and 42 percent of
male residential clients reported being physical-
ly abused in their lifetime. Regarding HIV-asso-
ciated behaviors, 29 percent of MECCA clients
have used substances intravenously and 29 per-
cent have had sex with someone they knew was
using substances intravenously. 
Resources needed for 
implementation
In this study, we are evaluating two models of
case management, comprehensive and broker-
age, compared with standard treatment. Case
managers who use the comprehensive model
provide mental health counseling as part of
that service. For those clients receiving services
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with the brokerage case manager, they are
referred for mental health services (if needed)
based on their ability to pay; those with insur-
ance have more options in our area than those
on public funding.
We have a manual for both models, but train-
ing would be needed to carry out either model
with competency. In our area, cultural compe-
tency also includes working with those from
rural areas as well as smaller towns. We have
found that our case managers can help clients
overcome barriers to services through educa-
tion, direct referral, and transportation.
Empirical data
The primary analysis of outcome data focuses
on drug use by condition. Preliminary analysis
shows overall drug use decreased from intake
through both follow-up evaluation points for
each drug class. The main drugs of use were
alcohol, cocaine, marijuana, and metham-
phetamine. For these four drug classes, clients
receiving comprehensive case management
reported a significant decrease from intake to
the 3-month followup and then reported a
smaller decrease by the 6-month session.
Clients in the standard treatment condition
also reported a significant decrease in use of
these four drugs from intake to the 3-month
session, although no decreases were noted by
the 6-month session. Clients receiving broker-
age case management reported a significant
decrease in use from intake to the 3-month ses-
sion, but at the 6-month point, they reported
moderate increases.
Publications 
Hall, J.A., Carswell, C., Walsh, E., Huber,
D.L., and Jampoler, J. Iowa case manage-
ment: Innovative social casework. Social
Work, in press.
Hall, J.A., Vaughan, M., and Rick, G. Iowa
case management for rural substance abuse:
Preliminary results. Journal of Case
Management. Under review.
Hall, J.A., Vaughan, M.S., Vaughn, T., Block,
R.I., and Schut, A. Iowa case management
for rural drug abuse: Preliminary results.
Care Management Journals 1(4):232–243,
1999.
Huber, D.L., Hall, J.A., and Vaughn, T. The
dose of case management interventions.
Lippincott’s Case Management 6(3):119–126,
2001.
Ingram, J., Vaughan, M.S., and Hall, J. The
effectiveness of case management for sub-
stance abuse clients with mood or anxiety dis-
orders. To be submitted to Psychiatric
Services.
Kehrli, A.J. Access and utilization of case man-
agement services with substance abusing
clients. In development.
Vaughan, M.S., Hall, J.A., Richards, B., and
Carswell, C. A comparison of computer-
based versus pencil and paper assessment of
drug use. Research on Social Work Practice,
in press.
Vaughan, M.S., Hall, J.A., and Rick, G.
Impact of case management on use of health
services by rural clients in substance abuse
treatment. Journal of Drug Issues
30(2):435–464, 2000.
Vaughan, M.S., Huber, D., and Hall, J.A.
Impact of Iowa case management on family
functioning for substance abuse treatment
clients. Adolescent and Family Health, in
press.
Vaughn, T., Vaughan, M.S., Saleh, S., and
Hall, J.A. Participation and retention in
drug abuse treatment services research.
Submitted to Journal of Substance Abuse
Treatment.
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CMHS/CSAT Collaborative
Effort to Prevent
Homelessness
Contact information
Colleen Clark, Ph.D.
Principal Investigator
Department of Mental Health Law and Policy
MHC 2732
Florida Mental Health Institute 
University of South Florida
Tampa, FL 33612
Phone: (813) 974-9022
Fax: (813) 974-9327
E-mail: cclark@fmhi.usf.edu
Description of intervention
The Boley Homelessness Prevention Project
provides quality housing, housing-related sup-
port services, and linkages to a wide array of
psychosocial, clinical, and medical services.
Services range from immediate needs (food,
shelter, clothing) to permanent housing and
vocational training for individuals who are
homeless and have mental illnesses or co-occur-
ring substance use disorders. The program
provides housing or assists clients in finding
housing of their choice, and then provides
housing-related support services. The Boley
Centers employ a psychiatric rehabilitation
approach that incorporates the Fellowship
House and Fountain House models and the
case manager specialist model.
Setting
Located in West Central Florida, Boley Centers
for Behavioral Healthcare, Inc., is a private
nonprofit agency providing psychosocial reha-
bilitation services since 1970 for people with
severe mental illnesses who may also have sub-
stance use disorders. Boley provides an array
of residential and supportive services to over
600 persons at any given time and about 1,000
people in any given year.
Patient characteristics
The Boley Homelessness Prevention Project is
an important program of Boley Centers. Of the
92 individuals served in 1996, all individuals
had been homeless or at risk of homelessness
when they entered the program. The “model”
person served would be male, white, never
married, in his forties, with a primary diagno-
sis of a psychotic disorder and a secondary
diagnosis of a substance use disorder.
Resources needed for 
implementation
The most important aspect of staff training is
training in a psychosocial rehabilitation model.
This may come either from formal training out-
side the agency or through mentoring within
the agency. Staff-resident interactions are con-
sidered vital to the effectiveness of the inter-
vention and are based on mutual respect. The
model emphasizes providing services as needed
and or/requested rather than mandatory or
prescribed services.
Funding for services in the project follows a
fairly typical pattern of community mental
health agencies, i.e., a combination of State
ADM (alcohol, drugs, or mental disorders) and
Medicaid funding with some county and other
patient fees. Boley Centers is a model of inno-
vation for funding the acquisition and rehabili-
tation of housing. Each housing site may have a
different combination of HUD, City Revitali-
zation, County, private gifts, and client fees.
Although initially met with a “NIMBY” atti-
tude, they have developed a reputation for
revitalizing urban neighborhoods and are now
sought-after partners in housing and planning.
Empirical data
The results of the meta-analysis of eight sites
studied in the CMHS/CSAT Collaborative
Program to Prevent Homelessness strongly
supported programs, including Boley, that
guarantee housing and provide housing sup-
port services. These significant effects are being
written up have not been published to date.
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In addition, our local analysis demonstrated
that, for people with relatively high levels of
psychiatric symptoms and substance use, the
Boley intervention was more effective than spe-
cialized case management in helping to main-
tain stable housing. For people with relatively
low or moderate levels of symptoms and sub-
stance use, specialized case management was
equally effective. These findings are summa-
rized in publications below.
Publications
Descriptive publications
Boley Centers for Behavioral Health Care,
Inc.: The Homelessness Prevention Project—
1996-1997: A Descriptive Manual.
This is a comprehensive description of the con-
ceptual framework, environmental context,
development of the intervention, client popula-
tion, structure, and process of the intervention,
the agency/community network, evaluation
activities, residents’ stories, and lessons
learned and recommendations. It is available
from Colleen Clark (see above for contact
information).
Clark, C., and Rich, A. “Boley Centers for
Behavioral Health Care, Inc.: Housing
Related Support Services.” Reinforcing
Upstream: Interim Status Report of the
Center for Mental Health Services and
Center for Substance Abuse Treatment
Collaborative Effort to Prevent
Homelessness, 1999.
Clark, C., and Rich, A. “Boley Homelessness
Prevention Project: Final Report.” Final
project deliverable to the CMHS/CSAT
Collaborative Program to Prevent
Homelessness, 2000.
Clark, C., Teague, G., and Henry, R.
Prevention of Homelessness in Florida. Co-
published simultaneously in Alcoholism
Treatment Quarterly 17(1/2): 73–91; and in
Conrad, K. et al., eds. Homelessness
Prevention in Treatment of Substance Abuse
and Mental Illness; Logic, Models, and
Implementation of Eight American Projects.
The Haworth Press, Inc., 1999. pp. 73–91.
Publications of the outcomes
Clark, C. Policy Brief 14: Ending
Homelessness Among Person with Serious
Mental Illness: What Works Best for Whom?
Louis de la Parte Florida Mental Health
Institute Series. November, 2001.
Clark, C., and Rich, A. Ameliorating homeless-
ness for adults with mental illness: What
works for whom? Psychiatric Services, in
press.
CODAC Behavioral Health:
Managing Co-Occurring
Disorders in an Opioid
Agonist Setting
Contact information
James C. Carleton, M.S.
Director of Opioid Treatment Services
CODAC Behavioral Health
1052 Park Ave.
Cranston, RI 02910
Phone: (401) 275-5039 
Fax: (401) 942-3590 
E-mail: jcarleton@codacinc.org
Description of intervention
This program provides uninsured methadone
clients with psychiatric evaluation, care, medi-
cation, and casework, all at no cost. It was
developed on the premise that a client seeking
treatment should find “no wrong door” that
might impede progress in finding help of this
nature. Given this, a client seeking help for
emotional problems, lacking the means to
access these services, is referred, evaluated,
and treated onsite in the Co-Occurring
Disorders Program. The program is a collabo-
rative effort of CODAC Behavioral Health, a
substance abuse and behavioral disorders
treatment facility, and Gateway Healthcare, a
large, multi-site, mental health center. It is
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staffed by a Psychiatrist (Gateway), Licensed
Mental Health Professional (CODAC), and
Caseworker (Gateway). Twice per week, onsite
at the CODAC Providence methadone clinic,
clients are seen and treated on referral from
the methadone treatment staff. As a result,
CODAC clients receive “methadone friendly”
psychiatric care, in a timely fashion, onsite at
their primary clinic. They are followed after-
hours as if they were ordinary clients of the
prescribing psychiatrist at Gateway
Healthcare. 
Setting
The Co-Occurring Disorders Program is locat-
ed at CODAC Behavioral Health’s Providence,
RI, location. Gateway Healthcare, the collabo-
rative psychiatric treatment component, is
located in nearby Pawtucket, RI. CODAC
Behavioral Health, historically a substance
abuse treatment facility, is in its 30th year.
CODAC serves approximately 2,200 clients,
out of which 1,050 are agonist clients, utilizing
both methadone and LAAM. 
Client characteristics
All of the clients who participate in the Co-
Occurring Disorders Program are opioid ago-
nist clients of CODAC Behavioral Health. They
are referred on a voluntary basis. None have
health insurance or related benefits.
The gender breakdown is 60 percent female, 40
percent male. The average client age range is
late thirties to early forties. The racial break-
down, from most to least, is Caucasian,
Hispanic, and African American.
The most common diagnosis treated is that of
Mood Disorder. This would include depressive
disorders, dysthymic disorders, bipolar I and
II, and cyclothymic disorders. Also common
are Anxiety Disorders, to include panic, agora-
phobia, obsessive-compulsive disorder, and
posttraumatic stress disorder. Many clients also
carry the diagnosis of Personality Disorder,
coded on Axis II. 
In terms of severity, all clients are outpatient
and are required to make multiple trips to the
clinic each week. Several clients have been hos-
pitalized while under our care, and aggressive
casework managed to provide continuity of
treatment. 
Resources needed for 
implementation
This project is entirely funded by a grant from
the Department of Mental Health, Retardation,
and Hospitals, Division of Substance Abuse,
State of Rhode Island. We are in the first year
of a 3-year project.
Medication is provided free of charge, through
a State-administered program, the Community
Mental Health Medication Assistance Program
(CMAP). 
Successful implementation required coopera-
tion on a number of levels. CODAC and
Gateway needed to effectively collaborate to
design the program and win a competitive bid
process. That accomplished, we desired regula-
tory cooperation to site the program at an
existing methadone treatment facility, and
practice psychiatric medicine. Further, we
required regulatory approval to qualify our
clients for CMAP, and free medication, if with-
in a restricted formulary. Finally, the program
was designed to be attractive to clients, and
existing methadone staff. It needed to fit well
with the present services and be accessible to
referring staff and clients. Built into the pro-
gram was a series of inservice trainings
designed to educate the staff regarding the ser-
vice, and its obvious benefits.
In summary, establishing a program of this
nature requires collaboration between multiple
systems. One must have the expertise to design
and fund a project. Cooperation between three
or more regulatory bodies is involved as you
site a non-traditional service in an established,
substance abuse treatment facility. Finally, the
value of the service must be stressed to the ulti-
mate consumers, and the intrasystem referral
sources. Dependent on the demographics of
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your locale, it may be essential to have bilin-
gual, culturally competent staff. The program’s
credibility will depend on it. 
Empirical data
Program evaluation provides for a number of
measures to assess the level of success. As these
are clients on a methadone treatment program,
some well-defined indicators emerge. First, tox-
icology screening tells us whether the client is
drug-free. It is hoped an effective mental health
intervention will reduce illicit drug use.
Second, an empirical, 32-item scale, the
BASIS-32, is administered at 3- and 6-month
intervals. This scale rates a client’s progress
along five areas of difficulty: relation to
self/others, depression/anxiety, living skills,
impulsive/addictive, and psychosis. Third, the
overall behavior and demeanor of the client is
evaluated by the behavioral health specialist.
We are still early on in the data collection pro-
cess; however, the first set of results appears to
be trending positive.
The data are unpublished at this point. Our
plan is to collect 12 months’ worth of evalua-
tion data prior to publication.
Publications
There are no publications associated with this
program.
Community Connections
Contact information
Rebecca Wolfson Berley, M.S.W.
Director of Trauma Education
Community Connections
801 Pennsylvania Avenue, SE
Suite 201
Washington, DC 20003
Phone: (202) 608-4735
Fax: (202) 608-4286
E-mail: rwolfson@communityconnectionsdc.org
Web site: www.communityconnectionsdc.org
Description of Intervention
Community Connections, a provider of com-
prehensive human services in Washington, DC,
is the lead agency for the DC Trauma
Collaboration Study (DCTCS). This project
was funded by SAMHSA to develop and evalu-
ate the effectiveness of services for women trau-
ma survivors with co-occurring substance use
and mental disorders. Agency staff developed a
comprehensive, integrated, trauma-focused
network of services with four key intervention
components: Trauma Recovery and
Empowerment Model (TREM) groups,
Integrated Trauma Services Teams (ITSTs),
Collateral Groups (on issues such as substance
abuse, parenting, domestic violence, and spiri-
tuality), and a peer support program. 
Setting
The experimental sites are two community
mental health and substance abuse treatment
programs in Washington, DC: Community
Connections and Lutheran Social Services. The
control sites are two similar programs in
Baltimore, MD: North Baltimore Center and
People Encouraging People.
Client characteristics
Women enrolled in the study had histories of
trauma (physical and/or sexual abuse) as well
as a substance abuse diagnosis and a mental ill-
ness diagnosis (at least one current and one
within the past 5 years).
Resources needed for 
implementation
Primary clinicians received cross-training in
trauma, mental health, and substance abuse
problems and related interventions. Consumer-
survivors were involved in planning, imple-
menting, and evaluating the project; they also
developed a Women’s Support and
Empowerment Center to provide peer support
services.
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Empirical data
Preliminary findings from the DCTCS indicate
that the TREM intervention is feasible (that
clinicians can learn to implement it in a consis-
tent way with fidelity to the treatment manual);
that consumers complete it at high rates (over
75 percent of the women involved in the first
eight groups completed more than 75 percent of
the sessions); and that consumer satisfaction is
very high. Other early outcome data suggest
that this integrated package of services built
around the central TREM group intervention is
helpful to participants in both substance abuse
and mental health domains. Pilot data collected
in other program evaluation projects suggest
potential benefits for TREM participants in a
number of outcome domains: decreased mental
health symptoms, increased recovery skills,
and enhanced overall functioning; reduced uti-
lization of inpatient hospitalization and emer-
gency rooms; and decreased high-risk behav-
ior.
Publications
Copeland, M.E., and Harris, M. Healing the
Trauma of Abuse: A Women’s Workbook.
New Harbinger Press, 2000. 
Fallot, R.D., and Harris, M. The Trauma
Recovery and Empowerment Model
(TREM): Conceptual and practical issues in
a group intervention for women.
Community Mental Health Journal, in
press.
Goodman, L.A., Dutton, M.A., and Harris,
M. Physical and sexual assault prevalence
among episodically homeless women with
serious mental illness. American Journal of
Orthopsychiatry 65(4):468–478, 1995. 
Goodman, L.A, Dutton, M.A., and Harris, M.
The relationship between dimensions of vio-
lent victimization and symptom severity
among episodically homeless, mentally ill
women. Journal of Traumatic Stress
10(1):51–70, 1997. 
Goodman, L., and Fallot, R.D. HIV risk
behavior and poor urban women with seri-
ous mental disorders: Association with
childhood physical and sexual abuse.
American Journal of Orthopsychiatry 68
(1):73–83, 1998. 
Harris, M. Modifications in service delivery
and clinical treatment for women diagnosed
with severe mental illness who are also the
survivors of sexual abuse trauma. Journal
of Mental Health Administration
21:397–406, 1994.
Harris, M. Treating sexual abuse trauma with
dually diagnosed women. Community
Mental Health Journal 32:4, 1996. 
Harris, M., ed. Sexual Abuse in the Lives of
Women Diagnosed with Severe Mental
Illness. Newark, NJ: Harwood Academic
Publishers, 1997. 
Harris, M., and the Community Connections
Trauma Work Group. Trauma Recovery
and Empowerment: A Guide for Clinicians
Working with Women in Groups. New
York: The Free Press, 1998.
Harris, M., and Fallot, R.D., eds. Using
Trauma Theory to Design Service Systems.
New Directions for Mental Health Services
Series. San Francisco: Jossey-Bass, 2001.
The Dual Assessment and
Recovery Track (DART)
Contact information
Stanley Sacks, Ph.D., Principal Investigator
Center for the Integration of Research and 
Practice
National Development and Research Institutes,
Inc.
71 West 23 Street, 8th Floor
New York, NY 10010
Phone: (212) 845-4648
Fax: (917) 438-0894
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Description of intervention
Consistent with findings from the literature, the
Dual Assessment and Recovery Track (DART)
uses the conceptual framework, structure, and
principles of TC treatment found effective for
clients with co-occurring substance abuse and
mental disorders (e.g., fostering personal
responsibility and self-help to cope with life dif-
ficulties, use of the peer community as the heal-
ing agent and as an essential support for attain-
ing and sustaining recovery, and promoting a
change in lifestyle) and (1) adds critical COD
interventions (“Understanding the Inter-rela-
tionship of Mental Health and Substance Abuse
Issues,” “Trauma-Informed Addictions
Treatment”), (2) builds case management skills
to help clients obtain appropriate services, and
(3) improves comorbidity assessment and treat-
ment planning to improve service delivery for
individuals with COD in outpatient substance
abuse treatment settings.
Staffing
DART is provided as a special treatment track
within an Intensive Outpatient Program (IOP)
that the clients attend 3 days a week for 5
hours per day; the IOP is part of a community-
based substance abuse treatment program. One
counselor, trained and experienced in provid-
ing treatment services for individuals with co-
occurring disorders, provides the DART inter-
ventions that are incorporated within the stan-
dard IOP treatment program. The DART
counselor reports to the IOP Program
Supervisor. The DART counselor provides the
two specialized weekly treatment groups (cited
above) as well as individual case management
services for 25 clients.
Setting
Gaudenzia, Inc. is a private, not-for-profit
agency that was incorporated in Pennsylvania
in 1968 to provide treatment, prevention, and
other services to those with substance abuse
treatment needs. Gaudenzia employs 350 peo-
ple, operating 34 programs at 20 facilities, to
provide residential services, traditional outpa-
tient services (e.g., counseling, outreach), and
intensive outpatient services. Target groups
include adults, women with children, the home-
less, people who are HIV/AIDS symptomatic,
and those with co-occurring disorders. 
The program is located in downtown
Philadelphia on two floors of a recently reno-
vated 8-story facility that houses the outpatient
treatment program, administrative offices, and
several specialized residential treatment pro-
grams. 
Client characteristics
The DART program is designed to serve men
and women who abuse substances and who
have co-occurring mental disorders. The clients
are primarily minority (75 percent African
American; 12 percent Hispanic) adults, unmar-
ried (71 percent) with an average age of 35.
They are undereducated (on average, 11 years
of education), unemployed (25 percent were
employed in the last year), and 48 percent are
on probation or parole. Cocaine is the major
drug of choice (50 percent of the clients), fol-
lowed by cannabis (32 percent). Eighty-three
percent of clients report depression at some
time; 24 percent have attempted suicide.
Female clients report a high incidence of physi-
cal (76 percent) and sexual abuse (44 percent). 
Resources needed for 
implementation
Training. The treatment program is best imple-
mented by a substance abuse counselor trained
and experienced in providing interventions for
individuals with COD. Additionally, since
DART is operated as a specialized treatment
track within a standard outpatient treatment
program, staff cross-training plays a key role in
strengthening the dual diagnosis orientation of
DART. Monthly training seminars were con-
ducted to prepare staff for implementing
DART. The cross-training curriculum included
formal didactic training and technical assis-
tance in program modification for co-occurring
disorders.
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Stakeholder Participation. The following prin-
ciples were utilized to facilitate participation by
key administrative and program staff: program
planning and modification for COD are con-
ducted within agency and system guidelines; all
key stakeholders are involved in planning for
implementation; and a collaborative relation-
ship is fostered between administrative, ser-
vice, and training staff.
Empirical data
The DART program is currently being evaluat-
ed for program effectiveness, costs, and cost-
effectiveness. The examination of effectiveness
compares DART with the standard substance
abuse outpatient program.
Clients with COD are randomly assigned to
either the DART program model, with
enhanced interventions for individuals with
COD, or to the standard outpatient substance
abuse program. The study employs both GAIN
M90 scales recommended by CSAT to assess
client outcomes across several critical domains
(Substance Use, Physical Health, Mental and
Emotional Health, Environment and Living
Situation, Legal, and Vocational), and two
main standardized psychological scales—Brief
Symptom Inventory, and Beck Depression
Inventory-II (Beck et al. 1996)—to assess out-
comes related to psychological, as well as other
areas, of client functioning. Findings from the
evaluation of this program will be applicable to
both TC and non-TC agencies, thereby increas-
ing the impact of the model.
Evaluation of a Treatment
Model for Co-Occurring
Addictive Treatment Stress
Disorder
Contact information
Linda K. Frisman, Ph.D.
Principal Investigator 
Connecticut Department of Mental Health and 
Addiction Services
Hartford, CT 06134
Phone: (860) 418-6788
Fax: (860) 418-6692
E-mail: frisman@uconnvm.uconn.edu
Description of intervention
This eight-session TARGET model integrates
cognitive–behavioral, motivational enhance-
ment, relational/emotional focuses, and relapse
prevention principles and procedures for trau-
ma recovery and substance abuse recovery. It
provides an alternative to exposure-based
treatment for posttraumatic stress disorder
that is based on recent research and clinical
evidence.
Setting 
Study participants are recruited from three
outpatient substance abuse clinics in
Connecticut: the Morris Foundation in
Waterbury, the Rushford Center in
Middletown, and LMG Inc. in Stamford. These
private, non-profit agencies have extensive
experience working with persons with co-occur-
ring mental disorders. The Morris Foundation,
in addition to outpatient services, operates a
therapeutic shelter, a residential substance
abuse program, and a women and children’s
residential program. Clients receive intense
outpatient services with group therapy and
psychoeducational groups, typically for 4
weeks.
The Rushford Center provides a continuum of
progressive, multi-modal inpatient and outpa-
tient treatment programs for adult men and
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women. Services include detoxification, resi-
dential programs, day and evening partial hos-
pitalization, and a halfway house. 
LMG offers outpatient and residential services
for men, women, youth, and seniors. Services
include detoxification, methadone maintenance,
family treatment, and career development.
Patient characteristics
Study participants are adults (age 18 and over)
with co-occurring substance use and trauma-
related disorders. In order to enter the study, a
participant must
1. Have a history of exposure to an event(s)
fulfilling the conditions for DSM-IV post-
traumatic stress disorder (PTSD) Criterion
A psychological trauma.
2. Meet criteria for a substance use disorder.
3. Meet DSM-IV criteria for one of the follow-
ing: (1) PTSD within the past year; or (2)
Disorders of Extreme Stress, Not Otherwise
Specified (DESNOS) plus at least one or
more DSM-IV Axis I or II disorders includ-
ing: major depressive disorder, dysthymic
disorder, dissociative disorder. 
Resources needed for 
implementation
In addition to the cost of the group clinician
and center costs, we needed the following:
• Consultation with trauma expert (first year
of implementation)
• Training in model and cultural competence 
• Art supplies for creative arts exercises
• Gift incentives for group participation 
• Snacks for groups 
• Drug test supplies
Only the time of clinicians and related charges
are reimbursed by most insurance plans; how-
ever, we cannot charge because of Medicare
rules regarding research.
Empirical data
This study is still in the field; no findings are
available at this time. 
Publications
The TARGET manual is now available from
the above address.
Homelessness Prevention TC
for Addicted Mothers
Contact information
Jo Ann Sacks, Ph.D., Principal Investigator
Center for the Integration of Research & 
Practice 
National Development and Research Institutes,
Inc. 
71 W 23rd St., 8th Floor
New York, NY 10010
Tel: (212) 845-4648
Fax: (917) 438-0894
Description of the 
intervention
The program, for mothers and their children,
uses TC principles and methods to address the
problem of substance abuse, to provide a foun-
dation for a full personal recovery or change,
and to furnish an environment within which
homelessness prevention interventions occur.
The specific homelessness prevention activities
include 14 distinctive interventions that
address family preservation, work, housing sta-
bilization, and building a supportive communi-
ty. The mothers progress through program
stages and typically move from residential to
permanent housing.
Staffing
The residential program is staffed 24 hours a
day, 7 days a week, with a combination of
supervisors, counselors, and house managers.
Three staff members, including at least one
supervisor, are present during peak program-
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ming hours (9 a.m. to 9 p.m.); two staff mem-
bers are present overnight. The Director and
Clinical Supervisor are available for consulta-
tion on an emergency pager system when they
are not on-site. The Prevention Specialist pro-
vides special parenting skills training groups on
weekdays and substance abuse prevention
groups for children during the family education
activities on Sunday, enriching the staffing at
those times. The Transitional program is
staffed with one counselor/case manager for
approximately 20 individuals. A Prevention
Specialist and Child Care Worker staff the
Child Care program with the help of two or
three mothers who are assigned to participate
in the Child Care program each day as part of
their parenting training.
Setting
Gaudenzia is a private, not-for-profit TC-ori-
ented agency, incorporated in Pennsylvania in
1968 to provide treatment, prevention and
other services to people with substance abuse
and related problems. Two of Gaudenzia’s 34
programs, New Image in Philadelphia and
Kindred House in West Chester, were devel-
oped in 1989 (in cooperation with the City of
Philadelphia Health Department and the U.S.
Public Health Service) as programs to prevent
homelessness among those homeless, substance-
abusing women who were pregnant and/or who
were parenting at least one child. Each mother
entering the program is allowed to bring up to
two of her dependent children with her.
Both program sites share similar physical
design elements, including: bedroom space
occupied by two or three mothers and their
young children; gender-specific dormitory bed-
rooms shared by up to four older children;
communal dining and recreational space; infant
and pre-school nursery/day care space; group
meeting rooms and office space for administra-
tive work, and individual counseling.
Client characteristics
The program is for homeless substance-abusing
mothers (most with COD) and their children.
The clients can be characterized as predomi-
nantly minorities (80 percent), average age 33,
never married (66 percent), from broken
homes (71 percent) and with less than a high
school education (53 percent). The women
reported three children on average, with only
one child having primary residence with the
mother at baseline. The women show a history
of drug use (97 percent), arrest (76 percent),
homelessness 62 percent), and moderate levels
of psychological symptoms, as indicated by
average Beck Depression Inventory (BDI)
scores of 17.69 (SD=10.2) and average
Symptom Check-List 90-Revised Global
Severity Index (SCL 90-R) scores of 65.07
(SD=10.27). 
Resources needed for 
implementation
Follow six principles for successful program
implementation. 
1. Work within the guidelines of agency and
system.
2. Involve stakeholders in the project.
3. Use a strategic program planning approach
and involve all key staff in program plan-
ning and refinement.
4. Employ active training and technical assis-
tance during the refinement and implemen-
tation of new elements.
5. Review program fidelity periodically.
6. Develop ownership and a firm collaborative
relationship among service, training, and
evaluation staff.
Empirical data
This women’s therapeutic community enhanced
with programming focused on the prevention of
homelessness was evaluated using a quasi-exper-
imental design. Propensity analysis was used to
select a subgroup in which the Experimental (E)
and Comparison (C) participants were compara-
ble. At the domain level, statistically significant
450 Emerging Models
relative improvement for the E group was found
in psychological dysfunction and health. In the
former domain, significant improvement was
found on two standard psychological inventories
measuring symptoms, for example, depression.
In the latter domain, significant improvements
included ratings of the women’s health and
adherence to medication regimens. No signifi-
cant difference was found at the domain levels of
family preservation and housing stabilization,
but the results were mixed over specific out-
comes in each; e.g., mothers in the E group
showed better outcomes on the number of chil-
dren residing with the mother and the number
of children for whom the mother assumes finan-
cial responsibility. These results show the feasi-
bility of extending the range and applicability of
the TC model to address the specific problems of
homeless mothers with COD and their children. 
Publications
Sacks, J.Y., Sacks, S., Harle, M., and De
Leon, G. Homelessness prevention thera-
peutic community (TC) for addicted moth-
ers. In: Conrad, K.J., Matters, M.D.,
Hanrahan, P., and Luchins, D.J. (eds).
Homelessness prevention in treatment of
substance abuse and mental illness: Logic
models and implementation of eight
American projects. Alcoholism Treatment
Quarterly 17(1/2):33–51, 1999.
Sacks, S., Sacks, J.Y., Bernhardt, A.I.,
Harle, M., and De Leon, G. Homelessness
Prevention TC for Addicted Mothers: A
Program Manual. Center for Mental Health
Services (CMHS)/Center for Substance
Abuse Treatment (CSAT), Rockville, MD,
GFA SM 96-01, CFDA #93.230—Grant #1
UD9 SM51969-01. New York, NY:
NDRI/CTCR, 1997.
Sacks, S., Sacks, J.Y., McKendrick, K.,
Pearson, F.S., and Banks, S. TC for
Homeless, Addicted Mothers and Their
Children: Change in Psychological and
Health Status, Family Re-integration and
Housing. Journal of Behavioral Health
Services & Research (in review).
Improving Services for
Substance Abusers With
Comorbid Depression
Contact information
Joe Horton, M.S.W., LCSW, Project Manager
Washington University
One Brookings Drive
St. Louis, MO 63130
Phone: (314) 286-2499
Fax: (314) 286-2265
E-mail: jch1@gwbmail.wustl.edu
Description of intervention
The overall goal of the study is to document the
effectiveness of a program to increase the iden-
tification of depression among people who
abuse substances and to improve the treatment
services offered to people with these complex
co-occurring conditions. This goal is being
addressed by conducting in-person psychiatric
assessments on 500 consecutive adult admis-
sions to the Chestnut Health Systems substance
abuse treatment programs in Madison County,
MO, using the Diagnostic Interview Schedule
IV (DIS).
Setting
The program is located in rural Madison
County, MO. Illinois Chestnut Health System is
a community mental health agency.
Client characteristics
The populations are diverse—probation/
parole, Department of Family Services,
Department of Corrections, and public and
private programs. This is primarily a popula-
tion with substance use disorders, and 27 per-
cent are currently diagnosed with depression.
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Resources needed for 
implementation
Chestnut Health System is self-supportive
through grants and State funding. Most barri-
ers have been overcome by the staff from
Washington University working closely with the
Chestnut staff to solve problems on a weekly
basis.
Empirical data
Outcome measures have not been evaluated as
there is a 6-month and 12-month followup.
Currently only baseline data are available,
which do not lead to outcome measures.
Publications
Compton, W. Improving treatment services for
substance abusers with comorbid depression.
Journal of Substance Abuse Treatment, 2001.
Multi-Disciplinary Mental
Health and Substance Abuse
Treatment
Contact information
Robert Calsyn, Ph.D., Principal Investigator
University of Missouri
8001 Natural Bridge Road
St. Louis, MO 63121
Phone: (314) 516-5421
Fax: (314) 516-5210
E-mail: robert_calsyn@umsl.edu
Description of intervention
Multi-disciplinary mental health and substance
abuse treatment team with case management to
coordinate HIV/AIDS primary care and other
services. Study participants randomly assigned
to integrated services or care-as-usual, which
consists of limited availability of mental health
and substance abuse services, and case man-
agement. To date, 159 individuals are enrolled
in the study. Results are not yet available.
Setting
Community-based integrated mental health,
substance abuse, and case management ser-
vices provider.
Client characteristics
Multiply diagnosed individuals recruited from
metropolitan area, Ryan White-funded case
management providers.
Resources needed for 
implementation
Keys to successful implementation include (1)
steering committee of target populations, Ryan
White program staff, and other service
providers; (2) assertive community treatment
team that coordinates care of triple-diagnosed
clients.
Orange County Needs-Based
Treatment Intervention for
Mothers’ Engagement (ON
TIME) Project
Contact information
Nancy K. Young, Ph.D., Co-Principal 
Investigator
Children and Family Futures
4940 Irvine Blvd., Suite 202
Irvine, CA 92620
Phone: (714) 505-3525 
Fax: (714) 505-3626
E-mail: nkyoung@cffutures.com
Description of intervention
The ON TIME project, a partnership of
researchers and public and private agencies, is
designed to address the need for timely inter-
vention with women affected by substance
abuse and child welfare. The goals of the pro-
ject are: (1) to assess the ability of alcohol and
other drug (AOD) and social service systems to
respond to the new timelines of the Adoption
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and Safe Families Act (ASFA) among women
who need AOD treatment; (2) to test the effec-
tiveness of outreach, intervention, engagement,
and re-engagement strategies with women who
abuse substances under ASFA; and (3) to mea-
sure four primary outcomes: decrease sub-
stance use, increase treatment compliance,
increase family stability, and increase partici-
pation in employment activities. This interven-
tion is provided by outreach Recovery Mentors
who are extensively trained in Motivational
Enhancement Therapy and have personal
experience in recovery and social service sys-
tems. 
Setting
The ON TIME project is a county-wide pro-
gram serving women in Orange County,
California. The project is a collaboration
among organizations in the county that serve in
the best interests of children and their families.
Orangewood Children’s Foundation is the
grantee, providing administrative support to
the project through its role as a community
leader on children’s issues. Children and
Family Futures is a non-profit organization
that offers strategic planning and evaluation to
local and State entities that provide services to
children whose parents have substance abuse
issues. Southern California Alcohol and Drug
Programs run several substance abuse treat-
ment agencies in surrounding areas and employ
the Recovery Mentors. Finally, UCLA Drug
Abuse Research Center provides the analysis of
data involving follow-up interviews. These
agencies work in collaboration with Children
and Family Services, the county child welfare
organization. The Recovery Mentors are out-
stationed at the dependency court. They pro-
vide Motivational Enhancement Therapy and
serve as liaisons to treatment providers in the
community. 
Client characteristics
Women over the age of 18 are eligible for the
project if they have substance abuse allegations
in the dependency court petition. These women
have a multitude of issues co-occurring with
substance use such as mental health issues,
domestic violence involvement, criminal back-
grounds, and welfare and employment issues.
Resources needed for 
implementation
The key to implementation for ON TIME was
the need for a communication protocol among
partner agencies. Due to confidentiality1 con-
cerns, as well as the research protocol involving
human subjects, clients sign a consent form for
participation and to allow communication
between social services, attorney groups, and
the ON TIME project staff. The Recovery
Mentors were extensively trained in
Motivational Enhancement Therapy tech-
niques, the Addiction Severity Index, ASAM
Patient Placement Criteria, and other tools for
intervention. Resources required for imple-
mentation include the curriculum and training
materials for these tools as well as purchase of
the tools themselves. It was essential in the
recruitment of Recovery Mentors that they
reflect the cultural diversity of the community.
One of the mentors is bilingual in Spanish,
reflecting the 50 percent Hispanic/Latino popu-
lation in the county, and all four mentors are
women in recovery from addiction. 
Empirical data
Preliminary findings include: significantly
fewer ON TIME mothers had positive urine
toxicology tests between the Detention Hearing
and the 21-day hearing than the comparison
group of mothers who did not receive these ser-
vices; a higher percentage of ON TIME women
entered treatment prior to their 6-month
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1Confidentiality is governed by the Federal “Confidentiality of Alcohol and Drug Abuse Patient Records” regulations (42
CFR Part 2) and the federal “Standards for Privacy of Individually Identifiable Health Information” (45 CFR Parts
160 and 164).
review than the comparison group. Among cur-
rent ON TIME clients, they significantly
increased their readiness to make lifestyle
changes in the first 3 weeks of participation; 86
percent and 82 percent of the clients had fol-
low-up interviews at 3 and 9 months; mothers
reported a significant decrease in illicit sub-
stance use and alcohol consumption at the 3-
and 9-month interviews; and the ASI scores sig-
nificantly decreased between baseline and 9-
month interviews in all areas except employ-
ment.
Project SPIRIT: Seeking the
Pathways Into Recovering
Integrated Treatment
Contact information
Roy M. Gabriel, Ph.D.
Principal Investigator
RMC Research Corporation
522 SW Fifth Avenue, Suite 1407
Portland, OR 97024
E-mail: roy_gabriel@rmccorp.com
Description of intervention
Project SPIRIT is an evaluation study designed
to document and demonstrate the effectiveness
of integrated treatment approaches for treating
persons with co-occurring substance abuse and
mental health problems. Study participants are
naturalistically or quasi-randomly assigned to
one of six treatment agencies depending on the
recruitment source. Study participants are cur-
rently being recruited from central locations
(i.e., family health clinic, detoxification agency)
that subsequently refer these individuals to
treatment and directly from the participating
treatment agencies themselves. Each participat-
ing agency has been categorized as an integrat-
ed treatment program, a COD track program,
or a nonspecialized program based on prelimi-
nary process information collected from each
site.
Setting
The agencies involved in the study are all locat-
ed in the Portland (Oregon) metropolitan area.
They range from a small SA/MH treatment ser-
vice-only agency to a large, multi-program
social service agency dedicated to meeting the
array of needs of the city’s most indigent, dis-
advantaged individuals.
Patient characteristics 
All potential study clients are screened using
the Millon Clinical Multiaxial Inventory III
(MCMI). Client eligibility is defined as having a
clinically diagnosed alcohol or drug depen-
dence or addiction treatment determined by a
certified clinician and a suspected Axis I or
Axis II mental health program detected by
MCMI. The agencies range from 50 percent to
77 percent of their COD clients evidencing Axis
I severe clinical syndromes.
Resources needed for 
implementation
MH services are covered in a managed care
system that differs from the managed care sys-
tem that governs substance abuse services. This
poses serious obstacles to providers trying to
treat individuals with co-occurring SA and MH
disorders.
Empirical data
Baseline data collection is complete. Documen-
tation of the three treatment approaches is
ongoing and includes provider surveys,
provider interviews, client focus groups, and
document reviews. The baseline sample size is
N=280, split among the three models under
study: Integration (n=109), serial/parallel
(n=98), and no MH services (n=73). As of
September 1, 2002, the 6-month follow-up
response rate is approximately 86 percent.
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Publications
A progress report on Project SPIRIT activities
will include the evolution of the client recruit-
ment strategy to include multiple sources, mod-
ifications to the original study design and anal-
ysis plan, a detailed description of the screen-
ing process, current description of the study
population, experiences working with health
clinic physicians, and preliminary results from
the provider survey. Current project reports
include a Study Methods Report, detailing the
design and instrumentation of the study; and a
Baseline Report, characterizing the sample in
terms of their demographics, treatment history,
alcohol and drug use, MH symptomatology,
and criminal justice history.
The Rural HIV/AIDS, Substance
Abuse, Mental Health
Outcomes Study
Contact information
Kate Whettan-Goldstein, Ph.D., M.P.H., 
Principal Investigator
Center for Health Policy, Law & Management
Duke University
125 Old Chemistry Building, Box 90253
Durham, NC 27708
Phone: (919) 684-8012
E-mail: kwg@hpolicy.duke.edu
Rachel Stevens, M.P.H., Project Director
Phone: (919) 684-3368
Fax: (919) 681-9034
E-mail: rstevens@hpolicy.duke.edu
Description of intervention
Twelve months of intensive outpatient mental
health and substance abuse counseling in con-
junction with rural case manager contracts and
transportation services to promote treatment
adherence. Subgroups of study participants
compared across time; care-as-usual for those
who do not engage in intervention services con-
sists of the limited amount of counseling avail-
able at the HIV/AIDS clinics.
Setting
Two integrated outpatient mental health and
substance abuse service providers linked to
nearby HIV/AIDS primary care clinics. One is
based in Durham, NC (The Duke Addictions
Program), the other in Fayetteville, NC (coun-
ty mental health agency).
Client characteristics
Multiply diagnosed individuals from rural
counties who receive care from one of the
HIV/AIDS clinics.
Resources needed for 
implementation
This model program receives funding from
NIDA, SAMHSA, HRSA, NIMH, and NIAAA.
All of our staff have experience in a variety of
settings in points of diverse backgrounds. Our
main barrier is transportation costs, which are
continually being addressed by various AIDS-
related service agencies. The addition of a
recruitment and retention specialist who fol-
lows up on contacts has greatly increased the
retention rate.
Trauma Adaptive Recovery
Group Education and Therapy
for Addiction Recovery 
(TARGET-AR)
Contact information
Julian Ford, Ph.D., Co-Principal Investigator
Department of Psychiatry
University of Connecticut Health Center
263 Farmington Avenue
Farmington, CT 06030
Phone: (860) 679-2730
Fax: (860) 679-4326
E-mail: ford@psychiatry.uchc.edu
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Description of intervention
This nine-session model integrates neurobiolog-
ical, developmental, cognitive–behavioral,
motivational enhancement, relational/emotion
focuses, and relapse prevention principles and
procedures for trauma recovery and substance
abuse recovery. It provides an alternative to
exposure-based treatment for PTSD that is
based on recent research and clinical evidence.
Participants learn a structured set of skills for
managing traumatic stress symptoms in their
current life, described by the acronym “FREE-
DOM” (Focusing to reduce anxiety and
increase mental alertness; Recognizing specific
stress triggers; identifying primary Emotions;
Evaluating primary thoughts/self-statements;
Defining an organizing personal goal; identify-
ing one Option that represents a successful step
toward that goal that the individual actually
accomplished during a current stressful experi-
ence; recognizing how that option had the
added benefit of Making a contribution), by
reflecting the person’s core values and making
a difference in others’ lives. The model assists
participants in understanding the effects of
trauma on the body, emotions, mind, relation-
ships, and spirituality, and in using the FREE-
DOM skills to manage current stressors in ways
that enable the person to shift away from “sur-
vival” coping to productive living. Participants
are encouraged to focus on dealing with the
impact that trauma experiences have had on
their current lives rather than recounting
detailed trauma memories, and the FREEDOM
skills are used as a way to enable participants
to examine trauma memories in a contained
manner—and only if the participant feels that
this would be helpful in dealing with current
stressors. Most participants choose to examine
trauma memories using the FREEDOM skills
with an individual counselor rather than in the
group, or in order to share a specific limited
aspect of a key trauma memory in the group.
The TARGET model has the following theoreti-
cal/clinical base: Recovery from trauma is pos-
sible when a person is able to shift from living
in “survival” mode to focusing on personal
growth and effectiveness in intimate, family,
friendship, and work relationships. Recovery is
not based on “getting through” or becoming
“desensitized” to trauma memories, but on
having access to a support system and a way of
making fully informed life decisions that funda-
mentally shift a person’s bodily processes and
mindset from surviving trauma to personal
growth and development. Recovery is unique
for each gender and each individual, but
always involves three basic changes that occur
gradually: isolation, betrayal, and abandon-
ment, gradually changing to trust, mutuality,
and engagement within safe, reliable, and emo-
tionally sustaining relationships. Terror, hyper-
vigilance, dissociation, and powerlessness grad-
ually change to a realistic sense of personal
effectiveness with a clear focus on immediate
emotions, thoughts, and goals in each experi-
ence. Emotional numbing, spiritual alienation,
and hopelessness gradually shift to involve-
ment, self-esteem, faith, and hope as the per-
son becomes able to recognize how she or he
actually is living according to her or his true
values and making a unique contribution to the
safety and well-being of other people.
Setting
Study participants are recruited from three
outpatient substance abuse clinics: the Morris
Foundation in Waterbury, and The Connection
and Rushford Center in Middletown. These
private, non-profit agencies have extensive
experience working with persons with co-occur-
ring mental disorders. The Morris Foundation,
in addition to outpatient services, operates a
therapeutic shelter, a residential substance
abuse program, and a women and children’s
residential program. Clients receive intense
outpatient services with group therapy and
psychoeducational groups, typically for 4
weeks.
The Rushford Center provides a continuum of
progressive, multi-modal inpatient and outpa-
tient treatment programs for adult men and
women. Services include detoxification, resi-
dential programs, day and evening partial hos-
pitalization, and a halfway house.
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The Connection is a statewide agency operating
over 30 separate programs. It offers assistance
with a wide variety of behavioral and social
problems, including homelessness, sex offenses,
problem gambling, HIV-related needs, child
abuse/neglect, and substance abuse.
Client characteristics
Study participants are adults (age 18 and over)
with co-occurring substance use and trauma-
related disorders. In order to enter the study, a
participant must:
• Have a history of exposure to an event(s) ful-
filling the conditions for DSM-IV PTSD
Criterion A psychological trauma.
• Meet criteria for a substance use disorder.
• Meet DSM-IV criteria for one of the follow-
ing: (1) PTSD within the past year, or (2)
Disorders of Extreme Stress, Not Otherwise
Specified plus at least one or more DSM-IV
Axis I or II disorders including major depres-
sive disorder, dysthymic disorder, and disso-
ciative disorder.
Resources needed for 
implementation
In addition to the cost of the group clinician
and center costs, the following were needed:
• Consultation with trauma expert (weekly
during first year of implementation)
• Training in model and cultural competence
• Art supplies for creative arts exercises
• Incentives for group participation
• Snacks for groups
• Drug test supplies
Only the time of clinicians and related charges
are reimbursed by most insurance plans; how-
ever, Medicare rules regarding research pre-
vents the program from charging clients.
Empirical data
TARGET-RMI is in the second phase of a qual-
itative evaluation at Capitol Region Mental
Health Center, with groups ongoing for hear-
ing-impaired women, hearing women, hearing-
impaired men, and hearing men. Between
March and June 2002, three additional com-
munity mental health centers and one addition-
al addiction agency received training and began
1 year of clinical pilot work in preparation for
a multi-site controlled trial in the mental health
sector to complement and extend the 3-year
randomized controlled trial (separate men’s
and women’s groups). The three addiction
agencies now underway are under the auspices
of the Co-Occurring Disorders study. Both ver-
sions of TARGET are being pilot tested by clin-
icians in Holland who were trained (April 2000)
by Dr. Ford; a controlled clinical trial is sched-
uled to begin later this year.
Publications
The TARGET manual will be available soon; it
is currently being modified. It is being translat-
ed into Spanish and has been translated into
Dutch.
Programs
Following is a full listing of programs that were
asked to provide more information for this
appendix. The models described in this
appendix came from the responses that were
received.
• Orange County Needs-Based Treatment
Intervention for Mothers’ Engagement (ON
TIME) Project
• Access to Medical and Substance Abuse
Treatment in the Setting of Prescribing
Syringes to Active Injection Drug Users
• Case Management for Rural Substance Abuse
• Improving Services for Substance Abusers
With Comorbid Depression
• Rural HIV/AIDS, Substance Abuse, Mental
Health Outcomes Study
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• Multi-Disciplinary Mental Health and
Substance Abuse Treatment
• Trauma Adaptive Recovery Group Education
and Therapy for Addiction Recovery (TAR-
GET-AR)
• Managing Co-Occurring Disorders in an
Opioid Agonist Setting
• College Drinking
• Outreach-Assisted Case Management: A
Model for HIV and STD Prevention
• Linkages of Primary Care Patients to
Substance Abuse Treatment
• Evaluation of ADMIRE Plus Program for
Co-Occurring Disorders
• Evaluation of a Treatment Model for Co-
Occurring Addictive and Traumatic Stress
Disorders
• Managing Co-Occurring Disorders in
Methadone Clinics
• Increasing Substance Abuse Treatment
Compliance for Persons With Traumatic
Brain Injury
• Project SPIRIT: Seeking Pathways Into
Receiving Integrated Treatment
• Dual Assessment and Recovery Track
(DART)
• Facilitating Substance Abuse Treatment for
HIV Patients
• Linking Female Sex Workers to Substance
Abuse Treatment
• Multiple Diagnoses Cost Study and
Intervention Study
• Project to Reduce Overutilization of
Detoxification services (PROUD)
• Integrated Service Agency (ISA) Home Visit
Family Intervention Model
• Boley Homelessness Prevention Project
• Gaudenzia
• The Housing Continuum
• Representative Payee-Money Management
Program
• Consumer Preference Independent Living
(CPIL) 
• Project HOME (Housing, Opportunities,
Medical care, and Education)
458 Emerging Models
Appendix F:
Common Medications
for Disorders
This appendix contains the Pharmacological Management section from
TIP 9, Assessment and Treatment of Clients With Coexisting Mental
Illness and Alcohol and Other Drug Abuse (Center for Substance Abuse
Treatment 1994a, pp. 91–94). This section is followed by an adaptation
of the text of Psychotherapeutic Medications 2004: What Every
Counselor Should Know, a publication of the Mid-America Addiction
Technology Transfer Center. Many of the terms are highly technical;
however, to define them is beyond the scope of the TIP. The counselor
can understand the fundamental information contained in each section
without knowing the definition of every term. This appendix provides
the counselor with a handy reference on various psychotropic medica-
tions and their use. 
Pharmacologic Risk Factors 
Addiction is not a fixed and rigid event. Like mental disorders, addiction
is a dynamic process, with fluctuations in severity, rate of progression,
and symptom manifestation and with differences in the speed of onset.
Both disorders are greatly influenced by several factors, including genet-
ic susceptibility, environment, and pharmacologic influences. Certain
people have a high risk for these disorders (genetic risk); some situations
can evoke or help to sustain these disorders (environmental risk); and
some drugs are more likely than others to cause psychiatric or substance
use disorder problems (pharmacologic risk).
Pharmacologic effects can be therapeutic or detrimental. Medication
often produces both effects. Therapeutic pharmacologic effects include
the indicated purposes and desired outcomes of taking prescribed medi-
cations, such as a decrease in the frequency and severity of episodes of
depression produced by antidepressants.
Detrimental pharmacologic effects include unwanted side effects such as
dry mouth or constipation resulting from antidepressant use. Side effects
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perceived as noxious by clients may decrease
their compliance with taking the medications as
directed.
Some detrimental pharmacologic effects relate
to abuse and addiction potential. For example,
some medications may be stimulating, sedating,
or euphorigenic and may promote physical
dependence and tolerance. These effects can
promote the use of medication for longer peri-
ods and at higher doses than prescribed.
Thus, prescribing medication involves striking
a balance between therapeutic and detrimental
pharmacologic effects. For instance, therapeu-
tic antianxiety effects of the benzodiazepines
are balanced against detrimental pharmacolog-
ic effects of sedation and physical dependency.
Similarly, the desired therapeutic effect of
abstinence from alcohol is balanced by the pos-
sibility of damage to the liver from prescribed
disulfiram (Antabuse).
Side effects of prescription medications vary
greatly and include detrimental pharmacologic
effects that may promote abuse or addiction.
With regard to clients with co-occurring disor-
ders, special attention should be given to detri-
mental effects, in terms of (1) medication com-
pliance, (2) abuse and addiction potential, (3)
substance use disorder relapse, and (4) psychi-
atric disorder relapse (Ries 1993).
Psychoactive Potential
Not all psychiatric medications are psychoac-
tive. The term psychoactive describes the abili-
ty of certain medications, drugs, and other
substances to cause acute psychomotor effects
and a relatively rapid change in mood or
thought. Changes in mood include stimulation,
sedation, and euphoria. Thought changes can
include a disordering of thought such as delu-
sions, hallucinations, and illusions. Behavioral
changes can include an acceleration or retarda-
tion of motor activity. All drugs of abuse are by
definition psychoactive.
In contrast, certain nonpsychoactive medica-
tions such as lithium (Eskalith) can, over time,
normalize the abnormal mood and behavior of
clients with bipolar disorder. Because these
effects take several days or weeks to occur, and
do not involve acute mood alteration, it is not
accurate to describe these drugs as psychoac-
tive, euphorigenic, or mood altering. Rather,
they might be described as mood regulators.
Similarly, some drugs, such as antipsychotic
medications, cause normalization of thinking
processes but do not cause acute mood alter-
ation or euphoria. 
However, some antidepressant and antipsy-
chotic medications have pharmacologic side
effects such as mild sedation or mild stimula-
tion. Indeed, the side effects of these medica-
tions can be used clinically. Physicians can use
a mildly sedating antidepressant medication for
clients with depression and insomnia, or a
mildly stimulating antipsychotic medication for
clients with psychosis and hypersomnia or
lethargy (Davis and Goldman 1992). While the
side effects of these drugs include a mild effect
on mood, they are not euphorigenic.
Nevertheless, case reports of misuse of nonpsy-
choactive medications have been noted, and
use should be monitored carefully in clients
with co-occurring disorders. 
While psychoactive drugs are generally consid-
ered to have high risk for abuse and addiction,
mood-regulating drugs are not. A few other
medications exert a mild psychoactive effect
without having addiction potential. For exam-
ple, the older antihistamines such as doxy-
lamine (Unisom) exert mild sedative effects, but
not euphoric effects.
Reinforcement Potential
Some drugs promote reinforcement, or the
increased likelihood of repeated use.
Reinforcement can occur by either the removal
of negative symptoms or conditions or the
amplification of positive symptoms or states.
For example, self-medication that delays or
prevents an unpleasant event (such as with-
drawal) from occurring becomes reinforcing.
Thus, using a benzodiazepine to avoid alcohol
withdrawal can increase the likelihood of con-
tinued use. Positive reinforcement involves
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strengthening the possibility that a certain
behavior will be repeated through reward and
satisfaction, as with drug-induced euphoria or
drug-induced feelings of well-being. A classic
example is the pleasure derived from moderate
to high doses of opioids or stimulants. Drugs
that are immediately reinforcing are more like-
ly to lead to psychiatric or substance use prob-
lems. 
Tolerance and Withdrawal
Potential
Long-term or chronic use of certain medica-
tions can cause tolerance to the subjective and
therapeutic effects and prompt dosage increas-
es to recreate the desired effects. In addition,
many drugs cause a well-defined withdrawal
phenomenon after the cessation of chronic use.
Clients’ attempts to avoid withdrawal syn-
dromes often lead them to additional drug use.
Thus, drugs that promote tolerance and with-
drawal generally have higher risks for abuse
and addiction.
A Stepwise Treatment
Model
As can be seen, there are pharmacologic as well
as hereditary and environmental factors that
influence the development of substance use dis-
orders. All of these factors should be consid-
ered before prescribing medication, especially
when the client is at high risk for developing a
substance use disorder. High-risk clients
include people with both psychiatric and sub-
stance use disorders, as well as clients with a
psychiatric disorder and a family history of
substance use disorders.
One aspect of this issue relates to the pharma-
cologic profile of certain medications that are
used in the treatment of specific psychiatric
disorders. For instance, many medications
used to treat symptoms of depression and psy-
chosis are not psychoactive or euphorigenic.
However, many of the medications used to treat
symptoms of anxiety, such as the benzodi-
azepines, are psychoactive, reinforcing, have
potential for tolerance and withdrawal, and
have an abuse potential, especially among peo-
ple who are at high risk for substance use dis-
orders. Other antianxiety medications, such as
buspirone (BuSpar), are not psychoactive or
reinforcing and have low abuse potential, even
among people at high risk. 
Thus, decisions about whether and when to
prescribe medication to a high-risk client
should include a risk-benefit analysis that con-
siders the risk of medication abuse, the risk of
undertreating a psychiatric problem, the type
and severity of the psychiatric problem, the
relationship between the psychiatric disorder
and the substance use disorder for the individ-
ual client, and the therapeutic benefits of
resolving the psychiatric and substance abuse
problems.
For example, the early and aggressive medica-
tion of high-risk clients who have severe pre-
sentations of psychotic depression, mania, and
schizophrenia is often necessary to prevent fur-
ther psychiatric deterioration and possible
death. For these clients, rapid and aggressive
medication can shorten the length of the psy-
chiatric episodes. In contrast, prescribing ben-
zodiazepines to high-risk clients with similarly
severe anxiety involves a substantial risk of
promoting or exacerbating a substance use dis-
order. For these high-risk clients, the use of
psychoactive medication should not be the first
line of treatment. Rather, for some high-risk
clients, treatment efforts should involve a step-
wise treatment model that begins with conser-
vative approaches and progressively becomes
more aggressive if the treatment goals are not
met (Landry et al. 1991a). For example, the
stepwise treatment model for treating high-risk
clients with anxiety disorders may involve three
progressive levels of treatment: (1) nonpharma-
cologic approaches when possible; (2) nonpsy-
choactive medication when nonpharmacologic
approaches are insufficient; and (3) psychoac-
tive medications when other treatment
approaches provide limited or no relief
(Landry et al. 1991a).
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Nonpharmacologic
Approaches
Depending on the psychiatric disorders and
personal variables, numerous nonpharmaco-
logic approaches can help clients manage all or
some aspects of their psychiatric disorders.
Examples include psychotherapy, cognitive
therapy, behavioral therapy, relaxation skills,
meditation, biofeedback, acupuncture, hyp-
notherapy, self-help groups, support groups,
exercise, and education.
Nonpsychoactive
Pharmacotherapy
Some medications are not psychoactive and do
not cause acute psychomotor effects or eupho-
ria. Some medications do not cause psychoac-
tive or psychomotor effects at therapeutic doses
but may exert limited psychoactive effects at
high doses (often not euphoria, but sometimes
dysphoria). 
For practical purposes, all of these medications
can be described as nonpsychoactive, since the
psychoactive effect is not prominent.
Medications used in psychiatry that are not
euphorigenic or significantly psychoactive
include but are not limited to the azapirones
(for example, buspirone), the amino acids,
beta-blockers, antidepressants, monoamine
oxidase inhibitors, antipsychotics, lithium,
antihistamines, anticonvulsants, and anti-
cholinergic medications. 
Psychoactive
Pharmacotherapy
Some medications can cause significant and
acute alterations in psychomotor, emotional,
and mental activity at therapeutic doses. At
higher doses, and for some clients, some of
these medications can also cause euphoric reac-
tions. Medications that are potentially psy-
choactive include opioids, stimulants, benzodi-
azepines, barbiturates, and other sedative-hyp-
notics. 
Stepwise Treatment Principles
One of the emphases of stepwise treatment is to
encourage nondrug treatment strategies for
each emerging symptom before medications are
prescribed. Nondrug treatment strategies alone
are inappropriate for acute and severe symp-
toms of schizophrenia and mood disorders, but
nondrug strategies do have their place in the
treatment of virtually any psychiatric problem
and may provide partial or total relief of some
symptoms related to severe psychiatric disor-
ders. For example, relaxation therapy can min-
imize or eliminate somatic symptoms of anxiety
that may accompany an agitated depression.
A second emphasis of stepwise treatment is to
encourage the use of medications that have a
low abuse potential. This conservative
approach must be balanced against other ther-
apeutic and safety considerations in acute and
severe conditions, such as psychosis or mania.
On the other hand, a conservative approach is
not the same as undermedication of psychiatric
problems. Undermedication often leads to psy-
chiatric deterioration and may promote sub-
stance abuse relapse. There should be a bal-
ance between effective treatment and safety.
A third emphasis of stepwise treatment is to
encourage the idea that different treatment
approaches should be viewed as complemen-
tary, not competitive. For example, if psy-
chotherapy or group therapy does not provide
complete relief from a situational depression
(such as prolonged grief), then antidepressants
should be considered as an adjunct to the psy-
chotherapy, but not as a substitute for psy-
chotherapy.
In practice, treatment providers often use a
combination of drug and nondrug strategies.
This practice includes medication to treat the
acute manifestations of the disorder while the
individual learns long-term management strate-
gies. For example, an individual may be pre-
scribed nonpsychoactive buspirone to reduce
anxiety symptoms while learning stress reduc-
tion techniques and attending group therapy. 
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These guidelines are broad, general, and more
applicable to chronic than to acute psychiatric
problems. Also, these guidelines have limited
application to severe psychiatric problems.
Psychotherapeutic
Medications 2004:
What Every Counselor
Should Know
Following is the text of Psychotherapeutic
Medications 2004: What Every Counselor
Should Know, a publication of the Mid-
America Addiction Technology Transfer Center
(MATTC), which was adapted for this TIP.
This brochure is updated annually and is avail-
able via the MATTC Web site at
www.mattc.org. The brochure addresses the
following areas:
• Antipsychotics/Neuroleptics
• Antimanic Medications
• Antidepressant Medications
• Antianxiety Medications
• Stimulant Medications
• Narcotic and Opioid Analgesics
• Antiparkinsonian Medications
• Hypnotics
• Addiction Treatment Medications
For physicians desiring a more in-depth discus-
sion regarding the challenges of treating specif-
ic population groups with substance use disor-
ders (e.g., homeless, older adults, people with
HIV/AIDS or hepatitis, pregnant or nursing
women, etc.), which includes medication com-
pliance, adverse drug interactions, and relapse
with the use of potentially addictive medica-
tions, readers are referred to the current edi-
tion of the American Society of Addiction
Medicine’s (ASAM’s) Principles of Addiction
Medicine, Third Edition (ASAM 2003).
Tips For Communicating With
Physicians About Clients and
Medication
Send a written report
The goal is to get your concerns included in the
client’s medical record. When information is in
a medical record, it is more likely to be acted
on. Records of phone calls and letters are
rarely placed in the chart (readers may go to
www.mattc.org to download a sample form).
Make it look like a report—
and be brief
Include date of report, client name, and Social
Security Number. Most medical consultation
reports are one page. Longer reports are less
likely to be read. Include and prominently
label sections:
• Presenting Problem
• Assessment
• Treatment and Progress
• Recommendations and Questions
Keep the tone neutral
Provide details about the client’s use or abuse
of prescription medications. Avoid making
direct recommendations about prescribed med-
ications. Allow the physician to draw his or her
own conclusions. This will enhance your
alliance with the physician and makes it more
likely he or she will act on your input.
Talking with clients about
their medication
Untreated psychiatric problems are a common
cause for treatment failure in substance abuse
treatment programs. Supporting clients with
mental illness in continuing to take their psy-
chiatric medications can significantly improve
substance abuse treatment outcomes.
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Getting started
Take 5–10 minutes every few sessions to go over
these topics with your clients:
• Remind them that taking care of their mental
health will help prevent relapse.
• Ask how their psychiatric medication is help-
ful.
• Acknowledge that taking a pill every day is a
hassle.
• Acknowledge that everybody on medication
misses taking it sometimes.
• Do not ask if they have missed any doses,
rather ask, “How many doses have you
missed?”
• Ask if they felt or acted different on days
when they missed their medication.
• Was missing the medication related to any
substance use relapse?
• Without judgment, ask “Why did you miss
the medication? Did you forget, or did you
choose not to take it at that time?”
For clients who forgot, ask
them to consider the follow-
ing strategies
• Keep medication where it cannot be missed:
with the TV remote control, near the refrig-
erator, or taped to the handle of a tooth-
brush. Everyone has two or three things they
do everyday without fail. Put the medication
in a place where it cannot be avoided when
doing that activity, but always away from
children.
• Suggest they use an alarm clock set for the
time of day they should take their medica-
tion. Reset the alarm as needed.
For clients who admit to
choosing not to take their
medication
• Acknowledge they have a right to choose
NOT to use any medication.
• Stress that they owe it to themselves to make
sure their decision is well thought out. It is an
important decision about their personal
health.
• Ask their reason for choosing not to take the
medication.
• Don’t accept “I just don’t like pills.” Tell them
you’re sure they wouldn’t make such an
important decision without having a reason.
• Offer as examples reasons others might
choose not to take medication. For instance,
they:
1. Don’t believe they ever needed it; never
were mentally ill
2. Don’t believe they need it anymore; cured
3. Don’t like the side effects
4. Fear the medication will harm them
5. Struggle with objections or ridicule of
friends and family members
6. Feel taking medication means they are not
personally in control
Transition to topics other
than psychiatric medications
Ask what supports or techniques they use to
assist with emotions and behaviors when they
choose not to take the medication.
General Approach
The approach when talking with clients about
psychiatric medication is exactly the same as
when talking about their substance abuse deci-
sions.
• Explore the triggers or cues that led to the
undesired behavior (either taking drugs of
abuse or not taking prescribed psychiatric
medications).
• Review why the undesired behavior seemed
like a good idea at the time.
• Review the actual outcome resulting from
their choice.
• Ask if their choice got them what they were
seeking.
• Strategize with clients what they could do dif-
ferently in the future.
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Note to Practitioners
Name brand medications have a limited patent.
When the patent expires the medication may be
made as a generic. The generic name of a medi-
cation is the actual name of the drug and never
changes. Do not be surprised to see a generic
drug made by many different manufacturers.
Manufacturers can make many forms of a sin-
gle drug with only slight variations. Several
drugs have been made in an extended release
form (CR, controlled release; ER or XR,
extended release; and SR, sustained release).
Extended release drugs act over a long period
of time and do not have to be dosed as often. 
A new formulation for drugs is a quick, orally
dissolving tablet that can be taken without
water. Two patent drugs that have been formu-
lated as quick dissolving tablets are Remeron
SolTab and Zyprexa Zydis.
Antipsychotics/Neuroleptics
Generic and brand names
Generic Brand
Traditional antipsychotics
chlorpromazine Thorazine, 
Largactil
fluphenazine Prolixin+, 
Permitil, 
Anatensol
haloperidol Haldol
loxapine Loxitane, 
Daxolin
mesoridazine Serentil
molindone Moban, Lidone
perphenazine Trilafon, 
Etrafon
pimozide Orap
thioridazine Mellaril
thiothixene Navane
trifluoperazine Stelazine
Novel or atypical antipsychotics
aripiprazole Abilify
clozapine Clozaril+
olanzapine Zyprexa, 
Zyprexa Zydis
quetiapine Seroquel*
risperidone Risperdal
risperidone
long-acting injection Risperdal 
Consta
ziprasidone Geodon
+ Can cause a serious side effect in the blood
system; must have regular blood tests to mon-
itor potential side effects. Approximately 1 to
2 percent of patients who take clozapine
develop a condition called agranulocytosis, in
which their white blood cell count drops
drastically. As a result, the patient is at high
risk for infections due to a compromised
immune system, and this could be fatal.
However, most patients can be treated suc-
cessfully by stopping clozapine treatment. To
maintain safety, white blood cell count must
be checked each week for 6 months and
every 2 weeks thereafter. The results must be
sent to the patient’s pharmacy before the
patient can pick up the next supply of medi-
cation.
* Seroquel is often used for insomnia.
Purpose
Antipsychotics are most typically used for per-
sons who experience psychotic symptoms as a
result of having some form of schizophrenia,
severe depression, or bipolar illness. They may
465Common Medications for Disorders
be used to treat brief psychotic episodes caused
by drugs of abuse or other conditions.
Psychotic symptoms may include being out of
touch with reality, “hearing voices,” and hav-
ing false perceptions (e.g., thinking you are a
famous person, thinking someone is out to hurt
you). These medications can be effective in
either minimizing or stopping the appearance
of these symptoms altogether. In some cases,
these medications can shorten the course of the
illness or prevent it from happening again.
The newest antipsychotics—risperdone, olan-
zapine, quetiapine, ziprasidone, and aripipra-
zole—are showing positive effects across a
range of disorders. These medications also
seem to have a mood-stabilizing effect and are
used for bipolar disorder, as well as being
added to antidepressants for severe depres-
sions. Some have been shown to be effective at
relieving anxiety in low doses, but this use is
not approved by the Food and Drug
Administration (FDA).
Usual dose, frequency, and
side effects
All drugs have specific doses and frequencies.
The physician will specify the exact amount of
medication and when it should be taken. How
much medicine and how often to take it are
specified on the prescription bottle. Many med-
ications are taken once a day, some at bedtime
to take advantage of the drowsiness side effect
of some antipsychotic medications. Some medi-
cations are taken in pill form or liquid form.
Other medications are given by injection once
or twice per month to ensure that the medica-
tion is taken reliably. It is important to take
medications on schedule. It is important that
patients talk to their doctor so that they know
about side effects of medications and what they
need to do to monitor their health.
Prolixen, like other medications marked with
+, can very rarely cause serious side effects in
the blood system called blood dyscrasias
(abnormalities or irregularities in the blood
cells). Persons taking any medications marked
with a + may need to have blood tests on a reg-
ular basis to check for these blood disorders.
Novel or atypical antipsychotics like Clozaril,
Risperdal, Seroquel, and Zyprexa are different
from traditional antipsychotics. Novel or atypi-
cal antipsychotic medications are more power-
ful with treatment-resistant schizophrenia but
may also be used with severe depression or
other psychiatric illness. Because the atypical
antipsychotics work in a slightly different way
than traditional antipsychotics they are less
likely to produce serious side effects, such as
tardive dyskinesia or neuroleptic malignant
syndrome (NMS). The most common mild side
effects are either sedation or agitation, espe-
cially when starting the medications. The most
worrisome side effects are weight gain and ele-
vated blood sugar and lipids. There is also
some evidence that the use of atypical neu-
roleptics may lead to the development of dia-
betes mellitus (Sernyak et al. 2002). These
issues can be medically worrisome as well as
lead to medication noncompliance. Since both
the effectiveness and side effect profiles vary
across both medications and patients, matching
the right medication to the right patient is the
key. The older antipsychotics are cheap, and
the newer ones expensive. People taking
Clozaril must have a blood test every two weeks
in order to monitor for a potential side effect,
agranulocytosis, which is a serious blood disor-
der. In general, the newer antipsychotics, when
taken in proper dosage, have fewer clinical side
effects and a broader treatment response than
traditional antipsychotics.
Tardive dyskinesia
• Involuntary movements of the tongue or
mouth
• Jerky, purposeless movements of legs, arms,
or entire body
• Usually seen with long-term treatment using
traditional antipsychotic medications, some-
times seen with atypical antipsychotic medi-
cations
• More often seen in women
• Risk increases with age and length of time on
the medication
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Neuroleptic malignant syndrome 
• Blood pressure up and down
• Dazed and confused
• Difficulty breathing
• Muscle stiffness
• Rapid heart rate
• Sweating and shakiness
• Temperature above normal
Diabetes mellitus
• Associated with atypical neuroleptics
• Excessive thirst
• Headaches
• Frequent urination
• Cuts/blemishes heal slowly
• Fatigue
Other
• Blurred vision
• Changes in sexual functioning
• Constipation
• Diminished enthusiasm
• Dizziness
• Drowsiness
• Dry mouth
• Lowered blood pressure
• Muscle rigidity
• Nasal congestion
• Restlessness
• Sensitivity to bright light
• Slowed heart rate
• Slurred speech
• Upset stomach
• Weight gain
Note: Any side effects that bother a person
need to be reported to the physician and dis-
cussed with him or her.
Anticholinergic/antiparkinsonian medications
like Cogentin and Artane may be prescribed in
order to control movement difficulties associat-
ed with the use of antipsychotic medications.
Abilify is a new antipsychotic released in
December 2002. The medication acts as both
an enhancer and an inhibitor of dopamine pro-
duction by “sensing” when there is too little or
too much dopamine in the brain. Useful in the
treatment of schizophrenia and other psychotic
disorders, side effects include headache, anxi-
ety, and insomnia. Risperdal Consta, approved
in November 2003, is an injection of microen-
capsulated medication that releases into the
body at a constant level. An injection is usually
given every two weeks. Side effects are similar
to those for Risperdal.
Emergency conditions
Contact a physician and/or seek emergency
medical assistance if the person experiences
involuntary muscle movements, painful muscle
spasms, difficulty in urinating, eye pain, skin
rash, or the symptoms noted under neuroleptic
malignant syndrome and tardive dyskinesia.
Cautions
• Doctors and pharmacists should be told
about all medications being taken (including
dosage), including over-the-counter prepara-
tions, vitamins, minerals, and herbal supple-
ments (e.g., St. John’s wort, echinacea,
ginko, ginseng, etc.).
• People taking antipsychotic drugs should not
increase their dose unless this has been
checked with their physician and a change is
ordered.
Special considerations for
pregnant women
For women of child-bearing age who may be or
think they may be pregnant, the physician
should discuss the safety of this medication
before starting, continuing, or discontinuing
medication treatment. Substance abuse coun-
selors may have a role in encouraging this dis-
cussion by suggesting this to their clients.
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Antimanic Medications
Generic and brand names
Generic Brand
Lithium products
lithium carbonate* Eskalith, 
Eskalith CR, 
Lithane, 
Lithobid, 
Lithonate, 
Lithotabs
lithium citrate* Cibalith
Anticonvulsant products
Carbamazepine* Tegretol
divalproex sodium* Depakote, 
Depakote 
Sprinkle, 
Depakote ER
gabapentin Neurontin
lamotrigine Lamictal
levetiracetam Keppra+
oxcarbazepine Trileptal
tiagabine hydrochloride Gabitril
topiramate Topamax, 
Topamax 
Sprinkle
valproate sodium* Depakene, 
Depacon
valproic acid* Depakene
*Needs blood level monitoring
Other
olanzapine Zyprexa, 
Zyprexa Zydis 
(see antipsy-
chotics for side 
effects)
quetiapine fumarate Seroquel
risperidone Risperdal
ziprasidone Geodon
+ Keppra is noted for causing mood changes,
primarily depression and anger in some peo-
ple. This may limit its use as a mood stabiliz-
er.
It is likely that all of the newer atypical
antipsychotics mentioned above will soon be
FDA approved for mania. 
Purpose
Antimanic drugs are used to control the mood
swings of bipolar (manic–depressive) illness,
leveling mood swings so that the client operates
in a moderate mood zone. These medications
even out mood swings, which can decrease
some of the suicidal and other self-harm behav-
iors seen with bipolar disorders. Additionally,
appropriate treatment with antimanic drugs
can reduce a patient’s violent outbursts toward
others or property. Bipolar illness is character-
ized by cycling mood changes from severe highs
(mania) to severe lows (depression). Cycles of
mood may be predominantly manic or depres-
sive with normal moods between cycles. The
“highs” and “lows” vary in intensity, frequen-
cy, and severity. Mania, if left untreated, may
worsen into a psychotic state. The depression
may result in thoughts of suicide. Bipolar
cycles that occur more often than three times a
year are considered “rapid cycling,” a condi-
tion often found in those people with higher
rates of substance abuse. Antimanic medica-
tions even out the mood swings so that the per-
son operates in a more moderate zone. By lev-
eling mood swings, some of the suicidal and
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other self-harming behaviors seen with bipolar
disorder can be decreased.
Usual Dose Frequency and
Side Effects
All drugs have specific doses and frequencies.
The physician will specify the exact amount of
medication and when it should be taken. How
much medicine and how often to take it are
specified on the prescription bottle. Most medi-
cations in this class are given two to four times
per day. Some extended release formulations
may be given every 12 hours. Dosage is deter-
mined by the active amount of the drug found
in the person’s blood after taking the medica-
tion and by his or her response to the medica-
tion. Expect a check of monthly blood levels
until the person is well established at the opti-
mal dose. The most common side effects to the
anticonvulsants are sedation and weight gain.
Some anticonvulsants are generic and relatively
inexpensive, others are quite expensive.
Lithium’s most common side effects are tremor,
acne, and weight gain. The most common side
effects for the atypical antipsychotics are men-
tioned above in that section.
Potential side effects
• Blurred vision
• Coma*
• Diarrhea*
• Drowsiness
• Fatigue
• Hand tremor*
• Increased thirst and urination*
• Inflammation of the pancreas
• Irregular heart beats
• Kidney damage*
• Liver inflammation (hepatitis)
• Nausea or vomiting
• Problems with the blood (both red and white
blood cells)
• Rash and skin changes
• Seizures
• Under- or overactive thyroid*
• Weakness
• Weight gain
* Lithium, anticonvulsants, and atypical
antipsychotics only. Effects vary greatly
between patients.
Note: People taking lithium may require more
fluids than they did before taking lithium. Too
much fluid in a person’s diet can “wash” the
lithium out of his or her system. Too little fluid
can allow the lithium to concentrate in the sys-
tem. Additionally, anything that can decrease
sodium in the body (i.e., decreased table salt
intake, a low-salt diet, excessive sweating dur-
ing strenuous exercise, diarrhea, vomiting,
etc.) could result in lithium toxicity. People
taking any antimanic drugs should have blood
levels tested regularly to check the concentra-
tion level of the drug in their bodies.
Emergency conditions
Lithium overdose is a life-threatening emergen-
cy. Signs of lithium toxicity may include nau-
sea, vomiting, diarrhea, drowsiness, mental
dullness, slurred speech, confusion, dizziness,
muscle twitching, irregular heartbeat, and
blurred vision.
Cautions
• Doctors and pharmacists should be told
about all medications being taken (including
dosage), including over-the-counter prepara-
tions, vitamins, minerals, and herbal supple-
ments (e.g., St. John’s wort, echinacea,
ginko, ginseng, etc.).
• People taking antimanic drugs should not
increase their dose unless this has been
checked with their physician and a change is
ordered.
• Take medications as ordered and at the pre-
scribed times.
• Persons taking antimanic drugs are particu-
larly vulnerable to adverse medical conse-
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quences if they concurrently use alcohol
and/or illicit drugs.
• Lithium can cause birth defects in the first 3
months of pregnancy.
• Thyroid function must be monitored if a per-
son takes lithium.
• Heavy sweating or use of products that cause
excessive urination (e.g., coffee, tea, some
high caffeine sodas, diuretics) can lower the
level of lithium in the blood.
• Blood tests for drug levels need to be checked
every 1 to 2 months.
• Use of these drugs will lower the effectiveness
of birth control medications.
Special considerations for
pregnant women
Generally, the use of antipsychotic medications
should be avoided in the first trimester unless
the mother poses danger to herself, to others,
or to the unborn child, or if the mother
exhibits profound psychosis (Cohen 1989).
Some, such as valproic acid, are associated
with several disfiguring malformations if taken
during pregnancy. If this type of medication
must be used during pregnancy, the woman
must be told that there is substantial risk of
malformations (Robert et al. 2001). Lithium is
also a suggested teratogen; children who were
exposed before week 12 of gestation should be
apprised of the increased risk of cardiac
abnormalities. For women taking lithium, the
medication should be monitored every 2 weeks
and ultrasound should be performed on the
fetus to exclude goiter (Mortola 1989). 
Tapering and discontinuation of antipsychotic
medication 10 days to 2 weeks before delivery
is generally advised, though the protocols vary
by medication (Mortola 1989). For all women
of child-bearing age who may be or think they
may be pregnant, the physician should discuss
the safety of this medication before starting,
continuing, or discontinuing medication treat-
ment. Substance abuse counselors may have a
role in encouraging this discussion between
their clients and the prescribing clinician.
Antidepressant Medications
Generic and brand names
Generic Brand
Monoamine oxidase inhibitors
isocarboxazid Marplan
phenelzine Nardil
tranylcypromine Parnate
Tricyclics and quatracyclics
amitriptyline Elavil
amoxapine Asendin
clomipramine Anafranil
desipramine Nopramin, 
Pertofrane
doxepin Sinequan
imipramine Tofranil
maprotiline Ludiomil
nortriptyline Pamelor
protriptyline Vivactil
SSRIs—selective serotonin reuptake inhibitors
citalopram Celexa
escitalopram oxalate Lexapro
fluoxetine Prozac, Prozac
Weekly, 
Sarafem
fluvoxamine Luvox
paroxetine Paxil, Paxil CR
sertraline Zoloft
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Others
bupropion Wellbutrin, 
Wellbutrin SR
mirtazapine Remeron, 
Remeron 
SolTab
nefazodone Serzone
trazodone Desyrel
venlafaxine Effexor, 
Effexor ER
Purpose
Antidepressant medications are used for mod-
erate to serious depressions, but they can also
be very helpful for milder depressions such as
dysthymia. Most antidepressants must be taken
for a period of 3 to 4 weeks to begin to reduce
or take away the symptoms of depression but a
full therapeutic effect may not be present for
several months. Treatment for a single episode
of major depression should continued for two
years before discontinuing, and since major
depression is a chronic recurrent illness in
many patients, chronic use of antidepressants
is often indicated. Discontinuing antidepressant
therapy before the depression is completely
resolved may result in the client decompensat-
ing and possibly becoming medication resistant.
Untreated depression may result in suicide.
Therefore, treatment for depression must be
taken as seriously as treatment for any other
major life-threatening illness. Antidepressants
are also the first line medications for certain
anxiety disorders such as panic disorder, social
phobia, and obsessive-compulsive disorders.
Types of antidepressants
Older and less commonly used (due to safety
and side effects) antidepressants include the
tricyclic and quatracyclic antidepressants
(named for their chemical structures) and the
monoamine oxidase (MAO) inhibitors. MAO
inhibitors are used for “atypical depressions,”
which produce symptoms like oversleeping,
anxiety or panic attacks, and phobias. MAO
inhibitors may also be used when a person does
not respond to other antidepressants. The most
frequently used class of antidepressants is the
selective serotonin reuptake inhibitors (SSRIs).
They are often prescribed because of their
broad effectiveness, low side effects, and safety.
The SSRIs are thought to affect the serotonin
system to reduce symptoms of depression, and
include fluoxetine, paroxetine, sertraline,
citalopram, and escitalopram. Prozac Weekly
is an extended release formula of Prozac (flu-
oxetine) that can be dosed once per week.
Sarafem is fluoxetine under another label used
for treatment of premenstrual dysphoric disor-
der. Other new antidepressants, such as ven-
lafaxine (Effexor) work on both the serotonin
and norepinephrine levels. Bupropion
(Wellbutrin) is an antidepressant unrelated to
other antidepressants; it has more effect on
norepinephrine and dopamine levels than on
serotonin levels in the brain. In addition,
bupropion can be “activating” (as opposed to
sedating) and, although not associated with
weight gain or sexual dysfunction like many
other antidepressant medications, it should be
avoided by people who are at risk for or who
currently have a seizure disorder.
Usual dose and frequency
and side effects
All drugs have specific doses and frequencies.
The physician will specify the exact amount of
medication and when it should be taken. How
much medicine and how often to take it are
specified on the prescription bottle. Several
factors are considered before an antidepressant
is prescribed: the type of drug, the person’s
individual body chemistry, weight, and age.
Clients are generally started on a low dose, and
the dosage is slowly raised until the optimal
effects are reached without the appearance of
troublesome side effects. The most usual side
effects to the older tricyclics are common and
include dry mouth and sedation, but these
drugs are inexpensive. For SSRIs, both mild
sedation and mild agitation are sometimes
found and this class includes both generic mod-
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erate-expense and brand-only (expensive) ver-
sions. The most difficult SSRI side effect is
decreased sexual performance, which may be
difficult for many patients to discuss.
Sleeplessness and agitation are the most com-
mon side effects for both bupropion and ven-
lafaxine (both expensive, but bupropion is soon
to be generic with decreased cost).
Potential side effects
MAO inhibitors
• Blood cell problems (both white and red
cells)
• Dizziness when changing position
• Fluid retention
• Headache
• High blood pressure crisis
• Insomnia
• Lack of appetite
• Rapid heart beat
Tricyclics and quatracyclics
• Allergic reactions
• Blood cell problems (both white and red
cells)
• Blurred vision
• Change in sexual desire
• Changes in heartbeat and rhythm
• Constipation
• Decrease in sexual ability
• Difficulty with urination
• Dizziness when changing position
• Dry mouth
• Fatigue
• Heart block
• Increased sweating
• Kidney failure (with Asendin)
• Muscle twitches
• Neuroleptic malignant syndrome (with
Asendin)
• Seizures
• Stroke
• Weakness
• Weight gain
SSRIs
• Anxiety, agitation, or nervousness
• Change in sexual desire
• Confusion
• Decrease in sexual ability
• Diarrhea or loose stools
• Dizziness
• Dry mouth
• Headache
• Heart rhythm changes
• Increased sweating
• Insomnia or sleepiness
• Lack or increase of appetite
• Shakiness
• Stomach upset
• Taste disturbances (with Wellbutrin)
• Weight loss or gain
Emergency conditions
An overdose of any of the MAO inhibitors, tri-
cyclics, quatracyclics, or other antidepressants
is serious and potentially life threatening and
must be reported to a physician immediately.
While the potential for a fatal outcome is much
less with the SSRIs, the possibility that a per-
son has attempted suicide should be dealt with
as an emergency situation that needs immediate
intervention.
Symptoms of tricyclic and quatracyclic over-
dose may include rapid heartbeat, dilated
pupils, flushed face, agitation, loss of con-
sciousness, seizures, irregular heart rhythm,
heart and breathing stopping, and death.
Cautions
• Doctors and pharmacists should be told
about all medications being taken (including
dosage), including over-the-counter prepara-
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tions, vitamins, minerals, and herbal supple-
ments (e.g., St. John’s wort, echinacea,
ginko, ginseng, etc.).
• People taking antidepressant drugs should
not increase their dose unless this has been
checked with their physician and a change is
ordered.
• Withdrawal from SSRIs and other new
antidepressants can cause flu-like symptoms.
Discontinuting antidepressant therapy should
be done gradually under a physician’s care.
• Take medications as ordered and at the pre-
scribed times.
• Persons taking MAO inhibitors must avoid
all foods with high levels of tryptophan or
tyramine (aged cheese, wine, beer, chicken
liver, chocolate, bananas, soy sauce, meat
tenderizers, salami, bologna, and pickled
fish). High levels of caffeine must also be
avoided. If eaten, these foods may react with
the MAO inhibitors to raise blood pressure to
dangerous levels.
• Many drugs interact with the MAO
inhibitors. Largely for this reason they are
rarely used. Do not take any other medica-
tions unless they are approved by the treat-
ing physician. Even a simple over-the-
counter cold medication can cause life-threat-
ening side effects.
• Clients using MAO inhibitor antidepressants
should check all new medications with a
physician or pharmacist before taking them.
• People taking antidepressant drugs are par-
ticularly vulnerable to adverse medical con-
sequences if they concurrently use alcohol
and/or street drugs.
• If there is little to no change after 3 to 4
weeks, talk to the doctor about raising the
dose or changing the antidepressant.
• Treatment with antidepressants usually lasts
a minimum 9 to 12 months. Many patients
are on long-term antidepressant therapy to
avoid the frequency and severity of depres-
sive episodes.
Special considerations for
pregnant women
The use of SSRIs, a class of antidepressant
medication, is safer for the mother and fetus
than are tricyclic antidepressants (Garbis and
McElhatton 2001). Fluoxetine (Prozac) is the
most studied SSRI in pregnancy and no
increased incidence in malformations was
noted, nor were there neurodevelopmental
effects observed in preschool-age children
(Garbis and McElhatton 2001). However, possi-
ble neonatal withdrawal signs have been
observed. Given that the greatest amount of
data are available for fluoxetine (Prozac), this
is the recommended SSRI for use during preg-
nancy (Garbis and McElhatton 2001). MAO
inhibitors use is contraindicated in pregnancy,
and its use should be discontinued immediately
if a woman discovers she is pregnant (Mortola
1989). The physician should discuss the safety
of this medication before starting, continuing,
or discontinuing medication treatment with all
women of child-bearing age who may be or
think they may be pregnant. Substance abuse
counselors may have a role in encouraging this
discussion between their clients and the pre-
scribing physician.
Antianxiety Medications
Generic and brand names
Generic Brand
Antidepressants see above
Benzodiazepines
alprazolam Xanax
chlordiazepoxide Librium, 
Libritabs, 
Librax
clonazepam Klonopin
clorazepate Tranxene
diazepam Valium
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lorazepam Ativan
oxazepam Serax
Beta-blockers
propranolol Inderal
Other
buspirone BuSpar
hydroxyzine embonate Atarax
hydroxyzine pamoate Vistaril
meprobamate Miltown
olanzapine Zyprexa, 
Zyprexa Zydis
quetiapine fumarate Seroquel
risperidone Risperdal
Purpose
Antianxiety medications are used to help calm
and relax the anxious person as well as remove
troubling symptoms associated with generalized
anxiety disorder, posttraumatic stress disorder,
panic, phobia, and obsessive-compulsive disor-
ders. The most common antianxiety medica-
tions are the antidepressants and the benzodi-
azepines. The SSRI antidepressants have
become first line medications for the treatment
of panic, social phobia, and (in higher doses)
obsessive-compulsive disorders. Both benzodi-
azepines and meprobamate (no longer readily
available) are cross tolerant with alcohol, are
abusable, and have a market as street drugs;
thus most addiction medicine physicians only
use them acutely as alcohol withdrawal
medicines, or as sedatives in acutely psychotic
or manic psychiatric patients. If used in outpa-
tients, these patients would need careful moni-
toring for tolerance and abuse. They both have
a depressant effect on the central nervous sys-
tem and are relatively fast acting. Miltown,
rarely prescribed anymore, is a non-benzodi-
azepine but works very much like one to quick-
ly calm anxiety.
Beta-blockers work on the central nervous sys-
tem to reduce the flight or fight response.
Inderal is occasionally prescribed for perfor-
mance anxiety and is nonaddictive. 
BuSpar works through the serotonin system to
induce calm. BuSpar takes 3 to 4 weeks to get
into the brain to successfully combat anxiety.
Atarax and Vistaril are antihistamines that use
the drowsiness side effect of the antihistamine
group to calm and relax. Vistaril and Atarax
work within an hour of being taken and, like
BuSpar, are not addictive.
Low doses of Risperdal, Seroquel, and Zyprexa
may be used (though this is expensive, off-label
and is not FDA approved) as non-addictive
antianxiety medications, usually in cases in
which several other medications have failed.
Their special formulation works to reduce anx-
iety and help the person think more clearly,
though the mechanism for this is unclear.
Usual dose, frequency, and
side effects
All drugs have specific doses and frequencies.
The physician will specify the exact amount of
medication and when it should be taken. How
much medicine and how often to take it are
specified on the prescription bottle. Inderal is
taken as needed for performance anxiety or
regularly if it is being used for treatment of a
heart condition. People are usually started on
a low dose of medication, which is raised grad-
ually over time until symptoms are removed or
diminished. Major factors considered in estab-
lishing the correct dose are individual body
chemistry, weight, and ability to tolerate the
medication. Clients taking benzodiazepines for
longer than 4 to 8 weeks may develop physical
tolerance to the medication. Benzodiazepines
have a moderate potential for abuse.
Withdrawal symptoms may occur even when
taken as directed, if regular use of benzodi-
azepines is abruptly stopped. Withdrawal from
high dose abuse of benzodiazepines may be a
life-threatening situation. For these reasons
benzodiazepines are usually prescribed for
brief periods of time—days or weeks—and
474 Common Medications for Disorders
sometimes intermittently for stressful situations
or anxiety attacks. Ongoing continuous use of
benzodiazepines is not recommended for most
people, especially those with a past or current
history of substance abuse or dependence. 
Beta-blockers act on the sympathetic nervous
system and are not considered addictive. They
also are used to treat hypertension, thus side
effects might be low blood pressure or dizzi-
ness. Beta-blockers may enhance the effects of
other psychotropic medications and are inex-
pensive.
BuSpar is often used for control of mild anxi-
ety and is considered safe for long-term thera-
py but is expensive.
Vistaril and Atarax are both antihistamines,
are used as safe nonaddictive medications to
reduce anxiety, and are inexpensive. They may
be used for longer-term therapy. They enhance
the sedative effect of other drugs that cause
drowsiness, and their most common side effects
are dry mouth and sedation, but in older men,
urinary retention may develop and is serious.
Potential side effects
• Blood cell irregularities
• Constipation
• Depression
• Drowsiness or lightheadedness
• Dry mouth
• Fatigue
• Heart collapse
• Irregular heart beat (Miltown)
• Loss of coordination
• Memory impairment (Inderal)
• Mental slowing or confusion
• Slowed heart beat (Valium)
• Stomach upset
• Suppressed breathing
• Weight gain
Potential for abuse or 
dependence
Between 11 and 15 percent of the American
public takes a form of antianxiety medication—
including benzodiazepines—at least once each
year, and if antidepressants are included, this
figure is doubled. Benzodiazepines may cause
at least mild physical dependence in almost
everyone who uses the medication for longer
than 6 months (i.e., if the medicine is abruptly
stopped, the person will experience anxiety,
increased blood pressure, fast heart beat, and
insomnia). However, becoming physically
dependent on benzodiazepines does not mean
abuse or addiction. Fewer than 1 percent of
those without an addiction history who take
benzodiazepines develop a substance abuse
problem. In general, abuse and dependence
occur at lower rates with long-acting antianxi-
ety medications (e.g., Klonopin, Serax, and
Tranxene). Abuse and dependence are more
likely to occur with faster-acting, high-potency
antianxiety medications (e.g., Ativan, Valium,
and Xanax).
Emergency conditions
High doses of Valium can cause slowed heart-
beat, suppression of breathing, and heart stop-
page.
Withdrawal from regular use of any of the ben-
zodiazepines and similar medications must be
done slowly over a month’s time. Abrupt with-
drawal from these drugs can cause hallucina-
tions, delusions and delirium, disorientation,
difficulty breathing, hyperactivity, and grand
mal seizures. To avoid these acute withdrawal
symptoms, a protocol for decreasing or taper-
ing off doses of benzodiazepine is needed.
Overdose on the older tricyclic medications,
which are often used for combined anxiety
depression disorders, can be life threatening
and immediate referral to emergency care is
indicated.
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Cautions
• Doctors and pharmacists should be told
about all medications being taken (including
dosage), including over-the-counter prepara-
tions, vitamins, minerals, and herbal supple-
ments (e.g., St. John’s wort, echinacea,
ginko, ginseng, etc.).
• People taking antianxiety drugs should not
increase their dose unless this has been
checked with their physician and a change is
ordered.
• People should not discontinue use of these
medications without talking to a doctor.
• People taking antianxiety medication are
particularly vulnerable to adverse medical
consequences if they concurrently use alcohol
and/or illicit drugs.
• Using alcohol in combination with benzodi-
azepines may result in breathing failure and
sudden death.
Special considerations for
pregnant women
For use of the antidepressants in pregnancy, see
above section. The current state of knowledge
suggests that benzodiazepine therapy in general
does not have as much of a teratogenic (produc-
ing a deformed baby) risk as do other anticon-
vulsants as long as they are given over a short
time period. It appears that short-acting benzo-
diazepines, like those used to treat alcohol with-
drawal, can be used in low doses for acute uses
such as detoxification, even in the first trimester
(Robert et al. 2001). Long-acting benzodi-
azepines should be avoided—their use during
the third trimester or near delivery can result
in a withdrawal syndrome in the baby (Garbis
and McElhatton 2001). 
During pregnancy, the protein binding of many
drugs, including methadone and diazepam (a
benzodiazepine), is decreased (e.g., Adams and
Wacher 1968; Dean et al. 1980; Ganrot 1972)
with the greatest decrease noted during the
third trimester (Perucca and Crema 1982). This
decreased binding may be due to the decreased
levels of albumin reported during pregnancy
(Yoshikawa et al. 1984). From a clinical stand-
point, it may be that pregnant women could be
at risk for developing greater toxicity and side
effects, yet at the same time an increase in
metabolism of the drug may result (such as
found with methadone). This may result in
reduced therapeutic effect from the drug, since
many women require an increase in their dose
of methadone during the last trimester (Pond et
al. 1985). It should be noted that there is a doc-
umented withdrawal syndrome in neonates who
have been prenatally exposed to benzodi-
azepines (Sutton and Hinderliter 1990) and this
syndrome may be delayed in onset more than
that associated with other drugs. For more
information, see the forthcoming TIP Substance
Abuse Treatment: Addressing the Specific
Needs of Women (CSAT in development b).
For all women of child-bearing age who may be
or think they may be pregnant, the physician
should discuss the safety of this medication
before starting, continuing, or discontinuing
medication treatment. Substance abuse coun-
selors may have a role in encouraging this dis-
cussion by suggesting this to their clients. 
Stimulant Medications
Generic and brand names
Generic Brand
d-amphetamine Dexedrine
l & d-amphetamine Adderall, 
Adderall CII, 
Adderall XR
methamphetamine Desoxyn
methylphenidate Ritalin, Ritalin 
SR, Concerta, 
Metadate ER, 
Metadate CD,
Methylin ER, 
Focalin
pemoline Cylert
modafinil Provigil
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Non-stimulants for AD/HD
atomoxetine hydrochloride Strattera+
bupropion Wellbutrin++
guanfacine Tenex
+ Strattera is FDA approved 
+ + Studies have shown bupropion to be effec-
tive, but it is not FDA approved for this use
Purpose
Used to treat attention deficit/hyperactivity dis-
order (AD/HD), which is typically diagnosed in
childhood but also occurring in adults.
Symptoms consistent with AD/HD include short
attention span, excessive activity (hyperactivi-
ty), impulsivity, and emotional development
below the level expected for the client’s age.
The underlying manifestation of AD/HD is that
it severely impacts and interferes with a per-
son’s daily functioning. Other conditions that
may be treated with stimulants are narcolepsy,
obesity, and sometimes depression. While stim-
ulants have been shown to reduce substance
abuse onset in children, for adult populations
with substance abuse problems, most addiction
medicine doctors use antidepressants or atom-
oxitine. People with AD/HD generally report
that they feel “normal” when taking stimulants.
They cite increased concentration, focus, and
ability to stay on task and behave appropriate-
ly when taking the medications.
Non-stimulant medications differ somewhat.
Strattera blocks the reuptake of nore-
pinephrine. It works by leaving more nore-
pinephrine in the brain, which in turn reduces
the symptoms of AD/HD. Tenex and Wellbutrin
are non-stimulants that have been used suc-
cessfully to treat symptoms of AD/HD. The
advantage of these medications is that they are
non-addictive.
Usual dose, frequency, and
side effects
All drugs have specific doses and frequencies.
The physician will specify the exact amount of
medication and when it should be taken. How
much medicine and how often to take it are
specified on the prescription bottle. With stim-
ulants there may be periods when the medica-
tion is not to be taken. The most common side
effects of the stimulants are nervousness, sleep-
lessness, and loss of appetite. Some are expen-
sive, but others are generic and quite inexpen-
sive.
Potential side effects
Stimulants
• Blood disorders (Ritalin and Cylert)
• Change in heart rhythm
• Delayed growth
• Dilated pupils
• Elevated blood pressure
• Euphoria
• Excitability
• Increased pulse rate
• Insomnia
• Irritability
• Liver damage (Cylert)
• Loss of appetite
• Rash
• Seizures (Ritalin and Cylert)
• Tourette’s syndrome (Cylert)
• Tremor
Non-stimulants for AD/HD
• Strattera side effects include: 
– High blood pressure
– Nervousness and the side effects similar to 
norepinephrine-sparing antidepressants
• Wellbutrin side effects include increased
chance of seizure activity.
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• Tenex side effects include:
– Constipation
– Dizziness
– Dry mouth
– Low blood pressure
– Sleepiness
Note: People taking these medications need to
be monitored closely for tolerance and depen-
dence. AD/HD patients generally note
increased concentration, focus, and ability to
stay on task and behave appropriately when
taking the medications.
Potential for abuse or 
dependence
Prescription stimulant medications may be mis-
used. Recreational or non-medically indicated
uses have been reported for performance
enhancement and/or weight loss. People with
AD/HD or narcolepsy rarely abuse or become
dependent on stimulant medications.
Emergency conditions
Psychiatric symptoms including paranoid delu-
sions, thought disorder, and hallucinations
have been reported with prolonged use or when
taken at high dosages. Overdose with stimu-
lants is a medical emergency. Seek help imme-
diately.
Cautions
• Doctors and pharmacists should be told
about all medications being taken (including
dosage), including over-the-counter prepara-
tions, vitamins, minerals, and herbal supple-
ments (e.g., St. John’s wort, echinacea,
ginko, ginseng, etc.).
• People taking stimulant drugs should not
increase their dose unless this has been
checked with their physician and a change is
ordered.
• People taking stimulant medications are par-
ticularly vulnerable to adverse medical con-
sequences if they concurrently use alcohol
and/or illicit drugs.
• With stimulants, there is the potential for
development of tolerance and dependence on
the medications with accompanying with-
drawal. The potential for abuse and misuse is
high, as is true with all schedule II drugs.
Special considerations for
pregnant women
For women of child-bearing age who may be or
think they may be pregnant, the physician
should discuss the safety of this medication
before starting, continuing, or discontinuing
medication treatment. Substance abuse coun-
selors may have a role in encouraging this dis-
cussion by suggesting this to their clients.
Narcotic and Opioid
Analgesics
Natural opioids
• Opium, morphine, and codeine products
Pure, semi- or totally syn-
thetic derivatives, opioids
• Heroin, Percodan, Demerol, Darvon, oxy-
codone, and others
Generic and brand names
Generic Brand
buprenorphine Buprinex
buprenorphine Subutex, 
Suboxone*
butorphanol tartarate Stadol 
spray
codeine phosphate Codeine 
tablets
codeine sulfate Codeine 
tablets
478 Common Medications for Disorders
dihydromorphone hydrochloride Dilaudid-5,
Dilaudid 
HP
fentanyl transdermal Duragesic 
patches
fentanyl transmucosal Fentanyl, 
Oraley
hydromorphone hydrochloride Dilaudid
meperidine hydrochloride Demerol
methadone hydrochloride Methadone
morphine hydrochloride Morphine
morphine sulfate Oramorph, 
Roxanol, 
Statex
oxycodone hydrochloride Roxicodone,
OxyContin
oxymorphone hydrochloride Numorphan
pentazocine hydrochloride Talwin
propoxyphene hydrochloride Darvon
propoxyphene napsylate Darvon-N
tramadol hydrochloride Ultram
* Combined with naloxone and taken sublin-
gually
The following products use a combination of an
opioid or narcotic along with aspirin, Tylenol,
or other pain reliever to treat mild to moderate
pain.
Anesxia 5/50
Capital with Codeine
Darvocet N 100
Darvocet N 50
E-Lor or Wygesic
Empirin or Phenaphen with Codeine #3
Empirin or Phenaphen with Codeine #4
Endocet, Percocet, or Roxicet
Fioricet with Codeine
Fiorinal with Codeine
Lorcet Plus
Lortab
Percodan
Roxicet
Roxicet oral solution (contains alcohol)
Roxiprin
Talacen
Talwin Compound
Tylenol with Codeine
Tylenol with Codeine syrup (contains alcohol)
Tylox
Vicodin
Vicodin ES
Purpose
Some of these drugs are used to control acute
pain that is moderate to severe. They are nor-
mally used only for acute pain—and for a short
time—because they could become addictive. An
exception is using opioids to alleviate the
chronic pain associated with cancer, where
research has shown that abuse or addiction to
these medications rarely occurs. Severe and
chronic pain has long been undertreated in the
United States. This is partly due to concerns
about addiction and partly due to laws that
made certain opioids, like heroin, illegal.
However, people with addictions still feel pain
and, in certain situations, they need pain man-
agement just like anyone else. To manage pain,
doctors are beginning to prescribe opioids more
freely—including methadone and buprenor-
phine, which are recognized as effective pain
medications.
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Methadone is a synthetic opioid used in heroin
detoxification programs and to maintain sobri-
ety from heroin addiction. Many people who
have been addicted to heroin have returned to
a productive life because of methadone mainte-
nance programs. Methadone is also occasional-
ly used to provide relief for specific types of
pain. 
Usual dose and frequency
All drugs have specific doses and frequencies.
A doctor will specify the exact amount of medi-
cation and when a person should take it. How
much medicine and how often to take it are
always specified on the prescription bottle.
Many medications are taken two or more times
a day. Some medications are taken in pill or
liquid form. Others are taken in liquid form. A
few are taken in a nasal spray or as transder-
mal patches. Injectable narcotics are not listed
here because they are not often used outside a
hospital setting. There are many nonaddictive
pain medications (medications that pose no risk
for addiction) available for pain management
that can be used after acute pain is reduced.
Potential side effects
• Constipation
• Decreased ability to see clearly
• Decreased ability to think clearly
• Flushing and sweating
• Pupil constriction
• Respiratory depression
• Stomach upset
• Tolerance
Potential for abuse or 
dependence
With opioid medications, there is a potential
for the development of tolerance and depen-
dence as well as the possibility of abuse and
severe withdrawal reactions.
Emergency conditions
• Convulsions and/or cardiac arrest with high
dosages
• Overdose may increase pulse rate, and result
in convulsions followed by coma or death
• Overdose may depress the breathing centers
in the brain leading to lack of ability to
breathe
Cautions
• Doctors and pharmacists should be told
about all medications being taken (including
dosage), including over-the-counter prepara-
tions, vitamins, minerals, and herbal supple-
ments (e.g., St. John’s wort, echinacea,
ginko, ginseng, etc.).
• People taking opioid drugs should not
increase their dose unless this has been
checked with their physician and a change is
ordered.
• Persons taking an opioid medication are par-
ticularly vulnerable to adverse medical con-
sequences if they concurrently use alcohol
and/or illicit drugs, because alcohol and illicit
drugs can increase the sedation effects of the
opioids.
• With opioid medications there is a potential
for the development of tolerance and depen-
dence as well as the possibility of abuse and
severe withdrawal reactions.
Special considerations for
pregnant women
For all women of child-bearing age who may be
or think they may be pregnant, the physician
should discuss the safety of this medication
before starting, continuing, or discontinuing
medication treatment. Both pregnant women
and their unborn infants can become tolerant
and physically dependent on opioids and this
dependence as well as possible withdrawal syn-
dromes need to be assessed. Substance abuse
counselors may have a role in encouraging this
discussion by suggesting this to their clients.
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Antiparkinsonian Medications
Generic and brand names
Generic Brand
amantadine hydrochloride Symmetrel,
Symadine
benzotropine maleate Cogentin
diphenhydramine hydrochloride Benadryl
trihexyphenidyl hydrochloride Artane
Purpose
These medications are used to counteract the
side effects of the antipsychotic drugs. They are
called antiparkinsonian because the neurologi-
cal side effects of the antipsychotic medications
are similar to the symptoms of Parkinson’s dis-
ease.
Usual dose and frequency
The amount of the medication and the correct
times to take it are labeled on the prescription
bottle. These medications have very specific
doses, and too much can be harmful. As with
all medications, a doctor must be consulted in
order to safely change the dose in response to
side-effect symptoms of the antiparkinsonian
medications.
Potential side effects
• Constipation
• Dizziness
• Dry mouth
• Heart failure
• Irritability
• Light-headedness
• Stomach upset
• Tiredness
Emergency conditions
Report any overdose, changes in heart rate or
rhythm to the doctor immediately.
Abuse liability of anticholin-
ergic medications
Anticholinergic medications such as ben-
ztropine, trihexyophenidyl, and dipheny-
dramine are used as adjuncts to neuroleptics to
control extrapyramidal side effects. However,
despite their utility, these substances can be
abused by some patients with severe mental ill-
ness who require neuroleptics. One patient sur-
vey found that many abusers of anticholiner-
gics used these agents “to get high, to increase
pleasure, to decrease depression, to increase
energy and to relax” (Buhrich et al. 2000, p.
929). The survey also found that the misuse of
other drugs accompanied the misuse of anti-
cholinergics. Consequently, in the context of
COD, providers and consumers need to be
aware of the abuse potential of anticholiner-
gics. Open communication between providers
and patients is critical to avoid complication
from the abuse of these substances.
Cautions
• Doctors and pharmacists should be told
about all medications being taken (including
dosage), including over-the-counter prepara-
tions, vitamins, minerals, and herbal supple-
ments (e.g., St. John’s wort, echinacea,
ginko, ginseng, etc.).
• People taking antiparkinsonian drugs should
not increase their dose unless this has been
checked with their physician and a change is
ordered.
Special considerations for
pregnant women
The risk of malformation associated with ben-
ztropine, trihexylphenidyl, and diphenhy-
dramine is not clear, although there is some
evidence to suggest that amantadine may be
teratogenic (Mortola 1989). For all women of
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child-bearing age who may be or think they
may be pregnant, the physician should discuss
the safety of this medication before starting,
continuing, or discontinuing medication treat-
ment. Substance abuse counselors may have a
role in encouraging this discussion by suggest-
ing this to their clients.
Hypnotics
Generic and brand names
Generic Brand
Barbiturates
secobarbital Seconal
Benzodiazepines
estazolam ProSom
flurazepam Dalmane
temazepam Restoril
triazolam Halcion
Non-benzodiazepine
zaleplon Sonata
zolpidem Ambien
sedating antidepressants trazedone, mir-
tazepine, 
Serzone, 
tricyclics
anticonvulsants gabapentin, 
divalproex, 
topiramate
Purpose
Hypnotics are used to help a person with sleep
disturbances get restful sleep. Lack of sleep is
one of the greatest problems faced by people
with chemical dependency and psychiatric ill-
ness. It can cause the symptoms of these disor-
ders to worsen. For example, mood changes,
psychosis, and irritability increase with insom-
nia. Lack of sleep diminishes a person’s ability
to think clearly or process information. Sleep–
wake cycles and the body’s ability to heal itself
also suffer when a person is sleep deprived.
Older hypnotics cause the body to slow down
and “pass out” or sleep. However, they also
have a tendency to disturb sleep-staging cycles. 
Benzodiazepines enhance the body’s natural
calming agents, which induces sleep. Ambien
and Sonata are non-benzodiazepines that affect
one of the body’s receptors for the natural
calming agent, GABA. These medications
induce sleep. They are short acting and do not
disturb sleep-staging cycles. Rebound insomnia
is a side effect of both Ambien and Sonata.
This side effect can be produced if the medica-
tions are used for more than 2 weeks and then
abruptly stopped.
Antidepressant sleep enhancers work by using
their sleep producing side effects to induce
sleep. They are nonaddictive but have the
capacity to produce all the side effects of their
class of antidepressant. Atypical antipsychotics
use their calming and sedation side effects to
induce sleep. They are non-addictive but have
the capacity to produce all the side effects of
atypical antipsychotics.
Paradoxically, those with addiction disorders
can become rapidly tolerant and dependent on
the most commonly used hypnotics, which are
the benzodiazepines and zolpidem (barbitu-
rates are now rarely used). Tolerance can lead
to decreasing effectiveness, escalating doses,
and an even worse sleep disorder when the
agent is withdrawn. For this reason, most
addiction medicine doctors use anticonvul-
sants, sedating antidepressants, or sedating
antihistamines if the sleep problem continues
past acute withdrawal symptoms. 
Usual dose and frequency
All drugs have specific doses and frequencies.
The physician will specify the exact amount of
medication and when it should be taken. How
much medicine and how often to take it are
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specified on the prescription bottle. All of these
medications are generally used for limited peri-
ods (3 to 4 days for barbiturates or up to a
month for others). For all of these medications,
tolerance develops quickly and eventually the
usual dose will no longer help the person to
sleep.
Potential side effects
• Breathing difficulty (Secobarbital)
• Dizziness
• Drowsiness
• Hangover or daytime sleepiness
• Headache
• Lethargy
• Weakness
Note: There are many drawbacks to long-term
use of hypnotics (sleeping pills) such as dam-
aged sleep staging and addiction. Even Ambien
and Sonata, if taken for longer than 7 to 14
days, can have a discontinuation rebound
insomnia effect. Newer nonaddictive medica-
tions are now available to treat insomnia.
Potential for abuse or 
dependence
See Potential for Abuse or Dependence for
benzodiazepines.
Emergency conditions
• Overdose with any of these medications can
be life threatening. Seek help immediately in
the event of an overdose.
• Combinations of alcohol and barbiturates or
alcohol and benzodiazepines can be deadly.
Cautions
• Doctors and pharmacists should be told
about all medications being taken (including
dosage), including over-the-counter prepara-
tions, vitamins, minerals, and herbal supple-
ments (e.g., St. John’s wort, echinacea,
ginko, ginseng, etc.).
• People taking hypnotic drugs should not
increase their dose unless this has been
checked with their physician and a change is
ordered.
• People taking hypnotic medications are par-
ticularly vulnerable to adverse medical con-
sequences if they concurrently use alcohol
and/or illicit drugs.
• With hypnotics, there is the potential for
development of tolerance and dependence on
the medications with accompanying with-
drawal. The potential for abuse and misuse is
high.
Special considerations for
pregnant women
Barbiturate use during pregnancy has been
studied to some extent, but the risk of medica-
tion should be discussed with the patient
(Robert et al. 2001). There also are reports of a
withdrawal syndrome in the neonate (newborn
baby) following prenatal exposure to some bar-
biturates (Kuhnz et al. 1988). For all women of
child-bearing age who may be or think they
may be pregnant, the physician should discuss
the safety of this medication before starting,
continuing, or discontinuing medication treat-
ment. Substance abuse counselors may have a
role in encouraging this discussion by suggest-
ing this to their clients.
Addiction Treatment
Medications
Generic and brand names
Generic Brand
Antialcoholic
Disulfram Antabuse
Opiate blockers and antialcoholic
Naltrexone hydrochloride ReVia, Depade
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Partial opiate blockers
buprenorphine Suboxone, 
Subutex
Opiate maintenance
methadone hydrochloride Methadone
Other
Acamprosate*
* Works through the GABA system and holds
promise for alcohol craving and preventing
relapse through a different method than nal-
trexone. Not reported to be psychoactive.
Purpose
These drugs are used to reduce cravings and
the psychological reward from initial use of
alcohol or opioids.
Antabuse causes a toxic reaction if alcohol is
drunk; that is, it causes an unpleasant physical
reaction when the person consumes even a
small amount of alcohol. It is used as an aver-
sion therapy for some clients who chronically
abuse alcohol to help them remain in a state of
enforced sobriety which allows time for sup-
portive and psychotherapeutic treatment to be
applied. Antabuse is not psychoactive,
although it may make hallucinations worse at
high doses (i.e., above 500 mg/day). Patients
need to avoid all alcohol, even in other sources
such as cooking or skin care products, because
any alcohol can cause reactions.
Naltrexone completely blocks the pleasurable
reinforcement that comes from opioids. It is
more commonly used to reduce craving for
alcohol and reduce the duration of any relapse
to drinking. In research studies it has been
shown to moderately decrease alcohol craving
and relapse. It is nonpsychoactive, but can
interfere with the use of opioids for acute pain.
Buprenorphine is a prescription medication
approved in 2002 for treating opioid addiction.
It can be used for both opioid withdrawal and
as a substitute for opioids in long-term treat-
ment. Buprenorphine is the first medication
available to doctors for use in their office-based
practice. At low doses, it acts like methadone
and satisfies the dependent person’s need for
an opioid to avoid painful withdrawal. It does
not provide the user with the euphoria or rush
typically associated with use of other opioids or
narcotics. At moderate to high doses, it can
precipitate withdrawal. It is, therefore, safer in
overdose than methadone.
Methadone has been used in the United States
for maintenance treatment of opioid addiction
since the 1960s. It is a synthetic, long-acting
drug used in heroin detoxification programs to
maintain abstinence from heroin addiction.
When used in proper doses, methadone stops
the cravings but does not create euphoria,
sedation, or an analgesic effect. Many people
who have been addicted to heroin have
returned to a productive life because of
methadone maintenance treatment programs.
Methadone also is occasionally used to provide
relief for specific types of pain.
Usual dose and frequency
All drugs have specific doses and frequencies.
The physician will specify the exact amount of
medication and when it should be taken. How
much medicine and how often to take it are
specified on the prescription bottle. Antabuse
should never be given to clients without their
full knowledge or when they are intoxicated. It
should not be given until the client has
abstained from alcohol for at least 12 hours. A
daily, uninterrupted dose of Antabuse is con-
tinued until the client is in full and mature
recovery and has reorganized his or her life to
maintain recovery. Maintenance therapy may
be required for months or even years.
Naltrexone is usually taken once a day but can
be taken at a higher dose every second or third
day. It is usually started at full dose. Clients
should continue to take naltrexone until they
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have reached full and mature recovery and
have reorganized their life to maintain recov-
ery.
Suboxone is given as a sublingual tablet (it is
absorbed under the tongue). It is not absorbed
if swallowed or chewed. If injected intra-
venously, Suboxone will cause opioid withdraw-
al. Suboxone and Subutex can be given by pre-
scription and do not require daily attendance
at a clinic. This is an advantage for persons
who do not live near a methadone clinic.
Potential Side Effects
Potential side effects for Antabuse:
• Dark urine
• Drowsiness
• Eye pain
• Fatigue
• Impotence
• Indigestion
• Inflammation of optic nerve
• Jaundice
• Light colored stool
• Liver inflammation
• Loss of vision
• Psychotic reactions
• Skin rashes, itching
• Tingling sensation in arms and legs
Potential side effects for the opioid
blockers/opioids are similar to the class of opi-
oid drugs (if buprenorphine is given in high
dose, opioid withdrawal symptoms may occur):
• Abdominal cramps
• Body aches lasting 5–7 days
• Diarrhea
• Dizziness
• Fatigue
• Headache
• Insomnia
• Nausea
• Nervousness
• Opioid withdrawal (in some cases)
• Runny eyes and nose
• Severe anxiety
• Vomiting
Emergency Conditions
• Convulsions and/or cardiac arrest with high
dosages.
• Overdose may increase pulse rate, result in
convulsions followed by coma or death.
• Overdose may depress the breathing centers
in the brain leading to inability to breathe.
Cautions
• Doctors and pharmacists should be told
about all medications being taken, including
over-the-counter preparations.
• Persons taking Antabuse should be warned
to avoid even small amounts of alcohol in
other food products or “disguised forms”
(e.g., vanilla, sauces, vinegars, cold and
cough medicines, aftershave lotions, lini-
ments) as this will cause a reaction.
• Persons taking Antabuse should be warned
that consuming even small amounts of alco-
hol will produce flushing, throbbing in head
and neck, headache, difficulty breathing,
nausea, vomiting, sweating, thirst, chest
pain, rapid heart rate, blurred vision, dizzi-
ness, and confusion.
• Persons taking opioid medications should not
increase their dose unless this has been
checked with their physician and a change is
ordered.
• People taking opioid medications are particu-
larly vulnerable to adverse medical conse-
quences if they concurrently use alcohol
and/or illicit drugs.
• Persons taking Naltrexone should be warned
that if they are dependent on opioids, taking
Naltrexone will cause opioid withdrawal for
up to 3 days and block the effect of any opi-
oids taken for up to 3 days.
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Special considerations for
pregnant women
While it is not recommended that pregnant
women who are maintained on methadone
undergo detoxification, if these women require
detoxification, the safest time to detoxify them
is during the second trimester. For further
information, consult the forthcoming TIP
Substance Abuse Treatment: Addressing the
Specific Needs of Women (CSAT in develop-
ment b). In contrast, it is possible to detoxify
women dependent on heroin who are abusing
illicit opioids by using a methadone taper.
Buprenorphine has been examined in pregnan-
cy and appears to lack teratogenic effects but
may be associated with a withdrawal syndrome
in the neonate (Jones and Johnson 2001); how-
ever, regardless of the efficacy and safety of
buprenorphine with pregnant women, it has
not yet been approved for use with this popula-
tion. A National Institutes of Health consensus
panel recommended methadone maintenance as
the standard of care for pregnant women with
opioid dependence.  
Pregnant women should be maintained on an
adequate (i.e., therapeutic) methadone dose.
An effective dose prevents the onset of with-
drawal for 24 hours, reduces or eliminates
drug craving, and blocks the euphoric effects
of other narcotics. An effective dose usually is
in the range of 50–150mg (Drozdick et al.
2002). Dosage must be individually determined,
and some pregnant women may be able to be
successfully maintained on less than 50mg while
others may require much higher doses than
150mg. The dose often needs to be increased as
a woman progresses through gestation, due to
increases in blood volume and metabolic
changes specific to pregnancy (Drozdick et al.
2002; Finnegan and Wapner 1988).
Generally, dosing of methadone is for a 24-
hour period. However, because of metabolic
changes during pregnancy it might not be possi-
ble to adequately manage a pregnant woman
during a 24-hour period on a single dose. Split
dosing, particularly during the third trimester
of pregnancy, may stabilize the woman’s blood
methadone levels and effectively treat with-
drawal symptoms and craving. 
Breastfeeding is not contraindicated for women
who are on methadone. Very little methadone
comes through breast milk; the American
Academy of Pediatrics (AAP) Committee on
Drugs lists methadone as a “maternal medica-
tion usually compatible with breastfeeding”
(AAP 2001, pp. 780–781).
The Federal government mandates that prenatal
care be available for pregnant women on
methadone. It is the responsibility of treatment
providers to arrange this care. More than ever,
there is need for collaboration involving obstet-
ric, pediatric, and substance abuse treatment
caregivers. Comprehensive care for the pregnant
woman who is opioid dependent must include a
combination of methadone maintenance, prena-
tal care, and substance abuse treatment. 
Naloxone should not be given to a pregnant
woman as a last resort for severe opioid over-
dose. Withdrawal can result in spontaneous
abortion, premature labor, or stillbirth
(Weaver 2003). Propranolol (Inderal), labetalol
(Trandate), and metoprolol (Lopressor) are the
beta blockers of choice for treating hyperten-
sion (high blood pressure) during pregnancy
(McElhatton 2001); however the impact of
using them for alcohol detoxification during
pregnancy is unclear. 
For all women of child-bearing age who may be
or think they may be pregnant, the physician
should discuss the safety of this medication
before starting, continuing, or discontinuing
medication treatment. Substance abuse coun-
selors may have a role in encouraging this dis-
cussion by suggesting this to their clients.
This review is an extensive edit and update of
the 5th edition published in 2004; the original
version was published in 2000 by the Mid-
America Addiction Technology Transfer Center
University of Missouri-Kansas City
5100 Rockhill Road
Kansas City, Missouri 64110
www.mattc.org
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Appendix G:
Screening and
Assessment Instruments
Addiction Severity Index (ASI)
Purpose: The ASI is most useful as a general intake screening tool. It
effectively assesses a client’s status in several areas, and the composite
score measures how a client’s need for treatment changes over time. 
Clinical utility: The ASI has been used extensively for treatment plan-
ning and outcome evaluation. Outcome evaluation packages for indi-
vidual programs or for treatment systems are available.
Groups with whom this instrument has been used: Designed for
adults of both sexes who are not intoxicated (drugs or alcohol) when
interviewed. Also available in Spanish.
Format: Structured interview
Administration time: 50 minutes to 1 hour
Scoring time: 5 minutes for severity rating 
Computer scoring? Yes
Administrator training and qualifications: A self-training packet is
available as well as onsite training by experienced trainers.
Fee for use: No cost; minimal charges for photocopying and mailing
may apply.
Available from: A. Thomas McLellan, Ph.D. 
Building 7
PVAMC 
University Avenue 
Philadelphia, PA 19104 
Phone: (800) 238-2433
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Alcohol Use Disorders
Identification Test
(AUDIT)
Purpose: The purpose of the AUDIT is to
identify persons whose alcohol consumption
has become hazardous or harmful to their
health.
Clinical utility: The AUDIT screening proce-
dure is linked to a decision process that
includes brief intervention with heavy
drinkers or referral to specialized treatment
for patients who show evidence of more seri-
ous alcohol involvement.
Groups with whom this instrument has been
used: Adults, particularly primary care,
emergency room, surgery, and psychiatric
patients; DWI offenders; criminals in court,
jail, and prison; enlisted men in the armed
forces; and workers in employee assistance
programs and industrial settings.
Format: A 10-item screening questionnaire
with 3 questions on the amount and frequen-
cy of drinking, 3 questions on alcohol depen-
dence, and 4 on problems caused by alcohol.
Administration time: 2 minutes
Scoring time: 1 minute
Computer scoring? No
Administrator training and qualifications:
The AUDIT is administered by a health pro-
fessional or paraprofessional. Training is
required for administration. A detailed user’s
manual and a videotape training module
explain proper administration, procedures,
scoring, interpretation, and clinical manage-
ment.
Fee for use: No
Available from: Can be downloaded 
from Project Cork 
Web site: 
www.projectcork.org
Beck Depression
Inventory–II (BDI–II)
Purpose: Used to screen for the presence and
rate the severity of depression symptoms.
Clinical utility: The BDI–II consists of 21
items to assess the intensity of depression.
The BDI-II can be used to assess the intensity
of a client’s depression, and it can also be
used as a screening device to determine
whether there is any current indication of the
need for a referral for further evaluation.
Each item is a list of four statements arranged
in increasing severity about a particular
symptom of depression. These new items
bring the BDI–II into alignment with
Diagnostic and Statistical Manual for Mental
Disorders, 4th edition (DSM-IV) criteria.
Items on the new scale replace items that
dealt with symptoms of weight loss, changes in
body image, and somatic preoccupation.
Another item on the original BDI that tapped
work difficulty was revised to examine loss of
energy. Also, sleep loss and appetite loss items
were revised to assess both increases and
decreases in sleep and appetite.
Groups with whom this instrument has been
used: All clients age 13 through 80 who can
read and understand the instructions, and
clients who cannot read (requires reading the
statements to them).
Format: Paper-and-pencil self-administered
test. 
Administration time: 5 minutes, either self-
administered or administered verbally by a
trained administrator.
Scoring time: N/A
Computer scoring? No. Any staff member
can perform the simple scoring.
Administrator training and qualifications:
Doctoral-level training or masters-level train-
ing with supervision by a doctoral-level clini-
cian are required to interpret test results. 
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Fee for use: $66 for manual and package of
25 record forms.
Available from: The Psychological 
Corporation
19500 Bulderve
San Antonio, TX 78259
Phone: (800) 872-1726
www.psychcorp.com
CAGE Questionnaire
Purpose: The purpose of the CAGE
Questionnaire is to detect alcoholism.
Clinical utility: The CAGE Questionnaire is a
very useful bedside, clinical desk instrument
and has become the favorite of many family
practice and general internists—also very
popular in nursing.
Groups with whom this instrument has been
used: Adults and adolescents (over 16 years)
Format: Very brief, relatively nonconfronta-
tional questionnaire for detection of alco-
holism, usually directed “have you ever” but
may be focused to delineate past or present. 
Administration time: Less than 1 minute 
Scoring time: Instantaneous
Computer scoring? No
Administrator training and qualifications:
No training required for administration; it is
easy to learn, easy to remember, and easy to
replicate. 
Fee for use: No
Available from: May be downloaded from 
the Project Cork Web site:
www.projectcork.org
Circumstances,
Motivation, and
Readiness Scales 
(CMR Scales)
Purpose: The instrument is designed to pre-
dict retention in treatment and is applicable
to both residential and outpatient treatment
modalities.
Clinical utility: The instrument consists of
four derived scales measuring external pres-
sure to enter treatment, external pressure to
leave treatment, motivation to change, and
readiness for treatment. Items were devel-
oped from focus groups of recovering staff
and clients and retain much of the original
language. Clients entering substance abuse
treatment perceive the items as relevant to
their experience. 
Groups with whom this instrument has been
used: Adults
Format: 18 items at approximately a third-
grade reading level. Responses to the items
consist of a 5-point Likert scale on which the
individual rates each item on a scale from
Strongly Disagree to Strongly Agree. Versions
are also available in Spanish and Norwegian.
Administration time: 5 to 10 minutes 
Scoring time: Can be easily scored by revers-
ing negatively worded items and summing the
item values.
Computer scoring? No
Administrator training and qualifications:
Self-administered; no training required for
administration. 
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Fee for use: No
Available from: George De Leon, Ph.D., or
Gerald Melnick, Ph.D.
National Development and
Research Institutes, Inc.
71 West 23rd Street
8th Floor
New York, NY 1001
Phone: (212) 845-4400
Fax: (917) 438-0894
E-mail:
gerry.melnick@ndri.org
www.ndri.org
Clinical Institute
Withdrawal
Assessment (CIWA-Ar)
Purpose: Converts DSM-III-R items into
scores to track severity of withdrawal; mea-
sures severity of alcohol withdrawal.
Clinical utility: Aid to adjustment of care
related to withdrawal severity.
Groups with whom this instrument has been
used: Adults
Format: A 10-item scale for clinical quantifi-
cation of the severity of the alcohol withdraw-
al syndrome.
Administration time: 2 minutes 
Scoring time: 4 to 5 minutes
Computer scoring? No
Administrator training and qualifications:
Training is required and the CIWA is admin-
istered by nurses, doctors, and research asso-
ciates/detoxification unit workers.
Fee for use: No
Available from: Dr. E.M. Sellers
Ventana Clinical Research 
Corporation
340 College Street
Suite 400
Toronto, Canada
M5T 3A9
Phone: (416) 963-9338
Fax: (416) 963-9732
www.ventana-crc.com
Drug Abuse Screening
Test (DAST)
Purpose: The purpose of the DAST is (1) to
provide a brief, simple, practical, but valid
method for identifying individuals who are
abusing psychoactive drugs; and (2) to yield a
quantitative index score of the degree of
problems related to drug use and misuse. 
Clinical utility: Screening and case finding;
level of treatment and treatment/goal planning.
Groups with whom this instrument has been
used: Individuals with at least a sixth-grade
reading level.
Format: A 20-item instrument that may be
given in either a self-report or a structured
interview format; a “yes” or “no” response is
requested from each of 20 questions. 
Administration time: 5 minutes 
Scoring time: N/A
Computer scoring? No. The DAST is
planned to yield only one total or summary
score ranging from 0 to 20, which is computed
by summing all items that are endorsed in the
direction of increased drug problems. 
Administrator training and qualifications:
For a qualified drug counselor, only a careful
reading and adherence to the instructions in
the “DAST Guidelines for Administration and
Scoring,” which is provided, is required. No
other training is required.
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Fee for use: The DAST form and scoring key
are available either without cost or at nomi-
nal cost.
Available from: Centre for Addiction and 
Mental Health
Marketing and Sales
Services
33 Russell Street
Toronto, Ontario, Canada
M5S 2Sl 
Phone: (800) 661-1111
(Continental North
America)
International and Toronto
area: (416) 595-6059
Global Appraisal of
Individual Needs
(GAIN)
Purpose: The GAIN was developed to imple-
ment an integrated biopsychosocial model of
treatment assessment, planning, and outcome
monitoring that can be used for evaluation,
clinical practice, and administrative purposes.
Clinical utility: The GAIN embeds questions
for documenting substance use disorder,
attention deficit/hyperactivity disorder, oppo-
sitional defiant disorder, conduct disorder,
and pathological gambling; dimensional
patient placement criteria for
intoxication/withdrawal, health distress, men-
tal distress, and environment distress to guide
movement among and between levels of care;
treatment planning; reporting requirements
related to the State client data system; and
measures of a core set of clinical status and
service utilization outcomes used in the Drug
Outcome Monitoring Study.
Groups with whom this instrument has been
used: Adults and adolescents
Format: The content of the GAIN is divided
into eight areas: background and treatment
arrangements, substance use, physical health,
risk behaviors, mental health, environment,
legal, and vocational. In each area, the ques-
tions check for major problem areas and the
recency of any problems. 
Administration time: 15 to 30 minutes
Scoring time: 20 minutes
Computer scoring? No
Administrator training and qualifications:
N/A
Fee for use: The GAIN and its products are
tools that are proprietary products owned by
Chestnut Health Systems either exclusively or
jointly and protected under U.S. copyright
laws. The current work is in beta test form,
but can be used for evaluation and research
under a non-exclusive, non-transferable, lim-
ited license at the cost of $1 plus any materi-
als/assistance requested.
Available from: The Lighthouse Institute
Chestnut Health Systems
720 West Chestnut
Bloomington, IL 61701
Phone: (309) 827-6026
www.chestnut.org/li/gain/
Level of Care
Utilization System
(LOCUS)
Purpose: To assess immediate service needs
(e.g., for clients in crisis); to plan resource
needs over time, as in assessing service
requirements for defined populations; to
monitor changes in status or placement at dif-
ferent points in time. 
Clinical utility: LOCUS is divided into three
sections. The first section defines six evalua-
tion parameters or dimensions: (1) risk of
harm; (2) functional status; (3) medical,
addictive, and psychiatric co-morbidity; (4)
recovery environment; (5) treatment and
recovery history; and (6) engagement. A five-
point scale is constructed for each dimension
and the criteria for assigning a given rating or
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score in that dimension are elaborated. In
dimension IV, two subscales are defined,
while all other dimensions contain only one
scale.
Groups with whom this instrument has been
used: Adults
Format: A document that is divided into
three sections. 
Administration time: 15 to 30 minutes
Scoring time: 20 minutes
Computer scoring? No
Administrator training and qualifications:
N/A
Fee for use: No
Available from: American Association of 
Community Psychiatrists
www.wpic.pitt.edu/aacp/
find.html
Michigan Alcoholism
Screening Test (MAST)
Purpose: Used to screen for alcoholism with
a variety of populations.
Clinical utility: A 25-item questionnaire
designed to provide a rapid and effective
screen for lifetime alcohol-related problems
and alcoholism.
Groups with whom this instrument has been
used: Adults
Format: Consists of 25 questions 
Administration time: 10 minutes
Scoring time: 5 minutes
Computer scoring? No
Administrator training and qualifications:
No training required.
Fee for use: Fee for a copy but no fee for use.
Available from: Melvin L. Selzer, M.D.
6967 Paseo Laredo
La Jolla, CA 92037-6425
M.I.N.I. Plus
Purpose: Assists in the assessment and track-
ing of patients with greater efficiency and
accuracy.
Clinical utility: The M.I.N.I. is not designed
or intended to be used in place of a full medi-
cal and psychiatric evaluation by a qualified
licensed physician-psychiatrist. It is intended
only as a tool to facilitate accurate data col-
lection and processing of symptoms elicited by
trained personnel.
Groups with whom this instrument has been
used: Adults
Format: An abbreviated psychiatric struc-
tured interview that takes approximately 15
to 20 minutes to administer. It uses decision
tree logic to assess the major adult Axis I dis-
orders in DSM-IV and ICD-10. It elicits all
the symptoms listed in the symptom criteria
for DSM-IV and ICD-10 for 15 major Axis I
diagnostic categories, one Axis II disorder,
and for suicidality. Its diagnostic algorithms
are consistent with DSM-IV and ICD-10 diag-
nostic algorithms.
Administration time: 15 to 20 minutes
Scoring time: N/A
Computer scoring? A computerized version
of the M.I.N.I. is available in six languages in
the MINI Outcomes program.
Administrator training and qualifications:
The M.I.N.I. was designed to be used by
trained interviewers who do not have training
in psychiatry or psychology. 
Fee for use: The M.I.N.I. is made available
at no charge on the Internet, mainly for
researchers and clinicians who may make sin-
gle copies of the M.I.N.I. for their own use.
When the M.I.N.I. is used in a research study
or published paper, appropriate credit should
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be given for its use. The proper citation is
provided on the last page of the M.I.N.I.
Available from: Medical Outcome Systems,
Inc.
medical-outcomes.com
Psychiatric Research
Interview for
Substance and Mental
Disorders (PRISM)
Purpose: The instrument was designed to
maximize reliability and validity in communi-
ty samples, alcohol, drug, and co-occurring
disorder treatment samples. 
Clinical utility: Although primarily designed
as a research instrument, the PRISM pro-
vides systematic coverage of alcohol- and
drug-related experiences and symptoms that
may be useful in identifying areas of focus for
treatment. Additionally, the unusually high
reliability of the depression diagnoses in indi-
viduals with heavy drinking may provide a
better basis for treatment decisions than less
consistent methods for assessing major
depression and dysthymia.
Groups with whom this instrument has been
used: Adults
Format: The PRISM is a semistructured clin-
ician-administered interview that measures
DSM-III, DSM-III-R, and DSM-IV diagnoses
(current and past) of alcohol, drug, and psy-
chiatric disorders and continuous measures of
severity, organic, etiology, treatment, and
functional impairment. 
Administration time: 1 to 3 hours
Scoring time: Immediately
Computer scoring? Yes
Administrator training and qualifications:
Interviewer should have at least a master’s
degree in a clinical field and some clinical
experience. Training is required for adminis-
tration. Training for the administrator
involves a self-study manual, ratings of video-
tapes of interviews, and small group sessions
with an experienced trainer. 
Fee for use: No
Available from: Dr. Deborah Hasin 
New York State
Psychiatric Institute 
Box 123 722 
West 168th Street
New York, NY 10032 
Phone: (212) 960-5518 
Cost/source of computer-
ized scoring: Call Dr. 
Hasin for current 
information.
Readiness to Change
Questionnaire
Purpose: Designed to assist the clinician in
determining the stage of readiness for change
among problem drinkers or people with alco-
hol use disorders.
Clinical utility: Assesses drinker’s readiness
to change drinking behaviors; may be useful
in assignment to different types of treatment.
Groups with whom this instrument has been
used: Adults and adolescents
Format: A brief 12-item questionnaire con-
sisting of three subscales.
Administration time: 2 to 3 minutes
Scoring time: 1 to 2 minutes
Computer scoring? No
Administrator training and qualifications:
No training is required.
Fee for use: No
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Available from: Center for Alcohol and 
Drug Studies
Plummer Court, Carliol
Place
Newcastle upon Tyne
NE1 6UR
UNITED KINGDOM
Phone: 44(0)191219 5648
Fax: 44(0)191219 5649
Recovery Attitude and
Treatment Evaluator
(RAATE)
Purpose: Designed to assist in placing
patients into the appropriate level of care at
admission, in making continued stay or trans-
fer decisions during treatment (utilization
review), and documenting appropriateness of
discharge.
Clinical utility: The RAATE provides objec-
tive documentation to assist in making appro-
priate treatment placement decisions; it
strengthens individualized care and facilitates
more individualized treatment planning; it
measures treatment process; and it assesses
the need for continuing care and discharge
readiness.
Groups with whom this instrument has been
used: Adults
Format: A 35-item structured interview
Administration time: 20 to 30 minutes
Scoring time: Less than 5 minutes
Computer scoring? No
Administrator training and qualifications:
Training is required for administration. The
RAATE is administered by trained chemical
dependency professional (RAATE-CE) or
patient (RAATE-QI).
Fee for use: Yes. The RAATE manual is
available for $35.00 and the scoring templates
are $8.75.
Available from: Evince Clinical 
Assessments
P.O. Box 17305
Smithfield, RI 02917
Phone: (401) 231-2993
Toll-free in USA:
(800)-755-6299
www.evinceassessment.com
Structured Clinical
Interview for DSM-IV
Disorders (SCID-IV)
Purpose: Obtains Axis I and II diagnoses
using the DSM-IV diagnostic criteria for
enabling the interviewer to either rule out or
establish a diagnosis of “drug abuse” or
“drug dependence” and/or “alcohol abuse” or
“alcohol dependence.”
Clinical utility: A psychiatric interview.
Groups with whom this instrument has been
used: Psychiatric, medical, or community-
based normal adults.
Format: A psychiatric interview form in
which diagnosis can be made by the examiner
asking a series of approximately 10 questions
of a client.
Administration time: Administration of Axis
I and Axis II batteries may require more than
2 hours each for patients with multiple diag-
noses. The Psychoactive Substance Use
Disorders module may be administered by
itself in 30 to 60 minutes.
Scoring time: Approximately 10 minutes
Computer scoring? No. Diagnosis can be
made by the examiner asking a series of ques-
tions of a client. 
Administrator training and qualifications:
Designed for use by a trained clinical evalua-
tor at the master’s or doctoral level, although
in research settings it has been used by bach-
elor’s-level technicians with extensive train-
ing.
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Fee for use: Yes
Available from: American Psychiatric 
Publishing, Inc.
1400 K Street, N.W.
Washington, DC 20005
www.appi.org
Substance Abuse
Treatment Scale (SATS)
Purpose: To assess and monitor the progress
that people with severe mental illness make
toward recovery from substance use disorder.
Clinical utility: This scale is for assessing a
person’s stage of substance abuse treatment,
not for determining diagnosis.
Groups with whom this instrument has been
used: Adults, adolescents (over 16 years)
Format: Very brief, relatively nonconfronta-
tional questionnaire for detection of alco-
holism, usually directed by saying “have you
ever” but may be focused to delineate past or
present. 
Administration time: Less than 1 minute 
Scoring time: Instantaneous
Computer scoring? No
Administrator training and qualifications:
No training required for administration; it is
easy to learn, easy to remember, and easy to
replicate. 
Fee for use: No
Available from: Can be downloaded from the
Center for Mental Health Services Web site,
www.mentalhealth.org/cmhs/CommunitySupp
ort/research/toolkits/pn6toc.asp
University of Rhode
Island Change
Assessment (URICA)
Purpose: The URICA operationally defines
four theoretical stages of change—precontem-
plation, contemplation, action, and mainte-
nance—each assessed by eight items. 
Clinical utility: Assessment of stages of
change/readiness construct can be used as a
predictor, treatment matching, and outcome
variables. 
Groups with whom this instrument has been
used: Both inpatient and outpatient adults
Format: The URICA is a 32-item inventory
designed to assess an individual’s stage of
change located along a theorized continuum
of change.
Administration time: 5 to 10 minutes to com-
plete 
Scoring time: 4 to 5 minutes
Computer scoring? Yes, computer-scannable
forms.
Administrator training and qualifications:
N/A
Fee for use: No; instrument is in the public
domain. Available from author.
Available from: Carlo C. DiClemente
University of Maryland
Psychology Department
1000 Hilltop Circle
Baltimore, MD 21250
Phone: (410) 455-2415
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Appendix H:
Screening Instruments
This appendix reproduces two screening instruments available for unre-
stricted use: 
• Mental Health Screening Form-III (MHSF-III)
• Simple Screening Instrument for Substance Abuse (SSI-SA) 
One of the difficult decisions facing the consensus panel related to the
inclusion of specific screening and assessment instruments. The consen-
sus panel decided to include an instrument for the substance abuse field
to screen for mental health issues and an instrument for mental health
settings to use to screen for substance abuse issues.
Recognizing time, cost, and effort as severe initial barriers to implement-
ing anything new into a treatment service system, the consensus panel
selected two screening instruments that can be reproduced for free and
have instructions that can also be reproduced for free. Information
about other screening instruments and assessment tools is given in
appendix G. 
There is clear face validity as well as supportive psychometric findings to
the two screening instruments in this appendix. Neither the questions
nor the formats of the MHSF-III and the SSI-SA are likely to cause diffi-
culty for staff or clients. These two screening techniques require minimal
staff training for their use, and their simplicity makes their incorpora-
tion into treatment services relatively easy. Both instruments were
specifically designed for use within a clinical setting for clients receiving
or seeking treatment and for administration and use under the standard
conditions found in most substance abuse and/or mental health clinics.
The consensus panel cautions against other uses of these instruments,
unless the professionals deciding on such use have given full considera-
tion to the limitations of these two specialized screens.
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The Mental Health
Screening Form-III
With the permission of Project Return
Foundation, Inc., the consensus panel has
taken the opportunity to present the Mental
Health Screening Form-III in its entirety (see
also www.projectreturn.org and 
www.asapnys.org/Resources/mhscreen.pdf).
Guidelines for Using the
Mental Health Screening
Form-III
The Mental Health Screening Form-III was ini-
tially designed as a rough screening device for
clients seeking admission to substance abuse
treatment programs.
Each MHSF-III question is answered either
“yes” or “no.” All questions reflect the respon-
dent’s entire life history; therefore all questions
begin with the phrase “Have you ever...”
The preferred mode of administration is for
staff members to read each item to respondents
and get their “yes” and “no” responses. Then,
after completing all 18 questions (question 6
has two parts), the staff member should inquire
about any “yes” response by asking “When did
this problem first develop?”; “How long did it
last?”; “Did the problem develop before, dur-
ing, or after you started using substances?”;
and, “What was happening in your life at that
time?” This information can be written below
each item in the space provided. There is addi-
tional space for staff member comments at the
bottom of the form.
The MHSF-III can also be given directly to
clients to complete, providing they have suffi-
cient reading skills. If there is any doubt about
someone’s reading ability, have the client read
the MHSF-III instructions and question num-
ber one to the staff member monitoring this
process. If the client cannot read and/or com-
prehend the questions, the questions must be
read and/or explained to him or her.
Whether the MHSF-III is read to a client or he
reads the questions and responds on his own,
the completed MHSF-III should be carefully
reviewed by a staff member to determine how
best to use the information. It is strongly rec-
ommended that a qualified mental health spe-
cialist be consulted about any “yes” response to
questions 3 through 17. The mental health spe-
cialist will determine if a follow-up, face-to-face
interview is needed for a diagnosis and/or treat-
ment recommendation.
The MHSF-III features a “Total Score” line to
reflect the total number of “yes” responses.
The maximum score on the MHSF-III is 18
(question 6 has two parts). This feature will
permit programs to do research and program
evaluation on the mental health-chemical
dependence interface for their clients.1
The first four questions on the MHSF-III are
not unique to any particular diagnosis; howev-
er, questions 5 through 17 reflect symptoms
associated with the following diagnoses/diagnos-
tic categories: Q5, Schizophrenia; Q6,
Depressive Disorders; Q7, Posttraumatic Stress
Disorder; Q8, Phobias; Q9, Intermittent
Explosive Disorder; Q10, Delusional Disorder;
Q11, Sexual and Gender Identity Disorders;
Q12, Eating Disorders (Anorexia, Bulimia);
Q13, Manic Episode; Q14, Panic Disorder;
Q15, Obsessive-Compulsive Disorder; Q16,
Pathological Gambling; and Q17, Learning
Disorder and Mental Retardation.
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1Note: The “Total Score” cannot be used with any individual client. Summing the number of “yes” responses cannot be
taken to be indicative of more or less of any “trait” or “dimension.” Even the use of a “Total Score” for research and
program evaluation purposes requires careful understanding of and attention to the fact that fundamentally each item is
an independent and separate screening device/question on its own. That is, every “yes” item is a positive screen suggest-
ing the need for further evaluation, and most items are screens for a particular mental disorder. Anyone using “Total
Scores” for an appropriate narrow set of possibilities related to program evaluation and/or research should take care
that such use does not create confusion.
The relationship between the diagnoses/diag-
nostic categories and the above-cited questions
was investigated by having four mental health
specialists independently select the one MHSF-
III question that best matched a list of diag-
noses/diagnostic categories. All of the mental
health specialists matched the questions and
diagnoses/diagnostic categories in the same
manner, that is, as noted in the preceding para-
graph.
A “yes” response to any of questions 5 through
17 does not, by itself, ensure that a mental
health problem exists at this time. A “yes”
response raises only the possibility of a current
problem, which is why a consult with a mental
health specialist is strongly recommended.
Simple Screening
Instrument for
Substance Abuse
The Simple Screening Instrument for
Substance Abuse (SSI-SA) was developed by
the consensus panel of TIP 11, Simple
Screening Instruments for Outreach for
Alcohol and Other Drug Abuse and Infectious
Diseases (Center for Substance Abuse
Treatment 1994c). The SSI-SA has previously
been called the Simple Screening Instrument
for Outreach for Alcohol and Other Drug
Abuse; the Simple Screening Instrument (SSI);
and the Simple Screening Instrument for AOD
(SSI-AOD). To avoid confusion, the consensus
panel suggests using “SSI-SA” (Simple
Screening Instrument for Substance Abuse)
when referring to this screening instrument. 
As a government-supported document, the SSI-
SA is in the public domain, can be used without
charge or permission and can be reproduced
without limit, including the instructions. It is a
16-item scale, although only 14 items are scored
so that scores can range from 0 to 14. These 14
items were selected by the TIP 11 consensus
panelists from existing alcohol and drug abuse
screening tools. A score of 4 or greater has
become the established cut-off point for war-
ranting a referral for a full assessment.
Since its publication in 1994 the SSI-SA has
been widely used and its reliability and validity
investigated. Peters and colleagues (2004)
reported on a national survey of correctional
treatment for COD. Reviewing 20 COD treat-
ment programs in correctional settings from 13
States, the SSI-SA was identified as among the
most common screening instruments used.
Peters et al. (2000) found the SSI-SA to be
effective in identifying substance-dependent
inmates, and the SSI-SA demonstrated high
sensitivity (92.6 percent for alcohol or drug
dependence disorder, 87.0 percent for alcohol
or drug abuse or dependence disorder) and
excellent test-retest reliability (.97). Knight et
al. (2000) also found the SSI-SA a reliable sub-
stance abuse screening instrument among ado-
lescent medical patients. 
Peters and Peyton (1998) evaluated a number
of screening instruments for use by drug
courts and found the Alcohol Dependence
Scale/Addiction Severity Index – Drug Use
section combined, the Texas Christian
University Drug Dependence Screen
(TCUDS), and the SSI-SA “to hold consider-
able promise for use with participants in drug
court programs” (p. 17).
The Urban Institute (Moore and Mears 2003)
interviewed practitioners within correction-
based drug treatment programs in 13 States
selected to include a diversity of regions and
sizes. Again, the TCUDS and the SSI-SA were
widely used, as was the Michigan Alcohol
Screening Test (MAST). The TCUDS was
deemed to produce fewer false positives than
the SSI-SA. Winters (1995), in a small study of
95 clients from a drug evaluation program,
found a sensitivity of 97.0 percent and speci-
ficity of 55.2 percent. “Overall classification
accuracy or ‘hit rate’ was 84.2 percent ….
[Thus] false classifications occurred in 15.8
percent of the sample, yet the majority of the
errors are of the ‘false positive’ type … which
is the preferred type of error for a screening
test” (p. 3). For program administrators or
clinicians considering the SSI-SA for their own
screening purposes, the false–positive rate will
produce more referrals than other screening
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Mental Health Screening Form-III
Instructions: In this program, we help people with all their problems, not just their addictions. This com-
mitment includes helping people with emotional problems. Our staff is ready to help you to deal with any
emotional problems you may have, but we can do this only if we are aware of the problems. Any information
you provide to us on this form will be kept in strict confidence. It will not be released to any outside person
or agency without your permission. If you do not know how to answer these questions, ask the staff member
giving you this form for guidance. Please note, each item refers to your entire life history, not just your cur-
rent situation, this is why each question begins - “Have you ever ....”
1. Have you ever talked to a psychiatrist, psychologist, therapist, social worker, or counselor about an
emotional problem?
YES NO
2. Have you ever felt you needed help with your emotional problems, or have you had people tell you that
you should get help for your emotional problems? 
YES NO
3. Have you ever been advised to take medication for anxiety, depression, hearing voices, or for any other
emotional problem? 
YES NO
4. Have you ever been seen in a psychiatric emergency room or been hospitalized for psychiatric reasons?
YES NO
5. Have you ever heard voices no one else could hear or seen objects or things which others could not see?
YES NO
6. (a) Have you ever been depressed for weeks at a time, lost interest or pleasure in most activities, had
trouble concentrating and making decisions, or thought about killing yourself? 
YES NO
(b) Did you ever attempt to kill yourself? 
YES NO
7. Have you ever had nightmares or flashbacks as a result of being involved in some traumatic/terrible
event? For example, warfare, gang fights, fire, domestic violence, rape, incest, car accident, being shot
or stabbed?
YES NO
8. Have you ever experienced any strong fears? For example, of heights, insects, animals, dirt, attending
social events, being in a crowd, being alone, being in places where it may be hard to escape or get help?
YES NO
9. Have you ever given in to an aggressive urge or impulse, on more than one occasion, that resulted in
serious harm to others or led to the destruction of property? 
YES NO
10. Have you ever felt that people had something against you, without them necessarily saying so, or that
someone or some group may be trying to influence your thoughts or behavior? 
YES NO
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Mental Health Screening Form-III (continued)
11. Have you ever experienced any emotional problems associated with your sexual interests, your sexual
activities, or your choice of sexual partner? 
YES NO
12. Was there ever a period in your life when you spent a lot of time thinking and worrying about gaining
weight, becoming fat, or controlling your eating? For example, by repeatedly dieting or fasting, engaging
in much exercise to compensate for binge eating, taking enemas, or forcing yourself to throw up? 
YES NO
13. Have you ever had a period of time when you were so full of energy and your ideas came very rapidly,
when you talked nearly non-stop, when you moved quickly from one activity to another, when you need-
ed little sleep, and believed you could do almost anything? 
YES NO
14. Have you ever had spells or attacks when you suddenly felt anxious, frightened, uneasy to the extent
that you began sweating, your heart began to beat rapidly, you were shaking or trembling, your stomach
was upset, you felt dizzy or unsteady, as if you would faint? 
YES NO
15. Have you ever had a persistent, lasting thought or impulse to do something over and over that caused
you considerable distress and interfered with normal routines, work, or your social relations? Examples
would include repeatedly counting things, checking and rechecking on things you had done, washing and
rewashing your hands, praying, or maintaining a very rigid schedule of daily activities from which you
could not deviate.
YES NO
16. Have you ever lost considerable sums of money through gambling or had problems at work, in school,
with your family and friends as a result of your gambling? 
YES NO
17. Have you ever been told by teachers, guidance counselors, or others that you have a special learning
problem?
YES NO
Print client’s name: __________________ Program to which client will be assigned: ________________
Name of admissions counselor: ______________________________ Date: ________________________
Reviewer’s comments:______________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
Total Score: ____________(each yes = 1 point)
Source: J.F.X. Carroll, Ph.D., and John J. McGinley, Ph.D.; Project Return Foundation, Inc., 2000.
This material may be reproduced or copied, in entirety, without permission.
www.asapnys.org/Resources/mhscreen.pdf
instruments, such as the TCUDS, might pro-
duce. On the other hand, the SSI-SA is likely
to correctly identify a high percentage of coop-
erative clients and to miss (false negatives) only
a few—that is, only a few people who warrant a
full evaluation and are likely to have a sub-
stance use disorder will be deemed by this
screening instrument not to warrant a full
assessment. Choosing a screening instrument
and designing a screening and assessment treat-
ment process are complex challenges that typi-
cally require expert input. 
Lastly, the National Health Care for the
Homeless Council recently developed general
recommendations for the care of homeless
patients (Bonin et al. 2004). Within these
guidelines are recommendations to consider the
SSI-SA to screen for substance use problems
(and the MHSF-III to screen for mental disor-
ders).
The following sections are reprinted from TIP
11.
Development of the SSI-SA
Routine screening for substance abuse can be
used to initiate the process of assessment by
identifying a client’s possible problems and
determining whether he or she needs a compre-
hensive assessment. Ideally, a screening instru-
ment for substance abuse should have a high
degree of sensitivity: It should be broad in its
detection of individuals who have a potential
substance abuse problem, regardless of the spe-
cific drug or drugs being abused. 
The substance abuse screening instrument pre-
sented in this section was designed to encom-
pass a broad spectrum of signs and symptoms
for substance use disorders. These conditions
are characterized by substance use that leads
to negative physical, social, and/or emotional
consequences and loss of control over one’s
pattern and amount of consumption of the sub-
stance(s) of abuse.
The view of substance abuse problems and dis-
orders presented in this section and reflected in
the screening instrument is consistent with that
adopted by the World Health Organization and
the American Psychiatric Association. Briefly
stated, this view holds that substance abuse dis-
orders are biopsychosocial disorders, causing
impairment and dysfunction in physical, emo-
tional, and social domains. Certain cognitive
and behavioral signs and symptoms are also
associated with substance abuse (see the obser-
vation checklist at the end of the screening
instrument for substance abuse). Although many
of these latter signs and symptoms can be the
result of various medical, psychiatric, and social
problems, individuals with a substance abuse
disorder generally exhibit several of them.
The screening instrument for substance abuse
was developed by first identifying five primary
content domains, which are described in the
sections that follow. The screening questions
then devised were assigned to one or more of
these categories. These screening questions
were adapted from existing tools found in the
published literature. Because most of these
existing tools were designed to screen for alco-
hol abuse, many items needed to be revised to
address other drugs. The sources for the
screening items included in the instrument are
shown in Figure H-1.
Domains Measured by the
Instrument
Substance consumption
A person’s consumption pattern—the frequen-
cy, length, and amount of use—of substances is
an important marker for evaluating whether he
or she has a substance abuse problem.
Questions 1, 10, and 11 in the substance abuse
screening instrument were formulated in order
to help delineate an individual’s consumption
pattern.
Patterns of substance consumption can vary
widely among individuals or even for the same
individual. Although substance use disorders
often consist of frequent, long-term use of sub-
stances, addiction problems may also be charac-
terized by periodic binges over shorter periods.
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Preoccupation and loss of
control
The symptoms of preoccupation and loss of
control are common in people with substance
use disorders. Preoccupation refers to an indi-
vidual spending inordinate amounts of time
concerned with matters pertaining to substance
use. Loss of control is a symptom usually typi-
fied by loss of control over one’s use of sub-
stances or over one’s behavior while using sub-
stances. These symptoms are measured by
screening test questions 2, 3, 9, 11, and 12.
The symptom of preoccupation is marked by
an individual’s tendency to spend a consider-
able amount of time thinking about, consum-
ing, and recovering from the effects of the sub-
stance(s) of abuse. In some cases, the individu-
al’s behavior may be noticeably altered by his
or her preoccupation with these matters. Such
an individual may, for example, lose interest in
personal relationships or may become less pro-
ductive at work as a result of constant preoccu-
pation with obtaining more of the substance of
abuse.
Loss of control over substance use is typified by
the consumption of more of the substance(s) of
abuse than originally intended. Many persons
with a substance abuse problem feel that they
have no direct, conscious control over how
much and how often they use substances. Such
an individual may, for example, initially intend
to have only one drink but then be unable to
keep from drinking more. He or she may find it
difficult or impossible to stop drinking once he
or she has started. In other instances, a person
who originally plans to use a drug for a short
period of time may find that he or she is
increasingly using it over longer periods than
originally intended.
Loss of behavioral control, on the other hand,
is typified by loss of inhibitions and by behav-
iors that are often destructive to oneself or oth-
ers. In many cases, these behaviors do not
occur when the individual is not using sub-
stances. A person with a substance use problem
may begin taking unnecessary risks and may
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Figure H-1
Sources for Items Included in the
Simple Screening Instrument for
Substance Abuse
Question No. Source Instrument
1 Revised Health Screening Survey 
(RHSS)
2 Michigan Alcohol Screening Test 
(MAST)
3 CAGE
4 MAST, CAGE
5 History of Trauma Scale, MAST, 
CAGE
6 MAST, Drug Abuse Screening 
Test (DAST)
7 MAST, Problem-Oriented 
Screening Instrument for 
Teenagers (POSIT)
8 MAST, DAST
9 MAST, DSM-II-R
10 POSIT, DSM-III-R
11 POSIT
12 POSIT
13 MAST, POSIT, CAGE, RHSS, 
Alcohol Use Disorders 
Identification Test 
(AUDIT), Addiction Severity
Index (ASI)
Note: References for these sources appear at the
end of this section.
act in an impulsive, dangerous manner.
Individuals who are intoxicated from substance
abuse may, for example, have sex with someone
in whom they ordinarily would not have a sexu-
al interest, or they may start an argument or
fight.
Adverse consequences
Addiction invariably involves adverse conse-
quences in numerous areas of an individual’s
life, including physical, psychological, and
social domains. In the screening instrument for
substance abuse, questions 5–9, 12, and 13 are
designed to elicit adverse consequences of sub-
stance abuse.
Examples of adverse physical consequences
resulting from substance abuse include experi-
encing blackouts, injury and trauma, or with-
drawal symptoms or contracting an infectious
disease associated with high-risk sexual behav-
iors. One of the most serious health threats to
people with substance use disorders, particu-
larly those who inject drugs intravenously, is
infection with HIV, the causative agent of
AIDS.
Adverse psychological consequences arising
from substance abuse include depression, anxi-
ety, mood changes, delusions, paranoia, and
psychosis. Negative social consequences include
involvement in arguments and fights; loss of
employment, intimate relationships, and
friends; and legal problems such as civil law-
suits or arrests for abuse, possession, or selling
of illicit drugs.
As an individual’s use continues over time and
addiction takes hold, adverse consequences
tend to worsen. Thus, people in the very early
stages of addiction may have fewer adverse
consequences than those in the later stages.
Individuals in the early stages of addiction may
therefore not make the connection between
their substance abuse and the onset of negative
consequences. For this reason, some of the
items directed at identifying substance-related
adverse consequences in the screening instru-
ment attempt to obtain this information with-
out making an overt association with substance
abuse.
Problem recognition
Making a mental link between one’s use of sub-
stances and the problems that result from it—
such as difficulties in personal relationships or
at work—is an important step in recognizing
one’s substance abuse problem. Questions 2–4
and 13–16 in the substance abuse screening
instrument are problem recognition items.
Some of these items ask about past contacts
with intervention and treatment services,
because both research and clinical experience
indicate that a history of such contacts can be a
valid indicator of substance abuse problems.
Some individuals who have experienced nega-
tive consequences resulting from their sub-
stance abuse will report these problems during
a screening assessment. Clients who show
insight about the relationship between these
negative consequences and their use of sub-
stances should be encouraged to seek help.
Many, if not most, people who abuse sub-
stances, however, do not consciously recognize
that they have a problem. Other reasons why a
person may not disclose a substance abuse
problem include denial, lack of insight, and
mistrust of the interviewer. These individuals
cannot be expected to respond affirmatively to
“transparent” problem recognition items—
those in the form of direct questions, such as
“Do you have a substance problem?”—during
a screening interview. For these individuals,
questions must be worded indirectly in order to
ascertain whether negative experiences have
ensued from the use of substances.
Tolerance and withdrawal
Substance abuse, particularly prolonged abuse,
can cause a variety of physiological problems
that are related to the development of tolerance
and withdrawal. Questions 5 and 10 are aimed
at determining whether an individual has expe-
rienced any of the signs of tolerance and with-
drawal.
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Tolerance is defined as the need to use increas-
ing amounts of a substance in order to create
the same effect. If tolerance has developed and
the individual stops using the substance of
abuse, it is common for withdrawal effects to
emerge.
Withdrawal from stimulants and related drugs
often includes symptoms of depression, agita-
tion, and lethargy; withdrawal from depres-
sants (including alcohol) often includes symp-
toms of anxiety, agitation, insomnia, and panic
attacks; and withdrawal from opioids produces
agitation, anxiety, and physical symptoms such
as abdominal pain, increased heart rate, and
sweating.
Administration of the Simple
Screening Instrument
Two versions of the simple screening instru-
ment are presented in this section. They have
been designed to be administered in the form of
either an interview (Figure H-2, p. 506) or a
self-administered test (Figure H-3, p. 509) to
individuals who may be at risk of having a sub-
stance abuse problem.
Use of the screening instrument should be
accompanied by a careful discussion about con-
fidentiality2 issues. The interviewer should also
be clear about the instrument’s purpose and
should make it understood that the information
elicited from the instrument will be used to
benefit, not to punish, the individual being
screened.
Ideally, the screening test should be adminis-
tered in its entirety. Situations may arise, how-
ever, in which there is inadequate time to
administer the entire test. Street outreach com-
munity workers, for example, may have very
limited time with an individual.
In such situations, a subset of the screening
instrument can be administered. The four
boldfaced questions—1, 2, 3, and 16—consti-
tute the short form of the screening instrument.
These items were selected because they repre-
sent the prominent signs and symptoms covered
by the full screening instrument. Although this
abbreviated version of the instrument will not
identify the variety of dimensions tapped by
the full instrument and is more prone to error,
it may serve as a starting point for the screen-
ing process.
Notes on the screening 
questions
The screening instrument begins with a ques-
tion about the individual’s consumption of sub-
stances (question 1). This question is intended
to help the interviewer decide whether to con-
tinue with the interview—if the response to this
first question is no, continued questioning may
be unnecessary.
Questions 2–4 are problem recognition items
intended to elicit an individual’s assessment of
whether too much of a substance is being used,
whether attempts have been made to stop or
control substance use, and whether previous
treatment has been sought. Answers to these
questions may help the service provider under-
stand how the individual thinks and feels about
his or her use of substances. People who later
report negative consequences as the result of
their substance use but who nevertheless
answer “no” to these problem recognition ques-
tions may have poor insight about their sub-
stance abuse or may be denying the severity of
their substance problem.
Questions 5–12 were designed to determine
whether an individual has experienced any
adverse consequences of substance abuse.
These include medical, psychological, social,
and legal problems that often are caused by
substance abuse and addiction. Some questions
are intended to elicit symptoms of aggression
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2Confidentiality is governed by the Federal “Confidentiality of Alcohol and Drug Abuse Patient Records” regulations (42
C.F.R. Part 2) and the Federal “Standards for Privacy of Individually Identifiable Health Information” (45 C.F.R.
Parts 160 and 164).
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Figure H-2
Simple Screening Instrument for Substance Abuse Interview Form
Note: Boldfaced questions constitute a short version of the screening instrument that can be administered
in situations that are not conducive to administering the entire test. Such situations may occur because of
time limitations or other conditions.
Introductory statement:
“I’m going to ask you a few questions about your use of alcohol and other drugs during the past 6 months.
Your answers will be kept private. Based on your answers to these questions, we may advise you to get a
more complete assessment. This would be voluntary—it would be your choice whether to have an addition-
al assessment or not.”
During the past 6 months...
1. Have you used alcohol or other drugs? (Such as wine, beer, hard liquor, pot, coke, heroin or
other opioids, uppers, downers, hallucinogens, or inhalants.) (yes/no)
2. Have you felt that you use too much alcohol or other drugs? (yes/no)
3. Have you tried to cut down or quit drinking or using drugs? (yes/no)
4. Have you gone to anyone for help because of your drinking or drug use? (Such as Alcoholics
Anonymous, Narcotics Anonymous, Cocaine Anonymous, counselors, or a treatment program.)
(yes/no)
5. Have you had any of the following?
• Blackouts or other periods of memory loss
• Injury to your head after drinking or using drugs
• Convulsions, or delirium tremens (“DTs”)
• Hepatitis or other liver problems
• Feeling sick, shaky, or depressed when you stopped drinking or using drugs
• Feeling “coke bugs,” or a crawling feeling under the skin, after you stopped using drugs
• Injury after drinking or using drugs
• Using needles to shoot drugs
6. Has drinking or other drug use caused problems between you and your family or friends? (yes/no)
7. Has your drinking or other drug use caused problems at school or at work? (yes/no)
8. Have you been arrested or had other legal problems? (Such as bouncing bad checks, driving while
intoxicated, theft, or drug possession.) (yes/no)
9. Have you lost your temper or gotten into arguments or fights while drinking or using drugs?
(yes/no)
10. Are you needing to drink or use drugs more and more to get the effect you want? (yes/no)
11. Do you spend a lot of time thinking about or trying to get alcohol or other drugs? (yes/no)
12. When drinking or using drugs, are you more likely to do something you wouldn’t normally do, such
as break rules, break the law, sell things that are important to you, or have unprotected sex with
someone? (yes/no)
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Figure H-2 (continued)
Simple Screening Instrument for Substance Abuse Interview Form
13. Do you feel bad or guilty about your drinking or drug use? (yes/no)
Now I have some questions that are not limited to the past 6 months.
14. Have you ever had a drinking or other drug problem? (yes/no)
15. Have any of your family members ever had a drinking or drug problem? (yes/no)
16.Do you feel that you have a drinking or drug problem now? (yes/no)
• Thanks for answering these questions.
• Do you have any questions for me?
• Is there something I can do to help you?
Notes: __________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
Observation Checklist
The following signs and symptoms may indicate a substance abuse problem in the individual being
screened:
• Needle track marks
• Skin abscesses, cigarette burns, or nicotine stains
• Tremors (shaking and twitching of hands and eyelids)
• Unclear speech: slurred, incoherent, or too rapid
• Unsteady gait: staggering, off balance 
• Dilated (enlarged) or constricted (pinpoint) pupils
• Scratching
• Swollen hands or feet
• Smell of alcohol or marijuana on breath
• Drug paraphernalia such as pipes, paper, needles, or roach clips
• “Nodding out” (dozing or falling asleep)
• Agitation
• Inability to focus
• Burns on the inside of the lips (from freebasing cocaine)
(question 9), physical tolerance (question 10),
preoccupation (question 11), and loss of con-
trol (question 12). Question 13 is designed to
tap feelings of guilt, which may indicate that
the individual has some awareness or recogni-
tion of a substance problem; questions 14 and
16 are intended to measure the respondent’s
awareness of a past or present problem; and
question 15 elicits the individual’s family histo-
ry of substance abuse problems. 
Parenthetical words or phrases that accompa-
ny some of the screening questions are intended
to provide the interviewer with specific exam-
ples of what is being looked for or to help the
respondent understand the question. For
instance, question 1 asks whether an individual
has used substances, and the wording in paren-
theses prompts the administrator to ask about
specific substances of abuse.
Scoring and interpretation
A preliminary scoring mechanism for the
screening instrument is provided in Figure H-4,
p. 511. 
Questions 1 and 15 are not scored, because
affirmative responses to these questions may
provide important background information
about the respondent but are too general for
use in scoring. The observational items are also
not intended to be scored, but the presence of
most of these signs and symptoms may indicate
a substance abuse problem.
It is expected that people with a substance
abuse problem will probably score 4 or more
on the screening instrument. A score of less
than 4, however, does not necessarily indicate
the absence of a substance abuse problem. A
low score may reflect a high degree of denial or
lack of truthfulness in the subject’s responses.
The scoring rules have not yet been validated,
and thus the substance abuse screening instru-
ment needs to be used in conjunction with
other established screening tools when making
referrals.
Referral Issues
The substance abuse screening instrument, as a
first step in the process of assessment for sub-
stance abuse problems, can help service
providers determine whether an individual
should be referred for a more thorough assess-
ment. When an individual with a potential sub-
stance abuse problem is identified through the
instrument, the interviewer has the further
responsibility of linking the individual to
resources for further assessment and treatment.
Agencies and providers using the substance
abuse screening instrument should be prepared
to make an appropriate referral when the
screening identifies a person with a possible
substance abuse problem. A phone number
written on a piece of paper is not likely to be
effective in linking the individual to the appro-
priate resource for assessment and treatment.
Rather, a thorough familiarity with local com-
munity resources is needed on the part of the
service provider. The referring provider should
take a proactive role in learning about the
availability of appointments or treatment slots,
costs, transportation needs, and the names of
contact people at the agencies to which refer-
rals are made.
Because many individuals identified as having
possible substance abuse problems receive ser-
vices from more than one agency, it is essential
that one agency assume primary responsibility
for the client. The ideal model is a case man-
agement system. Through personal contacts,
case managers can help patients progress
through various programs and systems, cut red
tape, and remove barriers to access to services.
Providing effective services for substance abuse
requires close cooperation among agencies.
Community linkages can help increase the
quality of treatment for patients, whereas
interagency competition decreases the quality
of comprehensive care.
Substance abuse problems should be seen with-
in the larger context of other problems, both
current and past, confronted by the individual.
Current problems such as instability in housing
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Figure H-3
Simple Screening Instrument for Substance Abuse Self-Administered Form
Directions: The questions that follow are about your use of alcohol and other drugs. Your answers will be
kept private. Mark the response that best fits for you. Answer the questions in terms of your experiences in
the past 6 months.
During the last 6 months...
1. Have you used alcohol or other drugs? (Such as wine, beer, hard liquor, pot, coke, heroin or other opi-
oids, uppers, downers, hallucinogens, or inhalants)
___Yes ___ No
2. Have you felt that you use too much alcohol or other drugs?
___Yes ___ No
3. Have you tried to cut down or quit drinking or using alcohol or other drugs?
___Yes ___ No
4. Have you gone to anyone for help because of your drinking or drug use? (Such as Alcoholics
Anonymous, Narcotics Anonymous, Cocaine Anonymous, counselors, or a treatment program.)
___Yes ___ No
5. Have you had any health problems? For example, have you:
___Had blackouts or other periods of memory loss?
___Injured your head after drinking or using drugs?
___Had convulsions, delirium tremens (“DTs”)?
___Had hepatitis or other liver problems?
___Felt sick, shaky, or depressed when you stopped?
___Felt “coke bugs” or a crawling feeling under the skin after you stopped using drugs?
___Been injured after drinking or using?
___Used needles to shoot drugs?
6. Has drinking or other drug use caused problems between you and your family or friends?
___Yes ___ No
7. Has your drinking or other drug use caused problems at school or at work?
___Yes ___ No
and employment, homelessness, and hunger
often represent immediate needs that are more
pressing for the individual than treatment for
his or her substance abuse. Past crises, such as
incest, rape, and sexual abuse, can also affect
how an individual responds to the screening
questions.
Some of the items in the screening instrument
may trigger emotional distress or a crisis.
Reactions may sometimes include anxiety or
depression, which may be accompanied by sui-
cidal thoughts and behaviors. Agencies should
therefore develop specific protocols to manage
such crises. These protocols should include
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Figure H-3 (continued)
Simple Screening Instrument for Substance Abuse Self-Administered Form
8. Have you been arrested or had other legal problems? (Such as bouncing bad checks, driving while
intoxicated, theft, or drug possession.)
___Yes ___ No
9. Have you lost your temper or gotten into arguments or fights while drinking or using other drugs?
___Yes ___ No
10. Are you needing to drink or use drugs more and more to get the effect you want?
___Yes ___ No
11. Do you spend a lot of time thinking about or trying to get alcohol or other drugs?
___Yes ___ No
12. When drinking or using drugs, are you more likely to do something you wouldn’t normally do, such as
break rules, break the law, sell things that are important to you, or have unprotected sex with some-
one?
___Yes ___ No
13. Do you feel bad or guilty about your drinking or drug use?
___Yes ___ No
The next questions are about your lifetime experiences.
14. Have you ever had a drinking or other drug problem?
___Yes ___ No
15. Have any of your family members ever had a drinking or drug problem?
___Yes ___ No
16. Do you feel that you have a drinking or drug problem now?
___Yes ___ No
Thanks for filling out this questionnaire.
inhouse management and appropriate referrals
and followup.
See appendix C, Glossary, for substance abuse
screening terms.
Sources for the Substance
Screening Questions
Addiction Severity Index: McLellan, A.T.,
Luborsky, L., Woody, G.E., and O’Brien, C.P.
An improved diagnostic evaluation instrument
for substance abuse patients: The Addiction
Severity Index. Journal of Nervous and Mental
Disease 186:26–33, 1980.
AUDIT: Babor, T.F., De La Fuente, J.R., and
Saunders, J. AUDIT: Alcohol Use Disorders
Identification Test: Guidelines for Use in
Primary Health Care. Geneva: World Health
Organization, 1989.
CAGE: Mayfield, D., McLeod, G., and Hall, P.
The CAGE questionnaire: Validation of a new
alcoholism screening instrument. American
Journal of Psychiatry 131:1121–1123, 1974.
DAST: Skinner, H.A. Drug Abuse Screening
Test. Addictive Behavior 7:363–371, 1982.
DSM-III-R: American Psychiatric Association.
Diagnostic and Statistical Manual of Mental
Disorders, 3d Edition, Revised. Washington,
DC: American Psychiatric Association, 1987.
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Figure H-4
Scoring for the Simple Screening Instrument for Substance Abuse
Name/ID No.: ____________________________________ Date: ________________________________
Place/Location: __________________________________________________________________________
Items 1 and 15 are not scored. The following items are scored as 1 (yes) or 0 (no):
___ 2 ___ 7 ___ 12
___ 3 ___ 8 ___ 13
___ 4 ___ 9 ___ 14
___ 5 (any items listed) ___ 10 ___ 16
___ 6 ___ 11
Total score: ____     Score range: 0-14
Preliminary interpretation of responses:
Score Degree of Risk for Substance Abuse
0-1 None to low
2-3 Minimal
>4 Moderate to high: possible need for further assessment
History of Trauma Scale: Skinner, H.A., Holt,
S., Schuller, R., Roy, J., and Israel, Y.
Identification of alcohol abuse using laboratory
tests and a history of trauma. Annals of
Internal Medicine 101:847–851, 1984.
MAST: Selzer, M.L. The Michigan Alcohol
Screening Test: The quest for a new diagnostic
instrument. American Journal of Psychiatry
127:1653–1658, 1971.
POSIT: Rahdert, E.R. The Adolescent
Assessment and Referral System Manual.
DHHS Pub. No. (ADM) 91-1735. Rockville,
MD: National Institute on Drug Abuse, 1991.
RHSS: Fleming, M.F., and Barry, K.L. A
three-sample test of a masked alcohol screening
questionnaire. Alcohol 26:81–91, 1991.
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Appendix I:
Selected Sources of
Training
Sources of Training on Addiction
Disorders
Addiction Technology Transfer Centers (ATTCs)
Check with your local ATTC. Course offerings vary.
• www.nattc.org
• For curricula, lectures, videos, and printed training materials avail-
able through ATTCs, see www.nattc.org/resPubs.html
• For information on distance training offered by ATTCs and other
providers, see www.addictionED.org
Hazelden Institute
Hazelden offers training opportunities at many levels and locations. 
The Graduate School of Addiction Studies offers both a Master of Arts
in Addiction Studies and individualized programs. A Chemical
Dependency Counselor Certificate program is available for those with
less formal training. Contact the Graduate School at (888) 257-7800, ext.
4175 for more information.
• www.hazeldon.org
The Hazelden Distance Learning Center for Addiction Studies provides
opportunities for home-based study. Courses may be taken via the Web
or using traditional print materials. Contact the Distance Learning
Center at (800) 328-9000 for more information.
• www.dlcas.com
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National Association for
Alcohol and Drug Abuse
Counselors (NAADAC)
The NAADAC Web site includes lists of
approved education providers, distance learn-
ing opportunities, and post-secondary pro-
grams. Home study materials are also available
through NAADAC. Contact: (800) 548-0497.
• www.naadac.org
National Clearinghouse for
Alcohol and Drug Information
(NCADI)
The Substance Abuse and Mental Health
Services Administration’s (SAMHSA’s) NCADI
distributes materials developed by SAMHSA’s
Center for Substance Abuse Prevention and
Center for Substance Abuse Treatment, along
with several other agencies. Contact NCADI at
(800) 729-6686 for more information.
• www.ncadi.samhsa.gov
National Institute on Alcohol
Abuse and Alcoholism
(NIAAA)
Project Matching Alcoholism Treatment to
Client Heterogenity (MATCH) manuals are the
result of the collaborative efforts of the Project
MATCH investigators and are used as guides
by the therapists in the trial. They are present-
ed to the alcohol research community as stan-
dardized, well-documented intervention tools
for alcoholism treatment research. The manu-
als address 12-Step facilitation, motivational
enhancement, and cognitive–behavioral treat-
ments. 
• To access Project MATCH materials, see
www.niaaa.nih.gov/publications/match.htm
for an order form or write to:
National Institute on Alcohol Abuse and
Alcoholism
Publications Distribution Center
P.O. Box 10686
Rockville, MD 20849-0686
National Institute on Drug
Abuse (NIDA)
NIDA publishes a wide variety of treatment-
related materials, including a three-volume set
of therapy manuals for cocaine addiction.
Contact: (301) 443-1124. 
• www.nida.nih.gov
National Development and
Research Institutes, Inc. (NDRI)
NDRI offers an extensive training program of
75 courses in substance abuse and HIV/AIDS,
consultation, and technical assistance for pro-
gram development and implementation.
Contact: (212) 846-4566. 
• www.ndri.org 
Other University-Based
Training
A number of universities offer training. For
example, the Division on Addictions at
Harvard Medical School offers a fellowship in
addictions and other training for counselors,
MSWs, and other clinicians.
Rutgers Center for Alcohol
Studies
The Center for Alcohol Studies offers two types
of programs through its Education and
Training Division. Both the School of Alcohol
and Drug Studies and the Institute of Alcohol
and Drug Studies offer weeklong programs
throughout the summer months for interested
professionals and laypersons. During the aca-
demic year, professionals may choose 1-day
courses from the Continuing Professional
Education Seminars. Contact the Center’s
Education and Training Division at (732) 445-
4317 for more information.
• www.rci.rutgers.edu/~cas2/
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State Certifying Boards for
Chemical Dependency
Counseling
A list of individual State boards is available
through NAADAC. Contact: (800) 548-0497 or
visit www.naadac.org. Another list is available
through the International Certification and
Reciprocity Consortium. Contact: (919) 572-
6823. 
• www.icrcaoda.org/icrclist.htm
Sources of Training on
Mental Health
American Counseling
Association
Home study courses, learning institutes, and
onsite training. Contact: (703) 823-9800. 
• www.counseling.org
American Psychological
Association
Office of Continuing Professional Education.
Home study and other approved courses,
including some co-occurring disorder specific
offerings. Contact: (202) 336-5991. 
• www.apa.org/ce/
American Psychiatric
Association
Office of Continuing Medical Education. Gives
CME credits for review and exam based on the
Association’s annual meeting. Ask for a listing
of other conferences and courses available for
CME credits. Contact: (202) 682-6179. 
• www.psych.org
National Mental Health
Information Center (NMHIC)
This is a service of SAMHSA’s Center for
Mental Health Services. NMHIC distributes
materials developed by the Center for Mental
Health Services and other agencies. Several
training manuals are among the publications
offered. Contact NMHIC at (800) 789-2647 for
more information. 
• www.mentalhealth.samhsa.gov
National Institute of Mental
Health (NIMH)
NIMH provides a variety of manuals and
research reports, including texts on anxiety dis-
orders and depression. Contact: (301) 443-4513. 
• www.nimh.nih.gov
Sources of Training on
Co-Occurring Disorders
Addiction Technology Transfer
Centers (ATTCs)
Check with your local ATTC. Course offerings
vary. 
• www.nattc.org/regCenters.html
• For distance training offered by ATTCs and
other providers, see www.addictionED.org
• For curricula, lectures, videos, and printed
training materials:
www.nattc.org/resPubs.html (search for co-
occurring disorders)
Formal Continuing Education
COD Curricula 
Several examples follow:
Dual Recovery Project
Houston Community College, University of
Houston, Harris County MHMRA, Houston,
Texas. Contact: (713) 970-7000. 
• trustin@pol.net
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Integrated Program
Development and Clinical
Interventions
Foundations Associates and the Dual Diagnosis
Recovery Network in Nashville, TN provide
specialized training on implementation and
financing of integrated program models and
integrated clinical interventions. Contact: (888)
869-9230.
• www.dualdiagnosis.org; mcartwright@dual-
diagnosis.org
MISA Curriculum
Seven modules, Behavioral Healthcare
Resource Program, University of North
Carolina, School of Social Work. Contact:
(919) 962-1225.
• ssw@unc.edu
National Development and
Research Institutes
NDRI has a COD Curriculum with 10 modules
targeting the generalist. Contact: (646) 638-
2497. 
• www.ndri.org
Washington State Institute
for Mental Health Research
and Training
The institute has extensive training materials
as well as training videotapes on COD.
Contact: (253) 756-2741.
Miscellaneous Training
A variety of training opportunities are listed by
Kathleen Sciacca at 
• users.erols.com/ksciacca/upcom.htm
State-Sponsored Training
Many States have developed model curricula.
Listservs and
Discussion Groups on
Co-Occurring Disorders
The following is a selection of listservs and
discussion groups dealing specifically with the
topic of co-occurring disorders. These online
communication networks offer members the
opportunity to post suggestions or questions
to a large number of people at the same time.
Listservs differ in that they are generally
geared more toward professionals and are
more closely monitored. Discussion groups
are usually open to anyone, and may not be
closely monitored. Submissions to listservs
are distributed to all members, so before sub-
mitting a query or a comment to an entire
listserv group, you may wish to monitor the
discussions. 
CataList—The Official Catalog
of Listserv Lists
CataList, a general resource, is a catalog of
more than 55,000 listserv lists. It allows users
to browse listserv lists, search by keyword for
mailing lists of interest, and obtain information
about listserv host Web sites. CataList contains
information only about public lists; confidential
lists and lists of purely local interest are not in
the searchable database.
• www.lsoft.com/lists/listref.html
Co-Occurring Dialogues
As an expansion of services to the CSAT
Treatment Improvement Exchange on the
Web (www.treatment.org), the Division of
State and Community Assistance has estab-
lished Co-Occurring Dialogues, a listserv
focusing on issues related to dual diagnosis.
Subscription to the Co-Occurring Dialogues
discussion list (dualdx@treatment.org) is free
and unrestricted. Just send an e-mail to
dualdx@treatment.org stating a desire to sub-
scribe. A description of membership, pur-
pose, and utilization will follow your sub-
scription.
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This discussion list belongs to the field.
Membership is open, but the list is moderated,
and CSAT reserves the right to remove any
member who the agency feels is not interacting
in a professional manner. Co-Occurring
Dialogues is offered as a means of communica-
tion, idea sharing, brainstorming, sharing of
exciting publications and opportunities, etc. It
is an open vehicle for communication between
and among researchers, educators, treatment
agencies, the recovery community, treatment
providers, and all levels of government. 
• www.treatment.org/Topics/DualDialogues.html
Dual Diagnosis Bulletin
Board
This subdivision of the Dual Diagnosis Listserv
is a more general discussion area. Visitors can
review postings on the bulletin board by click-
ing on headings of interest, and/or submit
information for posting to the bulletin board.
This area is open to anyone, consumers as well
as professionals, and is not moderated.
• cgibin.erols.com/ksciacca/cgi-bin/bb/
Dual Diagnosis Listserv
This listserv is operated by Dr. Kathleen
Sciacca, Founding Executive Director of
Sciacca Comprehensive Service Development
for Mental Illness, Drug Addiction and
Alcoholism (MIDAA), located in New York
City. The listserv is an extension of the Dual
Diagnosis Web site (users.erols.com/ksciacca),
and is reserved for persons who are creden-
tialed in the mental health and substance abuse
fields and have an interest in the theory, prac-
tice, treatment, systemic change, and program
implementation for dual/multiple disorders in
various combinations. A resume or curriculum
vitae must be submitted in order to subscribe.
Membership is determined at the discretion of
the list manager. Once credential information is
received, members will receive a welcome mes-
sage informing them of acceptance to the list
and instructions on how to post to the forum.
• users.erols.com/ksciacca/ddl.htm
Dual Diagnosis Pages:
Colleagues List
The Colleagues List is a division of The Dual
Diagnosis Pages
(www.toad.net/~arcturus/dd/ddhome.htm), a
general resource Web site for co-occurring
addiction and personality disorders. The
Colleagues List allows professionals to act as
mutually supporting resources. Mental health
and substance abuse treatment professionals
can post a description of themselves and their
qualifications/background so that practitioners
with common interests, issues, or questions can
get in touch with each other.
• www.toad.net/~arcturus/dd/colleag.htm
MIDAS: Discussion Group
MIDAS is a member of the Dual Disorder Web
Ring, and offers a Discussion Group through
Yahoo.com. MIDAS is an Australian site pro-
vided by the South Western Sydney Area
Health Service, but it offers links to programs
and resources around the world. There are no
special conditions for joining the Discussion
Group, and new members are joining all the
time. However, the description given on the
home page freely acknowledges that the group
gets active only from time to time, sometimes
slowing down for months.
• www.swsahs.nsw.gov.au/areaser/Midas/
default.asp
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Appendix J: 
Dual Recovery Mutual 
Self-Help Programs and
Other Resources for
Consumers and Providers
Dual Recovery 12-Step Fellowships
Double Trouble in Recovery
The organization provides 12 steps that are based on a traditional adap-
tation of the original 12 steps. For example, the identified problem in
step one is changed to co-occurring disorders, and the population to be
assisted is changed in step 12 accordingly. The organization provides a
format for meetings that are chaired by members of the fellowship.
Contact information
Double Trouble in Recovery
c/o Mental Health Empowerment Project
271 Central Avenue
Albany, NY 12209
(518) 434-1393
www.doubletroubleinrecovery.org
Dual Diagnosis Anonymous
The organization provides a hybrid approach that developed 5 steps in
conjunction with the traditional 12 steps. The five steps differ from those
of other dual recovery groups in underscoring the potential need for
medical management, clinical interventions, and therapies. The organi-
zation provides a meeting format that is used by fellow members who
chair the meetings.
Contact information
Dual Diagnosis Anonymous
320 North E. Street, Suite 207
San Bernardino, CA 92401
(909) 888-9282
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Dual Disorders Anonymous 
The organization provides 12 steps that are
based on a traditional adaptation of the origi-
nal 12 steps. For example, the identified prob-
lem in step one is changed to co-occurring dis-
orders, and the population to be assisted is
changed in step 12 accordingly. The organiza-
tion provides a format for meetings that are
chaired by members of the fellowship.
Contact information
Dual Disorders Anonymous
P.O. Box 681264
Schaumburg, IL 60168
(847) 781-1553
Dual Recovery Anonymous
The organization provides 12 steps that are an
adapted and expanded version of the tradition-
al 12 steps. The expanded approach changes
the identified problem to co-occurring disor-
ders, and the population to be assisted is
changed accordingly. It also retains most of the
traditional language while modifying certain
terms in an effort to meet the needs of mental
health consumers. In addition, it incorporates
affirmations into three of the 12 steps. The
organization provides a meeting format that is
used by fellow members who chair the meet-
ings.
Contact information
Dual Recovery Anonymous World Services, 
Inc.
P.O. Box 8107
Prairie Village, KS 66208
(877) 883-2332 (toll free)
E-mail: draws@draonline.org
www.draonline.org
Dual Recovery Empowerment
Foundation
This organization offers the program Dual
Recovery Self-Help, which encompasses infor-
mation on dual recovery 12-Step fellowships;
12-Step principles for personal recovery, cop-
ing, and life skills; and forming dual recovery
12-Step groups and meetings.
Contact information
Dual Recovery Empowerment Foundation
P.O. Box 8708
Prairie Village, KS 66208
(615) 504-9797
rwth@kc.rr.com
Supported Mutual
Help for Dual Recovery
Dual Diagnosis Recovery
Network (DDRN)
The DDRN is a program of Foundations
Associates that derives part of its funding from
the Tennessee Department of Mental Health
and Developmental Disabilities, as well as the
Tennessee Department of Health, Bureau of
Alcohol and Drug Abuse Services. DDRN pro-
vides dual recovery mutual help information in
all areas of the services that are offered; educa-
tion and training through community pro-
grams, inservice training, workshops, State,
regional, and national conferences; advocacy
and coalition building through networking and
coordinating a statewide task force that engages
chemical dependency and mental health profes-
sionals, consumers, and family members; pro-
vides information through the Dual Network
quarterly journal and the resource and infor-
mation clearinghouse.
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Contact information
Dual Diagnosis Recovery Network (DDRN)
220 Venture Circle
Nashville, TN 37228
(888) 869-9230
www.dualdiagnosis.org
Support Together for
Emotional/Mental Serenity
and Sobriety (STEMSS) 
STEMSS is a psychoeducational group inter-
vention. The model has been developed to train
facilitators to initiate, implement, and maintain
support groups for consumers. The six steps of
the program and the support groups are
intended to complement participation in tradi-
tional 12-Step programs.
Contact information
Michael G. Bricker, Executive Director
STEMSS Institute and Bricker Clinic
140 E. Dekora Street
Saukville, WI 53080
(414) 268-0899
Other Resources for
Consumers and
Providers
Consumer Organization and
Networking Technical
Assistance Center (CONTAC)
CONTAC distributes a list of names and con-
tacts for resources and information on sub-
stance addictions, co-occurring disorders, ser-
vices, and mutual help support. CONTAC also
offers the Leadership Academy, a training pro-
gram that is designed to help consumers learn
how to engage in and develop consumer ser-
vices. Recently, a training component focusing
on substance abuse/dependence was developed
and incorporated into the program.
Contact information
Consumer Organization and Networking 
Technical Assistance Center (CONTAC)
1036 Quarrier Street, Suite 208A
Charleston, WV 25891
(304) 346-9992 or (888) 825-8324
www.contac.org
National Council on
Alcoholism and Drug
Dependence (NCADD)
NCADD has a nationwide network of nearly
100 affiliates. These affiliates provide informa-
tion and referrals to local services, including
counseling and treatment. NCADD also offers a
variety of publications and resources. 
Contact information
NCADD National Office
20 Exchange Place, Suite 2902
New York, NY 10005
(212) 269-7797
Fax: (212) 269-7510
E-mail: national@ncadd.org 
www.ncadd.org
National Empowerment
Center
The National Empowerment Center has pre-
pared an information packet, which includes a
series of published articles, newspaper articles,
and a listing of organizations and Federal agen-
cies that provide information, resources, and
technical assistance related to substance abuse
and dependence, co-occurring disorders, ser-
vices, and mutual help support.
Contact information
National Empowerment Center
599 Canal Street
Lawrence, MA 01840
(800) 769-3728
www.power2u.org
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National Mental Health
Association 
The National Mental Health Association has
expanded its mission to encompass substance
abuse/addictions and co-occurring disorders.
The organization continues to develop
resources, documents, and publications. A des-
ignated section on the organization’s Web site is
dedicated to co-occurring disorders. 
Contact information
National Mental Health Association
1021 Prince Street
Alexandria, VA 22314-2971
(800) 969-6642
TTY: (800) 433-5959
www.nmha.org
National Mental Health
Consumers’ Mutual Help
Clearinghouse
The organization has developed and offers a
resource kit, which provides the names and
contacts for resources and information on sub-
stance addictions, co-occurring disorders, ser-
vices, and mutual help support.
Contact information
National Mental Health Consumers’ Self-Help
Clearinghouse
1211 Chestnut Street, Suite 1207
Philadelphia, PA 19107
(800) 553-4KEY
www.mhselfhelp.org
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Appendix K:
Confidentiality
Federal Laws and the Right to
Confidentiality
In the early 1970s, Congress recognized that the stigma associated with
substance abuse and fear of prosecution deterred people from entering
treatment. As a result, it enacted legislation that gave clients in a sub-
stance abuse treatment program a right to confidentiality (42 USC
§290dd-2). For the 3 decades since the Federal confidentiality regula-
tions (42 C.F.R. Part 2, or Part 2) were issued in response to the Federal
mandate, confidentiality has been a cornerstone practice for substance
abuse treatment programs across the country.
In December 2000, the Department of Health and Human Services
(DHHS) issued the “Standards for Privacy of Individually Identifiable
Health Information” final rule (Privacy Rule), pursuant to the
Administrative Simplification provisions of the Health Insurance
Portability and Accountability Act of 1996 (HIPAA), 45 C.F.R. Parts
160 and 164, Subparts A and E. Substance abuse treatment programs
that are subject to HIPAA must comply with the Privacy Rule. The
Privacy Rule and other guidance regarding its requirements may be
accessed through the DHHS Office for Civil Rights (OCR) Web site at
www.hhs.gov/ocr/hipaa/. In addition, the Substance Abuse and Mental
Health Services Administration (SAMHSA) has issued guidance titled
“The Confidentiality of Alcohol and Drug Abuse Patient Records
Regulation and the HIPAA Privacy Rule: Implications for Alcohol and
Substance Abuse Programs,” which can be accessed through its Web site
at www.hipaa.samhsa.gov.
How the Two Federal Laws Relate to Each
Other and to State Law
Substance abuse treatment programs need to understand how both
Federal laws—the older substance abuse-specific Part 2 regulations and
the Privacy Rule—apply to their programs. 
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Applicability
Part 2
Part 2 applies to all programs (individuals or
organizations) specializing, in whole or in part,
in providing treatment, counseling, or assess-
ment and referral services for substance use
disorders (§§2.11, 2.12(e)). (Any citations in
this appendix that begin with §2 refer to sec-
tions of 42 C.F.R. Part 2.) Part 2 applies only
to programs that receive Federal assistance,
including indirect forms of Federal aid, such as
tax-exempt status or State or local government
funding that is from (in whole or in part) the
Federal government or any form of Medicaid
or Medicare funding for any purpose.
Privacy Rule
The Privacy Rule applies to healthcare
providers (persons or organizations that fur-
nish, bill, or are paid for health care in the
normal course of business) who transmit health
information
• In electronic form (generally, via computer-
based technology) and
• In connection with transactions for which
DHHS has adopted a HIPAA standard, such
as submitting healthcare claims to Medicaid
or private payors. 
Drug and alcohol programs are healthcare
providers because they furnish health care in
the normal course of business. However, only
those programs that transmit health informa-
tion in electronic form and in connection with a
HIPAA transaction, such as a healthcare claim,
are subject to the Privacy Rule (such pro-
grams, along with health plans and healthcare
clearinghouses, are HIPAA “covered entities”).
(For a list of the HIPAA transactions for which
standards have been adopted, see 45 C.F.R.
Part 162. Note that once a program is subject
to HIPAA, all “protected health information”
[see below] that the program transmits or
maintains about individuals is covered by the
Privacy Rule—whether the information is in
oral, written, or electronic form.)
Information protected
Part 2 requirements
The Part 2 requirements
• Apply to information about any individual
who has applied for or received any sub-
stance-abuse–related assessment, treatment,
or referral services and prohibit all disclo-
sures of information about that person that
are not specifically permitted by nine limited
exceptions.
• Are more restrictive of communications in
many instances than either the
doctor–patient or the attorney–client privi-
lege.
• Apply to information about current and for-
mer clients from the time they make an
appointment and apply to any information
that would identify them as individuals who
use substances either directly or by implica-
tion.
• Apply to information about clients who are
mandated into treatment as well as to infor-
mation about those who enter treatment vol-
untarily.
• Apply whether the person seeking informa-
tion already has that information, has other
ways of getting it, has some form of official
status, is authorized by State law, or comes
armed with a subpoena or search warrant. 
• Violating Part 2 is punishable by a fine of up
to $500 for a first offense and up to $5,000
for each subsequent offense (§2.4).
Privacy Rule requirements
Under the Privacy Rule, a program may not
use or disclose protected health information
except as permitted or required by the Rule.
See 45 C.F.R. §164.502(a). Protected health
information is defined as individually identifi-
able health information held or transmitted by
a covered entity or its “business associate,”
with limited exceptions. See 45 C.F.R.
§160.103. It does not include such information
in employment records or in certain education-
al records. The Privacy Rule permits disclo-
sures in many circumstances in which Part 2
would not. Most importantly, the Privacy Rule
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does not require that the client consent to dis-
closures made for “treatment, payment or
health care operations” (§§164.502(a)(1)(ii);
164.506(c)). (Citations in the form §164. . .
refer to sections in 45 C.F.R. Part 164.) Part 2
requires client consent for almost all such dis-
closures. There are civil and criminal penalties
for violations of the Privacy Rule. 
State laws and regulations
Covered entities will usually be able to comply
with both Privacy Rule and applicable State
law provisions. However, there may be situa-
tions in which the provisions of the Privacy
Rule and State law are contrary, which gener-
ally means the covered entity would find it
impossible to comply with both. If contrary, the
Privacy Rule overrides State law, unless the
State law is more stringent; that is, unless the
State law provides greater privacy protection
for the individual who is the subject of the pro-
tected health information. If the State law is
more stringent, programs must comply with the
State law. A Privacy Rule provision would also
not prevail over a contrary State law provision
where DHHS had granted an exception.
Working with both sets of
regulations
Substance abuse treatment programs that are
already complying with Part 2 should not have
a difficult time complying with the Privacy
Rule, as it parallels the requirements of Part 2
in many areas. Programs subject to both sets of
rules must comply with both, unless there is a
conflict between them. Generally, this will
mean that substance abuse treatment programs
should continue to follow Part 2. In some
instances, programs will have to establish new
policies and procedures or alter existing poli-
cies and procedures.
Security of records 
Part 2 requires programs to maintain written
records in a secure room, a locked file cabinet,
a safe, or other similar container. It requires
programs to adopt written procedures to regu-
late access to and use of clients’ records. Either
the program director or a single staff person
should be designated to process inquiries and
requests for information (§2.16).
Section 164.530(c) of the Privacy Rule requires
programs that are covered entities to maintain
reasonable and appropriate administrative,
technical, and physical safeguards to protect
the privacy of protected health information.
The issue of security is addressed in more
detail through a separate Security Rule issued
by DHHS on February 20, 2003, that establish-
es the administrative, physical, and technical
safeguards required to guard the integrity, con-
fidentiality, and availability of protected health
information that is electronically stored, main-
tained, or transmitted. See 45 C.F.R. §164.306.
Alcohol and substance abuse programs that are
covered entities must be in compliance with the
Security Rule by April 20, 2005. The Security
Rule can be accessed through the Centers for
Medicare and Medicaid Services Web site at
www.cms.hhs.gov.
More information can be obtained from the
technical assistance publication “The
Confidentiality of Alcohol and Drug Abuse
Patient Records Regulation and the HIPAA
Privacy Rule: Implications for Alcohol and
Substance Abuse Programs,” which can be
found at www.hipaa.samhsa.gov. For printed
copies, contact SAMHSA’s Health Information
Network at (800) 729-6686 or (301) 468-2600;
TDD (for hearing impaired) (800) 487-4889. 
525Confidentiality

Appendix L: 
Resource Panel 
Robert E. Anderson
Director 
Research and Program Applications 
National Association of State Alcohol and Drug Abuse Directors 
Washington, DC
Nancy Bateman, LCSW-C, CAC
Senior Staff Associate
Division of Professional Development and Advocacy
National Association of Social Workers
Washington, DC
James F. Callahan, D.P.A.
Executive Vice President
American Society of Addiction Medicine 
Chevy Chase, Maryland
Frank Canizales, M.S.W. 
Management Analyst, Alcohol Program 
Division of Clinical and Preventive Services
Indian Health Service
Rockville, Maryland
Cathi Coridan, M.A. 
Senior Director for Substance Abuse Programs and Policy
National Mental Health Association
Alexandria, Virginia
Jennifer Fiedelholtz
Public Health Analyst 
Office of Policy and Program Coordination
Substance Abuse and Mental Health Services Administration
Rockville, Maryland
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Ingrid D. Goldstrom, M.Sc.
Center for Mental Health Services
Rockville, Maryland 
Lynne M. Haverkos, M.D., M.P.H.
Program Director
Behavioral Pediatrics and Health Promotion
Research Program
National Institute of Child Health and 
Human Development
Bethesda, Maryland
Edward Hendrickson, LMFT, MAC
Clinical Supervisor
Arlington County Mental Health and 
Substance Abuse Services Division 
Arlington, Virginia 
Kevin D. Hennessy, Ph.D.
Senior Health Policy Analyst
Office of the Assistant Secretary
for Planning and Evaluation 
Department of Health and Human Services
Washington, DC 
James (Gil) Hill, Ph.D.
Director
Office of Rural Health and Substance Abuse
American Psychological Association
Washington, DC
Hendree E. Jones, Ph.D.
Assistant Professor
Department of Psychiatry and Behavioral
Sciences
Johns Hopkins University Center
Baltimore, Maryland
Diane M. Langhorst 
Clinical Supervisor
Substance Abuse Services 
Henrico Area Mental Health 
and Retardation Services
Richmond, Virginia
Tom Leibfried, M.P.A.
Vice President of Government Relations
National Council for Community Behavioral
Healthcare
Rockville, Maryland
James J. Manlandro, D.O.
Director 
Family Addiction Treatment Services, Inc. 
Dennisville, New Jersey 
Julia W. Maxwell, L.I.C.S.W., C.A.S.
Branch Director
Mental Health Addiction and Services
Branch
Commission on Mental Health Services
District of Columbia 
Washington, DC 
William F. Northey, Jr., Ph.D.
Research Specialist
American Association for Marriage and 
Family Therapy
Alexandria, Virginia
Fred C. Osher, M.D. 
Director 
Center for Behavioral Health, Justice
and Public Policy 
University of Maryland 
Jessup, Maryland 
Terry C. Pellmar, Ph.D. 
Director 
Board on Neuroscience and Behavioral
Health
Institute of Medicine 
Washington, DC
Ernst Quimby, Ph.D. 
Associate Professor
Department of Sociology 
and Anthropology
Howard University
Washington, DC
Susan E. Salasin
Director
Mental Health and Criminal Justice 
Program
Center for Mental Health Services
Rockville, Maryland
Laurel L. Stine, J.D., M.A.
Director of Federal Relations
Bazelon Center for Mental Health Law
Washington, DC
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Richard T. Suchinsky, M.D.
Associate Director for Addictive Disorders
and Psychiatric Rehabilitation
Mental Health and Behavioral Sciences
Services
Department of Veterans Affairs
Washington, DC
Jan Towers, Ph.D., CRNP
Director
Health Policy
American Academy of Nurse Practitioners
Washington, DC
Steve Wing
Senior Advisor for Drug Policy
Office of Policy and Program Coordination
Substance Abuse and Mental Health
Services Administration
Rockville, Maryland
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Appendix M: 
Cultural Competency
and Diversity Network
Participants
Raymond Daw, M.A.
Executive Director 
Na’nizhoozhi Center, Inc.
Gallup, New Mexico 
Disabilities Work Group 
Michael I. Fingerhood, M.D., FACP 
Associate Professor 
Department of Medicine
Center for Chemical Dependence
School of Medicine
Johns Hopkins Bayview Medical Center
Baltimore, Maryland
Aging Work Group 
Ting-Fun May Lai, M.S.W., CSW, CASAC
Director
Chinatown Alcoholism Center
Hamilton-Madison House
New York, New York
Asian and Pacific Islanders Work Group
Antony P. Stephen, Ph.D.
Executive Director
Mental Health & Behavioral Sciences
New Jersey Asian American Association for Human Services, Inc.
Elizabeth, New Jersey
Asian and Pacific Islanders Workgroup
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Richard T. Suchinsky, M.D. 
Associate Chief for Addictive Disorders 
and Psychiatric Rehabilitation
Mental Health and Behavioral Sciences 
Services
Department of Veterans Affairs
Washington, DC
Disabilities Work Group
Ann S. Yabusaki, Ph.D.
Director
Coalition for a Drug-Free Hawaii
Honolulu, Hawaii
Asian and Pacific Islanders Work Group
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Appendix N:
Field Reviewers
Calvin Baker
Addicted Homeless Project
Program Coordinator
Division of Addictions and Mental Health
Prince George’s County Health Department
Forestville, Maryland
Richard J. Bilangi, M.S.
Executive Director/President
Connecticut Counseling Centers, Inc. 
Middlebury, Connecticut
Dennis L. Bouffard, Ph.D.
Program Manager
Connecticut Valley Hospital
Addiction Services Division
Middletown, Connecticut
Kim P. Bowman, M.S.
Executive Director
Chester County Department of Drug and Alcohol Services
West Chester, Pennsylvania
Patricia Hess Bridgman, M.A., CCDC III-E
Associate Director
Ohio Council of Behavioral Healthcare Providers
Columbus, Ohio
Barry S. Brown, Ph.D.
Adjunct Professor
University of North Carolina at Wilmington
Carolina Beach, North Carolina
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Vivian B. Brown, Ph.D.
President/Chief Executive Officer
PROTOTYPES
Culver City, California
Tamara J. Cadet, M.S.W., MPH
Web Content Manager
Free to Grow: Head Start Partnerships to 
Promote Substance-Free Communities
Columbia University
Andover, Massachusetts
Sharon M. Cadiz, Ed.D.
Senior Director of Special Projects
Project Return Foundation, Inc.
New York, New York
Jerome F.X. Carroll, Ph.D.
Private Practice
Brooklyn, New York
Bruce Carruth, Ph.D., LCSW
Private Practice
Laredo, Texas
Michael Cartwright, Ph.D.
Executive Director
Foundations Associates
Nashville, Tennessee
Catherine S. Chichester, M.S.N., R.N., CS
Executive Director
Co-Occurring Collaborative of Southern 
Maine
Portland, Maine
Carol Coley, M.S., CAPT, USPHS
Senior Program Management Advisor
Division of State and Community Assistance
Systems Improvement Branch
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services 
Administration
Rockville, Maryland
Margaret A. Cramer, Ph.D.
Clinical Psychologist/Instructor
Melrose, Massachusetts
George De Leon, Ph.D. 
Director 
Center for Therapeutic Community Research
National Development and Research 
Institutes, Inc.
New York, New York
Janice M. Dyehouse, Ph.D., R.N., M.S.N.
Professor and Department Head
College of Nursing
University of Cincinnati
Cincinnati, Ohio
Benjamin M. Eiland, M.A., CATS, EAP
Director of Substance Abuse Services
Haight Ashbury Free Clinic
San Francisco, California
Dorothy J. Farr
Clinical Director 
Bucks County Drug and Alcohol 
Commission, Inc.
Warminster, Pennsylvania
Michael I. Fingerhood, M.D., FACP
Associate Professor
Department of Medicine
Center for Chemical Dependence
School of Medicine
Johns Hopkins Bayview Medical Center
Baltimore, Maryland
Jerry P. Flanzer, D.S.W., LCSW, CAC
Chief, Services
Division of Clinical and Services Research
National Institute on Drug Abuse
Bethesda, Maryland
Byron N. Fujita, Ph.D.
Senior Psychologist
Clackamas County Mental Health Center
Oregon City, Oregon
Gerard Gallucci, M.D., M.H.S.
Medical Director
Community Psychiatry Program
Bayview Medical Center
Johns Hopkins University
Baltimore, Maryland
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Mary Gillespie, Psy.D., CASAC
Psychologist
Saratoga Springs, New York
Karen Scott Griffin, M.S.
Director of Administration
Gaudenzia, Inc.
Norristown, Pennsylvania
Valerie A. Gruber, Ph.D., M.P.H.
Assistant Clinical Professor
University of California, San Francisco
San Francisco, California
Nancy Handmaker, Ph.D.
Professor
Department of Psychology
The University of New Mexico
Albuquerque, New Mexico
Edward Hendrickson, LMFT, MAC
Clinical Supervisor
Arlington County MHSASD
Arlington, Virginia
David Hodgins, Ph.D.
Professor 
Department of Psychology
University of Calgary
Calgary, Canada
Kimberly A. Johnson
Director
Maine Office of Substance Abuse
Augusta Mental Health Complex
Augusta, Maine
Edith Jungblut
Public Health Advisor
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services 
Administration
Rockville, Maryland
George A. Kanuck
Public Health Analyst
Co-Occurring and Homeless Branch
Division of State and Community Assistance
Center for Substance Abuse Treatment
Rockville, Maryland
Michael W. Kirby, Jr., Ph.D.
Chief Executive Officer
Arapahoe House, Inc.
Thornton, Colorado
Daniel R. Kivlahan, Ph.D.
Director
VA Center of Excellence in Substance Abuse 
Treatment and Education
VA Puget Sound Health Care System
Seattle, Washington
Ting-Fun May Lai, M.S.W., CSW, CASAC
Director
Chinatown Alcoholism Services
New York, New York
Linda Lantrip, D.O., R.N.
Medical Director
Central Oklahoma Community
Mental Health Center
Norman, Oklahoma
Robert M. Long, M.S., LCDC, LADC
Director of Substance Abuse and Dual 
Diagnosis Services
Kennebee Valley Mental Health Center
Augusta, Maine
Russell P. MacPherson, Ph.D., CAP, CAPP,
CCP, CDVC, DAC
President
RPM Addiction Prevention Training
Sanford, Florida
Philip R. Magaletta, Ph.D.
Clinical Training Coordinator
Federal Bureau of Prisons
Washington, DC
G. Alan Marlatt, Ph.D.
Professor of Psychology
Director, The Addictive Behaviors 
Research Center
University of Washington
Seattle, Washington
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Julia W. Maxwell, LICSW, CAS
Branch Manager
Department of Mental Health/
Community Services
Mental Health and Addiction Services
St. Elizabeth’s Campus
Washington, DC
Frank A. McCorry, Ph.D.
Director
Clinical Services Unit
N.Y.S. Office of Alcoholism and Substance 
Abuse Services
New York, New York
Gregory J. McHugo, Ph.D.
Research Associate Professor
Dartmouth Medical School
NH-Dartmouth Psychiatric Research Center
Lebanon, New Hampshire
David Mee-Lee, M.D., FASAM
DML Training and Consulting
Davis, California
Kenneth Minkoff, M.D.
Medical Director
Choate Health Management
Woburn, Massachusetts
Theresa Moyers, Ph.D.
Assistant Research Professor
Department of Psychology
University of New Mexico
Albuquerque, New Mexico
Ethan Nebelkopf, Ph.D., MFCC
Clinic Director
Family and Child Guidance Center
Native American Health Center
Oakland, California
Gwen M. Olitsky, M.S.
Chief Executive Officer
The Self-Help Institute for Training and 
Therapy 
Lansdale, Pennsylvania
Thomas A. Peltz, M.Ed., LMHC, CAS
Therapist
Private Practice
Beverly Farms, Massachusetts
Stephanie W. Perry, M.D.
Assistant Commissioner of Health
Bureau of Alcohol and Drug Abuse Services
Tennessee Department of Health
Nashville, Tennessee
Lawrence D. Rickards, Ph.D.
Co-Occurring Disorders Program Manager
Homeless Programs Branch
Center for Mental Health Services
Substance Abuse and Mental Health Services 
Administration
Rockville, Maryland
Jeffery L. Rohacek, M.S., CASAC
Psychologist II
McPike Addiction Treatment Center
Utica, New York
Edwin M. Rubin, Psy.D.
Psychologist
Aurora Behavioral Health Services
Aurora Health Care
Milwaukee, Wisconsin
Theresa Rubin-Ortiz, LCSW 
Clinical Director
Bonita House, Inc.
Oakland, California
Margaret M. Salinger, M.S.N., R.N., CARN
Unit/Program Manager
Coatesville VA Medical Center
Coatesville, Pennsylvania
Steven V. Sawicki
Assistant Program Director 
Center for Human Development
Connecticut Outreach-West
Waterbury, Connecticut
Anna M. Scheyett, M.S.W., LCSW, CASWCM
Clinical Assistant Professor
School of Social Work
University of North Carolina
Chapel Hill, North Carolina
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Marilyn S. Schmal, M.A., CSAC
Mental Health Therapist II
Arlington County Mental Health 
Substance Abuse Services
Arlington, Virginia
Darren C. Skinner, Ph.D., LSW, CAC
Director
Gaudenzia, Inc.
Gaudenzia House West Chester
West Chester, Pennsylvania
David E. Smith, M.D.
Founder and President
Haight Ashbury Free Clinics, Inc.
San Francisco, California
Antony P. Stephen, Ph.D.
Executive Director 
Mental Health and Behavioral Sciences
New Jersey Asian American Association for 
Human Services, Inc.
Elizabeth, New Jersey
Norm Suchar
Program and Policy Analyst 
National Alliance to End Homelessness
Washington, DC
Richard T. Suchinsky, M.D.
Associate Chief for Addictive Disorders 
and Psychiatric Rehabilitation
Mental Health and Behavioral Science 
Services
Department of Veterans Affairs
Washington, DC
Kimberly N. Sutton, Ph.D.
Director/Associate Professor of Psychiatry
Cork Institute on Alcohol and Other Drug 
Abuse
Morehouse School of Medicine
Atlanta, Georgia
Mary Lynn Ulrey, M.S., ARNP
Chief Operating Officer
Operation PAR, Inc.
Pinellas Park, Florida
Robert Walker, M.S.W., LCSW
Assistant Professor
Center on Drug and Alcohol Research
University of Kentucky
Lexington, Kentucky
Verner Stuart Westerberg, Ph.D.
President 
Addiction Services Research
Albuquerque, New Mexico
Aline G. Wommack, R.N., M.S.
Deputy Director 
Division of Substance Abuse and Addiction 
Medicine
UCSF Deputy Department of Psychiatry 
San Francisco, California
Ann S. Yabusaki, Ph.D.
Director 
Coalition for a Drug-Free Hawaii
Honolulu, Hawaii
Mariko Yamada, LCSW
Clinical Supervisor 
Asian American Drug Abuse Program Inc.
Gardena, California
Debby Young
Windsor, California
Joan E. Zweben, Ph.D.
Executive Director 
East Bay Community Recovery Project
University of California
Berkley, California
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5 A’s for smoking cessation, 217–218, 343
5 Rs for smoking cessation, 339
12-Step groups. See mutual self-help groups
42 C.F.R. Part 2, 45, 75, 357, 398, 505, 523
A
Access to Community Care and Effective
Services and Supports initiative, 9
access to services, 41
acute care settings, 184
accessing services in, 187
funding streams, 190
screening and assessment in, 186–187
acute stress disorder, 372
Addiction and Trauma Recovery Integration
Model, 208
addiction only services, 33
AD/HD. See attention deficit hyperactivity
disorder
AD/HD Behavior Checklist for Adults, 407
adherence, in outpatient settings, 147
advanced assessment techniques, 78
advanced clinician competencies, 57, 60
advocacy, 54, 148
consumer, 196
for dual recovery, 194
agency assessment, 48, 51
aftercare. See continuing care
alcohol, as cause of disorders, 250
withdrawal symptoms, 250
alcohol myopia, 328
alternative classification system for 
programs, 43
American Academy of Addiction Psychiatry,
140
American Osteopathic Association, 140
American Psychiatric Publishing, Inc., 18
American Society of Addiction Medicine. See
ASAM
anniversary reactions, 356
anorexia nervosa. See eating disorders
antisocial personality disorder, 224–226, 350
antisocial thinking-error work, 368
assessment, 364
case management, 367
case study, 224–226
characteristics of, 350
contracting, 364, 366
crisis stabilization, 365
diagnostic features and criteria, 225, 
359–362
engagement, 364
group therapy, 366
prevalence data, 224
resistance, 363
rule breaking, 369
sanctions, 369
step work handout, 360–361
strategies for working with, 366, 367
terminating counseling, 367
anxiety disorders, 26, 226, 369, 370. See also
individual disorders
assessment, 377–378
caffeine-induced, 251
case study, 378, 379, 383, 384
crisis stabilization, 378–380
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Notes: Because the entire volume is about substance abuse treatment and co-occurring disorders
(COD), the use of these terms as entry points has been minimized in this index. Tools and instru-
ments are listed by their commonly known acronyms. Reference locators for information con-
tained in figures appear in italics.
diagnostic features and criteria, 230
diagnostic process, 372
differential diagnosis, 372
engagement, 377
and mutual self-help groups, 382
in other disorders, 372–373
prevalence data, 226
screening, 377–378
and substance use, 373, 375–376
Arapahoe House, 145, 146, 152, 154
ASAM (American Society of Addiction
Medicine), 140
patient placement criteria, 3, 27–28, 33,
42, 71, 75, 83, 84, 143
ASI (Addiction Severity Index), 68, 75, 80,
90, 163, 169, 331, 487
Assertive Community Treatment (ACT), 9,
13, 147, 152–157
as compared to Intensive Case 
Management, 159
empirical evidence for, 156
essential features of, 156
modifications for integrating COD, 155
recommendations for successful use, 160
and supportive housing, 198
assessment, 42, 67, 138
in acute care settings, 186–187
agency, 48, 51
for antisocial personality disorder, 364
for anxiety disorders, 377–378
for attention deficit/hyperactivity 
disorder, 405
for borderline personality disorder, 356
considerations, 74
defined, 66, 68
as different from screening, 68
dimensions of, 84
for eating disorders, 422–423
instruments, 68, 69, 78–82, 150
for mood and anxiety disorders, 377–378
needs, 48
for nicotine dependence, 339–343
in outpatient settings, 145–146
for pathological gambling, 430
person-centered, 73
for posttraumatic stress disorder, 415
process, 71
for psychosis, 390
in residential settings, 163
validity of, 66
assessment steps, 72
step 1, engage the client, 72–74
step 2, identify collaterals, 74–75
step 3, screen for COD, 75–82
step 4, determine quadrant of care, 82–84
step 5, determine level of care, 84–85
step 6, determine diagnosis, 86–89
step 7, determine disability, 89–91
step 8, identify strengths and supports,
91–92
step 9, identify cultural needs, 92–93
step 10, identify problem domains, 93–94
step 11, determine stage of change, 94–95
step 12, plan treatment, 95–96
Association of Problem Gambling Service
Administrators, 428
attention deficit/hyperactivity disorder,
235–237, 402
case management, 407
case study, 235–237
crisis stabilization, 406
diagnostic features and criteria, 236–237
differential diagnosis, 403
engagement, 404–405
instruments, 406–407
prevalence, 403–404
psychoeducation, 407
screening and assessment, 405
symptom clusters, 403
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attitudes and values, provider, 56, 57
audience for this TIP, 16
AUDIT (Alcohol Use Disorders Identification
Test), 81, 488
avoidant personality disorder, 351
B
BAI (Beck Anxiety Inventory), 78, 378
barriers, 195
cultural and linguistic, 93
to integrated care, 188
systemic, 47, 139
to treatment for women, 203
basic clinician competencies, 56–57, 58
basic program, 43
BDI (Beck Depression Inventory), 69, 169
BDI-II (Beck Depression Inventory-II), 78,
378, 488
behavioral disconnects, for smoking cessa-
tion, 345
benefits management, 122
Binge-Eating Disorder, 418
bipolar disorder, 26, 370, 385, 386
case study, 229–231, 401–402
cocaine-induced symptoms of, 251
as compared to schizophrenia, 388
manic episodes, 387
prevalence, 389
and schizophrenia, 390
and substance use, 389–390
block grant requirements, 48
borderline personality disorder, 220–224,
350, 353
and anger management, 358
case study, 222
characteristics of, 350
crisis stabilization, 357
diagnostic features and criteria, 223
group therapy, 357
engagement, 355
recovery rate, 355
screening and assessment, 356
and substance abuse, 354
Bridging the Gap Between Research and
Practice, 55
brief reactive psychosis, 386
BSI-18 (Brief Symptom Inventory-18), 80
bulimia nervosa. See eating disorders
burnout, staff, 62
C
caffeine-induced anxiety, 251
CAGE questionnaire, 81, 489
Carlisle Foundation, 53
case studies
antisocial personality disorder, 224–226
anxiety disorders, 378, 379, 383, 384
attention deficit/hyperactivity disorder, 
235–237
bipolar disorder, 229–231, 401–402
borderline personality disorder, 222
cognitive–behavioral therapy, 127
Contingency Management, 124
diagnosis, 86, 87
disability, determination of, 89, 90
eating disorders, 242–245
identifying cultural needs, 92, 93
level of care placement, 84
mood disorders, 378, 379, 383, 384
motivational enhancement therapy, 121
mutual self-help groups, 136
nicotine dependence, 219–220
pathological gambling, 247–248, 431, 433,
435
posttraumatic stress disorder, 238–240,
416
problem domains, identifying, 93
psychosis, 395, 396, 400, 401
quadrants of care, 83
Relapse Prevention Therapy, 134
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repetition, 135
schizophrenia, 233–235
stages of change, 94
strengths and supports, identifying, 91
suicidality, 216
treatment planning, 69, 70
Catalog of Federal Domestic Assistance, 52
Center for Mental Health Services Managed
Care Initiative Panel, 38
centralized intake, 146
certification, 63
limitations of authority, 66
challenges in working with clients with COD,
103–104
Change Book: A Blueprint for Technology
Transfer, The, 152
“change talk,” 114–115
Changing the Conversation, 11, 55
Chevron Foundation, 53
child care, 203
CINA (Clinical Institute Narcotic
Assessment), 76
CIWA-Ar (Clinical Institute Withdrawal
Assessment), 76, 490
Clackamas County 
Mental Health Center, 145, 152, 153
program for persons in jails, 202
classification system, alternative, 43
client 
empowerment, 105
engagement, 39, 72
history, 86–88
role of, 126
Client Behavior Checklist, 405
Clinical Practice Guidelines on Treating
Tobacco Use and Dependence, U.S. Public
Health Service, 218
Clinical Trials Network, NIDA, 80, 112
clinician 
comfort level with client, 102–103
competencies, 56–57
role of, 126
clusters, DSM-IV, 24, 349–351
CMR scales (Circumstances, Motivation, and
Readiness), 105, 489
cocaine, as cause of disorders, 251
COD 
certification, 62
defined, 3, 26–27
terminology, 3
coercion, therapeutic, 394
cognitive–behavioral therapy, 125–127, 377,
433
case study, 127
cognitive impairments, 40, 133
collaboration
between recovery movements, 196
between substance abuse and mental 
health agencies, 145
defined, 45
collaterals, 67, 74–75, 365, 392, 431
Colorado Prison program, 203
Community Action Grants, 13
community building, 40
Community Connections, 209
community reintegration, 41
competencies
basic, 56–57, 58
integrated, 32
intermediate, 57, 59
Comprehensive Continuous Integrated
System of Care model, 35, 38
comprehensive services, 46
comprehensive system of care, 50
confidentiality, 45, 75, 357, 398, 505, 523
confrontation, 109–110, 169, 365
confused bias, 191
Conners Abbreviated Symptom
Questionnaire, 405
Conners Continuous Performance Test, 406
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consensus guidelines, State, 58
consultation, 138
defined, 45
psychopharmacologic, 149
Consumer Advisory Group, 143
Consumer Organization and Networking
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What Is a TIP?
Treatment Improvement Protocols (TIPs) are the products of a systematic and innovative process that brings together clinicians,
researchers, program managers, policymakers, and other Federal and non-Federal experts to reach consensus on state-of-the-art treatment
practices. TIPs are developed under CSAT’s Knowledge Application Program to improve the treatment capabilities of the Nation’s alcohol
and drug abuse treatment service system.
What Is a Quick Guide?
A Quick Guide clearly and concisely presents the primary information from a TIP in a pocket-sized booklet. Each Quick Guide is divided
into sections to help readers quickly locate relevant material. Some contain glossaries of terms or lists of resources. Page numbers from the
original TIP are referenced so providers can refer back to the source document for more information.
What Are KAP Keys?
Also based on TIPs, KAP Keys are handy, durable tools. Keys may include assessment or screening instruments, checklists, and summaries
of treatment phases. Printed on coated paper, each KAP Keys set is fastened together with a key ring and can be kept within a treatment
provider’s reach and consulted frequently. The Keys allow you—the busy clinician or program administrator—to locate information easily
and to use this information to enhance treatment services.
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This TIP, Substance Abuse Treatment for Persons With 
Co-Occurring Disorders, revises TIP 9, Assessment and Treatment
of Patients With Coexisting Mental Illness and Alcohol and Other
Drug Abuse. The revised TIP provides information about new
developments in the rapidly growing field of co-occurring 
substance use and mental disorders and captures the state-of-
the-art in the treatment of people with co-occurring 
disorders. The TIP focuses on what the substance abuse treat-
ment clinician needs to know and provides that information in
an accessible manner. The TIP synthesizes knowledge and
grounds it in the practical realities of clinical cases and real situ-
ations so the reader will come away with increased knowledge,
encouragement, and resourcefulness in working with clients
with co-occurring disorders.
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